<SEC-DOCUMENT>0000021076-22-000035.txt : 20221101
<SEC-HEADER>0000021076-22-000035.hdr.sgml : 20221101
<ACCEPTANCE-DATETIME>20221101164508
ACCESSION NUMBER:		0000021076-22-000035
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		66
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221101
DATE AS OF CHANGE:		20221101

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CLOROX CO /DE/
		CENTRAL INDEX KEY:			0000021076
		STANDARD INDUSTRIAL CLASSIFICATION:	SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842]
		IRS NUMBER:				310595760
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-07151
		FILM NUMBER:		221351095

	BUSINESS ADDRESS:	
		STREET 1:		THE CLOROX COMPANY
		STREET 2:		1221 BROADWAY
		CITY:			OAKLAND
		STATE:			CA
		ZIP:			94612-1888
		BUSINESS PHONE:		5102717000

	MAIL ADDRESS:	
		STREET 1:		P.O. BOX 24305
		CITY:			OAKLAND
		STATE:			CA
		ZIP:			94612-1305
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>clx-20220930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:705545e2-87bd-4296-a317-b2dac9e841f3,g:2063eff2-ec82-44e0-90e5-b1eb8fc3164f,d:bdb9440a3c394a6fb2a08b0b51efadd4--><html xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:clx="http://www.clorox.com/20220930" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>clx-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80L2ZyYWc6MDdhOTgxYzk0MmI5NGRlMzllYWNlODRjYWZlMjEwYmEvdGFibGU6MzBiNzI3ZjYxZjk5NDNkZmJjODY1NDBlYmIwNjFlMDEvdGFibGVyYW5nZTozMGI3MjdmNjFmOTk0M2RmYmM4NjU0MGViYjA2MWUwMV8zLTEtMS0xLTYyNzEz_529958f3-ab63-4475-b739-b5f805460759">0000021076</ix:nonNumeric><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80L2ZyYWc6MDdhOTgxYzk0MmI5NGRlMzllYWNlODRjYWZlMjEwYmEvdGFibGU6MzBiNzI3ZjYxZjk5NDNkZmJjODY1NDBlYmIwNjFlMDEvdGFibGVyYW5nZTozMGI3MjdmNjFmOTk0M2RmYmM4NjU0MGViYjA2MWUwMV80LTEtMS0xLTYyNzEz_c245c13d-87b3-4936-b847-946bf9caac6e">false</ix:nonNumeric><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80L2ZyYWc6MDdhOTgxYzk0MmI5NGRlMzllYWNlODRjYWZlMjEwYmEvdGFibGU6MzBiNzI3ZjYxZjk5NDNkZmJjODY1NDBlYmIwNjFlMDEvdGFibGVyYW5nZTozMGI3MjdmNjFmOTk0M2RmYmM4NjU0MGViYjA2MWUwMV81LTEtMS0xLTYyNzEz_3f9da604-9201-4c3b-a8a1-a48d742026fd">6/30</ix:nonNumeric><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80L2ZyYWc6MDdhOTgxYzk0MmI5NGRlMzllYWNlODRjYWZlMjEwYmEvdGFibGU6MzBiNzI3ZjYxZjk5NDNkZmJjODY1NDBlYmIwNjFlMDEvdGFibGVyYW5nZTozMGI3MjdmNjFmOTk0M2RmYmM4NjU0MGViYjA2MWUwMV82LTEtMS0xLTYyNzEz_b9cae450-2b6a-437e-8376-90e187141576">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80L2ZyYWc6MDdhOTgxYzk0MmI5NGRlMzllYWNlODRjYWZlMjEwYmEvdGFibGU6MzBiNzI3ZjYxZjk5NDNkZmJjODY1NDBlYmIwNjFlMDEvdGFibGVyYW5nZTozMGI3MjdmNjFmOTk0M2RmYmM4NjU0MGViYjA2MWUwMV83LTEtMS0xLTYyNzEz_207f4b4f-1938-4c6d-be96-d36772d43665">2023</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="clx-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e30c8ce95e6400b80f612d2b95a4680_I20221018"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ief9b7921268144ca978e6451b72f275f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if09ffc76813043a5aa916a91f25540db_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife6845f640b94b6d9b3a46784145e347_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i904c9b98d4a249328732ea1955c73b79_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34328a2b14f04362ad52a7edbae327fa_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd000e11a868483ca61bafef62dbda9f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47cf58703a824db8a0117fad3f780179_I20230630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09ad333c626b4d51be54887b41e252f1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">clx:CostOfGoodsAndServicesSoldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib61f3f9358bc4648a900ad8d686db004_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63f8e80373f44df188b7b0bba1958467_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">clx:OtherIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f9e22509a6d450fa6331417e37243f0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i341aba281f28491c9e0f804508f61995_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iace90036b5d84d608091db4139e10cb0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a0251ee71ad46aab3436fb41074e067_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i407e5b359a574869b044cdc2231bcc94_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id07f895c223b44f0af02d5bca7906d74_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id33bf162891042b581228081b2a7c697_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e8a89c05a0a4a16b4de18869bfd695f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b924fb632f04f0c94baf25d9aae883e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib118d948faed49dea943620ecb2804d1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">clx:PurchasesofInventoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba5d16b63ef34671b972df411f72c26c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">clx:PurchasesofInventoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87647bbf68694e6cb56844238655ccb6_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f677fe19c1746429e18febc5f25cfea_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7eed42a98cdf4c8484f4d6f50ba27c2c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89d66606b3294de5be2599b89449703f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc00d18fe4de47a698a3a7bc531123de_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5e13b9874e848cf9b0bb2bdda02efbd_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21899b87bd5e4a699970017caa794236_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i767f12083ea54bc4a43b4049513c1a15_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i179d67c234714ee4907a95545f754ed4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2217e4efada64de48ae6279d4cff1f35_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i830d873fccfc4a348844a4a1ec805c4e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2066cd30a255497092b1965c041e9697_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9d03b4e69154fb28b379075df843c40_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6332a61aea924b20b5a7f810ba642def_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i224d9fac5a284cae8a8129752c459c15_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i927e8b53d03f409c8397e57ad50983cf_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i298fa64546144e7c8725322be166049b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i340a0bfb85cc4a238353da0ab09b3e19_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f6c62d24498449dbd1912f053706e5f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i727b7773814a4b248462dd8c293d6447_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63b417fd4e2e4baca829a11debf18917_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12297feced3a40998cfae2f77b61fe69_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5714ee2d486c40e0920537af19846e5c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ccd25a4389e4143bcd3303d5a26ad64_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd434cb3d24d4c54a373f4e7355f9440_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9857e40c16694defb9128852a3249eee_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d46c7f6455a482fb10a18e1305a3b96_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c19bcb918ca49c096f1881179d2c512_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e781035dc6444a2bee2f22c5a1fe45f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a749b02bcb6491283cdb7b6391346d8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40dcc202c4e041af8d2d5be92340ac45_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic07dfcc355994c14808ed66f5abf1c36_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifeea7735269f42f1af408fc370004480_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d9e30fd0e724ca38629fa8a85472f94_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45536724bfd7435b9cb5468e757ce469_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12b8749fcb3a4647a6723c05d51fb551_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75626a99bf8247128cf595d793463677_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife4c0c7afd9144938f80700f00e2e503_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48ad05476c804a989876d463a18d0f08_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i743b074f5dff4cbb8b388b51e52d39ea_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77cea09568304a929a0021ea5531db88_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic520fafe28c44d34ac504762a168782a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic048de659b754fc9a1c06eb94c867694_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd3d0e49a60941ee8d18b67216bb2d26_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="id48f7675a8794df7843115f14fe4bb25_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e5e0252210049cfa75325d985e17243_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2d95a7621de4ea1b42295baf483de7b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7feccdfe1c8340ada0a48b4cad20e5f0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67937b96a80447d18275ba06851fb742_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56d5c5699f5b41ca84983f1f737c45bb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1a0121aacaa451b9fc9b38eb0223d9f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c212dd4fc614d22a2bc72979bf8a54e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd86e6e3a1b44f9b9471e84cc3d38d59_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6930f355cf7642b6887d05d83aef15c5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0196020330d14953b976bf363233729f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice68a02899784fd88d4432a3fb090772_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i730ffd508cf243709923d83ea9b803c6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c7699609a3549b8b86808d050c110d4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e8cfd1012e540b98b636dc848d3c3bc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaacd12e7523f4715be7afb04d18844aa_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cda18cb62f44748b28447a88f322746_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2284863f0fb44dcfae350d8ee4e1fd77_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf478d53ab4b4b9f980df8bc214e13cb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa3208678276429ca1a8f3db656730ee_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i888a4cf85c084a58ab95492d82a8d4a1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6052bc3b28d746c0bd0c11c456d9f13f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cf3392f32d3409285d213bbc6902517_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94279de6d96e4bd99aef13f69b2d95d3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida1b5d30c914404b95ad3394c7bdbfe4_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12b44d1ebaff43ac9c4d3e2a2bae7d0f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9d6549a44e94575912af38c44fff8a9_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b08aa96dca042dab59571ea3df315f4_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8678dafbf0e64ad3a1136c20a7706504_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d1bbb06b08d40428b604d332162f94c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffdbe24edf9f479bb05597d7938ccac2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2648e344424447c4982226cfa30a4b3e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05ae02b9557f460e90131cf855f3e5b2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i589ef1e1d7364af18ae1c4f29b187901_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf7e1839e4634249b8d12259ef4657a6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc23221332314a54bdc672565b6ca265_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic430fcc6fc214744a2f1da71a2c66678_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c3e1b9f5f034fcdacc2d71873899331_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90d469ba619141c2ace7f747b1d68050_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab66d6f5313944d98bde2718ad418ab2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4d5e6459eff4d29a673adf7eb5402d1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib209e83a487b430bafc14ba29f31ede4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15f764dde95c421bbfb594d9a2886d15_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eed3460799b4a04ba1ee3810ded507a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id337d4363166457ab49d51fd89cad69b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72dde26130df4e1c9e1eeb773672603e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3aaab4df1434368a525f9cb0ea76ec3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29278874f2bd4e64950e351a9d477fdb_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58b0a3cc9bf4444ea52a9aad02fafd3c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56269e6a9fc24521a48f5dbce03064f4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5f1f0fa07304fef96e2267e72a9854a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12cee7acd73141489be68129eaa031ae_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i800f404abef344e79689a216db23038a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icab4c536fd8d4a618d358572c4a848e7_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1947113776464ef48d89fbe12f701aff_D20220517-20220517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-17</xbrli:startDate><xbrli:endDate>2022-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0073bc5d83c4f66b1cb1bd49f9af101_D20220517-20220517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-17</xbrli:startDate><xbrli:endDate>2022-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31edb4dd7f44492f8d09aec0fa03e5c9_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2294f6a1f354e1fb535db2d898d6850_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id270c77784994d6b9347452cfa7bcfd5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id55f7224e21846c3acf2d3b00db79eb7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id97f6cb32d4443f685b8c442cb50ea2d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i227c62eeec2344e5bec7da0b046fdc53_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6800724d53e43ac84874399f3d245da_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i806e73012b0a480488ca9ea714e35107_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b7963d1f14a45a09a9a46e7127d2f99_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i849355af7bdb45cc8899544e54dcb57c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reportablesegment"><xbrli:measure>clx:reportableSegment</xbrli:measure></xbrli:unit><xbrli:context id="i4e8cd95aed9b4c81901ca7d5a53d1ce1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26e621abaf0d47d4b39a2fa43224768f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id69dc302ea5d43f9bc300bfd696c1476_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dadaf4c1716414abfe9786d4d65c91c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b42821a22844c5ca6f9e44fd13cb6c1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0de7a722ac64da8858c7bf8cee9b411_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f89b0641ef04737bd695667b84a20c8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6d2033d94204c51b0c34eb17cd5f6b5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i606ff00a1b9e43a3a6959e8d1ebb4977_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3fa7b12816f411cbaf987175543040a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a5f78e9f3c74fa9b02f7b5e6ee65670_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2183c0c64c434e5a9aeea41c54cb625b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74eb275af8db41049d9007f8bc834661_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3048afb6b1df4c98bbe9928ae66d4d4d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dbef4e516584b3c8b89e91c01bce178_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3007927605bd40d6aa8bd18ae2feac19_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i825a3f474bef4d57a41b659e4276eb92_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4923cfb94e8049c1ba541c14e5fc41f1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b90eb0ef6054ab7a5b9de59365a28ac_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i746c110841a342e1b5c9555eaa2e1ce1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedec36bdebec43808dffc518431446b5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide10fb2fb37f424dbdc6a428a5cbd88a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61a07a11680e4116a22f12f9e4f59402_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ab02c4c09bc448e9e4bbf6710b688a3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i417b78725106447a96236599f5fe7024_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3830eddd6eec4653b1b850774f83f799_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79dab9a38edd41d3a954624d9e05a0bb_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8117aec118647b49d7490ddbaeaea3e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97d7a4a287334750b35878de0c632079_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26bbe833ac1640c89c7c526a81516775_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i052b0fc813da42178769b516bf6454df_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i159d29d0958b4e4bba0eedf9dd60d3b5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i684f9f739fd74d75980dc46564a4fc1d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2769b1c5b55f417f9f0a0b3a7b69c023_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i264bcb59d1fb4a8b8f8f5ad7b7fe1dd8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ed314c335fd49008ec3b335ea3c14f9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i260a34245a4a4431a0f5f91d94de3567_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42e6cf57392445509d1e157867ac3729_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68962e875b5c463d9cda87f98c695ea9_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie488b698386942d488eb9191bf6c03e9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ca24239316c482eaa1b9a014e855a41_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id94210280c4f459a95a0145d49e7170a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59c4149e9cc24e3abe5f72106c11a911_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55565f7982054624baa5bc769685ff9a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia206ce29644b481c940c521fcb640e60_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3315b5d84b164803b2a50689febd9ff5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">FORM <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF84NA_db33ffe7-ac3b-4a7a-89ab-bc51e0098e7f">10-Q</ix:nonNumeric> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.768%"><tr><td style="width:0.1%"></td><td style="width:2.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.230%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Mark One)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6ZDVmNGFiODJjOWYwNDA4Y2IxZmEyNTNjMTA0NDJlNmMvdGFibGVyYW5nZTpkNWY0YWI4MmM5ZjA0MDhjYjFmYTI1M2MxMDQ0MmU2Y18xLTAtMS0xLTYyNzEz_3411974f-4734-43a4-96de-523349ce8ff8">&#9745;</ix:nonNumeric></span></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8xNjQ5MjY3NDQzNTkx_469d974a-c402-475d-ba81-15171c8f3ab4">September 30, 2022</ix:nonNumeric>. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OR</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.623%"><tr><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.959%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6OTY4ZjY0YmQwMmQ3NDY4MDk5YjNkMzY5NjZhMGM0OTgvdGFibGVyYW5nZTo5NjhmNjRiZDAyZDc0NjgwOTliM2QzNjk2NmEwYzQ5OF8wLTAtMS0xLTYyNzEz_ea602c60-d381-4905-a474-a41366a2d2e0">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission File Number: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8yMDI_3457f0e7-9e50-4f2c-819e-a7042ca278ff">1-07151</ix:nonNumeric> </span></div><div style="text-align:center"><img src="clx-20220930_g1.jpg" alt="clx-20220930_g1.jpg" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:518px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8yMDg_30d5aa44-21e4-4bcd-ad01-50eeadd5a220">THE CLOROX COMPANY</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.855%"><tr><td style="width:1.0%"></td><td style="width:48.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.973%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6MmRiNTM3N2YwODczNGQ4N2IxOTVjOTZiMjg3MjBiZGMvdGFibGVyYW5nZToyZGI1Mzc3ZjA4NzM0ZDg3YjE5NWM5NmIyODcyMGJkY18wLTAtMS0xLTYyNzEz_7166aac9-bdb6-430b-a27a-22c154236d44">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6MmRiNTM3N2YwODczNGQ4N2IxOTVjOTZiMjg3MjBiZGMvdGFibGVyYW5nZToyZGI1Mzc3ZjA4NzM0ZDg3YjE5NWM5NmIyODcyMGJkY18wLTEtMS0xLTYyNzEz_d96eb23c-8dbb-4eb0-b04e-d4c33ab6ac8a">31-0595760</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8yNjk_6071334b-6cfd-4224-89ef-3b4e27a93f12">1221 Broadway</ix:nonNumeric>, <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8yNzM_9263734f-8962-4dfe-84e4-297492bba5bf">Oakland</ix:nonNumeric>, <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8yNzc_417f86ff-b84b-4ec4-b14d-bef5bb9f9576">California</ix:nonNumeric>, <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8yODE_ba42c913-5e27-4de4-a4b9-92b8037fafaf">94612-1888</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip code)</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8zMzg_00d5a5c4-d7f6-4717-adb7-ea9d8f104af6">510</ix:nonNumeric>) <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8zNDI_d0e6e7d1-dea4-4536-bed3-22a77c17cc96">271-7000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.420%"><tr><td style="width:1.0%"></td><td style="width:36.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.635%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Former name, former address and former fiscal year, if changed since last report)</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">___________________</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6ZTQzMDc2YzhmYTA2NGQxMDg1ZTY3MTNiY2U1YmY2ZjQvdGFibGVyYW5nZTplNDMwNzZjOGZhMDY0ZDEwODVlNjcxM2JjZTViZjZmNF81LTAtMS0xLTYyNzEz_11540cb6-d76f-47e4-9e30-fdc480c66c4b">Common Stock - $1.00 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6ZTQzMDc2YzhmYTA2NGQxMDg1ZTY3MTNiY2U1YmY2ZjQvdGFibGVyYW5nZTplNDMwNzZjOGZhMDY0ZDEwODVlNjcxM2JjZTViZjZmNF81LTEtMS0xLTYyNzEz_62801d29-91ab-4816-9e50-7d26465e1ee2">CLX</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6ZTQzMDc2YzhmYTA2NGQxMDg1ZTY3MTNiY2U1YmY2ZjQvdGFibGVyYW5nZTplNDMwNzZjOGZhMDY0ZDEwODVlNjcxM2JjZTViZjZmNF81LTItMS0xLTYyNzEz_0f3dcae5-043d-42de-a1e5-a9b4b15c843d">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF83NDc_356bb48f-7efa-469b-81a1-5172fdb54a29">Yes</ix:nonNumeric>&#160;</span><span style="color:#333333;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8xMDY4_3de4cba2-ccde-4898-b4ff-78081881da54">Yes</ix:nonNumeric>&#160;</span><span style="color:#333333;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. &#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.942%"><tr><td style="width:1.0%"></td><td style="width:15.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.552%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.075%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6ZTU5NjlhZjFhMjhlNGUxMGExMWQxMWYxN2ZiNjk5YzMvdGFibGVyYW5nZTplNTk2OWFmMWEyOGU0ZTEwYTExZDExZjE3ZmI2OTljM18wLTAtMS0xLTYyNzEz_30442acf-4530-471b-bbdc-a85eef9d706c">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#333333;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller Reporting Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6ZTU5NjlhZjFhMjhlNGUxMGExMWQxMWYxN2ZiNjk5YzMvdGFibGVyYW5nZTplNTk2OWFmMWEyOGU0ZTEwYTExZDExZjE3ZmI2OTljM18wLTctMS0xLTYyNzEz_18ad6cc7-c1b1-402f-ba01-414385115734">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6ZTU5NjlhZjFhMjhlNGUxMGExMWQxMWYxN2ZiNjk5YzMvdGFibGVyYW5nZTplNTk2OWFmMWEyOGU0ZTEwYTExZDExZjE3ZmI2OTljM18wLTktMS0xLTYyNzEz_4c9e8f32-1cc5-452c-a442-4047db5fb1cf">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8xODAx_3f2b59aa-6704-4f1e-b707-3918e3fb2ce8">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#333333;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;18, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i2e30c8ce95e6400b80f612d2b95a4680_I20221018" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8xODMy_2d3622f0-ed34-48e8-bcdb-b12ccde72b5e">123,384,797</ix:nonFraction> shares outstanding of the registrant&#8217;s common stock ($1.00 par value).</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.985%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8211; FINANCIAL INFORMATION</span></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_10"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in millions, except per share data)</span></div><div style="margin-bottom:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:72.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.614%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.617%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMi0zLTEtMS02MjcxMw_1464b922-aa56-4987-a266-a975acd40d4f">1,740</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMi02LTEtMS02MjcxMw_d7d637a9-e812-4044-ba4d-9b0a52f58ac3">1,806</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMy0zLTEtMS02MjcxMw_3506dbf4-f616-4b8c-9d88-3f30fc2cbf75">1,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMy02LTEtMS02MjcxMw_812270d9-fce3-424b-a0ac-9069ad54493e">1,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfNC0zLTEtMS02MjcxMw_a7cd412b-72cb-4e7d-9db0-d0daeb19a032">626</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfNC02LTEtMS02MjcxMw_81119667-10ce-48d4-8e29-de4ce12936fd">670</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfNS0zLTEtMS02MjcxMw_1a472d3e-a150-4d02-86de-3a035f4cea0f">261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfNS02LTEtMS02MjcxMw_aa200401-464b-4dd5-92c5-b2355a6bdd35">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising costs</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfNi0zLTEtMS02MjcxMw_0b8992ac-acdf-45bb-922d-447cd97bfcd1">161</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfNi02LTEtMS02MjcxMw_91dc06d2-5a33-4638-a476-3e135849c2e8">182</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfNy0zLTEtMS02MjcxMw_8ac34814-b2d5-46ff-b473-da4a2f15df49">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfNy02LTEtMS02MjcxMw_e197feb6-622c-4330-bbe6-f0303543ef47">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfOS0zLTEtMS02MjcxMw_3f4e1ea1-47e6-4797-ad40-db3a7e83e01a">22</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfOS02LTEtMS02MjcxMw_c2a8670c-f0d1-4e8e-bbec-38f2b9910d89">25</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="clx:OtherExpenseIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTAtMy0xLTEtNjI3MTM_d43bc13e-417c-4473-9c69-de13ab5c91cd">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="clx:OtherExpenseIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTAtNi0xLTEtNjI3MTM_46962d8c-fc99-433a-beb2-d83e2ca09945">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTEtMy0xLTEtNjI3MTM_f2eba515-1fcd-43fc-934a-37326e3c3a9a">116</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTEtNi0xLTEtNjI3MTM_7d9d75d9-156e-403e-8aeb-aeb07e5832a5">185</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTItMy0xLTEtNjI3MTM_fb5b5fed-7050-4d81-a0f4-23dec782c53b">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTItNi0xLTEtNjI3MTM_41b648ca-19be-470f-8e3d-d20263b7e02f">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings </span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTMtMy0xLTEtNjI3MTM_015cffa2-3d1d-4473-b8ca-7dde27b6cde5">87</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTMtNi0xLTEtNjI3MTM_62b10f12-4f20-4d2c-aa00-abd0876ccfbf">143</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTQtMy0xLTEtNjI3MTM_143d6fcc-f1ad-4345-a11f-44ef1aab5c33">2</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTQtNi0xLTEtNjI3MTM_2c01574f-a0d4-4435-a677-4e631e84d043">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Clorox</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTUtMy0xLTEtNjI3MTM_c696232a-0f64-4b05-8bd5-eb371f324933">85</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTUtNi0xLTEtNjI3MTM_cfff2431-5547-47a8-8429-c84caf485f4e">142</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings per share attributable to Clorox</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net earnings per share</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTctMy0xLTEtNjI3MTM_25fb19b2-480d-473b-9946-af974d9fb4f1">0.69</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTctNi0xLTEtNjI3MTM_68e6d639-9858-4282-a7a4-e554fd122e74">1.15</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTgtMy0xLTEtNjI3MTM_99e54996-32e8-4e62-b02d-98306f2668a8">0.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTgtNi0xLTEtNjI3MTM_44b744be-d324-4666-8e09-8c92ff2e0bd3">1.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding (in thousands)</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjAtMy0xLTEtNjI3MTM_1b2815f0-2f9e-4db8-83a6-35ebe38d0672">123,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjAtNi0xLTEtNjI3MTM_3b14ce9c-41a7-4697-9a89-4ff398a1460d">122,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjEtMy0xLTEtNjI3MTM_122641bf-667f-4f95-86bd-d338bb4ff323">123,914</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjEtNi0xLTEtNjI3MTM_376ff4f8-ea21-4cef-8a5c-d844475d2d84">124,042</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjMtMy0xLTEtNjI3MTM_a83b0882-a663-4db3-99da-011f859c6eb4">51</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjMtNi0xLTEtNjI3MTM_a464afde-3e60-4642-bc06-7fc5e226749e">122</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Total comprehensive income attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjQtMy0xLTEtNjI3MTM_7dcc0952-f8ef-429b-97f4-f4d5ebaef13f">2</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjQtNi0xLTEtNjI3MTM_a915a5cb-f615-44fa-9758-1e88efce0ce7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income attributable to Clorox</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjUtMy0xLTEtNjI3MTM_5b2c4e66-7b67-4bbd-a55c-2a875947da27">49</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjUtNi0xLTEtNjI3MTM_6622f551-6997-4a92-91c6-002dd2192fb7">121</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_13"></div><hr style="page-break-after:always"/><div style="min-height:28.8pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in millions, except per share data)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.106%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="6" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNC0yLTEtMS02MjcxMw_7546e69f-3b94-4588-b9d5-2d0bb267ea96">278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNC01LTEtMS02MjcxMw_4f266e21-3f95-4505-a93f-05fb6a4e5d45">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNS0yLTEtMS02MjcxMw_13e4596a-eded-4ecd-a9bc-c275e52dde80">612</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNS01LTEtMS02MjcxMw_226f08d9-2ec3-4425-a70b-1c2772734823">681</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNi0yLTEtMS02MjcxMw_59f230a2-eaad-48c0-b44e-516a0471b58f">755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNi01LTEtMS02MjcxMw_d478dfc9-37f6-412d-8785-2b10514e5e80">755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNy0yLTEtMS02MjcxMw_aaa9d42e-7be2-4000-9303-9f8acf0cfdc0">118</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNy01LTEtMS02MjcxMw_898ecc6c-3ec3-48bb-bd2a-c1c756317906">106</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfOC0yLTEtMS02MjcxMw_0f1caef8-e86d-4a3b-8f2f-5d03001c172c">1,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfOC01LTEtMS02MjcxMw_f9498f7c-6542-45b1-a7da-ced2ea3946e8">1,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net of accumulated depreciation and amortization </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;of $<ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfOS0wLTEtMS02MjcxMy90ZXh0cmVnaW9uOmNmMTQwMzY3YWFkZTQzMTc4MjgwZjgzNTYyNzUwYjczXzk2_28d32ad3-6bef-4d0c-856e-d4f4710c6aed">2,575</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfOS0wLTEtMS02MjcxMy90ZXh0cmVnaW9uOmNmMTQwMzY3YWFkZTQzMTc4MjgwZjgzNTYyNzUwYjczXzEwMw_db9d00d2-4299-44b8-9e3f-84e3c316add3">2,530</ix:nonFraction>, respectively</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfOS0yLTEtMS02MjcxMw_bf482330-d5f8-44d5-8b4b-03d5279704c2">1,322</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfOS01LTEtMS02MjcxMw_8fe6eb01-38f9-47cc-a446-494e02bfc518">1,334</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTAtMi0xLTEtNjI3MTM_64554b04-805c-4cce-82ea-56c5c6ff8788">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTAtNS0xLTEtNjI3MTM_ca07f22e-1046-4756-abf6-255e8592c0b3">342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTEtMi0xLTEtNjI3MTM_21b2fbd3-988e-4da4-ae7f-2309fc732ffb">1,546</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTEtNS0xLTEtNjI3MTM_c17ba47a-03de-4e73-a6ff-a05d7d48188d">1,558</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="clx:TrademarksNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTItMi0xLTEtNjI3MTM_b26725c4-b987-4536-a66a-8f5596eab423">685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="clx:TrademarksNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTItNS0xLTEtNjI3MTM_969c0467-bc7b-43df-859a-b0af0f332296">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:OtherIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTMtMi0xLTEtNjI3MTM_74702328-35f5-4fc1-9367-633347068150">190</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:OtherIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTMtNS0xLTEtNjI3MTM_afe9ac12-c5b4-434c-a905-f346eb9bdb41">197</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTQtMi0xLTEtNjI3MTM_67fdbdbb-b60f-475d-99fb-822df006883e">311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTQtNS0xLTEtNjI3MTM_2dc182c9-dda2-467b-b3d5-1f9fdfa8d609">315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTUtMi0xLTEtNjI3MTM_353a6b13-dc8e-4949-a1c2-490e464fd3c8">6,153</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTUtNS0xLTEtNjI3MTM_be6f6806-3fc5-417a-a0b3-fe19ed656201">6,158</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTgtMi0xLTEtNjI3MTM_1a7cf547-5a25-4491-a04c-729567579b51">348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTgtNS0xLTEtNjI3MTM_eebe05c7-cbf1-4b12-9300-419b0fea9eec">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjAtMi0xLTEtNjI3MTM_e65a86ec-b691-4fab-b06f-e4ab6c620074">78</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjAtNS0xLTEtNjI3MTM_d7e2d9b7-eb7c-4c8d-b60e-63ed9a1c340f">78</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjEtMi0xLTEtNjI3MTM_c5d81042-ef8a-4aed-8259-e69aeedaa2b3">1,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjEtNS0xLTEtNjI3MTM_dbae282b-0c75-4281-abb6-50f5a65ef5d3">1,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjMtMi0xLTEtNjI3MTM_9f499014-c5d4-463c-ba20-1167b72ca494">2,010</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjMtNS0xLTEtNjI3MTM_4461c553-4605-4b60-ae4a-213dda4438c6">1,784</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjQtMi0xLTEtNjI3MTM_1a1e20b9-e472-448c-98f0-50a05582e88a">2,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjQtNS0xLTEtNjI3MTM_eb13d772-ae92-4374-bec7-abbde4345750">2,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjUtMi0xLTEtNjI3MTM_00bebe1b-506f-4aac-be77-1dacbbb911cf">308</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjUtNS0xLTEtNjI3MTM_1c048d2f-5b51-4d83-b07b-02b49a168a3f">314</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjYtMi0xLTEtNjI3MTM_7e5ccc07-ab44-47a0-9d71-1ec0064a567e">805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjYtNS0xLTEtNjI3MTM_826d9e20-569a-4d91-a91d-638b8bdabd3b">791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjctMi0xLTEtNjI3MTM_a2d430a5-0479-4288-bb8b-190be63843af">59</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjctNS0xLTEtNjI3MTM_efcfe285-f73d-4667-81b7-8e44e4786f87">66</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjgtMi0xLTEtNjI3MTM_bfc8dcaa-15c2-427d-9d48-85029754c6aa">5,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjgtNS0xLTEtNjI3MTM_b562cbef-f949-4e79-964c-640bd1b90b90">5,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjktMi0xLTEtNjI3MTM_bfb3a4ff-6a12-4688-a241-8d622d2ec349"></ix:nonFraction></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjktNS0xLTEtNjI3MTM_df5a400f-09d5-456b-bec4-9417768d468a"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock: $<ix:nonFraction unitRef="usdPerShare" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjpmNDg3Mjc2YmU0NjY0MjRmOTUzZDAyMDBhYzU4ODBiNF8yMQ_1a27da99-29cf-4b28-a206-51de937cb87b"><ix:nonFraction unitRef="usdPerShare" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjpmNDg3Mjc2YmU0NjY0MjRmOTUzZDAyMDBhYzU4ODBiNF8yMQ_2bffbb1f-d6ff-42d5-8ab3-5232a670b393">1.00</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjpmNDg3Mjc2YmU0NjY0MjRmOTUzZDAyMDBhYzU4ODBiNF8zNQ_6c40b2e1-560a-43ad-958a-cc275d628ddc"><ix:nonFraction unitRef="shares" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjpmNDg3Mjc2YmU0NjY0MjRmOTUzZDAyMDBhYzU4ODBiNF8zNQ_82dacf3d-3356-4939-b0a9-df571f1726b4">5,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjpmNDg3Mjc2YmU0NjY0MjRmOTUzZDAyMDBhYzU4ODBiNF81Nw_0371cffb-9cac-49f2-b9a7-e26c753ba089"><ix:nonFraction unitRef="shares" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjpmNDg3Mjc2YmU0NjY0MjRmOTUzZDAyMDBhYzU4ODBiNF81Nw_1310130a-2138-477a-9d1e-a0415ae95dc3"><ix:nonFraction unitRef="shares" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjpmNDg3Mjc2YmU0NjY0MjRmOTUzZDAyMDBhYzU4ODBiNF81Nw_77fab393-87b0-4265-97a5-67961f8bddd9"><ix:nonFraction unitRef="shares" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjpmNDg3Mjc2YmU0NjY0MjRmOTUzZDAyMDBhYzU4ODBiNF81Nw_a21b3321-5c29-439b-989e-087bdb3d4c54">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued or outstanding</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMi0xLTEtNjI3MTM_75695863-4648-45db-946f-525ff05c197f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtNS0xLTEtNjI3MTM_15da7c28-684a-4135-a78c-0732425f612f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock: $<ix:nonFraction unitRef="usdPerShare" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo2YzA2ZjQ5MDM0MjQ0NGI3YTBhZTRlN2Q0ZjM2ZTI1NF8xOQ_79ce7f7b-baf4-44d0-aaaa-abcadbd6f90a"><ix:nonFraction unitRef="usdPerShare" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo2YzA2ZjQ5MDM0MjQ0NGI3YTBhZTRlN2Q0ZjM2ZTI1NF8xOQ_8611673f-0c4f-42f7-bd05-12e02aa155b8">1.00</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo2YzA2ZjQ5MDM0MjQ0NGI3YTBhZTRlN2Q0ZjM2ZTI1NF8zMw_01f83d36-e887-44fc-8816-f48f374e466e"><ix:nonFraction unitRef="shares" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo2YzA2ZjQ5MDM0MjQ0NGI3YTBhZTRlN2Q0ZjM2ZTI1NF8zMw_a3698070-cadd-4ca0-9415-46cc5768632e">750,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo2YzA2ZjQ5MDM0MjQ0NGI3YTBhZTRlN2Q0ZjM2ZTI1NF81NQ_7bc8d734-3435-4529-a8b9-d2beda8e3d01"><ix:nonFraction unitRef="shares" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo2YzA2ZjQ5MDM0MjQ0NGI3YTBhZTRlN2Q0ZjM2ZTI1NF81NQ_8cc8b7e9-70e9-48c6-ac2f-4b26618ff53a">130,741,461</ix:nonFraction></ix:nonFraction> shares issued as of September&#160;30, 2022 and June&#160;30, 2022; and <ix:nonFraction unitRef="shares" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo2YzA2ZjQ5MDM0MjQ0NGI3YTBhZTRlN2Q0ZjM2ZTI1NF85Mw_7f668801-2c93-4876-a3c3-a9fee6d1ed41">123,355,986</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo2YzA2ZjQ5MDM0MjQ0NGI3YTBhZTRlN2Q0ZjM2ZTI1NF8xMDA_7ebcf9a4-0a0e-4045-a7bc-d16c02629a1a">123,152,132</ix:nonFraction> shares outstanding as of September&#160;30, 2022 and June&#160;30, 2022, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMi0xLTEtNjI3MTM_32e04ecc-eb59-42e9-b7e7-025b3d3b8739">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItNS0xLTEtNjI3MTM_310bb41e-a923-44c4-b22d-bceeb9a1a255">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzMtMi0xLTEtNjI3MTM_502d173e-15a7-4926-9b0f-b827d6eec5c8">1,193</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzMtNS0xLTEtNjI3MTM_4d537e39-783d-41f3-8118-7dcfc227997e">1,202</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzQtMi0xLTEtNjI3MTM_b0f05d67-1fbf-46e6-a0a1-0b88aa776e28">832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzQtNS0xLTEtNjI3MTM_830952cd-1aea-45c1-b4a9-3a60318b9c9d">1,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost: <ix:nonFraction unitRef="shares" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzUtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo5NGMwODhjMDYxZDM0YTM1ODVjYjEyMzcwNDc0ZmRiY18yOQ_7c112f0e-7dc0-4b0d-9c92-918058ece733">7,385,475</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzUtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo5NGMwODhjMDYxZDM0YTM1ODVjYjEyMzcwNDc0ZmRiY18zNg_0d320618-367d-4d99-aff6-5d0e3631198a">7,589,329</ix:nonFraction> shares as of September&#160;30, 2022 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;and June&#160;30, 2022, respectively</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzUtMi0xLTEtNjI3MTM_9f0c9504-f151-4d97-9692-099f86cc1389">1,315</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzUtNS0xLTEtNjI3MTM_0850b1c1-9964-4b71-91f1-a8aa03b1acea">1,346</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive net (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzYtMi0xLTEtNjI3MTM_70d871b3-a692-4e5c-8109-616cf112ee31">515</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzYtNS0xLTEtNjI3MTM_df614860-aaae-4f28-b991-c53a1bbfaf37">479</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Clorox stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzctMi0xLTEtNjI3MTM_0bf8453e-f5b5-4489-ace9-b94cf17eeb92">326</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzctNS0xLTEtNjI3MTM_99e66de9-bedd-4c83-afd3-69d95f87dec7">556</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzgtMi0xLTEtNjI3MTM_2127a167-3f27-4ca3-b772-af06c66447b7">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzgtNS0xLTEtNjI3MTM_02b1cbe5-7b26-4099-940a-9c50ed46ff43">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzktMi0xLTEtNjI3MTM_92efd5f1-097a-40ff-a92e-eb11ea5100bf">496</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzktNS0xLTEtNjI3MTM_8ce5141f-8754-40dc-aadb-8ef624dd35de">729</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNDAtMi0xLTEtNjI3MTM_8708ba5f-16e3-4673-a3d2-aa524ec3648b">6,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNDAtNS0xLTEtNjI3MTM_b8b2b944-267e-4232-9598-74f6d676817a">6,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span><br/></span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Cash Flows (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in millions)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMy0yLTEtMS02MjcxMw_2e42945b-e013-49a5-82d0-149ba685eb49">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMy01LTEtMS02MjcxMw_b73fb19a-ba6a-46bb-aaf1-0921b6e2f1ef">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash provided by operations:</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfNS0yLTEtMS02MjcxMw_a4c3c6e6-17dd-4ec6-96b4-a90bd191958f">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfNS01LTEtMS02MjcxMw_0d7375d2-89a9-4626-b240-7d87cca74559">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfNi0yLTEtMS02MjcxMw_2d58164b-b4e1-4a3b-8282-3cda72e3651d">10</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfNi01LTEtMS02MjcxMw_32d1fa2e-2790-4a8a-a7be-d1308c30a409">9</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfNy0yLTEtMS02MjcxMw_c16975c8-3976-4a75-8ce5-e2e58068f398">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfNy01LTEtMS02MjcxMw_03cb988b-ec6e-4860-80b3-51d0ebf22776">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfOS0yLTEtMS02MjcxMw_c49e9399-2684-4c62-b2aa-66457d35665e">16</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfOS01LTEtMS02MjcxMw_6c50f8cd-83fc-4626-af1a-ba7289acee47">8</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTEtMi0xLTEtNjI3MTM_82a7dbd3-8314-4203-bf3c-bfa8d95323f5">63</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTEtNS0xLTEtNjI3MTM_19bedaa1-35e2-4285-8535-982e86912186">53</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTItMi0xLTEtNjI3MTM_c39b9e40-b900-40fe-88af-d8b052a6a707">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTItNS0xLTEtNjI3MTM_b644b261-7f03-4524-b204-fcdbe6e50a8a">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTMtMi0xLTEtNjI3MTM_769f58dc-cf64-4c75-9836-7a659833510f">30</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTMtNS0xLTEtNjI3MTM_6d73d3a8-50d3-4c60-ac24-1c43c4045c52">14</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTQtMi0xLTEtNjI3MTM_36b03170-4b24-460b-80e9-8a98b6cd5a80">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTQtNS0xLTEtNjI3MTM_0206a8fe-9d47-4d43-a13f-7bb0f2f8a1e3">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets and liabilities, net</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="clx:OperatingLeaseRightofUseAssetAndLiabilityNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTUtMi0xLTEtNjI3MTM_fea170ad-7814-461f-805c-2b33d7de61b9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="clx:OperatingLeaseRightofUseAssetAndLiabilityNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTUtNS0xLTEtNjI3MTM_0c9c9d86-9312-4408-a664-7394f279ae7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 84.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable / prepaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTYtMi0xLTEtNjI3MTM_9836e7f1-5777-4c88-abac-e71daeff12c9">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTYtNS0xLTEtNjI3MTM_2b07d39a-7a74-4172-a151-88d4ef52f685">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operations</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTctMi0xLTEtNjI3MTM_cbf3be13-3dcb-4c40-9e9d-55716988a68e">178</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTctNS0xLTEtNjI3MTM_e1a3fe2f-c9a0-4cef-8ee4-781df89def71">41</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTktMi0xLTEtNjI3MTM_e3d8613d-107e-4b00-bd8b-7bd09f0a3a01">46</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTktNS0xLTEtNjI3MTM_d386b48d-f900-46bc-bc59-55a4cd8a2775">52</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjEtMi0xLTEtNjI3MTM_dc7c462c-e744-4654-b57b-aadd170818ce">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjEtNS0xLTEtNjI3MTM_71afc05e-459a-4c26-a567-2d4726baa20e">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjItMi0xLTEtNjI3MTM_c540929e-2a08-4af6-8c8b-4be0a15e867d">45</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjItNS0xLTEtNjI3MTM_60e58823-330c-4c88-b9a2-c7847a7440c9">56</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable, net</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjQtMi0xLTEtNjI3MTM_7049db36-392d-406f-9fda-49a851cb387a">111</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjQtNS0xLTEtNjI3MTM_18b9e68b-5b29-4fc5-8961-40a1a2c6d9bf">86</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjYtMi0xLTEtNjI3MTM_8daa9130-e85e-461f-902d-95b963e01d0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjYtNS0xLTEtNjI3MTM_1d6a52cd-f474-43b6-baa7-bcc2ca167f73">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends paid to Clorox stockholders</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjctMi0xLTEtNjI3MTM_b40291bc-98a6-43a5-b01b-1ca3da17a427">145</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjctNS0xLTEtNjI3MTM_5faf16d5-93de-42c8-9502-0f47b6abc3ac">142</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock for employee stock plans and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" sign="-" name="clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjktMi0xLTEtNjI3MTM_0a22fd35-98bf-43d5-829a-182a11c2412c">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" sign="-" name="clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjktNS0xLTEtNjI3MTM_2a9f66c2-8db8-4b70-bbf9-d265b1c6d4b6">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for financing activities</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzAtMi0xLTEtNjI3MTM_576d3184-5779-4658-873e-8c44b228b761">35</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzAtNS0xLTEtNjI3MTM_ab7e1a06-f264-47f5-9119-3ef73ed9dc8f">92</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzEtMi0xLTEtNjI3MTM_a938030e-84e8-493b-a993-a116f2d5582e">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzEtNS0xLTEtNjI3MTM_11531312-1167-4a52-acd9-7ef3de07f666">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzItMi0xLTEtNjI3MTM_0e4601ef-a3c7-40f3-aad3-1481921bc434">94</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzItNS0xLTEtNjI3MTM_523b868f-75ef-4eeb-b724-ff58a0c67dac">110</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzQtMi0xLTEtNjI3MTM_95254ae9-17f0-4554-9628-1742a9d537cd">186</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife6845f640b94b6d9b3a46784145e347_I20210630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzQtNS0xLTEtNjI3MTM_f54dbd19-4b6c-45f6-a6da-f8abd7f2d9a7">324</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzUtMi0xLTEtNjI3MTM_587d90fb-c2fd-48ba-98e6-39a9b3107151">280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i904c9b98d4a249328732ea1955c73b79_I20210930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzUtNS0xLTEtNjI3MTM_b3544994-9350-4b0e-ae1b-4ebd9ce7054c">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in millions, except per share data) </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1. <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xOS9mcmFnOjU3ZDMxYWQ2NmY2YzQwOGY5YmY0ZmE5M2I3MjQwY2Y1L3RleHRyZWdpb246NTdkMzFhZDY2ZjZjNDA4ZjliZjRmYTkzYjcyNDBjZjVfMjE0MQ_c6d9f828-4022-44c5-8c53-1a6047528359" continuedAt="i150e133fd937438d88e9be8afbeca1dc" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i150e133fd937438d88e9be8afbeca1dc"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xOS9mcmFnOjU3ZDMxYWQ2NmY2YzQwOGY5YmY0ZmE5M2I3MjQwY2Y1L3RleHRyZWdpb246NTdkMzFhZDY2ZjZjNDA4ZjliZjRmYTkzYjcyNDBjZjVfMjE0MA_2ddf452d-cdb8-4830-aebb-69a08b0fb7d1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements for the three months ended September 30, 2022 and 2021, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company or Clorox) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June&#160;30, 2022, which includes a complete set of footnote disclosures, including the Company&#8217;s significant accounting policies.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xOS9mcmFnOjU3ZDMxYWQ2NmY2YzQwOGY5YmY0ZmE5M2I3MjQwY2Y1L3RleHRyZWdpb246NTdkMzFhZDY2ZjZjNDA4ZjliZjRmYTkzYjcyNDBjZjVfMTY0OTI2NzQ2NTM2Mg_98cbe737-0d1f-4566-9acc-4589561a0c91" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Liabilities</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurs restructuring costs in connection with workforce reductions; consolidation or closure of a facility; sale or termination of a line of business; and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records employee termination liabilities once they are both probable and estimable for severance provided under the Company&#8217;s existing severance policy. Employee termination liabilities outside of the Company&#8217;s existing severance policy are recognized at the time relevant employees are notified, unless the employees will be retained to render service beyond a minimum retention period for transition purposes, in which case the liability is recognized ratably over the future service period. Other costs associated with a restructuring plan or exit or disposal activities, such as consulting and professional fees, facility exit costs, employee relocation, outplacement costs, accelerated depreciation or asset impairments associated with a restructuring plan, are recognized in the period in which the liability is incurred or the asset is impaired.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xOS9mcmFnOjU3ZDMxYWQ2NmY2YzQwOGY5YmY0ZmE5M2I3MjQwY2Y1L3RleHRyZWdpb246NTdkMzFhZDY2ZjZjNDA4ZjliZjRmYTkzYjcyNDBjZjVfMTY0OTI2NzQ3NTk4Ng_8e83aefb-493a-4f38-aef4-60912f5a6411" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.&#8221; These amendments require disclosure of the key terms of outstanding supplier finance programs and a rollforward of the related obligations.&#160;These amendments are effective for fiscal years beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. As these amendments relate to disclosures only, there were no impacts expected to the Company&#8217;s consolidated results of operations, financial position and cash flows.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_22"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2. <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RleHRyZWdpb246YjU4ODQwODE5Mjk5NGNkYzgxZmQzZTBkOTAxZjdlY2RfMjAyNg_16d83e56-f8a4-4e4c-ac04-557f1ea63b41" continuedAt="ib0fbfacdec1a4aa9b184eb0603c15892" escape="true">RESTRUCTURING AND RELATED COSTS</ix:nonNumeric></span></div><ix:continuation id="ib0fbfacdec1a4aa9b184eb0603c15892" continuedAt="i081679064cab42f0b632053b1b37a838"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2023, the Company began recognizing costs related to a plan that involves streamlining its operating model to meet its objectives of driving growth and productivity. The streamlined operating model is expected to enhance the Company&#8217;s ability to respond more quickly to changing consumer behaviors and innovate faster. The Company anticipates the implementation of this new model will be completed in fiscal year 2024, with different phases occurring throughout the implementation period.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company anticipates incurring approximately $<ix:nonFraction unitRef="usd" contextRef="i34328a2b14f04362ad52a7edbae327fa_I20220930" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RleHRyZWdpb246YjU4ODQwODE5Mjk5NGNkYzgxZmQzZTBkOTAxZjdlY2RfMjE5OTAyMzI5MTMwOA_a1b1bec5-143e-4eec-a0d5-b21c13de84dd">75</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="icd000e11a868483ca61bafef62dbda9f_I20220930" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RleHRyZWdpb246YjU4ODQwODE5Mjk5NGNkYzgxZmQzZTBkOTAxZjdlY2RfMjE5OTAyMzI5MTMxNQ_68ebde42-e38d-4359-9f25-44860509e615">100</ix:nonFraction> of costs in fiscal years 2023 and 2024 related to this initiative, of which approximately $<ix:nonFraction unitRef="usd" contextRef="i47cf58703a824db8a0117fad3f780179_I20230630" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RleHRyZWdpb246YjU4ODQwODE5Mjk5NGNkYzgxZmQzZTBkOTAxZjdlY2RfNzE0NjgyNTU5NDE3Ng_75889238-7f62-4a31-a4a3-5346b5040493">35</ix:nonFraction> is expected to be incurred in fiscal year 2023. Related costs are primarily expected to include employee-related costs to reduce certain staffing levels such as severance payments, as well as for consulting and other costs. Costs incurred are expected to be settled primarily in cash.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i081679064cab42f0b632053b1b37a838"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and related implementation costs, net were $<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RleHRyZWdpb246YjU4ODQwODE5Mjk5NGNkYzgxZmQzZTBkOTAxZjdlY2RfNzE0NjgyNTU5NDYwMw_95e18869-75b6-4da8-b2ae-0b9d17026345">19</ix:nonFraction> for the three months ended September&#160;30, 2022. <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RleHRyZWdpb246YjU4ODQwODE5Mjk5NGNkYzgxZmQzZTBkOTAxZjdlY2RfMTY0OTI2NzQ2NzA5OQ_943abe64-ce32-4e11-be62-1aa78ace7ae0" continuedAt="i16e8512e78794d99b41b69c026a076d0" escape="true">The following table summarizes the total restructuring and related implementation costs, net associated with the Company&#8217;s streamlined operating model plan as reflected in the Consolidated Statements of Earnings and Comprehensive Income.</ix:nonNumeric></span></div><div><ix:continuation id="i16e8512e78794d99b41b69c026a076d0"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:78.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.048%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Costs of products sold</span></div></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(<ix:nonFraction unitRef="usd" contextRef="i09ad333c626b4d51be54887b41e252f1_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjA5OTVjY2Q0ZWE4YTQxNmY4NzhlNTkyYzIxODRlOTk4L3RhYmxlcmFuZ2U6MDk5NWNjZDRlYThhNDE2Zjg3OGU1OTJjMjE4NGU5OThfMi0xLTEtMS05NjA5NQ_b0336ad4-80f1-464b-8fd2-b8098778db13">1</ix:nonFraction>)</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Selling and administrative expenses</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="ib61f3f9358bc4648a900ad8d686db004_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjA5OTVjY2Q0ZWE4YTQxNmY4NzhlNTkyYzIxODRlOTk4L3RhYmxlcmFuZ2U6MDk5NWNjZDRlYThhNDE2Zjg3OGU1OTJjMjE4NGU5OThfMy0xLTEtMS05NjA5NQ_f517c315-e10e-4f2f-822e-8c2f87cad934">1</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Other (income) expense, net:</span></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Employee-related costs</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i63f8e80373f44df188b7b0bba1958467_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjA5OTVjY2Q0ZWE4YTQxNmY4NzhlNTkyYzIxODRlOTk4L3RhYmxlcmFuZ2U6MDk5NWNjZDRlYThhNDE2Zjg3OGU1OTJjMjE4NGU5OThfNS0xLTEtMS05NjA5NQ_4d70cc54-da8c-48c4-a897-39bed25105c9">19</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Total, net</span></div></td><td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjA5OTVjY2Q0ZWE4YTQxNmY4NzhlNTkyYzIxODRlOTk4L3RhYmxlcmFuZ2U6MDk5NWNjZDRlYThhNDE2Zjg3OGU1OTJjMjE4NGU5OThfOC0xLTEtMS05NjA5NQ_54466a7b-30b1-4c93-8092-deaa06a4f737">19</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee-related costs primarily include severance and other termination benefits calculated based on salary levels, prior service and statutory requirements. Other costs primarily include consulting fees incurred for the organizational design and implementation of the future streamlined operating model, related processes and other professional fees incurred. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges for restructuring and related implementation costs are recorded in the Corporate segment as these initiatives are centrally directed and controlled and are not included in internal measures of segment operating performance.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may, from time to time, decide to pursue additional restructuring-related initiatives that involve costs in future periods. </span></div><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RleHRyZWdpb246YjU4ODQwODE5Mjk5NGNkYzgxZmQzZTBkOTAxZjdlY2RfMTY0OTI2NzQ2NzA5OA_12092833-a5dc-4c8e-befa-a38a859901d8" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the accrual for the streamlined operating model restructuring and related implementation costs discussed above, which are recorded within Accounts payable and accrued liabilities in the Consolidated Balance Sheets:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"></td><td style="width:60.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.950%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Employee-Related Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of June&#160;30, 2022</span></div></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i0f9e22509a6d450fa6331417e37243f0_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMS0xLTEtMS05NjI5OQ_0676b719-20eb-44f7-9a50-0ec1873204cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i341aba281f28491c9e0f804508f61995_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMS0zLTEtMS05NjMwNg_d937cea1-0105-44ac-8b89-84249d54f6e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMS01LTEtMS05NjMxMw_c0aee47d-2f06-4ceb-b9e1-cc8b8c6a2eba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Charges</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="iace90036b5d84d608091db4139e10cb0_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMi0xLTEtMS05NjI5OQ_eb171ac6-2052-44a7-aebc-4087867b7392">19</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i9a0251ee71ad46aab3436fb41074e067_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMi0zLTEtMS05NjMwNg_b9aa24c0-71b8-4002-bb8f-3ddd4647996d">3</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMi01LTEtMS05NjMxMw_d57f582a-2e48-4d23-8d79-8374ca9d2ed9">22</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Cash payments</span></td><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="iace90036b5d84d608091db4139e10cb0_D20220701-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMy0xLTEtMS05NjI5OQ_b9339e68-0faa-4bc2-9fa4-e8c319ce3595">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i9a0251ee71ad46aab3436fb41074e067_D20220701-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMy0zLTEtMS05NjMwNg_de767361-be3d-4587-8cbf-73dcec7e8943">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMy01LTEtMS05NjMxMw_1055c1bc-8c25-438e-8e06-321ffd298945">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of September&#160;30, 2022</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="i407e5b359a574869b044cdc2231bcc94_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfNS0xLTEtMS05NjI5OQ_ec744737-b59f-45a6-a71c-ce1954f09d2f">19</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="id07f895c223b44f0af02d5bca7906d74_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfNS0zLTEtMS05NjMwNg_70527ef4-7763-4a0f-99ac-60a04703a0e1">3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfNS01LTEtMS05NjMxMw_8cab965f-f943-489d-b2c5-6e5c9df14719">22</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3. <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RleHRyZWdpb246MGUwNzkxNWRiM2NlNGJkYzgwMGQ4NjE2OWY5ZThjNDJfODU_d1b9297a-5b1b-4211-b9c3-370947072a71" continuedAt="i0c3b8460fc154982bc2cc94a00f0ea50" escape="true">INVENTORIES, NET</ix:nonNumeric></span></div><ix:continuation id="i0c3b8460fc154982bc2cc94a00f0ea50"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RleHRyZWdpb246MGUwNzkxNWRiM2NlNGJkYzgwMGQ4NjE2OWY5ZThjNDJfODQ_dae50b8f-5f98-4c61-b098-3622e3ed64f4" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net, consisted of the following as of:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfMS0xLTEtMS02MjcxMw_7cc1e28e-5c5c-4aab-83aa-b549ea0bea99">639</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfMS0zLTEtMS02MjcxMw_91248013-dfe1-4013-99d3-53be697b2fe7">593</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and packaging</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfMi0xLTEtMS02MjcxMw_57729630-cd2f-4871-8215-4fcce1fb20cb">200</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfMi0zLTEtMS02MjcxMw_ca06e848-471f-4861-b85a-132047e0304e">191</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfMy0xLTEtMS02MjcxMw_12e81b5b-dced-429d-8e3e-04e6f148b418">15</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfMy0zLTEtMS02MjcxMw_eff727b4-f975-45fc-9acf-252167ede07c">16</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIFO allowances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:InventoryLIFOReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfNC0xLTEtMS02MjcxMw_66941e9d-5e13-4112-915d-89ae3fd3421c">94</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:InventoryLIFOReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfNC0zLTEtMS02MjcxMw_84cecae6-1d07-4b69-986c-c65827f754da">40</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="clx:InventoryCurrentAndNoncurrentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfNS0xLTEtMS05MTYwNg_1b0ddc79-40dc-4f34-801c-f69499cbf98f">760</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="clx:InventoryCurrentAndNoncurrentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfNS0zLTEtMS05MTYyMA_d7c932be-b90d-4199-822a-9a84be05d263">760</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Noncurrent inventories, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfNi0xLTEtMS05MTYxMw_ce33d93a-455a-4e00-b2ed-fecc2d0d6b75">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfNi0zLTEtMS05MTYyNw_c3732e7e-aa83-4996-8f78-3158ac980f92">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current inventories, net</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfNS0xLTEtMS02MjcxMw_45faaf19-b479-4ce7-bf63-3df6c80d5fd2">755</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfNS0zLTEtMS02MjcxMw_59717b83-0ed8-4ffb-ae33-ff648df3030d">755</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> Noncurrent inventories, net is recorded in Other assets.</span></div></ix:nonNumeric></ix:continuation><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_34"></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4. <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="clx:FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfNzk0NQ_7a9031b6-002d-4510-b129-84846145c7db" continuedAt="i425adcd46f9d4c558eeb85bcf7f448de" escape="true">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="i425adcd46f9d4c558eeb85bcf7f448de" continuedAt="i661cbabd16294f31bb9ab2918285c3cb"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Risk Management and Derivative Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain commodity, foreign currency and interest rate risks related to its ongoing business operations and uses derivative instruments to mitigate its exposure to these risks.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commodity Price Risk Management</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may use commodity futures, options and swap contracts to limit the impact of price volatility on a portion of its forecasted raw material requirements. These commodity derivatives may be exchange traded or over-the-counter contracts and are generally for a period of no longer than <ix:nonNumeric contextRef="id33bf162891042b581228081b2a7c697_D20220701-20220930" name="us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMjE5OTAyMzI2NjI0Ng_8cb72382-5925-43ea-8d59-0f0775f284ce">two years</ix:nonNumeric>. Commodity purchase and options contracts are measured at fair value using market quotations obtained from the Chicago Board of Trade commodity futures exchange and commodity derivative dealers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, and June&#160;30, 2022, the notional amount of commodity derivatives was $<ix:nonFraction unitRef="usd" contextRef="i6e8a89c05a0a4a16b4de18869bfd695f_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfNzk2_0ec41350-0daf-4dc0-b56d-0bbf38e0f10c">30</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i5b924fb632f04f0c94baf25d9aae883e_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMjE5OTAyMzI2NTk0Mg_84942d9d-5d07-4bcc-b2f8-3d23a3cc0b18">27</ix:nonFraction>, respectively, which related primarily to exposures in soybean oil used for the Food products business and jet fuel used for the Grilling business.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risk Management</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also enter into certain over-the-counter derivative contracts to manage a portion of the Company&#8217;s forecasted foreign currency exposure associated with the purchase of inventory. These foreign currency contracts generally have durations of no longer than <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMjE5OTAyMzI2NjI2OQ_6d7dbd82-0fe0-4322-bc24-49d6a71c9adc">two years</ix:nonNumeric>. The foreign exchange contracts are measured at fair value using information quoted by foreign exchange dealers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of outstanding foreign currency forward contracts used by the Company&#8217;s subsidiaries to hedge forecasted purchases of inventory were $<ix:nonFraction unitRef="usd" contextRef="ib118d948faed49dea943620ecb2804d1_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMTY1OA_577ee260-02b2-4c3e-8a75-5bead795fcb8">13</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iba5d16b63ef34671b972df411f72c26c_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMTY2NQ_cd34300a-ecda-4fbf-8df3-1f06170d63e9">31</ix:nonFraction> as of September&#160;30, 2022 and June&#160;30, 2022, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk Management</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may enter into over-the-counter interest rate contracts to fix a portion of the benchmark interest rate prior to the anticipated issuance of fixed rate debt. These interest rate contracts generally have durations of less than <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMjE5OTAyMzI2NjI4NA_8810f068-bef3-466e-b04d-ae7b7c747ba4">three years</ix:nonNumeric>. The interest rate contracts are measured at fair value using information quoted by bond dealers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held no interest rate contracts as of September&#160;30, 2022 and June&#160;30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commodity, Foreign Exchange and Interest Rate Derivatives </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company designates its commodity forward, futures and options contracts for forecasted purchases of raw materials, foreign currency forward contracts for forecasted purchases of inventory and interest rate contracts for forecasted interest payments as cash flow hedges.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued)</span></div></div><ix:continuation id="i661cbabd16294f31bb9ab2918285c3cb" continuedAt="i3f5c11c6565a4e7c9cf349088c5ab505"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfNzk1Mg_ee63373e-96dc-4d79-aa01-c91db3c336f8" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) recognized in Other comprehensive (loss) income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87647bbf68694e6cb56844238655ccb6_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjU3NDE1NTJiMjExYjQ0YjA4YzgyMmFkZDE3MjM5MWIwL3RhYmxlcmFuZ2U6NTc0MTU1MmIyMTFiNDRiMDhjODIyYWRkMTcyMzkxYjBfMy0xLTEtMS02MjcxMw_6a4133b5-a7ae-4d98-9e34-a4ed92ef1a69">3</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f677fe19c1746429e18febc5f25cfea_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjU3NDE1NTJiMjExYjQ0YjA4YzgyMmFkZDE3MjM5MWIwL3RhYmxlcmFuZ2U6NTc0MTU1MmIyMTFiNDRiMDhjODIyYWRkMTcyMzkxYjBfMy0zLTEtMS02MjcxMw_5ea9ad5f-4c3b-417d-918f-7cfa1c7136d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7eed42a98cdf4c8484f4d6f50ba27c2c_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjU3NDE1NTJiMjExYjQ0YjA4YzgyMmFkZDE3MjM5MWIwL3RhYmxlcmFuZ2U6NTc0MTU1MmIyMTFiNDRiMDhjODIyYWRkMTcyMzkxYjBfNC0xLTEtMS02MjcxMw_a2a00096-e694-4527-a14f-2fecd75128b4">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89d66606b3294de5be2599b89449703f_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjU3NDE1NTJiMjExYjQ0YjA4YzgyMmFkZDE3MjM5MWIwL3RhYmxlcmFuZ2U6NTc0MTU1MmIyMTFiNDRiMDhjODIyYWRkMTcyMzkxYjBfNC0zLTEtMS02MjcxMw_fb19164d-3753-4182-bfdd-df591dfd5262">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc00d18fe4de47a698a3a7bc531123de_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjU3NDE1NTJiMjExYjQ0YjA4YzgyMmFkZDE3MjM5MWIwL3RhYmxlcmFuZ2U6NTc0MTU1MmIyMTFiNDRiMDhjODIyYWRkMTcyMzkxYjBfNS0xLTEtMS02MjcxMw_2ee82088-2b29-4776-907c-72a063851112">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5e13b9874e848cf9b0bb2bdda02efbd_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjU3NDE1NTJiMjExYjQ0YjA4YzgyMmFkZDE3MjM5MWIwL3RhYmxlcmFuZ2U6NTc0MTU1MmIyMTFiNDRiMDhjODIyYWRkMTcyMzkxYjBfNS0zLTEtMS02MjcxMw_78f925b2-da5d-48d7-a2b0-4c7dace43461">3</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjU3NDE1NTJiMjExYjQ0YjA4YzgyMmFkZDE3MjM5MWIwL3RhYmxlcmFuZ2U6NTc0MTU1MmIyMTFiNDRiMDhjODIyYWRkMTcyMzkxYjBfNi0xLTEtMS02MjcxMw_dcb08e1c-1304-47ac-ab6d-40d895b9d3ae">2</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjU3NDE1NTJiMjExYjQ0YjA4YzgyMmFkZDE3MjM5MWIwL3RhYmxlcmFuZ2U6NTc0MTU1MmIyMTFiNDRiMDhjODIyYWRkMTcyMzkxYjBfNi0zLTEtMS02MjcxMw_900d4c22-a07b-4a66-8323-ef9b253b392b">4</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfNzkzNA_b8c74b53-9108-45a6-b449-64f8dd40d43e" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87647bbf68694e6cb56844238655ccb6_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOmUxZjliMzJlNmJhOTQ1ZmZhZWNhNjk1NDUxZWIwNjcyL3RhYmxlcmFuZ2U6ZTFmOWIzMmU2YmE5NDVmZmFlY2E2OTU0NTFlYjA2NzJfMy0yLTEtMS02MjcxMw_08d7c5cc-90ab-4fae-8c25-8d1a44e6f411">4</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f677fe19c1746429e18febc5f25cfea_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOmUxZjliMzJlNmJhOTQ1ZmZhZWNhNjk1NDUxZWIwNjcyL3RhYmxlcmFuZ2U6ZTFmOWIzMmU2YmE5NDVmZmFlY2E2OTU0NTFlYjA2NzJfMy00LTEtMS02MjcxMw_697edffe-91c4-469e-882c-df7261622f85">5</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7eed42a98cdf4c8484f4d6f50ba27c2c_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOmUxZjliMzJlNmJhOTQ1ZmZhZWNhNjk1NDUxZWIwNjcyL3RhYmxlcmFuZ2U6ZTFmOWIzMmU2YmE5NDVmZmFlY2E2OTU0NTFlYjA2NzJfNC0yLTEtMS02MjcxMw_66a22a97-9162-4986-afc0-61b9288e43e5">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89d66606b3294de5be2599b89449703f_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOmUxZjliMzJlNmJhOTQ1ZmZhZWNhNjk1NDUxZWIwNjcyL3RhYmxlcmFuZ2U6ZTFmOWIzMmU2YmE5NDVmZmFlY2E2OTU0NTFlYjA2NzJfNC00LTEtMS02MjcxMw_d0fda736-f22d-4a39-a581-590b6acecb07">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc00d18fe4de47a698a3a7bc531123de_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOmUxZjliMzJlNmJhOTQ1ZmZhZWNhNjk1NDUxZWIwNjcyL3RhYmxlcmFuZ2U6ZTFmOWIzMmU2YmE5NDVmZmFlY2E2OTU0NTFlYjA2NzJfNS0yLTEtMS02MjcxMw_e444d838-68f6-44a8-9868-be2029ed2e68">3</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5e13b9874e848cf9b0bb2bdda02efbd_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOmUxZjliMzJlNmJhOTQ1ZmZhZWNhNjk1NDUxZWIwNjcyL3RhYmxlcmFuZ2U6ZTFmOWIzMmU2YmE5NDVmZmFlY2E2OTU0NTFlYjA2NzJfNS00LTEtMS02MjcxMw_e5d9874e-8cc5-4825-89fb-11be5c8f532d">2</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOmUxZjliMzJlNmJhOTQ1ZmZhZWNhNjk1NDUxZWIwNjcyL3RhYmxlcmFuZ2U6ZTFmOWIzMmU2YmE5NDVmZmFlY2E2OTU0NTFlYjA2NzJfNi0yLTEtMS02MjcxMw_afbfc14e-3d8a-4ca9-924c-d2e5eac317e1">8</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOmUxZjliMzJlNmJhOTQ1ZmZhZWNhNjk1NDUxZWIwNjcyL3RhYmxlcmFuZ2U6ZTFmOWIzMmU2YmE5NDVmZmFlY2E2OTU0NTFlYjA2NzJfNi00LTEtMS02MjcxMw_2cce9c1d-64db-4e79-998e-4f99d35b7221">3</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amount of the existing net gain (loss) in Accumulated other comprehensive net (loss) income as of September&#160;30, 2022 that is expected to be reclassified into Net earnings within the next twelve months is $<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMzA3MA_38dad071-7907-4544-a701-befe5536ae9c">11</ix:nonFraction>. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Risk Management and Derivative Contract Requirements</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes a variety of financial institutions as counterparties for over-the-counter derivative instruments. The Company enters into agreements governing the use of over-the-counter derivative instruments and sets internal limits on the aggregate over-the-counter derivative instrument positions held with each counterparty. Certain terms of these agreements require the Company or the counterparty to post collateral when the fair value of the derivative instruments exceeds contractually-defined counterparty liability position limits. Of the over-the-counter derivative instruments in liability positions held as of both September&#160;30, 2022 and June&#160;30, 2022, <ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="INF" name="clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMTI2NDQzODM3MzAzMzU_293488ce-2d2b-4dd6-a1d7-225f8044d74d"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="INF" name="clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMTI2NDQzODM3MzAzMzU_a2d1e7b4-20c7-4b6e-99d8-b63a53bed709">none</ix:nonFraction></ix:nonFraction> contained such terms. As of both September&#160;30, 2022 and June&#160;30, 2022, neither the Company nor any counterparty was required to post any collateral, as no counterparty liability position limits were exceeded.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain terms of the agreements governing the Company&#8217;s over-the-counter derivative instruments require the Company&#8217;s credit ratings, as assigned by Standard &amp; Poor&#8217;s and Moody&#8217;s to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating. If the Company&#8217;s credit ratings were to fall below investment grade, the counterparties to the derivative instruments could request full collateralization on derivative instruments in net liability positions. As of both September&#160;30, 2022 and June&#160;30, 2022, the Company and each of its counterparties had been assigned investment grade ratings by both Standard &amp; Poor&#8217;s and Moody&#8217;s.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s exchange traded futures and options contracts used for commodity price risk management include requirements for the Company to post collateral in the form of a cash margin account held by the Company&#8217;s broker for trades conducted on that exchange. As of September&#160;30, 2022 and June&#160;30, 2022, the Company maintained cash margin balances related to exchange traded futures and options contracts of $<ix:nonFraction unitRef="usd" contextRef="i21899b87bd5e4a699970017caa794236_I20220930" decimals="-6" name="us-gaap:MarginDepositAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMTk3OTEyMDkzMTAzMzM_02e83074-84b7-44c6-83ce-be48e0223227">2</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i767f12083ea54bc4a43b4049513c1a15_I20220630" decimals="-6" name="us-gaap:MarginDepositAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfNTAwNg_c4467ad6-a81c-43c2-8ea1-5d9a285ed0e9">1</ix:nonFraction>, respectively, which are classified as Prepaid expenses and other current assets on the condensed consolidated balance sheets.</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued)</span></div></div><ix:continuation id="i3f5c11c6565a4e7c9cf349088c5ab505" continuedAt="i6aceb2334a804910a306f13d5f51ca5a"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trust Assets</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds interests in mutual funds and cash equivalents as part of trust assets related to its nonqualified deferred compensation plans. The participants in the nonqualified deferred compensation plans, who are the Company&#8217;s current and former employees, may select among certain mutual funds in which their compensation deferrals are invested in accordance with the terms of the plans and within the confines of the trusts, which hold the marketable securities. The trusts represent variable interest entities for which the Company is considered the primary beneficiary, and, therefore, trust assets are consolidated and included in Other assets in the condensed consolidated balance sheets. The interests in mutual funds are measured at fair value using quoted market prices. The Company has designated these marketable securities as trading investments.</span></div><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfNzkzNg_62cc9847-028c-4fd8-a600-c4e1fd5b2a2d" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of both September&#160;30, 2022 and June&#160;30, 2022, the Company&#8217;s financial assets and liabilities that were measured at fair value on a recurring basis included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company&#8217;s nonqualified deferred compensation plans, which were classified as Level 1.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s derivative instruments qualify for hedge accounting. <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfNzk0NA_cca775ef-e624-490e-857e-ebf9088b9250" continuedAt="ifd84c374c76241e8aea79cfeb6760f14" escape="true">The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s derivative instruments:</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt"><ix:continuation id="ifd84c374c76241e8aea79cfeb6760f14" continuedAt="i76e3b8ca2ad24b17aa243417581df0c0"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:24.231%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.022%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.479%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase options contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i179d67c234714ee4907a95545f754ed4_I20220930" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfMy01LTEtMS02MjcxMw_7fd16673-d07c-41ea-ab61-da1c2d51907a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2217e4efada64de48ae6279d4cff1f35_I20220930" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfMy03LTEtMS02MjcxMw_5445130a-7a00-40bd-abc2-e5088556b342">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830d873fccfc4a348844a4a1ec805c4e_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfMy05LTEtMS02MjcxMw_c61df99d-2fc1-4ab6-944c-4028ed3d9fa7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2066cd30a255497092b1965c041e9697_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfMy0xMS0xLTEtNjI3MTM_13739705-1ac8-4dd2-8f20-285e1d7f5b13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9d03b4e69154fb28b379075df843c40_I20220930" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNC01LTEtMS02MjcxMw_5d6cb2f1-4f0e-45af-a01d-0335ab0f40f0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6332a61aea924b20b5a7f810ba642def_I20220930" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNC03LTEtMS02MjcxMw_ff615df4-c32f-4833-b851-f32eb5bccd74">2</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i224d9fac5a284cae8a8129752c459c15_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNC05LTEtMS02MjcxMw_986d86fe-ce0b-43e2-9f2c-b0a65f8b98e6">6</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i927e8b53d03f409c8397e57ad50983cf_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNC0xMS0xLTEtNjI3MTM_a673a96b-4951-4776-98db-6533873010c8">6</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298fa64546144e7c8725322be166049b_I20220930" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNi01LTEtMS05MjE4OQ_7eadb313-a357-40b8-8bed-e8ebe5aa1ab7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i340a0bfb85cc4a238353da0ab09b3e19_I20220930" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNi03LTEtMS05MjE5Ng_1f4483ba-39ba-4ba0-9cbb-e87d9e6451da">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f6c62d24498449dbd1912f053706e5f_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNi05LTEtMS05MjIwMw_30829e32-1640-4f80-96e2-7b9b31609df6">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i727b7773814a4b248462dd8c293d6447_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNi0xMS0xLTEtOTIyMTA_b97539cf-a83a-40d0-b2e4-89b0effeabed">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63b417fd4e2e4baca829a11debf18917_I20220930" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNy01LTEtMS02MjcxMw_ee4560af-4c2a-4aa0-8d72-15cca0cbc7cc">4</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12297feced3a40998cfae2f77b61fe69_I20220930" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNy03LTEtMS02MjcxMw_69e93375-6402-4cb8-934d-15b4ca663457">4</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5714ee2d486c40e0920537af19846e5c_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNy05LTEtMS02MjcxMw_789678e8-00ca-4ba2-9048-98b90f17e1ed">7</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ccd25a4389e4143bcd3303d5a26ad64_I20220630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNy0xMS0xLTEtNjI3MTM_098daa91-1f9e-4b5c-a240-b3050b784f00">7</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase futures contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i179d67c234714ee4907a95545f754ed4_I20220930" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfOS01LTEtMS02MjcxMw_8ea2d458-61ce-459c-a1dd-38fa204cb990">1</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2217e4efada64de48ae6279d4cff1f35_I20220930" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfOS03LTEtMS02MjcxMw_e09081f2-745a-4f2e-ada3-21901c706840">1</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830d873fccfc4a348844a4a1ec805c4e_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfOS05LTEtMS02MjcxMw_93ebf461-2afe-417a-ace9-32ccba1c6168">1</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2066cd30a255497092b1965c041e9697_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfOS0xMS0xLTEtNjI3MTM_210f4122-4b89-4107-8417-19af87233648">1</ix:nonFraction>&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63b417fd4e2e4baca829a11debf18917_I20220930" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfMTItNS0xLTEtNjI3MTM_20ffb9d8-263b-4ed9-9f03-bc8e6c83cf42">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12297feced3a40998cfae2f77b61fe69_I20220930" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfMTItNy0xLTEtNjI3MTM_bbac37e4-ea96-4630-954f-ab821e8dbb22">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5714ee2d486c40e0920537af19846e5c_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfMTItOS0xLTEtNjI3MTM_03f79db5-3332-4456-a789-cf21cd03ed01">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ccd25a4389e4143bcd3303d5a26ad64_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfMTItMTEtMS0xLTYyNzEz_c2e6f5ee-d950-49ce-8974-b9239425d198">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued)</span></div></div><ix:continuation id="i6aceb2334a804910a306f13d5f51ca5a"><ix:continuation id="i76e3b8ca2ad24b17aa243417581df0c0"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s other assets and liabilities for which disclosure of fair value is required:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:24.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.942%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.506%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-bearing investments, including money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd434cb3d24d4c54a373f4e7355f9440_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMy01LTEtMS02MjcxMw_71ef9d7f-17ae-4944-b274-3dd204faf5b4">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9857e40c16694defb9128852a3249eee_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMy03LTEtMS02MjcxMw_e1246a68-8db5-4abf-942a-35828f6ae17c">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d46c7f6455a482fb10a18e1305a3b96_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMy05LTEtMS02MjcxMw_abb3de48-fe59-4df5-b988-9057cf008433">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c19bcb918ca49c096f1881179d2c512_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMy0xMS0xLTEtNjI3MTM_5f742bfb-2da7-4a3b-9fd1-8d93f479e8fb">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time deposits</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e781035dc6444a2bee2f22c5a1fe45f_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfNC01LTEtMS02MjcxMw_76d1adc1-d041-4a6e-b266-b94c87a240fc">4</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a749b02bcb6491283cdb7b6391346d8_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfNC03LTEtMS02MjcxMw_3babb31b-ebf3-43c8-a14e-b53faae70b42">4</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40dcc202c4e041af8d2d5be92340ac45_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfNC05LTEtMS02MjcxMw_27266fb7-69c3-4a94-84d7-c51735e904f0">4</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic07dfcc355994c14808ed66f5abf1c36_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfNC0xMS0xLTEtNjI3MTM_f4c36b7d-e2dc-4852-98b1-a6cc3e3d42e3">4</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trust assets for nonqualified deferred compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeea7735269f42f1af408fc370004480_I20220930" decimals="-6" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfNy01LTEtMS02MjcxMw_9cdb65e1-bc07-4a3f-af86-0ddfb7bedc03">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9e30fd0e724ca38629fa8a85472f94_I20220930" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfNy03LTEtMS02MjcxMw_83961f33-2d8f-4886-8706-778c322ca417">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45536724bfd7435b9cb5468e757ce469_I20220630" decimals="-6" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfNy05LTEtMS02MjcxMw_c5d01595-f561-4fd3-99ae-f88902956490">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b8749fcb3a4647a6723c05d51fb551_I20220630" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfNy0xMS0xLTEtNjI3MTM_42523b36-edc5-4933-80ea-7ca1e34edbf6">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63b417fd4e2e4baca829a11debf18917_I20220930" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfOC01LTEtMS02MjcxMw_b40989a0-4bfe-40e6-a649-e75f59fa313d">290</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12297feced3a40998cfae2f77b61fe69_I20220930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfOC03LTEtMS02MjcxMw_d2261bc8-4352-45b3-a8a9-81b93198263c">290</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5714ee2d486c40e0920537af19846e5c_I20220630" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfOC05LTEtMS02MjcxMw_40cac81a-f3f6-4e4c-b4bd-440d970d9086">209</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ccd25a4389e4143bcd3303d5a26ad64_I20220630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfOC0xMS0xLTEtNjI3MTM_2d3e6a6c-8e82-490b-bc59-1a9f4903125b">209</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75626a99bf8247128cf595d793463677_I20220930" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTAtNS0xLTEtNjI3MTM_59233b9f-c924-4b3d-b2a8-3ccfcd28c392">348</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4c0c7afd9144938f80700f00e2e503_I20220930" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTAtNy0xLTEtNjI3MTM_c19e4c7b-c3f1-4907-bf60-f41e942a8e2e">348</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48ad05476c804a989876d463a18d0f08_I20220630" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTAtOS0xLTEtNjI3MTM_9bb13516-6751-4899-8d64-64036e01d788">237</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i743b074f5dff4cbb8b388b51e52d39ea_I20220630" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTAtMTEtMS0xLTYyNzEz_054301c3-8802-4322-98b8-c4abfe2d9556">237</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">term debt and Long-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77cea09568304a929a0021ea5531db88_I20220930" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTItNS0xLTEtNjI3MTM_bb839359-6ffe-4f2a-86da-075b76716a05">2,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic520fafe28c44d34ac504762a168782a_I20220930" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTItNy0xLTEtNjI3MTM_c07c38ca-c024-45ce-9211-7f5363ade77e">2,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic048de659b754fc9a1c06eb94c867694_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTItOS0xLTEtNjI3MTM_75c3e0a2-064c-482c-ac4b-3c41134cf5d9">2,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd3d0e49a60941ee8d18b67216bb2d26_I20220630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTItMTEtMS0xLTYyNzEz_e82e24a8-e984-4a72-a1e7-5d6ca36e81e0">2,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63b417fd4e2e4baca829a11debf18917_I20220930" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTMtNS0xLTEtNjI3MTM_a8fccccd-18a8-439f-87c2-b7b18493371d">2,823</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12297feced3a40998cfae2f77b61fe69_I20220930" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTMtNy0xLTEtNjI3MTM_29ada014-e2bb-43ff-9732-b4f1adfa5890">2,606</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5714ee2d486c40e0920537af19846e5c_I20220630" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTMtOS0xLTEtNjI3MTM_0ce06152-51cb-4578-9633-50d171c87c53">2,711</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ccd25a4389e4143bcd3303d5a26ad64_I20220630" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTMtMTEtMS0xLTYyNzEz_acb875a2-5f40-4f15-bd9c-e68d05ad9358">2,623</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Cash and cash equivalents are composed of time deposits and other interest-bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Notes and loans payable are composed of outstanding U.S. commercial paper balances and/or amounts drawn on the Company&#8217;s credit agreements, all of which are recorded at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_37"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5. <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNy9mcmFnOjM5NjA2ZDNlMzYzYzRiZWM5Mzc0NDA0ODE2OGE4MTcxL3RleHRyZWdpb246Mzk2MDZkM2UzNjNjNGJlYzkzNzQ0MDQ4MTY4YTgxNzFfNzg0_906a6d8b-17de-4f5f-a60c-a8ad17d2a6e4" continuedAt="i05ea887eb5ce4d48855069313e2f5687" escape="true">INCOME TAXES</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i05ea887eb5ce4d48855069313e2f5687" continuedAt="i2304902f4df144caa151347e00e2df1e">In determining its quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The effective tax rate on earnings was <ix:nonFraction unitRef="number" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNy9mcmFnOjM5NjA2ZDNlMzYzYzRiZWM5Mzc0NDA0ODE2OGE4MTcxL3RleHRyZWdpb246Mzk2MDZkM2UzNjNjNGJlYzkzNzQ0MDQ4MTY4YTgxNzFfNTM2_4faebae1-9826-4611-a248-dd96de4c48fc">25.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNy9mcmFnOjM5NjA2ZDNlMzYzYzRiZWM5Mzc0NDA0ODE2OGE4MTcxL3RleHRyZWdpb246Mzk2MDZkM2UzNjNjNGJlYzkzNzQ0MDQ4MTY4YTgxNzFfMjc0ODc3OTA3NTg3MA_92520479-834e-4c93-9019-1927ea86a7fe">22.6</ix:nonFraction>% for the three months ended September&#160;30, 2022 and 2021, respectively.</ix:continuation></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2304902f4df144caa151347e00e2df1e">The Inflation Reduction Act (the &#8220;Act&#8221;) was signed into law on August 16, 2022. The Act introduces a new 15% corporate minimum tax for certain large corporations that becomes effective at the beginning of the Company&#8217;s fiscal 2024 and it imposes a 1% excise tax on the value of share repurchases, net of new share issuances, after December 31, 2022. These provisions, as well as the other corporate tax changes included in the Act, are not expected to have a material impact on the Company&#8217;s financial statements.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6. <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RleHRyZWdpb246NmQyZTkzNjkwN2E5NDNhMmE3NjdmMzcyYTlkYjBkYzlfNTk5_d933cf76-74f0-4e7c-b3e9-ee4595cf906b" continuedAt="i4e58cd4e59c34ec391f3180a3e1161cf" escape="true">NET EARNINGS PER SHARE (EPS)</ix:nonNumeric></span></div><ix:continuation id="i4e58cd4e59c34ec391f3180a3e1161cf"><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RleHRyZWdpb246NmQyZTkzNjkwN2E5NDNhMmE3NjdmMzcyYTlkYjBkYzlfNjAx_90eb5e42-e62a-4de9-8302-0bc7af2c0fc5" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:76.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.779%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.780%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RhYmxlOjYxNTExZTYyMzgxODRjMThiOGMzYmMxYjU5OTQ2YzNjL3RhYmxlcmFuZ2U6NjE1MTFlNjIzODE4NGMxOGI4YzNiYzFiNTk5NDZjM2NfMi0xLTEtMS02MjcxMw_12f966d5-e6cf-4390-840f-fbf64dc2cd79">123,339</ix:nonFraction></span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RhYmxlOjYxNTExZTYyMzgxODRjMThiOGMzYmMxYjU5OTQ2YzNjL3RhYmxlcmFuZ2U6NjE1MTFlNjIzODE4NGMxOGI4YzNiYzFiNTk5NDZjM2NfMi0zLTEtMS02MjcxMw_7b5f7cc0-f757-4150-83a8-4935ac552265">122,980</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RhYmxlOjYxNTExZTYyMzgxODRjMThiOGMzYmMxYjU5OTQ2YzNjL3RhYmxlcmFuZ2U6NjE1MTFlNjIzODE4NGMxOGI4YzNiYzFiNTk5NDZjM2NfMy0xLTEtMS02MjcxMw_7ddf5ce8-ce13-4518-847d-bd238718e3f2">575</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RhYmxlOjYxNTExZTYyMzgxODRjMThiOGMzYmMxYjU5OTQ2YzNjL3RhYmxlcmFuZ2U6NjE1MTFlNjIzODE4NGMxOGI4YzNiYzFiNTk5NDZjM2NfMy0zLTEtMS02MjcxMw_adc19553-5690-41f6-9c5c-ae874c2aedb2">1,062</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RhYmxlOjYxNTExZTYyMzgxODRjMThiOGMzYmMxYjU5OTQ2YzNjL3RhYmxlcmFuZ2U6NjE1MTFlNjIzODE4NGMxOGI4YzNiYzFiNTk5NDZjM2NfNC0xLTEtMS02MjcxMw_4e6aa33d-a978-41eb-984b-4f9664567599">123,914</ix:nonFraction></span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RhYmxlOjYxNTExZTYyMzgxODRjMThiOGMzYmMxYjU5OTQ2YzNjL3RhYmxlcmFuZ2U6NjE1MTFlNjIzODE4NGMxOGI4YzNiYzFiNTk5NDZjM2NfNC0zLTEtMS02MjcxMw_7130cd0a-9db6-49f4-a4ab-d903d937a5ea">124,042</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antidilutive stock options and other</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RhYmxlOjYxNTExZTYyMzgxODRjMThiOGMzYmMxYjU5OTQ2YzNjL3RhYmxlcmFuZ2U6NjE1MTFlNjIzODE4NGMxOGI4YzNiYzFiNTk5NDZjM2NfNi0xLTEtMS02MjcxMw_0e1d4c40-cefd-4c90-834a-a5cde307ce65">2,983</ix:nonFraction></span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RhYmxlOjYxNTExZTYyMzgxODRjMThiOGMzYmMxYjU5OTQ2YzNjL3RhYmxlcmFuZ2U6NjE1MTFlNjIzODE4NGMxOGI4YzNiYzFiNTk5NDZjM2NfNi0zLTEtMS02MjcxMw_f157c69e-f064-4712-a407-41aa8850266c">1,068</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Clorox.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_43"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7. <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RleHRyZWdpb246NWRiNTg2YjU5Y2VlNGVlZjhlNjQyNGI5MDJjYTRiYjBfMTQ0_d22b789a-ca80-4ac5-be7f-0857c7fe4946" continuedAt="i9300f2d371814f9da1650f3ea07bceff" escape="true">COMPREHENSIVE INCOME (LOSS) </ix:nonNumeric></span></div><ix:continuation id="i9300f2d371814f9da1650f3ea07bceff"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RleHRyZWdpb246NWRiNTg2YjU5Y2VlNGVlZjhlNjQyNGI5MDJjYTRiYjBfMTQz_2782be01-cbd2-4daa-a4bc-2441283e1696" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of Comprehensive income (loss) for the periods indicated:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:76.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.733%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings </span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfMi0xLTEtMS02MjcxMw_c0e78c62-2abd-4bb8-8117-7c0302c878c3">87</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfMi0zLTEtMS02MjcxMw_c369c924-8a2c-42b4-a1c6-d4c42ca59bf9">143</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfNC0xLTEtMS02MjcxMw_aab8fbc1-b56c-4950-9c0c-af533baa30cf">29</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfNC0zLTEtMS02MjcxMw_31ef3dc5-0c5f-4825-aaa5-f11d8e8a8ba8">23</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfNS0xLTEtMS02MjcxMw_98835505-659e-4545-87fc-c511735b2e2e">8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfNS0zLTEtMS02MjcxMw_0b611720-6cc4-437b-a0e7-4a98dfcfa556">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfNi0xLTEtMS02MjcxMw_1a815c1a-9659-44c8-aee4-d689bd6ff9e6">1</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfNi0zLTEtMS02MjcxMw_318e5055-2b71-4899-87dc-bd2885da8949">1</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfNy0xLTEtMS02MjcxMw_9c4a9a01-c34d-47e1-b8da-3b85ce99a4c9">36</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfNy0zLTEtMS02MjcxMw_0deff997-0165-4524-8b45-ae3ec020ee7f">21</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfOC0xLTEtMS02MjcxMw_6acdd09a-ca5c-4a30-bbb0-a28582b0def0">51</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfOC0zLTEtMS02MjcxMw_03349e90-4929-4637-b433-ee196a80d428">122</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Total comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfOS0xLTEtMS02MjcxMw_e904032c-ef05-4d5d-afd0-75c98a77b18f">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfOS0zLTEtMS02MjcxMw_7ba6ca85-c875-43e1-9425-ccf4b4880824">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income attributable to Clorox</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfMTAtMS0xLTEtNjI3MTM_7c6e04b8-c2c0-4aa1-85f8-ae195eafd038">49</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfMTAtMy0xLTEtNjI3MTM_59ef4bb6-bea5-45bd-a0f4-7245671b0ff7">121</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_46"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8. <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RleHRyZWdpb246ZmMyZTBhOTNkMGZkNGQxZThhNjgzZGM3NWIxY2Q3MjFfODIx_4579a02c-a4bc-44e4-b8e6-a18b9823d54a" continuedAt="i4f7a44e3690646d6800948afd1ce9eee" escape="true">STOCKHOLDERS</ix:nonNumeric></span><ix:continuation id="i4f7a44e3690646d6800948afd1ce9eee" continuedAt="i54baed864a574021b8e7ff54a7ca1cb6"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> EQUITY </span></ix:continuation></div><ix:continuation id="i54baed864a574021b8e7ff54a7ca1cb6" continuedAt="i8e1044f0698d4a47b9516f15cedd289e"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RleHRyZWdpb246ZmMyZTBhOTNkMGZkNGQxZThhNjgzZGM3NWIxY2Q3MjFfODI0_fe586a10-eae7-49da-ab5b-1c4592a500b4" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the components of Stockholders&#8217; equity were as follows for the periods indicated: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30</span></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%">(Dollars in millions except per share data; shares in thousands)</span></div></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non controlling interests</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id48f7675a8794df7843115f14fe4bb25_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy0xLTEtMS02MjcxMw_3eb31081-845c-410c-a3e2-d71acb372818">131</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id48f7675a8794df7843115f14fe4bb25_I20210630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy0zLTEtMS02MjcxMw_ef8b0000-dff3-4f1e-a563-c923cc631850">130,741</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5e0252210049cfa75325d985e17243_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy01LTEtMS02MjcxMw_0f7ba922-b7ee-411c-bce7-642b802f328d">1,186</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2d95a7621de4ea1b42295baf483de7b_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy03LTEtMS02MjcxMw_fd14cb86-6388-4c54-be6b-8503dd8041ed">1,036</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7feccdfe1c8340ada0a48b4cad20e5f0_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy05LTEtMS02MjcxMw_0ca99097-568f-4361-bef1-03b4e3f50b44">1,396</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7feccdfe1c8340ada0a48b4cad20e5f0_I20210630" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy0xMS0xLTEtNjI3MTM_c21a109c-ee33-44c6-8465-452d8597c8dc">7,961</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67937b96a80447d18275ba06851fb742_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy0xMy0xLTEtNjI3MTM_161ca6e4-3f5e-4e57-8d04-b74a85676cc4">546</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56d5c5699f5b41ca84983f1f737c45bb_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy0xNS0xLTEtNjI3MTM_5c6eb1d5-a014-4b4c-9f3f-96d6d40fc538">181</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife6845f640b94b6d9b3a46784145e347_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy0xNy0xLTEtNjI3MTM_1c885a22-8c66-40e8-87ab-d9eea8acb051">592</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1a0121aacaa451b9fc9b38eb0223d9f_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNC03LTEtMS02MjcxMw_b7115b57-7707-49d7-8257-c7c7c47dec7d">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c212dd4fc614d22a2bc72979bf8a54e_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNC0xNS0xLTEtNjI3MTM_6a789ca6-4bdb-4a62-890a-279719c79fe8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNC0xNy0xLTEtNjI3MTM_51d25408-6054-48b5-ac57-e401f4556e8b">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd86e6e3a1b44f9b9471e84cc3d38d59_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNS0xMy0xLTEtNjI3MTM_99bbc2df-1e88-45e2-ab7e-14dfa6d32ca1">21</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNS0xNy0xLTEtNjI3MTM_da9a3a37-8baa-43af-a1d5-901b6105a63c">21</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders  ($<ix:nonFraction unitRef="usdPerShare" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNi0wLTEtMS02MjcxMy90ZXh0cmVnaW9uOmM4NDcwOWFhN2YwNTRmYzQ4Y2EwNTU2MTllZDY5MjZiXzM5_a6c22c7c-b640-479a-9cfa-0719da5befa6">1.16</ix:nonFraction> per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1a0121aacaa451b9fc9b38eb0223d9f_D20210701-20210930" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNi03LTEtMS02MjcxMw_013800d7-c1f3-4db5-8554-e01fa313a004">143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNi0xNy0xLTEtNjI3MTM_8884d85b-ff49-44cd-8005-e8a2124e0473">143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c212dd4fc614d22a2bc72979bf8a54e_D20210701-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNy0xNS0xLTEtNjI3MTM_df4f9091-8815-4fb7-aaa0-821f35b7ac48">3</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNy0xNy0xLTEtNjI3MTM_36c0694e-251d-4053-bffb-7b2dece5f3c4">3</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6930f355cf7642b6887d05d83aef15c5_D20210701-20210930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfOS01LTEtMS02MjcxMw_83ff0667-ab21-492e-8a08-fa36b3b5257c">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfOS0xNy0xLTEtNjI3MTM_556c148b-854c-4e29-ba51-e2ea8ebb7264">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6930f355cf7642b6887d05d83aef15c5_D20210701-20210930" decimals="-6" sign="-" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTAtNS0xLTEtNjI3MTM_ab47ae0a-22cd-413b-96d0-e99eedadce49">29</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1a0121aacaa451b9fc9b38eb0223d9f_D20210701-20210930" decimals="-6" sign="-" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTAtNy0xLTEtNjI3MTM_d66d69ba-6e73-44eb-b639-d9fa2400d541">8</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0196020330d14953b976bf363233729f_D20210701-20210930" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTAtOS0xLTEtNjI3MTM_c16881dd-91ea-418b-a4bd-23c5f2cce5ea">32</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0196020330d14953b976bf363233729f_D20210701-20210930" decimals="-3" name="clx:OtherEmployeeStockPlanActivitiesShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTAtMTEtMS0xLTYyNzEz_a11a4f62-fe6b-4c84-a16c-139538e3732f">228</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" sign="-" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTAtMTctMS0xLTYyNzEz_d8e0e823-e3df-49e0-86de-57f9c12fc2e4">5</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0196020330d14953b976bf363233729f_D20210701-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTEtOS0xLTEtNjI3MTM_f8cd0e0d-39e8-4574-a624-657dd4d272fa">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0196020330d14953b976bf363233729f_D20210701-20210930" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTEtMTEtMS0xLTYyNzEz_f723e916-cd06-4bdc-8699-e676c575cece">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTEtMTctMS0xLTYyNzEz_3a5e8d55-1eba-4eb7-ab75-f64a34cf27e8">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice68a02899784fd88d4432a3fb090772_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtMS0xLTEtNjI3MTM_791e6863-539b-49e2-9ba4-30fe599223a4">131</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice68a02899784fd88d4432a3fb090772_I20210930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtMy0xLTEtNjI3MTM_0acde1e9-e49e-462a-a08e-d4040569595f">130,741</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i730ffd508cf243709923d83ea9b803c6_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtNS0xLTEtNjI3MTM_a7c7be2f-6dfa-4d7d-bfdc-610e9fe98e8d">1,166</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c7699609a3549b8b86808d050c110d4_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtNy0xLTEtNjI3MTM_f73cebb7-76a1-40ad-af7f-32216d5938b9">1,027</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e8cfd1012e540b98b636dc848d3c3bc_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtOS0xLTEtNjI3MTM_42c4483b-b58a-4919-9ede-55a67274b1e0">1,389</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5e8cfd1012e540b98b636dc848d3c3bc_I20210930" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtMTEtMS0xLTYyNzEz_5ffa51ea-3eb1-4d3b-ba41-9b06fcb8279c">7,885</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaacd12e7523f4715be7afb04d18844aa_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtMTMtMS0xLTYyNzEz_915f2348-3597-4ddd-94d3-e6825658f304">567</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cda18cb62f44748b28447a88f322746_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtMTUtMS0xLTYyNzEz_f2adf2ae-3593-4e42-b38a-25d81bff8a3d">179</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i904c9b98d4a249328732ea1955c73b79_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtMTctMS0xLTYyNzEz_ca312306-4c5f-48ba-80be-e2f27491b812">547</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2284863f0fb44dcfae350d8ee4e1fd77_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtMS0xLTEtNjI3MTM_2db1d450-1745-4a2f-bb41-10580eda249f">131</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2284863f0fb44dcfae350d8ee4e1fd77_I20220630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtMy0xLTEtNjI3MTM_afabe80d-d0a2-4b45-8823-ef05c81d6543">130,741</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf478d53ab4b4b9f980df8bc214e13cb_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtNS0xLTEtNjI3MTM_814183d4-d987-47ed-b207-b254b1336054">1,202</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3208678276429ca1a8f3db656730ee_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtNy0xLTEtNjI3MTM_204b439b-ca14-4c02-a99b-d4b9a33d639a">1,048</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i888a4cf85c084a58ab95492d82a8d4a1_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtOS0xLTEtNjI3MTM_90ab5153-d430-4ce5-aa42-ec0e28d67d97">1,346</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i888a4cf85c084a58ab95492d82a8d4a1_I20220630" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtMTEtMS0xLTYyNzEz_d0b42761-d981-406b-b7d7-d23de69cf06e">7,589</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6052bc3b28d746c0bd0c11c456d9f13f_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtMTMtMS0xLTYyNzEz_b97bf37c-b6af-4311-87ab-466da0673447">479</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf3392f32d3409285d213bbc6902517_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtMTUtMS0xLTYyNzEz_4b9c527a-9367-4dd9-ba24-21f12716046d">173</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtMTctMS0xLTYyNzEz_3dbdeac2-1740-4bd2-a47d-174a6122d3cb">729</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94279de6d96e4bd99aef13f69b2d95d3_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTYtNy0xLTEtNjI3MTM_a7577bba-3280-4aa3-b5dc-ee60a0064876">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida1b5d30c914404b95ad3394c7bdbfe4_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTYtMTUtMS0xLTYyNzEz_047923b2-de67-44dd-bea2-3fd550c0f2b1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTYtMTctMS0xLTYyNzEz_25c3a773-07b3-45c1-ac0e-aa6f455db2e3">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12b44d1ebaff43ac9c4d3e2a2bae7d0f_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTctMTMtMS0xLTYyNzEz_86727f3c-2fcc-47b5-874c-3db4f3baf126">36</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTctMTctMS0xLTYyNzEz_0c0a36fb-f6bb-4934-aedd-caa2eb95ec05">36</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders  ($<ix:nonFraction unitRef="usdPerShare" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTgtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo0ZDkxN2M2MDJiNjQ0ZjE1ODk3MTk3ZjliMTQxNTEyOF8zOQ_529fcdd5-5a29-416c-b217-030a46935847">2.36</ix:nonFraction> per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94279de6d96e4bd99aef13f69b2d95d3_D20220701-20220930" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTgtNy0xLTEtNjI3MTM_326b7fa4-44ff-4497-b7d3-f4cd71ff5197">293</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTgtMTctMS0xLTYyNzEz_f0142bc0-1f5d-44bc-bf33-68f8b437652b">293</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida1b5d30c914404b95ad3394c7bdbfe4_D20220701-20220930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTktMTUtMS0xLTYyNzEz_ca978155-f6ff-437a-88d5-d72be79dd83a">5</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTktMTctMS0xLTYyNzEz_9911072e-4119-476f-a6f7-9e259af07c0f">5</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9d6549a44e94575912af38c44fff8a9_D20220701-20220930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjEtNS0xLTEtNjI3MTM_0d1161a6-eb85-4b01-b609-f126a8e726da">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjEtMTctMS0xLTYyNzEz_4573a53b-c37b-41ce-8862-f7286622a10d">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9d6549a44e94575912af38c44fff8a9_D20220701-20220930" decimals="-6" sign="-" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjItNS0xLTEtNjI3MTM_d278c8ab-4c75-4ace-8692-c6bee875011f">19</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94279de6d96e4bd99aef13f69b2d95d3_D20220701-20220930" decimals="-6" sign="-" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjItNy0xLTEtNjI3MTM_734dd48b-f6ce-4d4d-988b-b9a9ff46a17a">8</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b08aa96dca042dab59571ea3df315f4_D20220701-20220930" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjItOS0xLTEtNjI3MTM_a024f123-c479-4f18-81d9-3628fc13b0fe">31</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b08aa96dca042dab59571ea3df315f4_D20220701-20220930" decimals="-3" name="clx:OtherEmployeeStockPlanActivitiesShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjItMTEtMS0xLTYyNzEz_aa8568d0-1a63-4eb1-882a-a5c946d2415c">204</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="clx:OtherEmployeeStockPlanActivitiesAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjItMTctMS0xLTYyNzEz_0f70896a-39dc-467a-aa20-056ee8fbd55c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8678dafbf0e64ad3a1136c20a7706504_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtMS0xLTEtNjI3MTM_7bfa4eec-35fc-4bb3-88f7-5fa5b11059ed">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8678dafbf0e64ad3a1136c20a7706504_I20220930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtMy0xLTEtNjI3MTM_490e6442-0a4b-4767-910c-97b672c33367">130,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d1bbb06b08d40428b604d332162f94c_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtNS0xLTEtNjI3MTM_9b3d4fa1-53ac-41ef-81ac-7d65fc9a88a2">1,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffdbe24edf9f479bb05597d7938ccac2_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtNy0xLTEtNjI3MTM_7a9df46e-7923-487e-a7f7-70abf94f868d">832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2648e344424447c4982226cfa30a4b3e_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtOS0xLTEtNjI3MTM_719f193e-b4d5-442c-8f2b-5a4bdcf47980">1,315</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2648e344424447c4982226cfa30a4b3e_I20220930" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtMTEtMS0xLTYyNzEz_2480bc27-15ad-442e-86a6-3c2f31100f1f">7,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05ae02b9557f460e90131cf855f3e5b2_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtMTMtMS0xLTYyNzEz_83f9b89a-f8da-445b-8d84-864935eb612c">515</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589ef1e1d7364af18ae1c4f29b187901_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtMTUtMS0xLTYyNzEz_0341fb1c-630b-4230-8c28-122a8a8df53e">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtMTctMS0xLTYyNzEz_b0d689f0-55a3-4cf7-8b16-ce548e4bbb26">496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;margin-top:2pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8. STOCKHOLDERS&#8217; EQUITY (Continued)</span></div></div><ix:continuation id="i8e1044f0698d4a47b9516f15cedd289e"><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RleHRyZWdpb246ZmMyZTBhOTNkMGZkNGQxZThhNjgzZGM3NWIxY2Q3MjFfODE5_0bd517fd-3444-46e9-ab09-24794c8b9aef" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive net (loss) income</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf7e1839e4634249b8d12259ef4657a6_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMi0xLTEtMS02MjcxMw_26d0b2d3-54a9-4c0b-9c41-1c22ed431d1e">403</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc23221332314a54bdc672565b6ca265_I20210630" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMi0zLTEtMS02MjcxMw_9ceba2d7-f367-41b5-b80a-c51f8eb70885">21</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic430fcc6fc214744a2f1da71a2c66678_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMi01LTEtMS02MjcxMw_51d86d3d-a098-4f92-83f0-ef23da6249d4">164</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67937b96a80447d18275ba06851fb742_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMi03LTEtMS02MjcxMw_5ca4d586-9d35-44ad-bf9b-693143d7cad5">546</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c3e1b9f5f034fcdacc2d71873899331_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMy0xLTEtMS02MjcxMw_f3579a56-28fd-457e-a9c4-53cce1ce2a7b">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90d469ba619141c2ace7f747b1d68050_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMy0zLTEtMS02MjcxMw_0a03f233-2798-4bc3-a5fb-a00ab72006e9">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab66d6f5313944d98bde2718ad418ab2_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMy01LTEtMS02MjcxMw_4b5cb966-bc98-49af-9349-ecc2559509f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd86e6e3a1b44f9b9471e84cc3d38d59_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMy03LTEtMS02MjcxMw_93d37f75-1d75-4be2-b1ba-55ca0cce10a1">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c3e1b9f5f034fcdacc2d71873899331_D20210701-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNC0xLTEtMS02MjcxMw_33a1ecb5-59d3-4d59-85da-8c6d8136fc29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90d469ba619141c2ace7f747b1d68050_D20210701-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNC0zLTEtMS02MjcxMw_2fa8ab34-8e55-4340-b645-c459f05581f6">3</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab66d6f5313944d98bde2718ad418ab2_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNC01LTEtMS02MjcxMw_c5d9a49f-eb4a-4916-88e0-9566edd8f77a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd86e6e3a1b44f9b9471e84cc3d38d59_D20210701-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNC03LTEtMS02MjcxMw_e1dd8218-5b29-4df8-9d27-95c4ca5cae76">1</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c3e1b9f5f034fcdacc2d71873899331_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNS0xLTEtMS02MjcxMw_2be8272d-d315-493e-8df3-19a1481ad47c">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90d469ba619141c2ace7f747b1d68050_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNS0zLTEtMS02MjcxMw_e624987b-b657-4761-b86e-bef8b3b964da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab66d6f5313944d98bde2718ad418ab2_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNS01LTEtMS02MjcxMw_ec39cc39-1874-4daf-9a35-5bf48616938b">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd86e6e3a1b44f9b9471e84cc3d38d59_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNS03LTEtMS02MjcxMw_58f28220-e8ab-43fd-b9c4-15b5829f252f">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c3e1b9f5f034fcdacc2d71873899331_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNi0xLTEtMS02MjcxMw_318f2031-aefc-46f7-902d-2fdad1ab2e1d">23</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90d469ba619141c2ace7f747b1d68050_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNi0zLTEtMS02MjcxMw_f6be6a49-507e-4f9b-9cda-aba35431c7a3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab66d6f5313944d98bde2718ad418ab2_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNi01LTEtMS02MjcxMw_3a0b4278-180f-4738-8c96-77b2d169374d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd86e6e3a1b44f9b9471e84cc3d38d59_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNi03LTEtMS02MjcxMw_3e3837e2-186a-4de7-b0c8-3710eb7d5a40">21</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4d5e6459eff4d29a673adf7eb5402d1_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNy0xLTEtMS02MjcxMw_4effdcc0-7e28-433e-a912-5596fea8bfb5">426</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib209e83a487b430bafc14ba29f31ede4_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNy0zLTEtMS02MjcxMw_07ae1a7e-2922-471d-bc8b-6c1b746ab62c">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15f764dde95c421bbfb594d9a2886d15_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNy01LTEtMS02MjcxMw_d827c7d0-901c-43e6-9a40-e09175b7b349">163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaacd12e7523f4715be7afb04d18844aa_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNy03LTEtMS02MjcxMw_fcb25925-045c-4466-8c23-ab2498530535">567</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6eed3460799b4a04ba1ee3810ded507a_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfOS0xLTEtMS02MjcxMw_54ca7e4e-6f32-408c-af55-9c765a449ca3">448</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id337d4363166457ab49d51fd89cad69b_I20220630" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfOS0zLTEtMS02MjcxMw_d83b9423-7e8b-4818-b21b-3288f3431d24">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72dde26130df4e1c9e1eeb773672603e_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfOS01LTEtMS02MjcxMw_750f0e62-300e-41df-abcf-d977e0fa4bb1">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6052bc3b28d746c0bd0c11c456d9f13f_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfOS03LTEtMS02MjcxMw_5e50e442-05ad-4445-83e0-aed8520b1ccb">479</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3aaab4df1434368a525f9cb0ea76ec3_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTAtMS0xLTEtNjI3MTM_66f4f32f-41de-4496-902b-241b782100cd">29</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29278874f2bd4e64950e351a9d477fdb_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTAtMy0xLTEtNjI3MTM_93de85aa-0b24-4ca1-8ea3-15b5ef7da980">2</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b0a3cc9bf4444ea52a9aad02fafd3c_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTAtNS0xLTEtNjI3MTM_ad92bdd1-2fda-42c7-8588-348491aa8a25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12b44d1ebaff43ac9c4d3e2a2bae7d0f_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTAtNy0xLTEtNjI3MTM_b101d741-eebf-4a42-8839-5dad87a055a9">31</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3aaab4df1434368a525f9cb0ea76ec3_D20220701-20220930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTEtMS0xLTEtNjI3MTM_c3a8ffe0-1aa2-44d0-b3d0-4844ebee2be0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29278874f2bd4e64950e351a9d477fdb_D20220701-20220930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTEtMy0xLTEtNjI3MTM_de6d5062-dcc7-40fd-9316-b954eb1b4b33">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b0a3cc9bf4444ea52a9aad02fafd3c_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTEtNS0xLTEtNjI3MTM_6445ff44-8f1f-4bc2-bc66-733f729c095f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12b44d1ebaff43ac9c4d3e2a2bae7d0f_D20220701-20220930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTEtNy0xLTEtNjI3MTM_7eca97a7-1cc3-423a-8524-c5e0f34dee66">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense), and other</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3aaab4df1434368a525f9cb0ea76ec3_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTItMS0xLTEtNjI3MTM_2e278909-f753-4f62-8152-fe66006a027b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29278874f2bd4e64950e351a9d477fdb_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTItMy0xLTEtNjI3MTM_db2e0aac-58c1-4815-966d-385af39c8f1b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b0a3cc9bf4444ea52a9aad02fafd3c_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTItNS0xLTEtNjI3MTM_f6bf5854-a6f2-46fd-b82e-83df853cbf3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b44d1ebaff43ac9c4d3e2a2bae7d0f_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTItNy0xLTEtNjI3MTM_0be84dd0-7338-4dd3-8117-ffa7763bef24">2</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3aaab4df1434368a525f9cb0ea76ec3_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTMtMS0xLTEtNjI3MTM_da7348ba-c5cd-43c0-9908-235fbd26e646">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29278874f2bd4e64950e351a9d477fdb_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTMtMy0xLTEtNjI3MTM_c736c9c8-cd4f-42dd-922c-cb9fbdaaf0c6">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b0a3cc9bf4444ea52a9aad02fafd3c_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTMtNS0xLTEtNjI3MTM_81b30bfe-e549-4b76-b31c-49da93974278">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12b44d1ebaff43ac9c4d3e2a2bae7d0f_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTMtNy0xLTEtNjI3MTM_ecb8c269-ebbe-4a6e-932a-fb4e4f42e629">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56269e6a9fc24521a48f5dbce03064f4_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTQtMS0xLTEtNjI3MTM_f292dcf4-bb9e-4de8-923e-e261d4b55660">477</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f1f0fa07304fef96e2267e72a9854a_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTQtMy0xLTEtNjI3MTM_35932307-cada-4139-8ca3-a2d44a4a8619">113</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12cee7acd73141489be68129eaa031ae_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTQtNS0xLTEtNjI3MTM_679a11e7-205f-4c1e-aaa0-12fae0f90066">151</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05ae02b9557f460e90131cf855f3e5b2_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTQtNy0xLTEtNjI3MTM_f4b68671-8b88-47ff-b32a-6c6283efecca">515</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in foreign currency translation adjustments are remeasurement losses on long-term intercompany loans where settlement is not planned or anticipated in the foreseeable future. There were <ix:nonFraction unitRef="usd" contextRef="i800f404abef344e79689a216db23038a_D20210701-20210930" decimals="INF" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RleHRyZWdpb246ZmMyZTBhOTNkMGZkNGQxZThhNjgzZGM3NWIxY2Q3MjFfNjg3_679ea739-2e37-421a-924b-19304e3229e9"><ix:nonFraction unitRef="usd" contextRef="icab4c536fd8d4a618d358572c4a848e7_D20220701-20220930" decimals="INF" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RleHRyZWdpb246ZmMyZTBhOTNkMGZkNGQxZThhNjgzZGM3NWIxY2Q3MjFfNjg3_76eeef66-384b-4c90-80e3-a3e262375d2e">no</ix:nonFraction></ix:nonFraction> amounts associated with these loans reclassified from Accumulated other comprehensive net (loss) income for the periods presented.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9. <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfODc0_51a2d807-8c97-4b3f-bb52-4d288d98b690" continuedAt="id3b6e2e67baa41b58be36bc50c2accc0" escape="true">EMPLOYEE BENEFIT PLANS</ix:nonNumeric></span></div><ix:continuation id="id3b6e2e67baa41b58be36bc50c2accc0"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a domestic qualified pension plan (the Plan). The Plan is frozen for all participants. The Plan generally was frozen effective June 30, 2011 for all employees, except for certain collectively bargained employees, whose Plan freeze was effective January 1, 2019. As a result of the Plan freeze, no employees are eligible to commence participation in the Plan or accrue any additional benefits under the Plan.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 17, 2022, the Company&#8217;s Board of Directors approved a resolution to terminate the Plan. The amendment will allow the settlement of the pension obligation with either a lump sum payout or a purchased annuity. It is expected to take <ix:nonNumeric contextRef="i1947113776464ef48d89fbe12f701aff_D20220517-20220517" name="clx:DefinedBenefitPlanPlanTerminationPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfMTg2OTE2OTc2OTY2NzM_aa0e634c-471a-4923-a628-9db18bd288fd">18</ix:nonNumeric> to <ix:nonNumeric contextRef="if0073bc5d83c4f66b1cb1bd49f9af101_D20220517-20220517" name="clx:DefinedBenefitPlanPlanTerminationPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfMTg2OTE2OTc2OTY2Nzg_e9328058-cb64-4e84-8e14-dce7f74e55c1">24</ix:nonNumeric> months to complete the termination from the date of the approved resolution to terminate the Plan. The completion of the process of offering and accepting lump sum elections are dependent on when certain regulatory approvals are obtained. Currently, there is not enough information available to determine the ultimate charge of the termination. The Plan is fully funded under specified Employee Retirement Income Security Act (ERISA) funding rules as of September&#160;30, 2022.</span></div><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfODcx_b5ce5adb-4e3f-4225-b7ea-2158fa37643b" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of net periodic benefit cost for the Company&#8217;s retirement income plans:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31edb4dd7f44492f8d09aec0fa03e5c9_D20220701-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RhYmxlOjZhMmFhM2RlYzdjNzQzZTU4MDI5MzhjOTlkMjhmMmVlL3RhYmxlcmFuZ2U6NmEyYWEzZGVjN2M3NDNlNTgwMjkzOGM5OWQyOGYyZWVfMy0xLTEtMS02MjcxMw_d5b9b3b3-88f1-4f1a-902d-213a3a1aec5f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2294f6a1f354e1fb535db2d898d6850_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RhYmxlOjZhMmFhM2RlYzdjNzQzZTU4MDI5MzhjOTlkMjhmMmVlL3RhYmxlcmFuZ2U6NmEyYWEzZGVjN2M3NDNlNTgwMjkzOGM5OWQyOGYyZWVfMy0zLTEtMS02MjcxMw_1f2289e3-7c24-414d-865b-0b483fa75da5">4</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31edb4dd7f44492f8d09aec0fa03e5c9_D20220701-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RhYmxlOjZhMmFhM2RlYzdjNzQzZTU4MDI5MzhjOTlkMjhmMmVlL3RhYmxlcmFuZ2U6NmEyYWEzZGVjN2M3NDNlNTgwMjkzOGM5OWQyOGYyZWVfNC0xLTEtMS02MjcxMw_afdab0b5-b556-45b9-865d-4ce0edd67b1d">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic2294f6a1f354e1fb535db2d898d6850_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RhYmxlOjZhMmFhM2RlYzdjNzQzZTU4MDI5MzhjOTlkMjhmMmVlL3RhYmxlcmFuZ2U6NmEyYWEzZGVjN2M3NDNlNTgwMjkzOGM5OWQyOGYyZWVfNC0zLTEtMS02MjcxMw_cadc2454-c70f-4a82-afa0-bea9936862b2">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized items</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31edb4dd7f44492f8d09aec0fa03e5c9_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RhYmxlOjZhMmFhM2RlYzdjNzQzZTU4MDI5MzhjOTlkMjhmMmVlL3RhYmxlcmFuZ2U6NmEyYWEzZGVjN2M3NDNlNTgwMjkzOGM5OWQyOGYyZWVfNi0xLTEtMS02MjcxMw_3e34d8b8-f2ee-438d-9b75-14fdf7bb4420">2</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2294f6a1f354e1fb535db2d898d6850_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RhYmxlOjZhMmFhM2RlYzdjNzQzZTU4MDI5MzhjOTlkMjhmMmVlL3RhYmxlcmFuZ2U6NmEyYWEzZGVjN2M3NDNlNTgwMjkzOGM5OWQyOGYyZWVfNi0zLTEtMS02MjcxMw_991cd769-62de-4d8d-ae9c-286ef5445550">2</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31edb4dd7f44492f8d09aec0fa03e5c9_D20220701-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RhYmxlOjZhMmFhM2RlYzdjNzQzZTU4MDI5MzhjOTlkMjhmMmVlL3RhYmxlcmFuZ2U6NmEyYWEzZGVjN2M3NDNlNTgwMjkzOGM5OWQyOGYyZWVfNy0xLTEtMS02MjcxMw_025b0347-5451-41df-89c8-98be13dc2e9e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2294f6a1f354e1fb535db2d898d6850_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RhYmxlOjZhMmFhM2RlYzdjNzQzZTU4MDI5MzhjOTlkMjhmMmVlL3RhYmxlcmFuZ2U6NmEyYWEzZGVjN2M3NDNlNTgwMjkzOGM5OWQyOGYyZWVfNy0zLTEtMS02MjcxMw_a5fef653-c23f-4d0d-b456-ef48e4cd93b2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2023 net periodic benefit cost is <ix:nonFraction unitRef="number" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfMjk3_945d13fd-9d9d-477e-a882-d57d460313d2">2.7</ix:nonFraction>%.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic benefit cost for the Company&#8217;s retirement health care plans was $<ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfMzgy_02998270-091a-41eb-8215-0a842d7625aa"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfMzgy_f4684324-7372-4246-9145-e4d806c8928d">0</ix:nonFraction></ix:nonFraction> for both the three months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2022 and 2021, the Company made $<ix:nonFraction unitRef="usd" contextRef="id270c77784994d6b9347452cfa7bcfd5_D20220701-20220930" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfNDkw_dd96d968-ec97-4095-ae28-c1b1fe66a696">2</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="id55f7224e21846c3acf2d3b00db79eb7_D20210701-20210930" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfNDk3_5863ec84-daab-4447-b7ee-23a0d22a2af0">3</ix:nonFraction> in contributions to its domestic retirement income plans, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service cost component of the net periodic benefit cost, if any, is reflected in employee benefit costs, all other components are reflected in Other (income) expense, net.</span></div></ix:continuation><div><span><br/></span></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_52"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10. <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfNDcyNQ_7e67b10d-1264-4fc8-aff9-fd3ed88c2e27" continuedAt="i5f60e64c9fef4c8c95a42e7077a78490" escape="true">OTHER CONTINGENCIES AND GUARANTEES</ix:nonNumeric></span></div><ix:continuation id="i5f60e64c9fef4c8c95a42e7077a78490" continuedAt="id5d9e1950f0b492ab0a7807ff77a53ee"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in certain environmental matters, including response actions at various locations. The Company had recorded liabilities totaling $<ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTk3OTEyMDkzMDY5NTE_962658d4-f1bb-4008-bc71-ce7adc72a4ec">27</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if09ffc76813043a5aa916a91f25540db_I20220630" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMjE2_5d663527-6016-4aec-bcdf-e3bd68417d5a">28</ix:nonFraction> as of September&#160;30, 2022 and June&#160;30, 2022, respectively, for its share of aggregate future remediation costs related to these matters. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One matter, which accounted for $<ix:nonFraction unitRef="usd" contextRef="id97f6cb32d4443f685b8c442cb50ea2d_I20220930" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMzUy_45f70106-4a41-40ba-a5f5-1c1ae2e03153">13</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i227c62eeec2344e5bec7da0b046fdc53_I20220630" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTk3OTEyMDkzMDY5NjY_c2bb48a7-73fb-4dbf-8e2c-8744fa97da4f">14</ix:nonFraction> of the recorded liability as of September&#160;30, 2022 and June&#160;30, 2022, respectively, relates to environmental costs associated with one of the Company&#8217;s former operations at a site located in Alameda County, California. In November 2016, at the request of regulators and with the assistance of environmental consultants, the Company submitted a Feasibility Study that evaluated various options for managing the site and included estimates of the related costs. Following further discussions with the regulators in 2017, the Company recorded an undiscounted liability for costs estimated to be incurred over a <ix:nonNumeric contextRef="ie6800724d53e43ac84874399f3d245da_D20220701-20220930" name="clx:RemediationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTY0OTI2NzQ0ODU1MQ_2827ae9b-a31b-45b1-bf68-9906c22be88d">30-year</ix:nonNumeric> period, based on one of the options in the Feasibility Study. In September 2021, as a result of an additional study and further discussions with regulators, the Company submitted a Soil Vapor Intrusion Report to the regulators, which has not resulted in a change to the recorded liability. While the Company believes its latest estimates of remediation costs are reasonable, the ultimate remediation requirements are not yet finalized and the regulators could require the Company to implement remediation actions for a longer period or take additional actions, which could include estimated undiscounted costs of up to approximately $<ix:nonFraction unitRef="usd" contextRef="id97f6cb32d4443f685b8c442cb50ea2d_I20220930" decimals="-6" name="clx:MaximumExposureUndiscountedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTU2OA_ab6444a0-29e5-43ca-b774-8e70c36c565f">28</ix:nonFraction> over an estimated <ix:nonNumeric contextRef="ie6800724d53e43ac84874399f3d245da_D20220701-20220930" name="clx:RemediationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTY0OTI2NzQ0ODU1MA_64493927-8445-4fbd-8ba4-4ed2bb3413f7">30-year</ix:nonNumeric> period, or require the Company to take different actions and incur additional costs. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Another matter in Dickinson County, Michigan, at the site of one of the Company&#8217;s former operations for which the Company is jointly and severally liable, accounted for $<ix:nonFraction unitRef="usd" contextRef="i806e73012b0a480488ca9ea714e35107_I20220930" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTg1Mg_50910c6b-4dc2-4fad-a57e-97acb3a73580"><ix:nonFraction unitRef="usd" contextRef="i5b7963d1f14a45a09a9a46e7127d2f99_I20220630" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTg1Mg_944214ab-8fb4-4006-8ee4-6b81b89f622f">9</ix:nonFraction></ix:nonFraction> of the recorded liability as of both September&#160;30, 2022 and June&#160;30, 2022. This amount reflects the Company&#8217;s agreement to be liable for <ix:nonFraction unitRef="number" contextRef="i849355af7bdb45cc8899544e54dcb57c_D20220701-20220930" decimals="3" name="clx:SiteContingencyAgreedPercentageOfCostSharing" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTk4Mg_fe9cf49b-4dc4-4e78-aa0b-5054e63b9e31">24.3</ix:nonFraction>% of the aggregate remediation and associated costs for this matter pursuant to a cost-sharing agreement with a third party. If the third party is unable to pay its share of the response and remediation obligations, the Company may be responsible for such obligations. With the assistance of environmental consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10: OTHER CONTINGENCIES AND GUARANTEES (continued)</span></div></div><ix:continuation id="id5d9e1950f0b492ab0a7807ff77a53ee"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expenditures, maintenance and other costs that may be incurred over an estimated <ix:nonNumeric contextRef="i849355af7bdb45cc8899544e54dcb57c_D20220701-20220930" name="clx:RemediationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTY0OTI2NzQ0ODU1Mg_c00f282b-38e8-4b01-8db6-11726ea6012c">30-year</ix:nonNumeric> remediation period. Although it is reasonably possible that the Company&#8217;s exposure may exceed the amount recorded for the Dickinson County matter, any amount of such additional exposures, or range of exposures, is not estimable at this time. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimated losses related to these matters are sensitive to a variety of uncertain factors, including the efficacy of any remediation efforts, changes in any remediation requirements and the future availability of alternative clean-up technologies. The Company is subject to various legal proceedings, claims and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements (including costs connected to the transition and unwinding of certain supply and manufacturing relationships), product liability, patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters. With respect to these proceedings, claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, either individually or in the aggregate, on the Company&#8217;s condensed consolidated financial statements taken as a whole.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with divestitures and other transactions, the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it is probable that it will make, any material payments relating to its indemnifications, and believes that any reasonably possible payments would not have a material adverse effect, either individually or in the aggregate, on the Company&#8217;s condensed consolidated financial statements taken as a whole.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had not recorded any material liabilities on the aforementioned as of both September&#160;30, 2022 and June&#160;30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was a party to letters of credit of $<ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="clx:LetterOfCreditBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTk3OTEyMDkzMDY5Nzc_0ed3f4ba-7c56-4e3d-865e-aaafe65799e8">15</ix:nonFraction> as of September&#160;30, 2022, primarily related to its insurance carriers, of which $<ix:nonFraction unitRef="usd" contextRef="ief9b7921268144ca978e6451b72f275f_I20220930" decimals="-6" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfNDcwMg_861034d2-7bc0-4591-9ea2-fcfd7a98982e">0</ix:nonFraction> had been drawn upon.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11. <ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RleHRyZWdpb246ZTcxNjUyYzIxN2ZkNDJkNzljZjEwZjcwZGRiZGJlNzBfMTU1OA_e513f6a1-7830-47b2-8cc4-eefbd753b291" continuedAt="i9eccc764ef2e4f8bbb50bbb8c28bac27" escape="true">SEGMENT RESULTS</ix:nonNumeric></span></div><ix:continuation id="i9eccc764ef2e4f8bbb50bbb8c28bac27" continuedAt="i5b75f7586a004c79ac4938a4f683be86"><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RleHRyZWdpb246ZTcxNjUyYzIxN2ZkNDJkNzljZjEwZjcwZGRiZGJlNzBfMTU0OQ_ce523cde-ccae-475a-9fc5-1e8c84b4c3ee" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates through strategic business units (SBUs) that are also the Company&#8217;s operating segments. The SBUs are then aggregated into <ix:nonFraction unitRef="reportablesegment" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RleHRyZWdpb246ZTcxNjUyYzIxN2ZkNDJkNzljZjEwZjcwZGRiZGJlNzBfMTcz_dce25948-a682-47e9-8989-de54cbd1078e">four</ix:nonFraction> reportable segments: Health and Wellness, Household, Lifestyle and International. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RleHRyZWdpb246ZTcxNjUyYzIxN2ZkNDJkNzljZjEwZjcwZGRiZGJlNzBfMTU1NQ_c9e2df3a-f5c6-4549-a099-f2bac34e6001" continuedAt="i02fdaf0d16c5422a97188ee30c58b0a0" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present reportable segment information and a reconciliation of the segment information to the Company&#8217;s consolidated net sales and earnings (losses) before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.130%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e8cd95aed9b4c81901ca7d5a53d1ce1_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMy0yLTEtMS02MjcxMw_8fcbe239-a2f8-46ea-86f6-3c5d7660ad81">712</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26e621abaf0d47d4b39a2fa43224768f_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMy00LTEtMS02MjcxMw_6ba1c773-4e6f-444c-9e6b-21ac65dac932">745</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69dc302ea5d43f9bc300bfd696c1476_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfNC0yLTEtMS02MjcxMw_d999db1d-c907-493d-9097-a98fe8ac4fa7">423</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dadaf4c1716414abfe9786d4d65c91c_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfNC00LTEtMS02MjcxMw_b1387c06-cd87-4af9-a780-c13f1a778650">442</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b42821a22844c5ca6f9e44fd13cb6c1_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfNS0yLTEtMS02MjcxMw_9561194e-9fa6-4c79-8123-e31180f58255">320</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0de7a722ac64da8858c7bf8cee9b411_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfNS00LTEtMS02MjcxMw_cc162576-bc33-478e-bf3e-77e683315d0c">331</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f89b0641ef04737bd695667b84a20c8_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfNi0yLTEtMS02MjcxMw_b8335bd2-da9a-4bd4-8c0c-a80a77258daf">285</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6d2033d94204c51b0c34eb17cd5f6b5_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfNi00LTEtMS02MjcxMw_61fd957c-1995-4adf-a074-1a4c89ac7ce1">288</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfOC0yLTEtMS02MjcxMw_1048203a-66bf-4694-a480-2d70aa3e8493">1,740</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfOC00LTEtMS02MjcxMw_f972c41b-80fb-4112-af95-b67ca578e154">1,806</ix:nonFraction>&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (losses) before income taxes</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e8cd95aed9b4c81901ca7d5a53d1ce1_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTMtMi0xLTEtNjI3MTM_1d10be57-43de-45d2-8e12-ab2ae22711f0">115</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26e621abaf0d47d4b39a2fa43224768f_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTMtNC0xLTEtNjI3MTM_0f886f59-a158-4267-a590-8ea0d41ae658">105</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69dc302ea5d43f9bc300bfd696c1476_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTQtMi0xLTEtNjI3MTM_a032d66b-5438-47d5-9f29-2a187863e167">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dadaf4c1716414abfe9786d4d65c91c_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTQtNC0xLTEtNjI3MTM_a83596ab-d01c-422e-b6a9-3854a125047d">36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b42821a22844c5ca6f9e44fd13cb6c1_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTUtMi0xLTEtNjI3MTM_3d05c89c-485f-40a1-963a-c6f8323b070f">60</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0de7a722ac64da8858c7bf8cee9b411_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTUtNC0xLTEtNjI3MTM_a98ed3f5-aead-4590-98be-930a5e5e34b0">93</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f89b0641ef04737bd695667b84a20c8_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTYtMi0xLTEtNjI3MTM_a71ecc9b-91b9-48ef-8af1-c1810fe2b916">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6d2033d94204c51b0c34eb17cd5f6b5_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTYtNC0xLTEtNjI3MTM_4adbe5ee-cf3b-4bdc-ab10-56b4439ce33e">30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i606ff00a1b9e43a3a6959e8d1ebb4977_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTctMi0xLTEtNjI3MTM_a3388ee8-e09a-40bc-88b7-e22d1d1fa64b">104</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3fa7b12816f411cbaf987175543040a_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTctNC0xLTEtNjI3MTM_6f87e157-3468-46d4-8795-955da4d34b53">79</ix:nonFraction>)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTgtMi0xLTEtNjI3MTM_ec0a9197-32a1-4e46-8239-a60336ecc625">116</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTgtNC0xLTEtNjI3MTM_1dd779a7-478f-45c6-b091-9086e9397fe5">185</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> The earnings (losses) before income taxes for Corporate includes restructuring and related implementation costs, net for the streamlined operating model of $<ix:nonFraction unitRef="usd" contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RleHRyZWdpb246ZTcxNjUyYzIxN2ZkNDJkNzljZjEwZjcwZGRiZGJlNzBfMTY0OTI2NzQ0NzQ4OA_cd6634b2-fdbc-472e-aa98-e00f2c9a77a9">19</ix:nonFraction> for the three-months ended September 30, 2022. While recorded within the Corporate segment, for informational purposes the following table provides the approximate restructuring and related implementation costs, net corresponding to the Company&#8217;s reportable segments as a percentage of the total costs: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.140%"><tr><td style="width:1.0%"></td><td style="width:24.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.107%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.901%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3a5f78e9f3c74fa9b02f7b5e6ee65670_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmRlNzM4YzdiYzc5NDRhNzliYWNlNDYwZjI1YmEwMjM1L3RhYmxlcmFuZ2U6ZGU3MzhjN2JjNzk0NGE3OWJhY2U0NjBmMjViYTAyMzVfMi0zLTEtMS0xMDc4NTI_66e16fa4-b013-489c-8352-47324dee4ee4">6</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2183c0c64c434e5a9aeea41c54cb625b_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmRlNzM4YzdiYzc5NDRhNzliYWNlNDYwZjI1YmEwMjM1L3RhYmxlcmFuZ2U6ZGU3MzhjN2JjNzk0NGE3OWJhY2U0NjBmMjViYTAyMzVfMy0zLTEtMS0xMDk0MTQ_33e2f315-e20f-4f4a-a2be-d09cca187891">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i74eb275af8db41049d9007f8bc834661_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmRlNzM4YzdiYzc5NDRhNzliYWNlNDYwZjI1YmEwMjM1L3RhYmxlcmFuZ2U6ZGU3MzhjN2JjNzk0NGE3OWJhY2U0NjBmMjViYTAyMzVfNC0zLTEtMS0xMDk0MTQ_30cee946-5a03-4f9c-8015-33126f8b890f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3048afb6b1df4c98bbe9928ae66d4d4d_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmRlNzM4YzdiYzc5NDRhNzliYWNlNDYwZjI1YmEwMjM1L3RhYmxlcmFuZ2U6ZGU3MzhjN2JjNzk0NGE3OWJhY2U0NjBmMjViYTAyMzVfNS0zLTEtMS0xMDk0MTQ_5b5ce435-b223-407d-bb03-f2792f4859da">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3dbef4e516584b3c8b89e91c01bce178_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmRlNzM4YzdiYzc5NDRhNzliYWNlNDYwZjI1YmEwMjM1L3RhYmxlcmFuZ2U6ZGU3MzhjN2JjNzk0NGE3OWJhY2U0NjBmMjViYTAyMzVfNi0zLTEtMS0xMDk0MTQ_8b924e97-0141-49ab-b79b-3246192afe24">70</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3007927605bd40d6aa8bd18ae2feac19_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmRlNzM4YzdiYzc5NDRhNzliYWNlNDYwZjI1YmEwMjM1L3RhYmxlcmFuZ2U6ZGU3MzhjN2JjNzk0NGE3OWJhY2U0NjBmMjViYTAyMzVfNy0zLTEtMS0xMDk0MTQ_6d9edad6-000a-4483-abbf-f9ec903cc97b">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intersegment sales are eliminated and are not included in the Company&#8217;s reportable segments&#8217; net sales.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales to the Company&#8217;s largest customer, Walmart Inc. and its affiliates, as a percentage of consolidated net sales, were <ix:nonFraction unitRef="number" contextRef="i825a3f474bef4d57a41b659e4276eb92_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RleHRyZWdpb246ZTcxNjUyYzIxN2ZkNDJkNzljZjEwZjcwZGRiZGJlNzBfMTM2MA_93a6d8f3-395e-4e6e-9b2b-922bfa3837a3">27</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i4923cfb94e8049c1ba541c14e5fc41f1_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RleHRyZWdpb246ZTcxNjUyYzIxN2ZkNDJkNzljZjEwZjcwZGRiZGJlNzBfMjc0ODc3OTA3NTMxMA_58941595-4e7f-4adf-b659-92e8d3512d37">25</ix:nonFraction>% for the three months ended September&#160;30, 2022 and 2021, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11. SEGMENT RESULTS (Continued)</span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><ix:continuation id="i5b75f7586a004c79ac4938a4f683be86"><ix:continuation id="i02fdaf0d16c5422a97188ee30c58b0a0"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides Net sales as a percentage of the Company&#8217;s consolidated net sales, disaggregated by SBU, for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.582%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cleaning</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8b90eb0ef6054ab7a5b9de59365a28ac_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMy0yLTEtMS02MjcxMw_621c0576-deb9-4723-b1bb-8ccccd129410">33</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i746c110841a342e1b5c9555eaa2e1ce1_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMy01LTEtMS02MjcxMw_01066a15-0c34-485d-a8b0-e3d97d7f11b8">33</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iedec36bdebec43808dffc518431446b5_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfNC0yLTEtMS02MjcxMw_ac610203-386e-451d-8466-a867b0916565">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide10fb2fb37f424dbdc6a428a5cbd88a_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfNC01LTEtMS02MjcxMw_dcc60cb3-72a4-4a70-8a15-241e6bbcfb7a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vitamins, Minerals and Supplements</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61a07a11680e4116a22f12f9e4f59402_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfNS0yLTEtMS02MjcxMw_2d35f0e4-cb18-4df2-bdd0-0e38ec29047c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ab02c4c09bc448e9e4bbf6710b688a3_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfNS01LTEtMS02MjcxMw_e5c68af4-6aca-4880-bf7e-6f33dde6aa38">3</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i417b78725106447a96236599f5fe7024_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfNi0yLTEtMS02MjcxMw_25b9f9fe-aa98-4726-9235-7d601de57f9d">41</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3830eddd6eec4653b1b850774f83f799_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfNi01LTEtMS02MjcxMw_5055f5e0-6ea8-455d-8247-501f4688e817">41</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bags and Wraps</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i79dab9a38edd41d3a954624d9e05a0bb_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfNy0yLTEtMS02MjcxMw_f506bdff-4d2c-4a40-9245-fb0683ff9be6">11</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie8117aec118647b49d7490ddbaeaea3e_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfNy01LTEtMS02MjcxMw_df37ec84-d9a1-4b88-bbcd-32cd4c61e3a0">12</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grilling</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97d7a4a287334750b35878de0c632079_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfOC0yLTEtMS05MjcxOA_1fdbd248-cac4-40d0-ad79-a62dba9b51da">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26bbe833ac1640c89c7c526a81516775_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfOC01LTEtMS05MjcxOA_03510dd5-4729-46e9-9b7e-b69c03e8ddf1">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cat Litter</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i052b0fc813da42178769b516bf6454df_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfOC0yLTEtMS02MjcxMw_5d3355f1-4374-400f-827a-b20ad0bdf5f5">8</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i159d29d0958b4e4bba0eedf9dd60d3b5_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfOC01LTEtMS02MjcxMw_5eaa3cf7-06a9-43d1-8381-d1043d6ca572">7</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i684f9f739fd74d75980dc46564a4fc1d_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTAtMi0xLTEtNjI3MTM_265fd4d7-d078-45bd-ac5f-b5b015bd2efa">24</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2769b1c5b55f417f9f0a0b3a7b69c023_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTAtNS0xLTEtNjI3MTM_a118a1f4-5cf8-4ebf-8520-c40156b93c01">25</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Food</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i264bcb59d1fb4a8b8f8f5ad7b7fe1dd8_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTEtMi0xLTEtNjI3MTM_be2858db-7ab0-4635-b966-592b58f0c9ac">10</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7ed314c335fd49008ec3b335ea3c14f9_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTEtNS0xLTEtNjI3MTM_f0a17d8c-d32b-41f1-8584-37b6f852d7ff">9</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natural Personal Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i260a34245a4a4431a0f5f91d94de3567_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTItMi0xLTEtNjI3MTM_02249e4a-4330-4a70-8b0f-b999d7bd8b4e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42e6cf57392445509d1e157867ac3729_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTItNS0xLTEtNjI3MTM_d47cf153-6d52-499c-8b4f-76cf5402d500">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Water Filtration</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i68962e875b5c463d9cda87f98c695ea9_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTMtMi0xLTEtNjI3MTM_bd43d1cc-e844-4710-a326-6b759635d151">5</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie488b698386942d488eb9191bf6c03e9_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTMtNS0xLTEtNjI3MTM_784c6551-004d-4884-a219-1c78ee43f4b1">5</ix:nonFraction>&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8ca24239316c482eaa1b9a014e855a41_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTQtMi0xLTEtNjI3MTM_ee24ec34-562a-44bb-9d65-f4c67552f039">19</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id94210280c4f459a95a0145d49e7170a_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTQtNS0xLTEtNjI3MTM_90b66b3a-3ea8-42ad-a311-c67a3cdb6e4a">18</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i59c4149e9cc24e3abe5f72106c11a911_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTUtMi0xLTEtNjI3MTM_23b4d277-4fab-4d53-b3a4-3009af5e5e18">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55565f7982054624baa5bc769685ff9a_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTUtNS0xLTEtNjI3MTM_b0cfd8e7-96bc-4960-986b-7af4c5b0af29">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia206ce29644b481c940c521fcb640e60_D20220701-20220930" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTYtMi0xLTEtNjI3MTM_faa6adb1-2b3f-4050-bbb5-17a66c7cb97b">100</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3315b5d84b164803b2a50689febd9ff5_D20210701-20210930" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTYtNS0xLTEtNjI3MTM_f34ea846-c2cf-4ca7-9183-f2bed86a1855">100</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></ix:continuation></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Clorox Company</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in millions, except per share data)</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (MD&amp;A) is designed to provide a reader of The Clorox Company&#8217;s (the Company or Clorox) financial statements with a narrative from the perspective of management on the Company&#8217;s financial condition, results of operations, liquidity and certain other factors that may affect future results. The following discussion of the Company&#8217;s financial condition and results of operations should be read in conjunction with MD&amp;A and the consolidated financial statements and related notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2022, which was filed with the SEC on August 10, 2022, and the unaudited condensed consolidated financial statements and related notes contained in this Quarterly Report on Form 10-Q (this Report). Unless otherwise noted, MD&amp;A compares the three month periods ended September&#160;30, 2022 (the current period) to the three month periods ended September&#160;30, 2021 (the prior period), with percentage and basis point calculations based on rounded numbers, except for per share data and the effective tax rate.</span></div><div style="margin-top:8pt"><span><br/></span></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_61"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE OVERVIEW</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clorox is a leading multinational manufacturer and marketer of consumer and professional products with approximately 9,000 employees worldwide. Clorox sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, drug, pet and military stores, third-party and owned e-commerce channels, and distributors. Clorox markets some of the most trusted and recognized consumer brand names, including its namesake bleach and cleaning products, Pine-Sol</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cleaners; Liquid-Plumr</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> clog removers; Poett</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> home care products; Fresh Step</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cat litter; Glad</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> bags and wraps; Kingsford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> grilling products; Hidden Valley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dressings, dips, seasonings and sauces; Brita</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> water-filtration products; Burt&#8217;s Bees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> natural personal care products; and RenewLife</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Rainbow Light</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Natural Vitality</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and NeoCell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vitamins, minerals and supplements. The Company also markets industry-leading products and technologies for professional customers, including those sold under the CloroxPro</span><span style="color:#0a0a0a;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Clorox Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand names. The Company has operations in more than 25 countries or territories and sells its products in more than 100 markets.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company primarily markets its leading brands in midsized categories considered to be financially attractive. Most of the Company&#8217;s products compete with other nationally advertised brands within each category and with &#8220;private label&#8221; brands.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates through strategic business units (SBUs) that are also the Company&#8217;s operating segments. These SBUs are then aggregated into four reportable segments: Health and Wellness, Household, Lifestyle and International. These four reportable segments consist of the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Health and Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the U.S. Products within this segment include cleaning products such as laundry additives and home care products, primarily under the Clorox</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Clorox2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Scentiva</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Pine-Sol, Liquid-Plumr, Tilex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Formula 409</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplements under the RenewLife, Natural Vitality, NeoCell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Rainbow Light brands.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Household</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of bags and wraps, grilling products and cat litter marketed and sold in the U.S. Products within this segment include bags and wraps under the Glad brand; grilling products under the Kingsford brand; and cat litter primarily under the Fresh Step</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Scoop Away</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Lifestyle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of food, natural personal care products and water-filtration products marketed and sold in the U.S. Products within this segment include dressings, dips, seasonings and sauces, primarily under the Hidden Valley brand; natural personal care products under the Burt&#8217;s Bees brand; and water-filtration products under the Brita brand.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of products sold outside the U.S. Products within this segment include laundry additives, home care products, water-filtration products, digestive health products; grilling products; cat litter; food; bags and wraps; natural personal care products; and professional cleaning and disinfecting products marketed primarily under the Clorox, Ayudin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Clorinda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Burt&#8217;s Bees brands.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RECENT EVENTS AFFECTING THE COMPANY</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal quarter ended September&#160;30, 2022, the Company continued to experience supply chain disruptions including the impacts of cost inflation resulting in persistently high manufacturing and logistics costs as well as higher commodity costs. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to these evolving challenges, ongoing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">uncertainties and economic and social disruptions remained present due to the continued effects of the coronavirus (COVID-19) pandemic, which were further heightened by the conflict in Ukraine that began in the previous fiscal year.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While demand for many of the products across the Company's portfolio remained strong compared to pre-pandemic levels, it has moderated versus the initial periods of the COVID-19 pandemic. An</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> inflationary environment marked by supply chain disruptions, higher manufacturing and logistics costs and higher commodity costs is expected to continue through fiscal year 2023. While we have not experienced significant disruptions in our operations during fiscal year 2023 to date, the risks of future negative impacts due to transportation, logistical or supply constraints and higher commodity costs for certain raw materials remain present, and the Company continues to experience corresponding incremental costs and gross margin pressures. For fiscal year 2023, the Company&#8217;s focus will be on addressing supply chain disruptions and volatility in commodity costs and foreign exchange markets and countering inflationary pressures through pricing actions and cost-cutting measures. In order to enhance the Company&#8217;s ability to respond more quickly to changing consumer behaviors and innovate faster, the Company has announced a streamlined operating model to be implemented over the course of fiscal years 2023 and 2024.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of continued inflationary pressures and geopolitical events, specifically the conflict in Ukraine, have increased global economic and political uncertainty due to the uncertainty around the duration and resolution of the conflict and potential economic and global supply chain disruptions. Additionally, the extent of COVID-19&#8217;s effect on the Company&#8217;s operational and financial performance in the future will depend on future developments, including the duration, spread, intensity and phase of the pandemic in different countries, the emergence of COVID-19 variants and the effectiveness of vaccines against these variants, the Company&#8217;s continued ability to manufacture and distribute its products, any future government actions affecting consumers, our business operations, including any vaccine mandates, or the economy in general, and effectiveness of global vaccines. All of these factors are difficult to predict considering the rapidly evolving landscape as the Company continues to expect a variable operating environment going forward. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on the impacts and our response to the coronavirus pandemic, refer to &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in Exhibit 99.1 of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2022.</span></div><div style="margin-top:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONSOLIDATED RESULTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,740&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,806&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.455%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage change versus the year-ago period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported (GAAP) Net Sales Growth / (Decrease)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Volume</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Acquisitions &amp; Divestitures</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Exchange Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Price/Mix/ Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Organic Sales Growth / (Decrease) (Non-GAAP)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Organic Volume </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) This represents the net impact on net sales growth / (decrease) from pricing actions, mix and other factors.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Organic sales growth/ (decrease) is defined as net sales growth / (decrease) excluding the effect of any acquisitions and divestitures and foreign exchange rate changes. See &#8220;Non-GAAP Financial Measures&#8221; below for reconciliation of organic sales growth / (decrease) to net sales growth / (decrease), the most directly comparable GAAP financial measure.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) Organic volume represents volume excluding the effect of any acquisitions and divestitures.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the current period decreased by 4%, reflecting lower shipments across all reportable segments. Volume decreased by 15% versus the prior period. The variance between volume and net sales was primarily due to the impact of favorable price mix.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased by 110 basis points in the current period from 37.1% to 36.0%. The decrease was primarily driven by higher manufacturing and logistics costs, unfavorable commodity costs and lower volume, partially offset by the benefit of price increases and cost savings. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expenses</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:33.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expenses</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as a percentage of net sales, increased by 190 basis points in the current period. The dollar increase in selling and administrative expenses was primarily due to the Company&#8217;s digital capabilities and productivity enhancements investments. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as a percentage of net sales, decreased by 80 basis points in the current period. The dollar decrease in advertising costs was primarily due to the timing of advertising spend. The Company&#8217;s U.S. retail advertising spend as a percentage of net sales was 11% in the current and prior periods.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a percentage of net sales, were essentially flat in the current period as compared to the prior period. The Company continues to invest behind product innovation and cost savings.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense, Other (income) expense, net, and the effective tax rate on earnings</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate on earnings</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $34 and $9 in the current and prior period, respectively.The variance was primarily due to restructuring and related implementation costs associated with the streamlined operating model incurred in the current period. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring and related costs</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2023, the Company began recognizing costs related to a plan that involves streamlining its operating model to meet its objectives of driving growth and productivity. The streamlined operating model is expected to enhance the Company&#8217;s ability to respond more quickly to changing consumer behaviors and innovate faster. The Company anticipates the implementation of this new model will be completed in fiscal year 2024, with different phases occurring throughout the implementation period.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once fully implemented, the Company expects annual cost savings to be approximately $75 to $100 annually, with benefits of approximately $25 anticipated in fiscal year 2023. The benefits of the streamlined operating model are currently expected to increase future cash flows as a result of cost savings that will be generated primarily in the areas of selling and administration, supply chain, marketing and research and development.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company anticipates incurring approximately $75 to $100 of costs in fiscal years 2023 and 2024 related to this initiative, of which approximately $35 is expected to be incurred in fiscal year 2023. Related costs are primarily expected to include employee-related costs to reduce certain staffing levels such as severance payments, as well as for consulting and other costs. Costs incurred are expected to be settled primarily in cash.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and related implementation costs, net were $19 for the three months ended September&#160;30, 2022, of which $16 was related to employee-related costs and $3 was related to other costs. For further details on the streamlined operating model and restructuring, refer to the Notes to Consolidated Financial Statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The effective tax rate on earnings </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was 25.0% and 22.6% for the current and prior period, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diluted net earnings per share</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net earnings per share</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.68&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.14&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diluted net earnings per share (EPS)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased by $0.46, or 40%, in the current period, primarily due to lower gross margin, decreased volume, higher selling and administrative expenses and implementation of the streamlined operating model, partially offset by the benefit of price increases.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SEGMENT RESULTS </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the results of the Company&#8217;s reportable segments and certain unallocated costs reflected in Corporate (see Notes to Condensed Consolidated Financial Statements for a reconciliation of segment results to consolidated results):</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health and Wellness</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.283%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volume and net sales decreased by 21% and 4% respectively, and earnings before income taxes increased by 10% during the current period. The volume decrease was primarily due to pricing actions and lower shipments from the ongoing normalization of consumer demand in Cleaning in the current period. The variance between volume and net sales was primarily due to the benefit of price increases and favorable mix. The increase in earnings before income taxes was primarily due to the net impacts of price increases, mix and lower advertising spend, partially offset by lower volume, </span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">costs associated with the voluntary recall of certain Pine-Sol scented products and unfavorable commodity costs</span><span style="color:#0070c0;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As announced on October 25, 2022, the Company made the determination to voluntarily recall certain Pine-Sol scented products sold in the United States, Canada and certain other countries due to a quality issue. Original Pine-Sol (pine scent) is not included in the recall. In the United States, the voluntary recall is being conducted in cooperation with  the Consumer Product Safety Commission.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Household</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.283%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volume, net sales and earnings before income taxes decreased by 14%, 4% and 39%, respectively, during the current period. The volume decrease was primarily driven by lower shipments across all SBUs due to pricing actions as well as lower shipments in Litter and Bags and Wraps as a result of supply chain constraints in the current period. The variance between volume and net sales was primarily due to the benefit of price increases. The decrease in earnings before income taxes was mainly due to higher manufacturing and logistics costs and unfavorable commodity costs, partially offset by the net impacts of price increases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lifestyle</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.283%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volume, net sales and earnings decreased by 10%, 3% and 35% respectively, during the current period. The volume decrease was primarily driven by pricing actions across all SBUs and lower shipments of Natural Personal Care products due to supply chain constraints in the current period. The variance between volume and net sales was mainly due to the benefit of price increases. The decrease in earnings before income taxes was primarily due to unfavorable commodity costs and higher manufacturing and logistics costs.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.283%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volume, net sales and earnings before income taxes decreased by 4%, 1% and 23%, respectively, during the current period.  The volume decrease was primarily due to pricing actions. The variance between volume and net sales was mainly due to the benefit of price increases, partially offset by unfavorable foreign currency exchange rates. The decrease in earnings before income taxes was primarily due to unfavorable foreign currency exchange rates, higher manufacturing and logistics costs and unfavorable commodity costs, partially offset by the net impacts of price increases. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Argentina</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective July 1, 2018, under the requirements of U.S. GAAP, Argentina was designated as a highly inflationary economy, and as a result the U.S. dollar replaced the Argentine peso as the functional currency of the Company&#8217;s subsidiaries in Argentina. Consequently, gains and losses from non-U.S. dollar denominated monetary assets and liabilities of Clorox Argentina are recognized in Other (income) expense, net in the condensed consolidated statement of earnings. The business environment in Argentina continues to be challenging due to significant volatility in Argentina&#8217;s currency, high inflation, economic recession and impacts of COVID-19. As of September&#160;30, 2022 and June&#160;30, 2022, the net asset position, excluding goodwill, of Clorox Argentina was $46 and $45, respectively. Of these net assets, cash balances were approximately $15 as of both September&#160;30, 2022 and June&#160;30, 2022. Net sales from Clorox Argentina represented approximately 2% of the Company&#8217;s consolidated net sales for the three months ended September&#160;30, 2022 and the fiscal year ended June&#160;30, 2022. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on the impacts of, and our response to, the business environment in Argentina, refer to &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate includes certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses before income taxes</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Losses before income taxes increased by $25 in the current three month period primarily due to restructuring and related charges associated with the implementation of the new streamlined operating model and the Company&#8217;s digital capabilities and productivity enhancements investments.</span></div><div><span><br/></span></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_73"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL POSITION AND LIQUIDITY</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial condition and liquidity remained strong as of September&#160;30, 2022. The following table summarizes cash activities:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operations</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for financing activities</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operations was $178 in the current three month period, compared with $41 in the prior three month period. The increase was primarily driven by a decrease in working capital and lower employee incentive compensation paid in the current period, partially offset by lower cash earnings in the current period. The decrease in working capital in the current period was primarily due to lower Accounts Receivable due to timing of sales and higher Accounts payable and accrued liabilities in the current period due to timing of payments, including accruals for restructuring and related costs associated with the streamlined operating model and the voluntary recall of certain Pine-Sol scented products.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Payment Terms Extension and Supply Chain Financing </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company initiated the extension of its payment terms with its suppliers in the second half of fiscal year 2020 in order to improve working capital as part of and to fund the IGNITE strategy and in keeping with evolving market practices. The Company&#8217;s current payment terms do not exceed 120 days in keeping with industry standards. The Company&#8217;s operating cash flows are directly impacted as a result of the extension of the payment terms with the suppliers.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of those ongoing efforts, the Company has arranged for a global financial institution to offer a voluntary supply chain finance (SCF) program for the benefit of the Company&#8217;s suppliers. Leveraging the Company&#8217;s credit rating, the SCF program enables suppliers to directly contract with the financial institution to receive payment from the financial institution prior to the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payment terms between the Company and the supplier by selling the Company&#8217;s payables to the financial institution. Participation in the program is at the sole discretion of the supplier and the Company has no economic interest in a supplier's decision to enter into the agreement and has no direct financial relationship with the financial institution, as it relates to the SCF program. Once a supplier elects to participate in the SCF program and reaches an agreement with the financial institution, the supplier elects which individual Company invoices to sell to the financial institution. The terms of the Company&#8217;s payment obligations are not impacted by a supplier&#8217;s participation in the program and as such, the SCF program has no direct impact on the Company&#8217;s balance sheets, cash flows or liquidity. No guarantees are provided by the Company or any of our subsidiaries under the SCF program. There would not be an expected material impact to the Company&#8217;s liquidity or capital resources if the financial institution or a supplier terminated the SCF arrangement.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All outstanding amounts related to suppliers participating in SCF are recorded within Accounts payable and accrued liabilities in the Consolidated Balance Sheets and the associated payments are included in operating activities within the Consolidated Statements of Cash Flows. As of September&#160;30, 2022 and June&#160;30, 2022, the amount due to suppliers participating in SCF and included in Accounts payable and accrued liabilities was $202 and $211, respectively. While the Company does not have direct access to information on, or influence over, which invoices a participating supplier elects to sell to the financial institution, the Company expects that the majority of these amounts have been sold to the financial institution.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used for investing activities was $45 in the current three month period, compared with $56 in the prior three month period. The year-over-year decrease was mainly due to lower capital spending in the current period.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used for financing activities was $35 in the current three month period, compared with $92 in the prior three month period. The year-over-year decrease was mainly due to higher net cash sourced from borrowings and lower treasury stock purchases in the current period.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Resources and Liquidity</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's current liabilities may periodically exceed current assets as a result of the Company's debt management policies, including the Company's use of commercial paper borrowings which fluctuates depending on the amount and timing of operating and investing cash flows and payments for shareholder transactions such as dividends. In addi</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tion, the Company&#8217;s cash generated from operations has decreased from historical levels primarily due to higher manufacturing and logistics costs and unfavorable commodity costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to take actions to address some of the effects of such cost increases, which include implementing price increases, driving cost savings and optimizing the Company&#8217;s supply chain.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global financial markets have experienced a significant increase in volatility due to heightened uncertainty, the impacts of cost inflation and continued economic and social disruptions caused by the COVID-19 outbreak and other geopolitical circumstances. Notwithstanding potential unforeseen adverse market conditions and as part of the Company&#8217;s regular assessment of its cash needs, the Company believes it will have the funds necessary to support our short- and long-term liquidity and operating needs, including the costs related to the announced streamlined operating model and its digital capabilities and productivity enhancements investments, based on our anticipated ability to generate positive cash flows from operations in the future, access to capital markets enabled by our strong short-term and long-term credit ratings and current borrowing availability.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Arrangements</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company maintained a $1,200 revolving credit agreement that matures in March 2027 (the Credit Agreement). There were no borrowings under the Credit Agreement as of September&#160;30, 2022 and June&#160;30, 2022, and the Company believes that borrowings under the Credit Agreement are and will continue to be available for general corporate purposes. The Credit Agreement includes certain restrictive covenants and limitations. The primary restrictive covenant is a minimum ratio of 4.0, calculated as total earnings before interest, taxes, depreciation and amortization and other similar non-cash charges and certain other items (Consolidated EBITDA) to total interest expense for the trailing four quarters (Interest Coverage ratio), as defined and described in the Credit Agreement.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was in compliance with all restrictive covenants and limitations in the Credit Agreement as of September&#160;30, 2022, and anticipates being in compliance with all restrictive covenants for the foreseeable future.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company maintained $34 of foreign and other credit lines, of which $4 was outstanding.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchases and Dividend Payments</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company had two stock repurchase programs: an open-market purchase program with an authorized aggregate purchase amount of up to $2,000, which has no expiration date, and a program to offset the anticipated impact of dilution related to stock-based awards (the Evergreen Program), which has no authorization limit on the dollar amount and no expiration date. During the three months ended September&#160;30, 2022 and 2021, the Company repurchased 0 and 152 thousand shares of common stock at a cost of $0 and $25, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends per share declared and total dividends paid to Clorox stockholders were as follows for the periods indicated: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:75.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.996%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends per share declared</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.36&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.16&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total dividends paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_76"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTINGENCIES</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements for information on the Company&#8217;s contingencies.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RECENTLY ISSUED ACCOUNTING STANDARDS</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes to Condensed Consolidated Financial Statements for a summary of recently issued accounting standards relevant to the Company. </span></div><div><span><br/></span></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_82"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NON-GAAP FINANCIAL MEASURES</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The non-GAAP financial measures that are included in this MD&amp;A and the reasons management believes they are useful to investors are described below. These measures should be considered supplemental in nature and are not intended to be a substitute for the related financial information prepared in accordance with U.S. GAAP. In addition, these measures may not be the same as similarly named measures presented by other companies.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organic sales growth / (decrease)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is defined as net sales growth / (decrease) excluding the effect of foreign exchange rate changes and any acquisitions and divestitures.&#160;Management believes that the presentation of organic sales growth / (decrease) is useful to investors because it excludes sales from any acquisitions and divestitures, which results in a comparison of sales only from the businesses that the Company was operating and expects to continue to operate throughout the relevant periods, and the Company&#8217;s estimate of the impact of foreign exchange rate changes, which are difficult to predict and out of the control of the Company and management.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of organic sales growth / (decrease) (non-GAAP) to net sales growth / (decrease) (GAAP), the most comparable GAAP measure:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:33.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage change versus the year-ago period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales growth / (decrease) (GAAP)</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Foreign Exchange</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add/(Subtract): Divestitures/Acquisitions</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic sales growth / (decrease) (non-GAAP)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cautionary Statement</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Report, including the exhibits hereto and the information incorporated by reference herein, contains &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements related to the expected or potential impact of the novel coronavirus (COVID-19) pandemic, and the related responses of governments, consumers, customers, suppliers, employees and the Company, on our business, operations, employees, financial condition and results of operations, and any such forward-looking statements, whether concerning the COVID-19 pandemic or otherwise, involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, organic sales growth, foreign currencies, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, foreign currency exchange rates, tax rates, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management&#8217;s estimates, beliefs, assumptions and projections. Words such as &#8220;could,&#8221; &#8220;may,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;targets,&#8221; &#8220;goals,&#8221; &#8220;projects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; &#8220;will,&#8221; &#8220;predicts,&#8221; and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management&#8217;s expectations, are described in the sections entitled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2022, and in this Report, as updated from time to time in the Company&#8217;s Securities and Exchange Commission filings. These factors include, but are not limited to:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the changing retail environment, including the growth of alternative retail channels and business models, and changing consumer preferences;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">volatility and increases in the costs of raw materials, energy, transportation, labor and other necessary supplies or services;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the Company to drive sales growth, increase prices and market share, grow its product categories and manage favorable product and geographic mix;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to supply chain issues, product shortages and disruptions to the business, as a result of increased supply chain dependencies due to an expanded supplier network and a reliance on certain single-source suppliers;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ongoing COVID-19 pandemic and related impacts, including on the availability of, and efficiency of the supply, manufacturing and distribution systems for, the Company&#8217;s products, including any significant disruption to such systems; on the demand for and sales of the Company&#8217;s products; and on worldwide, regional and local adverse economic conditions</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">intense competition in the Company&#8217;s markets;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unfavorable general economic and political conditions beyond our control, including recent supply chain disruptions, labor shortages, wage pressures, rising inflation, fuel and energy costs, foreign currency exchange rate fluctuations, weather events or natural disasters, disease outbreaks or pandemics, such as COVID-19, terrorism, and unstable geopolitical conditions, including the conflict in Ukraine;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to the Company&#8217;s use of and reliance on information technology systems, including potential security breaches, cyber-attacks, privacy breaches or data breaches that result in the unauthorized disclosure of consumer, customer, employee or Company information, or service interruptions, especially at a time when a large number of the Company&#8217;s employees are working remotely and accessing its technology infrastructure remotely;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the ability of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company to implement and generate cost savings and efficiencies, and successfully implement its business strategies, including achieving anticipated results and cost savings from the implementation of the streamlined operating model;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">dependence on key customers and risks related to customer consolidation and ordering patterns;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company&#8217;s ability to attract and retain key personnel, which may continue to be impacted by challenges in the labor market, such as wage inflation and sustained labor shortages;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company&#8217;s ability to maintain its business reputation and the reputation of its brands and products;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lower revenue, increased costs or reputational harm resulting from government actions and compliance with regulations, or any material costs imposed by changes in regulation;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the Company to successfully manage global political, legal, tax and regulatory risks, including changes in regulatory or administrative activity;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to international operations and international trade, including changing macroeconomic conditions as a result of inflation, volatile commodity prices and increases in raw and packaging materials prices, labor, energy and logistics; global economic or political instability; foreign currency fluctuations, such as devaluations, and foreign currency exchange rate controls; changes in governmental policies, including trade, travel or immigration restrictions, new or additional tariffs, and price or other controls; labor claims and civil unrest; continued high levels of inflation in Argentina; potential disruption from wars and military conflicts, including the conflict in Ukraine; impact of the United Kingdom&#8217;s exit from the European Union; potential negative impact and liabilities from the use, storage and transportation of chlorine in certain international markets where chlorine is used in the production of bleach; widespread health emergencies, such as COVID-19; and the possibility of nationalization, expropriation of assets or other government action;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of Environmental, Social, and Governance (ESG) issues, including those related to climate change and sustainability on our sales, operating costs or reputation;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the Company to innovate and to develop and introduce commercially successful products, or expand into adjacent categories and countries;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of product liability claims, labor claims and other legal, governmental or tax proceedings, including in foreign jurisdictions and in connection with any product recalls;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks relating to acquisitions, new ventures and divestitures, and associated costs; and the ability to complete announced transactions and, if completed, integration costs and potential contingent liabilities related to those transactions;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the accuracy of the Company&#8217;s estimates and assumptions on which its financial projections, including any sales or earnings guidance or outlook it may provide from time to time, are based;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to additional increases in the estimated fair value of P&amp;G&#8217;s interest in the Glad business;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">environmental matters, including costs associated with the remediation and monitoring of past contamination, and possible increases in costs resulting from actions by relevant regulators, and the handling and/or transportation of hazardous substances; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company&#8217;s ability to effectively utilize, assert and defend its intellectual property rights, and any infringement or claimed infringement by the Company of third-party intellectual property rights;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the performance of strategic alliances and other business relationships;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of the Company&#8217;s indebtedness and credit rating on its business operations and financial results and the Company&#8217;s ability to access capital markets and other funding sources;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company&#8217;s ability to pay and declare dividends or repurchase its stock in the future;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impacts of potential stockholder activism; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to any litigation associated with the exclusive forum provision in the Company&#8217;s bylaws. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s forward-looking statements in this Report are based on management&#8217;s current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this Report. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Report, unless the context requires otherwise, the terms &#8220;the Company,&#8221; &#8220;Clorox,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to The Clorox Company and its subsidiaries. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have not been any material changes to the Company&#8217;s market risk since June&#160;30, 2022. For additional information, refer to &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in Exhibit 99.1 of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_91"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management, with the participation of the Company&#8217;s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures as of the end of the period covered by this Report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company&#8217;s disclosure controls and procedures, as of the end of the period covered by this Report, were effective such that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and (ii) accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No change in the Company&#8217;s internal control over financial reporting occurred during the first fiscal quarter of the fiscal year ending June&#160;30, 2023, that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_97"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.A. Risk Factors</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding Risk Factors, please refer to Item 1.A. in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2022 and the information in &#8220;Cautionary Statement&#8221; included in this Report.</span></div><div><span><br/></span></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_100"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, the Board of Directors authorized the Company to repurchase up to $2,000 million in shares of common stock on the open market (the 2018 Open-Market Program), which has no expiration date.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 1999, the Board of Directors authorized a stock repurchase program to reduce or eliminate dilution upon the issuance of common stock pursuant to the Company&#8217;s stock compensation plans (the Evergreen Program). In November 2005, the Board of Directors authorized the extension of the Evergreen Program to reduce or eliminate dilution in connection with issuances of common stock pursuant to the Company&#8217;s 2005 Stock Incentive Plan. The Evergreen Program has no expiration date and has no specified limit as to dollar amount and therefore is not included in column [d] below.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the purchases of the Company&#8217;s securities by the Company and any affiliated purchasers within the meaning of Rule 10b-18(a)(3) (17 CFR 240.10b-18(a)(3)) during the first quarter of fiscal year 2023. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:27.199%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.589%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.641%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.110%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">[a]</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">[b]</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">[c]</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">[d]</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of<br/>Shares Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Price Paid</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">per Share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of<br/>Shares Purchased as<br/>Part of Publicly<br/>Announced Plans or<br/>Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maximum Number (or<br/>Approximate Dollar<br/>Value) of Shares that<br/>May Yet Be Purchased<br/>Under the Plans or<br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1 to 31, 2022</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$993 million</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1 to 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$993 million</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1 to 30, 2022</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$993 million</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Average price paid per share in the period includes commission.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Exhibit Index below, which is incorporated by reference herein.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit No.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.197%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq1fy23exhibit101.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="clxq1fy23exhibit101.htm">Form of Nonqualified Stock Option Award Agreement under the Company&#8217;s 2005 Stock Incentive Plan.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq1fy23exhibit102.htm">10.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq1fy23exhibit102.htm">Form of Performance Share Award Agreement under the Company&#8217;s 2005 Stock Incentive Plan for awards made in 2022.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq1fy23exhibit103.htm">10.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq1fy23exhibit103.htm">Form of Restricted Stock Unit Award Agreement under the Company&#8217;s 2005 Stock Incentive Plan (Annual Grant).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq1fy23exhibit104.htm">10.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq1fy23exhibit104.htm">Form of Restricted Stock Unit Award Agreement under the Company&#8217;s 2005 Stock Incentive Plan (Off-Cycle Grant).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq1fy23ex311ceocertifica.htm">31.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq1fy23ex311ceocertifica.htm">Certification by the Chief Executive Officer of the Company Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq1fy23ex312cfocertifica.htm">31.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq1fy23ex312cfocertifica.htm">Certification by the Chief Financial Officer of the Company Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq1fy23ex32ceocfocertifi.htm">32</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="clxq1fy23ex32ceocfocertifi.htm">Certification by the Chief Executive Officer and Chief Financial Officer of the Company Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="ibdb9440a3c394a6fb2a08b0b51efadd4_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.924%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THE CLOROX COMPANY</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DATE: November 1, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BY</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Laura Peck</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laura Peck<br/>Vice President &#8211; Chief Accounting Officer and Corporate Controller</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>clxq1fy23exhibit101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ib9f34871b95943c5b85fe7d0313ae739_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:112%">THE CLOROX COMPANY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:112%">2005 STOCK INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:112%">NONQUALIFIED STOCK OPTION AWARD AGREEMENT</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">NOTICE OF STOCK OPTION GRANT</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Clorox Company, a Delaware company (the &#8220;Company&#8221;), grants to the Optionee named below an option (the &#8220;Option&#8221;) to purchase, in accordance with the terms of The Clorox Company 2005 Stock Incentive Plan (the &#8220;Plan&#8221;) and this nonqualified stock option agreement (the &#8220;Agreement&#8221;), the number of shares of Common Stock of the Company (the &#8220;Shares&#8221;) at the exercise price per share (the &#8220;Exercise Price&#8221;) set forth as follows&#58;</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.551%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">OPTIONEE&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#60;&#60;&#60;Optionee Name - 1&#62;&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">OPTIONS GRANTED&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#60;&#60;&#60;Total Shares Granted&#62;&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">GRANT ID&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#60;&#60;&#60;Grant ID&#62;&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">EXERCISE PER SHARE&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#60;&#60;&#60;Grant Price - 1&#62;&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">DATE OF GRANT&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#60;&#60;&#60;Grant Date - 2&#62;&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">EXPIRATION DATE&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ten years from Date of Grant</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">VESTING SCHEDULE&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">25% vests on each of October 5 of 2023, 2024, 2025 and 2026, or the first trading day immediately preceding each such date if such date is not a trading day.</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">AGREEMENT</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Grant of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Company hereby grants to the Optionee the Option to purchase the Shares at the Exercise Price, subject to the terms, definitions and provisions of the Plan and this Agreement.  All terms, provisions, and conditions applicable to the Option set forth in the Plan and not set forth herein are incorporated by reference.  To the extent any provision hereof is inconsistent with a provision of the Plan, the provisions of the Plan will govern.  All capitalized terms that are used in this Agreement and not otherwise defined herein shall have the meanings ascribed to them in the Plan. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Exercise of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Right to Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Option shall be exercisable prior to the expiration date set forth above (the &#8220;Expiration Date&#8221;), in accordance with the vesting schedule set forth above (the &#8220;Vesting Schedule&#8221;) and with the applicable provisions of the Plan and this Agreement.  Except as otherwise specifically provided in this Agreement, in no event may this Option be exercised after the Expiration Date.  Although vested within the meaning of Section 83 of the Internal Revenue Code since no substantial risk of forfeiture exists once the options become exercisable according to the Vesting Schedule above, the Options will not be earned until the Optionee has fulfilled all of the conditions precedent set forth in this Agreement, including, but not limited to, the obligations set forth in Sections 7(b), 7(c), 7(d), 7(e) and Section 8, and the Optionee shall have no right to retain the Shares or the value thereof upon vesting or exercise of the Options until all conditions precedent have been satisfied.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Option shall be exercisable only by delivery of an exercise notice (the &#8220;Exercise Notice&#8221;), available on the UBS website, the Company&#8217;s designee, which shall state the election to exercise the Option, the whole number of vested Shares in respect of which the Option is being exercised and such other provisions as may be required by the Committee. Such Exercise Notice shall be signed by the Optionee and shall be delivered by mail or fax, to the Company&#8217;s designee accompanied by payment of the Exercise Price.  The Company may require the Optionee to furnish or execute such other documents as the Company shall reasonably deem necessary (1) to evidence such exercise and (2) to comply with or satisfy the requirements of the Securities Act of 1933, as amended, the Exchange Act, or any Applicable Laws.  The Option shall be deemed to be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.1</font></div></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">exercised upon receipt by the Company&#8217;s designee of such written notice accompanied by the Exercise Price.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">No Shares will be issued pursuant to the exercise of the Option unless such issuance and such exercise shall comply with all Applicable Laws.  Assuming such compliance, for income tax purposes, the Shares shall be considered transferred to the Optionee on the date on which the Option is exercised with respect to such Shares.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Pursuant to Section 16 of the Plan, the Committee shall have the power and the right to deduct or withhold, or require the Optionee to remit to the Company, an amount sufficient to satisfy any applicable tax withholding requirements applicable to this Option.  The Committee may condition the issuance of Shares upon the Optionee&#8217;s satisfaction of such withholding obligations.  The Optionee may elect to satisfy all or part of such withholding requirement by tendering previously-owned Shares or by having the Company withhold Shares having a Fair Market Value equal to the minimum statutory tax withholding rate that could be imposed on the transaction (or such other rate that will not result in a negative accounting impact) or in such other manner as is acceptable to the Company.  Such election shall be irrevocable, made in writing, signed by the Optionee, and shall be subject to any restrictions or limitations that the Committee, in its sole discretion, deems appropriate.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Method of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Pursuant to Section 6(f) of the Plan and subject to such limitations as the Committee may impose (including prohibition of one or more of the following payment methods), payment of the Exercise Price may be made in cash or by check, Shares or a combination thereof.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Termination of Employment or Service and Expiration of Exercise Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Termination of Employment or Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Optionee&#8217;s employment or service with the Company and its Subsidiaries is terminated, the Optionee may exercise all or part of this Option prior to the expiration dates set forth in paragraph (b) herein, but only to the extent that the Option had become vested before the Optionee&#8217;s employment or service terminated.  Notwithstanding the above, if the Optionee&#8217;s termination of employment or service is due to (1) Retirement and is more than 6 months from the Date of Grant set forth in this Agreement, then the Option shall continue to vest in accordance with the Vesting Schedule, or (2) death or Disability, the Option shall become 100% vested, and, in each case, shall remain exercisable until the expiration date determined pursuant to paragraph (b) of this Section.  </font></div><div><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Except as otherwise provided in this Section 4 or Section 5, when the Optionee&#8217;s employment or service with the Company and its Subsidiaries terminates (except when due to Retirement, death or Disability), this Option shall expire immediately with respect to the number of Shares for which the Option is not yet vested.  If the Optionee dies after termination of employment or service, but before the expiration of the Option, all or part of this Option may be exercised (prior to expiration) by the personal representative of the Optionee or by any person who has acquired this Option directly from the Optionee by will, bequest or inheritance, but only to the extent that the Option was vested and exercisable upon termination of the Optionee&#8217;s employment or service. </font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Expiration of Exercise Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Upon termination of the Optionee&#8217;s employment or service with the Company and its Subsidiaries, subject to Section 19 of the Plan, the Option shall expire on the earliest of the following occasions&#58;</font></div><div><font><br></font></div><div style="padding-left:108pt;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt">The Expiration Date&#59; </font></div><div><font><br></font></div><div style="padding-left:108pt;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt">The date ninety (90) days following the termination of the Optionee&#8217;s employment or service for any reason other than Cause, death, Disability, or Retirement&#59;</font></div><div><font><br></font></div><div style="padding-left:108pt;text-indent:-28.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt">The date one year following the termination of the Optionee&#8217;s employment or service due to death or Disability&#59; </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.1</font></div></div><div style="padding-left:108pt;text-indent:-28.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt">The date five (5) years following the termination of the Optionee&#8217;s employment or service due to Retirement, provided the Optionee&#8217;s Retirement is more than 6 months from the Date of Grant set forth in this Agreement&#59; or</font></div><div><font><br></font></div><div style="padding-left:108pt;text-indent:-25.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt">The date of termination of the Optionee&#8217;s employment or service for Cause.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Definition of &#8220;Retirement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;  For purposes of this Agreement, the Optionee&#8217;s employment or service shall be deemed to have terminated due to &#8220;Retirement&#8221; if the Optionee terminates employment or service as an Employee for any reason, including Disability (but other than for Cause) after (1) twenty (20) or more years of &#8220;vesting service,&#8221; which solely for purposes of this Agreement, shall be calculated under Article III of The Clorox Company 401(k) Plan (the &#8220;401(k) Plan&#8221;) entitled &#8220;Service&#8221; along with any other relevant provisions of the 401(k) Plan necessary or desirable to give full effect thereto, or any successor provisions, regardless of the status of the Optionee with respect to the 401(k) Plan (&#8220;Vesting Service&#8221;), or (2) attaining age fifty-five (55) with ten (10) or more years of Vesting Service.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Definition of &#8220;Disability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;  For purposes of this Agreement, the Optionee&#8217;s employment shall be deemed to have terminated due to the Optionee&#8217;s Disability if the Optionee is entitled to long-term disability benefits under the Company&#8217;s long-term disability plan or policy, as in effect on the date of termination of the Optionee&#8217;s employment.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Upon the occurrence of a Change in Control (including in the event the Optionee&#8217;s employment is terminated without Cause or by the Optionee for Good Reason upon or within twenty-four (24) months following consummation of a Change in Control), the Option shall be treated in accordance with Section 19 of the Plan.  </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For purposes of this Agreement, &#8220;Good Reason&#8221; shall mean the occurrence of any of the following with respect to the Optionee&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a) the assignment to the Optionee of any duties inconsistent in any material respect with the Optionee&#8217;s position (including offices and reporting requirements), authority, duties or responsibilities, as in effect immediately prior to the occurrence of the Change in Control or the date of the Optionee&#8217;s termination of employment, whichever is greater, or any other action by the Company which results in a material diminution in such position, authority, duties or responsibilities, excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Optionee&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b) any failure by the Company to substantially comply with, or any reduction by the Company in, any of the material provisions of the Optionee&#8217;s compensation plans, programs, agreements or arrangements as in effect immediately prior to the Change in Control, including, without limitation, any material reduction in base salary, cash incentive compensation target bonus opportunity, equity compensation opportunity in the aggregate, or employee benefits and perquisites in the aggregate, other than an isolated, insubstantial and inadvertent failure or reduction not occurring in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Optionee&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c) the Company&#8217;s requiring the Optionee to be based at any office or location other than that in effect immediately prior to the Change in Control or any office or location not requiring the Optionee&#8217;s commute to increase by more than 35 miles from his or her commute immediately prior to the Change in Control&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d) any purported termination by the Company of the Optionee&#8217;s employment other than (A) due to the death or Disability of the Optionee or (B) a termination of the Optionee&#8217;s employment by the Company for Cause&#59; or</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e) any material failure by the Company to require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Company to assume the obligations of the Company under this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.1</font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any termination by the Optionee for Good Reason shall be communicated by a written notice to the Company within a period not to exceed ninety (90) days of such Optionee&#8217;s knowledge of the condition. Such written notice (1) must indicate the specific termination provision in the Good Reason definition relied upon, (2) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Optionee&#8217;s employment under the provision so indicated and (3) the Optionee's intended date of termination if the Company does not cure the issue (which date shall be not less than thirty (30) days after the giving of such notice). After receipt by the Company of such written notice, the Company shall have thirty (30) days during which it may remedy the condition and thereby cure the event or circumstance constituting &#8220;Good Reason&#8221;.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Transferability of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Option shall not be transferable by the Optionee other than by will or the laws of descent and distribution, and the Option shall be exercisable during the Optionee&#8217;s lifetime only by the Optionee or on his or her behalf by the Optionee&#8217;s guardian or legal representative.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Protection of Trade Secrets and Limitations on Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div style="padding-left:108pt;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt;text-decoration:underline">&#8220;Affiliated Company&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> means any organization controlling, controlled by or under common control with the Company.</font></div><div><font><br></font></div><div style="padding-left:108pt;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt;text-decoration:underline">&#8220;Confidential Information&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> means the Company&#8217;s technical or business or personnel information not readily available to the public or generally known in the trade, including inventions, developments, trade secrets and other confidential information, knowledge, data and know-how of the Company or any Affiliated Company, whether or not they originated with the Optionee, or information which the Company or any Affiliated Company received from third parties under an obligation of confidentiality.</font></div><div><font><br></font></div><div style="padding-left:108pt;text-indent:-28.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt;text-decoration:underline">&#8220;Conflicting Product&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> means any product, process, machine, or service of any person or organization, other than the Company or any Affiliated Company, in existence or under development that (1) resembles or competes with a product, process, machine, or service upon or with which the Optionee shall have worked during the two years prior to the Optionee&#8217;s termination of employment with the Company or any Affiliated Company or (2) with respect to which during that period of time the Optionee, as a result of his&#47;her job performance and duties, shall have acquired knowledge of Confidential Information, and whose use or marketability could be enhanced by application to it of Confidential Information.  For purposes of this section, it shall be conclusively presumed that the Optionee has knowledge of information to which s&#47;he has been directly exposed through actual receipt or review of memorandum or documents containing such information or through actual attendance at meetings at which such information was discussed or disclosed.</font></div><div><font><br></font></div><div style="padding-left:108pt;text-indent:-28.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt;text-decoration:underline">&#8220;Conflicting Organization&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> means any person or organization that is engaged in or about to become engaged in research on or development, production, marketing or selling of a Conflicting Product.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Right to Retain Shares Contingent on Protection of Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In partial consideration for the award of this Option, the Optionee agrees that at all times, both during and after the term of the Optionee&#8217;s employment with the Company or any Affiliated Company, to hold in the strictest confidence, and not to use (except for the benefit of the Company at the Company&#8217;s direction) or disclose (except for the benefit of the Company at the Company&#8217;s direction), regardless of when disclosed to the Optionee, any and all Confidential Information of the Company or any Affiliated Company.  The Optionee understands that for purposes of this Section 7(b), Confidential Information further includes, but is not limited to, information pertaining to any aspect of the business of the Company or any Affiliated Company which is either information not known (or known as a result of a wrongful act of the Optionee or of others who were under confidentiality obligations as to the item or items involved) by actual or potential </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.1</font></div></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">competitors of the Company or other third parties not under confidentiality obligations to the Company.  If, prior to the expiration of the Option or at any time within one (1) year after the date of exercise of all or any portion of the Option, the Optionee discloses or uses, or threatens to disclose or use, any Confidential Information other than in the course of performing authorized services for the Company (or any Affiliated Company), the unexercised portion of the Option, whether vested or not, will be immediately forfeited and cancelled, and the Optionee shall immediately return to the Company the Shares or the pre-tax income derived from any disposition of the Shares.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">No Interference with Customers or Suppliers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In partial consideration for the award of this Option, in order to forestall the disclosure or use of Confidential Information as well as to avoid the Optionee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Optionee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company and to promote fair competition, the Optionee agrees that the Optionee&#8217;s right to exercise this Option is contingent upon the Optionee refraining, prior to the expiration of the Option and for a period of one (1) year after the date of exercise, for himself&#47;herself or any third party, directly or indirectly, from using Confidential Information to (1) divert or attempt to divert from the Company (or any Affiliated Company) any business of any kind in which it is engaged, or (2) intentionally solicit its customers with which it has a contractual relationship as to Conflicting Products, or interfere with the contractual relationship with any of its suppliers or customers (collectively, &#8220;Interfere&#8221;).  If, during the term of the Option or at any time within one (1) year after the date of exercise of all or any portion of the Option, the Optionee breaches his&#47;her obligation not to Interfere, the Optionee&#8217;s right to the Shares upon exercise of the Option shall not have been earned and the unexercised portion of the Option, whether vested or not, will be immediately cancelled, and the Optionee shall immediately return to the Company any Shares acquired upon exercise of the Option or the pre-tax income derived from any disposition of such Shares.  For avoidance of doubt, the term &#8220;Interfere&#8221; shall not include any advertisement of Conflicting Products through the use of media intended to reach a broad public audience (such as television, cable or radio broadcasts, generalized online marketing, or newspapers or magazines) or the broad distribution of coupons through the use of direct mail or through independent retail outlets.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">THE OPTIONEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT PROVIDES FOR THE CANCELLATION OF THE UNEXERCISED PORTION OF THE OPTION AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF SHARES ISSUED UPON AN EXERCISE OF THE OPTION IF THE OPTIONEE SHOULD CHOOSE TO VIOLATE THIS &#8220;NO INTERFERENCE WITH CUSTOMERS OR SUPPLIERS&#8221; PROVISION PRIOR TO THE EXPIRATION OF THE OPTION OR WITHIN ONE (1) YEAR AFTER EXERCISE.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">No Solicitation of Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In partial consideration for the award of this Option, in order to forestall the disclosure or use of Confidential Information, as well as to deter the Optionee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Optionee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company, and to promote fair competition, the Optionee agrees that the Optionee&#8217;s right to exercise this Option is contingent upon the Optionee refraining, prior to the expiration of the Option and for a period of one (1) year after the date of exercise, for himself&#47;herself or any third party, directly or indirectly, from soliciting for employment any person employed by the Company, or by any Affiliated Company, during the period of the solicited person&#8217;s employment and for a period of one (1) year after the termination of the solicited person&#8217;s employment with the Company or any Affiliated Company (collectively &#8220;Solicit&#8221;).  If, during the term of the Option or at any time within one (1) year after the date of exercise of all or any portion of the Option, the Optionee breaches his&#47;her obligation not to Solicit, the Optionee&#8217;s right to the Shares upon exercise of the Option shall not have been earned and the unexercised portion of the Option, whether vested or not, will be immediately cancelled, and the Optionee shall immediately return to the Company any Shares acquired upon exercise of the Option or the pre-tax income derived from any disposition of such Shares. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">THE OPTIONEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.1</font></div></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">PROVIDES FOR THE CANCELLATION OF THE UNEXERCISED PORTION OF THE OPTION AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF SHARES ISSUED UPON AN EXERCISE OF THE OPTION IF THE OPTIONEE SHOULD CHOOSE TO VIOLATE THIS NON-SOLICITATION OF EMPLOYEES PROVISION PRIOR TO THE EXPIRATION OF THE OPTION OR WITHIN ONE (1) YEAR AFTER EXERCISE.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Injunctive and Other Available Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By acceptance of this Option, the Optionee acknowledges that, if the Optionee were to breach or threaten to breach his&#47;her obligation hereunder not to Interfere or Solicit or not to disclose or use any Confidential Information other than in the course of performing authorized services for the Company (or any Affiliated Company), the harm caused to the Company by such breach or threatened breach would be, by its nature, irreparable because, among other things, damages would be significant and the monetary harm that would ensue would not be able to be readily proven, and that the Company would be entitled to injunctive and other appropriate relief to prevent threatened or continued breach and to such other remedies as may be available at law or in equity.  To the extent not prohibited by law, any cancellation of the Option pursuant to any of Sections 7(b) through 7(d) above shall not restrict, abridge or limit in any fashion the types and scope of injunctive and other available relief to the Company. Notwithstanding any provision of this Agreement to the contrary, nothing under this Agreement shall  limit, abridge, modify or otherwise restrict the Company (or any Affiliated Company) from pursuing any or all legal, equitable or other appropriate remedies to which the Company may be entitled under any other agreement with the Optionee, any other plan, program, policy or arrangement of the Company (or any Affiliated Company) under which the Optionee is covered or participates, or any applicable law, all to the fullest extent not prohibited under applicable law.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.17pt;text-decoration:underline">Permitted Reporting and Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding any language in this Agreement to the contrary, nothing in this Agreement prohibits Optionee from reporting possible violations of federal law or regulation to any governmental agency or governmental entity, or making other disclosures that are protected under federal law or regulation&#59; provided, that, in each case such communications and disclosures are consistent with applicable law.  Notwithstanding the foregoing, under no circumstance is Optionee authorized to disclose any information covered by the Company&#8217;s attorney-client privilege or attorney work product or the Company&#8217;s trade secrets without prior written consent of the Company&#8217;s Chief Legal Officer.  Any reporting or disclosure permitted under this Section 7(f) shall not result in the cancellation of Options. Optionee is entitled to certain immunities from liability under state and federal law for disclosing trade secrets if the disclosure was made to report or investigate an alleged violation of law, subject to certain conditions. Please see the Company&#8217;s Confidential Information Policy for further details. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Right to Retain Shares Contingent on Continuing Non-Conflicting Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In partial consideration for the award of this Option in order to forestall the disclosure or use of Confidential Information, as well as to deter the Optionee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Optionee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company, and to promote fair competition, the Optionee agrees that the Optionee&#8217;s right to exercise this Option is contingent upon the Optionee refraining, prior to the expiration of the Option and for a period of one (1) year after the date of exercise, from rendering services, directly or indirectly, as director, officer, employee, agent, consultant or otherwise, to any Conflicting Organization except a Conflicting Organization whose business is diversified and that, as to that part of its business to which the Optionee renders services, is not a Conflicting Organization, provided that the Company shall receive separate written assurances satisfactory to the Company from the Optionee and the Conflicting Organization that the Optionee shall not render services during such period with respect to a Conflicting Product.  If, prior to the expiration of the Option or at any time within one (1) year after the date of exercise of all or any portion of the Option, the Optionee shall render services to any Conflicting Organization other than as expressly permitted herein, the Optionee&#8217;s right to the Shares upon exercise of the Option shall not have been earned and the unexercised portion of the Option, whether vested or not, will be immediately cancelled, and the Optionee shall immediately return to the Company any Shares acquired upon exercise of the Option or the pre-tax income derived from any disposition of such Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">THE OPTIONEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.1</font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">THE OPTIONEE FROM RENDERING SERVICES TO A CONFLICTING ORGANIZATION, BUT PROVIDES FOR THE CANCELLATION OF THE UNEXERCISED PORTION OF THE OPTION AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF SHARES ISSUED UPON AN EXERCISE OF THE OPTION IF THE OPTIONEE SHOULD CHOOSE TO RENDER SUCH SERVICES PRIOR TO THE EXPIRATION OF THE OPTION OR WITHIN ONE (1) YEAR AFTER EXERCISE.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Repayment Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">&#91;Restatement of Financials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In the event that (1) the Company issues a significant restatement of financial results and (2) the Committee determines, in good faith, that the Optionee&#8217;s fraud or misconduct was a significant contributing factor to such restatement and (3) some or all of the Option that was granted and&#47;or vested prior to such restatement would not have been granted and&#47;or vested, as applicable, based upon the restated financial results, the Optionee shall immediately return to the Company the unexercised portion of the Option and any Shares or the pre-tax income derived from any disposition of the Shares previously received in upon exercise of the Option that would not have been granted and&#47;or vested based upon the restated financial results (the &#8220;Repayment Obligation&#8221;).  Notwithstanding anything herein to the contrary, in no event shall the Repayment Obligation apply to any portion of the Option that vested more than four years prior to the date the applicable restatement is announced.  The Company shall be able to enforce the Repayment Obligation by all legal means available, including, without limitation, by withholding such amount from other sums owed by the Company to the Grantee.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#91;1&#93;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">&#91;Clawback Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The award of this Option under the Plan granted to Participants who are &#8220;Covered Employees&#8221; (as defined in the Company&#8217;s Policy Regarding Clawback of Incentive Compensation, the &#8220;Policy&#8221;) is subject to clawback in accordance with the terms of the Policy, as amended from time to time, and pursuant to any other policy the Company may adopt as required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.  No recovery of any Award granted hereunder pursuant to such a clawback policy shall be treated as an event giving rise to a Participant&#8217;s right to terminate employment for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or any similar term) under any agreement with the Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#91;2&#93; &#91;3&#93;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt;text-decoration:underline">Miscellaneous Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Neither the Optionee nor the Optionee&#8217;s transferee or representative shall have any rights as a stockholder with respect to any Shares subject to this Option until the Option has been exercised and Share certificates have been issued to the Optionee, transferee or representative, as the case may be.  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Choice of Law, Exclusive Jurisdiction and Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">The courts of the State of Delaware shall have exclusive jurisdiction over any disputes or other proceedings relating to this Agreement, and venue shall reside with the courts in New Castle County, Delaware, including if jurisdiction shall so permit, the U.S. District Court for the District of Delaware.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  Accordingly, the Optionee agrees that any claim of any type relating to this Agreement must be brought and maintained in the appropriate court located in New Castle County, Delaware, including if jurisdiction will so permit, in the U.S. District Court for the State of Delaware.  The Optionee hereby consents to the jurisdiction over the Optionee of any such courts and waives all objections based on venue or inconvenient forum.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Modification or Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Agreement may be modified or amended by the Board or the Committee at any time&#59; provided, however, no modification or amendment to this Agreement shall be made which would materially and adversely affect the rights of the Optionee, without such Optionee&#8217;s written consent. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.1</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In the event any provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining provisions of this Agreement, and this Agreement shall be construed and enforced to reflect the intent of the parties to the fullest extent not prohibited by law, and in the event that such provision is not able to be so construed and enforced, then this Agreement shall be construed and enforced as if such illegal or invalid provision had not been included.  In amplification of the preceding sentence, in the event that the time period or scope of any provision is declared by a court or arbitrator of competent jurisdiction to exceed the maximum time period or scope that such court or arbitrator deems enforceable, then such court or arbitrator shall have the power to reduce the time period or scope to the maximum time period or scope permitted by law.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">References to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  All references to the Plan shall be deemed references to the Plan as may be amended.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.17pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The captions used in this Agreement are inserted for convenience and shall not be deemed a part of this Option for construction or interpretation.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Interpretation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Any dispute regarding the interpretation of this Agreement shall be submitted by the Optionee or by the Company forthwith to the Board or the Committee, which shall review such dispute at its next regular meeting.  The resolution of such dispute by the Board or the Committee shall be final and binding on all persons.  It is the intention of the Company and the Optionee to make the promises contained in this Agreement reasonable and binding only to the extent that it may be lawfully done under existing applicable laws.  This Agreement and the Plan constitute the entire and exclusive agreement between the Optionee and the Company, and it supersedes all prior agreements or understandings, whether written or oral, with respect to the grant of Options set forth in this Agreement.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Section 409A Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  To the extent applicable, it is intended that the Plan and this Agreement comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) and any related regulations or other guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service (&#8220;Section 409A&#8221;).  Any provision of the Plan or this Agreement that would cause this Award to fail to satisfy Section 409A shall have no force or effect until amended to comply with Section 409A, which amendment may be retroactive to the extent permitted by Section 409A.   </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.73pt;text-decoration:underline">Agreement with Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Receipt of any benefits under this Agreement by the Optionee shall constitute the Optionee&#8217;s acceptance of and agreement with all of the provisions of this Agreement and of the Plan that are applicable to this Agreement, and the Company shall administer this Agreement accordingly.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:202.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">THE CLOROX COMPANY</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                                                By&#58;  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">                                                                                                Its&#58;  Chief Executive Officer</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THE OPTIONEE ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT IS A UNILATERAL CONTRACT AND THAT THE OPTIONEE&#8217;S RIGHT TO THE SHARES PURSUANT TO THE OPTION HEREOF IS ACCEPTED AND EARNED ONLY BY CONTINUING EMPLOYMENT AT THE WILL OF THE COMPANY (NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS OPTION OR ACQUIRING SHARES HEREUNDER) AND BY COMPLIANCE WITH THE OPTIONEE&#8217;S VARIOUS OBLIGATIONS UNDER THIS AGREEMENT.  THE OPTIONEE FURTHER ACKNOWLEDGES AND AGREES THAT NOTHING IN THIS AGREEMENT, NOR IN THE PLAN, SHALL CONFER UPON THE OPTIONEE ANY RIGHT WITH RESPECT TO CONTINUATION OF EMPLOYMENT BY THE COMPANY, NOR SHALL IT INTERFERE IN ANY WAY WITH THE OPTIONEE&#8217;S RIGHT OR THE COMPANY&#8217;S RIGHT TO TERMINATE THE OPTIONEE&#8217;S EMPLOYMENT AT ANY TIME, FOR ANY REASON OR NO REASON, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.1</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WITH OR WITHOUT CAUSE, AND WITH OR WITHOUT ADVANCE NOTICE EXCEPT AS MAY BE REQUIRED BY APPLICABLE LAW.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Optionee acknowledges that a copy of the Plan and Plan Information are available for viewing on the Company&#8217;s internal HR website at</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">https&#58;&#47;&#47;clxweb.clorox.com&#47;hr&#47;Pages&#47;HRatClorox&#47;HRContentPages&#47;StockIncentiveProgram.aspx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, and the Company&#8217;s Annual Report and Proxy Statement (the &#8220;Prospectus Information&#8221;) are available for viewing on the Company&#8217;s Clorox website at</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"> https&#58;&#47;&#47;investors.thecloroxcompany.com&#47;investors&#47;financial-information&#47;sec-filings&#47;default.aspx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Optionee hereby consents to receive the Prospectus Information electronically or, in the alternative, to contact the HR Service Center at 1-800-709-7095 to request a paper copy of the Prospectus Information.  The Optionee represents that s&#47;he is familiar with the terms and provisions thereof, and hereby accepts this Agreement subject to all of the terms and provisions thereof.  The Optionee has reviewed the Plan and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands all provisions of this Agreement.  The Optionee acknowledges and hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Plan or this Agreement.  The Optionee further agrees to notify the Company upon any change in the residence address indicated below.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58;______________________________   Signed&#58;___________________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                                                                Optionee</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                Residence Address&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                ___________________________________</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                ___________________________________</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To be included in agreements for individuals who are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> subject to the Policy.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To be included in agreements for individuals who are required to file disclosure statements under Section 16(a) of the Securities Exchange Act or otherwise subject to the Policy.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note to Draft</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#58; Grants should include either section 12(a) (for individuals who are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> subject to the Policy) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">OR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> section 12(b) (for individuals who </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">are</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> subject to the Policy).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>clxq1fy23exhibit102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i2968503853d6401585098c7c14f3b1cb_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:112%">THE CLOROX COMPANY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:112%">2005 STOCK INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:112%">PERFORMANCE SHARE AWARD AGREEMENT</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">NOTICE OF PERFORMANCE SHARE GRANT                  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Clorox Company, a Delaware company (the &#8220;Company&#8221;), grants to the Grantee named below, in accordance with the terms of The Clorox Company 2005 Stock Incentive Plan (the &#8220;Plan&#8221;) and this performance share award agreement (the &#8220;Agreement&#8221;), the following number of Performance Shares on the terms set forth below&#58; </font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.756%"><tr><td style="width:1.0%"></td><td style="width:45.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.327%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">GRANTEE&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#60;&#60;&#60;Participant Name&#62;&#62;&#62;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">TARGET AWARD&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#60;&#60;&#60;Target Shares Granted&#62;&#62;&#62;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">GRANT ID&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#60;&#60;&#60;Grant ID&#62;&#62;&#62;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">PERFORMANCE PERIOD&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">July 1, 2022 through June 30, 2025</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">DATE OF GRANT&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#60;&#60;&#60;Grant Date - 2&#62;&#62;&#62;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SETTLEMENT DATE&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Within 120 days following the last day of the Performance Period or such later date in the event of a deferral per the terms of this Agreement, provided the Grantee has remained in the employment or service of the Company or its Subsidiaries through such date (except for a termination of employment or service due to death, Disability or Retirement, as provided below)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">AGREEMENT</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Grant of Performance Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> The Company hereby grants to the Grantee the Target Award set forth above, payment of which is dependent upon the achievement of certain performance goals more fully described in Section 3 of this Agreement.  This Award is subject to the terms, definitions and provisions of the Plan and this Agreement.  All terms, provisions, and conditions applicable to the Performance Shares set forth in the Plan and not set forth herein are incorporated by reference.  To the extent any provision hereof is inconsistent with a provision of the Plan, the provisions of the Plan will govern.  All capitalized terms that are used in this Agreement and not otherwise defined herein shall have the meanings ascribed to them in the Plan.  </font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Nature and Settlement of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Performance Shares awarded pursuant to this Agreement represent the opportunity to receive Shares of the Company and Dividend Equivalents on such Shares (as described in Section 4 below). The Company shall issue to the Grantee one Share for each vested Performance Share (plus any Dividend Equivalents accrued with respect to such vested Performance Shares), rounded to the nearest whole share, less any Shares withheld in accordance with the provisions of Section 7 of this Agreement. Settlement shall occur on a date chosen by the Committee, which date shall be within one hundred and twenty (120) days following the last day of the Performance Period (the &#8220;Settlement Date&#8221;), or any Deferred Settlement Date established pursuant to Section 6 of this Agreement, whichever is later, and except as specifically provided in Section 5 of this Agreement, provided the Grantee has remained in the employment or service of the Company or its Subsidiaries through the Settlement Date&#59; provided, that, in connection with a Change in Control as described in Section 8 of this Agreement, the Settlement Date shall be within sixty (60) days of either the Change in Control or the date of termination of employment without Cause or for &#8220;Good Reason&#8221; (as defined below), as applicable.  Although vested within the meaning of Section 83 of the Internal Revenue Code since no substantial risk of forfeiture exists at the Settlement Date, the Performance Shares (and any associated Dividend Equivalents) will not be earned until the Grantee has fulfilled all of the conditions precedent set forth in this Agreement, including, but not limited to, the obligations set forth in Sections 10(b), 10(c), 10(d), 10(e) and Section 11, and the Grantee shall have no right to retain the Shares or the value thereof upon vesting or settlement of the Performance Shares until all such conditions precedent have been satisfied.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Determination of Number of Performance Shares Vested</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The number of Performance Shares vested, if any, for the Performance Period shall be determined in accordance with the following formula&#58;  </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"># of Performance Shares &#61; Average Payout Percentage x Target Award</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The &#8220;Average Payout Percentage&#8221; is equal to the sum of the Payout Percentage for each of the fiscal years in the Performance Period, divided by three.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;Payout Percentage&#8221; for the first fiscal year in the Performance Period is based on the actual economic profit (&#8220;EP&#8221;) for such fiscal year, calculated as described below and , determined in accordance with the following table&#58; </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.737%"><tr><td style="width:1.0%"></td><td style="width:48.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EP (for the first fiscal year in the Performance Period)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EP Threshold*</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EP Target**</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EP Max***</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;Payout Percentage&#8221; for the second and third fiscal years in the Performance Period is based on the growth of annual EP, calculated as described below, for the applicable fiscal year as compared to the prior fiscal year (&#8220;EP Growth&#8221;), expressed as a percentage and calculated based upon EP at the end of each such fiscal year of the Performance Period, determined in accordance with the following table&#58; </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.737%"><tr><td style="width:1.0%"></td><td style="width:48.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EP Growth (for each of the second and third fiscal years in the Performance Period)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EP Growth Threshold*</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EP Growth Target**</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">%</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EP Growth Max***</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">%</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* Achievement of the EP Threshold amount (or below) or the EP Growth Threshold amount (or below), as the case may be, shall result in a Payout Percentage of 0% for the applicable fiscal year of the Performance Period.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> **  Achievement of the EP Target amount or the EP Growth Target amount, as the case may be, shall result in a Payout Percentage of 100% for the applicable fiscal year of the Performance Period.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> ***  Achievement of the EP Max amount (or above) or the EP Growth Max amount (or above), as the case may be, shall result in a Payout Percentage of 200% for the applicable fiscal year of the Performance Period.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Note&#58; Achievement of EP or EP Growth in between the Threshold and Target levels and in between the Target and Max levels shall be determined through linear interpolation. For the avoidance of doubt, if the EP or EP Growth in excess of the Threshold level is not achieved, the Payout Percentage for the applicable fiscal year of the Performance Period shall be 0%.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EP is defined as Earnings Before Interest &#38; Taxes, adjusted for non-cash restructuring charges, times one minus the tax rate, less capital charge.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Adjusted EPS is defined as diluted earnings per share adjusted for significant items that are nonrecurring or unusual as disclosed by the Company in its earnings releases.  Cumulative Adjusted EPS is defined as the sum of Adjusted EPS for each of the fiscal years in the Performance Period.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Notwithstanding any other provision in this Agreement to the contrary, (i) if EP for any fiscal year in the Performance Period is negative, the Payout Percentage for such fiscal year in the Performance Period shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.2</font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0% and (ii) if Cumulative Adjusted EPS is less than $            , the Average Payout Percentage shall be no greater than            %.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For avoidance of doubt, while the expectation is that EP for a given fiscal year shall be calculated based upon the Company&#8217;s financial statements for such fiscal year that are filed with the SEC, the Committee shall have the authority to include information not reflected in such financial statements for purposes of determining EP for such fiscal year if the Committee determines that the inclusion of such information more accurately reflects the financial performance of the Company for such fiscal year.  To the extent that such information used in a prior fiscal year is reflected in the filed financial statements for a subsequent fiscal year, appropriate changes shall be made to relevant information in such filed financial statements for purposes of calculating EP for such subsequent fiscal year to avoid double counting of the same information.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Notwithstanding the above, the applicable EP amount for the corresponding fiscal year that is used as the basis for calculating either EP or EP Growth results for such fiscal year shall be adjusted, fairly and appropriately, in accordance with the Plan and, as provided in this Agreement, to reflect accurately the direct and measurable effect of the impact of each of the following events not otherwise reflected in the determination of the EP goals or the initial EP levels (each, an &#8220;Event&#8221;) including, without limitation, the financial statement impact on the Company on account of the occurrence or potential occurrence of an Event&#58; (1) the acquisition or divestiture of a business, (2) a Change in Control, (3) U.S Federal changes in tax statutes or the addition or deletion of taxes to which the Company or any Affiliated Company is subject, (4) force majeure (including events known as &#8220;Acts of God&#8221;), (5) the adoption of new or revised accounting pronouncements or changes to application of accounting pronouncements, (6) an asset impairment charge other than for the final fiscal year of the Performance Period, and (7) any extraordinary, unusual or non-recurring item not previously listed. Notwithstanding the foregoing, an event listed in the preceding sentence shall not qualify as an Event, and therefore no adjustment shall be made to the EP goals or EP levels, unless the impact of the occurrence or potential occurrence of such an event listed in the preceding sentence exceeds $2 million in EP.  The purpose of any adjustments on account of the occurrence of an Event is to keep the probability of achieving the EP or EP Growth goals the same as if the Event triggering such adjustment had either not occurred or had not resulted in any financial statement impact. The determination of any adjustments shall be based on the Company&#8217;s accounting as set forth in its books and records (including business projections) and&#47;or in the annual budgets and&#47;or long range plans of the Company pursuant to which the EP and EP Growth goals were established.  The amount of any such adjustment shall be approved by the Committee in its good faith determination in accordance with the provisions of this paragraph.  To the extent applicable, the Committee shall condition the determination of the number of Performance Shares vested under this Section 3 upon the satisfaction of the adjusted EP goals or EP levels, as the case may be.  All Performance Shares that are not vested for the Performance Period shall be forfeited as of the last day of the Performance Period.</font></div><div style="text-indent:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Dividend Equivalent Rights.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  No Dividend Equivalents shall be paid to the Grantee prior to the settlement of the award.  Rather, such Dividend Equivalent payments will accrue and be notionally credited to the Grantee&#8217;s Performance Share account and paid out at the Payout Percentage in the form of additional Shares rounded down to the nearest whole Share (the &#8220;Dividend Equivalent Shares&#8221;) upon settlement of the award, as described in Section 2 above. </font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Termination of Continuous Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Except as otherwise provided in this Section 5 or Section 8, if the Grantee&#8217;s employment or service with the Company and its Subsidiaries is terminated for any reason prior to the Settlement Date, all Performance Shares and Dividend Equivalents subject to this Agreement shall be immediately forfeited.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Termination due to Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Grantee&#8217;s termination of employment or service is due to death or Disability, all Performance Shares and Dividend Equivalents shall immediately vest and will be paid upon completion of the Performance Period based on the level of performance achieved as of the end of such Performance Period.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Termination due to Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Grantee&#8217;s termination of employment or service is due to Retirement, the Performance Shares shall vest on a pro rata monthly basis, including full credit for partial months elapsed and rounded to the nearest whole Share, and will be paid upon completion of the Performance Period based on the level of performance achieved as of the end of such Performance Period&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.2</font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">provided, however, that this provision shall not apply in the event the Grantee&#8217;s employment or service is terminated for Cause.  The amount of the vested Award may be computed under the following formula&#58;  Target Award times (number of full months elapsed in Performance Period (i.e., rounding up for any partial month) divided by number of full months in Performance Period) times percent performance level achieved as of the end of the Performance Period.  Dividend Equivalents accrued through the Grantee&#8217;s date of termination due to Retirement shall be paid at the same time as the settlement of the vested Performance Shares.  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Definition of &#8220;Retirement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;  For purposes of this Agreement, the term &#8220;Retirement&#8221; shall mean termination of employment or service as an Employee after (1) twenty (20) or more years of &#8220;vesting service,&#8221; which solely for purposes of this Agreement, shall be calculated under Article III of The Clorox Company 401(k) Plan (the &#8220;401(k) Plan&#8221;) entitled &#8220;Service&#8221; along with any other relevant provisions of the 401(k) Plan necessary or desirable to give full effect thereto, or any successor provisions, regardless of the status of the Grantee with respect to the 401(k) Plan (&#8220;Vesting Service&#8221;), or (2) attaining age fifty-five with ten (10) or more years of Vesting Service.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Definition of &#8220;Disability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;  For purposes of this Agreement, the Grantee&#8217;s employment shall be deemed to have terminated due to the Grantee&#8217;s Disability if the Grantee is entitled to long-term disability benefits under the Company&#8217;s long-term disability plan or policy, as in effect on the date of termination of the Grantee&#8217;s employment.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Election to Defer Settlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt">Prior to the commencement of the last year of the Performance Period, the Grantee may elect to defer the settlement of the Performance Shares from the last day of the Performance Period until a date at least two years following such date, or until the Grantee&#8217;s later termination of employment or service.  In the event the termination of employment or service constitutes a &#8220;separation from service&#8221; (as defined in Section 1.409A-1(h) of the Treasury Department Regulations and including a termination of employment or service on account of Disability that does not satisfy the definition of &#8220;disability&#8221; under Section 409A-3(i)(4) of the Treasury Department Regulations), the settlement of the Performance Shares shall occur no earlier than the earlier of the date which is six (6) months after the date of the Grantee&#8217;s termination of employment or service or the date of death of the Grantee.   The date on which the Performance Shares are settled following a deferral election made in accordance with this Section 6(c) shall be referred to as the &#8220;Deferred Settlement Date&#8221;.  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">If the Grantee makes such an election, it will become irrevocable on the date of such election.  If the Grantee makes such an election, any Dividend Equivalents awarded with respect to such deferred Performance Shares shall also be deferred under the same terms.  If the Grantee makes such an election, but a transaction occurs that subjects the Grantee&#8217;s Performance Shares to Section 19 of the Plan prior to the Deferred Settlement Date, the Grantee&#8217;s deferral election will terminate and the Grantee&#8217;s Performance Shares and Dividend Equivalents will be settled as of the date of that transaction.  The Company may terminate any deferral hereunder if a change in law requires such termination.  </font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Pursuant to Section 16 of the Plan, the Committee shall have the power and the right to deduct or withhold, or require the Grantee to remit to the Company, an amount sufficient to satisfy any applicable tax withholding requirements applicable to this Award.  The Committee may condition the issuance of Shares upon the Grantee&#8217;s satisfaction of such withholding obligations.  The Grantee may elect to satisfy all or part of such withholding requirement by tendering previously-owned Shares or by having the Company withhold Shares having a Fair Market Value equal to the minimum statutory withholding rate that could be imposed on the transaction (or such other rate that will not result in a negative accounting impact) or in such other manner as is acceptable to the Company.  Such election shall be irrevocable, made in writing, signed by the Grantee, and shall be subject to any restriction or limitations that the Committee, in its sole discretion, deems appropriate. </font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Change in Control. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Upon the occurrence of a Change in Control, including in the event of the termination of the Grantee by the Company without Cause or the resignation of the Grantee for Good Reason within twenty-four (24) months following consummation of a Change in Control, the Performance Shares shall be treated in accordance with Section 19 of the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.2</font></div></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For purposes of this Agreement, &#8220;Good Reason&#8221; shall mean the occurrence of any of the following with respect to the Grantee&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a) the assignment to the Grantee of any duties inconsistent in any material respect with the Grantee&#8217;s position (including offices and reporting requirements), authority, duties or responsibilities, as in effect immediately prior to the occurrence of the Change in Control or the date of the Grantee&#8217;s termination of employment, whichever is greater, or any other action by the Company which results in a material diminution in such position, authority, duties or responsibilities, excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Grantee&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b) any failure by the Company to substantially comply with, or any reduction by the Company in, any of the material provisions of the Grantee&#8217;s compensation plans, programs, agreements or arrangements as in effect immediately prior to the Change in Control, including, without limitation, any material reduction in base salary, cash incentive compensation target bonus opportunity, equity compensation opportunity in the aggregate, or employee benefits and perquisites in the aggregate, other than an isolated, insubstantial and inadvertent failure or reduction not occurring in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Grantee&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c) the Company&#8217;s requiring the Grantee to be based at any office or location other than that in effect immediately prior to the Change in Control or any office or location not requiring the Grantee&#8217;s commute to increase by more than 35 miles from his or her commute immediately prior to the Change in Control&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d) any purported termination by the Company of the Grantee&#8217;s employment other than (A) due to the death or Disability of the Grantee or (B) a termination of the Grantee&#8217;s employment by the Company for Cause&#59; or</font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e) any material failure by the Company to require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Company to assume the obligations of the Company under this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. </font></div><div><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any termination by the Grantee for Good Reason shall be communicated by a written notice to the Company within a period not to exceed ninety (90) days of such Grantee&#8217;s knowledge of the condition. Such written notice (1) must indicate the specific termination provision in the Good Reason definition relied upon, (2) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Grantee&#8217;s employment under the provision so indicated and (3) the Grantee's intended date of termination if the Company does not cure the issue (which date shall be not less than thirty (30) days after the giving of such notice). After receipt by the Company of such written notice, the Company shall have thirty (30) days during which it may remedy the condition and thereby cure the event or circumstance constituting &#8220;Good Reason&#8221;.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Transferability of Performance Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Performance Shares shall not be transferable by the Grantee other than by will or by the laws of descent or distribution.  For avoidance of doubt, Shares issued to the Grantee in settlement of Performance Shares pursuant to Section 2 of this Agreement shall not be subject to any of the foregoing transferability restrictions.  </font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt;text-decoration:underline">Protection of Trade Secrets and Limitations on Retention.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Definitions.</font></div><div><font><br></font></div><div style="padding-left:58.5pt;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Affiliated Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means any organization controlling, controlled by or under common control with the Company. </font></div><div style="padding-left:58.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means the Company&#8217;s technical or business or personnel information not readily available to the public or generally known in the trade, including inventions, developments, trade secrets and other confidential information, knowledge, data and know-how of the Company or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.2</font></div></div><div style="padding-left:58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">any Affiliated Company, whether or not they originated with the Grantee, or information which the Company or any Affiliated Company received from third parties under an obligation of confidentiality.</font></div><div style="padding-left:58.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-indent:-28.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Conflicting Product</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means any product, process, machine, or service of any person or organization, other than the Company or any Affiliated Company, in existence or under development that (1) resembles or competes with a product, process, machine, or service upon or with which the Grantee shall have worked during the two years prior to the Grantee&#8217;s termination of employment with the Company or any Affiliated Company or (2) with respect to which during that period of time the Grantee, as a result of his&#47;her job performance and duties, shall have acquired knowledge of Confidential Information, and whose use or marketability could be enhanced by application to it of Confidential Information.  For purposes of this section, it shall be conclusively presumed that the Grantee has knowledge of information to which s&#47;he has been directly exposed through actual receipt or review of memorandum or documents containing such information or through actual attendance at meetings at which such information was discussed or disclosed.</font></div><div style="padding-left:58.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-indent:-28.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Conflicting Organization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means any person or organization that is engaged in or about to become engaged in research on or development, production, marketing or selling of a Conflicting Product.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Right to Retain Shares Contingent on Protection of Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In partial consideration for the award of these Performance Shares, the Grantee agrees that at all times, both during and after the term of the Grantee&#8217;s employment with the Company or any Affiliated Company, to hold in the strictest confidence, and not to use (except for the benefit of the Company at the Company&#8217;s direction) or disclose (except for the benefit of the Company at the Company&#8217;s direction), regardless of when disclosed to the Grantee, any and all Confidential Information of the Company or any Affiliated Company.  The Grantee understands that for purposes of this Section 10(b), Confidential Information further includes, but is not limited to, information pertaining to any aspect of the business of the Company or any Affiliated Company which is either information not known (or known as a result of a wrongful act of the Grantee or of others who were under confidentiality obligations as to the item or items involved) by actual or potential competitors of the Company or other third parties not under confidentiality obligations to the Company.  If, prior to the expiration of the Performance Period or at any time within one (1) year after the Settlement Date, the Grantee discloses or uses, or threatens to disclose or use, any Confidential Information other than in the course of performing authorized services for the Company (or any Affiliated Company), the Performance Shares, whether vested or not, will be immediately forfeited and cancelled, and the Grantee shall immediately return to the Company the Shares or the pre-tax income derived from any disposition of the Shares.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">No Interference with Customers or Suppliers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In partial consideration for the award of these Performance Shares, in order to forestall the disclosure or use of Confidential Information as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to the Shares upon settlement of the Performance Shares is contingent upon the Grantee refraining, during the Performance Period and for a period of one (1) year after the Settlement Date of the Performance Shares, for himself&#47;herself or any third party, directly or indirectly, from using Confidential Information to (1) divert or attempt to divert from the Company (or any Affiliated Company) any business of any kind in which it is engaged, or (2) intentionally solicit its customers with which it has a contractual relationship as to Conflicting Products, or to interfere with the contractual relationship with any of its suppliers or customers (collectively, &#8220;Interfere&#8221;).  If, during the term of the Performance Period or at any time within one (1) year after the Settlement Date, the Grantee breaches his&#47;her obligation not to Interfere, the Grantee&#8217;s right to the Shares upon settlement of the Performance Shares shall not have been earned and the Performance Shares, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares or the pre-tax income derived from any disposition of the Shares.  For avoidance of doubt, the term &#8220;Interfere&#8221; shall not include any advertisement of Conflicting Products through the use of media intended to reach a broad public audience (such as television, cable or radio broadcasts, generalized online marketing , or newspapers or magazines) or the broad distribution of coupons through the use of direct mail or through independent retail outlets. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">THE GRANTEE </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.2</font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT PROVIDES FOR THE CANCELLATION OF THE PERFORMANCE SHARES AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO VIOLATE THIS &#8220;NO INTERFERENCE WITH CUSTOMERS OR SUPPLIERS&#8221; PROVISION DURING THE TERM OF THE PERFORMANCE PERIOD OR WITHIN ONE (1) YEAR AFTER THE SETTLEMENT DATE.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">No Solicitation of Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In partial consideration for the award of these Performance Shares, in order to forestall the disclosure or use of Confidential Information, as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company, and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to the Shares upon settlement of the Performance Shares is contingent upon the Grantee refraining, during the Performance Period and for a period of one (1) year after the Settlement Date, for himself&#47;herself or any third party, directly or indirectly, from soliciting for employment any person employed by the Company, or by any Affiliated Company, during the period of the solicited person&#8217;s employment and for a period of one (1) year after the termination of the solicited person&#8217;s employment with the Company or any Affiliated Company (collectively &#8220;Solicit&#8221;).  If, during the term of the Performance Period or at any time within one (1) year after the Settlement Date, the Grantee breaches his&#47;her obligation not to Solicit, the Grantee&#8217;s right to the Shares upon settlement of the Performance Shares shall not have been earned and the Performance Shares, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares or the pre-tax income derived from any disposition of the Shares. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT PROVIDES FOR THE CANCELLATION OF THE PERFORMANCE SHARES AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO VIOLATE THIS NON-SOLICITATION OF EMPLOYEES PROVISION DURING THE TERM OF THE PERFORMANCE PERIOD OR WITHIN ONE (1) YEAR AFTER THE SETTLEMENT DATE.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Injunctive and Other Available Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By acceptance of these Performance Shares, the Grantee acknowledges that, if the Grantee were to breach or threaten to breach his&#47;her obligation hereunder not to Interfere or Solicit or not to disclose or use any Confidential Information other than in the course of performing authorized services for the Company (or any Affiliated Company), the harm caused to the Company by such breach or threatened breach would be, by its nature, irreparable because, among other things, damages would be significant and the monetary harm that would ensue would not be able to be readily proven, and that the Company would be entitled to injunctive and other appropriate relief to prevent threatened or continued breach and to such other remedies as may be available at law or in equity.  To the extent not prohibited by law, any cancellation of the Performance Shares pursuant to any of Sections 10(b) through 10(d) above shall not restrict, abridge or otherwise limit in any fashion the types and scope of injunctive and other available relief to the Company.  Notwithstanding any provision of this Agreement to the contrary, nothing under this Agreement shall  limit, abridge, modify or otherwise restrict the Company (or any Affiliated Company) from pursuing any or all legal, equitable or other appropriate remedies to which the Company may be entitled under any other agreement with the Grantee, any other plan, program, policy or arrangement of the Company (or any Affiliated Company) under which the Grantee is covered or participates, or any applicable law, all to the fullest extent not prohibited under applicable law.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.17pt;text-decoration:underline">Permitted Reporting and Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding any language in this Agreement to the contrary, nothing in this Agreement prohibits Grantee from reporting possible violations of federal law or regulation to any governmental agency or governmental entity, or making other disclosures that are protected under federal law or regulation&#59; provided, that, in each case such communications and disclosures are consistent with applicable law.  Notwithstanding the foregoing, under no circumstance is Grantee authorized to disclose any information covered by the Company&#8217;s attorney-client privilege or attorney work product or the Company&#8217;s trade secrets without prior written consent of the Company&#8217;s Chief Legal Officer.  Any reporting or disclosure permitted under this Section 10(f) shall not result in the cancellation of Performance Shares. Grantee is entitled to certain immunities from liability under state and federal law for disclosing </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.2</font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">trade secrets if the disclosure was made to report or investigate an alleged violation of law, subject to certain conditions. Please see the Company&#8217;s Confidential Information Policy for further details.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt;text-decoration:underline">Right to Retain Shares Contingent on Continuing Non-Conflicting Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In partial consideration for the award of these Performance Shares, in order to forestall the disclosure or use of Confidential Information, as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company, and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to the Shares upon settlement of the Performance Shares is contingent upon the Grantee refraining, during the term of the Performance Period and for a period of one (1) year after the Settlement Date, from rendering services, directly or indirectly, as director, officer, employee, agent, consultant or otherwise, to any Conflicting Organization except a Conflicting Organization whose business is diversified and that, as to that part of its business to which the Grantee renders services, is not a Conflicting Organization, provided that the Company shall receive separate written assurances satisfactory to the Company from the Grantee and the Conflicting Organization that the Grantee shall not render services during such period with respect to a Conflicting Product.  If, prior to the expiration of the Performance Period or at any time within one (1) year after the Settlement Date, the Grantee shall render services to any Conflicting Organization other than as expressly permitted herein, the Grantee&#8217;s right to the Shares upon settlement of the Performance Shares shall not have been earned and the Performance Shares, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares or the pre-tax income derived from any disposition of the Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE GRANTEE FROM RENDERING SERVICES TO A CONFLICTING ORGANIZATION, BUT PROVIDES FOR THE CANCELLATION OF THE PERFORMANCE SHARES AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO RENDER SUCH SERVICES DURING THE TERM OF THE PERFORMANCE PERIOD OR WITHIN ONE (1) YEAR AFTER THE SETTLEMENT DATE. </font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt;text-decoration:underline">Repayment Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">&#91;Restatement of Financials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In the event that (1) the Company issues a restatement of financial results to correct a material error and (2) the Committee determines, in good faith, that the Grantee&#8217;s fraud or willful misconduct was a significant contributing factor to the need to issue such restatement and (3) some or all of the Performance Shares that were granted and&#47;or vested prior to such restatement would not have been granted and&#47;or vested, as applicable, based upon the restated financial results, the Grantee shall immediately return to the Company the Performance Shares or any Shares or the pre-tax income derived from any disposition of the Shares previously received in settlement of the Performance Shares that would not have been granted and&#47;or vested based upon the restated financial results (the &#8220;Repayment Obligation&#8221;).  The Company shall be able to enforce the Repayment Obligation by all legal means available, including, without limitation, by withholding such amount from other sums owed by the Company to the Grantee.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#91;1&#93;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Clawback Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Awards under the Plan granted to Participants who are &#8220;Covered Employees&#8221; (as defined in the Company&#8217;s Policy Regarding Clawback of Incentive Compensation, the &#8220;Policy&#8221;) are subject to clawback in accordance with the terms of the Policy, as amended from time to time, and pursuant to any other policy the Company may adopt as required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.  No recovery of any Award granted hereunder pursuant to such a clawback policy shall be treated as an event giving rise to a Participant&#8217;s right to terminate employment for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or any similar term) under any agreement with the Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#91;2&#93; &#91;3&#93;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt;text-decoration:underline">Miscellaneous Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Neither the Grantee nor the Grantee&#8217;s transferee or representative shall have any rights as a stockholder with respect to any Shares subject to this Award until the Performance Shares have been settled and Share certificates have been issued to the Grantee, transferee or representative, as the case may be.  </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.2</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Choice of Law, Exclusive Jurisdiction and Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">The courts of the State of Delaware shall have exclusive jurisdiction over any disputes or other proceedings relating to this Agreement, and venue shall reside with the courts in New Castle County, Delaware, including if jurisdiction shall so permit, the U.S. District Court for the District of Delaware.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  Accordingly, the Grantee agrees that any claim of any type relating to this Agreement must be brought and maintained in the appropriate court located in New Castle County, Delaware, including if jurisdiction will so permit, in the U.S. District Court for the State of Delaware.  The Grantee hereby consents to the jurisdiction over the Grantee of any such courts and waives all objections based on venue or inconvenient forum.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Modification or Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Agreement may be modified or amended by the Board or the Committee at any time&#59; provided, however, no modification or amendment to this Agreement shall be made which would materially and adversely affect the rights of the Grantee, without such Grantee&#8217;s written consent. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In the event any provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining provisions of this Agreement, and this Agreement shall be construed and enforced to reflect the intent of the parties to the fullest extent not prohibited by law, and in the event that such provision is not able to be so construed and enforced, then this Agreement shall be construed and enforced as if such illegal or invalid provision had not been included.  In amplification of the preceding sentence, in the event that the time period or scope of any provision is declared by a court or arbitrator of competent jurisdiction to exceed the maximum time period or scope that such court or arbitrator deems enforceable, then such court or arbitrator shall have the power to reduce the time period or scope to the maximum time period or scope permitted by law.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">References to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  All references to the Plan shall be deemed references to the Plan as may be amended.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.17pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The captions used in this Agreement are inserted for convenience and shall not be deemed a part of this Agreement for construction or interpretation.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Interpretation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Any dispute regarding the interpretation of this Agreement shall be submitted by the Grantee or by the Company forthwith to the Board or the Committee, which shall review such dispute at its next regular meeting.  The resolution of such dispute by the Board or the Committee shall be final and binding on all persons.  It is the intention of the Company and the Grantee to make the promises contained in this Agreement reasonable and binding only to the extent that it may be lawfully done under existing applicable laws.  This Agreement and the Plan constitute the entire and exclusive agreement between the Grantee and the Company, and it supersedes all prior agreements or understandings, whether written or oral, with respect to the grant of Performance Shares set forth in this Agreement.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Section 409A Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  To the extent applicable, it is intended that the Plan and this Agreement comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) and any related regulations or other guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service (&#8220;Section 409A&#8221;).  Any provision of the Plan or this Agreement that would cause this Award to fail to satisfy Section 409A shall have no force or effect until amended to comply with Section 409A, which amendment may be retroactive to the extent permitted by Section 409A.   </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Notwithstanding any provision of the Plan to the contrary, if the Grantee is a &#8220;specified employee&#8221; (as defined in Section 1.409A-1(i) of the Treasury Department Regulations) at the time of the Grantee&#8217;s &#8220;separation from service&#8221; (as defined in Section 1.409A-1(h) of the Treasury Department Regulations and including a termination of employment or service on account of Disability that does not satisfy the definition of &#8220;disability&#8221; under Section 409A-3(i)(4) of the Treasury Department Regulations), and payments to the Grantee hereunder are not exempt from Section 409A as a short-term deferral or otherwise, these payments, to the extent otherwise payable within six (6) months after the Grantee&#8217;s separation from service shall be delayed until the earlier of the date which is six (6) months after the date of the Grantee&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.2</font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">separation from service or the date of death of the Grantee.  Any payments that were scheduled to be paid during the six (6) month period following the Grantee&#8217;s separation from service, but which were delayed pursuant to this Section 13(h), shall be paid without interest on, or as soon as administratively practicable after, the first day following the six (6) month anniversary of the Grantee&#8217;s separation from service (or, if earlier, the date of the Grantee&#8217;s death).  Any payments that were originally scheduled to be paid following the six (6) months after the Grantee&#8217;s separation from service shall continue to be paid in accordance with their predetermined schedule.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.73pt;text-decoration:underline">Agreement with Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Receipt of any benefits under this Agreement by the Grantee shall constitute the Grantee&#8217;s acceptance of and agreement with all of the provisions of this Agreement and of the Plan that are applicable to this Agreement, and the Company shall administer this Agreement accordingly.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">                                                                </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">               &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">THE CLOROX COMPANY</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                                                By&#58;  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">                                                                                                Its&#58;   Chief Executive Officer </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THE GRANTEE ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT IS A UNILATERAL CONTRACT AND THAT THE GRANTEE&#8217;S RIGHT TO THE SHARES PURSUANT TO THIS AGREEMENT IS ACCEPTED AND EARNED ONLY BY CONTINUING EMPLOYMENT (FOR PURPOSES OF THIS PARAGRAPH, IGNORING ANY ELECTION TO DEFER SETTLEMENT PURSUANT TO SECTION 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AT THE WILL OF THE COMPANY (NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS AWARD OR ACQUIRING SHARES HEREUNDER) AND BY ACHIEVEMENT OF THE PERFORMANCE CRITERIA AND BY COMPLIANCE WITH THE GRANTEE&#8217;S VARIOUS OBLIGATIONS UNDER THIS AGREEMENT.  THE GRANTEE FURTHER ACKNOWLEDGES AND AGREES THAT NOTHING IN THIS AGREEMENT, NOR IN THE PLAN, SHALL CONFER UPON THE GRANTEE ANY RIGHT WITH RESPECT TO CONTINUATION OF EMPLOYMENT BY THE COMPANY, NOR SHALL IT INTERFERE IN ANY WAY WITH THE GRANTEE&#8217;S RIGHT OR THE COMPANY&#8217;S RIGHT TO TERMINATE THE GRANTEE&#8217;S EMPLOYMENT AT ANY TIME, FOR ANY REASON OR NO REASON, WITH OR WITHOUT CAUSE, AND WITH OR WITHOUT ADVANCE NOTICE EXCEPT AS MAY BE REQUIRED BY APPLICABLE LAW.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Grantee acknowledges that a copy of the Plan and Plan Information are available for viewing on the Company&#8217;s internal HR website at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">https&#58;&#47;&#47;clxweb.clorox.com&#47;hr&#47;Pages&#47;HRatClorox&#47;HRContentPages&#47;StockIncentiveProgram.aspx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, and the Company&#8217;s Annual Report and Proxy Statement (the &#8220;Prospectus Information&#8221;) are available for viewing on the Company&#8217;s Clorox website at</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">https&#58;&#47;&#47;investors.thecloroxcompany.com&#47;investors&#47;financial-information&#47;sec-filings&#47;default.aspx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Grantee hereby consents to receive the Prospectus Information electronically or, in the alternative, to contact the HR Service Center at 1-800-709-7095 to request a paper copy of the Prospectus Information.  The Grantee represents that s&#47;he is familiar with the terms and provisions thereof, and hereby accepts this Agreement subject to all of the terms and provisions thereof.  The Grantee has reviewed the Plan and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands all provisions of the Agreement.  The Grantee acknowledges and hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Plan or this Agreement.  The Grantee further agrees to notify the Company upon any change in the residence address indicated below.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; ____________________________    Signed&#58; _________________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                                                                Grantee</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                                Residence Address&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                                __________________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                                __________________________________</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Exhibit 10.2</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To be included in agreements for individuals who are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> subject to the Policy.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To be included in agreements for individuals who are required to file disclosure statements under Section 16(a) of the Securities Exchange Act or otherwise subject to the Policy.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note to Draft</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#58; Grants should include either section 12(a) (for individuals who are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> subject to the Policy) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">OR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> section 12(b) (for individuals who </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">are</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> subject to the Policy).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>clxq1fy23exhibit103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia9a3e61829f14e55aa24150a099b8dab_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 10.3</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:112%">THE CLOROX COMPANY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:112%">2005 STOCK INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:112%">RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:112%">(US Employees)</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">SUMMARY OF RESTRICTED STOCK UNIT AWARD</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Clorox Company, a Delaware company (the &#8220;Company&#8221;), grants to the Grantee named below, in accordance with the terms of The Clorox Company 2005 Stock Incentive Plan (the &#8220;Plan&#8221;) and this restricted stock unit award agreement (the &#8220;Agreement&#8221;), the following number of Restricted Stock Units (the &#8220;Units&#8221;), on the terms set forth below&#58;</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.551%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">GRANTEE</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#60;&#60;Participant ID&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">TOTAL RESTRICTED UNITS AWARDED</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#60;&#60;Units Granted&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">DATE OF AWARD</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#60;&#60;Grant Date&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PERIOD OF RESTRICTION</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">25% vests on each of October 5, 2023, 2024, 2025 and 2026, or the first trading day immediately preceding each such date if such date is not a trading day&#59; provided, that an additional number of whole Units shall vest during any calendar year in which the Grantee is eligible under this Agreement to terminate employment or services due to Retirement in an amount sufficient to satisfy any applicable tax withholding amounts arising due to such Retirement eligibility (disregarding any fractional Unit).</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">TERMS OF AGREEMENT</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Grant of Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Company hereby grants to the Grantee the Units set forth above, subject to the terms, definitions and provisions of the Plan and this Agreement.  All terms, provisions, and conditions applicable to the Units set forth in the Plan and not set forth herein are incorporated by reference.  To the extent any provision hereof is inconsistent with a provision of the Plan, the provisions of the Plan will govern.  All capitalized terms that are used in this Agreement and not otherwise defined herein shall have the meanings ascribed to them in the Plan.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Nature and Settlement of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Units represent an unfunded, unsecured promise by the Company to issue Shares.  Units will become vested and be settled in Shares on a one Share for one Unit basis, rounded to the nearest whole Share, less any Shares withheld in accordance with the provisions of Section 4 of this Agreement.  Settlement shall occur as soon as practicable after the Period of Restriction lapses as provided in the Summary of Restricted Stock Unit Award above, but in any event, within the period ending on the later to occur of  the date that is 2 &#189; months from the end of (1) the Grantee&#8217;s tax year that includes the date of the lapse of the Period of Restriction, or (2) the Company&#8217;s tax year that includes the date of the lapse of the Period of Restriction (which payment schedule is intended to comply with the &#8220;short-term deferral&#8221; exemption from the application of Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;)) (the &#8220;Settlement Date&#8221;).  Although the Units shall be vested within the meaning of Section 83 of the Internal Revenue Code since no substantial risk of forfeiture exists after the Period of Restriction lapses, the Units will not be earned until the Grantee has fulfilled all of the conditions precedent set forth in this Agreement, including, but not limited to, the obligations set forth in Section 9(b), 9(c), 9(d), 9(e) and Section 10, and the Grantee shall have no right to retain the Shares or the value thereof upon vesting or settlement of the Units until all such conditions precedent have been satisfied.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No Dividend Equivalents shall be paid to the Grantee prior to the lapse of the Period of Restriction.  Rather, such Dividend Equivalent payments will accrue and be notionally credited to the Grantee&#8217;s RSU account and paid out in the form of additional Shares, rounded down to the nearest whole Share, after the lapse of the Period of Restriction, within the time period described in Section 2 above.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 10.3</font></div></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Pursuant to Section 16 of the Plan, the Committee shall have the power and the right to deduct or withhold, or require the Grantee to remit to the Company, an amount sufficient to satisfy any applicable tax withholding requirements applicable to this Award.  The Committee may condition the issuance of Shares in settlement of Units upon the Grantee&#8217;s satisfaction of such withholding obligations.  The Grantee may elect to satisfy all or part of such withholding requirement by tendering previously-owned Shares or by having the Company withhold Shares having a Fair Market Value equal to the minimum statutory tax withholding rate that could be imposed on the transaction (or such other rate that will not result in a negative accounting impact) or in such other manner as is acceptable to the Company.  Such election shall be irrevocable, made in writing, signed by the Grantee, and shall be subject to any restrictions or limitations that the Committee, in its sole discretion, deems appropriate.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Termination of Employment or Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt">Except as otherwise provided in this Section 5 or Section 8, if the Grantee&#8217;s employment or service with the Company and its Subsidiaries is terminated for any reason, any Units for which the Period of Restriction has not lapsed before such termination of employment or service  (the &#8220;Unvested Units&#8221;) and&#47;or any Dividend Equivalents related thereto shall be forfeited.  Notwithstanding the above, if the Grantee&#8217;s termination of employment or service is due to (i) Retirement and is more than 6 months from the date of award set forth in this Agreement, then the restrictions on the Units and all Dividend Equivalents related thereto shall continue to lapse in accordance with the Period of Restriction provided in the Summary of Restricted Stock Unit Award above, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> that the &#8220;Settlement Date&#8221; for such Units and Dividend Equivalents shall occur no later than December 31 of the calendar year in which the applicable Period of Restriction lapses or (ii) death or Disability, the Units shall become 100% vested and the Period of Restriction on the Units shall lapse and all Dividend Equivalents related thereto shall become immediately vested and payable as of such termination date.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">Definition of &#8220;Disability.&#8221;  For purposes of this Agreement, the Grantee&#8217;s employment shall be deemed to have terminated due to the Grantee&#8217;s Disability if the Grantee is entitled to long-term disability benefits under the Company&#8217;s long-term disability plan or policy, as in effect on the date of termination of the Grantee&#8217;s employment.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt">Definition of &#8220;Retirement.&#8221;  For purposes of this Agreement, the Grantee&#8217;s employment or service shall be deemed to have terminated due to  &#8220;Retirement&#8221; if the Grantee terminates employment or service as an Employee for any reason, including Disability (but other than for Cause) after (1) twenty (20) or more years of &#8220;vesting service,&#8221; which solely for purposes of this Agreement, shall be calculated under Article III of The Clorox Company 401(k) Plan (the &#8220;401(k) Plan&#8221;) entitled &#8220;Service&#8221; along with any other relevant provisions of the 401(k) Plan necessary or desirable to give full effect thereto, or any successor provisions, regardless of the status of the Grantee with respect to the 401(k) Plan (&#8220;Vesting Service&#8221;), or (2) attaining age fifty-five (55) with ten (10) or more years of Vesting Service.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Authorization to Return Forfeited Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.   The Grantee authorizes the Company or its designee to return to the Company all Units and related Dividend Equivalents and Shares subject thereto which are forfeited along with any cash or other property held with respect to or in substitution of such Units, related Dividend Equivalents and&#47;or Shares.  Any such action shall comply with all applicable provisions of this Agreement or the Plan.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Transferability of Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Unless otherwise determined by the Committee, Units shall not be transferable by the Grantee other than by will or by the laws of descent or distribution.  For avoidance of doubt, Shares issued to the Grantee in settlement of Units pursuant to Section 2 of this Agreement shall not be subject to any of the foregoing transferability restrictions.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Upon the occurrence of a Change in Control (including in the event the Grantee&#8217;s employment is terminated without Cause or by the Grantee for Good Reason upon or within twenty-four (24) months following consummation of a Change in Control), the Units shall be treated in accordance with Section 19 of the Plan.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 10.3</font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For purposes of this Agreement, &#8220;Good Reason&#8221; shall mean the occurrence of any of the following with respect to the Grantee&#58;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a) the assignment to the Grantee of any duties inconsistent in any material respect with the Grantee&#8217;s position (including offices and reporting requirements), authority, duties or responsibilities, as in effect immediately prior to the occurrence of the Change in Control or the date of the Grantee&#8217;s termination of employment, whichever is greater, or any other action by the Company which results in a material diminution in such position, authority, duties or responsibilities, excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Grantee&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b) any failure by the Company to substantially comply with, or any reduction by the Company in, any of the material provisions of the Grantee&#8217;s compensation plans, programs, agreements or arrangements as in effect immediately prior to the Change in Control, including, without limitation, any material reduction in base salary, cash incentive compensation target bonus opportunity, equity compensation opportunity in the aggregate, or employee benefits and perquisites in the aggregate, other than an isolated, insubstantial and inadvertent failure or reduction not occurring in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Grantee&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c) the Company&#8217;s requiring the Grantee to be based at any office or location other than that in effect immediately prior to the Change in Control or any office or location not requiring the Grantee&#8217;s commute to increase by more than 35 miles from his or her commute immediately prior to the Change in Control&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d) any purported termination by the Company of the Grantee&#8217;s employment other than (A) due to the death or Disability of the Grantee or (B) a termination of the Grantee&#8217;s employment by the Company for Cause&#59; or</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e) any material failure by the Company to require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Company to assume the obligations of the Company under this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any termination by the Grantee for Good Reason shall be communicated by a written notice to the Company within a period not to exceed ninety (90) days of such Grantee&#8217;s knowledge of the condition. Such written notice (1) must indicate the specific termination provision in the Good Reason definition relied upon, (2) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Grantee&#8217;s employment under the provision so indicated and (3) the Grantee's intended date of termination if the Company does not cure the issue (which date shall be not less than thirty (30) days after the giving of such notice). After receipt by the Company of such written notice, the Company shall have thirty (30) days during which it may remedy the condition and thereby cure the event or circumstance constituting &#8220;Good Reason&#8221;.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Protection of Trade Secrets and Limitations on Retention</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:58.5pt;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Affiliated Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means any organization controlling, controlled by or under common control with the Company.</font></div><div style="padding-left:58.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means the Company&#8217;s technical or business or personnel information not readily available to the public or generally known in the trade, including inventions, developments, trade secrets and other confidential information, knowledge, data and know-how of the Company or any Affiliated Company, whether or not they originated with the Grantee, or information which the Company or any Affiliated Company received from third parties under an obligation of confidentiality.</font></div><div style="padding-left:58.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-indent:-28.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Conflicting Product</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means any product, process, machine, or service of any person or organization, other than the Company or any Affiliated Company, in existence or under development that (1) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 10.3</font></div></div><div style="padding-left:58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">resembles or competes with a product, process, machine, or service upon or with which the Grantee shall have worked during the two years prior to the Grantee&#8217;s termination of employment with the Company or any Affiliated Company or (2) with respect to which during that period of time the Grantee, as a result of his&#47;her job performance and duties, shall have acquired knowledge of Confidential Information, and whose use or marketability could be enhanced by application to it of Confidential Information.  For purposes of this section, it shall be conclusively presumed that the Grantee has knowledge of information to which s&#47;he has been directly exposed through actual receipt or review of memorandum or documents containing such information or through actual attendance at meetings at which such information was discussed or disclosed.</font></div><div style="padding-left:58.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-indent:-28.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Conflicting Organization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means any person or organization that is engaged in or about to become engaged in research on or development, production, marketing or selling of a Conflicting Product.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Right to Retain Units&#47;Shares Contingent on Protection of Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In partial consideration for the award of these Units, the Grantee agrees that at all times, both during and after the term of the Grantee&#8217;s employment with the Company or any Affiliated Company, to hold in the strictest confidence, and not to use (except for the benefit of the Company at the Company&#8217;s direction) or disclose (except for the benefit of the Company at the Company&#8217;s direction), regardless of when disclosed to the Grantee, any and all Confidential Information of the Company or any Affiliated Company.  The Grantee understands that for purposes of this Section 9(b), Confidential Information further includes, but is not limited to, information pertaining to any aspect of the business of the Company or any Affiliated Company which is either information not known (or known as a result of a wrongful act of the Grantee or of others who were under confidentiality obligations as to the item or items involved) by actual or potential competitors of the Company or other third parties not under confidentiality obligations to the Company.  If, prior to the expiration of the Period of Restriction or at any time within one (1) year after the Settlement Date, the Grantee discloses or uses, or threatens to disclose or use, any Confidential Information other than in the course of performing authorized services for the Company (or any Affiliated Company), the Units, whether vested or not, will be immediately forfeited and cancelled, and the Grantee shall immediately return to the Company the Shares issued in settlement of the Units or the pre-tax income derived from any disposition of such Shares.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">No Interference with Customers or Suppliers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In partial consideration for the award of these Units, in order to forestall the disclosure or use of Confidential Information as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to receive the Shares upon settlement of the Units is contingent upon the Grantee refraining, during the Period of Restriction and for a period of one (1) year after the Settlement Date, for himself&#47;herself or any third party, directly or indirectly, from using Confidential Information to (1) divert or attempt to divert from the Company (or any Affiliated Company) any business of any kind in which it is engaged, or (2) intentionally solicit its customers with which it has a contractual relationship as to Conflicting Products, or interfere with the contractual relationship with any of its suppliers or customers (collectively, &#8220;Interfere&#8221;).  If, during the Period of Restriction or at any time within one (1) year after the Settlement Date, the Grantee breaches his&#47;her obligation not to Interfere, the Grantee&#8217;s right to the Shares upon settlement of the Units shall not have been earned and the Units, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares issued in settlement of the Units or the pre-tax income derived from any disposition of such Shares.  For avoidance of doubt, the term &#8220;Interfere&#8221; shall not include any advertisement of Conflicting Products through the use of media intended to reach a broad public audience (such as television, cable or radio broadcasts, generalized online marketing, or newspapers or magazines) or the broad distribution of coupons through the use of direct mail or through independent retail outlets. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT PROVIDES FOR THE CANCELLATION OF THE UNITS AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO VIOLATE THIS &#8220;NO INTERFERENCE WITH CUSTOMERS OR SUPPLIERS&#8221; PROVISION DURING THE PERIOD OF RESTRICTION OR WITHIN ONE (1) YEAR AFTER THE SETTLEMENT DATE.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 10.3</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">No Solicitation of Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In partial consideration for the award of these Units, in order to forestall the disclosure or use of Confidential Information, as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company, and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to receive the Shares upon settlement of the Units is contingent upon the Grantee refraining, during the Period of Restriction and for a period of one (1) year after the Settlement Date, for himself&#47;herself or any third party, directly or indirectly, from soliciting for employment any person employed by the Company, or by any Affiliated Company, during the period of the solicited person&#8217;s employment and for a period of one (1) year after the termination of the solicited person&#8217;s employment with the Company or any Affiliated Company (collectively &#8220;Solicit&#8221;).  If, during the term of the Period of Restriction or at any time within one (1) year after the Settlement Date, the Grantee breaches his&#47;her obligation not to Solicit, the Grantee&#8217;s right to the Shares upon settlement of the Units shall not have been earned and the Units, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares issued in settlement of the Units or the pre-tax income derived from any disposition of such Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT PROVIDES FOR THE CANCELLATION OF THE UNITS AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO VIOLATE THIS NON-SOLICITATION OF EMPLOYEES PROVISION DURING THE PERIOD OF RESTRICTION OR WITHIN ONE (1) YEAR AFTER THE SETTLEMENT DATE.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Injunctive and Other Available Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By acceptance of these Units and any Shares issued in settlement thereof, the Grantee acknowledges that, if the Grantee were to breach or threaten to breach his&#47;her obligation hereunder not to Interfere or Solicit or not to disclose or use any Confidential Information other than in the course of performing authorized services for the Company (or any Affiliated Company), the harm caused to the Company by such breach or threatened breach would be, by its nature, irreparable because, among other things, damages would be significant and the monetary harm that would ensue would not be able to be readily proven, and that the Company would be entitled to injunctive and other appropriate relief to prevent threatened or continued breach and to such other remedies as may be available at law or in equity.  To the extent not prohibited by law, any cancellation of the Units pursuant to any of Sections 9(b) through 9(d) above shall not restrict, abridge or otherwise limit in any fashion the types and scope of injunctive and other available relief to the Company. Notwithstanding any provision of this Agreement to the contrary, nothing under this Agreement shall  limit, abridge, modify or otherwise restrict the Company (or any Affiliated Company) from pursuing any or all legal, equitable or other appropriate remedies to which the Company may be entitled under any other agreement with the Grantee, any other plan, program, policy or arrangement of the Company (or any Affiliated Company) under which the Grantee is covered or participates, or any applicable law, all to the fullest extent not prohibited under applicable law.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.17pt;text-decoration:underline">Permitted Reporting and Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding any language in this Agreement to the contrary, nothing in this Agreement prohibits Grantee from reporting possible violations of federal law or regulation to any governmental agency or governmental entity, or making other disclosures that are protected under federal law or regulation&#59; provided, that, in each case such communications and disclosures are consistent with applicable law.  Notwithstanding the foregoing, under no circumstance is Grantee authorized to disclose any information covered by the Company&#8217;s attorney-client privilege or attorney work product or the Company&#8217;s trade secrets without prior written consent of the Company&#8217;s Chief Legal Officer.  Any reporting or disclosure permitted under this Section 9(f) shall not result in the cancellation of Shares.  Grantee is entitled to certain immunities from liability under state and federal law for disclosing trade secrets if the disclosure was made to report or investigate an alleged violation of law, subject to certain conditions. Please see the Company&#8217;s Confidential Information Policy for further details.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt;text-decoration:underline">Right to Retain Units&#47;Shares Contingent on Continuing Non-Conflicting Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In partial consideration for the award of these Units in order to forestall the disclosure or use of Confidential Information, as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company, and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to receive the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 10.3</font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Shares upon settlement of the Units is contingent upon the Grantee refraining, during the Period of Restriction and for a period of one (1) year after the Settlement Date, from rendering services, directly or indirectly, as director, officer, employee, agent, consultant or otherwise, to any Conflicting Organization except a Conflicting Organization whose business is diversified and that, as to that part of its business to which the Grantee renders services, is not a Conflicting Organization, provided that the Company shall receive separate written assurances satisfactory to the Company from the Grantee and the Conflicting Organization that the Grantee shall not render services during such period with respect to a Conflicting Product.  If, prior to the expiration of the Period of Restriction or at any time within one (1) year after the Settlement Date, the Grantee shall render services to any Conflicting Organization other than as expressly permitted herein, the Grantee&#8217;s right to the Shares upon settlement of the Units shall not have been earned and the Units, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares issued in settlement of the Units or the pre-tax income derived from any disposition of such Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE GRANTEE FROM RENDERING SERVICES TO A CONFLICTING ORGANIZATION, BUT PROVIDES FOR THE CANCELLATION OF THE UNITS AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO RENDER SUCH SERVICES DURING THE PERIOD OF RESTRICTION OR WITHIN ONE YEAR AFTER THE SETTLEMENT DATE.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt;text-decoration:underline">Repayment Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">&#91;Restatement of Financials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In the event that (1) the Company issues a restatement of financial results to correct a material error and (2) the Committee determines, in good faith, that the Grantee&#8217;s fraud or willful misconduct was a significant contributing factor to the need to issue such restatement and (3) some or all of the Units that were granted and&#47;or vested prior to such restatement would not have been granted and&#47;or vested, as applicable, based upon the restated financial results, the Grantee shall immediately return to the Company any Units or any Shares or the pre-tax income derived from any disposition of any Shares previously received in settlement of the Units that would not have been granted and&#47;or vested based upon the restated financial results (the &#8220;Repayment Obligation&#8221;).  The Company shall be able to enforce the Repayment Obligation by all legal means available, including, without limitation, by withholding such amount from other sums owed by the Company to the Grantee.&#93; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#91;1&#93;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">&#91;Clawback Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Awards under the Plan granted to Participants who are &#8220;Covered Employees&#8221; (as defined in the Company&#8217;s Policy Regarding Clawback of Incentive Compensation, the &#8220;Policy&#8221;) are subject to clawback in accordance with the terms of the Policy, as amended from time to time, and pursuant to any other policy the Company may adopt as required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.  No recovery of any Award granted hereunder pursuant to such a clawback policy shall be treated as an event giving rise to a Participant&#8217;s right to terminate employment for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or any similar term) under any agreement with the Company.&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#91;2&#93; &#91;3&#93;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt;text-decoration:underline">Miscellaneous Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Neither the Grantee nor the Grantee&#8217;s transferee or representative shall have any rights as a stockholder with respect to any Shares subject to this Award until the Units have been settled and Share certificates have been issued to the Grantee, transferee or representative, as the case may be.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"> </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Choice of Law, Exclusive Jurisdiction and Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">The courts of the State of Delaware shall have exclusive jurisdiction over any disputes or other proceedings relating to this Agreement, and venue shall reside with the courts in New Castle County, Delaware, including if jurisdiction shall so permit, the U.S. District Court for the District of Delaware.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  Accordingly, the Grantee agrees that any claim of any type relating to this Agreement must be brought and maintained in the appropriate court located in New Castle County, Delaware, including if jurisdiction will so permit, in the U.S. District Court for the State of Delaware.  The </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 10.3</font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grantee hereby consents to the jurisdiction over the Grantee of any such courts and waives all objections based on venue or inconvenient forum.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Modification or Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Agreement may be modified or amended by the Board or the Committee at any time&#59; provided, however, no modification or amendment to this Agreement shall be made which would materially and adversely affect the rights of the Grantee, without such Grantee&#8217;s written consent. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In the event any provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining provisions of this Agreement, and this Agreement shall be construed and enforced to reflect the intent of the parties to the fullest extent not prohibited by law, and in the event that such provision is not able to be so construed and enforced, then this Agreement shall be construed and enforced as if such illegal or invalid provision had not been included.  In amplification of the preceding sentence, in the event that the time period or scope of any provision is declared by a court or arbitrator of competent jurisdiction to exceed the maximum time period or scope that such court or arbitrator deems enforceable, then such court or arbitrator shall have the power to reduce the time period or scope to the maximum time period or scope permitted by law.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">References to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  All references to the Plan shall be deemed references to the Plan as may be amended.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.17pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The captions used in this Agreement are inserted for convenience and shall not be deemed a part of this Agreement for construction or interpretation.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Interpretation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Any dispute regarding the interpretation of this Agreement shall be submitted by the Grantee or by the Company forthwith to the Board or the Committee, which shall review such dispute at its next regular meeting.  The resolution of such dispute by the Board or the Committee shall be final and binding on all persons.  It is the intention of the Company and the Grantee to make the promises contained in this Agreement reasonable and binding only to the extent that it may be lawfully done under existing applicable laws.  This Agreement and the Plan constitute the entire and exclusive agreement between the Grantee and the Company, and it supersedes all prior agreements or understandings, whether written or oral, with respect to the grant of Units set forth in this Agreement.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Section 409A Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  To the extent applicable, it is intended that the Plan and this Agreement comply with the requirements of Section 409A of the Code, and any related regulations or other guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service (&#8220;Section 409A&#8221;).  Any provision of the Plan or this Agreement that would cause this Award to fail to satisfy Section 409A shall have no force or effect until amended to comply with Section 409A, which amendment may be retroactive to the extent permitted by Section 409A.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Notwithstanding any provision of the Plan to the contrary, if the Grantee is a &#8220;specified employee&#8221; (as defined in Section 1.409A-1(i) of the Treasury Department Regulations) at the time of the Grantee&#8217;s &#8220;separation from service&#8221; (as defined in Section 1.409A-1(h) of the Treasury Department Regulations and including a termination of employment or service on account of Disability that does not satisfy the definition of &#8220;disability&#8221; under Section 409A-3(i)(4) of the Treasury Department Regulations), and payments to the Grantee hereunder are not exempt from Section 409A as a short-term deferral or otherwise, these payments, to the extent otherwise payable within six (6) months after the Grantee&#8217;s separation from service shall be delayed until the earlier of the date which is six (6) months after the date of the Grantee&#8217;s separation from service or the date of death of the Grantee.  Any payments that were scheduled to be paid during the six (6) month period following the Grantee&#8217;s separation from service, but which were delayed pursuant to this Section 12(h), shall be paid without interest on, or as soon as administratively practicable after, the first day following the six (6) month anniversary of the Grantee&#8217;s separation from service (or, if earlier, the date of the Grantee&#8217;s death).  Any payments that were originally scheduled to be paid following the six (6) months after the Grantee&#8217;s separation from service shall continue to be paid in accordance with their predetermined schedule. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 10.3</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.73pt;text-decoration:underline">Agreement with Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Receipt of any benefits under this Agreement by the Grantee shall constitute the Grantee&#8217;s acceptance of and agreement with all of the provisions of this Agreement and of the Plan that are applicable to this Agreement, and the Company shall administer this Agreement accordingly.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">THE CLOROX COMPANY</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                                                By&#58;  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">                                                                                                Its&#58;  Chief Executive Officer</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THE GRANTEE ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT IS A UNILATERAL CONTRACT AND THAT THE GRANTEE&#8217;S RIGHT TO THE SHARES PURSUANT TO THIS AGREEMENT IS ACCEPTED AND EARNED ONLY BY CONTINUING EMPLOYMENT AT THE WILL OF THE COMPANY (NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS AWARD OR ACQUIRING SHARES HEREUNDER) AND BY COMPLIANCE WITH THE GRANTEE&#8217;S VARIOUS OBLIGATIONS UNDER THIS AGREEMENT.  THE GRANTEE FURTHER ACKNOWLEDGES AND AGREES THAT NOTHING IN THIS AGREEMENT, NOR IN THE PLAN, SHALL CONFER UPON THE GRANTEE ANY RIGHT WITH RESPECT TO CONTINUATION OF EMPLOYMENT BY THE COMPANY, NOR SHALL IT INTERFERE IN ANY WAY WITH THE GRANTEE&#8217;S RIGHT OR THE COMPANY&#8217;S RIGHT TO TERMINATE THE GRANTEE&#8217;S EMPLOYMENT AT ANY TIME, FOR ANY REASON OR NO REASON, WITH OR WITHOUT CAUSE, AND WITH OR WITHOUT ADVANCE NOTICE EXCEPT AS MAY BE REQUIRED BY APPLICABLE LAW.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Grantee acknowledges that a copy of the Plan and Plan Information are available for viewing on the Company&#8217;s internal HR website at https&#58;&#47;&#47;clxweb.clorox.com&#47;hr&#47;Pages&#47;HRatClorox&#47;HRContentPages&#47;StockIncentiveProgram.aspx, and the Company&#8217;s Annual Report and Proxy Statement (the &#8220;Prospectus Information&#8221;) are available for viewing on the Company&#8217;s Clorox web site at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">https&#58;&#47;&#47;investors.thecloroxcompany.com&#47;investors&#47;financial-information&#47;sec-filings&#47;default.aspx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Grantee hereby consents to receive the Prospectus Information electronically, or, in the alternative, to contact the HR Service Center at 1-800-709-7095 to request a paper copy of the Prospectus Information.  The Grantee represents that s&#47;he is familiar with the terms and provisions thereof, and hereby accepts this Agreement subject to all of the terms and provisions thereof.  The Grantee has reviewed the Plan and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands all provisions of this Agreement.  The Grantee acknowledges and hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Plan or this Agreement.  The Grantee further agrees to notify the Company upon any change in the residence address indicated below.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58;______________________________   Signed&#58;___________________________________</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                                                                Grantee</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                Residence Address&#58;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                ___________________________________</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                ___________________________________</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font><br></font></div><div><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To be included in agreements for individuals who are </font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">not</font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> subject to the Policy.</font></div><div><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To be included in agreements for individuals who are required to file disclosure statements under Section 16(a) of the Securities Exchange Act or otherwise subject to the Policy.</font></div><div><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note to Draft</font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#58; Grants should include either section 12(a) (for individuals who are </font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">not</font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> subject to the Policy) </font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">OR</font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> section 12(b) (for individuals who </font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">are</font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> subject to the Policy).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>clxq1fy23exhibit104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic804c5507eed4a38a6c1f1d70d3e4b90_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 10.4</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:112%">THE CLOROX COMPANY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:112%">2005 STOCK INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:112%">RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:112%">(US Employees)</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">SUMMARY OF RESTRICTED STOCK UNIT AWARD</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Clorox Company, a Delaware company (the &#8220;Company&#8221;), grants to the Grantee named below, in accordance with the terms of The Clorox Company 2005 Stock Incentive Plan (the &#8220;Plan&#8221;) and this restricted stock unit award agreement (the &#8220;Agreement&#8221;), the following number of Restricted Stock Units (the &#8220;Units&#8221;), on the terms set forth below&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.551%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">GRANTEE</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#60;&#60;Participant ID&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">TOTAL RESTRICTED UNITS AWARDED</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#60;&#60;Units Granted&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">DATE OF AWARD</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#60;&#60;Grant Date&#62;&#62;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PERIOD OF RESTRICTION</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1&#47;3 of the award vests on each of the first three anniversaries of the date of award</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">TERMS OF AGREEMENT</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Grant of Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Company hereby grants to the Grantee the Units set forth above, subject to the terms, definitions and provisions of the Plan and this Agreement.  All terms, provisions, and conditions applicable to the Units set forth in the Plan and not set forth herein are incorporated by reference.  To the extent any provision hereof is inconsistent with a provision of the Plan, the provisions of the Plan will govern.  All capitalized terms that are used in this Agreement and not otherwise defined herein shall have the meanings ascribed to them in the Plan.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Nature and Settlement of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Units represent an unfunded, unsecured promise by the Company to issue Shares.  Units will become vested and be settled in Shares on a one Share for one Unit basis, rounded to the nearest whole Share, less any Shares withheld in accordance with the provisions of Section 4 of this Agreement.  Settlement shall occur as soon as practicable after the Period of Restriction lapses as provided in the Summary of Restricted Stock Unit Award above, but in any event, within the period ending on the later to occur of  the date that is 2 &#189; months from the end of (1) the Grantee&#8217;s tax year that includes the date of the lapse of the Period of Restriction, or (2) the Company&#8217;s tax year that includes the date of the lapse of the Period of Restriction (which payment schedule is intended to comply with the &#8220;short-term deferral&#8221; exemption from the application of Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;)) (the &#8220;Settlement Date&#8221;).  Although the Units shall be vested within the meaning of Section 83 of the Internal Revenue Code since no substantial risk of forfeiture exists after the Period of Restriction lapses, the Units will not be earned until the Grantee has fulfilled all of the conditions precedent set forth in this Agreement, including, but not limited to, the obligations set forth in Section 9(b), 9(c), 9(d), 9(e) and Section 10, and the Grantee shall have no right to retain the Shares or the value thereof upon vesting or settlement of the Units until all such conditions precedent have been satisfied.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No Dividend Equivalents shall be paid to the Grantee prior to the lapse of the Period of Restriction.  Rather, such Dividend Equivalent payments will accrue and be notionally credited to the Grantee&#8217;s RSU account and paid out in the form of additional Shares, rounded down to the nearest whole Share, after the lapse of the Period of Restriction, within the time period described in Section 2 above.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"> </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Pursuant to Section 16 of the Plan, the Committee shall have the power and the right to deduct or withhold, or require the Grantee to remit to the Company, an amount sufficient to satisfy any applicable tax withholding requirements applicable to this Award.  The Committee may condition the issuance of Shares in settlement of Units upon the Grantee&#8217;s satisfaction of such withholding obligations.  The Grantee may elect to satisfy all or part of such withholding requirement by tendering previously-owned Shares or by having the Company withhold Shares having a Fair Market Value equal to the minimum statutory tax withholding rate that could be imposed on the transaction (or such other rate that will not result in a negative accounting impact) or in such other manner as is acceptable to the Company.  Such election shall be irrevocable, made in writing, signed </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 10.4</font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">by the Grantee, and shall be subject to any restrictions or limitations that the Committee, in its sole discretion, deems appropriate.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Termination of Employment or Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt">Except as otherwise provided in this Section 5 or Section 8, if the Grantee&#8217;s employment or service with the Company and its Subsidiaries is terminated for any reason, any Units for which the Period of Restriction has not lapsed before such termination of employment or service (the &#8220;Unvested Units&#8221;) and&#47;or any Dividend Equivalents related thereto shall be forfeited.  Notwithstanding the above, if the Grantee&#8217;s termination of employment or service is due to death or Disability, the Units shall become 100% vested and the Period of Restriction on the Units shall lapse and all Dividend Equivalents related thereto shall become immediately vested and payable as of such termination date.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">Definition of &#8220;Disability.&#8221;  For purposes of this Agreement, the Grantee&#8217;s employment shall be deemed to have terminated due to the Grantee&#8217;s Disability if the Grantee is entitled to long-term disability benefits under the Company&#8217;s long-term disability plan or policy, as in effect on the date of termination of the Grantee&#8217;s employment.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Authorization to Return Forfeited Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.   The Grantee authorizes the Company or its designee to return to the Company all Units and related Dividend Equivalents and Shares subject thereto which are forfeited along with any cash or other property held with respect to or in substitution of such Units, related Dividend Equivalents and&#47;or Shares.  Any such action shall comply with all applicable provisions of this Agreement or the Plan.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Transferability of Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Unless otherwise determined by the Committee, Units shall not be transferable by the Grantee other than by will or by the laws of descent or distribution.  For avoidance of doubt, Shares issued to the Grantee in settlement of Units pursuant to Section 2 of this Agreement shall not be subject to any of the foregoing transferability restrictions.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Upon the occurrence of a Change in Control (including in the event the Grantee&#8217;s employment is terminated without Cause or by the Grantee for Good Reason upon or within twenty-four (24) months following consummation of a Change in Control), the Units shall be treated in accordance with Section 19 of the Plan.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For purposes of this Agreement, &#8220;Good Reason&#8221; shall mean the occurrence of any of the following with respect to the Grantee&#58;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a) the assignment to the Grantee of any duties inconsistent in any material respect with the Grantee&#8217;s position (including offices and reporting requirements), authority, duties or responsibilities, as in effect immediately prior to the occurrence of the Change in Control or the date of the Grantee&#8217;s termination of employment, whichever is greater, or any other action by the Company which results in a material diminution in such position, authority, duties or responsibilities, excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Grantee&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b) any failure by the Company to substantially comply with, or any reduction by the Company in, any of the material provisions of the Grantee&#8217;s compensation plans, programs, agreements or arrangements as in effect immediately prior to the Change in Control, including, without limitation, any material reduction in base salary, cash incentive compensation target bonus opportunity, equity compensation opportunity in the aggregate, or employee benefits and perquisites in the aggregate, other than an isolated, insubstantial and inadvertent failure or reduction not occurring in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Grantee&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c) the Company&#8217;s requiring the Grantee to be based at any office or location other than that in effect immediately prior to the Change in Control or any office or location not requiring the Grantee&#8217;s commute to increase by more than 35 miles from his or her commute immediately prior to the Change in Control&#59;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 10.4</font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d) any purported termination by the Company of the Grantee&#8217;s employment other than (A) due to the death or Disability of the Grantee or (B) a termination of the Grantee&#8217;s employment by the Company for Cause&#59; or</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e) any material failure by the Company to require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Company to assume the obligations of the Company under this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any termination by the Grantee for Good Reason shall be communicated by a written notice to the Company within a period not to exceed ninety (90) days of such Grantee&#8217;s knowledge of the condition. Such written notice (1) must indicate the specific termination provision in the Good Reason definition relied upon, (2) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Grantee&#8217;s employment under the provision so indicated and (3) the Grantee's intended date of termination if the Company does not cure the issue (which date shall be not less than thirty (30) days after the giving of such notice). After receipt by the Company of such written notice, the Company shall have thirty (30) days during which it may remedy the condition and thereby cure the event or circumstance constituting &#8220;Good Reason&#8221;.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Protection of Trade Secrets and Limitations on Retention</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:58.5pt;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Affiliated Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means any organization controlling, controlled by or under common control with the Company.</font></div><div style="padding-left:58.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means the Company&#8217;s technical or business or personnel information not readily available to the public or generally known in the trade, including inventions, developments, trade secrets and other confidential information, knowledge, data and know-how of the Company or any Affiliated Company, whether or not they originated with the Grantee, or information which the Company or any Affiliated Company received from third parties under an obligation of confidentiality.</font></div><div style="padding-left:58.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-indent:-28.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Conflicting Product</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means any product, process, machine, or service of any person or organization, other than the Company or any Affiliated Company, in existence or under development that (1) resembles or competes with a product, process, machine, or service upon or with which the Grantee shall have worked during the two years prior to the Grantee&#8217;s termination of employment with the Company or any Affiliated Company or (2) with respect to which during that period of time the Grantee, as a result of his&#47;her job performance and duties, shall have acquired knowledge of Confidential Information, and whose use or marketability could be enhanced by application to it of Confidential Information.  For purposes of this section, it shall be conclusively presumed that the Grantee has knowledge of information to which s&#47;he has been directly exposed through actual receipt or review of memorandum or documents containing such information or through actual attendance at meetings at which such information was discussed or disclosed.</font></div><div style="padding-left:58.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-indent:-28.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Conflicting Organization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; means any person or organization that is engaged in or about to become engaged in research on or development, production, marketing or selling of a Conflicting Product.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Right to Retain Units&#47;Shares Contingent on Protection of Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In partial consideration for the award of these Units, the Grantee agrees that at all times, both during and after the term of the Grantee&#8217;s employment with the Company or any Affiliated Company, to hold in the strictest confidence, and not to use (except for the benefit of the Company at the Company&#8217;s direction) or disclose (except for the benefit of the Company at the Company&#8217;s direction), regardless of when disclosed to the Grantee, any and all Confidential Information of the Company or any Affiliated Company.  The Grantee understands that for purposes of this Section 9(b), Confidential Information further includes, but is not limited to, information pertaining to any aspect of the business of the Company or any Affiliated Company which is either information not known (or known as a result of a wrongful act of the Grantee or of others who were under confidentiality obligations as to the item or items involved) by actual or potential competitors of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 10.4</font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Company or other third parties not under confidentiality obligations to the Company.  If, prior to the expiration of the Period of Restriction or at any time within one (1) year after the Settlement Date, the Grantee discloses or uses, or threatens to disclose or use, any Confidential Information other than in the course of performing authorized services for the Company (or any Affiliated Company), the Units, whether vested or not, will be immediately forfeited and cancelled, and the Grantee shall immediately return to the Company the Shares issued in settlement of the Units or the pre-tax income derived from any disposition of such Shares.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">No Interference with Customers or Suppliers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In partial consideration for the award of these Units, in order to forestall the disclosure or use of Confidential Information as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to receive the Shares upon settlement of the Units is contingent upon the Grantee refraining, during the Period of Restriction and for a period of one (1) year after the Settlement Date, for himself&#47;herself or any third party, directly or indirectly, from using Confidential Information to (1) divert or attempt to divert from the Company (or any Affiliated Company) any business of any kind in which it is engaged, or (2) intentionally solicit its customers with which it has a contractual relationship as to Conflicting Products, or interfere with the contractual relationship with any of its suppliers or customers (collectively, &#8220;Interfere&#8221;).  If, during the Period of Restriction or at any time within one (1) year after the Settlement Date, the Grantee breaches his&#47;her obligation not to Interfere, the Grantee&#8217;s right to the Shares upon settlement of the Units shall not have been earned and the Units, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares issued in settlement of the Units or the pre-tax income derived from any disposition of such Shares.  For avoidance of doubt, the term &#8220;Interfere&#8221; shall not include any advertisement of Conflicting Products through the use of media intended to reach a broad public audience (such as television, cable or radio broadcasts, generalized online marketing, or newspapers or magazines) or the broad distribution of coupons through the use of direct mail or through independent retail outlets. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT PROVIDES FOR THE CANCELLATION OF THE UNITS AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO VIOLATE THIS &#8220;NO INTERFERENCE WITH CUSTOMERS OR SUPPLIERS&#8221; PROVISION DURING THE PERIOD OF RESTRICTION OR WITHIN ONE (1) YEAR AFTER THE SETTLEMENT DATE.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">No Solicitation of Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In partial consideration for the award of these Units, in order to forestall the disclosure or use of Confidential Information, as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company, and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to receive the Shares upon settlement of the Units is contingent upon the Grantee refraining, during the Period of Restriction and for a period of one (1) year after the Settlement Date, for himself&#47;herself or any third party, directly or indirectly, from soliciting for employment any person employed by the Company, or by any Affiliated Company, during the period of the solicited person&#8217;s employment and for a period of one (1) year after the termination of the solicited person&#8217;s employment with the Company or any Affiliated Company (collectively &#8220;Solicit&#8221;).  If, during the term of the Period of Restriction or at any time within one (1) year after the Settlement Date, the Grantee breaches his&#47;her obligation not to Solicit, the Grantee&#8217;s right to the Shares upon settlement of the Units shall not have been earned and the Units, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares issued in settlement of the Units or the pre-tax income derived from any disposition of such Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT PROVIDES FOR THE CANCELLATION OF THE UNITS AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO VIOLATE THIS NON-SOLICITATION OF EMPLOYEES PROVISION DURING THE PERIOD OF RESTRICTION OR WITHIN ONE (1) YEAR AFTER THE SETTLEMENT DATE.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 10.4</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Injunctive and Other Available Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By acceptance of these Units and any Shares issued in settlement thereof, the Grantee acknowledges that, if the Grantee were to breach or threaten to breach his&#47;her obligation hereunder not to Interfere or Solicit or not to disclose or use any Confidential Information other than in the course of performing authorized services for the Company (or any Affiliated Company), the harm caused to the Company by such breach or threatened breach would be, by its nature, irreparable because, among other things, damages would be significant and the monetary harm that would ensue would not be able to be readily proven, and that the Company would be entitled to injunctive and other appropriate relief to prevent threatened or continued breach and to such other remedies as may be available at law or in equity.  To the extent not prohibited by law, any cancellation of the Units pursuant to any of Sections 9(b) through 9(d) above shall not restrict, abridge or otherwise limit in any fashion the types and scope of injunctive and other available relief to the Company. Notwithstanding any provision of this Agreement to the contrary, nothing under this Agreement shall  limit, abridge, modify or otherwise restrict the Company (or any Affiliated Company) from pursuing any or all legal, equitable or other appropriate remedies to which the Company may be entitled under any other agreement with the Grantee, any other plan, program, policy or arrangement of the Company (or any Affiliated Company) under which the Grantee is covered or participates, or any applicable law, all to the fullest extent not prohibited under applicable law.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.17pt;text-decoration:underline">Permitted Reporting and Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding any language in this Agreement to the contrary, nothing in this Agreement prohibits Grantee from reporting possible violations of federal law or regulation to any governmental agency or governmental entity, or making other disclosures that are protected under federal law or regulation&#59; provided, that, in each case such communications and disclosures are consistent with applicable law.  Notwithstanding the foregoing, under no circumstance is Grantee authorized to disclose any information covered by the Company&#8217;s attorney-client privilege or attorney work product or the Company&#8217;s trade secrets without prior written consent of the Company&#8217;s Chief Legal Officer.  Any reporting or disclosure permitted under this Section 9(f) shall not result in the cancellation of Shares.  Grantee is entitled to certain immunities from liability under state and federal law for disclosing trade secrets if the disclosure was made to report or investigate an alleged violation of law, subject to certain conditions. Please see the Company&#8217;s Confidential Information Policy for further details.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt;text-decoration:underline">Right to Retain Units&#47;Shares Contingent on Continuing Non-Conflicting Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In partial consideration for the award of these Units in order to forestall the disclosure or use of Confidential Information, as well as to deter the Grantee&#8217;s intentional interference with the contractual relations of the Company or any Affiliated Company, the Grantee&#8217;s intentional interference with prospective economic advantage of the Company or any Affiliated Company, and to promote fair competition, the Grantee agrees that the Grantee&#8217;s right to receive the Shares upon settlement of the Units is contingent upon the Grantee refraining, during the Period of Restriction and for a period of one (1) year after the Settlement Date, from rendering services, directly or indirectly, as director, officer, employee, agent, consultant or otherwise, to any Conflicting Organization except a Conflicting Organization whose business is diversified and that, as to that part of its business to which the Grantee renders services, is not a Conflicting Organization, provided that the Company shall receive separate written assurances satisfactory to the Company from the Grantee and the Conflicting Organization that the Grantee shall not render services during such period with respect to a Conflicting Product.  If, prior to the expiration of the Period of Restriction or at any time within one (1) year after the Settlement Date, the Grantee shall render services to any Conflicting Organization other than as expressly permitted herein, the Grantee&#8217;s right to the Shares upon settlement of the Units shall not have been earned and the Units, whether vested or not, will be immediately cancelled, and the Grantee shall immediately return to the Company the Shares issued in settlement of the Units or the pre-tax income derived from any disposition of such Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE GRANTEE FROM RENDERING SERVICES TO A CONFLICTING ORGANIZATION, BUT PROVIDES FOR THE CANCELLATION OF THE UNITS AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO RENDER SUCH SERVICES DURING THE PERIOD OF RESTRICTION OR WITHIN ONE YEAR AFTER THE SETTLEMENT DATE.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt;text-decoration:underline">Repayment Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 10.4</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Restatement of Financials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In the event that (1) the Company issues a restatement of financial results to correct a material error and (2) the Committee determines, in good faith, that the Grantee&#8217;s fraud or willful misconduct was a significant contributing factor to the need to issue such restatement and (3) some or all of the Units that were granted and&#47;or vested prior to such restatement would not have been granted and&#47;or vested, as applicable, based upon the restated financial results, the Grantee shall immediately return to the Company any Units or any Shares or the pre-tax income derived from any disposition of any Shares previously received in settlement of the Units that would not have been granted and&#47;or vested based upon the restated financial results (the &#8220;Repayment Obligation&#8221;).  The Company shall be able to enforce the Repayment Obligation by all legal means available, including, without limitation, by withholding such amount from other sums owed by the Company to the Grantee.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#91;1&#93;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Clawback Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Awards under the Plan granted to Participants who are &#8220;Covered Employees&#8221; (as defined in the Company&#8217;s Policy Regarding Clawback of Incentive Compensation, the &#8220;Policy&#8221;) are subject to clawback in accordance with the terms of the Policy, as amended from time to time, and pursuant to any other policy the Company may adopt as required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.  No recovery of any Award granted hereunder pursuant to such a clawback policy shall be treated as an event giving rise to a Participant&#8217;s right to terminate employment for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or any similar term) under any agreement with the Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#91;2&#93; &#91;3&#93;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt;text-decoration:underline">Miscellaneous Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Neither the Grantee nor the Grantee&#8217;s transferee or representative shall have any rights as a stockholder with respect to any Shares subject to this Award until the Units have been settled and Share certificates have been issued to the Grantee, transferee or representative, as the case may be.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"> </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Choice of Law, Exclusive Jurisdiction and Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">The courts of the State of Delaware shall have exclusive jurisdiction over any disputes or other proceedings relating to this Agreement, and venue shall reside with the courts in New Castle County, Delaware, including if jurisdiction shall so permit, the U.S. District Court for the District of Delaware.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  Accordingly, the Grantee agrees that any claim of any type relating to this Agreement must be brought and maintained in the appropriate court located in New Castle County, Delaware, including if jurisdiction will so permit, in the U.S. District Court for the State of Delaware.  The Grantee hereby consents to the jurisdiction over the Grantee of any such courts and waives all objections based on venue or inconvenient forum.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">Modification or Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Agreement may be modified or amended by the Board or the Committee at any time&#59; provided, however, no modification or amendment to this Agreement shall be made which would materially and adversely affect the rights of the Grantee, without such Grantee&#8217;s written consent. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In the event any provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining provisions of this Agreement, and this Agreement shall be construed and enforced to reflect the intent of the parties to the fullest extent not prohibited by law, and in the event that such provision is not able to be so construed and enforced, then this Agreement shall be construed and enforced as if such illegal or invalid provision had not been included.  In amplification of the preceding sentence, in the event that the time period or scope of any provision is declared by a court or arbitrator of competent jurisdiction to exceed the maximum time period or scope that such court or arbitrator deems enforceable, then such court or arbitrator shall have the power to reduce the time period or scope to the maximum time period or scope permitted by law.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:11.07pt;text-decoration:underline">References to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  All references to the Plan shall be deemed references to the Plan as may be amended.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.17pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The captions used in this Agreement are inserted for convenience and shall not be deemed a part of this Agreement for construction or interpretation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 10.4</font></div></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Interpretation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Any dispute regarding the interpretation of this Agreement shall be submitted by the Grantee or by the Company forthwith to the Board or the Committee, which shall review such dispute at its next regular meeting.  The resolution of such dispute by the Board or the Committee shall be final and binding on all persons.  It is the intention of the Company and the Grantee to make the promises contained in this Agreement reasonable and binding only to the extent that it may be lawfully done under existing applicable laws.  This Agreement and the Plan constitute the entire and exclusive agreement between the Grantee and the Company, and it supersedes all prior agreements or understandings, whether written or oral, with respect to the grant of Units set forth in this Agreement.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Section 409A Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  To the extent applicable, it is intended that the Plan and this Agreement comply with the requirements of Section 409A of the Code, and any related regulations or other guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service (&#8220;Section 409A&#8221;).  Any provision of the Plan or this Agreement that would cause this Award to fail to satisfy Section 409A shall have no force or effect until amended to comply with Section 409A, which amendment may be retroactive to the extent permitted by Section 409A.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Notwithstanding any provision of the Plan to the contrary, if the Grantee is a &#8220;specified employee&#8221; (as defined in Section 1.409A-1(i) of the Treasury Department Regulations) at the time of the Grantee&#8217;s &#8220;separation from service&#8221; (as defined in Section 1.409A-1(h) of the Treasury Department Regulations and including a termination of employment or service on account of Disability that does not satisfy the definition of &#8220;disability&#8221; under Section 409A-3(i)(4) of the Treasury Department Regulations), and payments to the Grantee hereunder are not exempt from Section 409A as a short-term deferral or otherwise, these payments, to the extent otherwise payable within six (6) months after the Grantee&#8217;s separation from service shall be delayed until the earlier of the date which is six (6) months after the date of the Grantee&#8217;s separation from service or the date of death of the Grantee.  Any payments that were scheduled to be paid during the six (6) month period following the Grantee&#8217;s separation from service, but which were delayed pursuant to this Section 12(h), shall be paid without interest on, or as soon as administratively practicable after, the first day following the six (6) month anniversary of the Grantee&#8217;s separation from service (or, if earlier, the date of the Grantee&#8217;s death).  Any payments that were originally scheduled to be paid following the six (6) months after the Grantee&#8217;s separation from service shall continue to be paid in accordance with their predetermined schedule. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.73pt;text-decoration:underline">Agreement with Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Receipt of any benefits under this Agreement by the Grantee shall constitute the Grantee&#8217;s acceptance of and agreement with all of the provisions of this Agreement and of the Plan that are applicable to this Agreement, and the Company shall administer this Agreement accordingly.</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">_____________________________</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To be included in agreements for individuals who are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> subject to the Policy.</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To be included in agreements for individuals who are required to file disclosure statements under Section 16(a) of the Securities Exchange Act or otherwise subject to the Policy.</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note to Draft</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#58; Grants should include either section 12(a) (for individuals who are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> subject to the Policy) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">OR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> section 12(b) (for individuals who </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">are</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> subject to the Policy).</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">THE CLOROX COMPANY</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                                                By&#58;  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">                                                                                                Its&#58;  Chief Executive Officer</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THE GRANTEE ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT IS A UNILATERAL CONTRACT AND THAT THE GRANTEE&#8217;S RIGHT TO THE SHARES PURSUANT TO THIS AGREEMENT IS ACCEPTED AND EARNED ONLY BY CONTINUING EMPLOYMENT AT THE WILL OF THE COMPANY (NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS AWARD OR ACQUIRING SHARES HEREUNDER) AND BY COMPLIANCE WITH THE GRANTEE&#8217;S VARIOUS OBLIGATIONS UNDER THIS AGREEMENT.  THE GRANTEE FURTHER ACKNOWLEDGES AND AGREES THAT NOTHING IN THIS AGREEMENT, NOR IN THE PLAN, SHALL CONFER UPON THE </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 10.4</font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">GRANTEE ANY RIGHT WITH RESPECT TO CONTINUATION OF EMPLOYMENT BY THE COMPANY, NOR SHALL IT INTERFERE IN ANY WAY WITH THE GRANTEE&#8217;S RIGHT OR THE COMPANY&#8217;S RIGHT TO TERMINATE THE GRANTEE&#8217;S EMPLOYMENT AT ANY TIME, FOR ANY REASON OR NO REASON, WITH OR WITHOUT CAUSE, AND WITH OR WITHOUT ADVANCE NOTICE EXCEPT AS MAY BE REQUIRED BY APPLICABLE LAW.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Grantee acknowledges that a copy of the Plan and Plan Information are available for viewing on the Company&#8217;s internal HR website at https&#58;&#47;&#47;clxweb.clorox.com&#47;hr&#47;Pages&#47;HRatClorox&#47;HRContentPages&#47;StockIncentiveProgram.aspx, and the Company&#8217;s Annual Report and Proxy Statement (the &#8220;Prospectus Information&#8221;) are available for viewing on the Company&#8217;s Clorox web site at </font><font style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">https&#58;&#47;&#47;investors.thecloroxcompany.com&#47;investors&#47;financial-information&#47;sec-filings&#47;default.aspx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Grantee hereby consents to receive the Prospectus Information electronically, or, in the alternative, to contact the HR Service Center at 1-800-709-7095 to request a paper copy of the Prospectus Information.  The Grantee represents that s&#47;he is familiar with the terms and provisions thereof, and hereby accepts this Agreement subject to all of the terms and provisions thereof.  The Grantee has reviewed the Plan and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands all provisions of this Agreement.  The Grantee acknowledges and hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Plan or this Agreement.  The Grantee further agrees to notify the Company upon any change in the residence address indicated below.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58;______________________________   Signed&#58;___________________________________</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                                                                Grantee</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                Residence Address&#58;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                ___________________________________</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">                                                                ___________________________________</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:18pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>clxq1fy23ex311ceocertifica.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ieb23b2a4a20b4645bb5cc3fea44616a7_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Linda Rendle, certify that&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of The Clorox Company&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.035%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November 1, 2022</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Linda Rendle</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Linda Rendle</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>clxq1fy23ex312cfocertifica.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia466aa9705c64afe942f994a50ea653b_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Kevin B. Jacobsen, certify that&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of The Clorox Company&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:8pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.497%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November 1, 2022</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kevin B. Jacobsen</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin B. Jacobsen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President - Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>8
<FILENAME>clxq1fy23ex32ceocfocertifi.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i05e93ed2b06f46afaafd36a689d85cf4_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the periodic report of The Clorox Company (the &#8220;Company&#8221;) on Form 10-Q for the period ended September</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30, 2022,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as filed with the Securities and Exchange Commission (the &#8220;Report&#8221;), we, Linda Rendle, Chief Executive Officer of the Company, and Kevin B. Jacobsen, Executive Vice President - Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to our knowledge&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Certification has not been, and shall not be deemed, &#8220;filed&#8221; with the Securities and Exchange Commission.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November 1, 2022</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.497%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Linda Rendle</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Linda Rendle</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kevin B. Jacobsen</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin B. Jacobsen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President - Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>clx-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:705545e2-87bd-4296-a317-b2dac9e841f3,g:2063eff2-ec82-44e0-90e5-b1eb8fc3164f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:clx="http://www.clorox.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.clorox.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clx-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clx-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clx-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clx-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.clorox.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited">
        <link:definition>0000002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>0000003 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>0000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGANDRELATEDCOSTS" roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS">
        <link:definition>0000007 - Disclosure - RESTRUCTURING AND RELATED COSTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESNET" roleURI="http://www.clorox.com/role/INVENTORIESNET">
        <link:definition>0000008 - Disclosure - INVENTORIES, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS">
        <link:definition>0000009 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.clorox.com/role/INCOMETAXES">
        <link:definition>0000010 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETEARNINGSPERSHAREEPS" roleURI="http://www.clorox.com/role/NETEARNINGSPERSHAREEPS">
        <link:definition>0000011 - Disclosure - NET EARNINGS PER SHARE (EPS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPREHENSIVEINCOMELOSS" roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS">
        <link:definition>0000012 - Disclosure - COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITY">
        <link:definition>0000013 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANS" roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANS">
        <link:definition>0000014 - Disclosure - EMPLOYEE BENEFIT PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONTINGENCIESANDGUARANTEES" roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES">
        <link:definition>0000015 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTRESULTS" roleURI="http://www.clorox.com/role/SEGMENTRESULTS">
        <link:definition>0000016 - Disclosure - SEGMENT RESULTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGANDRELATEDCOSTSTables" roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables">
        <link:definition>0000018 - Disclosure - RESTRUCTURING AND RELATED COSTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESNETTables" roleURI="http://www.clorox.com/role/INVENTORIESNETTables">
        <link:definition>0000019 - Disclosure - INVENTORIES, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables">
        <link:definition>0000020 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETEARNINGSPERSHAREEPSTables" roleURI="http://www.clorox.com/role/NETEARNINGSPERSHAREEPSTables">
        <link:definition>0000021 - Disclosure - NET EARNINGS PER SHARE (EPS) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPREHENSIVEINCOMELOSSTables" roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables">
        <link:definition>0000022 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>0000023 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANSTables" roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables">
        <link:definition>0000024 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTRESULTSTables" roleURI="http://www.clorox.com/role/SEGMENTRESULTSTables">
        <link:definition>0000025 - Disclosure - SEGMENT RESULTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails" roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails">
        <link:definition>0000026 - Disclosure - RESTRUCTURING AND RELATED COSTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails">
        <link:definition>0000027 - Disclosure - RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails" roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails">
        <link:definition>0000028 - Disclosure - RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESNETDetails" roleURI="http://www.clorox.com/role/INVENTORIESNETDetails">
        <link:definition>0000029 - Disclosure - INVENTORIES, NET (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESNETDetails_1" roleURI="http://www.clorox.com/role/INVENTORIESNETDetails_1">
        <link:definition>0000029 - Disclosure - INVENTORIES, NET (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>0000030 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails">
        <link:definition>0000031 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails">
        <link:definition>0000032 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails">
        <link:definition>0000033 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNarrativeDetails" roleURI="http://www.clorox.com/role/INCOMETAXESNarrativeDetails">
        <link:definition>0000034 - Disclosure - INCOME TAXES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails" roleURI="http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails">
        <link:definition>0000035 - Disclosure - NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails">
        <link:definition>0000036 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofEquityDetails" roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails">
        <link:definition>0000037 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Equity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails">
        <link:definition>0000038 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNarrativeDetails" roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails">
        <link:definition>0000039 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANSNarrativeDetails" roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails">
        <link:definition>0000040 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails">
        <link:definition>0000041 - Disclosure - EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONTINGENCIESANDGUARANTEESDetails" roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails">
        <link:definition>0000042 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTRESULTSNarrativeDetails" roleURI="http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails">
        <link:definition>0000043 - Disclosure - SEGMENT RESULTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTRESULTSReportableSegmentInformationDetails" roleURI="http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails">
        <link:definition>0000044 - Disclosure - SEGMENT RESULTS (Reportable Segment Information ) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTRESULTSNetSalesPercentagesDetails" roleURI="http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails">
        <link:definition>0000045 - Disclosure - SEGMENT RESULTS (Net Sales Percentages) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" abstract="false" name="TrustAssetsForNonqualifiedDeferredCompensationPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_AlamedaCountyCaliforniaMatterMember" abstract="true" name="AlamedaCountyCaliforniaMatterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_PurchasesofInventoryMember" abstract="true" name="PurchasesofInventoryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" abstract="true" name="FinancialInstrumentsAndFairValueMeasurementsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="clx_OtherExpenseIncomeNet" abstract="false" name="OtherExpenseIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_VitaminsMineralsAndSupplementsMember" abstract="true" name="VitaminsMineralsAndSupplementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_ProfessionalProductsMember" abstract="true" name="ProfessionalProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_RetirementIncomeMember" abstract="false" name="RetirementIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_CommodityPurchaseDerivativeContractsDomain" abstract="true" name="CommodityPurchaseDerivativeContractsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_CleaningMember" abstract="false" name="CleaningMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_MaximumExposureUndiscountedCost" abstract="false" name="MaximumExposureUndiscountedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_InternationalMember" abstract="false" name="InternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_TrademarksNet" abstract="false" name="TrademarksNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_LetterOfCreditBorrowingCapacity" abstract="false" name="LetterOfCreditBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_HealthAndWellnessMember" abstract="true" name="HealthAndWellnessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_CostOfGoodsAndServicesSoldMember" abstract="true" name="CostOfGoodsAndServicesSoldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_TotalCommodityPurchaseDerivativeContractsMember" abstract="true" name="TotalCommodityPurchaseDerivativeContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_WalmartStoresIncMember" abstract="false" name="WalmartStoresIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_RemediationPeriod" abstract="false" name="RemediationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="clx_NaturalPersonalCareMember" abstract="true" name="NaturalPersonalCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_FoodProductsMember" abstract="true" name="FoodProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_DickinsonCountyMichiganMatterMember" abstract="true" name="DickinsonCountyMichiganMatterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_HouseholdMember" abstract="false" name="HouseholdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_InventoryCurrentAndNoncurrentNet" abstract="false" name="InventoryCurrentAndNoncurrentNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_DefinedBenefitPlanPlanTerminationPeriod" abstract="false" name="DefinedBenefitPlanPlanTerminationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="clx_NotesAndLoansPayableMember" abstract="true" name="NotesAndLoansPayableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" abstract="false" name="DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_OtherEmployeeStockPlanActivitiesAmount" abstract="false" name="OtherEmployeeStockPlanActivitiesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" abstract="false" name="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="clx_RestructuringAndRelatedCostsBenchmarkMember" abstract="true" name="RestructuringAndRelatedCostsBenchmarkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_CatLitterMember" abstract="true" name="CatLitterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_LifestyleMember" abstract="false" name="LifestyleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_OtherEmployeeStockPlanActivitiesShares" abstract="false" name="OtherEmployeeStockPlanActivitiesShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clx_WaterFiltrationMember" abstract="true" name="WaterFiltrationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_CommodityPurchaseDerivativeContractsAxis" abstract="true" name="CommodityPurchaseDerivativeContractsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="clx_SiteContingencyAgreedPercentageOfCostSharing" abstract="false" name="SiteContingencyAgreedPercentageOfCostSharing" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" abstract="false" name="IssuanceOfCommonStockForEmployeeStockPlansAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_OtherIncomeExpenseNetMember" abstract="true" name="OtherIncomeExpenseNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_BagsWrapsAndContainersMember" abstract="true" name="BagsWrapsAndContainersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_LongTermInterCompanyLoansMember" abstract="false" name="LongTermInterCompanyLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clx_OperatingLeaseRightofUseAssetAndLiabilityNet" abstract="false" name="OperatingLeaseRightofUseAssetAndLiabilityNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clx_GrillingMember" abstract="true" name="GrillingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>clx-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:705545e2-87bd-4296-a317-b2dac9e841f3,g:2063eff2-ec82-44e0-90e5-b1eb8fc3164f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="clx-20220930.xsd#CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_48f183d8-05b0-4621-ae94-8b51a633314b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fab725fa-840a-4a55-a972-708494ccfb14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_48f183d8-05b0-4621-ae94-8b51a633314b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fab725fa-840a-4a55-a972-708494ccfb14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_dd9598d9-055f-4728-bf49-fca30ded97cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_48f183d8-05b0-4621-ae94-8b51a633314b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_dd9598d9-055f-4728-bf49-fca30ded97cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4bbdf1cd-8128-4cce-a288-4d82dc775dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6d4ab7b5-e475-4602-94f8-c6ca1591b7da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4bbdf1cd-8128-4cce-a288-4d82dc775dd9" xlink:to="loc_us-gaap_ProfitLoss_6d4ab7b5-e475-4602-94f8-c6ca1591b7da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b259db5b-f4cd-4042-bd3b-40c1caf9ed3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4bbdf1cd-8128-4cce-a288-4d82dc775dd9" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b259db5b-f4cd-4042-bd3b-40c1caf9ed3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_aaf77a85-2d7d-4b54-9bfa-748307c6ba41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6e758697-0306-4d8d-a371-50824c59ffd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_aaf77a85-2d7d-4b54-9bfa-748307c6ba41" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6e758697-0306-4d8d-a371-50824c59ffd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_c5726a20-5ba8-4677-8098-b5fc2e75417a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_aaf77a85-2d7d-4b54-9bfa-748307c6ba41" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_c5726a20-5ba8-4677-8098-b5fc2e75417a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_51a44e56-691c-4545-94eb-d92abe2c279b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_0b6a4b82-3eaa-4730-b2d1-1aa2e5aae8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_51a44e56-691c-4545-94eb-d92abe2c279b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_0b6a4b82-3eaa-4730-b2d1-1aa2e5aae8a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_7a304eb4-9ce1-42af-805b-471f3803213f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_51a44e56-691c-4545-94eb-d92abe2c279b" xlink:to="loc_us-gaap_AdvertisingExpense_7a304eb4-9ce1-42af-805b-471f3803213f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_1d48bddb-65ac-49e8-ab13-e17fdfb76547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_51a44e56-691c-4545-94eb-d92abe2c279b" xlink:to="loc_us-gaap_InterestExpense_1d48bddb-65ac-49e8-ab13-e17fdfb76547" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_682ed7b9-f073-4990-8f08-d7acb5b7dbbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_51a44e56-691c-4545-94eb-d92abe2c279b" xlink:to="loc_us-gaap_GrossProfit_682ed7b9-f073-4990-8f08-d7acb5b7dbbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8f190540-979c-41ba-a08e-7d39bbc395d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_51a44e56-691c-4545-94eb-d92abe2c279b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8f190540-979c-41ba-a08e-7d39bbc395d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherExpenseIncomeNet_c58ab0ad-664c-4825-9334-14c8b4978763" xlink:href="clx-20220930.xsd#clx_OtherExpenseIncomeNet"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_51a44e56-691c-4545-94eb-d92abe2c279b" xlink:to="loc_clx_OtherExpenseIncomeNet_c58ab0ad-664c-4825-9334-14c8b4978763" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c43495d3-7472-4316-96e0-0fad7192cc35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_52d58e83-60a8-48e5-a036-ee5bd2f74606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_c43495d3-7472-4316-96e0-0fad7192cc35" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_52d58e83-60a8-48e5-a036-ee5bd2f74606" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b291f1e4-2d0c-458d-baba-19a2cc43ab78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_c43495d3-7472-4316-96e0-0fad7192cc35" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b291f1e4-2d0c-458d-baba-19a2cc43ab78" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="clx-20220930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ee45a3b1-6044-4004-a25a-b5b50281c58a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_c03dd679-69d0-4d35-a124-7655c7d4710f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ee45a3b1-6044-4004-a25a-b5b50281c58a" xlink:to="loc_us-gaap_PreferredStockValue_c03dd679-69d0-4d35-a124-7655c7d4710f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3d2cc0e3-629f-48f6-85be-fc5e3db48682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ee45a3b1-6044-4004-a25a-b5b50281c58a" xlink:to="loc_us-gaap_CommonStockValue_3d2cc0e3-629f-48f6-85be-fc5e3db48682" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_bf9729a3-71b2-430b-bbea-f792bd2adefb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ee45a3b1-6044-4004-a25a-b5b50281c58a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_bf9729a3-71b2-430b-bbea-f792bd2adefb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_227ef384-27e4-438b-b630-f0bbb5b8b39b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ee45a3b1-6044-4004-a25a-b5b50281c58a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_227ef384-27e4-438b-b630-f0bbb5b8b39b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_4eeb8c9f-1cec-4646-93a2-687688bee374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ee45a3b1-6044-4004-a25a-b5b50281c58a" xlink:to="loc_us-gaap_TreasuryStockValue_4eeb8c9f-1cec-4646-93a2-687688bee374" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c2ddb2a7-478f-44cf-90d7-cf0d6cfb4cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ee45a3b1-6044-4004-a25a-b5b50281c58a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c2ddb2a7-478f-44cf-90d7-cf0d6cfb4cae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2d13ae4d-9ecc-4f9e-a55d-3fb95cc7c53c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5dbfb169-4de6-4b48-8a5b-abf7c16c6c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2d13ae4d-9ecc-4f9e-a55d-3fb95cc7c53c" xlink:to="loc_us-gaap_LiabilitiesCurrent_5dbfb169-4de6-4b48-8a5b-abf7c16c6c27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c7ef0eee-f39f-4861-b3da-8f0c1d3dcab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2d13ae4d-9ecc-4f9e-a55d-3fb95cc7c53c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c7ef0eee-f39f-4861-b3da-8f0c1d3dcab6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c8ad82f3-f5b8-4bb2-a7c6-39fd3ee99fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2d13ae4d-9ecc-4f9e-a55d-3fb95cc7c53c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c8ad82f3-f5b8-4bb2-a7c6-39fd3ee99fd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a4dcbd72-0f10-4427-b721-0187e71d0356" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2d13ae4d-9ecc-4f9e-a55d-3fb95cc7c53c" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a4dcbd72-0f10-4427-b721-0187e71d0356" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0db557b3-0313-42eb-a9fd-4a57e1a3ae69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2d13ae4d-9ecc-4f9e-a55d-3fb95cc7c53c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0db557b3-0313-42eb-a9fd-4a57e1a3ae69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_12f40d5a-88d1-43c6-90b1-4d091ae57556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_faf76b81-d1cd-47f7-a31d-9cd1aae169fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_12f40d5a-88d1-43c6-90b1-4d091ae57556" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_faf76b81-d1cd-47f7-a31d-9cd1aae169fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_45dbe12a-2ad6-4e24-9272-6ed0e6e23de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_12f40d5a-88d1-43c6-90b1-4d091ae57556" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_45dbe12a-2ad6-4e24-9272-6ed0e6e23de1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_20a2de5b-db0a-4dfb-8e28-5c1888e8ece4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_12f40d5a-88d1-43c6-90b1-4d091ae57556" xlink:to="loc_us-gaap_CommercialPaper_20a2de5b-db0a-4dfb-8e28-5c1888e8ece4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_87bcc272-e1a5-457b-a9f5-ba6ab9c2c141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6affb929-2e0d-4273-bcc9-36eec3f155de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_87bcc272-e1a5-457b-a9f5-ba6ab9c2c141" xlink:to="loc_us-gaap_Liabilities_6affb929-2e0d-4273-bcc9-36eec3f155de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_7791bd2f-811e-4cb2-8b53-236154e695a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_87bcc272-e1a5-457b-a9f5-ba6ab9c2c141" xlink:to="loc_us-gaap_CommitmentsAndContingencies_7791bd2f-811e-4cb2-8b53-236154e695a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_db0ce30f-69bb-471d-acb4-2bf68a1c1815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_87bcc272-e1a5-457b-a9f5-ba6ab9c2c141" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_db0ce30f-69bb-471d-acb4-2bf68a1c1815" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_98899b09-7d97-4374-944f-6eb2dde9a03b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_391e6d3d-1ac6-4805-aacd-ffe480ce0527" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_98899b09-7d97-4374-944f-6eb2dde9a03b" xlink:to="loc_us-gaap_Goodwill_391e6d3d-1ac6-4805-aacd-ffe480ce0527" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_74d54c91-d98d-4984-a446-4949546edbbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_98899b09-7d97-4374-944f-6eb2dde9a03b" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_74d54c91-d98d-4984-a446-4949546edbbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1690e5ef-8330-4f56-979a-7e81837aea44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_98899b09-7d97-4374-944f-6eb2dde9a03b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1690e5ef-8330-4f56-979a-7e81837aea44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_54683908-13b7-408b-ae1a-51ace36e4fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_98899b09-7d97-4374-944f-6eb2dde9a03b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_54683908-13b7-408b-ae1a-51ace36e4fc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5751e850-b765-4840-bfa0-fdca091bbf9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_98899b09-7d97-4374-944f-6eb2dde9a03b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5751e850-b765-4840-bfa0-fdca091bbf9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrademarksNet_28ed793f-2458-4a0d-9c7d-ae6895de74b5" xlink:href="clx-20220930.xsd#clx_TrademarksNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_98899b09-7d97-4374-944f-6eb2dde9a03b" xlink:to="loc_clx_TrademarksNet_28ed793f-2458-4a0d-9c7d-ae6895de74b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5415a007-99c4-406b-8baf-769e8859b264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_98899b09-7d97-4374-944f-6eb2dde9a03b" xlink:to="loc_us-gaap_AssetsCurrent_5415a007-99c4-406b-8baf-769e8859b264" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_96194136-5c2f-4c73-b41c-93656ae38cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a04c24dd-8217-4f50-be53-dfe7dff8c530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_96194136-5c2f-4c73-b41c-93656ae38cdc" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a04c24dd-8217-4f50-be53-dfe7dff8c530" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_efc5d208-7f98-495c-b4a7-ab92bcf9bfa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_96194136-5c2f-4c73-b41c-93656ae38cdc" xlink:to="loc_us-gaap_InventoryNet_efc5d208-7f98-495c-b4a7-ab92bcf9bfa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_96cf8bf7-db69-44c8-8277-f9c56e9ea90e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_96194136-5c2f-4c73-b41c-93656ae38cdc" xlink:to="loc_us-gaap_ReceivablesNetCurrent_96cf8bf7-db69-44c8-8277-f9c56e9ea90e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b3d477a3-12e4-4588-9736-d3e93effda26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_96194136-5c2f-4c73-b41c-93656ae38cdc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b3d477a3-12e4-4588-9736-d3e93effda26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b9131031-3c50-46b7-aa9a-10c76356403b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_9be5b3a5-88fe-4c89-b451-fbd2f60f313d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b9131031-3c50-46b7-aa9a-10c76356403b" xlink:to="loc_us-gaap_MinorityInterest_9be5b3a5-88fe-4c89-b451-fbd2f60f313d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_00aaa8ee-b5f1-495f-a455-36c736c77d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b9131031-3c50-46b7-aa9a-10c76356403b" xlink:to="loc_us-gaap_StockholdersEquity_00aaa8ee-b5f1-495f-a455-36c736c77d6a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="clx-20220930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d4fc9fff-d45b-44cc-9364-7b2540ea8446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_0348a7e5-c2e1-44d9-80cd-ccb48c7541a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d4fc9fff-d45b-44cc-9364-7b2540ea8446" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_0348a7e5-c2e1-44d9-80cd-ccb48c7541a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_59aa9576-5bac-47d7-8dca-7b54a6077f17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d4fc9fff-d45b-44cc-9364-7b2540ea8446" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_59aa9576-5bac-47d7-8dca-7b54a6077f17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_1d4231ad-d1e7-4475-be94-ddcaf1df9371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d4fc9fff-d45b-44cc-9364-7b2540ea8446" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_1d4231ad-d1e7-4475-be94-ddcaf1df9371" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_38e13d13-3145-4c32-a4a3-030daf1b7b45" xlink:href="clx-20220930.xsd#clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d4fc9fff-d45b-44cc-9364-7b2540ea8446" xlink:to="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_38e13d13-3145-4c32-a4a3-030daf1b7b45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a5455a1c-1afe-4bd5-8913-d6ef2233b662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bf08cf41-de10-478f-b393-3e441ecf3041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a5455a1c-1afe-4bd5-8913-d6ef2233b662" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bf08cf41-de10-478f-b393-3e441ecf3041" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_afac0596-ddc9-41d1-8ed8-6a3fdc60054d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a5455a1c-1afe-4bd5-8913-d6ef2233b662" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_afac0596-ddc9-41d1-8ed8-6a3fdc60054d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9f80d17-6a75-472c-bcfd-18149aa02dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f21c22ae-be3f-4911-a10b-1f64775c56b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9f80d17-6a75-472c-bcfd-18149aa02dd5" xlink:to="loc_us-gaap_ProfitLoss_f21c22ae-be3f-4911-a10b-1f64775c56b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_284fdfaa-de2b-4165-b4df-8cdd3a6a0a98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9f80d17-6a75-472c-bcfd-18149aa02dd5" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_284fdfaa-de2b-4165-b4df-8cdd3a6a0a98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_82df4b36-23b8-40e2-80d6-7ba448b0847a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9f80d17-6a75-472c-bcfd-18149aa02dd5" xlink:to="loc_us-gaap_ShareBasedCompensation_82df4b36-23b8-40e2-80d6-7ba448b0847a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_691b882d-c670-4fb8-9fd0-84aead13bafe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9f80d17-6a75-472c-bcfd-18149aa02dd5" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_691b882d-c670-4fb8-9fd0-84aead13bafe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_7b2b1238-946d-4721-b48e-8336edf44a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9f80d17-6a75-472c-bcfd-18149aa02dd5" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_7b2b1238-946d-4721-b48e-8336edf44a75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_49eeb546-a970-4c72-9e3b-3c1435dc6636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9f80d17-6a75-472c-bcfd-18149aa02dd5" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_49eeb546-a970-4c72-9e3b-3c1435dc6636" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1ec1fa74-162d-43f4-ae1d-bfa029741ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9f80d17-6a75-472c-bcfd-18149aa02dd5" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1ec1fa74-162d-43f4-ae1d-bfa029741ee2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4652a133-c689-4177-81cb-2ac70a7e2a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9f80d17-6a75-472c-bcfd-18149aa02dd5" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4652a133-c689-4177-81cb-2ac70a7e2a97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1bc542c7-4f9d-4064-a4ab-5554ba31e770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9f80d17-6a75-472c-bcfd-18149aa02dd5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1bc542c7-4f9d-4064-a4ab-5554ba31e770" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_e7c8f901-c34c-48d0-8d6f-170c7d7ebbc4" xlink:href="clx-20220930.xsd#clx_OperatingLeaseRightofUseAssetAndLiabilityNet"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9f80d17-6a75-472c-bcfd-18149aa02dd5" xlink:to="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_e7c8f901-c34c-48d0-8d6f-170c7d7ebbc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_57081282-f7d2-4e3e-8041-88facf39add6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9f80d17-6a75-472c-bcfd-18149aa02dd5" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_57081282-f7d2-4e3e-8041-88facf39add6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_55fcdee0-1efa-4aa2-a03d-e216d73b9c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f864d3a-3aa1-4fe3-93ec-f426aa896669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_55fcdee0-1efa-4aa2-a03d-e216d73b9c3e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f864d3a-3aa1-4fe3-93ec-f426aa896669" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec8a768b-a19e-4a98-9260-421db16f03b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_55fcdee0-1efa-4aa2-a03d-e216d73b9c3e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec8a768b-a19e-4a98-9260-421db16f03b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bdfbbc4e-884e-464b-ab56-ea53a472fffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_55fcdee0-1efa-4aa2-a03d-e216d73b9c3e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bdfbbc4e-884e-464b-ab56-ea53a472fffb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d88d7482-36be-4004-87e3-29479276a6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_55fcdee0-1efa-4aa2-a03d-e216d73b9c3e" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d88d7482-36be-4004-87e3-29479276a6dd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNETDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#INVENTORIESNETDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/INVENTORIESNETDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_InventoryCurrentAndNoncurrentNet_c0b065d6-e9bd-4e24-bed7-f2564d8ce776" xlink:href="clx-20220930.xsd#clx_InventoryCurrentAndNoncurrentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_fc1aac2d-8880-4f4e-a823-adf97445be6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_clx_InventoryCurrentAndNoncurrentNet_c0b065d6-e9bd-4e24-bed7-f2564d8ce776" xlink:to="loc_us-gaap_InventoryNet_fc1aac2d-8880-4f4e-a823-adf97445be6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_7fdaa97b-1637-4a88-91d5-685a559babe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_clx_InventoryCurrentAndNoncurrentNet_c0b065d6-e9bd-4e24-bed7-f2564d8ce776" xlink:to="loc_us-gaap_InventoryNoncurrent_7fdaa97b-1637-4a88-91d5-685a559babe8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNETDetails_1" xlink:type="simple" xlink:href="clx-20220930.xsd#INVENTORIESNETDetails_1"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/INVENTORIESNETDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_InventoryCurrentAndNoncurrentNet_b0a54930-176e-4c6a-abc8-3dc7e587e15c" xlink:href="clx-20220930.xsd#clx_InventoryCurrentAndNoncurrentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_4e9f17a6-10c6-4f07-afb6-d75f760e8445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_clx_InventoryCurrentAndNoncurrentNet_b0a54930-176e-4c6a-abc8-3dc7e587e15c" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_4e9f17a6-10c6-4f07-afb6-d75f760e8445" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve_af667de0-d5cb-4b3a-8136-8f70122bfab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_clx_InventoryCurrentAndNoncurrentNet_b0a54930-176e-4c6a-abc8-3dc7e587e15c" xlink:to="loc_us-gaap_InventoryLIFOReserve_af667de0-d5cb-4b3a-8136-8f70122bfab5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_b00e2918-e41a-4247-aed2-69da6f93b0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_clx_InventoryCurrentAndNoncurrentNet_b0a54930-176e-4c6a-abc8-3dc7e587e15c" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_b00e2918-e41a-4247-aed2-69da6f93b0ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_2725b7b1-a7d0-4395-bdcb-3a13fb724e51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_clx_InventoryCurrentAndNoncurrentNet_b0a54930-176e-4c6a-abc8-3dc7e587e15c" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_2725b7b1-a7d0-4395-bdcb-3a13fb724e51" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_1cee6be5-a930-4411-b12e-9ee3e4074c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue_807ce1f7-0452-4861-89e0-025e89030b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_1cee6be5-a930-4411-b12e-9ee3e4074c74" xlink:to="loc_us-gaap_ShorttermDebtFairValue_807ce1f7-0452-4861-89e0-025e89030b27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_a80f066a-d4fb-4fc8-ab8b-7212ff2ea10b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_1cee6be5-a930-4411-b12e-9ee3e4074c74" xlink:to="loc_us-gaap_DebtInstrumentFairValue_a80f066a-d4fb-4fc8-ab8b-7212ff2ea10b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5e5cb5bd-a2f3-4447-935f-e4f71f295ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_db0ac6e8-4f27-4bbd-a406-338761d0fbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5e5cb5bd-a2f3-4447-935f-e4f71f295ca2" xlink:to="loc_us-gaap_LongTermDebt_db0ac6e8-4f27-4bbd-a406-338761d0fbfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_d398b1e5-548c-4abd-923e-d95b52eebe0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5e5cb5bd-a2f3-4447-935f-e4f71f295ca2" xlink:to="loc_us-gaap_CommercialPaper_d398b1e5-548c-4abd-923e-d95b52eebe0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8e7eb1d7-d78c-4df2-85ee-e688f42bcdd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0607ffce-17bb-4fc9-97a0-f9c8e51df951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8e7eb1d7-d78c-4df2-85ee-e688f42bcdd9" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0607ffce-17bb-4fc9-97a0-f9c8e51df951" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_273dd842-e0e4-406d-ab9d-bf6111b5dc97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8e7eb1d7-d78c-4df2-85ee-e688f42bcdd9" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_273dd842-e0e4-406d-ab9d-bf6111b5dc97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_32ca2bf4-41f3-46d4-8158-ceca1a0a5175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_c10b6c7c-e860-4d28-bf45-9634cb6838f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_32ca2bf4-41f3-46d4-8158-ceca1a0a5175" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_c10b6c7c-e860-4d28-bf45-9634cb6838f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_aa049d33-96c4-4ff9-9694-0c9e33a8de10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_32ca2bf4-41f3-46d4-8158-ceca1a0a5175" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_aa049d33-96c4-4ff9-9694-0c9e33a8de10" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0a548012-465b-45e9-b637-b56ee16229e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d5e97545-8610-46ce-bf00-c670dd96a428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0a548012-465b-45e9-b637-b56ee16229e2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d5e97545-8610-46ce-bf00-c670dd96a428" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6f438829-e36b-4471-85d5-12f724166305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0a548012-465b-45e9-b637-b56ee16229e2" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6f438829-e36b-4471-85d5-12f724166305" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_571533ae-0ae1-4b4a-b33c-d7792b84407d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_eaa221df-fa2c-4717-93e6-de493546d614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_571533ae-0ae1-4b4a-b33c-d7792b84407d" xlink:to="loc_us-gaap_ProfitLoss_eaa221df-fa2c-4717-93e6-de493546d614" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2f9748cb-6cfa-4b51-8c11-05353b73ecfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_571533ae-0ae1-4b4a-b33c-d7792b84407d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2f9748cb-6cfa-4b51-8c11-05353b73ecfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c4b0dc18-c392-45e8-8420-5b0137c45847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_c6e63a2c-37ae-48f3-93d6-cb0102b682da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c4b0dc18-c392-45e8-8420-5b0137c45847" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_c6e63a2c-37ae-48f3-93d6-cb0102b682da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_83515281-9209-46f7-9f8c-a3869ef17e59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c4b0dc18-c392-45e8-8420-5b0137c45847" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_83515281-9209-46f7-9f8c-a3869ef17e59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ddfd20c1-a892-4fe3-870b-b92d6ed91197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c4b0dc18-c392-45e8-8420-5b0137c45847" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ddfd20c1-a892-4fe3-870b-b92d6ed91197" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3130f76a-669b-4154-a8d3-bbf364932738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_b7d23e94-be23-4495-ab3a-4f463038aa84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3130f76a-669b-4154-a8d3-bbf364932738" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_b7d23e94-be23-4495-ab3a-4f463038aa84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8d5e8cb4-3adb-41d6-a7e3-d25c9a8e88d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3130f76a-669b-4154-a8d3-bbf364932738" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8d5e8cb4-3adb-41d6-a7e3-d25c9a8e88d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_96c2fbb6-a22c-439e-a6a6-947971b8fcb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3130f76a-669b-4154-a8d3-bbf364932738" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_96c2fbb6-a22c-439e-a6a6-947971b8fcb9" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>clx-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:705545e2-87bd-4296-a317-b2dac9e841f3,g:2063eff2-ec82-44e0-90e5-b1eb8fc3164f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails" xlink:type="extended" id="id127ef20ac3644448b0ba1a6d63bec19_RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1ccc231c-cb3a-40ff-8c82-265cbf6f21a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_02b3dd49-8656-47e0-861e-e552abe4e8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1ccc231c-cb3a-40ff-8c82-265cbf6f21a4" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_02b3dd49-8656-47e0-861e-e552abe4e8d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_2303b075-9c4e-4a43-a4f6-0a2bf1f0a38a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1ccc231c-cb3a-40ff-8c82-265cbf6f21a4" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_2303b075-9c4e-4a43-a4f6-0a2bf1f0a38a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039728fc-e226-4acc-8ae1-1cb0a3b775ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1ccc231c-cb3a-40ff-8c82-265cbf6f21a4" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039728fc-e226-4acc-8ae1-1cb0a3b775ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_169d4d82-5a17-4ac5-ac3d-06a9c6bf9613" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039728fc-e226-4acc-8ae1-1cb0a3b775ea" xlink:to="loc_srt_RangeAxis_169d4d82-5a17-4ac5-ac3d-06a9c6bf9613" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_169d4d82-5a17-4ac5-ac3d-06a9c6bf9613_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_169d4d82-5a17-4ac5-ac3d-06a9c6bf9613" xlink:to="loc_srt_RangeMember_169d4d82-5a17-4ac5-ac3d-06a9c6bf9613_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a4e9c80a-3da0-48be-ae13-bdb82ef8bbcf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_169d4d82-5a17-4ac5-ac3d-06a9c6bf9613" xlink:to="loc_srt_RangeMember_a4e9c80a-3da0-48be-ae13-bdb82ef8bbcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_35df82f9-f58e-4cf8-9e0d-e23a40d62c32" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a4e9c80a-3da0-48be-ae13-bdb82ef8bbcf" xlink:to="loc_srt_MinimumMember_35df82f9-f58e-4cf8-9e0d-e23a40d62c32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_44339ef0-5fb1-4bdd-b34f-7e94ab1a6667" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a4e9c80a-3da0-48be-ae13-bdb82ef8bbcf" xlink:to="loc_srt_MaximumMember_44339ef0-5fb1-4bdd-b34f-7e94ab1a6667" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_789f5bd7-28ad-4fdb-8125-6127d1d32e75" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039728fc-e226-4acc-8ae1-1cb0a3b775ea" xlink:to="loc_srt_StatementScenarioAxis_789f5bd7-28ad-4fdb-8125-6127d1d32e75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_789f5bd7-28ad-4fdb-8125-6127d1d32e75_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_789f5bd7-28ad-4fdb-8125-6127d1d32e75" xlink:to="loc_srt_ScenarioUnspecifiedDomain_789f5bd7-28ad-4fdb-8125-6127d1d32e75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f9aa92d6-1d4c-44e4-aebf-8aba6c4bf657" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_789f5bd7-28ad-4fdb-8125-6127d1d32e75" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f9aa92d6-1d4c-44e4-aebf-8aba6c4bf657" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_04980bd9-474b-41a0-8e4b-64a23a794232" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_f9aa92d6-1d4c-44e4-aebf-8aba6c4bf657" xlink:to="loc_srt_ScenarioForecastMember_04980bd9-474b-41a0-8e4b-64a23a794232" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" xlink:type="extended" id="i97fac5d79018449c9bbac9e62613041b_RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_4c3f144f-bc19-479e-aaf2-7210fd8011db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_44654992-1910-46ca-93be-79f6d065be0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4c3f144f-bc19-479e-aaf2-7210fd8011db" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_44654992-1910-46ca-93be-79f6d065be0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c16c3f38-d4b5-44af-9dd9-6a47ae5e4939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4c3f144f-bc19-479e-aaf2-7210fd8011db" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c16c3f38-d4b5-44af-9dd9-6a47ae5e4939" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_875dfff8-d6fd-4835-84eb-bed46fa0c582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c16c3f38-d4b5-44af-9dd9-6a47ae5e4939" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_875dfff8-d6fd-4835-84eb-bed46fa0c582" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_875dfff8-d6fd-4835-84eb-bed46fa0c582_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_875dfff8-d6fd-4835-84eb-bed46fa0c582" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_875dfff8-d6fd-4835-84eb-bed46fa0c582_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9ff39512-0760-4601-88a0-664bda457ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_875dfff8-d6fd-4835-84eb-bed46fa0c582" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9ff39512-0760-4601-88a0-664bda457ca3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CostOfGoodsAndServicesSoldMember_31a555ce-e4fa-4b86-8449-c0488d92e6a8" xlink:href="clx-20220930.xsd#clx_CostOfGoodsAndServicesSoldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9ff39512-0760-4601-88a0-664bda457ca3" xlink:to="loc_clx_CostOfGoodsAndServicesSoldMember_31a555ce-e4fa-4b86-8449-c0488d92e6a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_f0fa8a1d-2b98-4285-ab80-1624be478c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9ff39512-0760-4601-88a0-664bda457ca3" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_f0fa8a1d-2b98-4285-ab80-1624be478c32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherIncomeExpenseNetMember_bb9d924f-dcf5-43e5-bb7d-355ec469c3b1" xlink:href="clx-20220930.xsd#clx_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9ff39512-0760-4601-88a0-664bda457ca3" xlink:to="loc_clx_OtherIncomeExpenseNetMember_bb9d924f-dcf5-43e5-bb7d-355ec469c3b1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails" xlink:type="extended" id="i7c47ef9d40aa4e11810b50752bb1a3f2_RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_05f80b70-deeb-4018-a110-281d5981ba84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_e6c73e99-8a7d-4d87-bbc9-629b837eeb57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_05f80b70-deeb-4018-a110-281d5981ba84" xlink:to="loc_us-gaap_RestructuringReserveRollForward_e6c73e99-8a7d-4d87-bbc9-629b837eeb57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_a31af360-599f-4657-bd37-e8bb1f6152e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e6c73e99-8a7d-4d87-bbc9-629b837eeb57" xlink:to="loc_us-gaap_RestructuringReserve_a31af360-599f-4657-bd37-e8bb1f6152e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_8ad31e9b-3e7b-4437-8354-863203bece14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e6c73e99-8a7d-4d87-bbc9-629b837eeb57" xlink:to="loc_us-gaap_RestructuringCharges_8ad31e9b-3e7b-4437-8354-863203bece14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_be252e8d-4b7e-4efd-b20a-183d30531a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e6c73e99-8a7d-4d87-bbc9-629b837eeb57" xlink:to="loc_us-gaap_PaymentsForRestructuring_be252e8d-4b7e-4efd-b20a-183d30531a11" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_04746fff-7ee7-417b-bea3-a03f48f25e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8ba695cd-7ede-47fd-8b31-e07b5809cd6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_05f80b70-deeb-4018-a110-281d5981ba84" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8ba695cd-7ede-47fd-8b31-e07b5809cd6f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_3acc3f12-5ee0-42b9-acb4-4dca6cbee4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8ba695cd-7ede-47fd-8b31-e07b5809cd6f" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_3acc3f12-5ee0-42b9-acb4-4dca6cbee4d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_3acc3f12-5ee0-42b9-acb4-4dca6cbee4d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_3acc3f12-5ee0-42b9-acb4-4dca6cbee4d9" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_3acc3f12-5ee0-42b9-acb4-4dca6cbee4d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_443c8d94-44f9-4b0b-9faf-cf1c81ce1047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_3acc3f12-5ee0-42b9-acb4-4dca6cbee4d9" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_443c8d94-44f9-4b0b-9faf-cf1c81ce1047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_3227cca0-d14a-4cb7-9c37-a5f38e656022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_443c8d94-44f9-4b0b-9faf-cf1c81ce1047" xlink:to="loc_us-gaap_EmployeeSeveranceMember_3227cca0-d14a-4cb7-9c37-a5f38e656022" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_a5fea260-48fc-4abe-9ec5-b8336da6e02a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_443c8d94-44f9-4b0b-9faf-cf1c81ce1047" xlink:to="loc_us-gaap_OtherRestructuringMember_a5fea260-48fc-4abe-9ec5-b8336da6e02a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended" id="i20bfaa38f1eb40938c2298d21b4ebb5d_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_e7513086-3d16-48da-b07d-7a200a8de850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_e7513086-3d16-48da-b07d-7a200a8de850" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_d54d1a23-81f1-48d8-8e32-0775e021b7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:to="loc_us-gaap_DerivativeNotionalAmount_d54d1a23-81f1-48d8-8e32-0775e021b7c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_069bb42d-0494-4841-a122-16b6c105650b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:to="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_069bb42d-0494-4841-a122-16b6c105650b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_c3f7256c-cdb0-4418-bd28-0cb167548d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_c3f7256c-cdb0-4418-bd28-0cb167548d2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d6301f04-7acb-4061-9b4b-921e28f47bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d6301f04-7acb-4061-9b4b-921e28f47bd3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_e9a21502-9298-4476-9fe2-7ff722d942dc" xlink:href="clx-20220930.xsd#clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:to="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_e9a21502-9298-4476-9fe2-7ff722d942dc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarginDepositAssets_c9d6a53c-c579-44f6-a326-80ca7c53ca83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarginDepositAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:to="loc_us-gaap_MarginDepositAssets_c9d6a53c-c579-44f6-a326-80ca7c53ca83" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_63eb91a4-6b90-49ee-9ea4-c8c27c1ef80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:to="loc_us-gaap_DerivativeTable_63eb91a4-6b90-49ee-9ea4-c8c27c1ef80b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsAxis_1caf872c-f9d0-40dd-ba3b-b7041c509513" xlink:href="clx-20220930.xsd#clx_CommodityPurchaseDerivativeContractsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_63eb91a4-6b90-49ee-9ea4-c8c27c1ef80b" xlink:to="loc_clx_CommodityPurchaseDerivativeContractsAxis_1caf872c-f9d0-40dd-ba3b-b7041c509513" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsDomain_1caf872c-f9d0-40dd-ba3b-b7041c509513_default" xlink:href="clx-20220930.xsd#clx_CommodityPurchaseDerivativeContractsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsAxis_1caf872c-f9d0-40dd-ba3b-b7041c509513" xlink:to="loc_clx_CommodityPurchaseDerivativeContractsDomain_1caf872c-f9d0-40dd-ba3b-b7041c509513_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsDomain_66bf031e-e889-4fdb-80c5-910ce2b5c69a" xlink:href="clx-20220930.xsd#clx_CommodityPurchaseDerivativeContractsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsAxis_1caf872c-f9d0-40dd-ba3b-b7041c509513" xlink:to="loc_clx_CommodityPurchaseDerivativeContractsDomain_66bf031e-e889-4fdb-80c5-910ce2b5c69a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TotalCommodityPurchaseDerivativeContractsMember_5dc1eae9-ed24-4520-8aec-71b17b9eab28" xlink:href="clx-20220930.xsd#clx_TotalCommodityPurchaseDerivativeContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsDomain_66bf031e-e889-4fdb-80c5-910ce2b5c69a" xlink:to="loc_clx_TotalCommodityPurchaseDerivativeContractsMember_5dc1eae9-ed24-4520-8aec-71b17b9eab28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_fb4fbc97-d488-41ac-8327-e4d77828d7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_63eb91a4-6b90-49ee-9ea4-c8c27c1ef80b" xlink:to="loc_us-gaap_TransactionTypeAxis_fb4fbc97-d488-41ac-8327-e4d77828d7a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_fb4fbc97-d488-41ac-8327-e4d77828d7a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TransactionTypeAxis_fb4fbc97-d488-41ac-8327-e4d77828d7a1" xlink:to="loc_us-gaap_TransactionDomain_fb4fbc97-d488-41ac-8327-e4d77828d7a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_7feb95a3-eddf-430d-8aaf-fe601534231b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TransactionTypeAxis_fb4fbc97-d488-41ac-8327-e4d77828d7a1" xlink:to="loc_us-gaap_TransactionDomain_7feb95a3-eddf-430d-8aaf-fe601534231b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_PurchasesofInventoryMember_b5289143-4c2b-4f01-9e1d-f29d96467dcb" xlink:href="clx-20220930.xsd#clx_PurchasesofInventoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransactionDomain_7feb95a3-eddf-430d-8aaf-fe601534231b" xlink:to="loc_clx_PurchasesofInventoryMember_b5289143-4c2b-4f01-9e1d-f29d96467dcb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_22a6e6cb-0d1c-4a8a-bb9e-2e727950af52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_63eb91a4-6b90-49ee-9ea4-c8c27c1ef80b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_22a6e6cb-0d1c-4a8a-bb9e-2e727950af52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_22a6e6cb-0d1c-4a8a-bb9e-2e727950af52_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_22a6e6cb-0d1c-4a8a-bb9e-2e727950af52" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_22a6e6cb-0d1c-4a8a-bb9e-2e727950af52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_eac1b946-a1db-41b7-b46b-565c26222d86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_22a6e6cb-0d1c-4a8a-bb9e-2e727950af52" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_eac1b946-a1db-41b7-b46b-565c26222d86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_0daf31ca-9897-4f0e-8774-ea7a24f6e8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eac1b946-a1db-41b7-b46b-565c26222d86" xlink:to="loc_us-gaap_ForeignExchangeContractMember_0daf31ca-9897-4f0e-8774-ea7a24f6e8a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_720702b1-c671-4fe0-b3f2-46af9e0a4852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eac1b946-a1db-41b7-b46b-565c26222d86" xlink:to="loc_us-gaap_CommodityContractMember_720702b1-c671-4fe0-b3f2-46af9e0a4852" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" xlink:type="extended" id="i4f1efff03ad24d9db245fb3a11d37312_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5d4ce57a-c09e-466d-a7d5-bd3c522e47c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_92bee14f-b118-4ee2-b75b-b48f1c14281f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5d4ce57a-c09e-466d-a7d5-bd3c522e47c9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_92bee14f-b118-4ee2-b75b-b48f1c14281f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_96538c24-d28e-499b-8d99-d6c64f7447fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5d4ce57a-c09e-466d-a7d5-bd3c522e47c9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_96538c24-d28e-499b-8d99-d6c64f7447fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_af3197b2-8c06-4c28-96e2-82f5c341e42f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5d4ce57a-c09e-466d-a7d5-bd3c522e47c9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_af3197b2-8c06-4c28-96e2-82f5c341e42f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_033316c0-8c1c-4f15-8384-df67d6182f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_af3197b2-8c06-4c28-96e2-82f5c341e42f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_033316c0-8c1c-4f15-8384-df67d6182f00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_033316c0-8c1c-4f15-8384-df67d6182f00_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_033316c0-8c1c-4f15-8384-df67d6182f00" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_033316c0-8c1c-4f15-8384-df67d6182f00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_609c31fa-999b-4ed9-8ccd-2e032433989c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_033316c0-8c1c-4f15-8384-df67d6182f00" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_609c31fa-999b-4ed9-8ccd-2e032433989c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_b855a5aa-d27d-494d-b951-0449111dd273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_609c31fa-999b-4ed9-8ccd-2e032433989c" xlink:to="loc_us-gaap_CommodityContractMember_b855a5aa-d27d-494d-b951-0449111dd273" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_d3640245-fac8-4316-8312-92244cd8805d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_609c31fa-999b-4ed9-8ccd-2e032433989c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_d3640245-fac8-4316-8312-92244cd8805d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_c9831e96-19d7-42e3-8f2b-5afc88226f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_609c31fa-999b-4ed9-8ccd-2e032433989c" xlink:to="loc_us-gaap_InterestRateContractMember_c9831e96-19d7-42e3-8f2b-5afc88226f3b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" xlink:type="extended" id="ic6e85238f3034f4a8856376cb8a12179_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c37d4d92-7038-4fe6-9a53-88007f61e43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_039534f0-f769-4bab-8d1e-1aae18b492e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c37d4d92-7038-4fe6-9a53-88007f61e43b" xlink:to="loc_us-gaap_DerivativeAssets_039534f0-f769-4bab-8d1e-1aae18b492e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_6e4ea69c-3045-44fb-9dc3-a897aed90292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c37d4d92-7038-4fe6-9a53-88007f61e43b" xlink:to="loc_us-gaap_DerivativeLiabilities_6e4ea69c-3045-44fb-9dc3-a897aed90292" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c7fb6c6e-13ec-43eb-a2bf-6debc9bc1721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c37d4d92-7038-4fe6-9a53-88007f61e43b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c7fb6c6e-13ec-43eb-a2bf-6debc9bc1721" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3a8679a3-9889-4459-bcdb-9c3b102fbb85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c7fb6c6e-13ec-43eb-a2bf-6debc9bc1721" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3a8679a3-9889-4459-bcdb-9c3b102fbb85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3a8679a3-9889-4459-bcdb-9c3b102fbb85_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3a8679a3-9889-4459-bcdb-9c3b102fbb85" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3a8679a3-9889-4459-bcdb-9c3b102fbb85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3a11b460-6bb5-43ea-b764-04becbf09f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3a8679a3-9889-4459-bcdb-9c3b102fbb85" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3a11b460-6bb5-43ea-b764-04becbf09f62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_94b5c99c-9931-42d8-b546-02b0dff69a57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3a11b460-6bb5-43ea-b764-04becbf09f62" xlink:to="loc_us-gaap_CommodityContractMember_94b5c99c-9931-42d8-b546-02b0dff69a57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_f60a6bc7-9c12-48ee-9f23-c611aa353c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3a11b460-6bb5-43ea-b764-04becbf09f62" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_f60a6bc7-9c12-48ee-9f23-c611aa353c27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_659d5434-2e5c-43f5-ab75-0b316bfcec7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c7fb6c6e-13ec-43eb-a2bf-6debc9bc1721" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_659d5434-2e5c-43f5-ab75-0b316bfcec7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_659d5434-2e5c-43f5-ab75-0b316bfcec7e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_659d5434-2e5c-43f5-ab75-0b316bfcec7e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_659d5434-2e5c-43f5-ab75-0b316bfcec7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31588ef3-feff-4e3b-a365-6574d2e45fad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_659d5434-2e5c-43f5-ab75-0b316bfcec7e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31588ef3-feff-4e3b-a365-6574d2e45fad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8f3ed332-fa38-434d-8254-61c5800c1ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31588ef3-feff-4e3b-a365-6574d2e45fad" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8f3ed332-fa38-434d-8254-61c5800c1ffc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b62a7ed6-9f3c-4a93-b3f2-8af30985862f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31588ef3-feff-4e3b-a365-6574d2e45fad" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b62a7ed6-9f3c-4a93-b3f2-8af30985862f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_da07e5c8-40f7-4501-9bbd-96dff79cdcf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c7fb6c6e-13ec-43eb-a2bf-6debc9bc1721" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_da07e5c8-40f7-4501-9bbd-96dff79cdcf0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_da07e5c8-40f7-4501-9bbd-96dff79cdcf0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_da07e5c8-40f7-4501-9bbd-96dff79cdcf0" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_da07e5c8-40f7-4501-9bbd-96dff79cdcf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6bd44ebf-9a74-4772-841a-fe34bd28574d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_da07e5c8-40f7-4501-9bbd-96dff79cdcf0" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6bd44ebf-9a74-4772-841a-fe34bd28574d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d58bae0e-a07f-47d2-87f8-0e74e281de18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6bd44ebf-9a74-4772-841a-fe34bd28574d" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d58bae0e-a07f-47d2-87f8-0e74e281de18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_4fcb9078-39c2-4a6f-9850-0cfca103ecfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d58bae0e-a07f-47d2-87f8-0e74e281de18" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_4fcb9078-39c2-4a6f-9850-0cfca103ecfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_4b266906-94f7-4d6b-8434-2187d1dcabef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d58bae0e-a07f-47d2-87f8-0e74e281de18" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_4b266906-94f7-4d6b-8434-2187d1dcabef" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="extended" id="i079beb8c8e4746b4b2740a8646d4f7b0_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8c398cf6-499f-4c57-8c99-6887ea629c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_dcc51633-b04c-4235-baa7-009c6e97cec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8c398cf6-499f-4c57-8c99-6887ea629c59" xlink:to="loc_us-gaap_AssetsAbstract_dcc51633-b04c-4235-baa7-009c6e97cec5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7b81d14b-a178-4680-a542-77b8f3ef2b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dcc51633-b04c-4235-baa7-009c6e97cec5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7b81d14b-a178-4680-a542-77b8f3ef2b56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_893e95a2-d812-4c1d-bc99-ed80207636d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dcc51633-b04c-4235-baa7-009c6e97cec5" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_893e95a2-d812-4c1d-bc99-ed80207636d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_a8fedadc-31aa-4d2b-93a7-ae375dd59af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dcc51633-b04c-4235-baa7-009c6e97cec5" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_a8fedadc-31aa-4d2b-93a7-ae375dd59af4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_489284a4-b45d-4022-b4c2-242cc8579439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dcc51633-b04c-4235-baa7-009c6e97cec5" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_489284a4-b45d-4022-b4c2-242cc8579439" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_899fa1ef-575d-4f49-a925-221c6b0ae9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dcc51633-b04c-4235-baa7-009c6e97cec5" xlink:to="loc_us-gaap_Assets_899fa1ef-575d-4f49-a925-221c6b0ae9e4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_f7c50e05-2a7c-4d98-a46e-182316bd7eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dcc51633-b04c-4235-baa7-009c6e97cec5" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_f7c50e05-2a7c-4d98-a46e-182316bd7eb5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_c32516e9-4b9d-48ed-b33b-c498300baddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8c398cf6-499f-4c57-8c99-6887ea629c59" xlink:to="loc_us-gaap_LiabilitiesAbstract_c32516e9-4b9d-48ed-b33b-c498300baddc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_db5b18fb-2b1a-46b1-af18-9e4f09467dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_c32516e9-4b9d-48ed-b33b-c498300baddc" xlink:to="loc_us-gaap_CommercialPaper_db5b18fb-2b1a-46b1-af18-9e4f09467dfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue_cb237d87-69dd-4388-9d9e-c89419bf0372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_c32516e9-4b9d-48ed-b33b-c498300baddc" xlink:to="loc_us-gaap_ShorttermDebtFairValue_cb237d87-69dd-4388-9d9e-c89419bf0372" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_01f02888-0e29-4d08-a54b-6019c1f837c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_c32516e9-4b9d-48ed-b33b-c498300baddc" xlink:to="loc_us-gaap_LongTermDebt_01f02888-0e29-4d08-a54b-6019c1f837c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_884d8054-accf-47ac-b98f-e315e700ab99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_c32516e9-4b9d-48ed-b33b-c498300baddc" xlink:to="loc_us-gaap_DebtInstrumentFairValue_884d8054-accf-47ac-b98f-e315e700ab99" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5cf83496-7e42-435b-b7f9-9e202ef7e4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_c32516e9-4b9d-48ed-b33b-c498300baddc" xlink:to="loc_us-gaap_Liabilities_5cf83496-7e42-435b-b7f9-9e202ef7e4d2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_7796185d-8321-49bd-aa08-5a286798a5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_c32516e9-4b9d-48ed-b33b-c498300baddc" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_7796185d-8321-49bd-aa08-5a286798a5d8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_710e0ec2-165a-4fec-a163-f171be4a7ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8c398cf6-499f-4c57-8c99-6887ea629c59" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_710e0ec2-165a-4fec-a163-f171be4a7ccc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_69939c50-fc6d-450e-aff1-6770e3213e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_710e0ec2-165a-4fec-a163-f171be4a7ccc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_69939c50-fc6d-450e-aff1-6770e3213e0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_69939c50-fc6d-450e-aff1-6770e3213e0d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_69939c50-fc6d-450e-aff1-6770e3213e0d" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_69939c50-fc6d-450e-aff1-6770e3213e0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c249a8d7-d89a-4893-9022-6eb41dbb2c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_69939c50-fc6d-450e-aff1-6770e3213e0d" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c249a8d7-d89a-4893-9022-6eb41dbb2c6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_c1295c08-d1f8-4549-b107-7c556c632b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c249a8d7-d89a-4893-9022-6eb41dbb2c6c" xlink:to="loc_us-gaap_MoneyMarketFundsMember_c1295c08-d1f8-4549-b107-7c556c632b78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_72f5d231-6375-44ae-bffa-8b4780c0bf6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c249a8d7-d89a-4893-9022-6eb41dbb2c6c" xlink:to="loc_us-gaap_BankTimeDepositsMember_72f5d231-6375-44ae-bffa-8b4780c0bf6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9eb825a-2840-45c0-943a-87c4f9a90545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_710e0ec2-165a-4fec-a163-f171be4a7ccc" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9eb825a-2840-45c0-943a-87c4f9a90545" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9eb825a-2840-45c0-943a-87c4f9a90545_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9eb825a-2840-45c0-943a-87c4f9a90545" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9eb825a-2840-45c0-943a-87c4f9a90545_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b298b6f-cc79-4b07-8baa-acc712797b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9eb825a-2840-45c0-943a-87c4f9a90545" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b298b6f-cc79-4b07-8baa-acc712797b29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_26e7edc9-6dc1-496b-abc3-f4e8aabd0439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b298b6f-cc79-4b07-8baa-acc712797b29" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_26e7edc9-6dc1-496b-abc3-f4e8aabd0439" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_e1b08694-75c3-4b62-8312-e2c1b9c91618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b298b6f-cc79-4b07-8baa-acc712797b29" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_e1b08694-75c3-4b62-8312-e2c1b9c91618" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_0a91f008-609f-4fdd-b4cd-7b293ac047b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_710e0ec2-165a-4fec-a163-f171be4a7ccc" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_0a91f008-609f-4fdd-b4cd-7b293ac047b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_0a91f008-609f-4fdd-b4cd-7b293ac047b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_0a91f008-609f-4fdd-b4cd-7b293ac047b5" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_0a91f008-609f-4fdd-b4cd-7b293ac047b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e6b66ad0-b35a-40d1-9089-b0051dc20bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_0a91f008-609f-4fdd-b4cd-7b293ac047b5" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e6b66ad0-b35a-40d1-9089-b0051dc20bdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_21c21216-2ead-4b53-8604-bcda0c1b0a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e6b66ad0-b35a-40d1-9089-b0051dc20bdb" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_21c21216-2ead-4b53-8604-bcda0c1b0a4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_a28b152b-a156-4bb4-9923-c9a7722aa6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_21c21216-2ead-4b53-8604-bcda0c1b0a4c" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_a28b152b-a156-4bb4-9923-c9a7722aa6fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_660a41e5-8278-4f40-a914-107f4d6b7be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_21c21216-2ead-4b53-8604-bcda0c1b0a4c" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_660a41e5-8278-4f40-a914-107f4d6b7be3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_6e80e289-8737-4171-b7db-3776a75ff3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_710e0ec2-165a-4fec-a163-f171be4a7ccc" xlink:to="loc_us-gaap_InvestmentTypeAxis_6e80e289-8737-4171-b7db-3776a75ff3b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_6e80e289-8737-4171-b7db-3776a75ff3b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_6e80e289-8737-4171-b7db-3776a75ff3b1" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_6e80e289-8737-4171-b7db-3776a75ff3b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_2bd1eabf-0a42-4d9c-8cc6-38245e9b5203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_6e80e289-8737-4171-b7db-3776a75ff3b1" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_2bd1eabf-0a42-4d9c-8cc6-38245e9b5203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_bed4de8a-c8a8-4f8b-bbe1-ca3c9d62f41c" xlink:href="clx-20220930.xsd#clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2bd1eabf-0a42-4d9c-8cc6-38245e9b5203" xlink:to="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_bed4de8a-c8a8-4f8b-bbe1-ca3c9d62f41c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_378b3ba8-0f41-412b-bc9e-88e2802d37cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_710e0ec2-165a-4fec-a163-f171be4a7ccc" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_378b3ba8-0f41-412b-bc9e-88e2802d37cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_378b3ba8-0f41-412b-bc9e-88e2802d37cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_378b3ba8-0f41-412b-bc9e-88e2802d37cc" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_378b3ba8-0f41-412b-bc9e-88e2802d37cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_ca1a3dc9-f376-4e06-9b5b-32713cdbc00c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_378b3ba8-0f41-412b-bc9e-88e2802d37cc" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_ca1a3dc9-f376-4e06-9b5b-32713cdbc00c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NotesAndLoansPayableMember_253cedaf-66b7-49b6-bfaf-f7347655aa61" xlink:href="clx-20220930.xsd#clx_NotesAndLoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_ca1a3dc9-f376-4e06-9b5b-32713cdbc00c" xlink:to="loc_clx_NotesAndLoansPayableMember_253cedaf-66b7-49b6-bfaf-f7347655aa61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9b8f003e-6bea-41bd-b451-3bdc3bc930e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_710e0ec2-165a-4fec-a163-f171be4a7ccc" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9b8f003e-6bea-41bd-b451-3bdc3bc930e0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9b8f003e-6bea-41bd-b451-3bdc3bc930e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9b8f003e-6bea-41bd-b451-3bdc3bc930e0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9b8f003e-6bea-41bd-b451-3bdc3bc930e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d0ef76c3-7e87-4ee7-8ca2-03caa0774e46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9b8f003e-6bea-41bd-b451-3bdc3bc930e0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d0ef76c3-7e87-4ee7-8ca2-03caa0774e46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_1c75c806-07c2-4671-ac86-8feebc1ab2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d0ef76c3-7e87-4ee7-8ca2-03caa0774e46" xlink:to="loc_us-gaap_LongTermDebtMember_1c75c806-07c2-4671-ac86-8feebc1ab2d8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#STOCKHOLDERSEQUITYScheduleofEquityDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" xlink:type="extended" id="icad67f4970ac4a4dbda01e20773d36cf_STOCKHOLDERSEQUITYScheduleofEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_020d9e2f-2272-4bcf-9baa-653717b0e46d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_0747f62d-67a8-419c-a793-b82425b4e6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_020d9e2f-2272-4bcf-9baa-653717b0e46d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_0747f62d-67a8-419c-a793-b82425b4e6d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_020d9e2f-2272-4bcf-9baa-653717b0e46d" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7618119d-8d32-4dba-865f-c4bceaef2756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7618119d-8d32-4dba-865f-c4bceaef2756" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_fb05ea8e-1944-455a-b7a7-612a857cee46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_fb05ea8e-1944-455a-b7a7-612a857cee46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_48a46a89-f5b9-4fb3-a408-28ca95a8040a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_TreasuryStockCommonShares_48a46a89-f5b9-4fb3-a408-28ca95a8040a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1f5b4bfd-2d81-49ad-b729-42a513e16443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_ProfitLoss_1f5b4bfd-2d81-49ad-b729-42a513e16443" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_315fb335-cff7-4da5-ab53-4749b59b6bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_315fb335-cff7-4da5-ab53-4749b59b6bad" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_b3209fd5-d645-4222-bc80-6d75d95d0916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_Dividends_b3209fd5-d645-4222-bc80-6d75d95d0916" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_8e8a2711-53b8-439b-be20-88bd8526f458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_8e8a2711-53b8-439b-be20-88bd8526f458" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_acafc81d-7500-4586-984d-b19b8e67c39b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_acafc81d-7500-4586-984d-b19b8e67c39b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesAmount_90ce05a7-ec7d-43fd-be2c-62097fe1bbdd" xlink:href="clx-20220930.xsd#clx_OtherEmployeeStockPlanActivitiesAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_clx_OtherEmployeeStockPlanActivitiesAmount_90ce05a7-ec7d-43fd-be2c-62097fe1bbdd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesShares_bf823b9e-04c1-43e5-9e9b-c340e15c3e25" xlink:href="clx-20220930.xsd#clx_OtherEmployeeStockPlanActivitiesShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_clx_OtherEmployeeStockPlanActivitiesShares_bf823b9e-04c1-43e5-9e9b-c340e15c3e25" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3347dc9b-1c47-4bbd-802a-4d3425a9378d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3347dc9b-1c47-4bbd-802a-4d3425a9378d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_18b4d52e-f510-4df6-a816-0312598da20f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_18b4d52e-f510-4df6-a816-0312598da20f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eb04a4a8-150f-449c-83f3-eb3d0b09ce6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ab5d065e-ca9b-4e90-b292-b0e92b93db6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_af87ba72-faa1-4051-aad0-2bf70ec2f048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_b7522216-a7a5-486a-bc58-eea1ff351446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_020d9e2f-2272-4bcf-9baa-653717b0e46d" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_b7522216-a7a5-486a-bc58-eea1ff351446" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_99079885-adcc-41fb-9492-16be57b8df0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b7522216-a7a5-486a-bc58-eea1ff351446" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_99079885-adcc-41fb-9492-16be57b8df0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_99079885-adcc-41fb-9492-16be57b8df0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_99079885-adcc-41fb-9492-16be57b8df0a" xlink:to="loc_us-gaap_EquityComponentDomain_99079885-adcc-41fb-9492-16be57b8df0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_928c7cc0-fe48-41a7-be7d-e94013fa4c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_99079885-adcc-41fb-9492-16be57b8df0a" xlink:to="loc_us-gaap_EquityComponentDomain_928c7cc0-fe48-41a7-be7d-e94013fa4c49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_35b38e1d-1add-4c40-98ae-7cf0ab03de5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_928c7cc0-fe48-41a7-be7d-e94013fa4c49" xlink:to="loc_us-gaap_CommonStockMember_35b38e1d-1add-4c40-98ae-7cf0ab03de5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_710238d1-d1a3-4ea2-824e-d18362ccda95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_928c7cc0-fe48-41a7-be7d-e94013fa4c49" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_710238d1-d1a3-4ea2-824e-d18362ccda95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cda2928f-05f9-487b-ae11-fa398b8075e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_928c7cc0-fe48-41a7-be7d-e94013fa4c49" xlink:to="loc_us-gaap_RetainedEarningsMember_cda2928f-05f9-487b-ae11-fa398b8075e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_fc88c074-5d8b-48a9-bedd-e1d0f635be4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_928c7cc0-fe48-41a7-be7d-e94013fa4c49" xlink:to="loc_us-gaap_TreasuryStockCommonMember_fc88c074-5d8b-48a9-bedd-e1d0f635be4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8114262e-dc97-4501-aae8-369eb4bf0d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_928c7cc0-fe48-41a7-be7d-e94013fa4c49" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8114262e-dc97-4501-aae8-369eb4bf0d62" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_3c2f2f60-01ec-48ee-884c-e3ec3fd51381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_928c7cc0-fe48-41a7-be7d-e94013fa4c49" xlink:to="loc_us-gaap_NoncontrollingInterestMember_3c2f2f60-01ec-48ee-884c-e3ec3fd51381" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="extended" id="id0abd3e0f2e24255974ba6e1ffd67992_STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_10b2f093-a993-41ab-9d39-ce7e77172a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_6a894f09-a96f-4bc1-aa2a-101ea0d77c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_10b2f093-a993-41ab-9d39-ce7e77172a9a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_6a894f09-a96f-4bc1-aa2a-101ea0d77c76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4df1590f-07bb-41bc-a63e-4faff29d05c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_6a894f09-a96f-4bc1-aa2a-101ea0d77c76" xlink:to="loc_us-gaap_StockholdersEquity_4df1590f-07bb-41bc-a63e-4faff29d05c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_7ab7f13f-5e72-4278-97fd-b8839935a9f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_6a894f09-a96f-4bc1-aa2a-101ea0d77c76" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_7ab7f13f-5e72-4278-97fd-b8839935a9f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_192fe39e-df53-4228-972e-7cb638d35e09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_6a894f09-a96f-4bc1-aa2a-101ea0d77c76" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_192fe39e-df53-4228-972e-7cb638d35e09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_b98b1755-c5ee-41aa-9033-0e899985a690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_6a894f09-a96f-4bc1-aa2a-101ea0d77c76" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_b98b1755-c5ee-41aa-9033-0e899985a690" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2c70df40-8e85-496e-9620-00f96fa871bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_6a894f09-a96f-4bc1-aa2a-101ea0d77c76" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2c70df40-8e85-496e-9620-00f96fa871bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8c41bce3-18ef-4a24-8de7-4be965b1cb92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b01e9459-79a1-495f-9b2d-a9f3eed5ed12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_10b2f093-a993-41ab-9d39-ce7e77172a9a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b01e9459-79a1-495f-9b2d-a9f3eed5ed12" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_53b96b46-cc91-46b5-b525-7e720f3499e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b01e9459-79a1-495f-9b2d-a9f3eed5ed12" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_53b96b46-cc91-46b5-b525-7e720f3499e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_53b96b46-cc91-46b5-b525-7e720f3499e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_53b96b46-cc91-46b5-b525-7e720f3499e5" xlink:to="loc_us-gaap_EquityComponentDomain_53b96b46-cc91-46b5-b525-7e720f3499e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a3aef91e-200c-49f4-a771-cfe863f091d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_53b96b46-cc91-46b5-b525-7e720f3499e5" xlink:to="loc_us-gaap_EquityComponentDomain_a3aef91e-200c-49f4-a771-cfe863f091d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_076011ec-edeb-4daf-a0bc-2e0066e30f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a3aef91e-200c-49f4-a771-cfe863f091d3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_076011ec-edeb-4daf-a0bc-2e0066e30f5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_ba7d39c9-50d3-44d8-8da2-078544c5d20b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_076011ec-edeb-4daf-a0bc-2e0066e30f5e" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_ba7d39c9-50d3-44d8-8da2-078544c5d20b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_4c820315-2041-40d3-a383-35ff207464f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_076011ec-edeb-4daf-a0bc-2e0066e30f5e" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_4c820315-2041-40d3-a383-35ff207464f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_77f9ee9d-1ea8-4f3c-9b8a-d439a18649b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_076011ec-edeb-4daf-a0bc-2e0066e30f5e" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_77f9ee9d-1ea8-4f3c-9b8a-d439a18649b0" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended" id="i1017d02e86784c499e0e1763b8917fd9_STOCKHOLDERSEQUITYNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_31553cd8-5964-4a72-9ad2-d40a51cc74b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_611e87a5-cf5e-4f05-9ea0-0a4092d28770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_31553cd8-5964-4a72-9ad2-d40a51cc74b1" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_611e87a5-cf5e-4f05-9ea0-0a4092d28770" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fc2dfc7c-1d14-498a-9da6-7acd74ce1930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_31553cd8-5964-4a72-9ad2-d40a51cc74b1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fc2dfc7c-1d14-498a-9da6-7acd74ce1930" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_8aab71cb-79e9-40b2-9f1d-545a877d40ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fc2dfc7c-1d14-498a-9da6-7acd74ce1930" xlink:to="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_8aab71cb-79e9-40b2-9f1d-545a877d40ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_8aab71cb-79e9-40b2-9f1d-545a877d40ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_8aab71cb-79e9-40b2-9f1d-545a877d40ec" xlink:to="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_8aab71cb-79e9-40b2-9f1d-545a877d40ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_bf66f301-4070-40a3-bbde-42296083c4db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_8aab71cb-79e9-40b2-9f1d-545a877d40ec" xlink:to="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_bf66f301-4070-40a3-bbde-42296083c4db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LongTermInterCompanyLoansMember_79ae5468-427a-482b-a27a-12dcde4e5cbe" xlink:href="clx-20220930.xsd#clx_LongTermInterCompanyLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_bf66f301-4070-40a3-bbde-42296083c4db" xlink:to="loc_clx_LongTermInterCompanyLoansMember_79ae5468-427a-482b-a27a-12dcde4e5cbe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#EMPLOYEEBENEFITPLANSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="extended" id="i0ac70cea232a4b9faf3bb9c32e75e1e7_EMPLOYEEBENEFITPLANSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb67e8d9-b625-47b5-871b-b57594634d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DefinedBenefitPlanPlanTerminationPeriod_2f8f4260-8062-481e-85a6-4b0639008bcf" xlink:href="clx-20220930.xsd#clx_DefinedBenefitPlanPlanTerminationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb67e8d9-b625-47b5-871b-b57594634d46" xlink:to="loc_clx_DefinedBenefitPlanPlanTerminationPeriod_2f8f4260-8062-481e-85a6-4b0639008bcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ca5718da-c90e-46ee-9042-4273142aeff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb67e8d9-b625-47b5-871b-b57594634d46" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ca5718da-c90e-46ee-9042-4273142aeff7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_89f8bf8a-5d25-4354-8c26-273791931ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb67e8d9-b625-47b5-871b-b57594634d46" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_89f8bf8a-5d25-4354-8c26-273791931ab4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a8eaab9-be39-4fbd-ac3d-770725082ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb67e8d9-b625-47b5-871b-b57594634d46" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a8eaab9-be39-4fbd-ac3d-770725082ed1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_c9574d75-1ad8-411f-a51f-d36ce4967a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a8eaab9-be39-4fbd-ac3d-770725082ed1" xlink:to="loc_us-gaap_PlanNameAxis_c9574d75-1ad8-411f-a51f-d36ce4967a78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c9574d75-1ad8-411f-a51f-d36ce4967a78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_c9574d75-1ad8-411f-a51f-d36ce4967a78" xlink:to="loc_us-gaap_PlanNameDomain_c9574d75-1ad8-411f-a51f-d36ce4967a78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_bf845934-f1c8-4f51-b4c5-f7de55d691eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_c9574d75-1ad8-411f-a51f-d36ce4967a78" xlink:to="loc_us-gaap_PlanNameDomain_bf845934-f1c8-4f51-b4c5-f7de55d691eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RetirementIncomeMember_acf6845d-ad66-457e-a4dc-bcaf7a8e686f" xlink:href="clx-20220930.xsd#clx_RetirementIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_bf845934-f1c8-4f51-b4c5-f7de55d691eb" xlink:to="loc_clx_RetirementIncomeMember_acf6845d-ad66-457e-a4dc-bcaf7a8e686f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6bc90d24-ade0-49ee-9563-66fdc1a10d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a8eaab9-be39-4fbd-ac3d-770725082ed1" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6bc90d24-ade0-49ee-9563-66fdc1a10d04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6bc90d24-ade0-49ee-9563-66fdc1a10d04_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6bc90d24-ade0-49ee-9563-66fdc1a10d04" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6bc90d24-ade0-49ee-9563-66fdc1a10d04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_dd538bb1-283e-4ca9-aae4-18acf46d2ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6bc90d24-ade0-49ee-9563-66fdc1a10d04" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_dd538bb1-283e-4ca9-aae4-18acf46d2ce7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_c1c80da1-dca9-4c6a-b048-82144ff1e319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_dd538bb1-283e-4ca9-aae4-18acf46d2ce7" xlink:to="loc_us-gaap_DomesticPlanMember_c1c80da1-dca9-4c6a-b048-82144ff1e319" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d85767b7-4686-4a80-9b06-4a0274489bdd" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_c1c80da1-dca9-4c6a-b048-82144ff1e319" xlink:to="loc_country_US_d85767b7-4686-4a80-9b06-4a0274489bdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0b801a15-d080-424e-983f-394d82e44060" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a8eaab9-be39-4fbd-ac3d-770725082ed1" xlink:to="loc_srt_RangeAxis_0b801a15-d080-424e-983f-394d82e44060" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0b801a15-d080-424e-983f-394d82e44060_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0b801a15-d080-424e-983f-394d82e44060" xlink:to="loc_srt_RangeMember_0b801a15-d080-424e-983f-394d82e44060_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0601322d-988b-4f1a-a943-98051c252591" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0b801a15-d080-424e-983f-394d82e44060" xlink:to="loc_srt_RangeMember_0601322d-988b-4f1a-a943-98051c252591" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a072a2a9-da0a-4c94-adc3-47c989ffe526" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0601322d-988b-4f1a-a943-98051c252591" xlink:to="loc_srt_MinimumMember_a072a2a9-da0a-4c94-adc3-47c989ffe526" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e15d071a-c4b5-4b4a-a11c-6440d66008eb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0601322d-988b-4f1a-a943-98051c252591" xlink:to="loc_srt_MaximumMember_e15d071a-c4b5-4b4a-a11c-6440d66008eb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="extended" id="i44a492dc006b437d8e945fb9d03fedd5_EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2db4d1c5-ef9a-4797-b3d7-f3f54953206a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_1b2ede88-0a40-4e9c-904a-96b9a3497763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2db4d1c5-ef9a-4797-b3d7-f3f54953206a" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_1b2ede88-0a40-4e9c-904a-96b9a3497763" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5e6304d2-b04e-4124-86f1-7d48d3436724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2db4d1c5-ef9a-4797-b3d7-f3f54953206a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5e6304d2-b04e-4124-86f1-7d48d3436724" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_9cc1b945-2bf4-49a8-923c-aa1ab8175adc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2db4d1c5-ef9a-4797-b3d7-f3f54953206a" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_9cc1b945-2bf4-49a8-923c-aa1ab8175adc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_20885f77-5527-4395-aece-472a3f0511ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2db4d1c5-ef9a-4797-b3d7-f3f54953206a" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_20885f77-5527-4395-aece-472a3f0511ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_b6756594-222b-4a32-8380-be81f5e3fd33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2db4d1c5-ef9a-4797-b3d7-f3f54953206a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_b6756594-222b-4a32-8380-be81f5e3fd33" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df2a420c-6428-49c2-990e-cdc2ae9a0eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2db4d1c5-ef9a-4797-b3d7-f3f54953206a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df2a420c-6428-49c2-990e-cdc2ae9a0eee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_556b63e7-04cd-4481-9a17-2c60b5a0d59f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df2a420c-6428-49c2-990e-cdc2ae9a0eee" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_556b63e7-04cd-4481-9a17-2c60b5a0d59f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_556b63e7-04cd-4481-9a17-2c60b5a0d59f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_556b63e7-04cd-4481-9a17-2c60b5a0d59f" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_556b63e7-04cd-4481-9a17-2c60b5a0d59f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_28384d1d-650c-4936-ad6a-d21f0e6e94a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_556b63e7-04cd-4481-9a17-2c60b5a0d59f" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_28384d1d-650c-4936-ad6a-d21f0e6e94a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_91fe4ed3-515b-4c31-b67e-e480fc5293ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_28384d1d-650c-4936-ad6a-d21f0e6e94a6" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_91fe4ed3-515b-4c31-b67e-e480fc5293ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f1df1590-e844-49f4-9220-88c8a49f7f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df2a420c-6428-49c2-990e-cdc2ae9a0eee" xlink:to="loc_us-gaap_PlanNameAxis_f1df1590-e844-49f4-9220-88c8a49f7f78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f1df1590-e844-49f4-9220-88c8a49f7f78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_f1df1590-e844-49f4-9220-88c8a49f7f78" xlink:to="loc_us-gaap_PlanNameDomain_f1df1590-e844-49f4-9220-88c8a49f7f78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_aa949124-b46c-4fbd-ba89-36cd1a879691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_f1df1590-e844-49f4-9220-88c8a49f7f78" xlink:to="loc_us-gaap_PlanNameDomain_aa949124-b46c-4fbd-ba89-36cd1a879691" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RetirementIncomeMember_e746437f-02b4-45d8-a4e4-bf3b9047361e" xlink:href="clx-20220930.xsd#clx_RetirementIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_aa949124-b46c-4fbd-ba89-36cd1a879691" xlink:to="loc_clx_RetirementIncomeMember_e746437f-02b4-45d8-a4e4-bf3b9047361e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#OTHERCONTINGENCIESANDGUARANTEESDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" xlink:type="extended" id="i68888e4c800f40ba8eb32695ebb0c851_OTHERCONTINGENCIESANDGUARANTEESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_aa7c24b2-43b6-4937-ab0d-b82a2fd057aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_d9ce6e37-0b9d-4156-925a-2f88bb84fa49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_aa7c24b2-43b6-4937-ab0d-b82a2fd057aa" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_d9ce6e37-0b9d-4156-925a-2f88bb84fa49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RemediationPeriod_a34279e9-686c-4c3b-b7e1-3ad9a934fe56" xlink:href="clx-20220930.xsd#clx_RemediationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_aa7c24b2-43b6-4937-ab0d-b82a2fd057aa" xlink:to="loc_clx_RemediationPeriod_a34279e9-686c-4c3b-b7e1-3ad9a934fe56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_MaximumExposureUndiscountedCost_0d31e428-bda3-47d5-ac59-c4881431132e" xlink:href="clx-20220930.xsd#clx_MaximumExposureUndiscountedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_aa7c24b2-43b6-4937-ab0d-b82a2fd057aa" xlink:to="loc_clx_MaximumExposureUndiscountedCost_0d31e428-bda3-47d5-ac59-c4881431132e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_SiteContingencyAgreedPercentageOfCostSharing_ca983c1a-0411-40eb-b78f-35a5dca1e70e" xlink:href="clx-20220930.xsd#clx_SiteContingencyAgreedPercentageOfCostSharing"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_aa7c24b2-43b6-4937-ab0d-b82a2fd057aa" xlink:to="loc_clx_SiteContingencyAgreedPercentageOfCostSharing_ca983c1a-0411-40eb-b78f-35a5dca1e70e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LetterOfCreditBorrowingCapacity_fb42e4c8-bafd-4c71-86cc-b2d1069f4220" xlink:href="clx-20220930.xsd#clx_LetterOfCreditBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_aa7c24b2-43b6-4937-ab0d-b82a2fd057aa" xlink:to="loc_clx_LetterOfCreditBorrowingCapacity_fb42e4c8-bafd-4c71-86cc-b2d1069f4220" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_416a4ced-7888-44b8-a1df-6b015371bdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_aa7c24b2-43b6-4937-ab0d-b82a2fd057aa" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_416a4ced-7888-44b8-a1df-6b015371bdb4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_074d2c01-7222-4e8e-bd32-5e6b7de429f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_aa7c24b2-43b6-4937-ab0d-b82a2fd057aa" xlink:to="loc_us-gaap_LossContingenciesTable_074d2c01-7222-4e8e-bd32-5e6b7de429f8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b3766617-43f0-42fc-8813-c300684fe16d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_074d2c01-7222-4e8e-bd32-5e6b7de429f8" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b3766617-43f0-42fc-8813-c300684fe16d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_b3766617-43f0-42fc-8813-c300684fe16d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b3766617-43f0-42fc-8813-c300684fe16d" xlink:to="loc_us-gaap_LossContingencyNatureDomain_b3766617-43f0-42fc-8813-c300684fe16d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_476f65ee-818f-4ac4-8b2d-77fe4cad8abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b3766617-43f0-42fc-8813-c300684fe16d" xlink:to="loc_us-gaap_LossContingencyNatureDomain_476f65ee-818f-4ac4-8b2d-77fe4cad8abb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_AlamedaCountyCaliforniaMatterMember_252030b1-f02e-4dec-88bf-1e845b5358e5" xlink:href="clx-20220930.xsd#clx_AlamedaCountyCaliforniaMatterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_476f65ee-818f-4ac4-8b2d-77fe4cad8abb" xlink:to="loc_clx_AlamedaCountyCaliforniaMatterMember_252030b1-f02e-4dec-88bf-1e845b5358e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DickinsonCountyMichiganMatterMember_70871900-ffb2-4013-81e6-a28f94880409" xlink:href="clx-20220930.xsd#clx_DickinsonCountyMichiganMatterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_476f65ee-818f-4ac4-8b2d-77fe4cad8abb" xlink:to="loc_clx_DickinsonCountyMichiganMatterMember_70871900-ffb2-4013-81e6-a28f94880409" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#SEGMENTRESULTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" xlink:type="extended" id="if66854f9ca73486e91e4c49c06da8e4c_SEGMENTRESULTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_e8ccf14e-8b3c-4e09-ae97-11906abd3c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_b23ae2c0-ca3d-472b-86da-a6cad75fe6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_e8ccf14e-8b3c-4e09-ae97-11906abd3c39" xlink:to="loc_us-gaap_NumberOfReportableSegments_b23ae2c0-ca3d-472b-86da-a6cad75fe6d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_b6fb1be9-72d8-4a23-bf5c-79ff098f5bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_e8ccf14e-8b3c-4e09-ae97-11906abd3c39" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_b6fb1be9-72d8-4a23-bf5c-79ff098f5bbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_9a690f67-2230-4f5b-a28a-ae383bc8952f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_e8ccf14e-8b3c-4e09-ae97-11906abd3c39" xlink:to="loc_us-gaap_ConcentrationRiskTable_9a690f67-2230-4f5b-a28a-ae383bc8952f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d7d94959-6f84-481d-8f13-ab8c94386a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_9a690f67-2230-4f5b-a28a-ae383bc8952f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d7d94959-6f84-481d-8f13-ab8c94386a09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d7d94959-6f84-481d-8f13-ab8c94386a09_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d7d94959-6f84-481d-8f13-ab8c94386a09" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d7d94959-6f84-481d-8f13-ab8c94386a09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_22a19f22-e81a-4908-bca2-80cea87c34ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d7d94959-6f84-481d-8f13-ab8c94386a09" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_22a19f22-e81a-4908-bca2-80cea87c34ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_0ab21946-ed9f-4c95-90f3-b82cab67be5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_22a19f22-e81a-4908-bca2-80cea87c34ff" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_0ab21946-ed9f-4c95-90f3-b82cab67be5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e85647ff-a765-4062-b519-e899673d8140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_9a690f67-2230-4f5b-a28a-ae383bc8952f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e85647ff-a765-4062-b519-e899673d8140" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e85647ff-a765-4062-b519-e899673d8140_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e85647ff-a765-4062-b519-e899673d8140" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e85647ff-a765-4062-b519-e899673d8140_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_2fb933c7-3bca-409c-a59e-9c144d587dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e85647ff-a765-4062-b519-e899673d8140" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_2fb933c7-3bca-409c-a59e-9c144d587dd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_ffd6630d-1641-4b47-aa1f-e77962580df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_2fb933c7-3bca-409c-a59e-9c144d587dd3" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_ffd6630d-1641-4b47-aa1f-e77962580df3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_f2e199bb-ad49-4f47-a86e-a0b795246fb7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_9a690f67-2230-4f5b-a28a-ae383bc8952f" xlink:to="loc_srt_MajorCustomersAxis_f2e199bb-ad49-4f47-a86e-a0b795246fb7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_f2e199bb-ad49-4f47-a86e-a0b795246fb7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_f2e199bb-ad49-4f47-a86e-a0b795246fb7" xlink:to="loc_srt_NameOfMajorCustomerDomain_f2e199bb-ad49-4f47-a86e-a0b795246fb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_ae5bcb7e-a9d3-456d-87cc-4544a5f74841" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_f2e199bb-ad49-4f47-a86e-a0b795246fb7" xlink:to="loc_srt_NameOfMajorCustomerDomain_ae5bcb7e-a9d3-456d-87cc-4544a5f74841" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WalmartStoresIncMember_4a57cd1b-72d9-43f4-bb0b-76c9aed9934e" xlink:href="clx-20220930.xsd#clx_WalmartStoresIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_ae5bcb7e-a9d3-456d-87cc-4544a5f74841" xlink:to="loc_clx_WalmartStoresIncMember_4a57cd1b-72d9-43f4-bb0b-76c9aed9934e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#SEGMENTRESULTSReportableSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" xlink:type="extended" id="i7449f7561e22464bb620bc05211119cc_SEGMENTRESULTSReportableSegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_63354229-e371-49ed-8bb1-689c66a27efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dc2c5f1e-c2b4-41ad-ab61-af0efdde0f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_63354229-e371-49ed-8bb1-689c66a27efd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dc2c5f1e-c2b4-41ad-ab61-af0efdde0f2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2b7d1a6d-19bd-4f88-900e-e150c00c5624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_63354229-e371-49ed-8bb1-689c66a27efd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2b7d1a6d-19bd-4f88-900e-e150c00c5624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_7f339809-59dd-419a-8557-19d2b4b8f32e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_63354229-e371-49ed-8bb1-689c66a27efd" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_7f339809-59dd-419a-8557-19d2b4b8f32e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_df81374b-8232-4253-8b79-65bd5c1beafe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_63354229-e371-49ed-8bb1-689c66a27efd" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_df81374b-8232-4253-8b79-65bd5c1beafe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10de62ff-354b-41cd-98d9-bf131bc442e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_63354229-e371-49ed-8bb1-689c66a27efd" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10de62ff-354b-41cd-98d9-bf131bc442e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_60026f2c-d5b6-4cd3-8218-040e559daa6c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10de62ff-354b-41cd-98d9-bf131bc442e4" xlink:to="loc_srt_ConsolidationItemsAxis_60026f2c-d5b6-4cd3-8218-040e559daa6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_60026f2c-d5b6-4cd3-8218-040e559daa6c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_60026f2c-d5b6-4cd3-8218-040e559daa6c" xlink:to="loc_srt_ConsolidationItemsDomain_60026f2c-d5b6-4cd3-8218-040e559daa6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b4800c7d-0d9b-488c-95eb-961fcdb48d12" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_60026f2c-d5b6-4cd3-8218-040e559daa6c" xlink:to="loc_srt_ConsolidationItemsDomain_b4800c7d-0d9b-488c-95eb-961fcdb48d12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_28d531e4-1291-4029-b5cd-6d0ce35856a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b4800c7d-0d9b-488c-95eb-961fcdb48d12" xlink:to="loc_us-gaap_OperatingSegmentsMember_28d531e4-1291-4029-b5cd-6d0ce35856a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_7b8f3ad5-9f95-4cd8-919c-631d13c7ccd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b4800c7d-0d9b-488c-95eb-961fcdb48d12" xlink:to="loc_us-gaap_CorporateNonSegmentMember_7b8f3ad5-9f95-4cd8-919c-631d13c7ccd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_eaa20007-404d-4654-a475-7faba536b451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10de62ff-354b-41cd-98d9-bf131bc442e4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_eaa20007-404d-4654-a475-7faba536b451" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_eaa20007-404d-4654-a475-7faba536b451_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eaa20007-404d-4654-a475-7faba536b451" xlink:to="loc_us-gaap_SegmentDomain_eaa20007-404d-4654-a475-7faba536b451_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5a050525-91f9-4e0a-916e-8d42e1fb094f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eaa20007-404d-4654-a475-7faba536b451" xlink:to="loc_us-gaap_SegmentDomain_5a050525-91f9-4e0a-916e-8d42e1fb094f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember_9bca5926-e52a-4c05-9091-bfe6cb9be1ba" xlink:href="clx-20220930.xsd#clx_HealthAndWellnessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5a050525-91f9-4e0a-916e-8d42e1fb094f" xlink:to="loc_clx_HealthAndWellnessMember_9bca5926-e52a-4c05-9091-bfe6cb9be1ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HouseholdMember_60558a6d-7c78-42e9-a74a-43be95c31ea9" xlink:href="clx-20220930.xsd#clx_HouseholdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5a050525-91f9-4e0a-916e-8d42e1fb094f" xlink:to="loc_clx_HouseholdMember_60558a6d-7c78-42e9-a74a-43be95c31ea9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LifestyleMember_c8e70a64-6660-48b9-8f43-8cd2198d9985" xlink:href="clx-20220930.xsd#clx_LifestyleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5a050525-91f9-4e0a-916e-8d42e1fb094f" xlink:to="loc_clx_LifestyleMember_c8e70a64-6660-48b9-8f43-8cd2198d9985" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalMember_3a9c4e8d-4aaa-4628-a84d-7dcbf13c8217" xlink:href="clx-20220930.xsd#clx_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5a050525-91f9-4e0a-916e-8d42e1fb094f" xlink:to="loc_clx_InternationalMember_3a9c4e8d-4aaa-4628-a84d-7dcbf13c8217" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_4860af05-59f0-414f-90ae-0c0011083bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10de62ff-354b-41cd-98d9-bf131bc442e4" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_4860af05-59f0-414f-90ae-0c0011083bb1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4860af05-59f0-414f-90ae-0c0011083bb1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_4860af05-59f0-414f-90ae-0c0011083bb1" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4860af05-59f0-414f-90ae-0c0011083bb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3237fa35-2b6a-4d44-9069-ff4677883e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_4860af05-59f0-414f-90ae-0c0011083bb1" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3237fa35-2b6a-4d44-9069-ff4677883e99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RestructuringAndRelatedCostsBenchmarkMember_d813aacb-8e16-4e47-86ee-d691a270201d" xlink:href="clx-20220930.xsd#clx_RestructuringAndRelatedCostsBenchmarkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3237fa35-2b6a-4d44-9069-ff4677883e99" xlink:to="loc_clx_RestructuringAndRelatedCostsBenchmarkMember_d813aacb-8e16-4e47-86ee-d691a270201d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_6555c482-9d69-45b4-af86-88abb06cf890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10de62ff-354b-41cd-98d9-bf131bc442e4" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_6555c482-9d69-45b4-af86-88abb06cf890" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_6555c482-9d69-45b4-af86-88abb06cf890_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6555c482-9d69-45b4-af86-88abb06cf890" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_6555c482-9d69-45b4-af86-88abb06cf890_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_27d0ce47-07b7-42d9-9b4a-d87e27f46192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6555c482-9d69-45b4-af86-88abb06cf890" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_27d0ce47-07b7-42d9-9b4a-d87e27f46192" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_abb468e6-cdba-4aeb-92aa-d950c392dd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_27d0ce47-07b7-42d9-9b4a-d87e27f46192" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_abb468e6-cdba-4aeb-92aa-d950c392dd15" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#SEGMENTRESULTSNetSalesPercentagesDetails"/>
  <link:definitionLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" xlink:type="extended" id="ia6ea1a7eb6444b68aa64ba82775eac20_SEGMENTRESULTSNetSalesPercentagesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7b27b54a-8999-4503-9be8-fc2b1bfa9bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_ccc1fd15-5fbb-441a-9d80-d0d771ef1414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7b27b54a-8999-4503-9be8-fc2b1bfa9bc8" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_ccc1fd15-5fbb-441a-9d80-d0d771ef1414" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_248703ea-eff7-439a-9764-df264c469e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7b27b54a-8999-4503-9be8-fc2b1bfa9bc8" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_248703ea-eff7-439a-9764-df264c469e90" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_453f2747-09f0-4673-b1a0-fae4221bc109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_248703ea-eff7-439a-9764-df264c469e90" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_453f2747-09f0-4673-b1a0-fae4221bc109" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_453f2747-09f0-4673-b1a0-fae4221bc109_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_453f2747-09f0-4673-b1a0-fae4221bc109" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_453f2747-09f0-4673-b1a0-fae4221bc109_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c8d6ab4a-ed5a-4b9c-b320-e6f95081e27f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_453f2747-09f0-4673-b1a0-fae4221bc109" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c8d6ab4a-ed5a-4b9c-b320-e6f95081e27f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_a35a48c5-0e23-433a-bbf2-d73ae6f873af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c8d6ab4a-ed5a-4b9c-b320-e6f95081e27f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_a35a48c5-0e23-433a-bbf2-d73ae6f873af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ba4353d1-fb6e-420d-a92b-9b1578793ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_248703ea-eff7-439a-9764-df264c469e90" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ba4353d1-fb6e-420d-a92b-9b1578793ca8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ba4353d1-fb6e-420d-a92b-9b1578793ca8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ba4353d1-fb6e-420d-a92b-9b1578793ca8" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ba4353d1-fb6e-420d-a92b-9b1578793ca8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_21869ff3-702f-4779-bf6c-6064ad467e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ba4353d1-fb6e-420d-a92b-9b1578793ca8" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_21869ff3-702f-4779-bf6c-6064ad467e3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_f943b7f3-0231-4eb7-9ee0-b1015eead6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_21869ff3-702f-4779-bf6c-6064ad467e3d" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_f943b7f3-0231-4eb7-9ee0-b1015eead6c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1768922c-4c32-445f-9a98-532911f63944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_248703ea-eff7-439a-9764-df264c469e90" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1768922c-4c32-445f-9a98-532911f63944" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1768922c-4c32-445f-9a98-532911f63944_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1768922c-4c32-445f-9a98-532911f63944" xlink:to="loc_us-gaap_SegmentDomain_1768922c-4c32-445f-9a98-532911f63944_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3d93375a-9f7c-484f-bde7-d16ff396dde4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1768922c-4c32-445f-9a98-532911f63944" xlink:to="loc_us-gaap_SegmentDomain_3d93375a-9f7c-484f-bde7-d16ff396dde4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember_3255cc33-f182-4a24-aca1-2ca0031a6b4b" xlink:href="clx-20220930.xsd#clx_HealthAndWellnessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3d93375a-9f7c-484f-bde7-d16ff396dde4" xlink:to="loc_clx_HealthAndWellnessMember_3255cc33-f182-4a24-aca1-2ca0031a6b4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HouseholdMember_a0b59db4-eadd-4f4f-8467-f982c9a824da" xlink:href="clx-20220930.xsd#clx_HouseholdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3d93375a-9f7c-484f-bde7-d16ff396dde4" xlink:to="loc_clx_HouseholdMember_a0b59db4-eadd-4f4f-8467-f982c9a824da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LifestyleMember_abcd725c-ffcf-485f-8aae-21be032ffd41" xlink:href="clx-20220930.xsd#clx_LifestyleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3d93375a-9f7c-484f-bde7-d16ff396dde4" xlink:to="loc_clx_LifestyleMember_abcd725c-ffcf-485f-8aae-21be032ffd41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalMember_4058ebf0-08ab-4efe-a843-66a85fa334b7" xlink:href="clx-20220930.xsd#clx_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3d93375a-9f7c-484f-bde7-d16ff396dde4" xlink:to="loc_clx_InternationalMember_4058ebf0-08ab-4efe-a843-66a85fa334b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_1014fea2-54b2-4530-9d1c-903bf707b55a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_248703ea-eff7-439a-9764-df264c469e90" xlink:to="loc_us-gaap_SubsegmentsAxis_1014fea2-54b2-4530-9d1c-903bf707b55a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_1014fea2-54b2-4530-9d1c-903bf707b55a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_1014fea2-54b2-4530-9d1c-903bf707b55a" xlink:to="loc_us-gaap_SubsegmentsDomain_1014fea2-54b2-4530-9d1c-903bf707b55a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_1014fea2-54b2-4530-9d1c-903bf707b55a" xlink:to="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CleaningMember_c0d5b77d-6832-45b3-bbc2-98a044899dcf" xlink:href="clx-20220930.xsd#clx_CleaningMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_CleaningMember_c0d5b77d-6832-45b3-bbc2-98a044899dcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ProfessionalProductsMember_7f12d69f-2e54-49c8-abe8-8654f1bcc82d" xlink:href="clx-20220930.xsd#clx_ProfessionalProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_ProfessionalProductsMember_7f12d69f-2e54-49c8-abe8-8654f1bcc82d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VitaminsMineralsAndSupplementsMember_abd8a118-9128-4c7d-988f-c1d6053232f9" xlink:href="clx-20220930.xsd#clx_VitaminsMineralsAndSupplementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_VitaminsMineralsAndSupplementsMember_abd8a118-9128-4c7d-988f-c1d6053232f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BagsWrapsAndContainersMember_ba5ea91c-3ad8-4aef-af0a-bdb505445350" xlink:href="clx-20220930.xsd#clx_BagsWrapsAndContainersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_BagsWrapsAndContainersMember_ba5ea91c-3ad8-4aef-af0a-bdb505445350" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_GrillingMember_f1fd1373-af03-4bea-a206-41ecfb2ccbaf" xlink:href="clx-20220930.xsd#clx_GrillingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_GrillingMember_f1fd1373-af03-4bea-a206-41ecfb2ccbaf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CatLitterMember_a6133d44-fb76-4871-b507-1a0208ddc25e" xlink:href="clx-20220930.xsd#clx_CatLitterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_CatLitterMember_a6133d44-fb76-4871-b507-1a0208ddc25e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FoodProductsMember_d0e7d881-363c-44ee-bad4-fcb0bcbb8f99" xlink:href="clx-20220930.xsd#clx_FoodProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_FoodProductsMember_d0e7d881-363c-44ee-bad4-fcb0bcbb8f99" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NaturalPersonalCareMember_66259065-81ef-4014-a7cb-6da30e766785" xlink:href="clx-20220930.xsd#clx_NaturalPersonalCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_NaturalPersonalCareMember_66259065-81ef-4014-a7cb-6da30e766785" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WaterFiltrationMember_31b5bbd3-7b2a-4f4c-b146-21eb5f8b68a6" xlink:href="clx-20220930.xsd#clx_WaterFiltrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_WaterFiltrationMember_31b5bbd3-7b2a-4f4c-b146-21eb5f8b68a6" xlink:type="arc" order="8"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>clx-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:705545e2-87bd-4296-a317-b2dac9e841f3,g:2063eff2-ec82-44e0-90e5-b1eb8fc3164f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b21ad042-f3af-48ca-8409-d4eb193496aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bc6bdbd9-5479-4df3-be95-946b8cee8482_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings to net cash provided by operations:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_4efbad84-81e0-47a7-9d6d-c1fffbf62756_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_3caae39e-4950-4444-be0c-d8f7f8f085c2_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_47d920c0-a1a7-48d0-815a-2ab12e03861c_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_2b52d6dc-6149-4896-84eb-1759daa6076e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_09735883-51d7-4671-9727-9d15a254180b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_200e597e-6c87-4374-8407-544cecdecf87_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_fd903b4d-cfae-4ea6-ba26-d8bd726393d6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_b8ef8821-bd58-465c-8384-e4838972e580_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e8ead3af-ce72-41d9-bab7-4dd6a917dd64_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_1c255944-fbf6-4535-9456-00c2aeb0e5f1_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_9d7ee22e-7d64-45bf-ba33-ec6d719563ac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_faefc0fe-f408-4776-aba4-1e5d3b0f2138_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_25db98ce-3a82-45f0-aad0-5da2750c3561_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_d8d60b3f-5308-4839-9b0a-fe4ee101b9b3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ecc6d826-6001-4a4a-ba66-86c243468ba4_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4364d95b-142d-4cf6-837c-5fa3a8c657aa_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_5a817636-1e6d-4bf2-9f8f-d2842a8e93db_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e86776ac-73b0-4d4f-a3d4-f6ffa80069de_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_b2a44c25-e5ad-41f8-8d09-80aaa3eed84d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_19b21b1b-18ca-44f9-9ead-c750f981e8cf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_52adf5e1-96f4-40ea-a37f-8ed53afc17d7_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trust assets for nonqualified deferred compensation plans, estimated fair value</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_347614bf-19fc-4a23-a2b0-b615ef824ccc_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_153257f7-cd00-4229-8355-b19f521931d8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid to Clorox stockholders</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_9019e6f6-1269-4c4c-b76b-c4bb99c7272f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_21bc3be6-dfb3-4443-bfce-ac6fe958fcff_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt and Long-term debt, estimated fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_b1e7761b-91a7-4d0c-8c1f-5cee50f08941_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Accrual Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_4c14f735-e669-4cac-b04d-e62e95af2d9c_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Accrual Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_71810ce6-2a02-4a34-bc69-b2c917e6c002_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange derivative contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_4253196c-df85-41b0-b768-ea1a78dc3a94_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_d0c1c4d9-1517-46d5-a78e-f7b329b61cbf_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of September&#160;30, 2022 and June&#160;30, 2022; and 123,355,986 and 123,152,132 shares outstanding as of September&#160;30, 2022 and June&#160;30, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_c1632b8b-beb1-493c-ae54-964d0118b868_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_RemediationPeriod_9027997f-831a-4cda-ba9d-74f42ecbb936_terseLabel_en-US" xlink:label="lab_clx_RemediationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remediation period (in years)</link:label>
    <link:label id="lab_clx_RemediationPeriod_label_en-US" xlink:label="lab_clx_RemediationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remediation period</link:label>
    <link:label id="lab_clx_RemediationPeriod_documentation_en-US" xlink:label="lab_clx_RemediationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated time frame of disbursements over which remediation efforts are estimated to occur for an individual site.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RemediationPeriod" xlink:href="clx-20220930.xsd#clx_RemediationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_RemediationPeriod" xlink:to="lab_clx_RemediationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_CleaningMember_1d055aab-a2cf-4187-bb69-67126a89de1e_terseLabel_en-US" xlink:label="lab_clx_CleaningMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cleaning</link:label>
    <link:label id="lab_clx_CleaningMember_label_en-US" xlink:label="lab_clx_CleaningMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cleaning [Member]</link:label>
    <link:label id="lab_clx_CleaningMember_documentation_en-US" xlink:label="lab_clx_CleaningMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cleaning [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CleaningMember" xlink:href="clx-20220930.xsd#clx_CleaningMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_CleaningMember" xlink:to="lab_clx_CleaningMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_461b99ca-1f91-4dbf-9abc-870e8c6fb396_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trust assets for nonqualified deferred compensation plans</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationPlanAssets" xlink:to="lab_us-gaap_DeferredCompensationPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_77116fa9-e121-47fb-9f92-c693070313de_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ac319238-71b0-48ae-9f87-65913e3bb2fe_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_f3a08b16-e3a7-42d6-8d52-6101feede300_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_LifestyleMember_686c7f5e-3479-4048-8fbd-c50c1c29babe_terseLabel_en-US" xlink:label="lab_clx_LifestyleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lifestyle</link:label>
    <link:label id="lab_clx_LifestyleMember_label_en-US" xlink:label="lab_clx_LifestyleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lifestyle [Member]</link:label>
    <link:label id="lab_clx_LifestyleMember_documentation_en-US" xlink:label="lab_clx_LifestyleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lifestyle [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LifestyleMember" xlink:href="clx-20220930.xsd#clx_LifestyleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_LifestyleMember" xlink:to="lab_clx_LifestyleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsAxis_3bf47a07-5637-4d4f-9c17-da95d0ecd852_terseLabel_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Axis]</link:label>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsAxis_label_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Axis]</link:label>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsAxis_documentation_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsAxis" xlink:href="clx-20220930.xsd#clx_CommodityPurchaseDerivativeContractsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsAxis" xlink:to="lab_clx_CommodityPurchaseDerivativeContractsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_bec3a5b0-02c4-4dd2-b2dc-8da9d7245cdc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Derivative Instruments Designated as Hedging Instruments on OCI</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_001c9e38-a3fd-48d0-bbd1-68a71cb2ebe8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_249ea9f5-c0bf-4e29-9c38-0ab6bb8daf81_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_8a27eb9b-8b51-4cf9-a66b-abffcd0049e6_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amount of the existing net gain (loss) to be reclassified into earnings in the next 12 months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_6c228e0e-5126-4267-b85a-250a46b3a7fa_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_6b1b6c0a-b7ec-43de-9627-ca44ebb6e68a_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_5e3d37aa-a8a5-4077-9de7-32658cbb61f1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_49506652-558a-4e43-97e3-bf4ae3ef03f6_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_757ef751-b6f7-4dae-882b-98478ca31415_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_00393af7-c322-4281-a2ca-4f07ca9ac8ba_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d902be17-e887-4371-b643-51feadaea22a_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost (benefit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_de24ffa5-1bbf-439a-a6ad-81e2ff1dcaec_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_165cb006-3894-40df-a520-5d4446867653_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_dd71f6f0-99e9-46f9-8a88-628b040149a0_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net earnings attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f7bfbfc6-d0f0-4d91-9db9-f8414e22d32b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER CONTINGENCIES AND GUARANTEES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_a4a440fe-ae72-4b64-a062-e8a616b6ea71_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_0b460b2e-f1e6-4bbb-9a3b-4dcdf539f63e_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_195b8e16-1eb2-4870-9744-5985465ef85a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_93404751-2daa-4b74-bcb7-1be6724d8601_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock purchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_VitaminsMineralsAndSupplementsMember_61219b2f-6ab2-46bd-8bbc-7e63e8a8b6b0_terseLabel_en-US" xlink:label="lab_clx_VitaminsMineralsAndSupplementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitamins, Minerals and Supplements</link:label>
    <link:label id="lab_clx_VitaminsMineralsAndSupplementsMember_label_en-US" xlink:label="lab_clx_VitaminsMineralsAndSupplementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitamins, Minerals and Supplements [Member]</link:label>
    <link:label id="lab_clx_VitaminsMineralsAndSupplementsMember_documentation_en-US" xlink:label="lab_clx_VitaminsMineralsAndSupplementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitamins, Minerals and Supplements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VitaminsMineralsAndSupplementsMember" xlink:href="clx-20220930.xsd#clx_VitaminsMineralsAndSupplementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_VitaminsMineralsAndSupplementsMember" xlink:to="lab_clx_VitaminsMineralsAndSupplementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_f0ccd0f2-b848-4131-b428-ccb5388753b8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_110249c7-43ca-47fc-bfc1-a254a9a5d41b_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to Clorox</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_193ae5b2-ebdc-4b33-9027-438d0f1e2409_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gains (losses) on derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_94555ae6-e5d1-43f4-a563-e3a214e73e6a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive stock options and other (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_cb32f054-a70b-4d26-8b47-e0db36d81ba3_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_d8abca58-c319-43ca-8037-f22e97c12078_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_915bda67-22da-4342-9626-0ebce3f024be_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_26516b43-2914-4838-ada0-7510c2694e97_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_984b0818-ec54-41fb-8b91-ab930443b41c_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_541f85a9-8b0d-413c-b9c9-131e80430e0f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used for investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_e0f951d4-a101-44d5-8637-afb1c581552f_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesShares_f1c8b262-1c2e-49ef-9d69-da47b031d18c_terseLabel_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other employee stock plan activities (in shares)</link:label>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesShares_label_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Employee Stock Plan Activities, Shares</link:label>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesShares_documentation_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued during the period as a result of exercises of employee stock options or the vesting of other share-based awards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesShares" xlink:href="clx-20220930.xsd#clx_OtherEmployeeStockPlanActivitiesShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_OtherEmployeeStockPlanActivitiesShares" xlink:to="lab_clx_OtherEmployeeStockPlanActivitiesShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_8d3a3075-f467-4b1d-837f-4cb9f7154384_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f8af3898-7eca-4a26-bdd9-4275d3ff1d40_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive (loss) income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4e8d3437-f0c2-4b8a-a072-af0a31050c8a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_47378b7f-1a49-4d7f-9b39-de69f712c675_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets, estimated fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_c9e2813a-3cfc-4cc4-a12b-458f3d035e97_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income attributable to Clorox</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_GrillingMember_644181c4-a85e-40b9-908f-03188c407658_terseLabel_en-US" xlink:label="lab_clx_GrillingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grilling</link:label>
    <link:label id="lab_clx_GrillingMember_label_en-US" xlink:label="lab_clx_GrillingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grilling [Member]</link:label>
    <link:label id="lab_clx_GrillingMember_documentation_en-US" xlink:label="lab_clx_GrillingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grilling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_GrillingMember" xlink:href="clx-20220930.xsd#clx_GrillingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_GrillingMember" xlink:to="lab_clx_GrillingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_071b93e2-d725-432b-94c7-ccbc406f8a25_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected Financial Information Relating to the Company's Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_d98624ee-9ddf-4794-ad55-b4cb45a6dcc4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_RestructuringAndRelatedCostsBenchmarkMember_eab2d02d-d267-4aeb-98cf-f3a840b1a0b0_terseLabel_en-US" xlink:label="lab_clx_RestructuringAndRelatedCostsBenchmarkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs</link:label>
    <link:label id="lab_clx_RestructuringAndRelatedCostsBenchmarkMember_label_en-US" xlink:label="lab_clx_RestructuringAndRelatedCostsBenchmarkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs Benchmark [Member]</link:label>
    <link:label id="lab_clx_RestructuringAndRelatedCostsBenchmarkMember_documentation_en-US" xlink:label="lab_clx_RestructuringAndRelatedCostsBenchmarkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs Benchmark</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RestructuringAndRelatedCostsBenchmarkMember" xlink:href="clx-20220930.xsd#clx_RestructuringAndRelatedCostsBenchmarkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_RestructuringAndRelatedCostsBenchmarkMember" xlink:to="lab_clx_RestructuringAndRelatedCostsBenchmarkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_390f9cc5-3712-4dff-ace7-0ca1a45798db_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_f4d0ad35-0196-4360-8168-b54d27f483c2_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_c4e5d0f9-6456-433b-a415-b632540aff7c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_1dfc4be3-2136-4487-80f5-60745be2b1b2_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_LongTermInterCompanyLoansMember_2ceddf42-e94b-46fd-9080-e2b1a5721288_terseLabel_en-US" xlink:label="lab_clx_LongTermInterCompanyLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Inter-Company Loans</link:label>
    <link:label id="lab_clx_LongTermInterCompanyLoansMember_label_en-US" xlink:label="lab_clx_LongTermInterCompanyLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Inter-Company Loans [Member]</link:label>
    <link:label id="lab_clx_LongTermInterCompanyLoansMember_documentation_en-US" xlink:label="lab_clx_LongTermInterCompanyLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term inter-company loans included in foreign currency adjustments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LongTermInterCompanyLoansMember" xlink:href="clx-20220930.xsd#clx_LongTermInterCompanyLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_LongTermInterCompanyLoansMember" xlink:to="lab_clx_LongTermInterCompanyLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_83ee0792-8ccb-4851-97b6-06c6452cbb57_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_a00dc109-8f6a-4e93-8a27-5b571b0d4d68_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_7745ae8e-e656-4e97-8953-a9bafe111b96_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_e8c771a2-90b7-42ea-9a63-0a827d566390_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-Related Costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_c8b6f88c-0280-4750-8bea-d7bd13010403_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_e15e947d-a836-4ea9-8e4a-581820af9dd5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_ProfessionalProductsMember_5281ca2e-2e34-40e5-a645-2ea1302b1da0_terseLabel_en-US" xlink:label="lab_clx_ProfessionalProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Products</link:label>
    <link:label id="lab_clx_ProfessionalProductsMember_label_en-US" xlink:label="lab_clx_ProfessionalProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Products [Member]</link:label>
    <link:label id="lab_clx_ProfessionalProductsMember_documentation_en-US" xlink:label="lab_clx_ProfessionalProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ProfessionalProductsMember" xlink:href="clx-20220930.xsd#clx_ProfessionalProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_ProfessionalProductsMember" xlink:to="lab_clx_ProfessionalProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_dfb2362e-6755-4842-94fe-43c87ceea449_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommodityContractMember_017b34de-59e8-4669-a2d2-3d558dd68318_terseLabel_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity purchase derivative contracts</link:label>
    <link:label id="lab_us-gaap_CommodityContractMember_5d3b6ee1-e5d1-4cf3-bad1-6e56997f81f2_verboseLabel_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity purchase options contracts</link:label>
    <link:label id="lab_us-gaap_CommodityContractMember_label_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommodityContractMember" xlink:to="lab_us-gaap_CommodityContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_f101288e-819e-4ff3-8bc3-21fb3df44ac2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8fdff82c-de9d-4f58-bdee-ce2333650037_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_5d824d17-a352-4e72-9cbb-fca3e29e5473_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_950c306c-a55e-46c0-b4b8-dce5111b5651_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_0e4b3784-a80e-4855-a404-285a0760cfc9_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_TrademarksNet_2e64d00a-db67-4f53-ac7c-9c8ca7c553ea_terseLabel_en-US" xlink:label="lab_clx_TrademarksNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, net</link:label>
    <link:label id="lab_clx_TrademarksNet_label_en-US" xlink:label="lab_clx_TrademarksNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, net</link:label>
    <link:label id="lab_clx_TrademarksNet_documentation_en-US" xlink:label="lab_clx_TrademarksNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite or finite period of benefit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrademarksNet" xlink:href="clx-20220930.xsd#clx_TrademarksNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_TrademarksNet" xlink:to="lab_clx_TrademarksNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_a224c151-11dd-4cea-b6cc-fb69292b46e6_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_b32df118-b1b8-43f4-b84b-bd59fdd5b80b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_72d4a64d-bb9b-4d54-b6be-5bfe6802ac44_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operations</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_9c5b9a3f-46ea-401e-bdb8-77e8e2b91dc5_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_1659ccc2-6803-417a-92bd-588bdc222f19_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_ea61b3a2-4153-4142-af83-f1c35201f09e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_5480a001-e84a-447e-8d8d-df7f9185e67c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d7c7ee9f-d73c-4cac-b3d7-f8a9312a0e7e_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_24844092-3197-4519-b9db-08193a2d388c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_f7de175d-198d-4f96-81ec-71bd8d6163a4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net of accumulated depreciation and amortization of $2,575 and $2,530, respectively</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_HouseholdMember_1451de19-6640-4ce7-897a-e8951d3e6532_terseLabel_en-US" xlink:label="lab_clx_HouseholdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Household</link:label>
    <link:label id="lab_clx_HouseholdMember_label_en-US" xlink:label="lab_clx_HouseholdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Household [Member]</link:label>
    <link:label id="lab_clx_HouseholdMember_documentation_en-US" xlink:label="lab_clx_HouseholdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Household [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HouseholdMember" xlink:href="clx-20220930.xsd#clx_HouseholdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_HouseholdMember" xlink:to="lab_clx_HouseholdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_LetterOfCreditBorrowingCapacity_306ac271-1dfc-4994-bfbc-74d1d6f118a5_terseLabel_en-US" xlink:label="lab_clx_LetterOfCreditBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit</link:label>
    <link:label id="lab_clx_LetterOfCreditBorrowingCapacity_label_en-US" xlink:label="lab_clx_LetterOfCreditBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit</link:label>
    <link:label id="lab_clx_LetterOfCreditBorrowingCapacity_documentation_en-US" xlink:label="lab_clx_LetterOfCreditBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing capacity under the letter of credit without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LetterOfCreditBorrowingCapacity" xlink:href="clx-20220930.xsd#clx_LetterOfCreditBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_LetterOfCreditBorrowingCapacity" xlink:to="lab_clx_LetterOfCreditBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_13bbdd52-fe1f-4a2d-aa66-83aedf14d966_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_34a86e73-74fa-4ab7-9592-9c310d10f4f3_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost: 7,385,475 and 7,589,329 shares as of September&#160;30, 2022 and June&#160;30, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_5013c8ce-6906-49a6-8efb-09c614a34110_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefit adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_674f48ad-0a41-49d0-9466-f78b1184b3a7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt and Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionDomain_8ccc8609-fb97-4057-a4db-97867db3a544_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_TransactionDomain_label_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionDomain" xlink:to="lab_us-gaap_TransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_b4499b5f-e7be-46a5-ab29-03214e8b047a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and related implementation, expected cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_f2fea4d6-37f0-4273-abb4-c78daae37fcd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends to Clorox stockholders</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_737acdcb-3808-41f7-9ae6-6f752b84ff53_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt and Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_101356b2-eb5b-4966-a019-29421b7d7800_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_70a39a5e-01d9-4f17-ae61-626c318fbd18_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RESTRUCTURING AND RELATED COSTS</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_4ad89052-6527-475f-963c-c72cf988ea35_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_21ab6631-131c-459e-99a9-3878ec5c00d8_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_420d5d1a-7224-455e-b079-cd477f124514_terseLabel_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time deposits</link:label>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_label_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Time Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BankTimeDepositsMember" xlink:to="lab_us-gaap_BankTimeDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_8c77beee-0a6f-49e5-92c0-05c69f5a33a6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_1a8bb9c3-9bfa-4da3-b868-17d42ca03de1_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7eeb2161-c60c-46e2-bfee-44e273b588a3_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8f19c4b9-8dc3-4417-8dc9-30bdb4b7e933_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive net (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_TotalCommodityPurchaseDerivativeContractsMember_98c0420c-b480-46cb-8360-7bbff940d944_terseLabel_en-US" xlink:label="lab_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Commodity Purchase Derivative Contracts</link:label>
    <link:label id="lab_clx_TotalCommodityPurchaseDerivativeContractsMember_label_en-US" xlink:label="lab_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Commodity Purchase Derivative Contracts [Member]</link:label>
    <link:label id="lab_clx_TotalCommodityPurchaseDerivativeContractsMember_documentation_en-US" xlink:label="lab_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Commodity Purchase Derivative Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:href="clx-20220930.xsd#clx_TotalCommodityPurchaseDerivativeContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:to="lab_clx_TotalCommodityPurchaseDerivativeContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_5068f57b-ac77-4944-add4-7f41c5b435ca_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_116ecfda-1259-4cb6-a48f-4be4a3e3148f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average long-term expected rate or return on plan assets (percentage)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3e9cf3ed-4047-4c3b-90b3-bbfdb9306b50_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_97053ab1-963b-4761-92e5-c9033e2c35d1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_be8fb623-b73f-442c-8015-8a291fe465d6_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_f1fd9604-eec8-4520-b7af-4e57bc1a9226_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_b593838b-3076-4803-9596-10505a44bbc6_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_RetirementIncomeMember_ead36cea-a9e5-40b1-9602-0fb0c552853d_terseLabel_en-US" xlink:label="lab_clx_RetirementIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Income Plans</link:label>
    <link:label id="lab_clx_RetirementIncomeMember_label_en-US" xlink:label="lab_clx_RetirementIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Income Plans [Member]</link:label>
    <link:label id="lab_clx_RetirementIncomeMember_documentation_en-US" xlink:label="lab_clx_RetirementIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RetirementIncomeMember" xlink:href="clx-20220930.xsd#clx_RetirementIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_RetirementIncomeMember" xlink:to="lab_clx_RetirementIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_f68ab20d-4754-47c6-bdbe-355b92e60d6f_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_a9782b71-6c65-40a0-8ed5-c27354a0186c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_e4c8368c-bcb1-4927-998d-5b73a67a2898_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b936853f-b268-4b7d-a502-9fc21070c158_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_ed18c118-ffe8-4753-877f-eae970f1267b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_e7cec0c4-d7fe-48e2-8b6e-a05c47a5f2b2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_f691d376-aa91-4fe1-afd5-e53f27936da2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_f936c1cc-a956-43a3-9ce1-f5b5a37ba3f7_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_9c899453-f76c-428e-9d91-3c4c75e4f434_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_fea2ce8b-7fcc-40d7-8477-48ea47a16ab7_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_43db3f57-5c4d-47fa-aa4b-740e938990ec_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_AlamedaCountyCaliforniaMatterMember_1327d96d-cbd5-4cfc-bdec-61fd4ca787c8_terseLabel_en-US" xlink:label="lab_clx_AlamedaCountyCaliforniaMatterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alameda County, California Matter</link:label>
    <link:label id="lab_clx_AlamedaCountyCaliforniaMatterMember_label_en-US" xlink:label="lab_clx_AlamedaCountyCaliforniaMatterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alameda County, California Matter [Member]</link:label>
    <link:label id="lab_clx_AlamedaCountyCaliforniaMatterMember_documentation_en-US" xlink:label="lab_clx_AlamedaCountyCaliforniaMatterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alameda County, California Matter [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_AlamedaCountyCaliforniaMatterMember" xlink:href="clx-20220930.xsd#clx_AlamedaCountyCaliforniaMatterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_AlamedaCountyCaliforniaMatterMember" xlink:to="lab_clx_AlamedaCountyCaliforniaMatterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_BagsWrapsAndContainersMember_58bd81ff-0cb1-48b8-8892-b52694a4352c_terseLabel_en-US" xlink:label="lab_clx_BagsWrapsAndContainersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bags and Wraps</link:label>
    <link:label id="lab_clx_BagsWrapsAndContainersMember_label_en-US" xlink:label="lab_clx_BagsWrapsAndContainersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bags, Wraps, And Containers [Member]</link:label>
    <link:label id="lab_clx_BagsWrapsAndContainersMember_documentation_en-US" xlink:label="lab_clx_BagsWrapsAndContainersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bags, Wraps, And Containers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BagsWrapsAndContainersMember" xlink:href="clx-20220930.xsd#clx_BagsWrapsAndContainersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_BagsWrapsAndContainersMember" xlink:to="lab_clx_BagsWrapsAndContainersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_7e4db34a-c7a2-47c4-91df-d5771663f058_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b7ae52a2-2171-41d0-813f-f733ad2fbd75_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_35a66a43-c7e1-412f-8646-27034ecb7bea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_5af2a538-16f3-49d9-98e7-48b894c17e68_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) recognized in Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_ce15c135-888f-4744-8bf7-d9c74a475e75_terseLabel_en-US" xlink:label="lab_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Foreign Currency Balance by Description [Axis]</link:label>
    <link:label id="lab_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_label_en-US" xlink:label="lab_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Foreign Currency Balance by Description [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:to="lab_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_da0a4abe-8ccc-4847-8990-a8edd34566f0_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_005965ff-e601-4f35-9767-7981881cff15_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_25e5e4f7-9741-4a7a-a788-d2ea5d226692_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_InventoryCurrentAndNoncurrentNet_5b764f00-ff45-4ef5-84a1-f8adb3f808f4_totalLabel_en-US" xlink:label="lab_clx_InventoryCurrentAndNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories, net</link:label>
    <link:label id="lab_clx_InventoryCurrentAndNoncurrentNet_label_en-US" xlink:label="lab_clx_InventoryCurrentAndNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current And Noncurrent, Net</link:label>
    <link:label id="lab_clx_InventoryCurrentAndNoncurrentNet_documentation_en-US" xlink:label="lab_clx_InventoryCurrentAndNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current And Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InventoryCurrentAndNoncurrentNet" xlink:href="clx-20220930.xsd#clx_InventoryCurrentAndNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_InventoryCurrentAndNoncurrentNet" xlink:to="lab_clx_InventoryCurrentAndNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_a4ab4f3d-d426-4705-bcb1-3013b7bb53b4_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f97bfcd-dfaf-4102-a7dc-9673888768b7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_90b967f0-548e-46f9-85c7-8d1d5812c2fa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_aa4617dc-64e6-417d-bc8a-4136169f35d5_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_01786b38-3e10-4946-8da8-d627bd39b81b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT RESULTS</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_DefinedBenefitPlanPlanTerminationPeriod_330e50e8-be98-44e2-9f27-b520356507c3_terseLabel_en-US" xlink:label="lab_clx_DefinedBenefitPlanPlanTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan termination period</link:label>
    <link:label id="lab_clx_DefinedBenefitPlanPlanTerminationPeriod_label_en-US" xlink:label="lab_clx_DefinedBenefitPlanPlanTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Termination Period</link:label>
    <link:label id="lab_clx_DefinedBenefitPlanPlanTerminationPeriod_documentation_en-US" xlink:label="lab_clx_DefinedBenefitPlanPlanTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Termination Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DefinedBenefitPlanPlanTerminationPeriod" xlink:href="clx-20220930.xsd#clx_DefinedBenefitPlanPlanTerminationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_DefinedBenefitPlanPlanTerminationPeriod" xlink:to="lab_clx_DefinedBenefitPlanPlanTerminationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2c9c2d52-9c90-4798-a968-48fa3d827f3d_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_da03888c-7e30-40ea-b195-ef53083ea41f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings per share attributable to Clorox</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_2c36670c-2d0d-4ab5-b30d-49a83bb2c2ba_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_9ac686bd-e997-4dc7-bb1b-6769ee8bff83_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discretionary contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarginDepositAssets_5b42c61a-0239-4271-bc93-89ea0ca37a0c_terseLabel_en-US" xlink:label="lab_us-gaap_MarginDepositAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash margin balances amount</link:label>
    <link:label id="lab_us-gaap_MarginDepositAssets_label_en-US" xlink:label="lab_us-gaap_MarginDepositAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Margin Deposit Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarginDepositAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarginDepositAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarginDepositAssets" xlink:to="lab_us-gaap_MarginDepositAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a0db761f-30ff-4da4-b30b-59a31bcc1b90_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_d92c947e-5f97-458d-8615-1b212cc99d30_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_5d29eb01-668b-487d-8dff-d4203cfa63d5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_52c4084d-9fda-4407-a283-6168d4f0d59d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_83f2503f-36a8-4809-a9fd-52056570b16b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_1dd5e17b-f6f0-4622-987a-082b4611da33_terseLabel_en-US" xlink:label="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets and liabilities, net</link:label>
    <link:label id="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_label_en-US" xlink:label="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset And Liability, Net</link:label>
    <link:label id="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_documentation_en-US" xlink:label="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset And Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:href="clx-20220930.xsd#clx_OperatingLeaseRightofUseAssetAndLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:to="lab_clx_OperatingLeaseRightofUseAssetAndLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e353eb9-cf75-4325-859f-d73f3eeb6130_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used for financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_bc10c074-2c80-4063-9825-2b619e43394c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2143b69f-e7c5-491e-99a9-04e576d4a61a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding (in thousands)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_fd3fc617-a1a8-4e6f-acee-4804253c1305_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_202d04b0-b999-495c-bb30-8274b5dbdba4_terseLabel_en-US" xlink:label="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trust assets for nonqualified deferred compensation plans</link:label>
    <link:label id="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_label_en-US" xlink:label="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trust Assets for nonqualified deferred compensation plans [Member]</link:label>
    <link:label id="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_documentation_en-US" xlink:label="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trust Assets For Nonqualified Deferred Compensation Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:href="clx-20220930.xsd#clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:to="lab_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_9b5db6dd-efe3-4349-8b0a-a22cc6b788e2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_04ebb43c-671c-469d-b750-c02441a65f95_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_d942ebb9-0357-49f6-89a8-9cb8e0388a0e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_fc996f4a-8752-46b4-97c4-06e18f39b91b_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1b77877e-fd92-4ba4-8498-4ded5835bdd2_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_db55ba7a-8afd-4c09-bf54-a302e759cc32_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a573c4cb-bf6a-4ba7-9f8a-0d20930094d2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (losses) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_85e76e10-96a0-4ebd-aeec-183d1b184f9c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_524afd50-5867-4b17-a91a-fa0d7f43f863_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET EARNINGS PER SHARE (EPS)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_46988169-5644-4fd5-a90a-82b3da0b5e30_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_095cf25b-e984-467b-86bd-5498c747e4b6_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for aggregate future remediation costs</link:label>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_label_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Environmental Loss Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:to="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_c711985e-bd76-430f-8e54-187655a71777_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1e47e04f-0fc2-4f83-8e00-2c5812eaadae_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_78f23dce-0515-4d1e-b6f2-4298efe4a2e5_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_faa6d976-3d05-45d5-b0f4-ce17c61c943e_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7c03f2c5-0352-4d50-b214-f44f952bec87_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_233cd0e8-1bd0-4312-9bfd-5329e92076a9_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_SiteContingencyAgreedPercentageOfCostSharing_0f6533e8-63dc-4a94-9eeb-ff66586cdd59_terseLabel_en-US" xlink:label="lab_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of liability for aggregate remediation and associated costs, other than legal fees</link:label>
    <link:label id="lab_clx_SiteContingencyAgreedPercentageOfCostSharing_label_en-US" xlink:label="lab_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of liability for aggregate remediation and associated costs, other than legal fees</link:label>
    <link:label id="lab_clx_SiteContingencyAgreedPercentageOfCostSharing_documentation_en-US" xlink:label="lab_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of costs that the entity has agreed to under cost-sharing arrangements with other potentially responsible parties for an individual site.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:href="clx-20220930.xsd#clx_SiteContingencyAgreedPercentageOfCostSharing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:to="lab_clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_d8b8a582-969c-40d8-83fe-d2557b6eea1b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Derivative Instruments Designated as Hedging Instruments on Net Earnings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_85031033-d560-42d0-aa14-d1fa0339135e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities for Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_f2ef2c7f-b11b-43d1-984f-e765ea437957_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_InternationalMember_06216d01-f570-42c9-83b9-2d712ddc8e21_terseLabel_en-US" xlink:label="lab_clx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_clx_InternationalMember_label_en-US" xlink:label="lab_clx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:label id="lab_clx_InternationalMember_documentation_en-US" xlink:label="lab_clx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalMember" xlink:href="clx-20220930.xsd#clx_InternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_InternationalMember" xlink:to="lab_clx_InternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_91c04dd8-7514-46ca-bc9a-5b7ce2af33b0_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_e2b525dc-b634-4b38-952f-ee474226b2b8_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum duration, commodity contracts (in years)</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time Hedged in Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:to="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_76fb82ce-7172-424d-8c6e-dcd3a070ea76_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_b384c923-2ded-4d46-9da7-2b16733f1ad7_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_51b6d7e8-17ce-479b-a815-c49c0fb31052_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_d552bf9c-2713-45f8-afb5-cbe38f3087f3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_a69f49b6-373c-4b12-ac8a-544334a0b563_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_9a9f7868-0c9e-4c90-b07c-c0a8b18b16d4_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit, amount outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_db30dd3e-2373-4fc4-912d-46e94c44a7fb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_2792215d-aff2-48be-a638-1df0f47df4e5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_4bc82c6f-8a28-4bbf-9be1-107e05b1db11_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_465291fb-1a1f-4574-85f3-57cc8f562566_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_7203a6bc-1792-4fd4-8cc6-7f315b9ca754_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_bb7734cc-c959-4cf5-843a-7946ee02394a_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMPLOYEE BENEFIT PLANS</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_PurchasesofInventoryMember_dac28fb0-4dee-420f-ae13-6db963532938_terseLabel_en-US" xlink:label="lab_clx_PurchasesofInventoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of Inventory</link:label>
    <link:label id="lab_clx_PurchasesofInventoryMember_label_en-US" xlink:label="lab_clx_PurchasesofInventoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of Inventory [Member]</link:label>
    <link:label id="lab_clx_PurchasesofInventoryMember_documentation_en-US" xlink:label="lab_clx_PurchasesofInventoryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of Inventory [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_PurchasesofInventoryMember" xlink:href="clx-20220930.xsd#clx_PurchasesofInventoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_PurchasesofInventoryMember" xlink:to="lab_clx_PurchasesofInventoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_FoodProductsMember_2816c35f-d5e5-4795-82ba-3c646dff8555_terseLabel_en-US" xlink:label="lab_clx_FoodProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Food</link:label>
    <link:label id="lab_clx_FoodProductsMember_label_en-US" xlink:label="lab_clx_FoodProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Food Products [Member]</link:label>
    <link:label id="lab_clx_FoodProductsMember_documentation_en-US" xlink:label="lab_clx_FoodProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Food Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FoodProductsMember" xlink:href="clx-20220930.xsd#clx_FoodProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_FoodProductsMember" xlink:to="lab_clx_FoodProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_18c8b906-07d5-4bb9-87e9-02944210fcc0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_cc17f2ee-e39d-4277-864d-0c3caa4c59a0_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e0e35d8d-928d-4228-82db-c11bbb691557_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9ae74410-8354-4ff7-809a-7e09549c3eb5_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_742a2b33-13e0-431a-8b13-734c2a3fd619_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_3bc018af-a3aa-4e89-a8d7-4112f8552afa_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_233a6c54-c96f-4e58-a73a-364048820589_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_2dc21047-455d-4f65-93f0-7d1c253fcab0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_0f842f18-e158-4591-8e89-d0c72617e502_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_98f455ef-ce64-4e38-8810-198b1a7e2bf6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_bf2c75a9-36a8-41c3-add8-6cf141fae04f_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_DickinsonCountyMichiganMatterMember_84844d6a-8eec-4f9c-a63e-11d2e2758ea0_terseLabel_en-US" xlink:label="lab_clx_DickinsonCountyMichiganMatterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dickinson County, Michigan Matter</link:label>
    <link:label id="lab_clx_DickinsonCountyMichiganMatterMember_label_en-US" xlink:label="lab_clx_DickinsonCountyMichiganMatterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dickinson County, Michigan Matter [Member]</link:label>
    <link:label id="lab_clx_DickinsonCountyMichiganMatterMember_documentation_en-US" xlink:label="lab_clx_DickinsonCountyMichiganMatterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dickinson County, Michigan Matter [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DickinsonCountyMichiganMatterMember" xlink:href="clx-20220930.xsd#clx_DickinsonCountyMichiganMatterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_DickinsonCountyMichiganMatterMember" xlink:to="lab_clx_DickinsonCountyMichiganMatterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_c3d0e47a-b3b8-4e53-8fc3-676b3dfc3ec0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_d6622e94-0e9f-4349-bd50-02c9ff6b41da_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non controlling interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_a04e6432-8bde-4b1f-9bbc-7531ba2e8acb_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_64d39ef1-c514-4bf7-88ef-93f52aceb6fc_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restructuring and related implementation costs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:to="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_f6742508-6aa0-47e9-a140-073be9d09146_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_94d19256-1134-4c21-b8fa-a02ab7df2083_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_78390dfd-516c-48ab-8d14-9a05508a8a0b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_2d666cdb-39be-4965-83f2-dde2dbcbc5ba_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e0680ca5-308d-4ed7-b3b1-e0da2630b3a8_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of unrecognized items</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_61801edb-4f55-4f16-969f-daa94e7f586e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_ae2fc46a-1c35-4f4b-af7a-bbe92cc3d39c_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_9daf93fa-8c78-45df-8125-1f140d099d46_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_58e3f1df-9a5c-4908-a596-3f6abeb9e07b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials and packaging</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_64c69a26-ed11-41b9-a9eb-b7f4dbe57cf7_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_bc208abe-4603-4fb8-8121-e3d017ce9e23_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_673e3722-7836-4ea0-91e5-242b1a8538ab_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_af067099-bafb-4f00-88a9-eba1f1cba10e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock_55bb5802-3713-4e0d-a7cb-70c45b4371c5_terseLabel_en-US" xlink:label="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock_label_en-US" xlink:label="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Text Block]</link:label>
    <link:label id="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock_documentation_en-US" xlink:label="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for financial instruments and fair value measurements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:href="clx-20220930.xsd#clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:to="lab_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_976d6890-b449-47e4-9522-31c5787f87f3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_169845bc-b979-4b13-bbb0-509330f1662e_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of stock options and other (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_6be5017d-aa80-4f4b-89ad-437d9545a80e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_ed3607c5-e62c-4448-8b32-b903692d9164_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionTypeAxis_ad254a21-f4f0-4d72-bb89-c71b465153f6_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:label id="lab_us-gaap_TransactionTypeAxis_label_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionTypeAxis" xlink:to="lab_us-gaap_TransactionTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d9e5d4c5-41c2-4415-b564-b8a62ee02d1b_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Total comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_2d943604-ea9c-4045-bf9e-14240642c85d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_ee42935b-a0c3-4d59-9ae1-94239c1056cf_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum duration, interest rate contracts (in years)</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time Hedged in Interest Rate Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" xlink:to="lab_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3e62a4a2-a21e-4978-81f5-cd4253942326_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate on earnings from continuing operations</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_1722d755-c508-4883-9794-0eaecd3c758e_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_bb5030be-06b2-4af3-a23b-d93fcf3cf42e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_581d68b3-4338-4ed1-a9dd-3a92ac4b8325_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_188e09a1-4d40-407e-a344-011a1c055371_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, estimated fair value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_15197795-a2e9-492d-bae3-1c36b035dc15_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_05dcf2c4-8c91-4f22-827e-46e736820dc5_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_e687af07-1075-4e8c-96f4-7d16f663029d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_d77b1a08-9d8b-4ea7-880e-322a5232a75e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_4a5f58a1-b8da-4f44-ae08-0160b3e3835d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gains (losses) on derivatives</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_df1a5b98-bed2-4bd4-a11c-9e852ab500a8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_f629d35e-7864-45c2-80c3-d16a21acfc88_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2e897922-a660-4b98-a59d-5803adf94d55_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_b53e444a-4ae9-4390-a4d8-e06822695f1a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_f5a5ca3c-810d-4d00-88d4-a684e60adcfc_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsDomain_cc411772-09ac-4872-a3b5-1e6943eee1b2_terseLabel_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Domain]</link:label>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsDomain_label_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Domain]</link:label>
    <link:label id="lab_clx_CommodityPurchaseDerivativeContractsDomain_documentation_en-US" xlink:label="lab_clx_CommodityPurchaseDerivativeContractsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Purchase Derivative Contracts [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsDomain" xlink:href="clx-20220930.xsd#clx_CommodityPurchaseDerivativeContractsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsDomain" xlink:to="lab_clx_CommodityPurchaseDerivativeContractsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_e8f1f120-0a5c-47c1-85fa-087894a02bb8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_18ac045d-6e12-4e69-9031-f0fde844053f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_e31f839d-af61-4e80-8640-4fd8dab0cbdd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_066090c2-d7e0-4499-8119-c571e3535afd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_88fd4205-c925-4d2c-8cd8-0ef5943b7fea_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from Accumulated other comprehensive net (loss) income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_84b9275f-938a-4c6f-bae7-31de65b64c63_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive net (loss) income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_0aef00e6-4f6d-4c1c-bc16-e8431b4129c7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_2798c6f0-7554-4987-b623-20b9fa60f948_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_1e40dbe0-ed73-450f-b2e0-882b5c306277_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ff9915d8-b2a4-4262-ab2d-942e5fd7e788_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefit adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_264710a5-8a5f-4d72-b16d-7e7e879040fe_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable / prepaid</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesAmount_52420f7a-5b15-4151-afc6-9c023bf4223e_terseLabel_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other employee stock plan activities</link:label>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesAmount_label_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Employee Stock Plan Activities, Amount</link:label>
    <link:label id="lab_clx_OtherEmployeeStockPlanActivitiesAmount_documentation_en-US" xlink:label="lab_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount includes the value of stock granted during the period as a result of exercises of employee stock options or vesting of other share-based awards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:href="clx-20220930.xsd#clx_OtherEmployeeStockPlanActivitiesAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:to="lab_clx_OtherEmployeeStockPlanActivitiesAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_8560a019-d6f1-4649-b5a7-ae8553644135_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_b7a1e7b6-5cbf-4de4-bfa7-fa5f0930d68a_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_OtherExpenseIncomeNet_474413f1-727b-4596-9161-8eda9973776d_terseLabel_en-US" xlink:label="lab_clx_OtherExpenseIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_clx_OtherExpenseIncomeNet_label_en-US" xlink:label="lab_clx_OtherExpenseIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense (Income), Net</link:label>
    <link:label id="lab_clx_OtherExpenseIncomeNet_documentation_en-US" xlink:label="lab_clx_OtherExpenseIncomeNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net amount of other income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherExpenseIncomeNet" xlink:href="clx-20220930.xsd#clx_OtherExpenseIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_OtherExpenseIncomeNet" xlink:to="lab_clx_OtherExpenseIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_1299327c-b939-45f9-8a55-b7af2ee08e47_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_1e6bc480-5333-446b-b0c0-c79ab3c11fc5_terseLabel_en-US" xlink:label="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</link:label>
    <link:label id="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_label_en-US" xlink:label="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</link:label>
    <link:label id="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_documentation_en-US" xlink:label="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments and Fair Value Measurements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:href="clx-20220930.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="lab_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_WaterFiltrationMember_75423048-b895-45c9-a05e-0e0d8a754866_terseLabel_en-US" xlink:label="lab_clx_WaterFiltrationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Water Filtration</link:label>
    <link:label id="lab_clx_WaterFiltrationMember_label_en-US" xlink:label="lab_clx_WaterFiltrationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Water Filtration [Member]</link:label>
    <link:label id="lab_clx_WaterFiltrationMember_documentation_en-US" xlink:label="lab_clx_WaterFiltrationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Water Filtration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WaterFiltrationMember" xlink:href="clx-20220930.xsd#clx_WaterFiltrationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_WaterFiltrationMember" xlink:to="lab_clx_WaterFiltrationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_c324b171-cb76-43f3-a6ba-f16d127f6365_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Clorox stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f5bd978c-5a1b-4a55-9d5a-1f7365d41ea3_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f5b84ae5-caa1-4fb5-a831-74f189b2cab4_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, ending</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_MaximumExposureUndiscountedCost_c67a43c6-1fe6-47bf-a3ea-334a3faa9d7c_terseLabel_en-US" xlink:label="lab_clx_MaximumExposureUndiscountedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum undiscounted costs</link:label>
    <link:label id="lab_clx_MaximumExposureUndiscountedCost_label_en-US" xlink:label="lab_clx_MaximumExposureUndiscountedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Exposure, Undiscounted Cost</link:label>
    <link:label id="lab_clx_MaximumExposureUndiscountedCost_documentation_en-US" xlink:label="lab_clx_MaximumExposureUndiscountedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum potential amount of future payments (undiscounted) that the Company could incur over an estimated remediation period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_MaximumExposureUndiscountedCost" xlink:href="clx-20220930.xsd#clx_MaximumExposureUndiscountedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_MaximumExposureUndiscountedCost" xlink:to="lab_clx_MaximumExposureUndiscountedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_895347f8-919d-46be-b98f-9c610e393370_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and loans payable, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_NaturalPersonalCareMember_535a86c9-1e7d-4023-9f34-ff3c24364b7a_terseLabel_en-US" xlink:label="lab_clx_NaturalPersonalCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natural Personal Care</link:label>
    <link:label id="lab_clx_NaturalPersonalCareMember_label_en-US" xlink:label="lab_clx_NaturalPersonalCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natural Personal Care [Member]</link:label>
    <link:label id="lab_clx_NaturalPersonalCareMember_documentation_en-US" xlink:label="lab_clx_NaturalPersonalCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natural Personal Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NaturalPersonalCareMember" xlink:href="clx-20220930.xsd#clx_NaturalPersonalCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_NaturalPersonalCareMember" xlink:to="lab_clx_NaturalPersonalCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_f83703f0-e66c-4292-848a-9a8de95ab3f8_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShorttermDebtFairValue_34186d62-40ba-413f-9373-06c411a4d442_terseLabel_en-US" xlink:label="lab_us-gaap_ShorttermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and loans payable, estimated fair value</link:label>
    <link:label id="lab_us-gaap_ShorttermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_ShorttermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShorttermDebtFairValue" xlink:to="lab_us-gaap_ShorttermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_ff2e2178-e3a4-49d4-a951-dae641105be4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_2ca8e886-d342-4bc7-9c18-9fabecff4ce5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_8efeecf7-8f7b-40ce-874a-81364edd2ae6_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_9ff64a41-b61b-4ae3-994a-7db721d7e015_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNoncurrent_f5142f98-dddc-4205-91a3-5439de1eddcd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Noncurrent inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNoncurrent_label_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNoncurrent" xlink:to="lab_us-gaap_InventoryNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_58687cc9-3302-45be-b854-bf6dbf22b2d6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_541bb7e8-cdd2-4680-bc54-e831eafecdf9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORIES, NET</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_035dfe12-5a95-48e7-a43c-3ddf1665f0b5_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_0363ac86-c8b0-4e1e-846d-c6c060778a46_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest-bearing investments, including money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a2ecbc43-6c6d-4ccf-962d-1d83246124d6_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_3a301b00-c84a-4c1f-b9c2-78859b616a7f_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum duration, foreign exchange contracts (in years)</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time, Foreign Currency Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:to="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_cdbc74e7-1147-41fe-8a68-f0942eb4d4c2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_18c65422-6933-4067-8b6d-077ff157d864_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_22eb90fa-414f-4da4-b4b7-a854f1bcf88a_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_878b5a1b-7de2-4331-a91c-725ee562a9c5_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_CostOfGoodsAndServicesSoldMember_b5f8f186-c5e5-4a5b-b79d-2b646e6d05af_terseLabel_en-US" xlink:label="lab_clx_CostOfGoodsAndServicesSoldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs of products sold</link:label>
    <link:label id="lab_clx_CostOfGoodsAndServicesSoldMember_label_en-US" xlink:label="lab_clx_CostOfGoodsAndServicesSoldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold [Member]</link:label>
    <link:label id="lab_clx_CostOfGoodsAndServicesSoldMember_documentation_en-US" xlink:label="lab_clx_CostOfGoodsAndServicesSoldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CostOfGoodsAndServicesSoldMember" xlink:href="clx-20220930.xsd#clx_CostOfGoodsAndServicesSoldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_CostOfGoodsAndServicesSoldMember" xlink:to="lab_clx_CostOfGoodsAndServicesSoldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_d9faf171-902d-42d4-95dc-4bc379d5655d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_fe506ac9-d3a8-4c76-b392-92818c419c21_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReserve_91c8db65-8c14-403d-9e22-60559cc6fcde_negatedLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIFO allowances</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReserve_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReserve" xlink:to="lab_us-gaap_InventoryLIFOReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_17915ce5-720f-4a79-b008-5d7332c72f5d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_1acc51f7-c0c8-4967-b77d-4a56ae1591a1_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Liabilities</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_d1ed72c5-687c-4310-a87d-b64bcab3301e_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_532dea5f-9a29-432b-b17d-fd0d1ad90841_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock purchased</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaper_a5664d8d-b53a-42a5-95f5-f1b1a723fd13_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and loans payable</link:label>
    <link:label id="lab_us-gaap_CommercialPaper_label_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaper" xlink:to="lab_us-gaap_CommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_505f2546-2c5a-4d3b-b017-448a56150071_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_a25f4fe5-6c59-4331-9127-6f40c4082719_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_HealthAndWellnessMember_60b77881-1b59-4e84-aa99-b6c965747696_terseLabel_en-US" xlink:label="lab_clx_HealthAndWellnessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health and Wellness</link:label>
    <link:label id="lab_clx_HealthAndWellnessMember_label_en-US" xlink:label="lab_clx_HealthAndWellnessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health and Wellness [Member]</link:label>
    <link:label id="lab_clx_HealthAndWellnessMember_documentation_en-US" xlink:label="lab_clx_HealthAndWellnessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health and Wellness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember" xlink:href="clx-20220930.xsd#clx_HealthAndWellnessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_HealthAndWellnessMember" xlink:to="lab_clx_HealthAndWellnessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_0195f4c7-dada-4129-a2c1-6dbd42a0e8e3_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_f47daa8a-f9bd-4086-8c42-132e80b6ed81_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_cf734102-e3f5-46c9-b9a9-8f63498a0b1f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_6b9f7d62-ab60-4770-9296-4b6499591dfa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_31295816-dd88-4e61-91c4-4e05e65101bf_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_871af698-5413-44f2-a9e5-8b1cc594ab61_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock purchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f6e70546-1a86-4f14-8a0e-b028f90269c4_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_fd828862-4f9b-4a3a-9f51-cda377cfe4d4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_58bd887c-92aa-4c58-a1b8-a3342fdc89fa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_19ab9841-0dd2-42af-be45-09f22be4fe92_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_119ad967-8edc-452b-a479-733ef6a5d4d7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsNet" xlink:to="lab_us-gaap_OtherIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_ea91b6f7-bb37-428f-916e-8728c8751600_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_41db9e75-199a-4f6e-90bc-e0095af26cb8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_7f3ec7b5-9aa0-4bce-a870-3beeea76c3cb_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_e1610495-35d2-4a8e-be47-4afed0214f2c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_8548c566-38a7-4d31-a293-494d14230b6a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Results</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_ae866a0d-4f71-4c88-9c2d-5fefaed82e82_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_55cefef4-b018-4783-bfd2-7513b72fd277_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ed2d2ed2-580a-4308-be38-a149150485f9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a4576ffd-42e4-40ff-a242-0f2c09de4ab0_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_df4b5927-5ccd-4738-b8ef-1ad872f7d6f0_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_3309e08f-dcaf-49fd-a923-6f9828691382_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_662d1560-d5c1-474b-93e5-b168ecd7576a_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_abd58106-1f9a-40e2-a45b-567a2057a550_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_950797b7-5e92-43d2-add5-59002708d9c6_terseLabel_en-US" xlink:label="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for employee stock plans and other</link:label>
    <link:label id="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_label_en-US" xlink:label="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance Of Common Stock For Employee Stock Plans And Other</link:label>
    <link:label id="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_documentation_en-US" xlink:label="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash inflow associated with the amount received from holders exercising their stock options. Also includes the net cash inflow (outflow) from other financing activities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:href="clx-20220930.xsd#clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:to="lab_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_f0739b9a-e234-440b-9861-e39098294035_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_CatLitterMember_ca4ea181-cf8a-47f8-9011-c90d9ec60ee9_terseLabel_en-US" xlink:label="lab_clx_CatLitterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cat Litter</link:label>
    <link:label id="lab_clx_CatLitterMember_label_en-US" xlink:label="lab_clx_CatLitterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cat Litter [Member]</link:label>
    <link:label id="lab_clx_CatLitterMember_documentation_en-US" xlink:label="lab_clx_CatLitterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cat Litter [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CatLitterMember" xlink:href="clx-20220930.xsd#clx_CatLitterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_CatLitterMember" xlink:to="lab_clx_CatLitterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_04c47f68-1402-4c56-8a60-3e6bb98f7dbe_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_294d23fb-3810-4631-b17e-1437a4dad5b5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_1b917650-56a6-46ad-93ad-100ec4909ce8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c40ce5f4-a137-414b-8fe0-c8c949d693ee_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Net (Loss) Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_85b58d83-9f6e-49c6-8e20-8331819014f7_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive net (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_8e05e220-4126-463f-ac4f-6f4c91fab273_totalLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, estimated fair value</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_6f57fa87-327f-4ba2-9025-da6a73037dcf_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_8c0fbbd1-6079-4b53-a525-0c6425dfa721_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_4e7dc15f-418d-4249-8fd5-057689420fbf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_WalmartStoresIncMember_fc7eb844-4ed1-4d1e-a82d-4d70dfa0bed6_terseLabel_en-US" xlink:label="lab_clx_WalmartStoresIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart Stores, Inc.</link:label>
    <link:label id="lab_clx_WalmartStoresIncMember_label_en-US" xlink:label="lab_clx_WalmartStoresIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart Stores, Inc. [Member]</link:label>
    <link:label id="lab_clx_WalmartStoresIncMember_documentation_en-US" xlink:label="lab_clx_WalmartStoresIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart Stores, Inc. and its affiliates [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WalmartStoresIncMember" xlink:href="clx-20220930.xsd#clx_WalmartStoresIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_WalmartStoresIncMember" xlink:to="lab_clx_WalmartStoresIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_cb95685b-3e7a-4938-8730-59e8eab46771_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate derivative contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_4e2a602f-159e-4736-83a9-e184134e6c39_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_8f19050f-3047-4490-bffe-88d7823cf4a8_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_NotesAndLoansPayableMember_0d11abd6-6c79-452f-bc2a-867cf5f4e18e_terseLabel_en-US" xlink:label="lab_clx_NotesAndLoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and loans payable</link:label>
    <link:label id="lab_clx_NotesAndLoansPayableMember_label_en-US" xlink:label="lab_clx_NotesAndLoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes And Loans Payable [Member]</link:label>
    <link:label id="lab_clx_NotesAndLoansPayableMember_documentation_en-US" xlink:label="lab_clx_NotesAndLoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NotesAndLoansPayableMember" xlink:href="clx-20220930.xsd#clx_NotesAndLoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_NotesAndLoansPayableMember" xlink:to="lab_clx_NotesAndLoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_75d5b64d-0367-4b2a-9786-ec24a53c7b8b_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0bcff9c2-65c8-41ef-9592-58ab7d81bbf9_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_03f77776-8ee6-4469-bf2c-c3b1f277c940_terseLabel_en-US" xlink:label="lab_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Foreign Currency Balance, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_label_en-US" xlink:label="lab_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Foreign Currency Balance, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:to="lab_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_922ff8ee-7610-4a49-ac4c-8926e21aaf6b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0442d35d-d21b-4862-b6a1-a569f5161dff_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_OtherIncomeExpenseNetMember_5e099014-e71b-499c-82c6-f9b7d2b90bad_terseLabel_en-US" xlink:label="lab_clx_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_clx_OtherIncomeExpenseNetMember_label_en-US" xlink:label="lab_clx_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense), Net [Member]</link:label>
    <link:label id="lab_clx_OtherIncomeExpenseNetMember_documentation_en-US" xlink:label="lab_clx_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherIncomeExpenseNetMember" xlink:href="clx-20220930.xsd#clx_OtherIncomeExpenseNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_OtherIncomeExpenseNetMember" xlink:to="lab_clx_OtherIncomeExpenseNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_1c512a34-9c2a-482b-b87a-540d9e903475_terseLabel_en-US" xlink:label="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments subject to contractually defined counterparty liability position limits</link:label>
    <link:label id="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_label_en-US" xlink:label="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Subject To Contractually Defined Counterparty Liability Position Limits</link:label>
    <link:label id="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_documentation_en-US" xlink:label="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments subject to contractually defined counterparty liability position limits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:href="clx-20220930.xsd#clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:to="lab_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_eb912e8a-de29-4268-94f5-2dccae736439_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_927d1d7e-caef-4a06-a4e8-30cc80094aff_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_82d6bb25-27d4-4dcf-98e0-936985bac60a_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_51d9ef3e-93fc-44d8-a4e5-e83a7474940d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_e3795332-88ca-43c4-baba-08813f8131ca_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_7ff20daf-8887-4af2-9501-b4caf61606db_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_7e025a02-6081-457f-847c-861cbbfe116d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>clx-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:705545e2-87bd-4296-a317-b2dac9e841f3,g:2063eff2-ec82-44e0-90e5-b1eb8fc3164f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.clorox.com/role/CoverPage" xlink:type="simple" xlink:href="clx-20220930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1164a794-25e8-4a71-9e2a-262b91d5894e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_DocumentType_1164a794-25e8-4a71-9e2a-262b91d5894e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_51ddb242-31e3-42ce-9c1a-a8002c5a666f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_DocumentQuarterlyReport_51ddb242-31e3-42ce-9c1a-a8002c5a666f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8e36bfb5-c657-4831-9743-22c0d17c3bec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_DocumentPeriodEndDate_8e36bfb5-c657-4831-9743-22c0d17c3bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_653f5193-418b-41c4-98c3-4a47e1afcabe" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_DocumentTransitionReport_653f5193-418b-41c4-98c3-4a47e1afcabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_f25eab51-5bbd-45d2-8d5c-61bbb9bdd9f5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_EntityFileNumber_f25eab51-5bbd-45d2-8d5c-61bbb9bdd9f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a8617cf0-7151-4109-9ee1-9614231cb035" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_EntityRegistrantName_a8617cf0-7151-4109-9ee1-9614231cb035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_01e60734-d9e3-4e95-945e-025246f4ba5d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_EntityIncorporationStateCountryCode_01e60734-d9e3-4e95-945e-025246f4ba5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_7ad6bc68-fd10-47c8-b801-11350fe346ad" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_EntityTaxIdentificationNumber_7ad6bc68-fd10-47c8-b801-11350fe346ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_5428fa7a-358c-4de5-80bb-89ec33ab6072" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_EntityAddressAddressLine1_5428fa7a-358c-4de5-80bb-89ec33ab6072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_5198c579-6e97-460c-9914-d4e805a7d55e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_EntityAddressCityOrTown_5198c579-6e97-460c-9914-d4e805a7d55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_3ee89946-a4c0-4996-9e5b-12eaf1e9b4dd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_EntityAddressStateOrProvince_3ee89946-a4c0-4996-9e5b-12eaf1e9b4dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9db3721f-5aeb-4df8-947b-3570f744ea19" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_EntityAddressPostalZipCode_9db3721f-5aeb-4df8-947b-3570f744ea19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_64760067-aeb5-4ef3-b3ce-02c57c6a9343" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_CityAreaCode_64760067-aeb5-4ef3-b3ce-02c57c6a9343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ceafb42a-ed00-4a01-a11c-203baeb21cde" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_LocalPhoneNumber_ceafb42a-ed00-4a01-a11c-203baeb21cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4b580459-17f0-49c4-b836-f444f6718a12" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_Security12bTitle_4b580459-17f0-49c4-b836-f444f6718a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a91a6390-3a2d-40d1-a461-37cd7a9dc419" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_TradingSymbol_a91a6390-3a2d-40d1-a461-37cd7a9dc419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_5c93dc09-353a-4aef-921f-8b3aab07805a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_SecurityExchangeName_5c93dc09-353a-4aef-921f-8b3aab07805a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_b6379822-0487-4c5c-a124-f7b447648764" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_EntityCurrentReportingStatus_b6379822-0487-4c5c-a124-f7b447648764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_175d0044-f1f0-4e19-b91b-557763338ff6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_EntityInteractiveDataCurrent_175d0044-f1f0-4e19-b91b-557763338ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_2dd4c7ae-3f55-487e-9fc4-8f5dda6ea770" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_EntityFilerCategory_2dd4c7ae-3f55-487e-9fc4-8f5dda6ea770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_af57b70c-f5e4-4a4b-b031-9b5eb5c350e2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_EntitySmallBusiness_af57b70c-f5e4-4a4b-b031-9b5eb5c350e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e0308e4a-7982-4d34-8c72-8e087c0b27f5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_EntityEmergingGrowthCompany_e0308e4a-7982-4d34-8c72-8e087c0b27f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_c1c679a0-a63f-47e5-8ab1-a928ae236414" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_EntityShellCompany_c1c679a0-a63f-47e5-8ab1-a928ae236414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_437b67e4-2a22-45b0-9b75-5811642b8bea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_437b67e4-2a22-45b0-9b75-5811642b8bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_ada740d1-c09f-43ed-b20c-9beb352da050" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_EntityCentralIndexKey_ada740d1-c09f-43ed-b20c-9beb352da050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f3a232fd-a272-4c19-a86e-6ad2ec640cdf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_AmendmentFlag_f3a232fd-a272-4c19-a86e-6ad2ec640cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c9e2ebb3-b823-4cdc-9040-4f7a47405757" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_CurrentFiscalYearEndDate_c9e2ebb3-b823-4cdc-9040-4f7a47405757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_75b2b4c8-dab1-48d8-a4a3-750625c07e65" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_DocumentFiscalPeriodFocus_75b2b4c8-dab1-48d8-a4a3-750625c07e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_a6567cbc-c51b-4cf0-a083-18374dc60f68" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95e6e205-0de5-421c-b16e-0909020e37fb" xlink:to="loc_dei_DocumentFiscalYearFocus_a6567cbc-c51b-4cf0-a083-18374dc60f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="clx-20220930.xsd#CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b351d9cf-3b57-4b5a-bed7-2a9dd87644b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b351d9cf-3b57-4b5a-bed7-2a9dd87644b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_8200ad5f-1ffb-44ab-84dc-1c0d7d568f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_8200ad5f-1ffb-44ab-84dc-1c0d7d568f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_87b3069b-4512-42a4-b29f-62fa1f5f798d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_us-gaap_GrossProfit_87b3069b-4512-42a4-b29f-62fa1f5f798d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7d36c8bf-4194-4618-b633-b31427167bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7d36c8bf-4194-4618-b633-b31427167bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_15ef2601-60d4-4d4d-bcef-b3bcdacc1cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_us-gaap_AdvertisingExpense_15ef2601-60d4-4d4d-bcef-b3bcdacc1cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_5cd6b8ab-c220-4f1d-960d-fad863bee7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_5cd6b8ab-c220-4f1d-960d-fad863bee7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_dd4ba2cf-6b3c-43da-9912-e0d650c34dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_us-gaap_InterestExpense_dd4ba2cf-6b3c-43da-9912-e0d650c34dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherExpenseIncomeNet_f4d57dc9-8de4-4b49-ae85-132d1f7ac50d" xlink:href="clx-20220930.xsd#clx_OtherExpenseIncomeNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_clx_OtherExpenseIncomeNet_f4d57dc9-8de4-4b49-ae85-132d1f7ac50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c2549e6d-8109-43fb-9e87-70283f55010d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c2549e6d-8109-43fb-9e87-70283f55010d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0b05e70c-1d1d-4d1c-ab97-fcd06c2563b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0b05e70c-1d1d-4d1c-ab97-fcd06c2563b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ed6efba5-e81b-49e3-8e44-44e71c844832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_us-gaap_ProfitLoss_ed6efba5-e81b-49e3-8e44-44e71c844832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_bb73e959-aadb-4758-8275-7669e00c8b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_bb73e959-aadb-4758-8275-7669e00c8b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_74d0ec70-1e41-4e0f-9d60-ba442002d0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_us-gaap_NetIncomeLoss_74d0ec70-1e41-4e0f-9d60-ba442002d0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c982e0f7-ec4d-4dee-9584-72c384230c47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_us-gaap_EarningsPerShareAbstract_c982e0f7-ec4d-4dee-9584-72c384230c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_9e5e4377-bf9f-4887-92d8-7af32c0e9bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c982e0f7-ec4d-4dee-9584-72c384230c47" xlink:to="loc_us-gaap_EarningsPerShareBasic_9e5e4377-bf9f-4887-92d8-7af32c0e9bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e370aaa4-3fe3-4d98-b611-38c5a96321b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c982e0f7-ec4d-4dee-9584-72c384230c47" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e370aaa4-3fe3-4d98-b611-38c5a96321b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b5c97223-3ffe-4627-92ad-e6d5d582d80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b5c97223-3ffe-4627-92ad-e6d5d582d80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3c09beaf-b5cc-49f4-99d9-d36d9c4aac42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b5c97223-3ffe-4627-92ad-e6d5d582d80b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3c09beaf-b5cc-49f4-99d9-d36d9c4aac42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_521c3b38-92a0-4349-9165-bad30bf8e33e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b5c97223-3ffe-4627-92ad-e6d5d582d80b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_521c3b38-92a0-4349-9165-bad30bf8e33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_cacb57e4-9d38-46d0-bdd5-01a29c900efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_cacb57e4-9d38-46d0-bdd5-01a29c900efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_6266b781-ad9c-48cf-8c7f-266d03aa0bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_6266b781-ad9c-48cf-8c7f-266d03aa0bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ea3edb41-6ab7-4090-9f9f-665c6e0533b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2f9c2fa1-7381-46b0-a74a-db60d3b8ce56" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_ea3edb41-6ab7-4090-9f9f-665c6e0533b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="clx-20220930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_837694e4-2e63-4e96-8df3-ff71d5200c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4cab4ebc-3f7e-4554-a0c2-5a12fadac0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_837694e4-2e63-4e96-8df3-ff71d5200c4c" xlink:to="loc_us-gaap_AssetsAbstract_4cab4ebc-3f7e-4554-a0c2-5a12fadac0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_9d17c9b9-0972-4489-8f4b-f0124264fa77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4cab4ebc-3f7e-4554-a0c2-5a12fadac0f6" xlink:to="loc_us-gaap_AssetsCurrentAbstract_9d17c9b9-0972-4489-8f4b-f0124264fa77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_366db443-c1b1-4a50-9057-405baea04134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d17c9b9-0972-4489-8f4b-f0124264fa77" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_366db443-c1b1-4a50-9057-405baea04134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_20690676-18b2-4916-830b-4158dbccb502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d17c9b9-0972-4489-8f4b-f0124264fa77" xlink:to="loc_us-gaap_ReceivablesNetCurrent_20690676-18b2-4916-830b-4158dbccb502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_584be450-4ad7-4e5d-9f0e-a6d8f7e8adee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d17c9b9-0972-4489-8f4b-f0124264fa77" xlink:to="loc_us-gaap_InventoryNet_584be450-4ad7-4e5d-9f0e-a6d8f7e8adee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3ef68c71-17c0-4cfa-95d3-1f320a358ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d17c9b9-0972-4489-8f4b-f0124264fa77" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3ef68c71-17c0-4cfa-95d3-1f320a358ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5315be3f-35dd-4532-800c-d68dcc5102e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d17c9b9-0972-4489-8f4b-f0124264fa77" xlink:to="loc_us-gaap_AssetsCurrent_5315be3f-35dd-4532-800c-d68dcc5102e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_563e080e-6f3e-4342-a343-5973d9c2a01c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4cab4ebc-3f7e-4554-a0c2-5a12fadac0f6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_563e080e-6f3e-4342-a343-5973d9c2a01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e0e12c36-b52c-4e14-b8a5-4360414489cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4cab4ebc-3f7e-4554-a0c2-5a12fadac0f6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e0e12c36-b52c-4e14-b8a5-4360414489cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9c86cace-7d82-40b0-be83-03c53c0d24e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4cab4ebc-3f7e-4554-a0c2-5a12fadac0f6" xlink:to="loc_us-gaap_Goodwill_9c86cace-7d82-40b0-be83-03c53c0d24e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrademarksNet_d2a79bad-af64-4e4e-9095-3d86c8309c24" xlink:href="clx-20220930.xsd#clx_TrademarksNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4cab4ebc-3f7e-4554-a0c2-5a12fadac0f6" xlink:to="loc_clx_TrademarksNet_d2a79bad-af64-4e4e-9095-3d86c8309c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_605debd3-a8fe-4e1b-940b-e3071d00c5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4cab4ebc-3f7e-4554-a0c2-5a12fadac0f6" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_605debd3-a8fe-4e1b-940b-e3071d00c5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8ab6b9f5-f591-4328-b802-877fd350ceba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4cab4ebc-3f7e-4554-a0c2-5a12fadac0f6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8ab6b9f5-f591-4328-b802-877fd350ceba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d51ca02d-d3ff-4144-b9d9-1d15d7d1b8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4cab4ebc-3f7e-4554-a0c2-5a12fadac0f6" xlink:to="loc_us-gaap_Assets_d51ca02d-d3ff-4144-b9d9-1d15d7d1b8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0d062123-d1d2-4dab-ad8e-18e55f018cad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_837694e4-2e63-4e96-8df3-ff71d5200c4c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0d062123-d1d2-4dab-ad8e-18e55f018cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_ed563907-dc85-467f-bcb4-bb4223725875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0d062123-d1d2-4dab-ad8e-18e55f018cad" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_ed563907-dc85-467f-bcb4-bb4223725875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_e51d149a-18c5-4e5d-a8bd-1730b622f48a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ed563907-dc85-467f-bcb4-bb4223725875" xlink:to="loc_us-gaap_CommercialPaper_e51d149a-18c5-4e5d-a8bd-1730b622f48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_95d0079c-6900-4078-bc7d-e1bd1036d085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ed563907-dc85-467f-bcb4-bb4223725875" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_95d0079c-6900-4078-bc7d-e1bd1036d085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_8c904579-6ffe-4f96-93a1-e2adaf6c0bec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ed563907-dc85-467f-bcb4-bb4223725875" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_8c904579-6ffe-4f96-93a1-e2adaf6c0bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a29db556-60b7-4fbb-84ad-c07d8c2d756d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ed563907-dc85-467f-bcb4-bb4223725875" xlink:to="loc_us-gaap_LiabilitiesCurrent_a29db556-60b7-4fbb-84ad-c07d8c2d756d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c6914ea9-88ae-44c7-a6c4-85ca351fe0ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0d062123-d1d2-4dab-ad8e-18e55f018cad" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c6914ea9-88ae-44c7-a6c4-85ca351fe0ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_890be98a-8a2c-4045-b303-c6789a0a72a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0d062123-d1d2-4dab-ad8e-18e55f018cad" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_890be98a-8a2c-4045-b303-c6789a0a72a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7750de47-a342-47b7-8dc5-b21d561c3e52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0d062123-d1d2-4dab-ad8e-18e55f018cad" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7750de47-a342-47b7-8dc5-b21d561c3e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_200e2e62-8628-4537-bb1d-ca0b7de465ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0d062123-d1d2-4dab-ad8e-18e55f018cad" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_200e2e62-8628-4537-bb1d-ca0b7de465ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_daa44a51-0f2b-4a36-b548-2f270586d11a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0d062123-d1d2-4dab-ad8e-18e55f018cad" xlink:to="loc_us-gaap_Liabilities_daa44a51-0f2b-4a36-b548-2f270586d11a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_25699ad0-84c3-4afe-8b59-fdc917563dba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0d062123-d1d2-4dab-ad8e-18e55f018cad" xlink:to="loc_us-gaap_CommitmentsAndContingencies_25699ad0-84c3-4afe-8b59-fdc917563dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_7884bfb9-6454-49f7-9a88-d7628dbe8702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0d062123-d1d2-4dab-ad8e-18e55f018cad" xlink:to="loc_us-gaap_StockholdersEquityAbstract_7884bfb9-6454-49f7-9a88-d7628dbe8702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_30104e57-d8e5-4dc9-a7ca-32d3e0f565d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7884bfb9-6454-49f7-9a88-d7628dbe8702" xlink:to="loc_us-gaap_PreferredStockValue_30104e57-d8e5-4dc9-a7ca-32d3e0f565d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_1e5440ec-8c1f-43e0-b6d4-f84321b11937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7884bfb9-6454-49f7-9a88-d7628dbe8702" xlink:to="loc_us-gaap_CommonStockValue_1e5440ec-8c1f-43e0-b6d4-f84321b11937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_64c2a35d-aed9-4965-bd97-bb2f8cb57a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7884bfb9-6454-49f7-9a88-d7628dbe8702" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_64c2a35d-aed9-4965-bd97-bb2f8cb57a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_03deb588-edb4-40bb-aa72-14ba2bffb171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7884bfb9-6454-49f7-9a88-d7628dbe8702" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_03deb588-edb4-40bb-aa72-14ba2bffb171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_92ac7760-e653-4e98-bc16-9ece4cf602ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7884bfb9-6454-49f7-9a88-d7628dbe8702" xlink:to="loc_us-gaap_TreasuryStockValue_92ac7760-e653-4e98-bc16-9ece4cf602ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e9918c0c-e6f7-4e0e-8cb7-5de158c0acc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7884bfb9-6454-49f7-9a88-d7628dbe8702" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e9918c0c-e6f7-4e0e-8cb7-5de158c0acc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2c033175-643e-4b55-911b-50e6d064f87c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7884bfb9-6454-49f7-9a88-d7628dbe8702" xlink:to="loc_us-gaap_StockholdersEquity_2c033175-643e-4b55-911b-50e6d064f87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_044d6189-4a79-4c6f-8e82-08b02cfccb17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7884bfb9-6454-49f7-9a88-d7628dbe8702" xlink:to="loc_us-gaap_MinorityInterest_044d6189-4a79-4c6f-8e82-08b02cfccb17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70415501-7f84-4408-a055-b496d2032d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_7884bfb9-6454-49f7-9a88-d7628dbe8702" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70415501-7f84-4408-a055-b496d2032d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7230e528-ccd6-4a11-a1f5-5d0f48652c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0d062123-d1d2-4dab-ad8e-18e55f018cad" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_7230e528-ccd6-4a11-a1f5-5d0f48652c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="clx-20220930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_1d865ac6-9327-4e51-98a1-2da424014e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4e653a72-d445-41cf-886e-57fd559be583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d865ac6-9327-4e51-98a1-2da424014e90" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4e653a72-d445-41cf-886e-57fd559be583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_d54b2341-937a-40c9-a758-95233c71733b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d865ac6-9327-4e51-98a1-2da424014e90" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_d54b2341-937a-40c9-a758-95233c71733b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_3d880207-4159-4802-b9e9-4ada83b582a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d865ac6-9327-4e51-98a1-2da424014e90" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_3d880207-4159-4802-b9e9-4ada83b582a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_dc9a64cf-0c92-4302-8d07-89e0fb2e79ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d865ac6-9327-4e51-98a1-2da424014e90" xlink:to="loc_us-gaap_PreferredStockSharesIssued_dc9a64cf-0c92-4302-8d07-89e0fb2e79ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_7c5815f9-452a-4a45-8940-bb7d17b6fed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d865ac6-9327-4e51-98a1-2da424014e90" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_7c5815f9-452a-4a45-8940-bb7d17b6fed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d67414e5-349b-426b-b566-5d476a844ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d865ac6-9327-4e51-98a1-2da424014e90" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d67414e5-349b-426b-b566-5d476a844ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4b881343-1240-427d-8934-95ad53776e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d865ac6-9327-4e51-98a1-2da424014e90" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4b881343-1240-427d-8934-95ad53776e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_0fca1ba9-9a49-4e1b-936c-2d6015fc98f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d865ac6-9327-4e51-98a1-2da424014e90" xlink:to="loc_us-gaap_CommonStockSharesIssued_0fca1ba9-9a49-4e1b-936c-2d6015fc98f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7bddc803-e164-426a-b92d-767822f15325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d865ac6-9327-4e51-98a1-2da424014e90" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_7bddc803-e164-426a-b92d-767822f15325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_2c38c5ff-2c44-4ba7-b37e-fa28d4f2464b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d865ac6-9327-4e51-98a1-2da424014e90" xlink:to="loc_us-gaap_TreasuryStockCommonShares_2c38c5ff-2c44-4ba7-b37e-fa28d4f2464b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="clx-20220930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_1d799473-8736-4302-a035-62b4a2e1a5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d5c728a7-4a63-4385-a611-2ffdabd2ce94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1d799473-8736-4302-a035-62b4a2e1a5f9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d5c728a7-4a63-4385-a611-2ffdabd2ce94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4aa8742b-01ee-419a-a2fb-1eb361cc9c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d5c728a7-4a63-4385-a611-2ffdabd2ce94" xlink:to="loc_us-gaap_ProfitLoss_4aa8742b-01ee-419a-a2fb-1eb361cc9c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_87ec7106-8012-4788-a6b3-ec08e7df3797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d5c728a7-4a63-4385-a611-2ffdabd2ce94" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_87ec7106-8012-4788-a6b3-ec08e7df3797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_bf27f561-0a4e-4eaa-bc79-8739c326d159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_87ec7106-8012-4788-a6b3-ec08e7df3797" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_bf27f561-0a4e-4eaa-bc79-8739c326d159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5ae3ddc5-7d76-465f-9036-7283bb5a2db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_87ec7106-8012-4788-a6b3-ec08e7df3797" xlink:to="loc_us-gaap_ShareBasedCompensation_5ae3ddc5-7d76-465f-9036-7283bb5a2db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_af8e47a3-e00c-4cbf-87f2-c745fae70a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_87ec7106-8012-4788-a6b3-ec08e7df3797" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_af8e47a3-e00c-4cbf-87f2-c745fae70a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_88e7e70a-1be1-4e00-9775-7b0376aa16e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_87ec7106-8012-4788-a6b3-ec08e7df3797" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_88e7e70a-1be1-4e00-9775-7b0376aa16e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5b6bc314-86e9-4962-b2c9-4e229b2d9ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_87ec7106-8012-4788-a6b3-ec08e7df3797" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5b6bc314-86e9-4962-b2c9-4e229b2d9ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_c4e837eb-bfdc-4287-9a5d-4b1e9c696d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5b6bc314-86e9-4962-b2c9-4e229b2d9ed9" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_c4e837eb-bfdc-4287-9a5d-4b1e9c696d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_36c3ae47-ba8f-4d92-9425-7066e5b30927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5b6bc314-86e9-4962-b2c9-4e229b2d9ed9" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_36c3ae47-ba8f-4d92-9425-7066e5b30927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c73eff79-361d-4a40-ad59-887ba46ea23b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5b6bc314-86e9-4962-b2c9-4e229b2d9ed9" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c73eff79-361d-4a40-ad59-887ba46ea23b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a9ef453e-e571-4886-9fa2-d65023607002" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5b6bc314-86e9-4962-b2c9-4e229b2d9ed9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a9ef453e-e571-4886-9fa2-d65023607002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_05b84d2f-85e5-40ca-bd10-db4eff6d9a34" xlink:href="clx-20220930.xsd#clx_OperatingLeaseRightofUseAssetAndLiabilityNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5b6bc314-86e9-4962-b2c9-4e229b2d9ed9" xlink:to="loc_clx_OperatingLeaseRightofUseAssetAndLiabilityNet_05b84d2f-85e5-40ca-bd10-db4eff6d9a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_6ecbb0bc-72fb-4bda-92c8-3eaaa281fd59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5b6bc314-86e9-4962-b2c9-4e229b2d9ed9" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_6ecbb0bc-72fb-4bda-92c8-3eaaa281fd59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6c2e9c86-c03a-4aba-ad16-a14d0b88fea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d5c728a7-4a63-4385-a611-2ffdabd2ce94" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6c2e9c86-c03a-4aba-ad16-a14d0b88fea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_aa5513c9-bbf3-42a7-a522-17d0370c9463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1d799473-8736-4302-a035-62b4a2e1a5f9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_aa5513c9-bbf3-42a7-a522-17d0370c9463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2cf8ae8f-5322-4db9-91da-152731b072ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_aa5513c9-bbf3-42a7-a522-17d0370c9463" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2cf8ae8f-5322-4db9-91da-152731b072ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_296b1b0a-ac12-437b-a2e0-5a1875ac9ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_aa5513c9-bbf3-42a7-a522-17d0370c9463" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_296b1b0a-ac12-437b-a2e0-5a1875ac9ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_117f07cf-8af2-480d-b69c-c15a3dc96635" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_aa5513c9-bbf3-42a7-a522-17d0370c9463" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_117f07cf-8af2-480d-b69c-c15a3dc96635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f809807c-b307-4b70-950d-cb79edb620dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1d799473-8736-4302-a035-62b4a2e1a5f9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f809807c-b307-4b70-950d-cb79edb620dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_44e0795b-14d6-4838-8fa4-4a24c0fab662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f809807c-b307-4b70-950d-cb79edb620dd" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_44e0795b-14d6-4838-8fa4-4a24c0fab662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6e4990df-a9b9-4492-8b7f-4be8c7a30f01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f809807c-b307-4b70-950d-cb79edb620dd" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6e4990df-a9b9-4492-8b7f-4be8c7a30f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_70392fee-76a1-40f7-a3c9-e1a0f81810d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f809807c-b307-4b70-950d-cb79edb620dd" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_70392fee-76a1-40f7-a3c9-e1a0f81810d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_6c7240d7-c130-4d44-9a03-02e9bd6ca540" xlink:href="clx-20220930.xsd#clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f809807c-b307-4b70-950d-cb79edb620dd" xlink:to="loc_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther_6c7240d7-c130-4d44-9a03-02e9bd6ca540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1549a265-bb0f-4acc-b2d3-58e67cd3de52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f809807c-b307-4b70-950d-cb79edb620dd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1549a265-bb0f-4acc-b2d3-58e67cd3de52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fd1f853f-169d-4759-8fe2-ad2f40942388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1d799473-8736-4302-a035-62b4a2e1a5f9" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fd1f853f-169d-4759-8fe2-ad2f40942388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_59e6406c-d54e-453e-a3bd-fc9a3f8c8c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1d799473-8736-4302-a035-62b4a2e1a5f9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_59e6406c-d54e-453e-a3bd-fc9a3f8c8c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_94e8ae55-3ae9-4de0-9198-14c7998c4773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1d799473-8736-4302-a035-62b4a2e1a5f9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_94e8ae55-3ae9-4de0-9198-14c7998c4773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_394c1f2c-3e52-4c67-b078-89298f4d36c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_94e8ae55-3ae9-4de0-9198-14c7998c4773" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_394c1f2c-3e52-4c67-b078-89298f4d36c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3451661c-2173-41c5-8fb8-4c782b0651c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_94e8ae55-3ae9-4de0-9198-14c7998c4773" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3451661c-2173-41c5-8fb8-4c782b0651c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="clx-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_86d26a6b-f046-4715-a6a3-9cd7127c5c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_7aae7684-2bad-45ae-bf7a-d5ccb22448a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_86d26a6b-f046-4715-a6a3-9cd7127c5c2c" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_7aae7684-2bad-45ae-bf7a-d5ccb22448a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS" xlink:type="simple" xlink:href="clx-20220930.xsd#RESTRUCTURINGANDRELATEDCOSTS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c10a26e1-3898-4149-8725-b4420791bc58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_ba87b88e-c937-453f-b6b6-b5dd9eb6abbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c10a26e1-3898-4149-8725-b4420791bc58" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_ba87b88e-c937-453f-b6b6-b5dd9eb6abbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNET" xlink:type="simple" xlink:href="clx-20220930.xsd#INVENTORIESNET"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/INVENTORIESNET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_e6916e8e-2e8d-4ae4-b358-d21cd095b5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_d8dc5b38-1fa2-4e79-9bda-150f45f1fe00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e6916e8e-2e8d-4ae4-b358-d21cd095b5e9" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_d8dc5b38-1fa2-4e79-9bda-150f45f1fe00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="clx-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_08d60d77-5af8-4396-b82f-5196236c7570" xlink:href="clx-20220930.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock_d3ede760-f98a-4e58-b4f6-9517316605a2" xlink:href="clx-20220930.xsd#clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_08d60d77-5af8-4396-b82f-5196236c7570" xlink:to="loc_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock_d3ede760-f98a-4e58-b4f6-9517316605a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INCOMETAXES" xlink:type="simple" xlink:href="clx-20220930.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_238c63fb-3204-48b4-8958-f53bb34ff3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_5f1da339-1287-4517-8b20-fa99d2c9e630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_238c63fb-3204-48b4-8958-f53bb34ff3c4" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_5f1da339-1287-4517-8b20-fa99d2c9e630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSPERSHAREEPS" xlink:type="simple" xlink:href="clx-20220930.xsd#NETEARNINGSPERSHAREEPS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/NETEARNINGSPERSHAREEPS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8011ac56-3149-4330-bdea-a798705288ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_2cb0a1fa-33cb-412d-8880-d0712f6c4bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8011ac56-3149-4330-bdea-a798705288ce" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_2cb0a1fa-33cb-412d-8880-d0712f6c4bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="clx-20220930.xsd#COMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_b97b7726-d7d0-4244-b1fa-02479ad9e0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_c41e88a1-1abc-4f78-92a7-41f2bfd68a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_b97b7726-d7d0-4244-b1fa-02479ad9e0f5" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_c41e88a1-1abc-4f78-92a7-41f2bfd68a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="clx-20220930.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5293c4d7-524e-4d07-a4b6-eed84c0c1488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_016fe90c-da8c-4ef1-acd5-70b677facc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5293c4d7-524e-4d07-a4b6-eed84c0c1488" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_016fe90c-da8c-4ef1-acd5-70b677facc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANS" xlink:type="simple" xlink:href="clx-20220930.xsd#EMPLOYEEBENEFITPLANS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_19722710-d3f6-4228-9d7c-ecf23d41112f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_084298ab-658f-4c51-b331-c29512aef82c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_19722710-d3f6-4228-9d7c-ecf23d41112f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_084298ab-658f-4c51-b331-c29512aef82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES" xlink:type="simple" xlink:href="clx-20220930.xsd#OTHERCONTINGENCIESANDGUARANTEES"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c770ef68-3b72-44c4-a405-ddf5bf8c7bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c41c4678-eb27-482b-9fa9-42190f3c1a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c770ef68-3b72-44c4-a405-ddf5bf8c7bf5" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c41c4678-eb27-482b-9fa9-42190f3c1a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTS" xlink:type="simple" xlink:href="clx-20220930.xsd#SEGMENTRESULTS"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_32f17d08-97ad-4ef4-936b-dc4ddeaa0413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_b0808d10-fc33-4f1f-a93a-763a578f4755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_32f17d08-97ad-4ef4-936b-dc4ddeaa0413" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_b0808d10-fc33-4f1f-a93a-763a578f4755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="clx-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d3b02623-0157-486c-9c10-c1418dc957ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c1f4d583-f7ef-487d-be5f-6c665c982d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d3b02623-0157-486c-9c10-c1418dc957ad" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c1f4d583-f7ef-487d-be5f-6c665c982d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_37c5dcdc-2130-4d70-811e-fb61f36c6d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d3b02623-0157-486c-9c10-c1418dc957ad" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_37c5dcdc-2130-4d70-811e-fb61f36c6d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6a14b83a-b471-4fe3-bad0-fc1129d493a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d3b02623-0157-486c-9c10-c1418dc957ad" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6a14b83a-b471-4fe3-bad0-fc1129d493a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_61444675-8f25-4e5c-a096-8d54e07f1b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d3b02623-0157-486c-9c10-c1418dc957ad" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_61444675-8f25-4e5c-a096-8d54e07f1b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_a7e83a83-55e8-455c-9b23-d5bacf467e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d3b02623-0157-486c-9c10-c1418dc957ad" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_a7e83a83-55e8-455c-9b23-d5bacf467e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables" xlink:type="simple" xlink:href="clx-20220930.xsd#RESTRUCTURINGANDRELATEDCOSTSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c629f858-e9c4-4b58-9c90-0785b8b6815e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_7cbbbae0-e2af-4a9d-891a-dbcfa42c3b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c629f858-e9c4-4b58-9c90-0785b8b6815e" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_7cbbbae0-e2af-4a9d-891a-dbcfa42c3b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_fbe37043-104b-4fea-8798-1c507df36c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c629f858-e9c4-4b58-9c90-0785b8b6815e" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_fbe37043-104b-4fea-8798-1c507df36c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNETTables" xlink:type="simple" xlink:href="clx-20220930.xsd#INVENTORIESNETTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/INVENTORIESNETTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_a287d152-98d7-43b3-9630-e064816a192f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c655700f-2a4f-4d48-90ec-b00febbeb9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_a287d152-98d7-43b3-9630-e064816a192f" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c655700f-2a4f-4d48-90ec-b00febbeb9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="clx-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_e5ce8976-4744-476b-a559-f06fbd92d999" xlink:href="clx-20220930.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f64b4707-661f-4344-8662-cfea8ac5b29b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_e5ce8976-4744-476b-a559-f06fbd92d999" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f64b4707-661f-4344-8662-cfea8ac5b29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_a4d24a40-c8ae-4b47-b484-91f4e88ed7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_e5ce8976-4744-476b-a559-f06fbd92d999" xlink:to="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_a4d24a40-c8ae-4b47-b484-91f4e88ed7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_a6faf625-281e-4193-97bb-6d3118484ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_e5ce8976-4744-476b-a559-f06fbd92d999" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_a6faf625-281e-4193-97bb-6d3118484ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSPERSHAREEPSTables" xlink:type="simple" xlink:href="clx-20220930.xsd#NETEARNINGSPERSHAREEPSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/NETEARNINGSPERSHAREEPSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c1bc763e-3458-48f0-84de-37904e5ba8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_444b4f63-fad1-4ddd-8f76-b6bea053bf20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c1bc763e-3458-48f0-84de-37904e5ba8a8" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_444b4f63-fad1-4ddd-8f76-b6bea053bf20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables" xlink:type="simple" xlink:href="clx-20220930.xsd#COMPREHENSIVEINCOMELOSSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_9c3ad071-1146-4592-825c-883ae81322b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_fbc32747-c84b-4b7a-b2b7-8ba2d69d1bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_9c3ad071-1146-4592-825c-883ae81322b5" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_fbc32747-c84b-4b7a-b2b7-8ba2d69d1bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="clx-20220930.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_da2f79ed-f2a2-409f-97dd-2d4ec6d332ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_c068b68b-b635-4552-9300-1ef1c491658f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_da2f79ed-f2a2-409f-97dd-2d4ec6d332ba" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_c068b68b-b635-4552-9300-1ef1c491658f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_35f0ab93-0266-4e84-9df2-cf4de9679c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_da2f79ed-f2a2-409f-97dd-2d4ec6d332ba" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_35f0ab93-0266-4e84-9df2-cf4de9679c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables" xlink:type="simple" xlink:href="clx-20220930.xsd#EMPLOYEEBENEFITPLANSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7a8333cb-9fca-489f-9f95-b4ab6ad5c715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_caa29b82-e6c7-4307-a117-6ce77e29ce71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7a8333cb-9fca-489f-9f95-b4ab6ad5c715" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_caa29b82-e6c7-4307-a117-6ce77e29ce71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSTables" xlink:type="simple" xlink:href="clx-20220930.xsd#SEGMENTRESULTSTables"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0170a9f4-1cb7-41f1-af25-07f3ca3218ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ed831d56-f608-4903-aadc-6dfc08af7ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0170a9f4-1cb7-41f1-af25-07f3ca3218ef" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ed831d56-f608-4903-aadc-6dfc08af7ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f0a9536f-5c9d-4f5e-b374-fb0a6544c319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039728fc-e226-4acc-8ae1-1cb0a3b775ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f0a9536f-5c9d-4f5e-b374-fb0a6544c319" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039728fc-e226-4acc-8ae1-1cb0a3b775ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_169d4d82-5a17-4ac5-ac3d-06a9c6bf9613" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039728fc-e226-4acc-8ae1-1cb0a3b775ea" xlink:to="loc_srt_RangeAxis_169d4d82-5a17-4ac5-ac3d-06a9c6bf9613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a4e9c80a-3da0-48be-ae13-bdb82ef8bbcf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_169d4d82-5a17-4ac5-ac3d-06a9c6bf9613" xlink:to="loc_srt_RangeMember_a4e9c80a-3da0-48be-ae13-bdb82ef8bbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_35df82f9-f58e-4cf8-9e0d-e23a40d62c32" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a4e9c80a-3da0-48be-ae13-bdb82ef8bbcf" xlink:to="loc_srt_MinimumMember_35df82f9-f58e-4cf8-9e0d-e23a40d62c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_44339ef0-5fb1-4bdd-b34f-7e94ab1a6667" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a4e9c80a-3da0-48be-ae13-bdb82ef8bbcf" xlink:to="loc_srt_MaximumMember_44339ef0-5fb1-4bdd-b34f-7e94ab1a6667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_789f5bd7-28ad-4fdb-8125-6127d1d32e75" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039728fc-e226-4acc-8ae1-1cb0a3b775ea" xlink:to="loc_srt_StatementScenarioAxis_789f5bd7-28ad-4fdb-8125-6127d1d32e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f9aa92d6-1d4c-44e4-aebf-8aba6c4bf657" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_789f5bd7-28ad-4fdb-8125-6127d1d32e75" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f9aa92d6-1d4c-44e4-aebf-8aba6c4bf657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_04980bd9-474b-41a0-8e4b-64a23a794232" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_f9aa92d6-1d4c-44e4-aebf-8aba6c4bf657" xlink:to="loc_srt_ScenarioForecastMember_04980bd9-474b-41a0-8e4b-64a23a794232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1ccc231c-cb3a-40ff-8c82-265cbf6f21a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039728fc-e226-4acc-8ae1-1cb0a3b775ea" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_1ccc231c-cb3a-40ff-8c82-265cbf6f21a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_02b3dd49-8656-47e0-861e-e552abe4e8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1ccc231c-cb3a-40ff-8c82-265cbf6f21a4" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_02b3dd49-8656-47e0-861e-e552abe4e8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_2303b075-9c4e-4a43-a4f6-0a2bf1f0a38a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1ccc231c-cb3a-40ff-8c82-265cbf6f21a4" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_2303b075-9c4e-4a43-a4f6-0a2bf1f0a38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_24167650-2d32-4d1f-bd30-3a3579c08227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c16c3f38-d4b5-44af-9dd9-6a47ae5e4939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_24167650-2d32-4d1f-bd30-3a3579c08227" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c16c3f38-d4b5-44af-9dd9-6a47ae5e4939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_875dfff8-d6fd-4835-84eb-bed46fa0c582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c16c3f38-d4b5-44af-9dd9-6a47ae5e4939" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_875dfff8-d6fd-4835-84eb-bed46fa0c582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9ff39512-0760-4601-88a0-664bda457ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_875dfff8-d6fd-4835-84eb-bed46fa0c582" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9ff39512-0760-4601-88a0-664bda457ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CostOfGoodsAndServicesSoldMember_31a555ce-e4fa-4b86-8449-c0488d92e6a8" xlink:href="clx-20220930.xsd#clx_CostOfGoodsAndServicesSoldMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9ff39512-0760-4601-88a0-664bda457ca3" xlink:to="loc_clx_CostOfGoodsAndServicesSoldMember_31a555ce-e4fa-4b86-8449-c0488d92e6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_f0fa8a1d-2b98-4285-ab80-1624be478c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9ff39512-0760-4601-88a0-664bda457ca3" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_f0fa8a1d-2b98-4285-ab80-1624be478c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherIncomeExpenseNetMember_bb9d924f-dcf5-43e5-bb7d-355ec469c3b1" xlink:href="clx-20220930.xsd#clx_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9ff39512-0760-4601-88a0-664bda457ca3" xlink:to="loc_clx_OtherIncomeExpenseNetMember_bb9d924f-dcf5-43e5-bb7d-355ec469c3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_4c3f144f-bc19-479e-aaf2-7210fd8011db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c16c3f38-d4b5-44af-9dd9-6a47ae5e4939" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_4c3f144f-bc19-479e-aaf2-7210fd8011db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_44654992-1910-46ca-93be-79f6d065be0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4c3f144f-bc19-479e-aaf2-7210fd8011db" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_44654992-1910-46ca-93be-79f6d065be0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_532d5d5e-e171-4422-9270-992f31f8c2a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8ba695cd-7ede-47fd-8b31-e07b5809cd6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_532d5d5e-e171-4422-9270-992f31f8c2a9" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8ba695cd-7ede-47fd-8b31-e07b5809cd6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_3acc3f12-5ee0-42b9-acb4-4dca6cbee4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8ba695cd-7ede-47fd-8b31-e07b5809cd6f" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_3acc3f12-5ee0-42b9-acb4-4dca6cbee4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_443c8d94-44f9-4b0b-9faf-cf1c81ce1047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_3acc3f12-5ee0-42b9-acb4-4dca6cbee4d9" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_443c8d94-44f9-4b0b-9faf-cf1c81ce1047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_3227cca0-d14a-4cb7-9c37-a5f38e656022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_443c8d94-44f9-4b0b-9faf-cf1c81ce1047" xlink:to="loc_us-gaap_EmployeeSeveranceMember_3227cca0-d14a-4cb7-9c37-a5f38e656022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_a5fea260-48fc-4abe-9ec5-b8336da6e02a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_443c8d94-44f9-4b0b-9faf-cf1c81ce1047" xlink:to="loc_us-gaap_OtherRestructuringMember_a5fea260-48fc-4abe-9ec5-b8336da6e02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_05f80b70-deeb-4018-a110-281d5981ba84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_8ba695cd-7ede-47fd-8b31-e07b5809cd6f" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_05f80b70-deeb-4018-a110-281d5981ba84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_e6c73e99-8a7d-4d87-bbc9-629b837eeb57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_05f80b70-deeb-4018-a110-281d5981ba84" xlink:to="loc_us-gaap_RestructuringReserveRollForward_e6c73e99-8a7d-4d87-bbc9-629b837eeb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_a31af360-599f-4657-bd37-e8bb1f6152e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e6c73e99-8a7d-4d87-bbc9-629b837eeb57" xlink:to="loc_us-gaap_RestructuringReserve_a31af360-599f-4657-bd37-e8bb1f6152e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_8ad31e9b-3e7b-4437-8354-863203bece14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e6c73e99-8a7d-4d87-bbc9-629b837eeb57" xlink:to="loc_us-gaap_RestructuringCharges_8ad31e9b-3e7b-4437-8354-863203bece14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_be252e8d-4b7e-4efd-b20a-183d30531a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e6c73e99-8a7d-4d87-bbc9-629b837eeb57" xlink:to="loc_us-gaap_PaymentsForRestructuring_be252e8d-4b7e-4efd-b20a-183d30531a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_04746fff-7ee7-417b-bea3-a03f48f25e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e6c73e99-8a7d-4d87-bbc9-629b837eeb57" xlink:to="loc_us-gaap_RestructuringReserve_04746fff-7ee7-417b-bea3-a03f48f25e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNETDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#INVENTORIESNETDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/INVENTORIESNETDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_d2262619-5b1c-4fba-9341-fdaf31ed4468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c70c41df-1c2a-4c8b-bdbe-d5667a024f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_d2262619-5b1c-4fba-9341-fdaf31ed4468" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c70c41df-1c2a-4c8b-bdbe-d5667a024f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_c9198840-2b4b-4056-91d2-108973f3a15d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_d2262619-5b1c-4fba-9341-fdaf31ed4468" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_c9198840-2b4b-4056-91d2-108973f3a15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_4d2d3a3f-81c1-4467-a8e5-bf96c76b7abd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_d2262619-5b1c-4fba-9341-fdaf31ed4468" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_4d2d3a3f-81c1-4467-a8e5-bf96c76b7abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve_fe086141-2852-402c-8f6c-c0f1a13d6bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_d2262619-5b1c-4fba-9341-fdaf31ed4468" xlink:to="loc_us-gaap_InventoryLIFOReserve_fe086141-2852-402c-8f6c-c0f1a13d6bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InventoryCurrentAndNoncurrentNet_3c6f28ed-fd95-4669-a552-8e1bb36edb9a" xlink:href="clx-20220930.xsd#clx_InventoryCurrentAndNoncurrentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_d2262619-5b1c-4fba-9341-fdaf31ed4468" xlink:to="loc_clx_InventoryCurrentAndNoncurrentNet_3c6f28ed-fd95-4669-a552-8e1bb36edb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_a740c979-de1d-4bb1-9e18-00af04c6d075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_d2262619-5b1c-4fba-9341-fdaf31ed4468" xlink:to="loc_us-gaap_InventoryNoncurrent_a740c979-de1d-4bb1-9e18-00af04c6d075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_eea8df07-02c9-4dd4-a966-c9c0b029a742" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_d2262619-5b1c-4fba-9341-fdaf31ed4468" xlink:to="loc_us-gaap_InventoryNet_eea8df07-02c9-4dd4-a966-c9c0b029a742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INVENTORIESNETDetails_1" xlink:type="simple" xlink:href="clx-20220930.xsd#INVENTORIESNETDetails_1"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/INVENTORIESNETDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_bb5d429f-faa0-4687-ba62-5171ea3bca95" xlink:href="clx-20220930.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_63eb91a4-6b90-49ee-9ea4-c8c27c1ef80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_bb5d429f-faa0-4687-ba62-5171ea3bca95" xlink:to="loc_us-gaap_DerivativeTable_63eb91a4-6b90-49ee-9ea4-c8c27c1ef80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsAxis_1caf872c-f9d0-40dd-ba3b-b7041c509513" xlink:href="clx-20220930.xsd#clx_CommodityPurchaseDerivativeContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_63eb91a4-6b90-49ee-9ea4-c8c27c1ef80b" xlink:to="loc_clx_CommodityPurchaseDerivativeContractsAxis_1caf872c-f9d0-40dd-ba3b-b7041c509513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CommodityPurchaseDerivativeContractsDomain_66bf031e-e889-4fdb-80c5-910ce2b5c69a" xlink:href="clx-20220930.xsd#clx_CommodityPurchaseDerivativeContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsAxis_1caf872c-f9d0-40dd-ba3b-b7041c509513" xlink:to="loc_clx_CommodityPurchaseDerivativeContractsDomain_66bf031e-e889-4fdb-80c5-910ce2b5c69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TotalCommodityPurchaseDerivativeContractsMember_5dc1eae9-ed24-4520-8aec-71b17b9eab28" xlink:href="clx-20220930.xsd#clx_TotalCommodityPurchaseDerivativeContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_CommodityPurchaseDerivativeContractsDomain_66bf031e-e889-4fdb-80c5-910ce2b5c69a" xlink:to="loc_clx_TotalCommodityPurchaseDerivativeContractsMember_5dc1eae9-ed24-4520-8aec-71b17b9eab28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_fb4fbc97-d488-41ac-8327-e4d77828d7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_63eb91a4-6b90-49ee-9ea4-c8c27c1ef80b" xlink:to="loc_us-gaap_TransactionTypeAxis_fb4fbc97-d488-41ac-8327-e4d77828d7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_7feb95a3-eddf-430d-8aaf-fe601534231b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionTypeAxis_fb4fbc97-d488-41ac-8327-e4d77828d7a1" xlink:to="loc_us-gaap_TransactionDomain_7feb95a3-eddf-430d-8aaf-fe601534231b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_PurchasesofInventoryMember_b5289143-4c2b-4f01-9e1d-f29d96467dcb" xlink:href="clx-20220930.xsd#clx_PurchasesofInventoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionDomain_7feb95a3-eddf-430d-8aaf-fe601534231b" xlink:to="loc_clx_PurchasesofInventoryMember_b5289143-4c2b-4f01-9e1d-f29d96467dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_22a6e6cb-0d1c-4a8a-bb9e-2e727950af52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_63eb91a4-6b90-49ee-9ea4-c8c27c1ef80b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_22a6e6cb-0d1c-4a8a-bb9e-2e727950af52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_eac1b946-a1db-41b7-b46b-565c26222d86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_22a6e6cb-0d1c-4a8a-bb9e-2e727950af52" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_eac1b946-a1db-41b7-b46b-565c26222d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_0daf31ca-9897-4f0e-8774-ea7a24f6e8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eac1b946-a1db-41b7-b46b-565c26222d86" xlink:to="loc_us-gaap_ForeignExchangeContractMember_0daf31ca-9897-4f0e-8774-ea7a24f6e8a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_720702b1-c671-4fe0-b3f2-46af9e0a4852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eac1b946-a1db-41b7-b46b-565c26222d86" xlink:to="loc_us-gaap_CommodityContractMember_720702b1-c671-4fe0-b3f2-46af9e0a4852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_63eb91a4-6b90-49ee-9ea4-c8c27c1ef80b" xlink:to="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_e7513086-3d16-48da-b07d-7a200a8de850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_e7513086-3d16-48da-b07d-7a200a8de850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_d54d1a23-81f1-48d8-8e32-0775e021b7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:to="loc_us-gaap_DerivativeNotionalAmount_d54d1a23-81f1-48d8-8e32-0775e021b7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_069bb42d-0494-4841-a122-16b6c105650b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:to="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_069bb42d-0494-4841-a122-16b6c105650b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_c3f7256c-cdb0-4418-bd28-0cb167548d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1_c3f7256c-cdb0-4418-bd28-0cb167548d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d6301f04-7acb-4061-9b4b-921e28f47bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d6301f04-7acb-4061-9b4b-921e28f47bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_e9a21502-9298-4476-9fe2-7ff722d942dc" xlink:href="clx-20220930.xsd#clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:to="loc_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_e9a21502-9298-4476-9fe2-7ff722d942dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarginDepositAssets_c9d6a53c-c579-44f6-a326-80ca7c53ca83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarginDepositAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_82313584-8f9d-4955-8b66-81c35a9fb11d" xlink:to="loc_us-gaap_MarginDepositAssets_c9d6a53c-c579-44f6-a326-80ca7c53ca83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_3f8e3dcb-3604-4236-a191-b91f92a7a217" xlink:href="clx-20220930.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_af3197b2-8c06-4c28-96e2-82f5c341e42f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_3f8e3dcb-3604-4236-a191-b91f92a7a217" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_af3197b2-8c06-4c28-96e2-82f5c341e42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_033316c0-8c1c-4f15-8384-df67d6182f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_af3197b2-8c06-4c28-96e2-82f5c341e42f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_033316c0-8c1c-4f15-8384-df67d6182f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_609c31fa-999b-4ed9-8ccd-2e032433989c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_033316c0-8c1c-4f15-8384-df67d6182f00" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_609c31fa-999b-4ed9-8ccd-2e032433989c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_b855a5aa-d27d-494d-b951-0449111dd273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_609c31fa-999b-4ed9-8ccd-2e032433989c" xlink:to="loc_us-gaap_CommodityContractMember_b855a5aa-d27d-494d-b951-0449111dd273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_d3640245-fac8-4316-8312-92244cd8805d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_609c31fa-999b-4ed9-8ccd-2e032433989c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_d3640245-fac8-4316-8312-92244cd8805d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_c9831e96-19d7-42e3-8f2b-5afc88226f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_609c31fa-999b-4ed9-8ccd-2e032433989c" xlink:to="loc_us-gaap_InterestRateContractMember_c9831e96-19d7-42e3-8f2b-5afc88226f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5d4ce57a-c09e-466d-a7d5-bd3c522e47c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_af3197b2-8c06-4c28-96e2-82f5c341e42f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5d4ce57a-c09e-466d-a7d5-bd3c522e47c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_92bee14f-b118-4ee2-b75b-b48f1c14281f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5d4ce57a-c09e-466d-a7d5-bd3c522e47c9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_92bee14f-b118-4ee2-b75b-b48f1c14281f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_96538c24-d28e-499b-8d99-d6c64f7447fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5d4ce57a-c09e-466d-a7d5-bd3c522e47c9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_96538c24-d28e-499b-8d99-d6c64f7447fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_4e0eec52-12a2-4921-8589-cc2d345defc8" xlink:href="clx-20220930.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c7fb6c6e-13ec-43eb-a2bf-6debc9bc1721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_4e0eec52-12a2-4921-8589-cc2d345defc8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c7fb6c6e-13ec-43eb-a2bf-6debc9bc1721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3a8679a3-9889-4459-bcdb-9c3b102fbb85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c7fb6c6e-13ec-43eb-a2bf-6debc9bc1721" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3a8679a3-9889-4459-bcdb-9c3b102fbb85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3a11b460-6bb5-43ea-b764-04becbf09f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3a8679a3-9889-4459-bcdb-9c3b102fbb85" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3a11b460-6bb5-43ea-b764-04becbf09f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_94b5c99c-9931-42d8-b546-02b0dff69a57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3a11b460-6bb5-43ea-b764-04becbf09f62" xlink:to="loc_us-gaap_CommodityContractMember_94b5c99c-9931-42d8-b546-02b0dff69a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_f60a6bc7-9c12-48ee-9f23-c611aa353c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3a11b460-6bb5-43ea-b764-04becbf09f62" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_f60a6bc7-9c12-48ee-9f23-c611aa353c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_659d5434-2e5c-43f5-ab75-0b316bfcec7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c7fb6c6e-13ec-43eb-a2bf-6debc9bc1721" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_659d5434-2e5c-43f5-ab75-0b316bfcec7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31588ef3-feff-4e3b-a365-6574d2e45fad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_659d5434-2e5c-43f5-ab75-0b316bfcec7e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31588ef3-feff-4e3b-a365-6574d2e45fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8f3ed332-fa38-434d-8254-61c5800c1ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31588ef3-feff-4e3b-a365-6574d2e45fad" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8f3ed332-fa38-434d-8254-61c5800c1ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b62a7ed6-9f3c-4a93-b3f2-8af30985862f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31588ef3-feff-4e3b-a365-6574d2e45fad" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b62a7ed6-9f3c-4a93-b3f2-8af30985862f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_da07e5c8-40f7-4501-9bbd-96dff79cdcf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c7fb6c6e-13ec-43eb-a2bf-6debc9bc1721" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_da07e5c8-40f7-4501-9bbd-96dff79cdcf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6bd44ebf-9a74-4772-841a-fe34bd28574d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_da07e5c8-40f7-4501-9bbd-96dff79cdcf0" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6bd44ebf-9a74-4772-841a-fe34bd28574d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d58bae0e-a07f-47d2-87f8-0e74e281de18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6bd44ebf-9a74-4772-841a-fe34bd28574d" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d58bae0e-a07f-47d2-87f8-0e74e281de18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_4fcb9078-39c2-4a6f-9850-0cfca103ecfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d58bae0e-a07f-47d2-87f8-0e74e281de18" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_4fcb9078-39c2-4a6f-9850-0cfca103ecfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_4b266906-94f7-4d6b-8434-2187d1dcabef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d58bae0e-a07f-47d2-87f8-0e74e281de18" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_4b266906-94f7-4d6b-8434-2187d1dcabef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c37d4d92-7038-4fe6-9a53-88007f61e43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c7fb6c6e-13ec-43eb-a2bf-6debc9bc1721" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c37d4d92-7038-4fe6-9a53-88007f61e43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_039534f0-f769-4bab-8d1e-1aae18b492e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c37d4d92-7038-4fe6-9a53-88007f61e43b" xlink:to="loc_us-gaap_DerivativeAssets_039534f0-f769-4bab-8d1e-1aae18b492e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_6e4ea69c-3045-44fb-9dc3-a897aed90292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c37d4d92-7038-4fe6-9a53-88007f61e43b" xlink:to="loc_us-gaap_DerivativeLiabilities_6e4ea69c-3045-44fb-9dc3-a897aed90292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_802b54fe-1aa7-4741-8d71-538b6f7ebfae" xlink:href="clx-20220930.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_710e0ec2-165a-4fec-a163-f171be4a7ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_802b54fe-1aa7-4741-8d71-538b6f7ebfae" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_710e0ec2-165a-4fec-a163-f171be4a7ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_69939c50-fc6d-450e-aff1-6770e3213e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_710e0ec2-165a-4fec-a163-f171be4a7ccc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_69939c50-fc6d-450e-aff1-6770e3213e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c249a8d7-d89a-4893-9022-6eb41dbb2c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_69939c50-fc6d-450e-aff1-6770e3213e0d" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c249a8d7-d89a-4893-9022-6eb41dbb2c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_c1295c08-d1f8-4549-b107-7c556c632b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c249a8d7-d89a-4893-9022-6eb41dbb2c6c" xlink:to="loc_us-gaap_MoneyMarketFundsMember_c1295c08-d1f8-4549-b107-7c556c632b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_72f5d231-6375-44ae-bffa-8b4780c0bf6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c249a8d7-d89a-4893-9022-6eb41dbb2c6c" xlink:to="loc_us-gaap_BankTimeDepositsMember_72f5d231-6375-44ae-bffa-8b4780c0bf6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9eb825a-2840-45c0-943a-87c4f9a90545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_710e0ec2-165a-4fec-a163-f171be4a7ccc" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9eb825a-2840-45c0-943a-87c4f9a90545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b298b6f-cc79-4b07-8baa-acc712797b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9eb825a-2840-45c0-943a-87c4f9a90545" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b298b6f-cc79-4b07-8baa-acc712797b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_26e7edc9-6dc1-496b-abc3-f4e8aabd0439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b298b6f-cc79-4b07-8baa-acc712797b29" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_26e7edc9-6dc1-496b-abc3-f4e8aabd0439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_e1b08694-75c3-4b62-8312-e2c1b9c91618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b298b6f-cc79-4b07-8baa-acc712797b29" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_e1b08694-75c3-4b62-8312-e2c1b9c91618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_0a91f008-609f-4fdd-b4cd-7b293ac047b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_710e0ec2-165a-4fec-a163-f171be4a7ccc" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_0a91f008-609f-4fdd-b4cd-7b293ac047b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e6b66ad0-b35a-40d1-9089-b0051dc20bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_0a91f008-609f-4fdd-b4cd-7b293ac047b5" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e6b66ad0-b35a-40d1-9089-b0051dc20bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_21c21216-2ead-4b53-8604-bcda0c1b0a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e6b66ad0-b35a-40d1-9089-b0051dc20bdb" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_21c21216-2ead-4b53-8604-bcda0c1b0a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_a28b152b-a156-4bb4-9923-c9a7722aa6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_21c21216-2ead-4b53-8604-bcda0c1b0a4c" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_a28b152b-a156-4bb4-9923-c9a7722aa6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_660a41e5-8278-4f40-a914-107f4d6b7be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_21c21216-2ead-4b53-8604-bcda0c1b0a4c" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_660a41e5-8278-4f40-a914-107f4d6b7be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_6e80e289-8737-4171-b7db-3776a75ff3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_710e0ec2-165a-4fec-a163-f171be4a7ccc" xlink:to="loc_us-gaap_InvestmentTypeAxis_6e80e289-8737-4171-b7db-3776a75ff3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_2bd1eabf-0a42-4d9c-8cc6-38245e9b5203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_6e80e289-8737-4171-b7db-3776a75ff3b1" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_2bd1eabf-0a42-4d9c-8cc6-38245e9b5203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_bed4de8a-c8a8-4f8b-bbe1-ca3c9d62f41c" xlink:href="clx-20220930.xsd#clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2bd1eabf-0a42-4d9c-8cc6-38245e9b5203" xlink:to="loc_clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_bed4de8a-c8a8-4f8b-bbe1-ca3c9d62f41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_378b3ba8-0f41-412b-bc9e-88e2802d37cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_710e0ec2-165a-4fec-a163-f171be4a7ccc" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_378b3ba8-0f41-412b-bc9e-88e2802d37cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_ca1a3dc9-f376-4e06-9b5b-32713cdbc00c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_378b3ba8-0f41-412b-bc9e-88e2802d37cc" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_ca1a3dc9-f376-4e06-9b5b-32713cdbc00c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NotesAndLoansPayableMember_253cedaf-66b7-49b6-bfaf-f7347655aa61" xlink:href="clx-20220930.xsd#clx_NotesAndLoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_ca1a3dc9-f376-4e06-9b5b-32713cdbc00c" xlink:to="loc_clx_NotesAndLoansPayableMember_253cedaf-66b7-49b6-bfaf-f7347655aa61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9b8f003e-6bea-41bd-b451-3bdc3bc930e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_710e0ec2-165a-4fec-a163-f171be4a7ccc" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9b8f003e-6bea-41bd-b451-3bdc3bc930e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d0ef76c3-7e87-4ee7-8ca2-03caa0774e46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9b8f003e-6bea-41bd-b451-3bdc3bc930e0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d0ef76c3-7e87-4ee7-8ca2-03caa0774e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_1c75c806-07c2-4671-ac86-8feebc1ab2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d0ef76c3-7e87-4ee7-8ca2-03caa0774e46" xlink:to="loc_us-gaap_LongTermDebtMember_1c75c806-07c2-4671-ac86-8feebc1ab2d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8c398cf6-499f-4c57-8c99-6887ea629c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_710e0ec2-165a-4fec-a163-f171be4a7ccc" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8c398cf6-499f-4c57-8c99-6887ea629c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_dcc51633-b04c-4235-baa7-009c6e97cec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8c398cf6-499f-4c57-8c99-6887ea629c59" xlink:to="loc_us-gaap_AssetsAbstract_dcc51633-b04c-4235-baa7-009c6e97cec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7b81d14b-a178-4680-a542-77b8f3ef2b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dcc51633-b04c-4235-baa7-009c6e97cec5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7b81d14b-a178-4680-a542-77b8f3ef2b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_893e95a2-d812-4c1d-bc99-ed80207636d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dcc51633-b04c-4235-baa7-009c6e97cec5" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_893e95a2-d812-4c1d-bc99-ed80207636d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_a8fedadc-31aa-4d2b-93a7-ae375dd59af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dcc51633-b04c-4235-baa7-009c6e97cec5" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_a8fedadc-31aa-4d2b-93a7-ae375dd59af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_489284a4-b45d-4022-b4c2-242cc8579439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dcc51633-b04c-4235-baa7-009c6e97cec5" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_489284a4-b45d-4022-b4c2-242cc8579439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_899fa1ef-575d-4f49-a925-221c6b0ae9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dcc51633-b04c-4235-baa7-009c6e97cec5" xlink:to="loc_us-gaap_Assets_899fa1ef-575d-4f49-a925-221c6b0ae9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_f7c50e05-2a7c-4d98-a46e-182316bd7eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dcc51633-b04c-4235-baa7-009c6e97cec5" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_f7c50e05-2a7c-4d98-a46e-182316bd7eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_c32516e9-4b9d-48ed-b33b-c498300baddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8c398cf6-499f-4c57-8c99-6887ea629c59" xlink:to="loc_us-gaap_LiabilitiesAbstract_c32516e9-4b9d-48ed-b33b-c498300baddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_db5b18fb-2b1a-46b1-af18-9e4f09467dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c32516e9-4b9d-48ed-b33b-c498300baddc" xlink:to="loc_us-gaap_CommercialPaper_db5b18fb-2b1a-46b1-af18-9e4f09467dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue_cb237d87-69dd-4388-9d9e-c89419bf0372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c32516e9-4b9d-48ed-b33b-c498300baddc" xlink:to="loc_us-gaap_ShorttermDebtFairValue_cb237d87-69dd-4388-9d9e-c89419bf0372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_01f02888-0e29-4d08-a54b-6019c1f837c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c32516e9-4b9d-48ed-b33b-c498300baddc" xlink:to="loc_us-gaap_LongTermDebt_01f02888-0e29-4d08-a54b-6019c1f837c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_884d8054-accf-47ac-b98f-e315e700ab99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c32516e9-4b9d-48ed-b33b-c498300baddc" xlink:to="loc_us-gaap_DebtInstrumentFairValue_884d8054-accf-47ac-b98f-e315e700ab99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5cf83496-7e42-435b-b7f9-9e202ef7e4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c32516e9-4b9d-48ed-b33b-c498300baddc" xlink:to="loc_us-gaap_Liabilities_5cf83496-7e42-435b-b7f9-9e202ef7e4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_7796185d-8321-49bd-aa08-5a286798a5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c32516e9-4b9d-48ed-b33b-c498300baddc" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_7796185d-8321-49bd-aa08-5a286798a5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#INCOMETAXESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9f67513e-9a84-477e-86cb-766ebefecaf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_84463fe3-bcd4-4572-98f7-9ea1f537ef05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9f67513e-9a84-477e-86cb-766ebefecaf6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_84463fe3-bcd4-4572-98f7-9ea1f537ef05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_26eb958d-d7f0-4869-b6ab-4cd86d7e5952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_83ab17d0-eb54-4a6e-b81a-8f1e6aeb370f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_26eb958d-d7f0-4869-b6ab-4cd86d7e5952" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_83ab17d0-eb54-4a6e-b81a-8f1e6aeb370f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9b6b43ef-b858-433a-8729-870971baf93a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_26eb958d-d7f0-4869-b6ab-4cd86d7e5952" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9b6b43ef-b858-433a-8729-870971baf93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_41f08ea0-d1b7-4ab7-83f5-3f50e51acbd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_26eb958d-d7f0-4869-b6ab-4cd86d7e5952" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_41f08ea0-d1b7-4ab7-83f5-3f50e51acbd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0c0b483-7c18-4c13-b581-8a8ce2f2378c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_26eb958d-d7f0-4869-b6ab-4cd86d7e5952" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0c0b483-7c18-4c13-b581-8a8ce2f2378c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_f363b133-d86c-4014-b621-93d642298ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b6e9087a-87ff-4672-94f8-b7dcb5ed28d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f363b133-d86c-4014-b621-93d642298ce3" xlink:to="loc_us-gaap_ProfitLoss_b6e9087a-87ff-4672-94f8-b7dcb5ed28d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_541c2e3b-da05-42dd-a771-fa2f2d8ad33a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f363b133-d86c-4014-b621-93d642298ce3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_541c2e3b-da05-42dd-a771-fa2f2d8ad33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_241c7a25-077e-4b56-8fb2-4c983fba5ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_541c2e3b-da05-42dd-a771-fa2f2d8ad33a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_241c7a25-077e-4b56-8fb2-4c983fba5ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b56f88ca-aa63-4c8b-970b-d82a1697b1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_541c2e3b-da05-42dd-a771-fa2f2d8ad33a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b56f88ca-aa63-4c8b-970b-d82a1697b1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_96bce9f3-73be-4aa3-8834-81c00b8d9851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_541c2e3b-da05-42dd-a771-fa2f2d8ad33a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_96bce9f3-73be-4aa3-8834-81c00b8d9851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d31744ae-f0f1-4373-ac31-b1d821774c15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_541c2e3b-da05-42dd-a771-fa2f2d8ad33a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d31744ae-f0f1-4373-ac31-b1d821774c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1f81ccd6-7368-4245-8471-d895535f1d58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f363b133-d86c-4014-b621-93d642298ce3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1f81ccd6-7368-4245-8471-d895535f1d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_99be46a3-69a8-4a13-bd55-5a12963547d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f363b133-d86c-4014-b621-93d642298ce3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_99be46a3-69a8-4a13-bd55-5a12963547d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4953d8e3-2a8a-4ef0-b159-08380fce5530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f363b133-d86c-4014-b621-93d642298ce3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_4953d8e3-2a8a-4ef0-b159-08380fce5530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#STOCKHOLDERSEQUITYScheduleofEquityDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_94610eba-f288-4327-b5ea-e4a8d3cfd403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_b7522216-a7a5-486a-bc58-eea1ff351446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_94610eba-f288-4327-b5ea-e4a8d3cfd403" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_b7522216-a7a5-486a-bc58-eea1ff351446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_99079885-adcc-41fb-9492-16be57b8df0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b7522216-a7a5-486a-bc58-eea1ff351446" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_99079885-adcc-41fb-9492-16be57b8df0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_928c7cc0-fe48-41a7-be7d-e94013fa4c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_99079885-adcc-41fb-9492-16be57b8df0a" xlink:to="loc_us-gaap_EquityComponentDomain_928c7cc0-fe48-41a7-be7d-e94013fa4c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_35b38e1d-1add-4c40-98ae-7cf0ab03de5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_928c7cc0-fe48-41a7-be7d-e94013fa4c49" xlink:to="loc_us-gaap_CommonStockMember_35b38e1d-1add-4c40-98ae-7cf0ab03de5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_710238d1-d1a3-4ea2-824e-d18362ccda95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_928c7cc0-fe48-41a7-be7d-e94013fa4c49" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_710238d1-d1a3-4ea2-824e-d18362ccda95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cda2928f-05f9-487b-ae11-fa398b8075e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_928c7cc0-fe48-41a7-be7d-e94013fa4c49" xlink:to="loc_us-gaap_RetainedEarningsMember_cda2928f-05f9-487b-ae11-fa398b8075e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_fc88c074-5d8b-48a9-bedd-e1d0f635be4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_928c7cc0-fe48-41a7-be7d-e94013fa4c49" xlink:to="loc_us-gaap_TreasuryStockCommonMember_fc88c074-5d8b-48a9-bedd-e1d0f635be4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8114262e-dc97-4501-aae8-369eb4bf0d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_928c7cc0-fe48-41a7-be7d-e94013fa4c49" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8114262e-dc97-4501-aae8-369eb4bf0d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_3c2f2f60-01ec-48ee-884c-e3ec3fd51381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_928c7cc0-fe48-41a7-be7d-e94013fa4c49" xlink:to="loc_us-gaap_NoncontrollingInterestMember_3c2f2f60-01ec-48ee-884c-e3ec3fd51381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_020d9e2f-2272-4bcf-9baa-653717b0e46d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b7522216-a7a5-486a-bc58-eea1ff351446" xlink:to="loc_us-gaap_ClassOfStockLineItems_020d9e2f-2272-4bcf-9baa-653717b0e46d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_0747f62d-67a8-419c-a793-b82425b4e6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_020d9e2f-2272-4bcf-9baa-653717b0e46d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_0747f62d-67a8-419c-a793-b82425b4e6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_020d9e2f-2272-4bcf-9baa-653717b0e46d" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7618119d-8d32-4dba-865f-c4bceaef2756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7618119d-8d32-4dba-865f-c4bceaef2756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_fb05ea8e-1944-455a-b7a7-612a857cee46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_fb05ea8e-1944-455a-b7a7-612a857cee46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_48a46a89-f5b9-4fb3-a408-28ca95a8040a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_TreasuryStockCommonShares_48a46a89-f5b9-4fb3-a408-28ca95a8040a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1f5b4bfd-2d81-49ad-b729-42a513e16443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_ProfitLoss_1f5b4bfd-2d81-49ad-b729-42a513e16443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_315fb335-cff7-4da5-ab53-4749b59b6bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_315fb335-cff7-4da5-ab53-4749b59b6bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_b3209fd5-d645-4222-bc80-6d75d95d0916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_Dividends_b3209fd5-d645-4222-bc80-6d75d95d0916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_8e8a2711-53b8-439b-be20-88bd8526f458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_8e8a2711-53b8-439b-be20-88bd8526f458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_acafc81d-7500-4586-984d-b19b8e67c39b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_acafc81d-7500-4586-984d-b19b8e67c39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesAmount_90ce05a7-ec7d-43fd-be2c-62097fe1bbdd" xlink:href="clx-20220930.xsd#clx_OtherEmployeeStockPlanActivitiesAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_clx_OtherEmployeeStockPlanActivitiesAmount_90ce05a7-ec7d-43fd-be2c-62097fe1bbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_OtherEmployeeStockPlanActivitiesShares_bf823b9e-04c1-43e5-9e9b-c340e15c3e25" xlink:href="clx-20220930.xsd#clx_OtherEmployeeStockPlanActivitiesShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_clx_OtherEmployeeStockPlanActivitiesShares_bf823b9e-04c1-43e5-9e9b-c340e15c3e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3347dc9b-1c47-4bbd-802a-4d3425a9378d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3347dc9b-1c47-4bbd-802a-4d3425a9378d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_18b4d52e-f510-4df6-a816-0312598da20f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_18b4d52e-f510-4df6-a816-0312598da20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eb04a4a8-150f-449c-83f3-eb3d0b09ce6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eb04a4a8-150f-449c-83f3-eb3d0b09ce6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ab5d065e-ca9b-4e90-b292-b0e92b93db6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ab5d065e-ca9b-4e90-b292-b0e92b93db6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_af87ba72-faa1-4051-aad0-2bf70ec2f048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2c8375c-85b4-4fc5-928b-aa75cc53e4f6" xlink:to="loc_us-gaap_TreasuryStockCommonShares_af87ba72-faa1-4051-aad0-2bf70ec2f048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9dfc43ec-7e0e-4e3f-81dc-f1810317d8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b01e9459-79a1-495f-9b2d-a9f3eed5ed12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9dfc43ec-7e0e-4e3f-81dc-f1810317d8f4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b01e9459-79a1-495f-9b2d-a9f3eed5ed12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_53b96b46-cc91-46b5-b525-7e720f3499e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b01e9459-79a1-495f-9b2d-a9f3eed5ed12" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_53b96b46-cc91-46b5-b525-7e720f3499e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a3aef91e-200c-49f4-a771-cfe863f091d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_53b96b46-cc91-46b5-b525-7e720f3499e5" xlink:to="loc_us-gaap_EquityComponentDomain_a3aef91e-200c-49f4-a771-cfe863f091d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_076011ec-edeb-4daf-a0bc-2e0066e30f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a3aef91e-200c-49f4-a771-cfe863f091d3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_076011ec-edeb-4daf-a0bc-2e0066e30f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_ba7d39c9-50d3-44d8-8da2-078544c5d20b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_076011ec-edeb-4daf-a0bc-2e0066e30f5e" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_ba7d39c9-50d3-44d8-8da2-078544c5d20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_4c820315-2041-40d3-a383-35ff207464f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_076011ec-edeb-4daf-a0bc-2e0066e30f5e" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_4c820315-2041-40d3-a383-35ff207464f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_77f9ee9d-1ea8-4f3c-9b8a-d439a18649b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_076011ec-edeb-4daf-a0bc-2e0066e30f5e" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_77f9ee9d-1ea8-4f3c-9b8a-d439a18649b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_10b2f093-a993-41ab-9d39-ce7e77172a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b01e9459-79a1-495f-9b2d-a9f3eed5ed12" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_10b2f093-a993-41ab-9d39-ce7e77172a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_6a894f09-a96f-4bc1-aa2a-101ea0d77c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_10b2f093-a993-41ab-9d39-ce7e77172a9a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_6a894f09-a96f-4bc1-aa2a-101ea0d77c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4df1590f-07bb-41bc-a63e-4faff29d05c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_6a894f09-a96f-4bc1-aa2a-101ea0d77c76" xlink:to="loc_us-gaap_StockholdersEquity_4df1590f-07bb-41bc-a63e-4faff29d05c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_7ab7f13f-5e72-4278-97fd-b8839935a9f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_6a894f09-a96f-4bc1-aa2a-101ea0d77c76" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_7ab7f13f-5e72-4278-97fd-b8839935a9f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_192fe39e-df53-4228-972e-7cb638d35e09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_6a894f09-a96f-4bc1-aa2a-101ea0d77c76" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_192fe39e-df53-4228-972e-7cb638d35e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_b98b1755-c5ee-41aa-9033-0e899985a690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_6a894f09-a96f-4bc1-aa2a-101ea0d77c76" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_b98b1755-c5ee-41aa-9033-0e899985a690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2c70df40-8e85-496e-9620-00f96fa871bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_6a894f09-a96f-4bc1-aa2a-101ea0d77c76" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2c70df40-8e85-496e-9620-00f96fa871bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8c41bce3-18ef-4a24-8de7-4be965b1cb92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_6a894f09-a96f-4bc1-aa2a-101ea0d77c76" xlink:to="loc_us-gaap_StockholdersEquity_8c41bce3-18ef-4a24-8de7-4be965b1cb92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f8f30121-34ec-4048-b1cd-adcb3b043232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fc2dfc7c-1d14-498a-9da6-7acd74ce1930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f8f30121-34ec-4048-b1cd-adcb3b043232" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fc2dfc7c-1d14-498a-9da6-7acd74ce1930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_8aab71cb-79e9-40b2-9f1d-545a877d40ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fc2dfc7c-1d14-498a-9da6-7acd74ce1930" xlink:to="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_8aab71cb-79e9-40b2-9f1d-545a877d40ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_bf66f301-4070-40a3-bbde-42296083c4db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_8aab71cb-79e9-40b2-9f1d-545a877d40ec" xlink:to="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_bf66f301-4070-40a3-bbde-42296083c4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LongTermInterCompanyLoansMember_79ae5468-427a-482b-a27a-12dcde4e5cbe" xlink:href="clx-20220930.xsd#clx_LongTermInterCompanyLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntercompanyForeignCurrencyBalanceNameDomain_bf66f301-4070-40a3-bbde-42296083c4db" xlink:to="loc_clx_LongTermInterCompanyLoansMember_79ae5468-427a-482b-a27a-12dcde4e5cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_31553cd8-5964-4a72-9ad2-d40a51cc74b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fc2dfc7c-1d14-498a-9da6-7acd74ce1930" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_31553cd8-5964-4a72-9ad2-d40a51cc74b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_611e87a5-cf5e-4f05-9ea0-0a4092d28770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_31553cd8-5964-4a72-9ad2-d40a51cc74b1" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_611e87a5-cf5e-4f05-9ea0-0a4092d28770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#EMPLOYEEBENEFITPLANSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_aba0791c-a165-4741-8d20-9f8c451b6a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a8eaab9-be39-4fbd-ac3d-770725082ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_aba0791c-a165-4741-8d20-9f8c451b6a87" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a8eaab9-be39-4fbd-ac3d-770725082ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_c9574d75-1ad8-411f-a51f-d36ce4967a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a8eaab9-be39-4fbd-ac3d-770725082ed1" xlink:to="loc_us-gaap_PlanNameAxis_c9574d75-1ad8-411f-a51f-d36ce4967a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_bf845934-f1c8-4f51-b4c5-f7de55d691eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_c9574d75-1ad8-411f-a51f-d36ce4967a78" xlink:to="loc_us-gaap_PlanNameDomain_bf845934-f1c8-4f51-b4c5-f7de55d691eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RetirementIncomeMember_acf6845d-ad66-457e-a4dc-bcaf7a8e686f" xlink:href="clx-20220930.xsd#clx_RetirementIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_bf845934-f1c8-4f51-b4c5-f7de55d691eb" xlink:to="loc_clx_RetirementIncomeMember_acf6845d-ad66-457e-a4dc-bcaf7a8e686f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6bc90d24-ade0-49ee-9563-66fdc1a10d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a8eaab9-be39-4fbd-ac3d-770725082ed1" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6bc90d24-ade0-49ee-9563-66fdc1a10d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_dd538bb1-283e-4ca9-aae4-18acf46d2ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6bc90d24-ade0-49ee-9563-66fdc1a10d04" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_dd538bb1-283e-4ca9-aae4-18acf46d2ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_c1c80da1-dca9-4c6a-b048-82144ff1e319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_dd538bb1-283e-4ca9-aae4-18acf46d2ce7" xlink:to="loc_us-gaap_DomesticPlanMember_c1c80da1-dca9-4c6a-b048-82144ff1e319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d85767b7-4686-4a80-9b06-4a0274489bdd" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_c1c80da1-dca9-4c6a-b048-82144ff1e319" xlink:to="loc_country_US_d85767b7-4686-4a80-9b06-4a0274489bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0b801a15-d080-424e-983f-394d82e44060" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a8eaab9-be39-4fbd-ac3d-770725082ed1" xlink:to="loc_srt_RangeAxis_0b801a15-d080-424e-983f-394d82e44060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0601322d-988b-4f1a-a943-98051c252591" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0b801a15-d080-424e-983f-394d82e44060" xlink:to="loc_srt_RangeMember_0601322d-988b-4f1a-a943-98051c252591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a072a2a9-da0a-4c94-adc3-47c989ffe526" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0601322d-988b-4f1a-a943-98051c252591" xlink:to="loc_srt_MinimumMember_a072a2a9-da0a-4c94-adc3-47c989ffe526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e15d071a-c4b5-4b4a-a11c-6440d66008eb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0601322d-988b-4f1a-a943-98051c252591" xlink:to="loc_srt_MaximumMember_e15d071a-c4b5-4b4a-a11c-6440d66008eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb67e8d9-b625-47b5-871b-b57594634d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7a8eaab9-be39-4fbd-ac3d-770725082ed1" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb67e8d9-b625-47b5-871b-b57594634d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DefinedBenefitPlanPlanTerminationPeriod_2f8f4260-8062-481e-85a6-4b0639008bcf" xlink:href="clx-20220930.xsd#clx_DefinedBenefitPlanPlanTerminationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb67e8d9-b625-47b5-871b-b57594634d46" xlink:to="loc_clx_DefinedBenefitPlanPlanTerminationPeriod_2f8f4260-8062-481e-85a6-4b0639008bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ca5718da-c90e-46ee-9042-4273142aeff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb67e8d9-b625-47b5-871b-b57594634d46" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ca5718da-c90e-46ee-9042-4273142aeff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_89f8bf8a-5d25-4354-8c26-273791931ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb67e8d9-b625-47b5-871b-b57594634d46" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_89f8bf8a-5d25-4354-8c26-273791931ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6ffee441-8e8e-4752-9c91-06e1e09abb7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df2a420c-6428-49c2-990e-cdc2ae9a0eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6ffee441-8e8e-4752-9c91-06e1e09abb7a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df2a420c-6428-49c2-990e-cdc2ae9a0eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_556b63e7-04cd-4481-9a17-2c60b5a0d59f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df2a420c-6428-49c2-990e-cdc2ae9a0eee" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_556b63e7-04cd-4481-9a17-2c60b5a0d59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_28384d1d-650c-4936-ad6a-d21f0e6e94a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_556b63e7-04cd-4481-9a17-2c60b5a0d59f" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_28384d1d-650c-4936-ad6a-d21f0e6e94a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_91fe4ed3-515b-4c31-b67e-e480fc5293ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_28384d1d-650c-4936-ad6a-d21f0e6e94a6" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_91fe4ed3-515b-4c31-b67e-e480fc5293ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f1df1590-e844-49f4-9220-88c8a49f7f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df2a420c-6428-49c2-990e-cdc2ae9a0eee" xlink:to="loc_us-gaap_PlanNameAxis_f1df1590-e844-49f4-9220-88c8a49f7f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_aa949124-b46c-4fbd-ba89-36cd1a879691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_f1df1590-e844-49f4-9220-88c8a49f7f78" xlink:to="loc_us-gaap_PlanNameDomain_aa949124-b46c-4fbd-ba89-36cd1a879691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RetirementIncomeMember_e746437f-02b4-45d8-a4e4-bf3b9047361e" xlink:href="clx-20220930.xsd#clx_RetirementIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_aa949124-b46c-4fbd-ba89-36cd1a879691" xlink:to="loc_clx_RetirementIncomeMember_e746437f-02b4-45d8-a4e4-bf3b9047361e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2db4d1c5-ef9a-4797-b3d7-f3f54953206a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df2a420c-6428-49c2-990e-cdc2ae9a0eee" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2db4d1c5-ef9a-4797-b3d7-f3f54953206a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_1b2ede88-0a40-4e9c-904a-96b9a3497763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2db4d1c5-ef9a-4797-b3d7-f3f54953206a" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_1b2ede88-0a40-4e9c-904a-96b9a3497763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5e6304d2-b04e-4124-86f1-7d48d3436724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2db4d1c5-ef9a-4797-b3d7-f3f54953206a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5e6304d2-b04e-4124-86f1-7d48d3436724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_9cc1b945-2bf4-49a8-923c-aa1ab8175adc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2db4d1c5-ef9a-4797-b3d7-f3f54953206a" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_9cc1b945-2bf4-49a8-923c-aa1ab8175adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_20885f77-5527-4395-aece-472a3f0511ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2db4d1c5-ef9a-4797-b3d7-f3f54953206a" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_20885f77-5527-4395-aece-472a3f0511ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_b6756594-222b-4a32-8380-be81f5e3fd33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2db4d1c5-ef9a-4797-b3d7-f3f54953206a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_b6756594-222b-4a32-8380-be81f5e3fd33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#OTHERCONTINGENCIESANDGUARANTEESDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6d57890a-8dfe-47b0-9f65-99601a8bbcad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_074d2c01-7222-4e8e-bd32-5e6b7de429f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6d57890a-8dfe-47b0-9f65-99601a8bbcad" xlink:to="loc_us-gaap_LossContingenciesTable_074d2c01-7222-4e8e-bd32-5e6b7de429f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b3766617-43f0-42fc-8813-c300684fe16d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_074d2c01-7222-4e8e-bd32-5e6b7de429f8" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b3766617-43f0-42fc-8813-c300684fe16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_476f65ee-818f-4ac4-8b2d-77fe4cad8abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b3766617-43f0-42fc-8813-c300684fe16d" xlink:to="loc_us-gaap_LossContingencyNatureDomain_476f65ee-818f-4ac4-8b2d-77fe4cad8abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_AlamedaCountyCaliforniaMatterMember_252030b1-f02e-4dec-88bf-1e845b5358e5" xlink:href="clx-20220930.xsd#clx_AlamedaCountyCaliforniaMatterMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_476f65ee-818f-4ac4-8b2d-77fe4cad8abb" xlink:to="loc_clx_AlamedaCountyCaliforniaMatterMember_252030b1-f02e-4dec-88bf-1e845b5358e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_DickinsonCountyMichiganMatterMember_70871900-ffb2-4013-81e6-a28f94880409" xlink:href="clx-20220930.xsd#clx_DickinsonCountyMichiganMatterMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_476f65ee-818f-4ac4-8b2d-77fe4cad8abb" xlink:to="loc_clx_DickinsonCountyMichiganMatterMember_70871900-ffb2-4013-81e6-a28f94880409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_aa7c24b2-43b6-4937-ab0d-b82a2fd057aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_074d2c01-7222-4e8e-bd32-5e6b7de429f8" xlink:to="loc_us-gaap_LossContingenciesLineItems_aa7c24b2-43b6-4937-ab0d-b82a2fd057aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_d9ce6e37-0b9d-4156-925a-2f88bb84fa49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_aa7c24b2-43b6-4937-ab0d-b82a2fd057aa" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_d9ce6e37-0b9d-4156-925a-2f88bb84fa49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RemediationPeriod_a34279e9-686c-4c3b-b7e1-3ad9a934fe56" xlink:href="clx-20220930.xsd#clx_RemediationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_aa7c24b2-43b6-4937-ab0d-b82a2fd057aa" xlink:to="loc_clx_RemediationPeriod_a34279e9-686c-4c3b-b7e1-3ad9a934fe56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_MaximumExposureUndiscountedCost_0d31e428-bda3-47d5-ac59-c4881431132e" xlink:href="clx-20220930.xsd#clx_MaximumExposureUndiscountedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_aa7c24b2-43b6-4937-ab0d-b82a2fd057aa" xlink:to="loc_clx_MaximumExposureUndiscountedCost_0d31e428-bda3-47d5-ac59-c4881431132e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_SiteContingencyAgreedPercentageOfCostSharing_ca983c1a-0411-40eb-b78f-35a5dca1e70e" xlink:href="clx-20220930.xsd#clx_SiteContingencyAgreedPercentageOfCostSharing"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_aa7c24b2-43b6-4937-ab0d-b82a2fd057aa" xlink:to="loc_clx_SiteContingencyAgreedPercentageOfCostSharing_ca983c1a-0411-40eb-b78f-35a5dca1e70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LetterOfCreditBorrowingCapacity_fb42e4c8-bafd-4c71-86cc-b2d1069f4220" xlink:href="clx-20220930.xsd#clx_LetterOfCreditBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_aa7c24b2-43b6-4937-ab0d-b82a2fd057aa" xlink:to="loc_clx_LetterOfCreditBorrowingCapacity_fb42e4c8-bafd-4c71-86cc-b2d1069f4220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_416a4ced-7888-44b8-a1df-6b015371bdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_aa7c24b2-43b6-4937-ab0d-b82a2fd057aa" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_416a4ced-7888-44b8-a1df-6b015371bdb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#SEGMENTRESULTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cad841cd-bb3b-42c5-bdca-75d5aba672d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_9a690f67-2230-4f5b-a28a-ae383bc8952f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cad841cd-bb3b-42c5-bdca-75d5aba672d3" xlink:to="loc_us-gaap_ConcentrationRiskTable_9a690f67-2230-4f5b-a28a-ae383bc8952f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d7d94959-6f84-481d-8f13-ab8c94386a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_9a690f67-2230-4f5b-a28a-ae383bc8952f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d7d94959-6f84-481d-8f13-ab8c94386a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_22a19f22-e81a-4908-bca2-80cea87c34ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d7d94959-6f84-481d-8f13-ab8c94386a09" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_22a19f22-e81a-4908-bca2-80cea87c34ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_0ab21946-ed9f-4c95-90f3-b82cab67be5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_22a19f22-e81a-4908-bca2-80cea87c34ff" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_0ab21946-ed9f-4c95-90f3-b82cab67be5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e85647ff-a765-4062-b519-e899673d8140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_9a690f67-2230-4f5b-a28a-ae383bc8952f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e85647ff-a765-4062-b519-e899673d8140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_2fb933c7-3bca-409c-a59e-9c144d587dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e85647ff-a765-4062-b519-e899673d8140" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_2fb933c7-3bca-409c-a59e-9c144d587dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_ffd6630d-1641-4b47-aa1f-e77962580df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_2fb933c7-3bca-409c-a59e-9c144d587dd3" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_ffd6630d-1641-4b47-aa1f-e77962580df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_f2e199bb-ad49-4f47-a86e-a0b795246fb7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_9a690f67-2230-4f5b-a28a-ae383bc8952f" xlink:to="loc_srt_MajorCustomersAxis_f2e199bb-ad49-4f47-a86e-a0b795246fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_ae5bcb7e-a9d3-456d-87cc-4544a5f74841" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_f2e199bb-ad49-4f47-a86e-a0b795246fb7" xlink:to="loc_srt_NameOfMajorCustomerDomain_ae5bcb7e-a9d3-456d-87cc-4544a5f74841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WalmartStoresIncMember_4a57cd1b-72d9-43f4-bb0b-76c9aed9934e" xlink:href="clx-20220930.xsd#clx_WalmartStoresIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_ae5bcb7e-a9d3-456d-87cc-4544a5f74841" xlink:to="loc_clx_WalmartStoresIncMember_4a57cd1b-72d9-43f4-bb0b-76c9aed9934e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_e8ccf14e-8b3c-4e09-ae97-11906abd3c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_9a690f67-2230-4f5b-a28a-ae383bc8952f" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_e8ccf14e-8b3c-4e09-ae97-11906abd3c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_b23ae2c0-ca3d-472b-86da-a6cad75fe6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_e8ccf14e-8b3c-4e09-ae97-11906abd3c39" xlink:to="loc_us-gaap_NumberOfReportableSegments_b23ae2c0-ca3d-472b-86da-a6cad75fe6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_b6fb1be9-72d8-4a23-bf5c-79ff098f5bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_e8ccf14e-8b3c-4e09-ae97-11906abd3c39" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_b6fb1be9-72d8-4a23-bf5c-79ff098f5bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#SEGMENTRESULTSReportableSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c02a546f-3185-4c7b-858d-d659b405a5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10de62ff-354b-41cd-98d9-bf131bc442e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c02a546f-3185-4c7b-858d-d659b405a5b7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10de62ff-354b-41cd-98d9-bf131bc442e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_60026f2c-d5b6-4cd3-8218-040e559daa6c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10de62ff-354b-41cd-98d9-bf131bc442e4" xlink:to="loc_srt_ConsolidationItemsAxis_60026f2c-d5b6-4cd3-8218-040e559daa6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b4800c7d-0d9b-488c-95eb-961fcdb48d12" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_60026f2c-d5b6-4cd3-8218-040e559daa6c" xlink:to="loc_srt_ConsolidationItemsDomain_b4800c7d-0d9b-488c-95eb-961fcdb48d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_28d531e4-1291-4029-b5cd-6d0ce35856a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b4800c7d-0d9b-488c-95eb-961fcdb48d12" xlink:to="loc_us-gaap_OperatingSegmentsMember_28d531e4-1291-4029-b5cd-6d0ce35856a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_7b8f3ad5-9f95-4cd8-919c-631d13c7ccd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b4800c7d-0d9b-488c-95eb-961fcdb48d12" xlink:to="loc_us-gaap_CorporateNonSegmentMember_7b8f3ad5-9f95-4cd8-919c-631d13c7ccd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_eaa20007-404d-4654-a475-7faba536b451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10de62ff-354b-41cd-98d9-bf131bc442e4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_eaa20007-404d-4654-a475-7faba536b451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5a050525-91f9-4e0a-916e-8d42e1fb094f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eaa20007-404d-4654-a475-7faba536b451" xlink:to="loc_us-gaap_SegmentDomain_5a050525-91f9-4e0a-916e-8d42e1fb094f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember_9bca5926-e52a-4c05-9091-bfe6cb9be1ba" xlink:href="clx-20220930.xsd#clx_HealthAndWellnessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5a050525-91f9-4e0a-916e-8d42e1fb094f" xlink:to="loc_clx_HealthAndWellnessMember_9bca5926-e52a-4c05-9091-bfe6cb9be1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HouseholdMember_60558a6d-7c78-42e9-a74a-43be95c31ea9" xlink:href="clx-20220930.xsd#clx_HouseholdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5a050525-91f9-4e0a-916e-8d42e1fb094f" xlink:to="loc_clx_HouseholdMember_60558a6d-7c78-42e9-a74a-43be95c31ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LifestyleMember_c8e70a64-6660-48b9-8f43-8cd2198d9985" xlink:href="clx-20220930.xsd#clx_LifestyleMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5a050525-91f9-4e0a-916e-8d42e1fb094f" xlink:to="loc_clx_LifestyleMember_c8e70a64-6660-48b9-8f43-8cd2198d9985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalMember_3a9c4e8d-4aaa-4628-a84d-7dcbf13c8217" xlink:href="clx-20220930.xsd#clx_InternationalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5a050525-91f9-4e0a-916e-8d42e1fb094f" xlink:to="loc_clx_InternationalMember_3a9c4e8d-4aaa-4628-a84d-7dcbf13c8217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_4860af05-59f0-414f-90ae-0c0011083bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10de62ff-354b-41cd-98d9-bf131bc442e4" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_4860af05-59f0-414f-90ae-0c0011083bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3237fa35-2b6a-4d44-9069-ff4677883e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_4860af05-59f0-414f-90ae-0c0011083bb1" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3237fa35-2b6a-4d44-9069-ff4677883e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_RestructuringAndRelatedCostsBenchmarkMember_d813aacb-8e16-4e47-86ee-d691a270201d" xlink:href="clx-20220930.xsd#clx_RestructuringAndRelatedCostsBenchmarkMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3237fa35-2b6a-4d44-9069-ff4677883e99" xlink:to="loc_clx_RestructuringAndRelatedCostsBenchmarkMember_d813aacb-8e16-4e47-86ee-d691a270201d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_6555c482-9d69-45b4-af86-88abb06cf890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10de62ff-354b-41cd-98d9-bf131bc442e4" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_6555c482-9d69-45b4-af86-88abb06cf890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_27d0ce47-07b7-42d9-9b4a-d87e27f46192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6555c482-9d69-45b4-af86-88abb06cf890" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_27d0ce47-07b7-42d9-9b4a-d87e27f46192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_abb468e6-cdba-4aeb-92aa-d950c392dd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_27d0ce47-07b7-42d9-9b4a-d87e27f46192" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_abb468e6-cdba-4aeb-92aa-d950c392dd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_63354229-e371-49ed-8bb1-689c66a27efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10de62ff-354b-41cd-98d9-bf131bc442e4" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_63354229-e371-49ed-8bb1-689c66a27efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dc2c5f1e-c2b4-41ad-ab61-af0efdde0f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_63354229-e371-49ed-8bb1-689c66a27efd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dc2c5f1e-c2b4-41ad-ab61-af0efdde0f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2b7d1a6d-19bd-4f88-900e-e150c00c5624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_63354229-e371-49ed-8bb1-689c66a27efd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2b7d1a6d-19bd-4f88-900e-e150c00c5624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_7f339809-59dd-419a-8557-19d2b4b8f32e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_63354229-e371-49ed-8bb1-689c66a27efd" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_7f339809-59dd-419a-8557-19d2b4b8f32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_df81374b-8232-4253-8b79-65bd5c1beafe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_63354229-e371-49ed-8bb1-689c66a27efd" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_df81374b-8232-4253-8b79-65bd5c1beafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" xlink:type="simple" xlink:href="clx-20220930.xsd#SEGMENTRESULTSNetSalesPercentagesDetails"/>
  <link:presentationLink xlink:role="http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f91d05ae-d06a-45a3-8e59-83714b524e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_248703ea-eff7-439a-9764-df264c469e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f91d05ae-d06a-45a3-8e59-83714b524e3f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_248703ea-eff7-439a-9764-df264c469e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_453f2747-09f0-4673-b1a0-fae4221bc109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_248703ea-eff7-439a-9764-df264c469e90" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_453f2747-09f0-4673-b1a0-fae4221bc109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c8d6ab4a-ed5a-4b9c-b320-e6f95081e27f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_453f2747-09f0-4673-b1a0-fae4221bc109" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c8d6ab4a-ed5a-4b9c-b320-e6f95081e27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_a35a48c5-0e23-433a-bbf2-d73ae6f873af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c8d6ab4a-ed5a-4b9c-b320-e6f95081e27f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_a35a48c5-0e23-433a-bbf2-d73ae6f873af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ba4353d1-fb6e-420d-a92b-9b1578793ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_248703ea-eff7-439a-9764-df264c469e90" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ba4353d1-fb6e-420d-a92b-9b1578793ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_21869ff3-702f-4779-bf6c-6064ad467e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ba4353d1-fb6e-420d-a92b-9b1578793ca8" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_21869ff3-702f-4779-bf6c-6064ad467e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_f943b7f3-0231-4eb7-9ee0-b1015eead6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_21869ff3-702f-4779-bf6c-6064ad467e3d" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_f943b7f3-0231-4eb7-9ee0-b1015eead6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1768922c-4c32-445f-9a98-532911f63944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_248703ea-eff7-439a-9764-df264c469e90" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1768922c-4c32-445f-9a98-532911f63944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3d93375a-9f7c-484f-bde7-d16ff396dde4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1768922c-4c32-445f-9a98-532911f63944" xlink:to="loc_us-gaap_SegmentDomain_3d93375a-9f7c-484f-bde7-d16ff396dde4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HealthAndWellnessMember_3255cc33-f182-4a24-aca1-2ca0031a6b4b" xlink:href="clx-20220930.xsd#clx_HealthAndWellnessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3d93375a-9f7c-484f-bde7-d16ff396dde4" xlink:to="loc_clx_HealthAndWellnessMember_3255cc33-f182-4a24-aca1-2ca0031a6b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_HouseholdMember_a0b59db4-eadd-4f4f-8467-f982c9a824da" xlink:href="clx-20220930.xsd#clx_HouseholdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3d93375a-9f7c-484f-bde7-d16ff396dde4" xlink:to="loc_clx_HouseholdMember_a0b59db4-eadd-4f4f-8467-f982c9a824da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_LifestyleMember_abcd725c-ffcf-485f-8aae-21be032ffd41" xlink:href="clx-20220930.xsd#clx_LifestyleMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3d93375a-9f7c-484f-bde7-d16ff396dde4" xlink:to="loc_clx_LifestyleMember_abcd725c-ffcf-485f-8aae-21be032ffd41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_InternationalMember_4058ebf0-08ab-4efe-a843-66a85fa334b7" xlink:href="clx-20220930.xsd#clx_InternationalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3d93375a-9f7c-484f-bde7-d16ff396dde4" xlink:to="loc_clx_InternationalMember_4058ebf0-08ab-4efe-a843-66a85fa334b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_1014fea2-54b2-4530-9d1c-903bf707b55a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_248703ea-eff7-439a-9764-df264c469e90" xlink:to="loc_us-gaap_SubsegmentsAxis_1014fea2-54b2-4530-9d1c-903bf707b55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_1014fea2-54b2-4530-9d1c-903bf707b55a" xlink:to="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CleaningMember_c0d5b77d-6832-45b3-bbc2-98a044899dcf" xlink:href="clx-20220930.xsd#clx_CleaningMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_CleaningMember_c0d5b77d-6832-45b3-bbc2-98a044899dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_ProfessionalProductsMember_7f12d69f-2e54-49c8-abe8-8654f1bcc82d" xlink:href="clx-20220930.xsd#clx_ProfessionalProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_ProfessionalProductsMember_7f12d69f-2e54-49c8-abe8-8654f1bcc82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_VitaminsMineralsAndSupplementsMember_abd8a118-9128-4c7d-988f-c1d6053232f9" xlink:href="clx-20220930.xsd#clx_VitaminsMineralsAndSupplementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_VitaminsMineralsAndSupplementsMember_abd8a118-9128-4c7d-988f-c1d6053232f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_BagsWrapsAndContainersMember_ba5ea91c-3ad8-4aef-af0a-bdb505445350" xlink:href="clx-20220930.xsd#clx_BagsWrapsAndContainersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_BagsWrapsAndContainersMember_ba5ea91c-3ad8-4aef-af0a-bdb505445350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_GrillingMember_f1fd1373-af03-4bea-a206-41ecfb2ccbaf" xlink:href="clx-20220930.xsd#clx_GrillingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_GrillingMember_f1fd1373-af03-4bea-a206-41ecfb2ccbaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_CatLitterMember_a6133d44-fb76-4871-b507-1a0208ddc25e" xlink:href="clx-20220930.xsd#clx_CatLitterMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_CatLitterMember_a6133d44-fb76-4871-b507-1a0208ddc25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_FoodProductsMember_d0e7d881-363c-44ee-bad4-fcb0bcbb8f99" xlink:href="clx-20220930.xsd#clx_FoodProductsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_FoodProductsMember_d0e7d881-363c-44ee-bad4-fcb0bcbb8f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_NaturalPersonalCareMember_66259065-81ef-4014-a7cb-6da30e766785" xlink:href="clx-20220930.xsd#clx_NaturalPersonalCareMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_NaturalPersonalCareMember_66259065-81ef-4014-a7cb-6da30e766785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clx_WaterFiltrationMember_31b5bbd3-7b2a-4f4c-b146-21eb5f8b68a6" xlink:href="clx-20220930.xsd#clx_WaterFiltrationMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_d28d54f0-d961-4d93-9741-b5e1ae7f05f7" xlink:to="loc_clx_WaterFiltrationMember_31b5bbd3-7b2a-4f4c-b146-21eb5f8b68a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7b27b54a-8999-4503-9be8-fc2b1bfa9bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_248703ea-eff7-439a-9764-df264c469e90" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_7b27b54a-8999-4503-9be8-fc2b1bfa9bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_ccc1fd15-5fbb-441a-9d80-d0d771ef1414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7b27b54a-8999-4503-9be8-fc2b1bfa9bc8" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_ccc1fd15-5fbb-441a-9d80-d0d771ef1414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>clx-20220930_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 clx-20220930_g1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0 Z17AI9@  34T *@    @  U$0  $
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M(&@VXN=5\*:G*LDZ0E@OVBWE7 N( Q"E@JLI90R+N4M]L4 %%?F3_P %2/\
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M$^*/"_['MS>>!6_>I>+::O>QF+U^UQPK%T_BV8H _?6BOS1_X)2?\'./P?\
M^"COCNQ^'_B/2KSX2_$_4&\FRTK4[M;C3]8FZ>3;76U/WQ.<12(C-P%+GBOT
MNH **_+33?\ @YK\,>$/VZ_V@/A?\1O!5OX/\&? :SU6ZN/$T6L&[N=8>TO;
M>TAMXK0PH/.N'G4*OFG!ZG&6'RAXR_X/*?B=>ZE/KWA/]E]Y/A]'-MAO=1U&
M[:69,X!::*#R8V/]T;P"<9:@#]^J*\\T3X^V_AK]F*P^)'Q,@L?AG##H,.M^
M(;;4K]7A\.%H5DEAEG(4-Y9)0L%&XC@<@5^1'[1G_!X2/$_Q3N/"'[,?P/\
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MS^TYX?\ V<?^"07Q3M=6NH%U7X@6:^%-%LV8>9>W%RP$FT>D<"S2$]M@[D4
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M]@!C<<.G[^>%O#&G^"?#6GZ-I-G;:;I.DVT=G96EO&(X;2"- D<:*.%554
M= !5^B@#\2O^"8G[&7Q:^&?_  <Y_M!_$SQ%\-_&FB?#WQ"WB4:9XBO=*EAT
MV_\ .OK=X?+G(V-O569<'D U^VM%% 'S+_P5>_X)A>#?^"K?[*M]\//%$S:3
MJEK+_:/AW78H1)-HE\JE5DVDC?$RDI)'D;E/!5E5E_&GX/\ Q2_X*5?\$ K2
M3X=R?#.Y^-GPETF1H](DM].NM=TZVB))S;7%KBXMD)R?*G4*ISA!DD_T844
M?SR_$_\ X*5_\%,O^"M^@7'PX^&_P+U?X1:#KR&RU35[72;O2V\E^'5M2OBJ
MPKMSGR )2,@$YP?TF_X(4_\ !$;P_P#\$A/@SJ,FH:A9^*/BKXR6,^(=;@C*
MV]O$G*65KN 80JQ+,[ -*V&( 5%7[THH _"'_@LK\+/VI/\ @MS^WSX5^!OA
M?X<_$3X>_LZ^%]7*S^*-:T2XLM.U*:/<+C59"X42(B;TM8LY<MNR/-^3]F/V
M3?V5O!G[%7[//ACX8^ -+32?"_A6S%K;(,&6=NLD\K8&^:5RSNW=F/08%>C4
M4 ?A/_P6;_X)$?%_]B_]O?PO^UO^QKX:UC4-:U#5S<^(?#>@637+V]\X)EG%
MO'S)9W:[UG0?==B>!(-G[&?L>_'W4_VFOV=_#?C#7/!/BCX<Z_J5N!JOAOQ!
M8R6E]I-TORRQD2*I>/<"4D  ="IP"2H],HH *R?'7@71_B=X+U;P[XBTRQUK
M0=<M)+'4+"\B$UO>02*5>-T/#*RD@@^M:U% 'X _M3?\&[?[27_!,C]H.\^,
M'["7C'5KC2YF:23PR+^./5+*+=N^RE9SY&H6P[++^\& -KL-YIV7_!Q!_P %
M'/A1;CP_XL_9._M37K?]W]JE\!:[ \[>I6*3RV/^Y@'M7]!5% '\Z/B_]F__
M (*;?\%]KZTT/XI6DGP3^$4TR375I?63:%IY .039%C>WC#@JLQ,88 [D/-?
MM#_P3'_X)A_#?_@E=^SO#X#\ VLES=7;K=:]KUXB_;]?NPN/-E(X5%!(CB7Y
M44GJS,S?1M% 'R)_P63_ ."1_A'_ (*Z?LS+X3U:[7P_XQ\.RO?^%?$ B\PZ
M9<LNUXY5X+V\H"K(H(.51AR@!_)#X,_M3?\ !3#_ ((8:#'\-/$?PAO?C-\.
M="'V;1KL:==:Y:VD QL6VOK,^9'#@?+%<KE!@!4 Q7]%5% '\[GQ;_;7_P""
MF7_!;'0;CX9^#/@W?_!OP/KR&SUC4%TV[T6*X@8$2)/J%X=WE%3AH[90[C*X
M<$J?U6_X(K_\$=/"G_!(7]GBXT.SO(?$?Q \4M%=>*O$0A\L7DB*1';P*>5M
MX=S[0?F9G=SC<%7[-HH _$S_ (.[_P!C/XM?M9>,_P!GF3X8?#;QIX_C\/#6
M3J;Z#I4M\MCYCZ>8Q(4!V[O+?&>NQO2OVJT92FDVJL"K+$@((Y!VBK-% 'EG
M[<_AG4O&O[$WQBT;1[&ZU35M6\$:U96-G;1F2:[GDL)TCB11RS,S!0!U)%?G
M=_P:-?LJ_$K]DW]C?XF:-\3O GBKP%JNI>,Q>VEIKNG2V,US!]AMT\Q%D )7
M<K#(XR"*_62B@ K\/_\ @J)^Q7\7?B;_ ,'./P!^)?AWX:^-=<^'WA^Z\+-J
M7B*RTF:;3;$07\KS&2<#8HC0AFR> :_<"B@#XM_X.(_^4+/[0'_8!B_]+;>O
MQ'_X)>_\$U/VCO#?[$/@/]KC]C_Q+=K\2(;S5-'\4>%9)XA'K=K!=MY9BCEQ
M%,I0*'@D(.Y%>,[^!^W'_!Q'_P H6?V@/^P#%_Z6V]>0_P#!I+_RA?\ "/\
MV,.L_P#I6U 'QYJG_!R!^WYH6GMX7O/V-[F/QU&OV?[1_P (EKIB:7&W>+8$
MD\\\2[?PJA^QQ_P0V_:7_P""LW[7>G_'C]N:YU#2O#.FRQR6_A6^V0WNIPHY
M=+)+6/Y;&SW??#8E?+<;G,H_H"HH CM+*'3[2*W@ACA@@01QQQJ%2-0,  #@
M #@ =*_"_P#X*D?\$"_C?^RS^V3=?M1_L0W]Q9ZW=7<NIZEX6T^:."[LKB4D
MW!M4D_<W%K,2Q>U?D%B%5U*JG[J44 ?@3X;_ .#CC]O_ ,.6D?A36OV.K[5O
M'$7^C?:!X1URW\Z0<;FMUR#SUVNJ^F!7#_M*_P#!)C]LW_@I9\ /B/\ M!?M
M/PZU=>+O#_A]XOAQ\+]"AS<Q7$LT2E_LD)<0HJ;G*$M/*57S" @#?T744 ?G
MW_P;(? 7QM^S9_P2?\-^%/B!X4U[P7XEM==U6:;3-8LGL[J-)+DLC&-P&"L#
MD''(KY'\)_L8?%RT_P"#O?4/BY)\-?&B?"^:>;9XJ.DRC26!\,?9P?M&-F#-
M^[Z_>XK]O** "OE?_@MO\,?$7QG_ ."4GQP\+>$M#U3Q)XDUKP\;>PTS3K=K
MBZO)/.B.R.-068X!.!Z5]444 ?G/_P &N/[/7CK]F+_@EI;>%_B)X1\0^"?$
M<?BO4[DZ;K5B]G=")_)V2;' .UL'!QS@U]P?M,? OP[^TU^SYXT^'WBZ-)/#
M7C#1[G2M0W8'E12QE3(">%9"0ZMV90>U=Q7Y\_\ !S#^WO\ \,-?\$O_ !5#
MI=]]E\9?%$GP?HFQ\2Q+.C?:[@8Y'EVPD 8?=>6+U% 'XS_\&O7_  3S7]I+
M_@JC=>(M0O(?$O@']GF:75(;Z,,UEJ%^9I(]/,0;[H9TDNAT/^CC/6OZGAP*
M_/\ _P"#:O\ 8%_X82_X)@>$_P"U;+[+XS^)F/&&N[TQ+#]H1?LMNV>1Y=L(
MLJ?NR/+ZFOT H *P_B'\.-#^+'@[4?#WB32K'6]#U:$P75E=Q"2&93Z@]QP0
M1R" 0016Y15TZDZ<U.FVFG=-:--;-/N3.$9Q<9JZ>Z9^2W[9?_! KQ!X5U"Z
MUSX,WRZ]I+$R'P[J,XCOK4==L$[8251V$A5N@W,:^!/B7\)O%7P8UF33_%_A
MO7/#-Y&<&/4K*2WS]&8;6'NI(K^F)^M>;_M5_P#)%-5_W#_(U_0/"'CYG6%]
MG@\R@L0M$I-\L^VLDFI?.-WU;/R?B'PKRZLI8G!S=%[V2YH_)-IK[[=D?SAI
M*LHRK*P]0<T^PC;5[U;6SCDO+J0[5A@0RR.3V"KDGZ8KU/\ : _Y*Q=?]=S_
M .A5^H'_  1Y_P"0"W^X?Y5_0W%_B#_8F3PS54/:<R^'FM;;KRN^_9'X_P .
M\+O,\P>!=7EMUY;[/M='YI_ [_@@3\7OVJ=>M=1M](7X9^'+EPUW?>((&B8H
M>2]O:C$K,1T#!$Z?,.E?L=_P3Y_X)@?#/_@G/X)EL_!]C)J/B/4HU35_$FHA
M7U'4<<[ 0,10@\B),+T)W'YJ^BF^\:D'2OXMXM\0,QSZI+G2I4F_@A=+YMMM
M_E?5)'].Y'D-++J$:?.ZDE]J5K_A_P %]VPHHHKX<]T**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#@_VG?V;?"?[7_P&\2?#7QU8W&I>$O%ENMKJ5M#=26LDT:R+( )(R&7YD4Y
M!'2L3]B_]BOX?_L _ JS^&_PQTNZT?PG874]Y!:W%]+>.DDS[Y#YDK,Y!8]"
M>*]7HH **** "BBB@ HHHH **** "BBB@ KYM_;D_P""3?P3_P""CGC7PCKG
MQ=\/ZIXFF\#AQI%L-8N;6SAWR(\A:&-U1RYCC#%@<J@'05])44 -AA6WA6.-
15C2,!551A5 Z "G444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016931507456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Oct. 18, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-07151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">THE CLOROX COMPANY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-0595760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1221 Broadway<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Oakland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94612-1888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">271-7000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock - $1.00 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CLX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123,384,797<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000021076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016931636400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,740<span></span>
</td>
<td class="nump">$ 1,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">1,114<span></span>
</td>
<td class="nump">1,136<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">626<span></span>
</td>
<td class="nump">670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling and administrative expenses</a></td>
<td class="nump">261<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development costs</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_OtherExpenseIncomeNet', window );">Other (income) expense, net</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net earnings attributable to noncontrolling interests</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Clorox</a></td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net earnings per share attributable to Clorox</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net earnings per share (in dollars per share)</a></td>
<td class="nump">$ 0.69<span></span>
</td>
<td class="nump">$ 1.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net earnings per share (in dollars per share)</a></td>
<td class="nump">$ 0.68<span></span>
</td>
<td class="nump">$ 1.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding (in thousands)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">123,339<span></span>
</td>
<td class="nump">122,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">123,914<span></span>
</td>
<td class="nump">124,042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Total comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to Clorox</a></td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">$ 121<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherExpenseIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherExpenseIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016931898016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 278<span></span>
</td>
<td class="nump">$ 183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net</a></td>
<td class="nump">612<span></span>
</td>
<td class="nump">681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">755<span></span>
</td>
<td class="nump">755<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,763<span></span>
</td>
<td class="nump">1,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net of accumulated depreciation and amortization of $2,575 and $2,530, respectively</a></td>
<td class="nump">1,322<span></span>
</td>
<td class="nump">1,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">336<span></span>
</td>
<td class="nump">342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,546<span></span>
</td>
<td class="nump">1,558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_TrademarksNet', window );">Trademarks, net</a></td>
<td class="nump">685<span></span>
</td>
<td class="nump">687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Other intangible assets, net</a></td>
<td class="nump">190<span></span>
</td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">311<span></span>
</td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">6,153<span></span>
</td>
<td class="nump">6,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Notes and loans payable</a></td>
<td class="nump">348<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,584<span></span>
</td>
<td class="nump">1,469<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,010<span></span>
</td>
<td class="nump">1,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">2,475<span></span>
</td>
<td class="nump">2,474<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">308<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">805<span></span>
</td>
<td class="nump">791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,657<span></span>
</td>
<td class="nump">5,429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of September&#160;30, 2022 and June&#160;30, 2022; and 123,355,986 and 123,152,132 shares outstanding as of September&#160;30, 2022 and June&#160;30, 2022, respectively</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,193<span></span>
</td>
<td class="nump">1,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">832<span></span>
</td>
<td class="nump">1,048<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost: 7,385,475 and 7,589,329 shares as of September&#160;30, 2022 and June&#160;30, 2022, respectively</a></td>
<td class="num">(1,315)<span></span>
</td>
<td class="num">(1,346)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive net (loss) income</a></td>
<td class="num">(515)<span></span>
</td>
<td class="num">(479)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Clorox stockholders&#8217; equity</a></td>
<td class="nump">326<span></span>
</td>
<td class="nump">556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">496<span></span>
</td>
<td class="nump">729<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 6,153<span></span>
</td>
<td class="nump">$ 6,158<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_TrademarksNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite or finite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_TrademarksNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016930445504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property, plant and equipment, accumulated depreciation and amortization</a></td>
<td class="nump">$ 2,575<span></span>
</td>
<td class="nump">$ 2,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">130,741,461<span></span>
</td>
<td class="nump">130,741,461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">123,355,986<span></span>
</td>
<td class="nump">123,152,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury Stock, Common, Shares</a></td>
<td class="nump">7,385,475<span></span>
</td>
<td class="nump">7,589,329<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016930403408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to net cash provided by operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables, net</a></td>
<td class="nump">63<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories, net</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(96)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_OperatingLeaseRightofUseAssetAndLiabilityNet', window );">Operating lease right-of-use assets and liabilities, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable', window );">Income taxes payable / prepaid</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operations</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(46)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used for investing activities</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Notes and loans payable, net</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Treasury stock purchased</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Cash dividends paid to Clorox stockholders</a></td>
<td class="num">(145)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther', window );">Issuance of common stock for employee stock plans and other</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used for financing activities</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents, and restricted cash</a></td>
<td class="nump">94<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash, cash equivalents, and restricted cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of period</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of period</a></td>
<td class="nump">$ 280<span></span>
</td>
<td class="nump">$ 214<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock options. Also includes the net cash inflow (outflow) from other financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OperatingLeaseRightofUseAssetAndLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-of-Use Asset And Liability, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OperatingLeaseRightofUseAssetAndLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016933612720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements for the three months ended September 30, 2022 and 2021, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company or Clorox) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June&#160;30, 2022, which includes a complete set of footnote disclosures, including the Company&#8217;s significant accounting policies.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Liabilities</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurs restructuring costs in connection with workforce reductions; consolidation or closure of a facility; sale or termination of a line of business; and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records employee termination liabilities once they are both probable and estimable for severance provided under the Company&#8217;s existing severance policy. Employee termination liabilities outside of the Company&#8217;s existing severance policy are recognized at the time relevant employees are notified, unless the employees will be retained to render service beyond a minimum retention period for transition purposes, in which case the liability is recognized ratably over the future service period. Other costs associated with a restructuring plan or exit or disposal activities, such as consulting and professional fees, facility exit costs, employee relocation, outplacement costs, accelerated depreciation or asset impairments associated with a restructuring plan, are recognized in the period in which the liability is incurred or the asset is impaired.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.&#8221; These amendments require disclosure of the key terms of outstanding supplier finance programs and a rollforward of the related obligations.&#160;These amendments are effective for fiscal years beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. As these amendments relate to disclosures only, there were no impacts expected to the Company&#8217;s consolidated results of operations, financial position and cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016934801776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING AND RELATED COSTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">RESTRUCTURING AND RELATED COSTS</a></td>
<td class="text">RESTRUCTURING AND RELATED COSTS<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2023, the Company began recognizing costs related to a plan that involves streamlining its operating model to meet its objectives of driving growth and productivity. The streamlined operating model is expected to enhance the Company&#8217;s ability to respond more quickly to changing consumer behaviors and innovate faster. The Company anticipates the implementation of this new model will be completed in fiscal year 2024, with different phases occurring throughout the implementation period.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company anticipates incurring approximately $75 to $100 of costs in fiscal years 2023 and 2024 related to this initiative, of which approximately $35 is expected to be incurred in fiscal year 2023. Related costs are primarily expected to include employee-related costs to reduce certain staffing levels such as severance payments, as well as for consulting and other costs. Costs incurred are expected to be settled primarily in cash.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and related implementation costs, net were $19 for the three months ended September&#160;30, 2022. The following table summarizes the total restructuring and related implementation costs, net associated with the Company&#8217;s streamlined operating model plan as reflected in the Consolidated Statements of Earnings and Comprehensive Income.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:78.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.048%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">9/30/2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Costs of products sold</span></div></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(1)</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Selling and administrative expenses</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">1</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Other (income) expense, net:</span></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Employee-related costs</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">19</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Total, net</span></div></td><td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">19&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee-related costs primarily include severance and other termination benefits calculated based on salary levels, prior service and statutory requirements. Other costs primarily include consulting fees incurred for the organizational design and implementation of the future streamlined operating model, related processes and other professional fees incurred. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges for restructuring and related implementation costs are recorded in the Corporate segment as these initiatives are centrally directed and controlled and are not included in internal measures of segment operating performance.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may, from time to time, decide to pursue additional restructuring-related initiatives that involve costs in future periods. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the accrual for the streamlined operating model restructuring and related implementation costs discussed above, which are recorded within Accounts payable and accrued liabilities in the Consolidated Balance Sheets:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"/><td style="width:60.646%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.950%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Employee-Related Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of June&#160;30, 2022</span></div></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Charges</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">19</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">22</span></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Cash payments</span></td><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of September&#160;30, 2022</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">19&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">22&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016930486336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES, NET<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES, NET</a></td>
<td class="text">INVENTORIES, NET<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net, consisted of the following as of:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and packaging</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIFO allowances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Noncurrent inventories, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current inventories, net</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> Noncurrent inventories, net is recorded in Other assets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016936223552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract', window );"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock', window );">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Risk Management and Derivative Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain commodity, foreign currency and interest rate risks related to its ongoing business operations and uses derivative instruments to mitigate its exposure to these risks.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commodity Price Risk Management</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may use commodity futures, options and swap contracts to limit the impact of price volatility on a portion of its forecasted raw material requirements. These commodity derivatives may be exchange traded or over-the-counter contracts and are generally for a period of no longer than two years. Commodity purchase and options contracts are measured at fair value using market quotations obtained from the Chicago Board of Trade commodity futures exchange and commodity derivative dealers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, and June&#160;30, 2022, the notional amount of commodity derivatives was $30 and $27, respectively, which related primarily to exposures in soybean oil used for the Food products business and jet fuel used for the Grilling business.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risk Management</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also enter into certain over-the-counter derivative contracts to manage a portion of the Company&#8217;s forecasted foreign currency exposure associated with the purchase of inventory. These foreign currency contracts generally have durations of no longer than two years. The foreign exchange contracts are measured at fair value using information quoted by foreign exchange dealers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of outstanding foreign currency forward contracts used by the Company&#8217;s subsidiaries to hedge forecasted purchases of inventory were $13 and $31 as of September&#160;30, 2022 and June&#160;30, 2022, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk Management</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may enter into over-the-counter interest rate contracts to fix a portion of the benchmark interest rate prior to the anticipated issuance of fixed rate debt. These interest rate contracts generally have durations of less than three years. The interest rate contracts are measured at fair value using information quoted by bond dealers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held no interest rate contracts as of September&#160;30, 2022 and June&#160;30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commodity, Foreign Exchange and Interest Rate Derivatives </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company designates its commodity forward, futures and options contracts for forecasted purchases of raw materials, foreign currency forward contracts for forecasted purchases of inventory and interest rate contracts for forecasted interest payments as cash flow hedges.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) recognized in Other comprehensive (loss) income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amount of the existing net gain (loss) in Accumulated other comprehensive net (loss) income as of September&#160;30, 2022 that is expected to be reclassified into Net earnings within the next twelve months is $11. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Risk Management and Derivative Contract Requirements</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes a variety of financial institutions as counterparties for over-the-counter derivative instruments. The Company enters into agreements governing the use of over-the-counter derivative instruments and sets internal limits on the aggregate over-the-counter derivative instrument positions held with each counterparty. Certain terms of these agreements require the Company or the counterparty to post collateral when the fair value of the derivative instruments exceeds contractually-defined counterparty liability position limits. Of the over-the-counter derivative instruments in liability positions held as of both September&#160;30, 2022 and June&#160;30, 2022, none contained such terms. As of both September&#160;30, 2022 and June&#160;30, 2022, neither the Company nor any counterparty was required to post any collateral, as no counterparty liability position limits were exceeded.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain terms of the agreements governing the Company&#8217;s over-the-counter derivative instruments require the Company&#8217;s credit ratings, as assigned by Standard &amp; Poor&#8217;s and Moody&#8217;s to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating. If the Company&#8217;s credit ratings were to fall below investment grade, the counterparties to the derivative instruments could request full collateralization on derivative instruments in net liability positions. As of both September&#160;30, 2022 and June&#160;30, 2022, the Company and each of its counterparties had been assigned investment grade ratings by both Standard &amp; Poor&#8217;s and Moody&#8217;s.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s exchange traded futures and options contracts used for commodity price risk management include requirements for the Company to post collateral in the form of a cash margin account held by the Company&#8217;s broker for trades conducted on that exchange. As of September&#160;30, 2022 and June&#160;30, 2022, the Company maintained cash margin balances related to exchange traded futures and options contracts of $2 and $1, respectively, which are classified as Prepaid expenses and other current assets on the condensed consolidated balance sheets.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trust Assets</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds interests in mutual funds and cash equivalents as part of trust assets related to its nonqualified deferred compensation plans. The participants in the nonqualified deferred compensation plans, who are the Company&#8217;s current and former employees, may select among certain mutual funds in which their compensation deferrals are invested in accordance with the terms of the plans and within the confines of the trusts, which hold the marketable securities. The trusts represent variable interest entities for which the Company is considered the primary beneficiary, and, therefore, trust assets are consolidated and included in Other assets in the condensed consolidated balance sheets. The interests in mutual funds are measured at fair value using quoted market prices. The Company has designated these marketable securities as trading investments.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of both September&#160;30, 2022 and June&#160;30, 2022, the Company&#8217;s financial assets and liabilities that were measured at fair value on a recurring basis included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company&#8217;s nonqualified deferred compensation plans, which were classified as Level 1.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s derivative instruments qualify for hedge accounting. The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s derivative instruments:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:24.231%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.479%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase options contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase futures contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s other assets and liabilities for which disclosure of fair value is required:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:24.158%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.506%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-bearing investments, including money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time deposits</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trust assets for nonqualified deferred compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">term debt and Long-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,823&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,606&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,711&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,623&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Cash and cash equivalents are composed of time deposits and other interest-bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Notes and loans payable are composed of outstanding U.S. commercial paper balances and/or amounts drawn on the Company&#8217;s credit agreements, all of which are recorded at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments and fair value measurements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments and Fair Value Measurements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_FinancialInstrumentsAndFairValueMeasurementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016932011712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXESIn determining its quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The effective tax rate on earnings was 25.0% and 22.6% for the three months ended September&#160;30, 2022 and 2021, respectively.The Inflation Reduction Act (the &#8220;Act&#8221;) was signed into law on August 16, 2022. The Act introduces a new 15% corporate minimum tax for certain large corporations that becomes effective at the beginning of the Company&#8217;s fiscal 2024 and it imposes a 1% excise tax on the value of share repurchases, net of new share issuances, after December 31, 2022. These provisions, as well as the other corporate tax changes included in the Act, are not expected to have a material impact on the Company&#8217;s financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016932098768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS PER SHARE (EPS)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET EARNINGS PER SHARE (EPS)</a></td>
<td class="text">NET EARNINGS PER SHARE (EPS)<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:76.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.779%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.780%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,339</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,980</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,914</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,042</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antidilutive stock options and other</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,983</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Clorox.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016930391840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME (LOSS)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="text">COMPREHENSIVE INCOME (LOSS) <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of Comprehensive income (loss) for the periods indicated:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:76.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.175%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.733%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings </span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Total comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income attributable to Clorox</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016932080368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> EQUITY </span><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the components of Stockholders&#8217; equity were as follows for the periods indicated: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.292%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30</span></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%">(Dollars in millions except per share data; shares in thousands)</span></div></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non controlling interests</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,396)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,961)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(546)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders  ($1.16 per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,166&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,389)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,885)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(567)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,048&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,346)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,589)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders  ($2.36 per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,193&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,315)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,385)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(515)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive net (loss) income</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(403)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(546)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(426)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(567)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense), and other</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(477)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(515)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in foreign currency translation adjustments are remeasurement losses on long-term intercompany loans where settlement is not planned or anticipated in the foreseeable future. There were no amounts associated with these loans reclassified from Accumulated other comprehensive net (loss) income for the periods presented.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016932098768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">EMPLOYEE BENEFIT PLANS</a></td>
<td class="text">EMPLOYEE BENEFIT PLANS<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a domestic qualified pension plan (the Plan). The Plan is frozen for all participants. The Plan generally was frozen effective June 30, 2011 for all employees, except for certain collectively bargained employees, whose Plan freeze was effective January 1, 2019. As a result of the Plan freeze, no employees are eligible to commence participation in the Plan or accrue any additional benefits under the Plan.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 17, 2022, the Company&#8217;s Board of Directors approved a resolution to terminate the Plan. The amendment will allow the settlement of the pension obligation with either a lump sum payout or a purchased annuity. It is expected to take 18 to 24 months to complete the termination from the date of the approved resolution to terminate the Plan. The completion of the process of offering and accepting lump sum elections are dependent on when certain regulatory approvals are obtained. Currently, there is not enough information available to determine the ultimate charge of the termination. The Plan is fully funded under specified Employee Retirement Income Security Act (ERISA) funding rules as of September&#160;30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of net periodic benefit cost for the Company&#8217;s retirement income plans:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized items</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2023 net periodic benefit cost is 2.7%.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic benefit cost for the Company&#8217;s retirement health care plans was $0 for both the three months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2022 and 2021, the Company made $2 and $3 in contributions to its domestic retirement income plans, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service cost component of the net periodic benefit cost, if any, is reflected in employee benefit costs, all other components are reflected in Other (income) expense, net.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016932159200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CONTINGENCIES AND GUARANTEES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">OTHER CONTINGENCIES AND GUARANTEES</a></td>
<td class="text">OTHER CONTINGENCIES AND GUARANTEES<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in certain environmental matters, including response actions at various locations. The Company had recorded liabilities totaling $27 and $28 as of September&#160;30, 2022 and June&#160;30, 2022, respectively, for its share of aggregate future remediation costs related to these matters. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One matter, which accounted for $13 and $14 of the recorded liability as of September&#160;30, 2022 and June&#160;30, 2022, respectively, relates to environmental costs associated with one of the Company&#8217;s former operations at a site located in Alameda County, California. In November 2016, at the request of regulators and with the assistance of environmental consultants, the Company submitted a Feasibility Study that evaluated various options for managing the site and included estimates of the related costs. Following further discussions with the regulators in 2017, the Company recorded an undiscounted liability for costs estimated to be incurred over a 30-year period, based on one of the options in the Feasibility Study. In September 2021, as a result of an additional study and further discussions with regulators, the Company submitted a Soil Vapor Intrusion Report to the regulators, which has not resulted in a change to the recorded liability. While the Company believes its latest estimates of remediation costs are reasonable, the ultimate remediation requirements are not yet finalized and the regulators could require the Company to implement remediation actions for a longer period or take additional actions, which could include estimated undiscounted costs of up to approximately $28 over an estimated 30-year period, or require the Company to take different actions and incur additional costs. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Another matter in Dickinson County, Michigan, at the site of one of the Company&#8217;s former operations for which the Company is jointly and severally liable, accounted for $9 of the recorded liability as of both September&#160;30, 2022 and June&#160;30, 2022. This amount reflects the Company&#8217;s agreement to be liable for 24.3% of the aggregate remediation and associated costs for this matter pursuant to a cost-sharing agreement with a third party. If the third party is unable to pay its share of the response and remediation obligations, the Company may be responsible for such obligations. With the assistance of environmental consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expenditures, maintenance and other costs that may be incurred over an estimated 30-year remediation period. Although it is reasonably possible that the Company&#8217;s exposure may exceed the amount recorded for the Dickinson County matter, any amount of such additional exposures, or range of exposures, is not estimable at this time. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimated losses related to these matters are sensitive to a variety of uncertain factors, including the efficacy of any remediation efforts, changes in any remediation requirements and the future availability of alternative clean-up technologies. The Company is subject to various legal proceedings, claims and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements (including costs connected to the transition and unwinding of certain supply and manufacturing relationships), product liability, patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters. With respect to these proceedings, claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, either individually or in the aggregate, on the Company&#8217;s condensed consolidated financial statements taken as a whole.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with divestitures and other transactions, the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it is probable that it will make, any material payments relating to its indemnifications, and believes that any reasonably possible payments would not have a material adverse effect, either individually or in the aggregate, on the Company&#8217;s condensed consolidated financial statements taken as a whole.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had not recorded any material liabilities on the aforementioned as of both September&#160;30, 2022 and June&#160;30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was a party to letters of credit of $15 as of September&#160;30, 2022, primarily related to its insurance carriers, of which $0 had been drawn upon.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016925832336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT RESULTS</a></td>
<td class="text">SEGMENT RESULTS<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates through strategic business units (SBUs) that are also the Company&#8217;s operating segments. The SBUs are then aggregated into four reportable segments: Health and Wellness, Household, Lifestyle and International. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present reportable segment information and a reconciliation of the segment information to the Company&#8217;s consolidated net sales and earnings (losses) before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.130%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,740&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,806&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (losses) before income taxes</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> The earnings (losses) before income taxes for Corporate includes restructuring and related implementation costs, net for the streamlined operating model of $19 for the three-months ended September 30, 2022. While recorded within the Corporate segment, for informational purposes the following table provides the approximate restructuring and related implementation costs, net corresponding to the Company&#8217;s reportable segments as a percentage of the total costs: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.140%"><tr><td style="width:1.0%"/><td style="width:24.665%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.901%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intersegment sales are eliminated and are not included in the Company&#8217;s reportable segments&#8217; net sales.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales to the Company&#8217;s largest customer, Walmart Inc. and its affiliates, as a percentage of consolidated net sales, were 27% and 25% for the three months ended September&#160;30, 2022 and 2021, respectively.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides Net sales as a percentage of the Company&#8217;s consolidated net sales, disaggregated by SBU, for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.582%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cleaning</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vitamins, Minerals and Supplements</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bags and Wraps</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grilling</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cat Litter</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Food</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natural Personal Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Water Filtration</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016930468064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements for the three months ended September 30, 2022 and 2021, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company or Clorox) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June&#160;30, 2022, which includes a complete set of footnote disclosures, including the Company&#8217;s significant accounting policies.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Restructuring Liabilities</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Liabilities</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurs restructuring costs in connection with workforce reductions; consolidation or closure of a facility; sale or termination of a line of business; and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records employee termination liabilities once they are both probable and estimable for severance provided under the Company&#8217;s existing severance policy. Employee termination liabilities outside of the Company&#8217;s existing severance policy are recognized at the time relevant employees are notified, unless the employees will be retained to render service beyond a minimum retention period for transition purposes, in which case the liability is recognized ratably over the future service period. Other costs associated with a restructuring plan or exit or disposal activities, such as consulting and professional fees, facility exit costs, employee relocation, outplacement costs, accelerated depreciation or asset impairments associated with a restructuring plan, are recognized in the period in which the liability is incurred or the asset is impaired.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.&#8221; These amendments require disclosure of the key terms of outstanding supplier finance programs and a rollforward of the related obligations.&#160;These amendments are effective for fiscal years beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. As these amendments relate to disclosures only, there were no impacts expected to the Company&#8217;s consolidated results of operations, financial position and cash flows.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of both September&#160;30, 2022 and June&#160;30, 2022, the Company&#8217;s financial assets and liabilities that were measured at fair value on a recurring basis included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company&#8217;s nonqualified deferred compensation plans, which were classified as Level 1.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Results</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates through strategic business units (SBUs) that are also the Company&#8217;s operating segments. The SBUs are then aggregated into four reportable segments: Health and Wellness, Household, Lifestyle and International. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016933459072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING AND RELATED COSTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs</a></td>
<td class="text">The following table summarizes the total restructuring and related implementation costs, net associated with the Company&#8217;s streamlined operating model plan as reflected in the Consolidated Statements of Earnings and Comprehensive Income.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:78.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.048%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">9/30/2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Costs of products sold</span></div></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(1)</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Selling and administrative expenses</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">1</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Other (income) expense, net:</span></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Employee-related costs</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">19</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Total, net</span></div></td><td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">19&#160;</span></td><td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve by Type of Cost</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the accrual for the streamlined operating model restructuring and related implementation costs discussed above, which are recorded within Accounts payable and accrued liabilities in the Consolidated Balance Sheets:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"/><td style="width:60.646%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.950%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Employee-Related Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of June&#160;30, 2022</span></div></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Charges</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">19</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">22</span></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Cash payments</span></td><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">&#8212;&#160;</span></td><td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of September&#160;30, 2022</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">19&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">22&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016932079136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories, Net</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net, consisted of the following as of:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and packaging</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIFO allowances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Noncurrent inventories, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current inventories, net</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> Noncurrent inventories, net is recorded in Other assets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016930367296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract', window );"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Effects of Derivative Instruments Designated as Hedging Instruments on OCI</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) recognized in Other comprehensive (loss) income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Effects of Derivative Instruments Designated as Hedging Instruments on Net Earnings</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Assets and Liabilities for Fair Value Disclosure</a></td>
<td class="text">The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s derivative instruments:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:24.231%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.479%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase options contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase futures contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about the balance sheet classification and the fair values of the Company&#8217;s other assets and liabilities for which disclosure of fair value is required:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:24.158%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.506%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Hierarchy<br/>Level</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-bearing investments, including money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time deposits</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trust assets for nonqualified deferred compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">term debt and Long-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,823&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,606&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,711&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,623&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Cash and cash equivalents are composed of time deposits and other interest-bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Notes and loans payable are composed of outstanding U.S. commercial paper balances and/or amounts drawn on the Company&#8217;s credit agreements, all of which are recorded at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments and Fair Value Measurements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_FinancialInstrumentsAndFairValueMeasurementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016932255520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS PER SHARE (EPS) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:76.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.779%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.780%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,339</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,980</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,914</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,042</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antidilutive stock options and other</span></td><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,983</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016932163920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME (LOSS) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of Comprehensive Income</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of Comprehensive income (loss) for the periods indicated:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:76.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.175%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.733%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings </span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Total comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income attributable to Clorox</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016933612720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of Stockholders Equity</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the components of Stockholders&#8217; equity were as follows for the periods indicated: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.292%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30</span></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%">(Dollars in millions except per share data; shares in thousands)</span></div></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Net (Loss) Income</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non controlling interests</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,396)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,961)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(546)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders  ($1.16 per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock purchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,166&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,389)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,885)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(567)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,048&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,346)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,589)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders  ($2.36 per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,193&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,315)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,385)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(515)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive net (loss) income</span></td></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(403)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(546)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(426)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(567)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense), and other</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(477)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(515)</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016930391840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Components of Net Periodic Benefit Cost</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of net periodic benefit cost for the Company&#8217;s retirement income plans:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized items</span></td><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2023 net periodic benefit cost is 2.7%.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016932080368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Selected Financial Information Relating to the Company's Segments</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present reportable segment information and a reconciliation of the segment information to the Company&#8217;s consolidated net sales and earnings (losses) before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.130%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,740&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,806&#160;</span></td><td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (losses) before income taxes</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> The earnings (losses) before income taxes for Corporate includes restructuring and related implementation costs, net for the streamlined operating model of $19 for the three-months ended September 30, 2022. While recorded within the Corporate segment, for informational purposes the following table provides the approximate restructuring and related implementation costs, net corresponding to the Company&#8217;s reportable segments as a percentage of the total costs: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.140%"><tr><td style="width:1.0%"/><td style="width:24.665%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.901%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides Net sales as a percentage of the Company&#8217;s consolidated net sales, disaggregated by SBU, for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.582%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cleaning</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vitamins, Minerals and Supplements</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bags and Wraps</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grilling</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cat Litter</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Food</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natural Personal Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Water Filtration</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/><td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016929057872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING AND RELATED COSTS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Total restructuring and related implementation costs</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and related implementation, expected cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and related implementation, expected cost</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and related implementation, expected cost</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016930535024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Total restructuring and related implementation costs</a></td>
<td class="nump">$ 19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=clx_CostOfGoodsAndServicesSoldMember', window );">Costs of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Total restructuring and related implementation costs</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Total restructuring and related implementation costs</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=clx_OtherIncomeExpenseNetMember', window );">Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Total restructuring and related implementation costs</a></td>
<td class="nump">$ 19<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=clx_CostOfGoodsAndServicesSoldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=clx_CostOfGoodsAndServicesSoldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=clx_OtherIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=clx_OtherIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016930338544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Accrual Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Accrual Balance</a></td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee-Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Accrual Balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Accrual Balance</a></td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Accrual Balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Accrual Balance</a></td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016929060080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES, NET (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">$ 639<span></span>
</td>
<td class="nump">$ 593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Raw materials and packaging</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLIFOReserve', window );">LIFO allowances</a></td>
<td class="num">(94)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_InventoryCurrentAndNoncurrentNet', window );">Total inventories, net</a></td>
<td class="nump">760<span></span>
</td>
<td class="nump">760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Less: Noncurrent inventories, net</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total current inventories, net</a></td>
<td class="nump">$ 755<span></span>
</td>
<td class="nump">$ 755<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_InventoryCurrentAndNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory, Current And Noncurrent, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_InventoryCurrentAndNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016930313632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge', window );">Maximum duration, foreign exchange contracts (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1', window );">Maximum duration, interest rate contracts (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Estimated amount of the existing net gain (loss) to be reclassified into earnings in the next 12 months</a></td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits', window );">Derivative instruments subject to contractually defined counterparty liability position limits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase derivative contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarginDepositAssets', window );">Cash margin balances amount</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=clx_PurchasesofInventoryMember', window );">Purchases of Inventory | Foreign exchange derivative contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 13,000,000<span></span>
</td>
<td class="nump">31,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_CommodityPurchaseDerivativeContractsAxis=clx_TotalCommodityPurchaseDerivativeContractsMember', window );">Total Commodity Purchase Derivative Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1', window );">Maximum duration, commodity contracts (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="nump">$ 27,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative instruments subject to contractually defined counterparty liability position limits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarginDepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash or securities placed with a broker or counterparty as security for a trading or derivatives securities position which was partially obtained with funds provided by the broker dealer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarginDepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum period the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=clx_PurchasesofInventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=clx_PurchasesofInventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_CommodityPurchaseDerivativeContractsAxis=clx_TotalCommodityPurchaseDerivativeContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_CommodityPurchaseDerivativeContractsAxis=clx_TotalCommodityPurchaseDerivativeContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016931233504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gains (losses) recognized in Other comprehensive (loss) income</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase derivative contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gains (losses) recognized in Other comprehensive (loss) income</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange derivative contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gains (losses) recognized in Other comprehensive (loss) income</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate derivative contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gains (losses) recognized in Other comprehensive (loss) income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016925925584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Assets</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Liabilities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Assets</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Liabilities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase options contracts | Fair Value, Inputs, Level 1 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Liabilities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase options contracts | Fair Value, Inputs, Level 1 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Liabilities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase options contracts | Fair Value, Inputs, Level 2 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase options contracts | Fair Value, Inputs, Level 2 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign exchange forward contracts | Fair Value, Inputs, Level 2 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign exchange forward contracts | Fair Value, Inputs, Level 2 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Assets</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016929558240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 278<span></span>
</td>
<td class="nump">$ 183<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">6,153<span></span>
</td>
<td class="nump">6,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Notes and loans payable</a></td>
<td class="nump">348<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,657<span></span>
</td>
<td class="nump">5,429<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">290<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,823<span></span>
</td>
<td class="nump">2,711<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets, estimated fair value</a></td>
<td class="nump">290<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities, estimated fair value</a></td>
<td class="nump">2,606<span></span>
</td>
<td class="nump">2,623<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 | Carrying Amount | Trust assets for nonqualified deferred compensation plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Trust assets for nonqualified deferred compensation plans</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 | Estimated Fair Value | Trust assets for nonqualified deferred compensation plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Trust assets for nonqualified deferred compensation plans, estimated fair value</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | Carrying Amount | Current maturities of long-term debt and Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Current maturities of long-term debt and Long-term debt</a></td>
<td class="nump">2,475<span></span>
</td>
<td class="nump">2,474<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | Carrying Amount | Notes and loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Notes and loans payable</a></td>
<td class="nump">348<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | Estimated Fair Value | Current maturities of long-term debt and Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Current maturities of long-term debt and Long-term debt, estimated fair value</a></td>
<td class="nump">2,258<span></span>
</td>
<td class="nump">2,386<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | Estimated Fair Value | Notes and loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShorttermDebtFairValue', window );">Notes and loans payable, estimated fair value</a></td>
<td class="nump">348<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Interest-bearing investments, including money market funds | Fair Value, Inputs, Level 1 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Interest-bearing investments, including money market funds | Fair Value, Inputs, Level 1 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents, estimated fair value</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember', window );">Time deposits | Fair Value, Inputs, Level 2 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember', window );">Time deposits | Fair Value, Inputs, Level 2 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents, estimated fair value</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShorttermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShorttermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=clx_NotesAndLoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=clx_NotesAndLoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016932131600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate on earnings from continuing operations</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">22.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016927050720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">123,339<span></span>
</td>
<td class="nump">122,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of stock options and other (in shares)</a></td>
<td class="nump">575<span></span>
</td>
<td class="nump">1,062<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">123,914<span></span>
</td>
<td class="nump">124,042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive stock options and other (in shares)</a></td>
<td class="nump">2,983<span></span>
</td>
<td class="nump">1,068<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016930569456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (loss) income, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net unrealized gains (losses) on derivatives</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and postretirement benefit adjustments</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive (loss) income, net of tax</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Total comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to Clorox</a></td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">$ 121<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016925718816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Schedule of Equity) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 2.36<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 729<span></span>
</td>
<td class="nump">$ 592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, common stock (in shares)</a></td>
<td class="nump">123,152,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance, treasury stock (in shares)</a></td>
<td class="nump">7,589,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends to Clorox stockholders</a></td>
<td class="num">(293)<span></span>
</td>
<td class="num">(143)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Dividends to noncontrolling interests</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesAmount', window );">Other employee stock plan activities</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 496<span></span>
</td>
<td class="nump">547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, common stock (in shares)</a></td>
<td class="nump">123,355,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance, treasury stock (in shares)</a></td>
<td class="nump">7,385,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, common stock (in shares)</a></td>
<td class="nump">130,741,000<span></span>
</td>
<td class="nump">130,741,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, common stock (in shares)</a></td>
<td class="nump">130,741,000<span></span>
</td>
<td class="nump">130,741,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 1,202<span></span>
</td>
<td class="nump">$ 1,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesAmount', window );">Other employee stock plan activities</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">1,193<span></span>
</td>
<td class="nump">1,166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">1,048<span></span>
</td>
<td class="nump">1,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends to Clorox stockholders</a></td>
<td class="num">(293)<span></span>
</td>
<td class="num">(143)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesAmount', window );">Other employee stock plan activities</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">832<span></span>
</td>
<td class="nump">1,027<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember', window );">Treasury Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">$ (1,346)<span></span>
</td>
<td class="num">$ (1,396)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance, treasury stock (in shares)</a></td>
<td class="nump">7,589,000<span></span>
</td>
<td class="nump">7,961,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesAmount', window );">Other employee stock plan activities</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesShares', window );">Other employee stock plan activities (in shares)</a></td>
<td class="nump">204,000<span></span>
</td>
<td class="nump">228,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock purchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(152,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">$ (1,315)<span></span>
</td>
<td class="num">$ (1,389)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance, treasury stock (in shares)</a></td>
<td class="nump">7,385,000<span></span>
</td>
<td class="nump">7,885,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Net (Loss) Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">$ (479)<span></span>
</td>
<td class="num">$ (546)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(515)<span></span>
</td>
<td class="num">(567)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Non controlling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Dividends to noncontrolling interests</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 170<span></span>
</td>
<td class="nump">$ 179<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherEmployeeStockPlanActivitiesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount includes the value of stock granted during the period as a result of exercises of employee stock options or vesting of other share-based awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherEmployeeStockPlanActivitiesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherEmployeeStockPlanActivitiesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of exercises of employee stock options or the vesting of other share-based awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherEmployeeStockPlanActivitiesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016929085968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="nump">$ 556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive (loss) income, net of tax</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">$ (21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="nump">326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive net (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="num">(479)<span></span>
</td>
<td class="num">(546)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from Accumulated other comprehensive net (loss) income</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax benefit (expense)</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive (loss) income, net of tax</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="num">(515)<span></span>
</td>
<td class="num">(567)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="num">(448)<span></span>
</td>
<td class="num">(403)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from Accumulated other comprehensive net (loss) income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax benefit (expense)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive (loss) income, net of tax</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="num">(477)<span></span>
</td>
<td class="num">(426)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Net unrealized gains (losses) on derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from Accumulated other comprehensive net (loss) income</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax benefit (expense)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive (loss) income, net of tax</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension and postretirement benefit adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="num">(152)<span></span>
</td>
<td class="num">(164)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from Accumulated other comprehensive net (loss) income</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax benefit (expense)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive (loss) income, net of tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="num">$ (151)<span></span>
</td>
<td class="num">$ (163)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016930469840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis=clx_LongTermInterCompanyLoansMember', window );">Long-Term Inter-Company Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from accumulated other comprehensive net (loss) income</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis=clx_LongTermInterCompanyLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis=clx_LongTermInterCompanyLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016930455520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 17, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=clx_RetirementIncomeMember', window );">Retirement Income Plans | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_DefinedBenefitPlanPlanTerminationPeriod', window );">Plan termination period</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=clx_RetirementIncomeMember', window );">Retirement Income Plans | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_DefinedBenefitPlanPlanTerminationPeriod', window );">Plan termination period</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=clx_RetirementIncomeMember', window );">Retirement Income Plans | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Discretionary contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DefinedBenefitPlanPlanTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Termination Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DefinedBenefitPlanPlanTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=clx_RetirementIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=clx_RetirementIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016925916672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Total</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Weighted average long-term expected rate or return on plan assets (percentage)</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits Plan | Retirement Income Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of unrecognized items</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Total</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=clx_RetirementIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=clx_RetirementIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016931965312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CONTINGENCIES AND GUARANTEES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Liability for aggregate future remediation costs</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_LetterOfCreditBorrowingCapacity', window );">Letter of credit</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letter of credit, amount outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_AlamedaCountyCaliforniaMatterMember', window );">Alameda County, California Matter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Liability for aggregate future remediation costs</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_RemediationPeriod', window );">Remediation period (in years)</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_MaximumExposureUndiscountedCost', window );">Maximum undiscounted costs</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_DickinsonCountyMichiganMatterMember', window );">Dickinson County, Michigan Matter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Liability for aggregate future remediation costs</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_RemediationPeriod', window );">Remediation period (in years)</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clx_SiteContingencyAgreedPercentageOfCostSharing', window );">Percentage of liability for aggregate remediation and associated costs, other than legal fees</a></td>
<td class="nump">24.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_LetterOfCreditBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowing capacity under the letter of credit without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_LetterOfCreditBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_MaximumExposureUndiscountedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) that the Company could incur over an estimated remediation period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_MaximumExposureUndiscountedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_RemediationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated time frame of disbursements over which remediation efforts are estimated to occur for an individual site.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_RemediationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_SiteContingencyAgreedPercentageOfCostSharing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of costs that the entity has agreed to under cost-sharing arrangements with other potentially responsible parties for an individual site.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_SiteContingencyAgreedPercentageOfCostSharing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForEnvironmentalLossContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs accrued as of the balance sheet date for environmental loss contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13237-110859<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13207-110859<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 5: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13237-110859<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 55<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=6571209&amp;loc=d3e13703-110860<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForEnvironmentalLossContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_AlamedaCountyCaliforniaMatterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_AlamedaCountyCaliforniaMatterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_DickinsonCountyMichiganMatterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=clx_DickinsonCountyMichiganMatterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016931839968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS (Narrative) (Details) - reportableSegment<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer | Customer Concentration Risk | Walmart Stores, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=clx_WalmartStoresIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=clx_WalmartStoresIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016925777712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS (Reportable Segment Information ) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,740<span></span>
</td>
<td class="nump">$ 1,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Total restructuring and related implementation costs</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=clx_RestructuringAndRelatedCostsBenchmarkMember', window );">Restructuring and Related Costs | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health and Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 712<span></span>
</td>
<td class="nump">745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="nump">$ 115<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health and Wellness | Restructuring and Related Costs | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Household</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 423<span></span>
</td>
<td class="nump">442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Household | Restructuring and Related Costs | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Lifestyle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 320<span></span>
</td>
<td class="nump">331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Lifestyle | Restructuring and Related Costs | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 285<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International | Restructuring and Related Costs | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="num">$ (104)<span></span>
</td>
<td class="num">$ (79)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate | Restructuring and Related Costs | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=clx_RestructuringAndRelatedCostsBenchmarkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=clx_RestructuringAndRelatedCostsBenchmarkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140016925816576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS (Net Sales Percentages) (Details) - Revenue from Contract with Customer - Product Concentration Risk<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Health and Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Health and Wellness | Cleaning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Health and Wellness | Professional Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Health and Wellness | Vitamins, Minerals and Supplements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Household</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Household | Bags and Wraps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Household | Grilling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Household | Cat Litter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Lifestyle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Lifestyle | Food</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Lifestyle | Natural Personal Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Lifestyle | Water Filtration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HealthAndWellnessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_CleaningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_CleaningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_ProfessionalProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_ProfessionalProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_VitaminsMineralsAndSupplementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_VitaminsMineralsAndSupplementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_BagsWrapsAndContainersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_BagsWrapsAndContainersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_GrillingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_GrillingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_CatLitterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_CatLitterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_FoodProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_FoodProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_NaturalPersonalCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_NaturalPersonalCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=clx_WaterFiltrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=clx_WaterFiltrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>clx-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:clx="http://www.clorox.com/20220930"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="clx-20220930.xsd" xlink:type="simple"/>
    <context id="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2e30c8ce95e6400b80f612d2b95a4680_I20221018">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2022-10-18</instant>
        </period>
    </context>
    <context id="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ief9b7921268144ca978e6451b72f275f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if09ffc76813043a5aa916a91f25540db_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ife6845f640b94b6d9b3a46784145e347_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i904c9b98d4a249328732ea1955c73b79_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i34328a2b14f04362ad52a7edbae327fa_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="icd000e11a868483ca61bafef62dbda9f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i47cf58703a824db8a0117fad3f780179_I20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="i09ad333c626b4d51be54887b41e252f1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">clx:CostOfGoodsAndServicesSoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib61f3f9358bc4648a900ad8d686db004_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i63f8e80373f44df188b7b0bba1958467_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">clx:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0f9e22509a6d450fa6331417e37243f0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i341aba281f28491c9e0f804508f61995_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iace90036b5d84d608091db4139e10cb0_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9a0251ee71ad46aab3436fb41074e067_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i407e5b359a574869b044cdc2231bcc94_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id07f895c223b44f0af02d5bca7906d74_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id33bf162891042b581228081b2a7c697_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6e8a89c05a0a4a16b4de18869bfd695f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5b924fb632f04f0c94baf25d9aae883e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="clx:CommodityPurchaseDerivativeContractsAxis">clx:TotalCommodityPurchaseDerivativeContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib118d948faed49dea943620ecb2804d1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">clx:PurchasesofInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iba5d16b63ef34671b972df411f72c26c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">clx:PurchasesofInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i87647bbf68694e6cb56844238655ccb6_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7f677fe19c1746429e18febc5f25cfea_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7eed42a98cdf4c8484f4d6f50ba27c2c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i89d66606b3294de5be2599b89449703f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icc00d18fe4de47a698a3a7bc531123de_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if5e13b9874e848cf9b0bb2bdda02efbd_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i21899b87bd5e4a699970017caa794236_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i767f12083ea54bc4a43b4049513c1a15_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i179d67c234714ee4907a95545f754ed4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2217e4efada64de48ae6279d4cff1f35_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i830d873fccfc4a348844a4a1ec805c4e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2066cd30a255497092b1965c041e9697_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic9d03b4e69154fb28b379075df843c40_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6332a61aea924b20b5a7f810ba642def_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i224d9fac5a284cae8a8129752c459c15_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i927e8b53d03f409c8397e57ad50983cf_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i298fa64546144e7c8725322be166049b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i340a0bfb85cc4a238353da0ab09b3e19_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4f6c62d24498449dbd1912f053706e5f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i727b7773814a4b248462dd8c293d6447_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i63b417fd4e2e4baca829a11debf18917_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i12297feced3a40998cfae2f77b61fe69_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5714ee2d486c40e0920537af19846e5c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4ccd25a4389e4143bcd3303d5a26ad64_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idd434cb3d24d4c54a373f4e7355f9440_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9857e40c16694defb9128852a3249eee_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8d46c7f6455a482fb10a18e1305a3b96_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7c19bcb918ca49c096f1881179d2c512_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3e781035dc6444a2bee2f22c5a1fe45f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5a749b02bcb6491283cdb7b6391346d8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i40dcc202c4e041af8d2d5be92340ac45_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic07dfcc355994c14808ed66f5abf1c36_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifeea7735269f42f1af408fc370004480_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0d9e30fd0e724ca38629fa8a85472f94_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i45536724bfd7435b9cb5468e757ce469_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i12b8749fcb3a4647a6723c05d51fb551_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i75626a99bf8247128cf595d793463677_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ife4c0c7afd9144938f80700f00e2e503_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i48ad05476c804a989876d463a18d0f08_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i743b074f5dff4cbb8b388b51e52d39ea_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i77cea09568304a929a0021ea5531db88_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic520fafe28c44d34ac504762a168782a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic048de659b754fc9a1c06eb94c867694_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idd3d0e49a60941ee8d18b67216bb2d26_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id48f7675a8794df7843115f14fe4bb25_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5e5e0252210049cfa75325d985e17243_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic2d95a7621de4ea1b42295baf483de7b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7feccdfe1c8340ada0a48b4cad20e5f0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i67937b96a80447d18275ba06851fb742_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i56d5c5699f5b41ca84983f1f737c45bb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia1a0121aacaa451b9fc9b38eb0223d9f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5c212dd4fc614d22a2bc72979bf8a54e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifd86e6e3a1b44f9b9471e84cc3d38d59_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6930f355cf7642b6887d05d83aef15c5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0196020330d14953b976bf363233729f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ice68a02899784fd88d4432a3fb090772_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i730ffd508cf243709923d83ea9b803c6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1c7699609a3549b8b86808d050c110d4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5e8cfd1012e540b98b636dc848d3c3bc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iaacd12e7523f4715be7afb04d18844aa_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7cda18cb62f44748b28447a88f322746_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2284863f0fb44dcfae350d8ee4e1fd77_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibf478d53ab4b4b9f980df8bc214e13cb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifa3208678276429ca1a8f3db656730ee_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i888a4cf85c084a58ab95492d82a8d4a1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6052bc3b28d746c0bd0c11c456d9f13f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8cf3392f32d3409285d213bbc6902517_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i94279de6d96e4bd99aef13f69b2d95d3_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ida1b5d30c914404b95ad3394c7bdbfe4_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i12b44d1ebaff43ac9c4d3e2a2bae7d0f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie9d6549a44e94575912af38c44fff8a9_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7b08aa96dca042dab59571ea3df315f4_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8678dafbf0e64ad3a1136c20a7706504_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9d1bbb06b08d40428b604d332162f94c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iffdbe24edf9f479bb05597d7938ccac2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2648e344424447c4982226cfa30a4b3e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i05ae02b9557f460e90131cf855f3e5b2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i589ef1e1d7364af18ae1c4f29b187901_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iaf7e1839e4634249b8d12259ef4657a6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icc23221332314a54bdc672565b6ca265_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic430fcc6fc214744a2f1da71a2c66678_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8c3e1b9f5f034fcdacc2d71873899331_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i90d469ba619141c2ace7f747b1d68050_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iab66d6f5313944d98bde2718ad418ab2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic4d5e6459eff4d29a673adf7eb5402d1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib209e83a487b430bafc14ba29f31ede4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i15f764dde95c421bbfb594d9a2886d15_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6eed3460799b4a04ba1ee3810ded507a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id337d4363166457ab49d51fd89cad69b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i72dde26130df4e1c9e1eeb773672603e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if3aaab4df1434368a525f9cb0ea76ec3_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i29278874f2bd4e64950e351a9d477fdb_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i58b0a3cc9bf4444ea52a9aad02fafd3c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i56269e6a9fc24521a48f5dbce03064f4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id5f1f0fa07304fef96e2267e72a9854a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i12cee7acd73141489be68129eaa031ae_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i800f404abef344e79689a216db23038a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icab4c536fd8d4a618d358572c4a848e7_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermInterCompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1947113776464ef48d89fbe12f701aff_D20220517-20220517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-17</startDate>
            <endDate>2022-05-17</endDate>
        </period>
    </context>
    <context id="if0073bc5d83c4f66b1cb1bd49f9af101_D20220517-20220517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-17</startDate>
            <endDate>2022-05-17</endDate>
        </period>
    </context>
    <context id="i31edb4dd7f44492f8d09aec0fa03e5c9_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic2294f6a1f354e1fb535db2d898d6850_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id270c77784994d6b9347452cfa7bcfd5_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id55f7224e21846c3acf2d3b00db79eb7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id97f6cb32d4443f685b8c442cb50ea2d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i227c62eeec2344e5bec7da0b046fdc53_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie6800724d53e43ac84874399f3d245da_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:AlamedaCountyCaliforniaMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i806e73012b0a480488ca9ea714e35107_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5b7963d1f14a45a09a9a46e7127d2f99_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i849355af7bdb45cc8899544e54dcb57c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">clx:DickinsonCountyMichiganMatterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4e8cd95aed9b4c81901ca7d5a53d1ce1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i26e621abaf0d47d4b39a2fa43224768f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id69dc302ea5d43f9bc300bfd696c1476_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3dadaf4c1716414abfe9786d4d65c91c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2b42821a22844c5ca6f9e44fd13cb6c1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id0de7a722ac64da8858c7bf8cee9b411_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6f89b0641ef04737bd695667b84a20c8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic6d2033d94204c51b0c34eb17cd5f6b5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i606ff00a1b9e43a3a6959e8d1ebb4977_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia3fa7b12816f411cbaf987175543040a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3a5f78e9f3c74fa9b02f7b5e6ee65670_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2183c0c64c434e5a9aeea41c54cb625b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i74eb275af8db41049d9007f8bc834661_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3048afb6b1df4c98bbe9928ae66d4d4d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3dbef4e516584b3c8b89e91c01bce178_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3007927605bd40d6aa8bd18ae2feac19_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">clx:RestructuringAndRelatedCostsBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i825a3f474bef4d57a41b659e4276eb92_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4923cfb94e8049c1ba541c14e5fc41f1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8b90eb0ef6054ab7a5b9de59365a28ac_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i746c110841a342e1b5c9555eaa2e1ce1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iedec36bdebec43808dffc518431446b5_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ide10fb2fb37f424dbdc6a428a5cbd88a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:ProfessionalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i61a07a11680e4116a22f12f9e4f59402_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3ab02c4c09bc448e9e4bbf6710b688a3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:VitaminsMineralsAndSupplementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i417b78725106447a96236599f5fe7024_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3830eddd6eec4653b1b850774f83f799_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HealthAndWellnessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i79dab9a38edd41d3a954624d9e05a0bb_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie8117aec118647b49d7490ddbaeaea3e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:BagsWrapsAndContainersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i97d7a4a287334750b35878de0c632079_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i26bbe833ac1640c89c7c526a81516775_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:GrillingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i052b0fc813da42178769b516bf6454df_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i159d29d0958b4e4bba0eedf9dd60d3b5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:CatLitterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i684f9f739fd74d75980dc46564a4fc1d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2769b1c5b55f417f9f0a0b3a7b69c023_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i264bcb59d1fb4a8b8f8f5ad7b7fe1dd8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7ed314c335fd49008ec3b335ea3c14f9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:FoodProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i260a34245a4a4431a0f5f91d94de3567_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i42e6cf57392445509d1e157867ac3729_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:NaturalPersonalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i68962e875b5c463d9cda87f98c695ea9_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie488b698386942d488eb9191bf6c03e9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">clx:WaterFiltrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8ca24239316c482eaa1b9a014e855a41_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id94210280c4f459a95a0145d49e7170a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i59c4149e9cc24e3abe5f72106c11a911_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i55565f7982054624baa5bc769685ff9a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia206ce29644b481c940c521fcb640e60_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3315b5d84b164803b2a50689febd9ff5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021076</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="reportablesegment">
        <measure>clx:reportableSegment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80L2ZyYWc6MDdhOTgxYzk0MmI5NGRlMzllYWNlODRjYWZlMjEwYmEvdGFibGU6MzBiNzI3ZjYxZjk5NDNkZmJjODY1NDBlYmIwNjFlMDEvdGFibGVyYW5nZTozMGI3MjdmNjFmOTk0M2RmYmM4NjU0MGViYjA2MWUwMV8zLTEtMS0xLTYyNzEz_529958f3-ab63-4475-b739-b5f805460759">0000021076</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80L2ZyYWc6MDdhOTgxYzk0MmI5NGRlMzllYWNlODRjYWZlMjEwYmEvdGFibGU6MzBiNzI3ZjYxZjk5NDNkZmJjODY1NDBlYmIwNjFlMDEvdGFibGVyYW5nZTozMGI3MjdmNjFmOTk0M2RmYmM4NjU0MGViYjA2MWUwMV80LTEtMS0xLTYyNzEz_c245c13d-87b3-4936-b847-946bf9caac6e">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80L2ZyYWc6MDdhOTgxYzk0MmI5NGRlMzllYWNlODRjYWZlMjEwYmEvdGFibGU6MzBiNzI3ZjYxZjk5NDNkZmJjODY1NDBlYmIwNjFlMDEvdGFibGVyYW5nZTozMGI3MjdmNjFmOTk0M2RmYmM4NjU0MGViYjA2MWUwMV81LTEtMS0xLTYyNzEz_3f9da604-9201-4c3b-a8a1-a48d742026fd">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80L2ZyYWc6MDdhOTgxYzk0MmI5NGRlMzllYWNlODRjYWZlMjEwYmEvdGFibGU6MzBiNzI3ZjYxZjk5NDNkZmJjODY1NDBlYmIwNjFlMDEvdGFibGVyYW5nZTozMGI3MjdmNjFmOTk0M2RmYmM4NjU0MGViYjA2MWUwMV82LTEtMS0xLTYyNzEz_b9cae450-2b6a-437e-8376-90e187141576">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80L2ZyYWc6MDdhOTgxYzk0MmI5NGRlMzllYWNlODRjYWZlMjEwYmEvdGFibGU6MzBiNzI3ZjYxZjk5NDNkZmJjODY1NDBlYmIwNjFlMDEvdGFibGVyYW5nZTozMGI3MjdmNjFmOTk0M2RmYmM4NjU0MGViYjA2MWUwMV83LTEtMS0xLTYyNzEz_207f4b4f-1938-4c6d-be96-d36772d43665">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentType
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF84NA_db33ffe7-ac3b-4a7a-89ab-bc51e0098e7f">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6ZDVmNGFiODJjOWYwNDA4Y2IxZmEyNTNjMTA0NDJlNmMvdGFibGVyYW5nZTpkNWY0YWI4MmM5ZjA0MDhjYjFmYTI1M2MxMDQ0MmU2Y18xLTAtMS0xLTYyNzEz_3411974f-4734-43a4-96de-523349ce8ff8">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8xNjQ5MjY3NDQzNTkx_469d974a-c402-475d-ba81-15171c8f3ab4">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6OTY4ZjY0YmQwMmQ3NDY4MDk5YjNkMzY5NjZhMGM0OTgvdGFibGVyYW5nZTo5NjhmNjRiZDAyZDc0NjgwOTliM2QzNjk2NmEwYzQ5OF8wLTAtMS0xLTYyNzEz_ea602c60-d381-4905-a474-a41366a2d2e0">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8yMDI_3457f0e7-9e50-4f2c-819e-a7042ca278ff">1-07151</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8yMDg_30d5aa44-21e4-4bcd-ad01-50eeadd5a220">THE CLOROX COMPANY</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6MmRiNTM3N2YwODczNGQ4N2IxOTVjOTZiMjg3MjBiZGMvdGFibGVyYW5nZToyZGI1Mzc3ZjA4NzM0ZDg3YjE5NWM5NmIyODcyMGJkY18wLTAtMS0xLTYyNzEz_7166aac9-bdb6-430b-a27a-22c154236d44">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6MmRiNTM3N2YwODczNGQ4N2IxOTVjOTZiMjg3MjBiZGMvdGFibGVyYW5nZToyZGI1Mzc3ZjA4NzM0ZDg3YjE5NWM5NmIyODcyMGJkY18wLTEtMS0xLTYyNzEz_d96eb23c-8dbb-4eb0-b04e-d4c33ab6ac8a">31-0595760</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8yNjk_6071334b-6cfd-4224-89ef-3b4e27a93f12">1221 Broadway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8yNzM_9263734f-8962-4dfe-84e4-297492bba5bf">Oakland</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8yNzc_417f86ff-b84b-4ec4-b14d-bef5bb9f9576">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8yODE_ba42c913-5e27-4de4-a4b9-92b8037fafaf">94612-1888</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8zMzg_00d5a5c4-d7f6-4717-adb7-ea9d8f104af6">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8zNDI_d0e6e7d1-dea4-4536-bed3-22a77c17cc96">271-7000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6ZTQzMDc2YzhmYTA2NGQxMDg1ZTY3MTNiY2U1YmY2ZjQvdGFibGVyYW5nZTplNDMwNzZjOGZhMDY0ZDEwODVlNjcxM2JjZTViZjZmNF81LTAtMS0xLTYyNzEz_11540cb6-d76f-47e4-9e30-fdc480c66c4b">Common Stock - $1.00 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6ZTQzMDc2YzhmYTA2NGQxMDg1ZTY3MTNiY2U1YmY2ZjQvdGFibGVyYW5nZTplNDMwNzZjOGZhMDY0ZDEwODVlNjcxM2JjZTViZjZmNF81LTEtMS0xLTYyNzEz_62801d29-91ab-4816-9e50-7d26465e1ee2">CLX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6ZTQzMDc2YzhmYTA2NGQxMDg1ZTY3MTNiY2U1YmY2ZjQvdGFibGVyYW5nZTplNDMwNzZjOGZhMDY0ZDEwODVlNjcxM2JjZTViZjZmNF81LTItMS0xLTYyNzEz_0f3dcae5-043d-42de-a1e5-a9b4b15c843d">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF83NDc_356bb48f-7efa-469b-81a1-5172fdb54a29">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8xMDY4_3de4cba2-ccde-4898-b4ff-78081881da54">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6ZTU5NjlhZjFhMjhlNGUxMGExMWQxMWYxN2ZiNjk5YzMvdGFibGVyYW5nZTplNTk2OWFmMWEyOGU0ZTEwYTExZDExZjE3ZmI2OTljM18wLTAtMS0xLTYyNzEz_30442acf-4530-471b-bbdc-a85eef9d706c">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6ZTU5NjlhZjFhMjhlNGUxMGExMWQxMWYxN2ZiNjk5YzMvdGFibGVyYW5nZTplNTk2OWFmMWEyOGU0ZTEwYTExZDExZjE3ZmI2OTljM18wLTctMS0xLTYyNzEz_18ad6cc7-c1b1-402f-ba01-414385115734">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGFibGU6ZTU5NjlhZjFhMjhlNGUxMGExMWQxMWYxN2ZiNjk5YzMvdGFibGVyYW5nZTplNTk2OWFmMWEyOGU0ZTEwYTExZDExZjE3ZmI2OTljM18wLTktMS0xLTYyNzEz_4c9e8f32-1cc5-452c-a442-4047db5fb1cf">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8xODAx_3f2b59aa-6704-4f1e-b707-3918e3fb2ce8">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i2e30c8ce95e6400b80f612d2b95a4680_I20221018"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xL2ZyYWc6YTllN2I0MjE4Mjc3NDY1OWJiOGUyNTM0ZTRjYTFkNTAvdGV4dHJlZ2lvbjphOWU3YjQyMTgyNzc0NjU5YmI4ZTI1MzRlNGNhMWQ1MF8xODMy_2d3622f0-ed34-48e8-bcdb-b12ccde72b5e"
      unitRef="shares">123384797</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMi0zLTEtMS02MjcxMw_1464b922-aa56-4987-a266-a975acd40d4f"
      unitRef="usd">1740000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMi02LTEtMS02MjcxMw_d7d637a9-e812-4044-ba4d-9b0a52f58ac3"
      unitRef="usd">1806000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMy0zLTEtMS02MjcxMw_3506dbf4-f616-4b8c-9d88-3f30fc2cbf75"
      unitRef="usd">1114000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMy02LTEtMS02MjcxMw_812270d9-fce3-424b-a0ac-9069ad54493e"
      unitRef="usd">1136000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfNC0zLTEtMS02MjcxMw_a7cd412b-72cb-4e7d-9db0-d0daeb19a032"
      unitRef="usd">626000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfNC02LTEtMS02MjcxMw_81119667-10ce-48d4-8e29-de4ce12936fd"
      unitRef="usd">670000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfNS0zLTEtMS02MjcxMw_1a472d3e-a150-4d02-86de-3a035f4cea0f"
      unitRef="usd">261000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfNS02LTEtMS02MjcxMw_aa200401-464b-4dd5-92c5-b2355a6bdd35"
      unitRef="usd">236000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfNi0zLTEtMS02MjcxMw_0b8992ac-acdf-45bb-922d-447cd97bfcd1"
      unitRef="usd">161000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfNi02LTEtMS02MjcxMw_91dc06d2-5a33-4638-a476-3e135849c2e8"
      unitRef="usd">182000000</us-gaap:AdvertisingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfNy0zLTEtMS02MjcxMw_8ac34814-b2d5-46ff-b473-da4a2f15df49"
      unitRef="usd">32000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfNy02LTEtMS02MjcxMw_e197feb6-622c-4330-bbe6-f0303543ef47"
      unitRef="usd">33000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:InterestExpense
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfOS0zLTEtMS02MjcxMw_3f4e1ea1-47e6-4797-ad40-db3a7e83e01a"
      unitRef="usd">22000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfOS02LTEtMS02MjcxMw_c2a8670c-f0d1-4e8e-bbec-38f2b9910d89"
      unitRef="usd">25000000</us-gaap:InterestExpense>
    <clx:OtherExpenseIncomeNet
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTAtMy0xLTEtNjI3MTM_d43bc13e-417c-4473-9c69-de13ab5c91cd"
      unitRef="usd">34000000</clx:OtherExpenseIncomeNet>
    <clx:OtherExpenseIncomeNet
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTAtNi0xLTEtNjI3MTM_46962d8c-fc99-433a-beb2-d83e2ca09945"
      unitRef="usd">9000000</clx:OtherExpenseIncomeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTEtMy0xLTEtNjI3MTM_f2eba515-1fcd-43fc-934a-37326e3c3a9a"
      unitRef="usd">116000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTEtNi0xLTEtNjI3MTM_7d9d75d9-156e-403e-8aeb-aeb07e5832a5"
      unitRef="usd">185000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTItMy0xLTEtNjI3MTM_fb5b5fed-7050-4d81-a0f4-23dec782c53b"
      unitRef="usd">29000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTItNi0xLTEtNjI3MTM_41b648ca-19be-470f-8e3d-d20263b7e02f"
      unitRef="usd">42000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTMtMy0xLTEtNjI3MTM_015cffa2-3d1d-4473-b8ca-7dde27b6cde5"
      unitRef="usd">87000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTMtNi0xLTEtNjI3MTM_62b10f12-4f20-4d2c-aa00-abd0876ccfbf"
      unitRef="usd">143000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTQtMy0xLTEtNjI3MTM_143d6fcc-f1ad-4345-a11f-44ef1aab5c33"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTQtNi0xLTEtNjI3MTM_2c01574f-a0d4-4435-a677-4e631e84d043"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTUtMy0xLTEtNjI3MTM_c696232a-0f64-4b05-8bd5-eb371f324933"
      unitRef="usd">85000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTUtNi0xLTEtNjI3MTM_cfff2431-5547-47a8-8429-c84caf485f4e"
      unitRef="usd">142000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTctMy0xLTEtNjI3MTM_25fb19b2-480d-473b-9946-af974d9fb4f1"
      unitRef="usdPerShare">0.69</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTctNi0xLTEtNjI3MTM_68e6d639-9858-4282-a7a4-e554fd122e74"
      unitRef="usdPerShare">1.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTgtMy0xLTEtNjI3MTM_99e54996-32e8-4e62-b02d-98306f2668a8"
      unitRef="usdPerShare">0.68</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMTgtNi0xLTEtNjI3MTM_44b744be-d324-4666-8e09-8c92ff2e0bd3"
      unitRef="usdPerShare">1.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjAtMy0xLTEtNjI3MTM_1b2815f0-2f9e-4db8-83a6-35ebe38d0672"
      unitRef="shares">123339000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjAtNi0xLTEtNjI3MTM_3b14ce9c-41a7-4697-9a89-4ff398a1460d"
      unitRef="shares">122980000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjEtMy0xLTEtNjI3MTM_122641bf-667f-4f95-86bd-d338bb4ff323"
      unitRef="shares">123914000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjEtNi0xLTEtNjI3MTM_376ff4f8-ea21-4cef-8a5c-d844475d2d84"
      unitRef="shares">124042000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjMtMy0xLTEtNjI3MTM_a83b0882-a663-4db3-99da-011f859c6eb4"
      unitRef="usd">51000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjMtNi0xLTEtNjI3MTM_a464afde-3e60-4642-bc06-7fc5e226749e"
      unitRef="usd">122000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjQtMy0xLTEtNjI3MTM_7dcc0952-f8ef-429b-97f4-f4d5ebaef13f"
      unitRef="usd">2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjQtNi0xLTEtNjI3MTM_a915a5cb-f615-44fa-9758-1e88efce0ce7"
      unitRef="usd">1000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjUtMy0xLTEtNjI3MTM_5b2c4e66-7b67-4bbd-a55c-2a875947da27"
      unitRef="usd">49000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMC9mcmFnOjg1YTVhNjg4Zjc3NjQxMWU4NTFhMDI4ZTkxZjZiMGUxL3RhYmxlOjc0MzM2NjVmNzM4MDQyOGY4NWYyMzhiNDk2NjA4Y2VmL3RhYmxlcmFuZ2U6NzQzMzY2NWY3MzgwNDI4Zjg1ZjIzOGI0OTY2MDhjZWZfMjUtNi0xLTEtNjI3MTM_6622f551-6997-4a92-91c6-002dd2192fb7"
      unitRef="usd">121000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNC0yLTEtMS02MjcxMw_7546e69f-3b94-4588-b9d5-2d0bb267ea96"
      unitRef="usd">278000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNC01LTEtMS02MjcxMw_4f266e21-3f95-4505-a93f-05fb6a4e5d45"
      unitRef="usd">183000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNS0yLTEtMS02MjcxMw_13e4596a-eded-4ecd-a9bc-c275e52dde80"
      unitRef="usd">612000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNS01LTEtMS02MjcxMw_226f08d9-2ec3-4425-a70b-1c2772734823"
      unitRef="usd">681000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNi0yLTEtMS02MjcxMw_59f230a2-eaad-48c0-b44e-516a0471b58f"
      unitRef="usd">755000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNi01LTEtMS02MjcxMw_d478dfc9-37f6-412d-8785-2b10514e5e80"
      unitRef="usd">755000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNy0yLTEtMS02MjcxMw_aaa9d42e-7be2-4000-9303-9f8acf0cfdc0"
      unitRef="usd">118000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNy01LTEtMS02MjcxMw_898ecc6c-3ec3-48bb-bd2a-c1c756317906"
      unitRef="usd">106000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfOC0yLTEtMS02MjcxMw_0f1caef8-e86d-4a3b-8f2f-5d03001c172c"
      unitRef="usd">1763000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfOC01LTEtMS02MjcxMw_f9498f7c-6542-45b1-a7da-ced2ea3946e8"
      unitRef="usd">1725000000</us-gaap:AssetsCurrent>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfOS0wLTEtMS02MjcxMy90ZXh0cmVnaW9uOmNmMTQwMzY3YWFkZTQzMTc4MjgwZjgzNTYyNzUwYjczXzk2_28d32ad3-6bef-4d0c-856e-d4f4710c6aed"
      unitRef="usd">2575000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfOS0wLTEtMS02MjcxMy90ZXh0cmVnaW9uOmNmMTQwMzY3YWFkZTQzMTc4MjgwZjgzNTYyNzUwYjczXzEwMw_db9d00d2-4299-44b8-9e3f-84e3c316add3"
      unitRef="usd">2530000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfOS0yLTEtMS02MjcxMw_bf482330-d5f8-44d5-8b4b-03d5279704c2"
      unitRef="usd">1322000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfOS01LTEtMS02MjcxMw_8fe6eb01-38f9-47cc-a446-494e02bfc518"
      unitRef="usd">1334000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTAtMi0xLTEtNjI3MTM_64554b04-805c-4cce-82ea-56c5c6ff8788"
      unitRef="usd">336000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTAtNS0xLTEtNjI3MTM_ca07f22e-1046-4756-abf6-255e8592c0b3"
      unitRef="usd">342000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTEtMi0xLTEtNjI3MTM_21b2fbd3-988e-4da4-ae7f-2309fc732ffb"
      unitRef="usd">1546000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTEtNS0xLTEtNjI3MTM_c17ba47a-03de-4e73-a6ff-a05d7d48188d"
      unitRef="usd">1558000000</us-gaap:Goodwill>
    <clx:TrademarksNet
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTItMi0xLTEtNjI3MTM_b26725c4-b987-4536-a66a-8f5596eab423"
      unitRef="usd">685000000</clx:TrademarksNet>
    <clx:TrademarksNet
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTItNS0xLTEtNjI3MTM_969c0467-bc7b-43df-859a-b0af0f332296"
      unitRef="usd">687000000</clx:TrademarksNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTMtMi0xLTEtNjI3MTM_74702328-35f5-4fc1-9367-633347068150"
      unitRef="usd">190000000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTMtNS0xLTEtNjI3MTM_afe9ac12-c5b4-434c-a905-f346eb9bdb41"
      unitRef="usd">197000000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTQtMi0xLTEtNjI3MTM_67fdbdbb-b60f-475d-99fb-822df006883e"
      unitRef="usd">311000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTQtNS0xLTEtNjI3MTM_2dc182c9-dda2-467b-b3d5-1f9fdfa8d609"
      unitRef="usd">315000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTUtMi0xLTEtNjI3MTM_353a6b13-dc8e-4949-a1c2-490e464fd3c8"
      unitRef="usd">6153000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTUtNS0xLTEtNjI3MTM_be6f6806-3fc5-417a-a0b3-fe19ed656201"
      unitRef="usd">6158000000</us-gaap:Assets>
    <us-gaap:CommercialPaper
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTgtMi0xLTEtNjI3MTM_1a7cf547-5a25-4491-a04c-729567579b51"
      unitRef="usd">348000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMTgtNS0xLTEtNjI3MTM_eebe05c7-cbf1-4b12-9300-419b0fea9eec"
      unitRef="usd">237000000</us-gaap:CommercialPaper>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjAtMi0xLTEtNjI3MTM_e65a86ec-b691-4fab-b06f-e4ab6c620074"
      unitRef="usd">78000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjAtNS0xLTEtNjI3MTM_d7e2d9b7-eb7c-4c8d-b60e-63ed9a1c340f"
      unitRef="usd">78000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjEtMi0xLTEtNjI3MTM_c5d81042-ef8a-4aed-8259-e69aeedaa2b3"
      unitRef="usd">1584000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjEtNS0xLTEtNjI3MTM_dbae282b-0c75-4281-abb6-50f5a65ef5d3"
      unitRef="usd">1469000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjMtMi0xLTEtNjI3MTM_9f499014-c5d4-463c-ba20-1167b72ca494"
      unitRef="usd">2010000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjMtNS0xLTEtNjI3MTM_4461c553-4605-4b60-ae4a-213dda4438c6"
      unitRef="usd">1784000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjQtMi0xLTEtNjI3MTM_1a1e20b9-e472-448c-98f0-50a05582e88a"
      unitRef="usd">2475000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjQtNS0xLTEtNjI3MTM_eb13d772-ae92-4374-bec7-abbde4345750"
      unitRef="usd">2474000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjUtMi0xLTEtNjI3MTM_00bebe1b-506f-4aac-be77-1dacbbb911cf"
      unitRef="usd">308000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjUtNS0xLTEtNjI3MTM_1c048d2f-5b51-4d83-b07b-02b49a168a3f"
      unitRef="usd">314000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjYtMi0xLTEtNjI3MTM_7e5ccc07-ab44-47a0-9d71-1ec0064a567e"
      unitRef="usd">805000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjYtNS0xLTEtNjI3MTM_826d9e20-569a-4d91-a91d-638b8bdabd3b"
      unitRef="usd">791000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjctMi0xLTEtNjI3MTM_a2d430a5-0479-4288-bb8b-190be63843af"
      unitRef="usd">59000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjctNS0xLTEtNjI3MTM_efcfe285-f73d-4667-81b7-8e44e4786f87"
      unitRef="usd">66000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjgtMi0xLTEtNjI3MTM_bfc8dcaa-15c2-427d-9d48-85029754c6aa"
      unitRef="usd">5657000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjgtNS0xLTEtNjI3MTM_b562cbef-f949-4e79-964c-640bd1b90b90"
      unitRef="usd">5429000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjktMi0xLTEtNjI3MTM_bfb3a4ff-6a12-4688-a241-8d622d2ec349"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMjktNS0xLTEtNjI3MTM_df5a400f-09d5-456b-bec4-9417768d468a"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjpmNDg3Mjc2YmU0NjY0MjRmOTUzZDAyMDBhYzU4ODBiNF8yMQ_1a27da99-29cf-4b28-a206-51de937cb87b"
      unitRef="usdPerShare">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjpmNDg3Mjc2YmU0NjY0MjRmOTUzZDAyMDBhYzU4ODBiNF8yMQ_2bffbb1f-d6ff-42d5-8ab3-5232a670b393"
      unitRef="usdPerShare">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjpmNDg3Mjc2YmU0NjY0MjRmOTUzZDAyMDBhYzU4ODBiNF8zNQ_6c40b2e1-560a-43ad-958a-cc275d628ddc"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjpmNDg3Mjc2YmU0NjY0MjRmOTUzZDAyMDBhYzU4ODBiNF8zNQ_82dacf3d-3356-4939-b0a9-df571f1726b4"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjpmNDg3Mjc2YmU0NjY0MjRmOTUzZDAyMDBhYzU4ODBiNF81Nw_0371cffb-9cac-49f2-b9a7-e26c753ba089"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjpmNDg3Mjc2YmU0NjY0MjRmOTUzZDAyMDBhYzU4ODBiNF81Nw_1310130a-2138-477a-9d1e-a0415ae95dc3"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjpmNDg3Mjc2YmU0NjY0MjRmOTUzZDAyMDBhYzU4ODBiNF81Nw_77fab393-87b0-4265-97a5-67961f8bddd9"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjpmNDg3Mjc2YmU0NjY0MjRmOTUzZDAyMDBhYzU4ODBiNF81Nw_a21b3321-5c29-439b-989e-087bdb3d4c54"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtMi0xLTEtNjI3MTM_75695863-4648-45db-946f-525ff05c197f"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzEtNS0xLTEtNjI3MTM_15da7c28-684a-4135-a78c-0732425f612f"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo2YzA2ZjQ5MDM0MjQ0NGI3YTBhZTRlN2Q0ZjM2ZTI1NF8xOQ_79ce7f7b-baf4-44d0-aaaa-abcadbd6f90a"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo2YzA2ZjQ5MDM0MjQ0NGI3YTBhZTRlN2Q0ZjM2ZTI1NF8xOQ_8611673f-0c4f-42f7-bd05-12e02aa155b8"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo2YzA2ZjQ5MDM0MjQ0NGI3YTBhZTRlN2Q0ZjM2ZTI1NF8zMw_01f83d36-e887-44fc-8816-f48f374e466e"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo2YzA2ZjQ5MDM0MjQ0NGI3YTBhZTRlN2Q0ZjM2ZTI1NF8zMw_a3698070-cadd-4ca0-9415-46cc5768632e"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo2YzA2ZjQ5MDM0MjQ0NGI3YTBhZTRlN2Q0ZjM2ZTI1NF81NQ_7bc8d734-3435-4529-a8b9-d2beda8e3d01"
      unitRef="shares">130741461</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo2YzA2ZjQ5MDM0MjQ0NGI3YTBhZTRlN2Q0ZjM2ZTI1NF81NQ_8cc8b7e9-70e9-48c6-ac2f-4b26618ff53a"
      unitRef="shares">130741461</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo2YzA2ZjQ5MDM0MjQ0NGI3YTBhZTRlN2Q0ZjM2ZTI1NF85Mw_7f668801-2c93-4876-a3c3-a9fee6d1ed41"
      unitRef="shares">123355986</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo2YzA2ZjQ5MDM0MjQ0NGI3YTBhZTRlN2Q0ZjM2ZTI1NF8xMDA_7ebcf9a4-0a0e-4045-a7bc-d16c02629a1a"
      unitRef="shares">123152132</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItMi0xLTEtNjI3MTM_32e04ecc-eb59-42e9-b7e7-025b3d3b8739"
      unitRef="usd">131000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzItNS0xLTEtNjI3MTM_310bb41e-a923-44c4-b22d-bceeb9a1a255"
      unitRef="usd">131000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzMtMi0xLTEtNjI3MTM_502d173e-15a7-4926-9b0f-b827d6eec5c8"
      unitRef="usd">1193000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzMtNS0xLTEtNjI3MTM_4d537e39-783d-41f3-8118-7dcfc227997e"
      unitRef="usd">1202000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzQtMi0xLTEtNjI3MTM_b0f05d67-1fbf-46e6-a0a1-0b88aa776e28"
      unitRef="usd">832000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzQtNS0xLTEtNjI3MTM_830952cd-1aea-45c1-b4a9-3a60318b9c9d"
      unitRef="usd">1048000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzUtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo5NGMwODhjMDYxZDM0YTM1ODVjYjEyMzcwNDc0ZmRiY18yOQ_7c112f0e-7dc0-4b0d-9c92-918058ece733"
      unitRef="shares">7385475</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzUtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo5NGMwODhjMDYxZDM0YTM1ODVjYjEyMzcwNDc0ZmRiY18zNg_0d320618-367d-4d99-aff6-5d0e3631198a"
      unitRef="shares">7589329</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzUtMi0xLTEtNjI3MTM_9f0c9504-f151-4d97-9692-099f86cc1389"
      unitRef="usd">1315000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzUtNS0xLTEtNjI3MTM_0850b1c1-9964-4b71-91f1-a8aa03b1acea"
      unitRef="usd">1346000000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzYtMi0xLTEtNjI3MTM_70d871b3-a692-4e5c-8109-616cf112ee31"
      unitRef="usd">-515000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzYtNS0xLTEtNjI3MTM_df614860-aaae-4f28-b991-c53a1bbfaf37"
      unitRef="usd">-479000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzctMi0xLTEtNjI3MTM_0bf8453e-f5b5-4489-ace9-b94cf17eeb92"
      unitRef="usd">326000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzctNS0xLTEtNjI3MTM_99e66de9-bedd-4c83-afd3-69d95f87dec7"
      unitRef="usd">556000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzgtMi0xLTEtNjI3MTM_2127a167-3f27-4ca3-b772-af06c66447b7"
      unitRef="usd">170000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzgtNS0xLTEtNjI3MTM_02b1cbe5-7b26-4099-940a-9c50ed46ff43"
      unitRef="usd">173000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzktMi0xLTEtNjI3MTM_92efd5f1-097a-40ff-a92e-eb11ea5100bf"
      unitRef="usd">496000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfMzktNS0xLTEtNjI3MTM_8ce5141f-8754-40dc-aadb-8ef624dd35de"
      unitRef="usd">729000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNDAtMi0xLTEtNjI3MTM_8708ba5f-16e3-4673-a3d2-aa524ec3648b"
      unitRef="usd">6153000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xMy9mcmFnOmE5Y2U5YWI1YzIwZTQwZGRhOWZjOGExMjMwMGQxMTRjL3RhYmxlOjE4ZDVkZWRlNDk1NDRmMmNiMzdmYzk3ZTdiZWUxMjYwL3RhYmxlcmFuZ2U6MThkNWRlZGU0OTU0NGYyY2IzN2ZjOTdlN2JlZTEyNjBfNDAtNS0xLTEtNjI3MTM_b8b2b944-267e-4232-9598-74f6d676817a"
      unitRef="usd">6158000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMy0yLTEtMS02MjcxMw_2e42945b-e013-49a5-82d0-149ba685eb49"
      unitRef="usd">87000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMy01LTEtMS02MjcxMw_b73fb19a-ba6a-46bb-aaf1-0921b6e2f1ef"
      unitRef="usd">143000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfNS0yLTEtMS02MjcxMw_a4c3c6e6-17dd-4ec6-96b4-a90bd191958f"
      unitRef="usd">56000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfNS01LTEtMS02MjcxMw_0d7375d2-89a9-4626-b240-7d87cca74559"
      unitRef="usd">55000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfNi0yLTEtMS02MjcxMw_2d58164b-b4e1-4a3b-8282-3cda72e3651d"
      unitRef="usd">10000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfNi01LTEtMS02MjcxMw_32d1fa2e-2790-4a8a-a7be-d1308c30a409"
      unitRef="usd">9000000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfNy0yLTEtMS02MjcxMw_c16975c8-3976-4a75-8ce5-e2e58068f398"
      unitRef="usd">-5000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfNy01LTEtMS02MjcxMw_03cb988b-ec6e-4860-80b3-51d0ebf22776"
      unitRef="usd">2000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfOS0yLTEtMS02MjcxMw_c49e9399-2684-4c62-b2aa-66457d35665e"
      unitRef="usd">-16000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfOS01LTEtMS02MjcxMw_6c50f8cd-83fc-4626-af1a-ba7289acee47"
      unitRef="usd">-8000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTEtMi0xLTEtNjI3MTM_82a7dbd3-8314-4203-bf3c-bfa8d95323f5"
      unitRef="usd">-63000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTEtNS0xLTEtNjI3MTM_19bedaa1-35e2-4285-8535-982e86912186"
      unitRef="usd">53000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTItMi0xLTEtNjI3MTM_c39b9e40-b900-40fe-88af-d8b052a6a707"
      unitRef="usd">6000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTItNS0xLTEtNjI3MTM_b644b261-7f03-4524-b204-fcdbe6e50a8a"
      unitRef="usd">37000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTMtMi0xLTEtNjI3MTM_769f58dc-cf64-4c75-9836-7a659833510f"
      unitRef="usd">30000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTMtNS0xLTEtNjI3MTM_6d73d3a8-50d3-4c60-ac24-1c43c4045c52"
      unitRef="usd">14000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTQtMi0xLTEtNjI3MTM_36b03170-4b24-460b-80e9-8a98b6cd5a80"
      unitRef="usd">-28000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTQtNS0xLTEtNjI3MTM_0206a8fe-9d47-4d43-a13f-7bb0f2f8a1e3"
      unitRef="usd">-96000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <clx:OperatingLeaseRightofUseAssetAndLiabilityNet
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTUtMi0xLTEtNjI3MTM_fea170ad-7814-461f-805c-2b33d7de61b9"
      unitRef="usd">1000000</clx:OperatingLeaseRightofUseAssetAndLiabilityNet>
    <clx:OperatingLeaseRightofUseAssetAndLiabilityNet
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTUtNS0xLTEtNjI3MTM_0c9c9d86-9312-4408-a664-7394f279ae7a"
      unitRef="usd">0</clx:OperatingLeaseRightofUseAssetAndLiabilityNet>
    <us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTYtMi0xLTEtNjI3MTM_9836e7f1-5777-4c88-abac-e71daeff12c9"
      unitRef="usd">14000000</us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTYtNS0xLTEtNjI3MTM_2b07d39a-7a74-4172-a151-88d4ef52f685"
      unitRef="usd">24000000</us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTctMi0xLTEtNjI3MTM_cbf3be13-3dcb-4c40-9e9d-55716988a68e"
      unitRef="usd">178000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTctNS0xLTEtNjI3MTM_e1a3fe2f-c9a0-4cef-8ee4-781df89def71"
      unitRef="usd">41000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTktMi0xLTEtNjI3MTM_e3d8613d-107e-4b00-bd8b-7bd09f0a3a01"
      unitRef="usd">46000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMTktNS0xLTEtNjI3MTM_d386b48d-f900-46bc-bc59-55a4cd8a2775"
      unitRef="usd">52000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjEtMi0xLTEtNjI3MTM_dc7c462c-e744-4654-b57b-aadd170818ce"
      unitRef="usd">-1000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjEtNS0xLTEtNjI3MTM_71afc05e-459a-4c26-a567-2d4726baa20e"
      unitRef="usd">4000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjItMi0xLTEtNjI3MTM_c540929e-2a08-4af6-8c8b-4be0a15e867d"
      unitRef="usd">-45000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjItNS0xLTEtNjI3MTM_60e58823-330c-4c88-b9a2-c7847a7440c9"
      unitRef="usd">-56000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjQtMi0xLTEtNjI3MTM_7049db36-392d-406f-9fda-49a851cb387a"
      unitRef="usd">111000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjQtNS0xLTEtNjI3MTM_18b9e68b-5b29-4fc5-8961-40a1a2c6d9bf"
      unitRef="usd">86000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjYtMi0xLTEtNjI3MTM_8daa9130-e85e-461f-902d-95b963e01d0c"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjYtNS0xLTEtNjI3MTM_1d6a52cd-f474-43b6-baa7-bcc2ca167f73"
      unitRef="usd">25000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjctMi0xLTEtNjI3MTM_b40291bc-98a6-43a5-b01b-1ca3da17a427"
      unitRef="usd">145000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjctNS0xLTEtNjI3MTM_5faf16d5-93de-42c8-9502-0f47b6abc3ac"
      unitRef="usd">142000000</us-gaap:PaymentsOfDividendsCommonStock>
    <clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjktMi0xLTEtNjI3MTM_0a22fd35-98bf-43d5-829a-182a11c2412c"
      unitRef="usd">-1000000</clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther>
    <clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMjktNS0xLTEtNjI3MTM_2a9f66c2-8db8-4b70-bbf9-d265b1c6d4b6"
      unitRef="usd">-11000000</clx:IssuanceOfCommonStockForEmployeeStockPlansAndOther>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzAtMi0xLTEtNjI3MTM_576d3184-5779-4658-873e-8c44b228b761"
      unitRef="usd">-35000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzAtNS0xLTEtNjI3MTM_ab7e1a06-f264-47f5-9119-3ef73ed9dc8f"
      unitRef="usd">-92000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzEtMi0xLTEtNjI3MTM_a938030e-84e8-493b-a993-a116f2d5582e"
      unitRef="usd">-4000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzEtNS0xLTEtNjI3MTM_11531312-1167-4a52-acd9-7ef3de07f666"
      unitRef="usd">-3000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzItMi0xLTEtNjI3MTM_0e4601ef-a3c7-40f3-aad3-1481921bc434"
      unitRef="usd">94000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzItNS0xLTEtNjI3MTM_523b868f-75ef-4eeb-b724-ff58a0c67dac"
      unitRef="usd">-110000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzQtMi0xLTEtNjI3MTM_95254ae9-17f0-4554-9628-1742a9d537cd"
      unitRef="usd">186000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ife6845f640b94b6d9b3a46784145e347_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzQtNS0xLTEtNjI3MTM_f54dbd19-4b6c-45f6-a6da-f8abd7f2d9a7"
      unitRef="usd">324000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzUtMi0xLTEtNjI3MTM_587d90fb-c2fd-48ba-98e6-39a9b3107151"
      unitRef="usd">280000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i904c9b98d4a249328732ea1955c73b79_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xNi9mcmFnOmVjNzk1ODYzYTRmZjQ0NGI5M2I3MzAwMTNlOTI4YThkL3RhYmxlOjE4YTY1ODM0ZDE3NzQzOWI4MjJkYWQ1MjI0NDYyMTM0L3RhYmxlcmFuZ2U6MThhNjU4MzRkMTc3NDM5YjgyMmRhZDUyMjQ0NjIxMzRfMzUtNS0xLTEtNjI3MTM_b3544994-9350-4b0e-ae1b-4ebd9ce7054c"
      unitRef="usd">214000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xOS9mcmFnOjU3ZDMxYWQ2NmY2YzQwOGY5YmY0ZmE5M2I3MjQwY2Y1L3RleHRyZWdpb246NTdkMzFhZDY2ZjZjNDA4ZjliZjRmYTkzYjcyNDBjZjVfMjE0MQ_c6d9f828-4022-44c5-8c53-1a6047528359">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited interim condensed consolidated financial statements for the three months ended September 30, 2022 and 2021, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company or Clorox) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June&#160;30, 2022, which includes a complete set of footnote disclosures, including the Company&#x2019;s significant accounting policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restructuring Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company incurs restructuring costs in connection with workforce reductions; consolidation or closure of a facility; sale or termination of a line of business; and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records employee termination liabilities once they are both probable and estimable for severance provided under the Company&#x2019;s existing severance policy. Employee termination liabilities outside of the Company&#x2019;s existing severance policy are recognized at the time relevant employees are notified, unless the employees will be retained to render service beyond a minimum retention period for transition purposes, in which case the liability is recognized ratably over the future service period. Other costs associated with a restructuring plan or exit or disposal activities, such as consulting and professional fees, facility exit costs, employee relocation, outplacement costs, accelerated depreciation or asset impairments associated with a restructuring plan, are recognized in the period in which the liability is incurred or the asset is impaired.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.&#x201d; These amendments require disclosure of the key terms of outstanding supplier finance programs and a rollforward of the related obligations.&#160;These amendments are effective for fiscal years beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. As these amendments relate to disclosures only, there were no impacts expected to the Company&#x2019;s consolidated results of operations, financial position and cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xOS9mcmFnOjU3ZDMxYWQ2NmY2YzQwOGY5YmY0ZmE5M2I3MjQwY2Y1L3RleHRyZWdpb246NTdkMzFhZDY2ZjZjNDA4ZjliZjRmYTkzYjcyNDBjZjVfMjE0MA_2ddf452d-cdb8-4830-aebb-69a08b0fb7d1">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited interim condensed consolidated financial statements for the three months ended September 30, 2022 and 2021, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company or Clorox) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June&#160;30, 2022, which includes a complete set of footnote disclosures, including the Company&#x2019;s significant accounting policies.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xOS9mcmFnOjU3ZDMxYWQ2NmY2YzQwOGY5YmY0ZmE5M2I3MjQwY2Y1L3RleHRyZWdpb246NTdkMzFhZDY2ZjZjNDA4ZjliZjRmYTkzYjcyNDBjZjVfMTY0OTI2NzQ2NTM2Mg_98cbe737-0d1f-4566-9acc-4589561a0c91">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restructuring Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company incurs restructuring costs in connection with workforce reductions; consolidation or closure of a facility; sale or termination of a line of business; and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records employee termination liabilities once they are both probable and estimable for severance provided under the Company&#x2019;s existing severance policy. Employee termination liabilities outside of the Company&#x2019;s existing severance policy are recognized at the time relevant employees are notified, unless the employees will be retained to render service beyond a minimum retention period for transition purposes, in which case the liability is recognized ratably over the future service period. Other costs associated with a restructuring plan or exit or disposal activities, such as consulting and professional fees, facility exit costs, employee relocation, outplacement costs, accelerated depreciation or asset impairments associated with a restructuring plan, are recognized in the period in which the liability is incurred or the asset is impaired.&lt;/span&gt;&lt;/div&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8xOS9mcmFnOjU3ZDMxYWQ2NmY2YzQwOGY5YmY0ZmE5M2I3MjQwY2Y1L3RleHRyZWdpb246NTdkMzFhZDY2ZjZjNDA4ZjliZjRmYTkzYjcyNDBjZjVfMTY0OTI2NzQ3NTk4Ng_8e83aefb-493a-4f38-aef4-60912f5a6411">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.&#x201d; These amendments require disclosure of the key terms of outstanding supplier finance programs and a rollforward of the related obligations.&#160;These amendments are effective for fiscal years beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. As these amendments relate to disclosures only, there were no impacts expected to the Company&#x2019;s consolidated results of operations, financial position and cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RleHRyZWdpb246YjU4ODQwODE5Mjk5NGNkYzgxZmQzZTBkOTAxZjdlY2RfMjAyNg_16d83e56-f8a4-4e4c-ac04-557f1ea63b41">RESTRUCTURING AND RELATED COSTS&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of fiscal year 2023, the Company began recognizing costs related to a plan that involves streamlining its operating model to meet its objectives of driving growth and productivity. The streamlined operating model is expected to enhance the Company&#x2019;s ability to respond more quickly to changing consumer behaviors and innovate faster. The Company anticipates the implementation of this new model will be completed in fiscal year 2024, with different phases occurring throughout the implementation period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company anticipates incurring approximately $75 to $100 of costs in fiscal years 2023 and 2024 related to this initiative, of which approximately $35 is expected to be incurred in fiscal year 2023. Related costs are primarily expected to include employee-related costs to reduce certain staffing levels such as severance payments, as well as for consulting and other costs. Costs incurred are expected to be settled primarily in cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring and related implementation costs, net were $19 for the three months ended September&#160;30, 2022. The following table summarizes the total restructuring and related implementation costs, net associated with the Company&#x2019;s streamlined operating model plan as reflected in the Consolidated Statements of Earnings and Comprehensive Income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.048%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Costs of products sold&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Selling and administrative expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Other (income) expense, net:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Employee-related costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Total, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employee-related costs primarily include severance and other termination benefits calculated based on salary levels, prior service and statutory requirements. Other costs primarily include consulting fees incurred for the organizational design and implementation of the future streamlined operating model, related processes and other professional fees incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Charges for restructuring and related implementation costs are recorded in the Corporate segment as these initiatives are centrally directed and controlled and are not included in internal measures of segment operating performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may, from time to time, decide to pursue additional restructuring-related initiatives that involve costs in future periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the accrual for the streamlined operating model restructuring and related implementation costs discussed above, which are recorded within Accounts payable and accrued liabilities in the Consolidated Balance Sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.950%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;Employee-Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Accrual Balance as of June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Accrual Balance as of September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i34328a2b14f04362ad52a7edbae327fa_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RleHRyZWdpb246YjU4ODQwODE5Mjk5NGNkYzgxZmQzZTBkOTAxZjdlY2RfMjE5OTAyMzI5MTMwOA_a1b1bec5-143e-4eec-a0d5-b21c13de84dd"
      unitRef="usd">75000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="icd000e11a868483ca61bafef62dbda9f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RleHRyZWdpb246YjU4ODQwODE5Mjk5NGNkYzgxZmQzZTBkOTAxZjdlY2RfMjE5OTAyMzI5MTMxNQ_68ebde42-e38d-4359-9f25-44860509e615"
      unitRef="usd">100000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i47cf58703a824db8a0117fad3f780179_I20230630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RleHRyZWdpb246YjU4ODQwODE5Mjk5NGNkYzgxZmQzZTBkOTAxZjdlY2RfNzE0NjgyNTU5NDE3Ng_75889238-7f62-4a31-a4a3-5346b5040493"
      unitRef="usd">35000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RleHRyZWdpb246YjU4ODQwODE5Mjk5NGNkYzgxZmQzZTBkOTAxZjdlY2RfNzE0NjgyNTU5NDYwMw_95e18869-75b6-4da8-b2ae-0b9d17026345"
      unitRef="usd">19000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RleHRyZWdpb246YjU4ODQwODE5Mjk5NGNkYzgxZmQzZTBkOTAxZjdlY2RfMTY0OTI2NzQ2NzA5OQ_943abe64-ce32-4e11-be62-1aa78ace7ae0">The following table summarizes the total restructuring and related implementation costs, net associated with the Company&#x2019;s streamlined operating model plan as reflected in the Consolidated Statements of Earnings and Comprehensive Income.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.048%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Costs of products sold&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Selling and administrative expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Other (income) expense, net:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Employee-related costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Total, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i09ad333c626b4d51be54887b41e252f1_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjA5OTVjY2Q0ZWE4YTQxNmY4NzhlNTkyYzIxODRlOTk4L3RhYmxlcmFuZ2U6MDk5NWNjZDRlYThhNDE2Zjg3OGU1OTJjMjE4NGU5OThfMi0xLTEtMS05NjA5NQ_b0336ad4-80f1-464b-8fd2-b8098778db13"
      unitRef="usd">-1000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ib61f3f9358bc4648a900ad8d686db004_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjA5OTVjY2Q0ZWE4YTQxNmY4NzhlNTkyYzIxODRlOTk4L3RhYmxlcmFuZ2U6MDk5NWNjZDRlYThhNDE2Zjg3OGU1OTJjMjE4NGU5OThfMy0xLTEtMS05NjA5NQ_f517c315-e10e-4f2f-822e-8c2f87cad934"
      unitRef="usd">1000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i63f8e80373f44df188b7b0bba1958467_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjA5OTVjY2Q0ZWE4YTQxNmY4NzhlNTkyYzIxODRlOTk4L3RhYmxlcmFuZ2U6MDk5NWNjZDRlYThhNDE2Zjg3OGU1OTJjMjE4NGU5OThfNS0xLTEtMS05NjA5NQ_4d70cc54-da8c-48c4-a897-39bed25105c9"
      unitRef="usd">19000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjA5OTVjY2Q0ZWE4YTQxNmY4NzhlNTkyYzIxODRlOTk4L3RhYmxlcmFuZ2U6MDk5NWNjZDRlYThhNDE2Zjg3OGU1OTJjMjE4NGU5OThfOC0xLTEtMS05NjA5NQ_54466a7b-30b1-4c93-8092-deaa06a4f737"
      unitRef="usd">19000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RleHRyZWdpb246YjU4ODQwODE5Mjk5NGNkYzgxZmQzZTBkOTAxZjdlY2RfMTY0OTI2NzQ2NzA5OA_12092833-a5dc-4c8e-befa-a38a859901d8">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the accrual for the streamlined operating model restructuring and related implementation costs discussed above, which are recorded within Accounts payable and accrued liabilities in the Consolidated Balance Sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.950%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%"&gt;Employee-Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Accrual Balance as of June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfbfbf;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;Accrual Balance as of September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i0f9e22509a6d450fa6331417e37243f0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMS0xLTEtMS05NjI5OQ_0676b719-20eb-44f7-9a50-0ec1873204cc"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i341aba281f28491c9e0f804508f61995_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMS0zLTEtMS05NjMwNg_d937cea1-0105-44ac-8b89-84249d54f6e7"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMS01LTEtMS05NjMxMw_c0aee47d-2f06-4ceb-b9e1-cc8b8c6a2eba"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="iace90036b5d84d608091db4139e10cb0_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMi0xLTEtMS05NjI5OQ_eb171ac6-2052-44a7-aebc-4087867b7392"
      unitRef="usd">19000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9a0251ee71ad46aab3436fb41074e067_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMi0zLTEtMS05NjMwNg_b9aa24c0-71b8-4002-bb8f-3ddd4647996d"
      unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMi01LTEtMS05NjMxMw_d57f582a-2e48-4d23-8d79-8374ca9d2ed9"
      unitRef="usd">22000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="iace90036b5d84d608091db4139e10cb0_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMy0xLTEtMS05NjI5OQ_b9339e68-0faa-4bc2-9fa4-e8c319ce3595"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i9a0251ee71ad46aab3436fb41074e067_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMy0zLTEtMS05NjMwNg_de767361-be3d-4587-8cbf-73dcec7e8943"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfMy01LTEtMS05NjMxMw_1055c1bc-8c25-438e-8e06-321ffd298945"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i407e5b359a574869b044cdc2231bcc94_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfNS0xLTEtMS05NjI5OQ_ec744737-b59f-45a6-a71c-ce1954f09d2f"
      unitRef="usd">19000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="id07f895c223b44f0af02d5bca7906d74_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfNS0zLTEtMS05NjMwNg_70527ef4-7763-4a0f-99ac-60a04703a0e1"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yMi9mcmFnOmI1ODg0MDgxOTI5OTRjZGM4MWZkM2UwZDkwMWY3ZWNkL3RhYmxlOjJkYTZkZmQxZDI3NDRmOTBiMzhiZmZmNzczZTI0OGU3L3RhYmxlcmFuZ2U6MmRhNmRmZDFkMjc0NGY5MGIzOGJmZmY3NzNlMjQ4ZTdfNS01LTEtMS05NjMxMw_8cab965f-f943-489d-b2c5-6e5c9df14719"
      unitRef="usd">22000000</us-gaap:RestructuringReserve>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RleHRyZWdpb246MGUwNzkxNWRiM2NlNGJkYzgwMGQ4NjE2OWY5ZThjNDJfODU_d1b9297a-5b1b-4211-b9c3-370947072a71">INVENTORIES, NET&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, net, consisted of the following as of:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6/30/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials and packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIFO allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Noncurrent inventories, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; Noncurrent inventories, net is recorded in Other assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RleHRyZWdpb246MGUwNzkxNWRiM2NlNGJkYzgwMGQ4NjE2OWY5ZThjNDJfODQ_dae50b8f-5f98-4c61-b098-3622e3ed64f4">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, net, consisted of the following as of:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6/30/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials and packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIFO allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Noncurrent inventories, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; Noncurrent inventories, net is recorded in Other assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfMS0xLTEtMS02MjcxMw_7cc1e28e-5c5c-4aab-83aa-b549ea0bea99"
      unitRef="usd">639000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfMS0zLTEtMS02MjcxMw_91248013-dfe1-4013-99d3-53be697b2fe7"
      unitRef="usd">593000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfMi0xLTEtMS02MjcxMw_57729630-cd2f-4871-8215-4fcce1fb20cb"
      unitRef="usd">200000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfMi0zLTEtMS02MjcxMw_ca06e848-471f-4861-b85a-132047e0304e"
      unitRef="usd">191000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfMy0xLTEtMS02MjcxMw_12e81b5b-dced-429d-8e3e-04e6f148b418"
      unitRef="usd">15000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfMy0zLTEtMS02MjcxMw_eff727b4-f975-45fc-9acf-252167ede07c"
      unitRef="usd">16000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryLIFOReserve
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfNC0xLTEtMS02MjcxMw_66941e9d-5e13-4112-915d-89ae3fd3421c"
      unitRef="usd">94000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryLIFOReserve
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfNC0zLTEtMS02MjcxMw_84cecae6-1d07-4b69-986c-c65827f754da"
      unitRef="usd">40000000</us-gaap:InventoryLIFOReserve>
    <clx:InventoryCurrentAndNoncurrentNet
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfNS0xLTEtMS05MTYwNg_1b0ddc79-40dc-4f34-801c-f69499cbf98f"
      unitRef="usd">760000000</clx:InventoryCurrentAndNoncurrentNet>
    <clx:InventoryCurrentAndNoncurrentNet
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfNS0zLTEtMS05MTYyMA_d7c932be-b90d-4199-822a-9a84be05d263"
      unitRef="usd">760000000</clx:InventoryCurrentAndNoncurrentNet>
    <us-gaap:InventoryNoncurrent
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfNi0xLTEtMS05MTYxMw_ce33d93a-455a-4e00-b2ed-fecc2d0d6b75"
      unitRef="usd">5000000</us-gaap:InventoryNoncurrent>
    <us-gaap:InventoryNoncurrent
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfNi0zLTEtMS05MTYyNw_c3732e7e-aa83-4996-8f78-3158ac980f92"
      unitRef="usd">5000000</us-gaap:InventoryNoncurrent>
    <us-gaap:InventoryNet
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfNS0xLTEtMS02MjcxMw_45faaf19-b479-4ce7-bf63-3df6c80d5fd2"
      unitRef="usd">755000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8yNS9mcmFnOjBlMDc5MTVkYjNjZTRiZGM4MDBkODYxNjlmOWU4YzQyL3RhYmxlOjAyN2VhYjQyZjRjNDQwZmNiM2YzYWRkZDYxNWEyMmI0L3RhYmxlcmFuZ2U6MDI3ZWFiNDJmNGM0NDBmY2IzZjNhZGRkNjE1YTIyYjRfNS0zLTEtMS02MjcxMw_59717b83-0ed8-4ffb-ae33-ff648df3030d"
      unitRef="usd">755000000</us-gaap:InventoryNet>
    <clx:FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfNzk0NQ_7a9031b6-002d-4510-b129-84846145c7db">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Risk Management and Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to certain commodity, foreign currency and interest rate risks related to its ongoing business operations and uses derivative instruments to mitigate its exposure to these risks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commodity Price Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may use commodity futures, options and swap contracts to limit the impact of price volatility on a portion of its forecasted raw material requirements. These commodity derivatives may be exchange traded or over-the-counter contracts and are generally for a period of no longer than two years. Commodity purchase and options contracts are measured at fair value using market quotations obtained from the Chicago Board of Trade commodity futures exchange and commodity derivative dealers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, and June&#160;30, 2022, the notional amount of commodity derivatives was $30 and $27, respectively, which related primarily to exposures in soybean oil used for the Food products business and jet fuel used for the Grilling business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may also enter into certain over-the-counter derivative contracts to manage a portion of the Company&#x2019;s forecasted foreign currency exposure associated with the purchase of inventory. These foreign currency contracts generally have durations of no longer than two years. The foreign exchange contracts are measured at fair value using information quoted by foreign exchange dealers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of outstanding foreign currency forward contracts used by the Company&#x2019;s subsidiaries to hedge forecasted purchases of inventory were $13 and $31 as of September&#160;30, 2022 and June&#160;30, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may enter into over-the-counter interest rate contracts to fix a portion of the benchmark interest rate prior to the anticipated issuance of fixed rate debt. These interest rate contracts generally have durations of less than three years. The interest rate contracts are measured at fair value using information quoted by bond dealers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held no interest rate contracts as of September&#160;30, 2022 and June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commodity, Foreign Exchange and Interest Rate Derivatives &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company designates its commodity forward, futures and options contracts for forecasted purchases of raw materials, foreign currency forward contracts for forecasted purchases of inventory and interest rate contracts for forecasted interest payments as cash flow hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains (losses) recognized in Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated amount of the existing net gain (loss) in Accumulated other comprehensive net (loss) income as of September&#160;30, 2022 that is expected to be reclassified into Net earnings within the next twelve months is $11. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Counterparty Risk Management and Derivative Contract Requirements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes a variety of financial institutions as counterparties for over-the-counter derivative instruments. The Company enters into agreements governing the use of over-the-counter derivative instruments and sets internal limits on the aggregate over-the-counter derivative instrument positions held with each counterparty. Certain terms of these agreements require the Company or the counterparty to post collateral when the fair value of the derivative instruments exceeds contractually-defined counterparty liability position limits. Of the over-the-counter derivative instruments in liability positions held as of both September&#160;30, 2022 and June&#160;30, 2022, none contained such terms. As of both September&#160;30, 2022 and June&#160;30, 2022, neither the Company nor any counterparty was required to post any collateral, as no counterparty liability position limits were exceeded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain terms of the agreements governing the Company&#x2019;s over-the-counter derivative instruments require the Company&#x2019;s credit ratings, as assigned by Standard &amp;amp; Poor&#x2019;s and Moody&#x2019;s to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating. If the Company&#x2019;s credit ratings were to fall below investment grade, the counterparties to the derivative instruments could request full collateralization on derivative instruments in net liability positions. As of both September&#160;30, 2022 and June&#160;30, 2022, the Company and each of its counterparties had been assigned investment grade ratings by both Standard &amp;amp; Poor&#x2019;s and Moody&#x2019;s.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s exchange traded futures and options contracts used for commodity price risk management include requirements for the Company to post collateral in the form of a cash margin account held by the Company&#x2019;s broker for trades conducted on that exchange. As of September&#160;30, 2022 and June&#160;30, 2022, the Company maintained cash margin balances related to exchange traded futures and options contracts of $2 and $1, respectively, which are classified as Prepaid expenses and other current assets on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Trust Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds interests in mutual funds and cash equivalents as part of trust assets related to its nonqualified deferred compensation plans. The participants in the nonqualified deferred compensation plans, who are the Company&#x2019;s current and former employees, may select among certain mutual funds in which their compensation deferrals are invested in accordance with the terms of the plans and within the confines of the trusts, which hold the marketable securities. The trusts represent variable interest entities for which the Company is considered the primary beneficiary, and, therefore, trust assets are consolidated and included in Other assets in the condensed consolidated balance sheets. The interests in mutual funds are measured at fair value using quoted market prices. The Company has designated these marketable securities as trading investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1: Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3: Unobservable inputs reflecting the reporting entity&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of both September&#160;30, 2022 and June&#160;30, 2022, the Company&#x2019;s financial assets and liabilities that were measured at fair value on a recurring basis included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company&#x2019;s nonqualified deferred compensation plans, which were classified as Level 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s derivative instruments qualify for hedge accounting. The following table provides information about the balance sheet classification and the fair values of the Company&#x2019;s derivative instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.479%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;6/30/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Hierarchy&lt;br/&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase options contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase swaps contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase futures contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about the balance sheet classification and the fair values of the Company&#x2019;s other assets and liabilities for which disclosure of fair value is required:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.942%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;6/30/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Hierarchy&lt;br/&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest-bearing investments, including money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trust assets for nonqualified deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes and loans payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes and loans payable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-term debt and Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;term debt and Long-term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Cash and cash equivalents are composed of time deposits and other interest-bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Notes and loans payable are composed of outstanding U.S. commercial paper balances and/or amounts drawn on the Company&#x2019;s credit agreements, all of which are recorded at cost, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.&lt;/span&gt;&lt;/div&gt;</clx:FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock>
    <us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1
      contextRef="id33bf162891042b581228081b2a7c697_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMjE5OTAyMzI2NjI0Ng_8cb72382-5925-43ea-8d59-0f0775f284ce">P2Y</us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6e8a89c05a0a4a16b4de18869bfd695f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfNzk2_0ec41350-0daf-4dc0-b56d-0bbf38e0f10c"
      unitRef="usd">30000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5b924fb632f04f0c94baf25d9aae883e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMjE5OTAyMzI2NTk0Mg_84942d9d-5d07-4bcc-b2f8-3d23a3cc0b18"
      unitRef="usd">27000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMjE5OTAyMzI2NjI2OQ_6d7dbd82-0fe0-4322-bc24-49d6a71c9adc">P2Y</us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib118d948faed49dea943620ecb2804d1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMTY1OA_577ee260-02b2-4c3e-8a75-5bead795fcb8"
      unitRef="usd">13000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iba5d16b63ef34671b972df411f72c26c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMTY2NQ_cd34300a-ecda-4fbf-8df3-1f06170d63e9"
      unitRef="usd">31000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMjE5OTAyMzI2NjI4NA_8810f068-bef3-466e-b04d-ae7b7c747ba4">P3Y</us-gaap:MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfNzk1Mg_ee63373e-96dc-4d79-aa01-c91db3c336f8">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains (losses) recognized in Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i87647bbf68694e6cb56844238655ccb6_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjU3NDE1NTJiMjExYjQ0YjA4YzgyMmFkZDE3MjM5MWIwL3RhYmxlcmFuZ2U6NTc0MTU1MmIyMTFiNDRiMDhjODIyYWRkMTcyMzkxYjBfMy0xLTEtMS02MjcxMw_6a4133b5-a7ae-4d98-9e34-a4ed92ef1a69"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7f677fe19c1746429e18febc5f25cfea_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjU3NDE1NTJiMjExYjQ0YjA4YzgyMmFkZDE3MjM5MWIwL3RhYmxlcmFuZ2U6NTc0MTU1MmIyMTFiNDRiMDhjODIyYWRkMTcyMzkxYjBfMy0zLTEtMS02MjcxMw_5ea9ad5f-4c3b-417d-918f-7cfa1c7136d2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7eed42a98cdf4c8484f4d6f50ba27c2c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjU3NDE1NTJiMjExYjQ0YjA4YzgyMmFkZDE3MjM5MWIwL3RhYmxlcmFuZ2U6NTc0MTU1MmIyMTFiNDRiMDhjODIyYWRkMTcyMzkxYjBfNC0xLTEtMS02MjcxMw_a2a00096-e694-4527-a14f-2fecd75128b4"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i89d66606b3294de5be2599b89449703f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjU3NDE1NTJiMjExYjQ0YjA4YzgyMmFkZDE3MjM5MWIwL3RhYmxlcmFuZ2U6NTc0MTU1MmIyMTFiNDRiMDhjODIyYWRkMTcyMzkxYjBfNC0zLTEtMS02MjcxMw_fb19164d-3753-4182-bfdd-df591dfd5262"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="icc00d18fe4de47a698a3a7bc531123de_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjU3NDE1NTJiMjExYjQ0YjA4YzgyMmFkZDE3MjM5MWIwL3RhYmxlcmFuZ2U6NTc0MTU1MmIyMTFiNDRiMDhjODIyYWRkMTcyMzkxYjBfNS0xLTEtMS02MjcxMw_2ee82088-2b29-4776-907c-72a063851112"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="if5e13b9874e848cf9b0bb2bdda02efbd_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjU3NDE1NTJiMjExYjQ0YjA4YzgyMmFkZDE3MjM5MWIwL3RhYmxlcmFuZ2U6NTc0MTU1MmIyMTFiNDRiMDhjODIyYWRkMTcyMzkxYjBfNS0zLTEtMS02MjcxMw_78f925b2-da5d-48d7-a2b0-4c7dace43461"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjU3NDE1NTJiMjExYjQ0YjA4YzgyMmFkZDE3MjM5MWIwL3RhYmxlcmFuZ2U6NTc0MTU1MmIyMTFiNDRiMDhjODIyYWRkMTcyMzkxYjBfNi0xLTEtMS02MjcxMw_dcb08e1c-1304-47ac-ab6d-40d895b9d3ae"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjU3NDE1NTJiMjExYjQ0YjA4YzgyMmFkZDE3MjM5MWIwL3RhYmxlcmFuZ2U6NTc0MTU1MmIyMTFiNDRiMDhjODIyYWRkMTcyMzkxYjBfNi0zLTEtMS02MjcxMw_900d4c22-a07b-4a66-8323-ef9b253b392b"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfNzkzNA_b8c74b53-9108-45a6-b449-64f8dd40d43e">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i87647bbf68694e6cb56844238655ccb6_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOmUxZjliMzJlNmJhOTQ1ZmZhZWNhNjk1NDUxZWIwNjcyL3RhYmxlcmFuZ2U6ZTFmOWIzMmU2YmE5NDVmZmFlY2E2OTU0NTFlYjA2NzJfMy0yLTEtMS02MjcxMw_08d7c5cc-90ab-4fae-8c25-8d1a44e6f411"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i7f677fe19c1746429e18febc5f25cfea_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOmUxZjliMzJlNmJhOTQ1ZmZhZWNhNjk1NDUxZWIwNjcyL3RhYmxlcmFuZ2U6ZTFmOWIzMmU2YmE5NDVmZmFlY2E2OTU0NTFlYjA2NzJfMy00LTEtMS02MjcxMw_697edffe-91c4-469e-882c-df7261622f85"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i7eed42a98cdf4c8484f4d6f50ba27c2c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOmUxZjliMzJlNmJhOTQ1ZmZhZWNhNjk1NDUxZWIwNjcyL3RhYmxlcmFuZ2U6ZTFmOWIzMmU2YmE5NDVmZmFlY2E2OTU0NTFlYjA2NzJfNC0yLTEtMS02MjcxMw_66a22a97-9162-4986-afc0-61b9288e43e5"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i89d66606b3294de5be2599b89449703f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOmUxZjliMzJlNmJhOTQ1ZmZhZWNhNjk1NDUxZWIwNjcyL3RhYmxlcmFuZ2U6ZTFmOWIzMmU2YmE5NDVmZmFlY2E2OTU0NTFlYjA2NzJfNC00LTEtMS02MjcxMw_d0fda736-f22d-4a39-a581-590b6acecb07"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="icc00d18fe4de47a698a3a7bc531123de_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOmUxZjliMzJlNmJhOTQ1ZmZhZWNhNjk1NDUxZWIwNjcyL3RhYmxlcmFuZ2U6ZTFmOWIzMmU2YmE5NDVmZmFlY2E2OTU0NTFlYjA2NzJfNS0yLTEtMS02MjcxMw_e444d838-68f6-44a8-9868-be2029ed2e68"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="if5e13b9874e848cf9b0bb2bdda02efbd_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOmUxZjliMzJlNmJhOTQ1ZmZhZWNhNjk1NDUxZWIwNjcyL3RhYmxlcmFuZ2U6ZTFmOWIzMmU2YmE5NDVmZmFlY2E2OTU0NTFlYjA2NzJfNS00LTEtMS02MjcxMw_e5d9874e-8cc5-4825-89fb-11be5c8f532d"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOmUxZjliMzJlNmJhOTQ1ZmZhZWNhNjk1NDUxZWIwNjcyL3RhYmxlcmFuZ2U6ZTFmOWIzMmU2YmE5NDVmZmFlY2E2OTU0NTFlYjA2NzJfNi0yLTEtMS02MjcxMw_afbfc14e-3d8a-4ca9-924c-d2e5eac317e1"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOmUxZjliMzJlNmJhOTQ1ZmZhZWNhNjk1NDUxZWIwNjcyL3RhYmxlcmFuZ2U6ZTFmOWIzMmU2YmE5NDVmZmFlY2E2OTU0NTFlYjA2NzJfNi00LTEtMS02MjcxMw_2cce9c1d-64db-4e79-998e-4f99d35b7221"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMzA3MA_38dad071-7907-4544-a701-befe5536ae9c"
      unitRef="usd">11000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMTI2NDQzODM3MzAzMzU_293488ce-2d2b-4dd6-a1d7-225f8044d74d"
      unitRef="usd">0</clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits>
    <clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMTI2NDQzODM3MzAzMzU_a2d1e7b4-20c7-4b6e-99d8-b63a53bed709"
      unitRef="usd">0</clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits>
    <us-gaap:MarginDepositAssets
      contextRef="i21899b87bd5e4a699970017caa794236_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfMTk3OTEyMDkzMTAzMzM_02e83074-84b7-44c6-83ce-be48e0223227"
      unitRef="usd">2000000</us-gaap:MarginDepositAssets>
    <us-gaap:MarginDepositAssets
      contextRef="i767f12083ea54bc4a43b4049513c1a15_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfNTAwNg_c4467ad6-a81c-43c2-8ea1-5d9a285ed0e9"
      unitRef="usd">1000000</us-gaap:MarginDepositAssets>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfNzkzNg_62cc9847-028c-4fd8-a600-c4e1fd5b2a2d">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1: Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3: Unobservable inputs reflecting the reporting entity&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of both September&#160;30, 2022 and June&#160;30, 2022, the Company&#x2019;s financial assets and liabilities that were measured at fair value on a recurring basis included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company&#x2019;s nonqualified deferred compensation plans, which were classified as Level 1.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RleHRyZWdpb246ZmYzZGFlNTRhZjJmNGQ3YmFlYjYwZmUxN2Q4M2Q3MjFfNzk0NA_cca775ef-e624-490e-857e-ebf9088b9250">The following table provides information about the balance sheet classification and the fair values of the Company&#x2019;s derivative instruments:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.479%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;6/30/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Hierarchy&lt;br/&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase options contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase swaps contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity purchase futures contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about the balance sheet classification and the fair values of the Company&#x2019;s other assets and liabilities for which disclosure of fair value is required:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.942%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;6/30/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Hierarchy&lt;br/&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest-bearing investments, including money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trust assets for nonqualified deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes and loans payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes and loans payable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-term debt and Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;term debt and Long-term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Cash and cash equivalents are composed of time deposits and other interest-bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Notes and loans payable are composed of outstanding U.S. commercial paper balances and/or amounts drawn on the Company&#x2019;s credit agreements, all of which are recorded at cost, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeAssets
      contextRef="i179d67c234714ee4907a95545f754ed4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfMy01LTEtMS02MjcxMw_7fd16673-d07c-41ea-ab61-da1c2d51907a"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i2217e4efada64de48ae6279d4cff1f35_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfMy03LTEtMS02MjcxMw_5445130a-7a00-40bd-abc2-e5088556b342"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i830d873fccfc4a348844a4a1ec805c4e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfMy05LTEtMS02MjcxMw_c61df99d-2fc1-4ab6-944c-4028ed3d9fa7"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i2066cd30a255497092b1965c041e9697_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfMy0xMS0xLTEtNjI3MTM_13739705-1ac8-4dd2-8f20-285e1d7f5b13"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ic9d03b4e69154fb28b379075df843c40_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNC01LTEtMS02MjcxMw_5d6cb2f1-4f0e-45af-a01d-0335ab0f40f0"
      unitRef="usd">2000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i6332a61aea924b20b5a7f810ba642def_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNC03LTEtMS02MjcxMw_ff615df4-c32f-4833-b851-f32eb5bccd74"
      unitRef="usd">2000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i224d9fac5a284cae8a8129752c459c15_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNC05LTEtMS02MjcxMw_986d86fe-ce0b-43e2-9f2c-b0a65f8b98e6"
      unitRef="usd">6000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i927e8b53d03f409c8397e57ad50983cf_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNC0xMS0xLTEtNjI3MTM_a673a96b-4951-4776-98db-6533873010c8"
      unitRef="usd">6000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i298fa64546144e7c8725322be166049b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNi01LTEtMS05MjE4OQ_7eadb313-a357-40b8-8bed-e8ebe5aa1ab7"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i340a0bfb85cc4a238353da0ab09b3e19_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNi03LTEtMS05MjE5Ng_1f4483ba-39ba-4ba0-9cbb-e87d9e6451da"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i4f6c62d24498449dbd1912f053706e5f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNi05LTEtMS05MjIwMw_30829e32-1640-4f80-96e2-7b9b31609df6"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i727b7773814a4b248462dd8c293d6447_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNi0xMS0xLTEtOTIyMTA_b97539cf-a83a-40d0-b2e4-89b0effeabed"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i63b417fd4e2e4baca829a11debf18917_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNy01LTEtMS02MjcxMw_ee4560af-4c2a-4aa0-8d72-15cca0cbc7cc"
      unitRef="usd">4000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i12297feced3a40998cfae2f77b61fe69_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNy03LTEtMS02MjcxMw_69e93375-6402-4cb8-934d-15b4ca663457"
      unitRef="usd">4000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i5714ee2d486c40e0920537af19846e5c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNy05LTEtMS02MjcxMw_789678e8-00ca-4ba2-9048-98b90f17e1ed"
      unitRef="usd">7000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i4ccd25a4389e4143bcd3303d5a26ad64_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfNy0xMS0xLTEtNjI3MTM_098daa91-1f9e-4b5c-a240-b3050b784f00"
      unitRef="usd">7000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="i179d67c234714ee4907a95545f754ed4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfOS01LTEtMS02MjcxMw_8ea2d458-61ce-459c-a1dd-38fa204cb990"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i2217e4efada64de48ae6279d4cff1f35_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfOS03LTEtMS02MjcxMw_e09081f2-745a-4f2e-ada3-21901c706840"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i830d873fccfc4a348844a4a1ec805c4e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfOS05LTEtMS02MjcxMw_93ebf461-2afe-417a-ace9-32ccba1c6168"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i2066cd30a255497092b1965c041e9697_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfOS0xMS0xLTEtNjI3MTM_210f4122-4b89-4107-8417-19af87233648"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i63b417fd4e2e4baca829a11debf18917_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfMTItNS0xLTEtNjI3MTM_20ffb9d8-263b-4ed9-9f03-bc8e6c83cf42"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i12297feced3a40998cfae2f77b61fe69_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfMTItNy0xLTEtNjI3MTM_bbac37e4-ea96-4630-954f-ab821e8dbb22"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i5714ee2d486c40e0920537af19846e5c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfMTItOS0xLTEtNjI3MTM_03f79db5-3332-4456-a789-cf21cd03ed01"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i4ccd25a4389e4143bcd3303d5a26ad64_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjliMDg4NjJlYzg4YTQzMGViMmNlNzZiZTMyNzkzZTllL3RhYmxlcmFuZ2U6OWIwODg2MmVjODhhNDMwZWIyY2U3NmJlMzI3OTNlOWVfMTItMTEtMS0xLTYyNzEz_c2e6f5ee-d950-49ce-8974-b9239425d198"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="idd434cb3d24d4c54a373f4e7355f9440_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMy01LTEtMS02MjcxMw_71ef9d7f-17ae-4944-b274-3dd204faf5b4"
      unitRef="usd">168000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9857e40c16694defb9128852a3249eee_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMy03LTEtMS02MjcxMw_e1246a68-8db5-4abf-942a-35828f6ae17c"
      unitRef="usd">168000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8d46c7f6455a482fb10a18e1305a3b96_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMy05LTEtMS02MjcxMw_abb3de48-fe59-4df5-b988-9057cf008433"
      unitRef="usd">86000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7c19bcb918ca49c096f1881179d2c512_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMy0xMS0xLTEtNjI3MTM_5f742bfb-2da7-4a3b-9fd1-8d93f479e8fb"
      unitRef="usd">86000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i3e781035dc6444a2bee2f22c5a1fe45f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfNC01LTEtMS02MjcxMw_76d1adc1-d041-4a6e-b266-b94c87a240fc"
      unitRef="usd">4000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i5a749b02bcb6491283cdb7b6391346d8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfNC03LTEtMS02MjcxMw_3babb31b-ebf3-43c8-a14e-b53faae70b42"
      unitRef="usd">4000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i40dcc202c4e041af8d2d5be92340ac45_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfNC05LTEtMS02MjcxMw_27266fb7-69c3-4a94-84d7-c51735e904f0"
      unitRef="usd">4000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic07dfcc355994c14808ed66f5abf1c36_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfNC0xMS0xLTEtNjI3MTM_f4c36b7d-e2dc-4852-98b1-a6cc3e3d42e3"
      unitRef="usd">4000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="ifeea7735269f42f1af408fc370004480_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfNy01LTEtMS02MjcxMw_9cdb65e1-bc07-4a3f-af86-0ddfb7bedc03"
      unitRef="usd">118000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0d9e30fd0e724ca38629fa8a85472f94_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfNy03LTEtMS02MjcxMw_83961f33-2d8f-4886-8706-778c322ca417"
      unitRef="usd">118000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i45536724bfd7435b9cb5468e757ce469_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfNy05LTEtMS02MjcxMw_c5d01595-f561-4fd3-99ae-f88902956490"
      unitRef="usd">119000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i12b8749fcb3a4647a6723c05d51fb551_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfNy0xMS0xLTEtNjI3MTM_42523b36-edc5-4933-80ea-7ca1e34edbf6"
      unitRef="usd">119000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:Assets
      contextRef="i63b417fd4e2e4baca829a11debf18917_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfOC01LTEtMS02MjcxMw_b40989a0-4bfe-40e6-a649-e75f59fa313d"
      unitRef="usd">290000000</us-gaap:Assets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i12297feced3a40998cfae2f77b61fe69_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfOC03LTEtMS02MjcxMw_d2261bc8-4352-45b3-a8a9-81b93198263c"
      unitRef="usd">290000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Assets
      contextRef="i5714ee2d486c40e0920537af19846e5c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfOC05LTEtMS02MjcxMw_40cac81a-f3f6-4e4c-b4bd-440d970d9086"
      unitRef="usd">209000000</us-gaap:Assets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4ccd25a4389e4143bcd3303d5a26ad64_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfOC0xMS0xLTEtNjI3MTM_2d3e6a6c-8e82-490b-bc59-1a9f4903125b"
      unitRef="usd">209000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CommercialPaper
      contextRef="i75626a99bf8247128cf595d793463677_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTAtNS0xLTEtNjI3MTM_59233b9f-c924-4b3d-b2a8-3ccfcd28c392"
      unitRef="usd">348000000</us-gaap:CommercialPaper>
    <us-gaap:ShorttermDebtFairValue
      contextRef="ife4c0c7afd9144938f80700f00e2e503_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTAtNy0xLTEtNjI3MTM_c19e4c7b-c3f1-4907-bf60-f41e942a8e2e"
      unitRef="usd">348000000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:CommercialPaper
      contextRef="i48ad05476c804a989876d463a18d0f08_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTAtOS0xLTEtNjI3MTM_9bb13516-6751-4899-8d64-64036e01d788"
      unitRef="usd">237000000</us-gaap:CommercialPaper>
    <us-gaap:ShorttermDebtFairValue
      contextRef="i743b074f5dff4cbb8b388b51e52d39ea_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTAtMTEtMS0xLTYyNzEz_054301c3-8802-4322-98b8-c4abfe2d9556"
      unitRef="usd">237000000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:LongTermDebt
      contextRef="i77cea09568304a929a0021ea5531db88_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTItNS0xLTEtNjI3MTM_bb839359-6ffe-4f2a-86da-075b76716a05"
      unitRef="usd">2475000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ic520fafe28c44d34ac504762a168782a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTItNy0xLTEtNjI3MTM_c07c38ca-c024-45ce-9211-7f5363ade77e"
      unitRef="usd">2258000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt
      contextRef="ic048de659b754fc9a1c06eb94c867694_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTItOS0xLTEtNjI3MTM_75c3e0a2-064c-482c-ac4b-3c41134cf5d9"
      unitRef="usd">2474000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="idd3d0e49a60941ee8d18b67216bb2d26_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTItMTEtMS0xLTYyNzEz_e82e24a8-e984-4a72-a1e7-5d6ca36e81e0"
      unitRef="usd">2386000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:Liabilities
      contextRef="i63b417fd4e2e4baca829a11debf18917_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTMtNS0xLTEtNjI3MTM_a8fccccd-18a8-439f-87c2-b7b18493371d"
      unitRef="usd">2823000000</us-gaap:Liabilities>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i12297feced3a40998cfae2f77b61fe69_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTMtNy0xLTEtNjI3MTM_29ada014-e2bb-43ff-9732-b4f1adfa5890"
      unitRef="usd">2606000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:Liabilities
      contextRef="i5714ee2d486c40e0920537af19846e5c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTMtOS0xLTEtNjI3MTM_0ce06152-51cb-4578-9633-50d171c87c53"
      unitRef="usd">2711000000</us-gaap:Liabilities>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i4ccd25a4389e4143bcd3303d5a26ad64_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNC9mcmFnOmZmM2RhZTU0YWYyZjRkN2JhZWI2MGZlMTdkODNkNzIxL3RhYmxlOjgxNGZhNTZkMGJhYzRkN2U5ZDg1NDZjYTZiYjg4MzIzL3RhYmxlcmFuZ2U6ODE0ZmE1NmQwYmFjNGQ3ZTlkODU0NmNhNmJiODgzMjNfMTMtMTEtMS0xLTYyNzEz_acb875a2-5f40-4f15-bd9c-e68d05ad9358"
      unitRef="usd">2623000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNy9mcmFnOjM5NjA2ZDNlMzYzYzRiZWM5Mzc0NDA0ODE2OGE4MTcxL3RleHRyZWdpb246Mzk2MDZkM2UzNjNjNGJlYzkzNzQ0MDQ4MTY4YTgxNzFfNzg0_906a6d8b-17de-4f5f-a60c-a8ad17d2a6e4">INCOME TAXESIn determining its quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The effective tax rate on earnings was 25.0% and 22.6% for the three months ended September&#160;30, 2022 and 2021, respectively.The Inflation Reduction Act (the &#x201c;Act&#x201d;) was signed into law on August 16, 2022. The Act introduces a new 15% corporate minimum tax for certain large corporations that becomes effective at the beginning of the Company&#x2019;s fiscal 2024 and it imposes a 1% excise tax on the value of share repurchases, net of new share issuances, after December 31, 2022. These provisions, as well as the other corporate tax changes included in the Act, are not expected to have a material impact on the Company&#x2019;s financial statements.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNy9mcmFnOjM5NjA2ZDNlMzYzYzRiZWM5Mzc0NDA0ODE2OGE4MTcxL3RleHRyZWdpb246Mzk2MDZkM2UzNjNjNGJlYzkzNzQ0MDQ4MTY4YTgxNzFfNTM2_4faebae1-9826-4611-a248-dd96de4c48fc"
      unitRef="number">0.250</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF8zNy9mcmFnOjM5NjA2ZDNlMzYzYzRiZWM5Mzc0NDA0ODE2OGE4MTcxL3RleHRyZWdpb246Mzk2MDZkM2UzNjNjNGJlYzkzNzQ0MDQ4MTY4YTgxNzFfMjc0ODc3OTA3NTg3MA_92520479-834e-4c93-9019-1927ea86a7fe"
      unitRef="number">0.226</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RleHRyZWdpb246NmQyZTkzNjkwN2E5NDNhMmE3NjdmMzcyYTlkYjBkYzlfNTk5_d933cf76-74f0-4e7c-b3e9-ee4595cf906b">NET EARNINGS PER SHARE (EPS)&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,339&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,980&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,914&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,042&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Antidilutive stock options and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,983&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Clorox.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RleHRyZWdpb246NmQyZTkzNjkwN2E5NDNhMmE3NjdmMzcyYTlkYjBkYzlfNjAx_90eb5e42-e62a-4de9-8302-0bc7af2c0fc5">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,339&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,980&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,914&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,042&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Antidilutive stock options and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,983&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RhYmxlOjYxNTExZTYyMzgxODRjMThiOGMzYmMxYjU5OTQ2YzNjL3RhYmxlcmFuZ2U6NjE1MTFlNjIzODE4NGMxOGI4YzNiYzFiNTk5NDZjM2NfMi0xLTEtMS02MjcxMw_12f966d5-e6cf-4390-840f-fbf64dc2cd79"
      unitRef="shares">123339000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RhYmxlOjYxNTExZTYyMzgxODRjMThiOGMzYmMxYjU5OTQ2YzNjL3RhYmxlcmFuZ2U6NjE1MTFlNjIzODE4NGMxOGI4YzNiYzFiNTk5NDZjM2NfMi0zLTEtMS02MjcxMw_7b5f7cc0-f757-4150-83a8-4935ac552265"
      unitRef="shares">122980000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RhYmxlOjYxNTExZTYyMzgxODRjMThiOGMzYmMxYjU5OTQ2YzNjL3RhYmxlcmFuZ2U6NjE1MTFlNjIzODE4NGMxOGI4YzNiYzFiNTk5NDZjM2NfMy0xLTEtMS02MjcxMw_7ddf5ce8-ce13-4518-847d-bd238718e3f2"
      unitRef="shares">575000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RhYmxlOjYxNTExZTYyMzgxODRjMThiOGMzYmMxYjU5OTQ2YzNjL3RhYmxlcmFuZ2U6NjE1MTFlNjIzODE4NGMxOGI4YzNiYzFiNTk5NDZjM2NfMy0zLTEtMS02MjcxMw_adc19553-5690-41f6-9c5c-ae874c2aedb2"
      unitRef="shares">1062000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RhYmxlOjYxNTExZTYyMzgxODRjMThiOGMzYmMxYjU5OTQ2YzNjL3RhYmxlcmFuZ2U6NjE1MTFlNjIzODE4NGMxOGI4YzNiYzFiNTk5NDZjM2NfNC0xLTEtMS02MjcxMw_4e6aa33d-a978-41eb-984b-4f9664567599"
      unitRef="shares">123914000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RhYmxlOjYxNTExZTYyMzgxODRjMThiOGMzYmMxYjU5OTQ2YzNjL3RhYmxlcmFuZ2U6NjE1MTFlNjIzODE4NGMxOGI4YzNiYzFiNTk5NDZjM2NfNC0zLTEtMS02MjcxMw_7130cd0a-9db6-49f4-a4ab-d903d937a5ea"
      unitRef="shares">124042000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RhYmxlOjYxNTExZTYyMzgxODRjMThiOGMzYmMxYjU5OTQ2YzNjL3RhYmxlcmFuZ2U6NjE1MTFlNjIzODE4NGMxOGI4YzNiYzFiNTk5NDZjM2NfNi0xLTEtMS02MjcxMw_0e1d4c40-cefd-4c90-834a-a5cde307ce65"
      unitRef="shares">2983000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80MC9mcmFnOjZkMmU5MzY5MDdhOTQzYTJhNzY3ZjM3MmE5ZGIwZGM5L3RhYmxlOjYxNTExZTYyMzgxODRjMThiOGMzYmMxYjU5OTQ2YzNjL3RhYmxlcmFuZ2U6NjE1MTFlNjIzODE4NGMxOGI4YzNiYzFiNTk5NDZjM2NfNi0zLTEtMS02MjcxMw_f157c69e-f064-4712-a407-41aa8850266c"
      unitRef="shares">1068000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RleHRyZWdpb246NWRiNTg2YjU5Y2VlNGVlZjhlNjQyNGI5MDJjYTRiYjBfMTQ0_d22b789a-ca80-4ac5-be7f-0857c7fe4946">COMPREHENSIVE INCOME (LOSS) &lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of Comprehensive income (loss) for the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefit adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Total comprehensive income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total comprehensive income attributable to Clorox&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RleHRyZWdpb246NWRiNTg2YjU5Y2VlNGVlZjhlNjQyNGI5MDJjYTRiYjBfMTQz_2782be01-cbd2-4daa-a4bc-2441283e1696">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of Comprehensive income (loss) for the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefit adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Total comprehensive income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total comprehensive income attributable to Clorox&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfMi0xLTEtMS02MjcxMw_c0e78c62-2abd-4bb8-8117-7c0302c878c3"
      unitRef="usd">87000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfMi0zLTEtMS02MjcxMw_c369c924-8a2c-42b4-a1c6-d4c42ca59bf9"
      unitRef="usd">143000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfNC0xLTEtMS02MjcxMw_aab8fbc1-b56c-4950-9c0c-af533baa30cf"
      unitRef="usd">-29000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfNC0zLTEtMS02MjcxMw_31ef3dc5-0c5f-4825-aaa5-f11d8e8a8ba8"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfNS0xLTEtMS02MjcxMw_98835505-659e-4545-87fc-c511735b2e2e"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfNS0zLTEtMS02MjcxMw_0b611720-6cc4-437b-a0e7-4a98dfcfa556"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfNi0xLTEtMS02MjcxMw_1a815c1a-9659-44c8-aee4-d689bd6ff9e6"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfNi0zLTEtMS02MjcxMw_318e5055-2b71-4899-87dc-bd2885da8949"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfNy0xLTEtMS02MjcxMw_9c4a9a01-c34d-47e1-b8da-3b85ce99a4c9"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfNy0zLTEtMS02MjcxMw_0deff997-0165-4524-8b45-ae3ec020ee7f"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfOC0xLTEtMS02MjcxMw_6acdd09a-ca5c-4a30-bbb0-a28582b0def0"
      unitRef="usd">51000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfOC0zLTEtMS02MjcxMw_03349e90-4929-4637-b433-ee196a80d428"
      unitRef="usd">122000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfOS0xLTEtMS02MjcxMw_e904032c-ef05-4d5d-afd0-75c98a77b18f"
      unitRef="usd">2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfOS0zLTEtMS02MjcxMw_7ba6ca85-c875-43e1-9425-ccf4b4880824"
      unitRef="usd">1000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfMTAtMS0xLTEtNjI3MTM_7c6e04b8-c2c0-4aa1-85f8-ae195eafd038"
      unitRef="usd">49000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80My9mcmFnOjVkYjU4NmI1OWNlZTRlZWY4ZTY0MjRiOTAyY2E0YmIwL3RhYmxlOjIxNzBiZDI2YTBjODQwYmFhZmMzMGYzM2M0NDU2ZDI0L3RhYmxlcmFuZ2U6MjE3MGJkMjZhMGM4NDBiYWFmYzMwZjMzYzQ0NTZkMjRfMTAtMy0xLTEtNjI3MTM_59ef4bb6-bea5-45bd-a0f4-7245671b0ff7"
      unitRef="usd">121000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RleHRyZWdpb246ZmMyZTBhOTNkMGZkNGQxZThhNjgzZGM3NWIxY2Q3MjFfODIx_4579a02c-a4bc-44e4-b8e6-a18b9823d54a">STOCKHOLDERS&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; EQUITY &lt;/span&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the components of Stockholders&#x2019; equity were as follows for the periods indicated: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%"&gt;(Dollars in millions except per share data; shares in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additional Paid-in Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Net (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders  ($1.16 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Treasury stock purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,389)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,589)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders  ($2.36 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension and postretirement benefit adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(426)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense), and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in foreign currency translation adjustments are remeasurement losses on long-term intercompany loans where settlement is not planned or anticipated in the foreseeable future. There were no amounts associated with these loans reclassified from Accumulated other comprehensive net (loss) income for the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RleHRyZWdpb246ZmMyZTBhOTNkMGZkNGQxZThhNjgzZGM3NWIxY2Q3MjFfODI0_fe586a10-eae7-49da-ab5b-1c4592a500b4">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the components of Stockholders&#x2019; equity were as follows for the periods indicated: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%"&gt;(Dollars in millions except per share data; shares in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additional Paid-in Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Net (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders  ($1.16 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Treasury stock purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,389)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,589)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to Clorox stockholders  ($2.36 per share declared)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividends to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other employee stock plan activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id48f7675a8794df7843115f14fe4bb25_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy0xLTEtMS02MjcxMw_3eb31081-845c-410c-a3e2-d71acb372818"
      unitRef="usd">131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id48f7675a8794df7843115f14fe4bb25_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy0zLTEtMS02MjcxMw_ef8b0000-dff3-4f1e-a563-c923cc631850"
      unitRef="shares">130741000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5e5e0252210049cfa75325d985e17243_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy01LTEtMS02MjcxMw_0f7ba922-b7ee-411c-bce7-642b802f328d"
      unitRef="usd">1186000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic2d95a7621de4ea1b42295baf483de7b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy03LTEtMS02MjcxMw_fd14cb86-6388-4c54-be6b-8503dd8041ed"
      unitRef="usd">1036000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7feccdfe1c8340ada0a48b4cad20e5f0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy05LTEtMS02MjcxMw_0ca99097-568f-4361-bef1-03b4e3f50b44"
      unitRef="usd">-1396000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i7feccdfe1c8340ada0a48b4cad20e5f0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy0xMS0xLTEtNjI3MTM_c21a109c-ee33-44c6-8465-452d8597c8dc"
      unitRef="shares">7961000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i67937b96a80447d18275ba06851fb742_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy0xMy0xLTEtNjI3MTM_161ca6e4-3f5e-4e57-8d04-b74a85676cc4"
      unitRef="usd">-546000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i56d5c5699f5b41ca84983f1f737c45bb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy0xNS0xLTEtNjI3MTM_5c6eb1d5-a014-4b4c-9f3f-96d6d40fc538"
      unitRef="usd">181000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ife6845f640b94b6d9b3a46784145e347_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMy0xNy0xLTEtNjI3MTM_1c885a22-8c66-40e8-87ab-d9eea8acb051"
      unitRef="usd">592000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ia1a0121aacaa451b9fc9b38eb0223d9f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNC03LTEtMS02MjcxMw_b7115b57-7707-49d7-8257-c7c7c47dec7d"
      unitRef="usd">142000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5c212dd4fc614d22a2bc72979bf8a54e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNC0xNS0xLTEtNjI3MTM_6a789ca6-4bdb-4a62-890a-279719c79fe8"
      unitRef="usd">1000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNC0xNy0xLTEtNjI3MTM_51d25408-6054-48b5-ac57-e401f4556e8b"
      unitRef="usd">143000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifd86e6e3a1b44f9b9471e84cc3d38d59_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNS0xMy0xLTEtNjI3MTM_99bbc2df-1e88-45e2-ab7e-14dfa6d32ca1"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNS0xNy0xLTEtNjI3MTM_da9a3a37-8baa-43af-a1d5-901b6105a63c"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNi0wLTEtMS02MjcxMy90ZXh0cmVnaW9uOmM4NDcwOWFhN2YwNTRmYzQ4Y2EwNTU2MTllZDY5MjZiXzM5_a6c22c7c-b640-479a-9cfa-0719da5befa6"
      unitRef="usdPerShare">1.16</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="ia1a0121aacaa451b9fc9b38eb0223d9f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNi03LTEtMS02MjcxMw_013800d7-c1f3-4db5-8554-e01fa313a004"
      unitRef="usd">143000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNi0xNy0xLTEtNjI3MTM_8884d85b-ff49-44cd-8005-e8a2124e0473"
      unitRef="usd">143000000</us-gaap:Dividends>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i5c212dd4fc614d22a2bc72979bf8a54e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNy0xNS0xLTEtNjI3MTM_df4f9091-8815-4fb7-aaa0-821f35b7ac48"
      unitRef="usd">3000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfNy0xNy0xLTEtNjI3MTM_36c0694e-251d-4053-bffb-7b2dece5f3c4"
      unitRef="usd">3000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6930f355cf7642b6887d05d83aef15c5_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfOS01LTEtMS02MjcxMw_83ff0667-ab21-492e-8a08-fa36b3b5257c"
      unitRef="usd">9000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfOS0xNy0xLTEtNjI3MTM_556c148b-854c-4e29-ba51-e2ea8ebb7264"
      unitRef="usd">9000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i6930f355cf7642b6887d05d83aef15c5_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTAtNS0xLTEtNjI3MTM_ab47ae0a-22cd-413b-96d0-e99eedadce49"
      unitRef="usd">-29000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="ia1a0121aacaa451b9fc9b38eb0223d9f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTAtNy0xLTEtNjI3MTM_d66d69ba-6e73-44eb-b639-d9fa2400d541"
      unitRef="usd">-8000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i0196020330d14953b976bf363233729f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTAtOS0xLTEtNjI3MTM_c16881dd-91ea-418b-a4bd-23c5f2cce5ea"
      unitRef="usd">32000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesShares
      contextRef="i0196020330d14953b976bf363233729f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTAtMTEtMS0xLTYyNzEz_a11a4f62-fe6b-4c84-a16c-139538e3732f"
      unitRef="shares">228000</clx:OtherEmployeeStockPlanActivitiesShares>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTAtMTctMS0xLTYyNzEz_d8e0e823-e3df-49e0-86de-57f9c12fc2e4"
      unitRef="usd">-5000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0196020330d14953b976bf363233729f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTEtOS0xLTEtNjI3MTM_f8cd0e0d-39e8-4574-a624-657dd4d272fa"
      unitRef="usd">25000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i0196020330d14953b976bf363233729f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTEtMTEtMS0xLTYyNzEz_f723e916-cd06-4bdc-8699-e676c575cece"
      unitRef="shares">152000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTEtMTctMS0xLTYyNzEz_3a5e8d55-1eba-4eb7-ab75-f64a34cf27e8"
      unitRef="usd">25000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ice68a02899784fd88d4432a3fb090772_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtMS0xLTEtNjI3MTM_791e6863-539b-49e2-9ba4-30fe599223a4"
      unitRef="usd">131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ice68a02899784fd88d4432a3fb090772_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtMy0xLTEtNjI3MTM_0acde1e9-e49e-462a-a08e-d4040569595f"
      unitRef="shares">130741000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i730ffd508cf243709923d83ea9b803c6_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtNS0xLTEtNjI3MTM_a7c7be2f-6dfa-4d7d-bfdc-610e9fe98e8d"
      unitRef="usd">1166000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1c7699609a3549b8b86808d050c110d4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtNy0xLTEtNjI3MTM_f73cebb7-76a1-40ad-af7f-32216d5938b9"
      unitRef="usd">1027000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5e8cfd1012e540b98b636dc848d3c3bc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtOS0xLTEtNjI3MTM_42c4483b-b58a-4919-9ede-55a67274b1e0"
      unitRef="usd">-1389000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i5e8cfd1012e540b98b636dc848d3c3bc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtMTEtMS0xLTYyNzEz_5ffa51ea-3eb1-4d3b-ba41-9b06fcb8279c"
      unitRef="shares">7885000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaacd12e7523f4715be7afb04d18844aa_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtMTMtMS0xLTYyNzEz_915f2348-3597-4ddd-94d3-e6825658f304"
      unitRef="usd">-567000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7cda18cb62f44748b28447a88f322746_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtMTUtMS0xLTYyNzEz_f2adf2ae-3593-4e42-b38a-25d81bff8a3d"
      unitRef="usd">179000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i904c9b98d4a249328732ea1955c73b79_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTMtMTctMS0xLTYyNzEz_ca312306-4c5f-48ba-80be-e2f27491b812"
      unitRef="usd">547000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2284863f0fb44dcfae350d8ee4e1fd77_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtMS0xLTEtNjI3MTM_2db1d450-1745-4a2f-bb41-10580eda249f"
      unitRef="usd">131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2284863f0fb44dcfae350d8ee4e1fd77_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtMy0xLTEtNjI3MTM_afabe80d-d0a2-4b45-8823-ef05c81d6543"
      unitRef="shares">130741000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf478d53ab4b4b9f980df8bc214e13cb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtNS0xLTEtNjI3MTM_814183d4-d987-47ed-b207-b254b1336054"
      unitRef="usd">1202000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifa3208678276429ca1a8f3db656730ee_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtNy0xLTEtNjI3MTM_204b439b-ca14-4c02-a99b-d4b9a33d639a"
      unitRef="usd">1048000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i888a4cf85c084a58ab95492d82a8d4a1_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtOS0xLTEtNjI3MTM_90ab5153-d430-4ce5-aa42-ec0e28d67d97"
      unitRef="usd">-1346000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i888a4cf85c084a58ab95492d82a8d4a1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtMTEtMS0xLTYyNzEz_d0b42761-d981-406b-b7d7-d23de69cf06e"
      unitRef="shares">7589000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6052bc3b28d746c0bd0c11c456d9f13f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtMTMtMS0xLTYyNzEz_b97bf37c-b6af-4311-87ab-466da0673447"
      unitRef="usd">-479000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8cf3392f32d3409285d213bbc6902517_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtMTUtMS0xLTYyNzEz_4b9c527a-9367-4dd9-ba24-21f12716046d"
      unitRef="usd">173000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTUtMTctMS0xLTYyNzEz_3dbdeac2-1740-4bd2-a47d-174a6122d3cb"
      unitRef="usd">729000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i94279de6d96e4bd99aef13f69b2d95d3_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTYtNy0xLTEtNjI3MTM_a7577bba-3280-4aa3-b5dc-ee60a0064876"
      unitRef="usd">85000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ida1b5d30c914404b95ad3394c7bdbfe4_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTYtMTUtMS0xLTYyNzEz_047923b2-de67-44dd-bea2-3fd550c0f2b1"
      unitRef="usd">2000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTYtMTctMS0xLTYyNzEz_25c3a773-07b3-45c1-ac0e-aa6f455db2e3"
      unitRef="usd">87000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i12b44d1ebaff43ac9c4d3e2a2bae7d0f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTctMTMtMS0xLTYyNzEz_86727f3c-2fcc-47b5-874c-3db4f3baf126"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTctMTctMS0xLTYyNzEz_0c0a36fb-f6bb-4934-aedd-caa2eb95ec05"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTgtMC0xLTEtNjI3MTMvdGV4dHJlZ2lvbjo0ZDkxN2M2MDJiNjQ0ZjE1ODk3MTk3ZjliMTQxNTEyOF8zOQ_529fcdd5-5a29-416c-b217-030a46935847"
      unitRef="usdPerShare">2.36</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="i94279de6d96e4bd99aef13f69b2d95d3_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTgtNy0xLTEtNjI3MTM_326b7fa4-44ff-4497-b7d3-f4cd71ff5197"
      unitRef="usd">293000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTgtMTctMS0xLTYyNzEz_f0142bc0-1f5d-44bc-bf33-68f8b437652b"
      unitRef="usd">293000000</us-gaap:Dividends>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ida1b5d30c914404b95ad3394c7bdbfe4_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTktMTUtMS0xLTYyNzEz_ca978155-f6ff-437a-88d5-d72be79dd83a"
      unitRef="usd">5000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMTktMTctMS0xLTYyNzEz_9911072e-4119-476f-a6f7-9e259af07c0f"
      unitRef="usd">5000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie9d6549a44e94575912af38c44fff8a9_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjEtNS0xLTEtNjI3MTM_0d1161a6-eb85-4b01-b609-f126a8e726da"
      unitRef="usd">10000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjEtMTctMS0xLTYyNzEz_4573a53b-c37b-41ce-8862-f7286622a10d"
      unitRef="usd">10000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="ie9d6549a44e94575912af38c44fff8a9_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjItNS0xLTEtNjI3MTM_d278c8ab-4c75-4ace-8692-c6bee875011f"
      unitRef="usd">-19000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i94279de6d96e4bd99aef13f69b2d95d3_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjItNy0xLTEtNjI3MTM_734dd48b-f6ce-4d4d-988b-b9a9ff46a17a"
      unitRef="usd">-8000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i7b08aa96dca042dab59571ea3df315f4_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjItOS0xLTEtNjI3MTM_a024f123-c479-4f18-81d9-3628fc13b0fe"
      unitRef="usd">31000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <clx:OtherEmployeeStockPlanActivitiesShares
      contextRef="i7b08aa96dca042dab59571ea3df315f4_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjItMTEtMS0xLTYyNzEz_aa8568d0-1a63-4eb1-882a-a5c946d2415c"
      unitRef="shares">204000</clx:OtherEmployeeStockPlanActivitiesShares>
    <clx:OtherEmployeeStockPlanActivitiesAmount
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjItMTctMS0xLTYyNzEz_0f70896a-39dc-467a-aa20-056ee8fbd55c"
      unitRef="usd">4000000</clx:OtherEmployeeStockPlanActivitiesAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8678dafbf0e64ad3a1136c20a7706504_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtMS0xLTEtNjI3MTM_7bfa4eec-35fc-4bb3-88f7-5fa5b11059ed"
      unitRef="usd">131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8678dafbf0e64ad3a1136c20a7706504_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtMy0xLTEtNjI3MTM_490e6442-0a4b-4767-910c-97b672c33367"
      unitRef="shares">130741000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9d1bbb06b08d40428b604d332162f94c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtNS0xLTEtNjI3MTM_9b3d4fa1-53ac-41ef-81ac-7d65fc9a88a2"
      unitRef="usd">1193000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iffdbe24edf9f479bb05597d7938ccac2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtNy0xLTEtNjI3MTM_7a9df46e-7923-487e-a7f7-70abf94f868d"
      unitRef="usd">832000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2648e344424447c4982226cfa30a4b3e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtOS0xLTEtNjI3MTM_719f193e-b4d5-442c-8f2b-5a4bdcf47980"
      unitRef="usd">-1315000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i2648e344424447c4982226cfa30a4b3e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtMTEtMS0xLTYyNzEz_2480bc27-15ad-442e-86a6-3c2f31100f1f"
      unitRef="shares">7385000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i05ae02b9557f460e90131cf855f3e5b2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtMTMtMS0xLTYyNzEz_83f9b89a-f8da-445b-8d84-864935eb612c"
      unitRef="usd">-515000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i589ef1e1d7364af18ae1c4f29b187901_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtMTUtMS0xLTYyNzEz_0341fb1c-630b-4230-8c28-122a8a8df53e"
      unitRef="usd">170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmEyNzBiNGFlMzA5ODRhMDM5Mzg3ZGNiNTc0MWI5YzJkL3RhYmxlcmFuZ2U6YTI3MGI0YWUzMDk4NGEwMzkzODdkY2I1NzQxYjljMmRfMjUtMTctMS0xLTYyNzEz_b0d689f0-55a3-4cf7-8b16-ce548e4bbb26"
      unitRef="usd">496000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RleHRyZWdpb246ZmMyZTBhOTNkMGZkNGQxZThhNjgzZGM3NWIxY2Q3MjFfODE5_0bd517fd-3444-46e9-ab09-24794c8b9aef">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension and postretirement benefit adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(426)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated other comprehensive net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense), and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="iaf7e1839e4634249b8d12259ef4657a6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMi0xLTEtMS02MjcxMw_26d0b2d3-54a9-4c0b-9c41-1c22ed431d1e"
      unitRef="usd">-403000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icc23221332314a54bdc672565b6ca265_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMi0zLTEtMS02MjcxMw_9ceba2d7-f367-41b5-b80a-c51f8eb70885"
      unitRef="usd">21000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic430fcc6fc214744a2f1da71a2c66678_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMi01LTEtMS02MjcxMw_51d86d3d-a098-4f92-83f0-ef23da6249d4"
      unitRef="usd">-164000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i67937b96a80447d18275ba06851fb742_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMi03LTEtMS02MjcxMw_5ca4d586-9d35-44ad-bf9b-693143d7cad5"
      unitRef="usd">-546000000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i8c3e1b9f5f034fcdacc2d71873899331_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMy0xLTEtMS02MjcxMw_f3579a56-28fd-457e-a9c4-53cce1ce2a7b"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i90d469ba619141c2ace7f747b1d68050_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMy0zLTEtMS02MjcxMw_0a03f233-2798-4bc3-a5fb-a00ab72006e9"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="iab66d6f5313944d98bde2718ad418ab2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMy01LTEtMS02MjcxMw_4b5cb966-bc98-49af-9349-ecc2559509f9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ifd86e6e3a1b44f9b9471e84cc3d38d59_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMy03LTEtMS02MjcxMw_93d37f75-1d75-4be2-b1ba-55ca0cce10a1"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i8c3e1b9f5f034fcdacc2d71873899331_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNC0xLTEtMS02MjcxMw_33a1ecb5-59d3-4d59-85da-8c6d8136fc29"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i90d469ba619141c2ace7f747b1d68050_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNC0zLTEtMS02MjcxMw_2fa8ab34-8e55-4340-b645-c459f05581f6"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="iab66d6f5313944d98bde2718ad418ab2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNC01LTEtMS02MjcxMw_c5d9a49f-eb4a-4916-88e0-9566edd8f77a"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ifd86e6e3a1b44f9b9471e84cc3d38d59_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNC03LTEtMS02MjcxMw_e1dd8218-5b29-4df8-9d27-95c4ca5cae76"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i8c3e1b9f5f034fcdacc2d71873899331_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNS0xLTEtMS02MjcxMw_2be8272d-d315-493e-8df3-19a1481ad47c"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i90d469ba619141c2ace7f747b1d68050_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNS0zLTEtMS02MjcxMw_e624987b-b657-4761-b86e-bef8b3b964da"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="iab66d6f5313944d98bde2718ad418ab2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNS01LTEtMS02MjcxMw_ec39cc39-1874-4daf-9a35-5bf48616938b"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ifd86e6e3a1b44f9b9471e84cc3d38d59_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNS03LTEtMS02MjcxMw_58f28220-e8ab-43fd-b9c4-15b5829f252f"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8c3e1b9f5f034fcdacc2d71873899331_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNi0xLTEtMS02MjcxMw_318f2031-aefc-46f7-902d-2fdad1ab2e1d"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i90d469ba619141c2ace7f747b1d68050_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNi0zLTEtMS02MjcxMw_f6be6a49-507e-4f9b-9cda-aba35431c7a3"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iab66d6f5313944d98bde2718ad418ab2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNi01LTEtMS02MjcxMw_3a0b4278-180f-4738-8c96-77b2d169374d"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifd86e6e3a1b44f9b9471e84cc3d38d59_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNi03LTEtMS02MjcxMw_3e3837e2-186a-4de7-b0c8-3710eb7d5a40"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ic4d5e6459eff4d29a673adf7eb5402d1_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNy0xLTEtMS02MjcxMw_4effdcc0-7e28-433e-a912-5596fea8bfb5"
      unitRef="usd">-426000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib209e83a487b430bafc14ba29f31ede4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNy0zLTEtMS02MjcxMw_07ae1a7e-2922-471d-bc8b-6c1b746ab62c"
      unitRef="usd">22000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i15f764dde95c421bbfb594d9a2886d15_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNy01LTEtMS02MjcxMw_d827c7d0-901c-43e6-9a40-e09175b7b349"
      unitRef="usd">-163000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaacd12e7523f4715be7afb04d18844aa_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfNy03LTEtMS02MjcxMw_fcb25925-045c-4466-8c23-ab2498530535"
      unitRef="usd">-567000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6eed3460799b4a04ba1ee3810ded507a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfOS0xLTEtMS02MjcxMw_54ca7e4e-6f32-408c-af55-9c765a449ca3"
      unitRef="usd">-448000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id337d4363166457ab49d51fd89cad69b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfOS0zLTEtMS02MjcxMw_d83b9423-7e8b-4818-b21b-3288f3431d24"
      unitRef="usd">121000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i72dde26130df4e1c9e1eeb773672603e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfOS01LTEtMS02MjcxMw_750f0e62-300e-41df-abcf-d977e0fa4bb1"
      unitRef="usd">-152000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6052bc3b28d746c0bd0c11c456d9f13f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfOS03LTEtMS02MjcxMw_5e50e442-05ad-4445-83e0-aed8520b1ccb"
      unitRef="usd">-479000000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="if3aaab4df1434368a525f9cb0ea76ec3_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTAtMS0xLTEtNjI3MTM_66f4f32f-41de-4496-902b-241b782100cd"
      unitRef="usd">-29000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i29278874f2bd4e64950e351a9d477fdb_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTAtMy0xLTEtNjI3MTM_93de85aa-0b24-4ca1-8ea3-15b5ef7da980"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i58b0a3cc9bf4444ea52a9aad02fafd3c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTAtNS0xLTEtNjI3MTM_ad92bdd1-2fda-42c7-8588-348491aa8a25"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i12b44d1ebaff43ac9c4d3e2a2bae7d0f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTAtNy0xLTEtNjI3MTM_b101d741-eebf-4a42-8839-5dad87a055a9"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="if3aaab4df1434368a525f9cb0ea76ec3_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTEtMS0xLTEtNjI3MTM_c3a8ffe0-1aa2-44d0-b3d0-4844ebee2be0"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i29278874f2bd4e64950e351a9d477fdb_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTEtMy0xLTEtNjI3MTM_de6d5062-dcc7-40fd-9316-b954eb1b4b33"
      unitRef="usd">8000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i58b0a3cc9bf4444ea52a9aad02fafd3c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTEtNS0xLTEtNjI3MTM_6445ff44-8f1f-4bc2-bc66-733f729c095f"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i12b44d1ebaff43ac9c4d3e2a2bae7d0f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTEtNy0xLTEtNjI3MTM_7eca97a7-1cc3-423a-8524-c5e0f34dee66"
      unitRef="usd">7000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="if3aaab4df1434368a525f9cb0ea76ec3_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTItMS0xLTEtNjI3MTM_2e278909-f753-4f62-8152-fe66006a027b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i29278874f2bd4e64950e351a9d477fdb_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTItMy0xLTEtNjI3MTM_db2e0aac-58c1-4815-966d-385af39c8f1b"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i58b0a3cc9bf4444ea52a9aad02fafd3c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTItNS0xLTEtNjI3MTM_f6bf5854-a6f2-46fd-b82e-83df853cbf3a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i12b44d1ebaff43ac9c4d3e2a2bae7d0f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTItNy0xLTEtNjI3MTM_0be84dd0-7338-4dd3-8117-ffa7763bef24"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if3aaab4df1434368a525f9cb0ea76ec3_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTMtMS0xLTEtNjI3MTM_da7348ba-c5cd-43c0-9908-235fbd26e646"
      unitRef="usd">-29000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i29278874f2bd4e64950e351a9d477fdb_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTMtMy0xLTEtNjI3MTM_c736c9c8-cd4f-42dd-922c-cb9fbdaaf0c6"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i58b0a3cc9bf4444ea52a9aad02fafd3c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTMtNS0xLTEtNjI3MTM_81b30bfe-e549-4b76-b31c-49da93974278"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i12b44d1ebaff43ac9c4d3e2a2bae7d0f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTMtNy0xLTEtNjI3MTM_ecb8c269-ebbe-4a6e-932a-fb4e4f42e629"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i56269e6a9fc24521a48f5dbce03064f4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTQtMS0xLTEtNjI3MTM_f292dcf4-bb9e-4de8-923e-e261d4b55660"
      unitRef="usd">-477000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id5f1f0fa07304fef96e2267e72a9854a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTQtMy0xLTEtNjI3MTM_35932307-cada-4139-8ca3-a2d44a4a8619"
      unitRef="usd">113000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i12cee7acd73141489be68129eaa031ae_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTQtNS0xLTEtNjI3MTM_679a11e7-205f-4c1e-aaa0-12fae0f90066"
      unitRef="usd">-151000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i05ae02b9557f460e90131cf855f3e5b2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RhYmxlOmQwYzI2MmJlYWNlMDRhYTQ5OTZmNzIwMWVjNzU3N2FjL3RhYmxlcmFuZ2U6ZDBjMjYyYmVhY2UwNGFhNDk5NmY3MjAxZWM3NTc3YWNfMTQtNy0xLTEtNjI3MTM_f4b68671-8b88-47ff-b32a-6c6283efecca"
      unitRef="usd">-515000000</us-gaap:StockholdersEquity>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i800f404abef344e79689a216db23038a_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RleHRyZWdpb246ZmMyZTBhOTNkMGZkNGQxZThhNjgzZGM3NWIxY2Q3MjFfNjg3_679ea739-2e37-421a-924b-19304e3229e9"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="icab4c536fd8d4a618d358572c4a848e7_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80Ni9mcmFnOmZjMmUwYTkzZDBmZDRkMWU4YTY4M2RjNzViMWNkNzIxL3RleHRyZWdpb246ZmMyZTBhOTNkMGZkNGQxZThhNjgzZGM3NWIxY2Q3MjFfNjg3_76eeef66-384b-4c90-80e3-a3e262375d2e"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfODc0_51a2d807-8c97-4b3f-bb52-4d288d98b690">EMPLOYEE BENEFIT PLANS&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a domestic qualified pension plan (the Plan). The Plan is frozen for all participants. The Plan generally was frozen effective June 30, 2011 for all employees, except for certain collectively bargained employees, whose Plan freeze was effective January 1, 2019. As a result of the Plan freeze, no employees are eligible to commence participation in the Plan or accrue any additional benefits under the Plan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On May 17, 2022, the Company&#x2019;s Board of Directors approved a resolution to terminate the Plan. The amendment will allow the settlement of the pension obligation with either a lump sum payout or a purchased annuity. It is expected to take 18 to 24 months to complete the termination from the date of the approved resolution to terminate the Plan. The completion of the process of offering and accepting lump sum elections are dependent on when certain regulatory approvals are obtained. Currently, there is not enough information available to determine the ultimate charge of the termination. The Plan is fully funded under specified Employee Retirement Income Security Act (ERISA) funding rules as of September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of net periodic benefit cost for the Company&#x2019;s retirement income plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of unrecognized items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2023 net periodic benefit cost is 2.7%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net periodic benefit cost for the Company&#x2019;s retirement health care plans was $0 for both the three months ended September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended September&#160;30, 2022 and 2021, the Company made $2 and $3 in contributions to its domestic retirement income plans, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Service cost component of the net periodic benefit cost, if any, is reflected in employee benefit costs, all other components are reflected in Other (income) expense, net.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <clx:DefinedBenefitPlanPlanTerminationPeriod
      contextRef="i1947113776464ef48d89fbe12f701aff_D20220517-20220517"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfMTg2OTE2OTc2OTY2NzM_aa0e634c-471a-4923-a628-9db18bd288fd">P18M</clx:DefinedBenefitPlanPlanTerminationPeriod>
    <clx:DefinedBenefitPlanPlanTerminationPeriod
      contextRef="if0073bc5d83c4f66b1cb1bd49f9af101_D20220517-20220517"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfMTg2OTE2OTc2OTY2Nzg_e9328058-cb64-4e84-8e14-dce7f74e55c1">P24M</clx:DefinedBenefitPlanPlanTerminationPeriod>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfODcx_b5ce5adb-4e3f-4225-b7ea-2158fa37643b">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of net periodic benefit cost for the Company&#x2019;s retirement income plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of unrecognized items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2023 net periodic benefit cost is 2.7%.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i31edb4dd7f44492f8d09aec0fa03e5c9_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RhYmxlOjZhMmFhM2RlYzdjNzQzZTU4MDI5MzhjOTlkMjhmMmVlL3RhYmxlcmFuZ2U6NmEyYWEzZGVjN2M3NDNlNTgwMjkzOGM5OWQyOGYyZWVfMy0xLTEtMS02MjcxMw_d5b9b3b3-88f1-4f1a-902d-213a3a1aec5f"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ic2294f6a1f354e1fb535db2d898d6850_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RhYmxlOjZhMmFhM2RlYzdjNzQzZTU4MDI5MzhjOTlkMjhmMmVlL3RhYmxlcmFuZ2U6NmEyYWEzZGVjN2M3NDNlNTgwMjkzOGM5OWQyOGYyZWVfMy0zLTEtMS02MjcxMw_1f2289e3-7c24-414d-865b-0b483fa75da5"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i31edb4dd7f44492f8d09aec0fa03e5c9_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RhYmxlOjZhMmFhM2RlYzdjNzQzZTU4MDI5MzhjOTlkMjhmMmVlL3RhYmxlcmFuZ2U6NmEyYWEzZGVjN2M3NDNlNTgwMjkzOGM5OWQyOGYyZWVfNC0xLTEtMS02MjcxMw_afdab0b5-b556-45b9-865d-4ce0edd67b1d"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ic2294f6a1f354e1fb535db2d898d6850_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RhYmxlOjZhMmFhM2RlYzdjNzQzZTU4MDI5MzhjOTlkMjhmMmVlL3RhYmxlcmFuZ2U6NmEyYWEzZGVjN2M3NDNlNTgwMjkzOGM5OWQyOGYyZWVfNC0zLTEtMS02MjcxMw_cadc2454-c70f-4a82-afa0-bea9936862b2"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i31edb4dd7f44492f8d09aec0fa03e5c9_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RhYmxlOjZhMmFhM2RlYzdjNzQzZTU4MDI5MzhjOTlkMjhmMmVlL3RhYmxlcmFuZ2U6NmEyYWEzZGVjN2M3NDNlNTgwMjkzOGM5OWQyOGYyZWVfNi0xLTEtMS02MjcxMw_3e34d8b8-f2ee-438d-9b75-14fdf7bb4420"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ic2294f6a1f354e1fb535db2d898d6850_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RhYmxlOjZhMmFhM2RlYzdjNzQzZTU4MDI5MzhjOTlkMjhmMmVlL3RhYmxlcmFuZ2U6NmEyYWEzZGVjN2M3NDNlNTgwMjkzOGM5OWQyOGYyZWVfNi0zLTEtMS02MjcxMw_991cd769-62de-4d8d-ae9c-286ef5445550"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i31edb4dd7f44492f8d09aec0fa03e5c9_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RhYmxlOjZhMmFhM2RlYzdjNzQzZTU4MDI5MzhjOTlkMjhmMmVlL3RhYmxlcmFuZ2U6NmEyYWEzZGVjN2M3NDNlNTgwMjkzOGM5OWQyOGYyZWVfNy0xLTEtMS02MjcxMw_025b0347-5451-41df-89c8-98be13dc2e9e"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ic2294f6a1f354e1fb535db2d898d6850_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RhYmxlOjZhMmFhM2RlYzdjNzQzZTU4MDI5MzhjOTlkMjhmMmVlL3RhYmxlcmFuZ2U6NmEyYWEzZGVjN2M3NDNlNTgwMjkzOGM5OWQyOGYyZWVfNy0zLTEtMS02MjcxMw_a5fef653-c23f-4d0d-b456-ef48e4cd93b2"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfMjk3_945d13fd-9d9d-477e-a882-d57d460313d2"
      unitRef="number">0.027</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfMzgy_02998270-091a-41eb-8215-0a842d7625aa"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfMzgy_f4684324-7372-4246-9145-e4d806c8928d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="id270c77784994d6b9347452cfa7bcfd5_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfNDkw_dd96d968-ec97-4095-ae28-c1b1fe66a696"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="id55f7224e21846c3acf2d3b00db79eb7_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF80OS9mcmFnOjA3MGY3ODVlNmViNzRiNDQ5YmQ3YmQ1MTcyYzYxNmE3L3RleHRyZWdpb246MDcwZjc4NWU2ZWI3NGI0NDliZDdiZDUxNzJjNjE2YTdfNDk3_5863ec84-daab-4447-b7ee-23a0d22a2af0"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfNDcyNQ_7e67b10d-1264-4fc8-aff9-fd3ed88c2e27">OTHER CONTINGENCIES AND GUARANTEES&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved in certain environmental matters, including response actions at various locations. The Company had recorded liabilities totaling $27 and $28 as of September&#160;30, 2022 and June&#160;30, 2022, respectively, for its share of aggregate future remediation costs related to these matters. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;One matter, which accounted for $13 and $14 of the recorded liability as of September&#160;30, 2022 and June&#160;30, 2022, respectively, relates to environmental costs associated with one of the Company&#x2019;s former operations at a site located in Alameda County, California. In November 2016, at the request of regulators and with the assistance of environmental consultants, the Company submitted a Feasibility Study that evaluated various options for managing the site and included estimates of the related costs. Following further discussions with the regulators in 2017, the Company recorded an undiscounted liability for costs estimated to be incurred over a 30-year period, based on one of the options in the Feasibility Study. In September 2021, as a result of an additional study and further discussions with regulators, the Company submitted a Soil Vapor Intrusion Report to the regulators, which has not resulted in a change to the recorded liability. While the Company believes its latest estimates of remediation costs are reasonable, the ultimate remediation requirements are not yet finalized and the regulators could require the Company to implement remediation actions for a longer period or take additional actions, which could include estimated undiscounted costs of up to approximately $28 over an estimated 30-year period, or require the Company to take different actions and incur additional costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Another matter in Dickinson County, Michigan, at the site of one of the Company&#x2019;s former operations for which the Company is jointly and severally liable, accounted for $9 of the recorded liability as of both September&#160;30, 2022 and June&#160;30, 2022. This amount reflects the Company&#x2019;s agreement to be liable for 24.3% of the aggregate remediation and associated costs for this matter pursuant to a cost-sharing agreement with a third party. If the third party is unable to pay its share of the response and remediation obligations, the Company may be responsible for such obligations. With the assistance of environmental consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;expenditures, maintenance and other costs that may be incurred over an estimated 30-year remediation period. Although it is reasonably possible that the Company&#x2019;s exposure may exceed the amount recorded for the Dickinson County matter, any amount of such additional exposures, or range of exposures, is not estimable at this time. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimated losses related to these matters are sensitive to a variety of uncertain factors, including the efficacy of any remediation efforts, changes in any remediation requirements and the future availability of alternative clean-up technologies. The Company is subject to various legal proceedings, claims and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements (including costs connected to the transition and unwinding of certain supply and manufacturing relationships), product liability, patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters. With respect to these proceedings, claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, either individually or in the aggregate, on the Company&#x2019;s condensed consolidated financial statements taken as a whole.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with divestitures and other transactions, the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it is probable that it will make, any material payments relating to its indemnifications, and believes that any reasonably possible payments would not have a material adverse effect, either individually or in the aggregate, on the Company&#x2019;s condensed consolidated financial statements taken as a whole.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had not recorded any material liabilities on the aforementioned as of both September&#160;30, 2022 and June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company was a party to letters of credit of $15 as of September&#160;30, 2022, primarily related to its insurance carriers, of which $0 had been drawn upon.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTk3OTEyMDkzMDY5NTE_962658d4-f1bb-4008-bc71-ce7adc72a4ec"
      unitRef="usd">27000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="if09ffc76813043a5aa916a91f25540db_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMjE2_5d663527-6016-4aec-bcdf-e3bd68417d5a"
      unitRef="usd">28000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="id97f6cb32d4443f685b8c442cb50ea2d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMzUy_45f70106-4a41-40ba-a5f5-1c1ae2e03153"
      unitRef="usd">13000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="i227c62eeec2344e5bec7da0b046fdc53_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTk3OTEyMDkzMDY5NjY_c2bb48a7-73fb-4dbf-8e2c-8744fa97da4f"
      unitRef="usd">14000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <clx:RemediationPeriod
      contextRef="ie6800724d53e43ac84874399f3d245da_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTY0OTI2NzQ0ODU1MQ_2827ae9b-a31b-45b1-bf68-9906c22be88d">P30Y</clx:RemediationPeriod>
    <clx:MaximumExposureUndiscountedCost
      contextRef="id97f6cb32d4443f685b8c442cb50ea2d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTU2OA_ab6444a0-29e5-43ca-b774-8e70c36c565f"
      unitRef="usd">28000000</clx:MaximumExposureUndiscountedCost>
    <clx:RemediationPeriod
      contextRef="ie6800724d53e43ac84874399f3d245da_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTY0OTI2NzQ0ODU1MA_64493927-8445-4fbd-8ba4-4ed2bb3413f7">P30Y</clx:RemediationPeriod>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="i806e73012b0a480488ca9ea714e35107_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTg1Mg_50910c6b-4dc2-4fad-a57e-97acb3a73580"
      unitRef="usd">9000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="i5b7963d1f14a45a09a9a46e7127d2f99_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTg1Mg_944214ab-8fb4-4006-8ee4-6b81b89f622f"
      unitRef="usd">9000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <clx:SiteContingencyAgreedPercentageOfCostSharing
      contextRef="i849355af7bdb45cc8899544e54dcb57c_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTk4Mg_fe9cf49b-4dc4-4e78-aa0b-5054e63b9e31"
      unitRef="number">0.243</clx:SiteContingencyAgreedPercentageOfCostSharing>
    <clx:RemediationPeriod
      contextRef="i849355af7bdb45cc8899544e54dcb57c_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTY0OTI2NzQ0ODU1Mg_c00f282b-38e8-4b01-8db6-11726ea6012c">P30Y</clx:RemediationPeriod>
    <clx:LetterOfCreditBorrowingCapacity
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfMTk3OTEyMDkzMDY5Nzc_0ed3f4ba-7c56-4e3d-865e-aaafe65799e8"
      unitRef="usd">15000000</clx:LetterOfCreditBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ief9b7921268144ca978e6451b72f275f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81Mi9mcmFnOjRhYzM1NzYxZTRhNjQ5OWJhOWJlYTY2M2Y5OTk0YTFhL3RleHRyZWdpb246NGFjMzU3NjFlNGE2NDk5YmE5YmVhNjYzZjk5OTRhMWFfNDcwMg_861034d2-7bc0-4591-9ea2-fcfd7a98982e"
      unitRef="usd">0</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RleHRyZWdpb246ZTcxNjUyYzIxN2ZkNDJkNzljZjEwZjcwZGRiZGJlNzBfMTU1OA_e513f6a1-7830-47b2-8cc4-eefbd753b291">SEGMENT RESULTS&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates through strategic business units (SBUs) that are also the Company&#x2019;s operating segments. The SBUs are then aggregated into four reportable segments: Health and Wellness, Household, Lifestyle and International. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below present reportable segment information and a reconciliation of the segment information to the Company&#x2019;s consolidated net sales and earnings (losses) before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate. &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings (losses) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; The earnings (losses) before income taxes for Corporate includes restructuring and related implementation costs, net for the streamlined operating model of $19 for the three-months ended September 30, 2022. While recorded within the Corporate segment, for informational purposes the following table provides the approximate restructuring and related implementation costs, net corresponding to the Company&#x2019;s reportable segments as a percentage of the total costs: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.140%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All intersegment sales are eliminated and are not included in the Company&#x2019;s reportable segments&#x2019; net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales to the Company&#x2019;s largest customer, Walmart Inc. and its affiliates, as a percentage of consolidated net sales, were 27% and 25% for the three months ended September&#160;30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides Net sales as a percentage of the Company&#x2019;s consolidated net sales, disaggregated by SBU, for the periods indicated:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cleaning&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vitamins, Minerals and Supplements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bags and Wraps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grilling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cat Litter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Food&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natural Personal Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Water Filtration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RleHRyZWdpb246ZTcxNjUyYzIxN2ZkNDJkNzljZjEwZjcwZGRiZGJlNzBfMTU0OQ_ce523cde-ccae-475a-9fc5-1e8c84b4c3ee">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates through strategic business units (SBUs) that are also the Company&#x2019;s operating segments. The SBUs are then aggregated into four reportable segments: Health and Wellness, Household, Lifestyle and International. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RleHRyZWdpb246ZTcxNjUyYzIxN2ZkNDJkNzljZjEwZjcwZGRiZGJlNzBfMTcz_dce25948-a682-47e9-8989-de54cbd1078e"
      unitRef="reportablesegment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RleHRyZWdpb246ZTcxNjUyYzIxN2ZkNDJkNzljZjEwZjcwZGRiZGJlNzBfMTU1NQ_c9e2df3a-f5c6-4549-a099-f2bac34e6001">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below present reportable segment information and a reconciliation of the segment information to the Company&#x2019;s consolidated net sales and earnings (losses) before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate. &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfbfbf;padding:0 1pt"/&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfbfbf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings (losses) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; The earnings (losses) before income taxes for Corporate includes restructuring and related implementation costs, net for the streamlined operating model of $19 for the three-months ended September 30, 2022. While recorded within the Corporate segment, for informational purposes the following table provides the approximate restructuring and related implementation costs, net corresponding to the Company&#x2019;s reportable segments as a percentage of the total costs: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.140%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides Net sales as a percentage of the Company&#x2019;s consolidated net sales, disaggregated by SBU, for the periods indicated:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cleaning&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vitamins, Minerals and Supplements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Health and Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bags and Wraps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grilling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cat Litter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Household&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Food&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natural Personal Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Water Filtration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#c0c0c0;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#c0c0c0;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#c0c0c0;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e8cd95aed9b4c81901ca7d5a53d1ce1_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMy0yLTEtMS02MjcxMw_8fcbe239-a2f8-46ea-86f6-3c5d7660ad81"
      unitRef="usd">712000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26e621abaf0d47d4b39a2fa43224768f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMy00LTEtMS02MjcxMw_6ba1c773-4e6f-444c-9e6b-21ac65dac932"
      unitRef="usd">745000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id69dc302ea5d43f9bc300bfd696c1476_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfNC0yLTEtMS02MjcxMw_d999db1d-c907-493d-9097-a98fe8ac4fa7"
      unitRef="usd">423000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3dadaf4c1716414abfe9786d4d65c91c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfNC00LTEtMS02MjcxMw_b1387c06-cd87-4af9-a780-c13f1a778650"
      unitRef="usd">442000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b42821a22844c5ca6f9e44fd13cb6c1_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfNS0yLTEtMS02MjcxMw_9561194e-9fa6-4c79-8123-e31180f58255"
      unitRef="usd">320000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0de7a722ac64da8858c7bf8cee9b411_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfNS00LTEtMS02MjcxMw_cc162576-bc33-478e-bf3e-77e683315d0c"
      unitRef="usd">331000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f89b0641ef04737bd695667b84a20c8_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfNi0yLTEtMS02MjcxMw_b8335bd2-da9a-4bd4-8c0c-a80a77258daf"
      unitRef="usd">285000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic6d2033d94204c51b0c34eb17cd5f6b5_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfNi00LTEtMS02MjcxMw_61fd957c-1995-4adf-a074-1a4c89ac7ce1"
      unitRef="usd">288000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfOC0yLTEtMS02MjcxMw_1048203a-66bf-4694-a480-2d70aa3e8493"
      unitRef="usd">1740000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfOC00LTEtMS02MjcxMw_f972c41b-80fb-4112-af95-b67ca578e154"
      unitRef="usd">1806000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4e8cd95aed9b4c81901ca7d5a53d1ce1_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTMtMi0xLTEtNjI3MTM_1d10be57-43de-45d2-8e12-ab2ae22711f0"
      unitRef="usd">115000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i26e621abaf0d47d4b39a2fa43224768f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTMtNC0xLTEtNjI3MTM_0f886f59-a158-4267-a590-8ea0d41ae658"
      unitRef="usd">105000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id69dc302ea5d43f9bc300bfd696c1476_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTQtMi0xLTEtNjI3MTM_a032d66b-5438-47d5-9f29-2a187863e167"
      unitRef="usd">22000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3dadaf4c1716414abfe9786d4d65c91c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTQtNC0xLTEtNjI3MTM_a83596ab-d01c-422e-b6a9-3854a125047d"
      unitRef="usd">36000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2b42821a22844c5ca6f9e44fd13cb6c1_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTUtMi0xLTEtNjI3MTM_3d05c89c-485f-40a1-963a-c6f8323b070f"
      unitRef="usd">60000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id0de7a722ac64da8858c7bf8cee9b411_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTUtNC0xLTEtNjI3MTM_a98ed3f5-aead-4590-98be-930a5e5e34b0"
      unitRef="usd">93000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6f89b0641ef04737bd695667b84a20c8_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTYtMi0xLTEtNjI3MTM_a71ecc9b-91b9-48ef-8af1-c1810fe2b916"
      unitRef="usd">23000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic6d2033d94204c51b0c34eb17cd5f6b5_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTYtNC0xLTEtNjI3MTM_4adbe5ee-cf3b-4bdc-ab10-56b4439ce33e"
      unitRef="usd">30000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i606ff00a1b9e43a3a6959e8d1ebb4977_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTctMi0xLTEtNjI3MTM_a3388ee8-e09a-40bc-88b7-e22d1d1fa64b"
      unitRef="usd">-104000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia3fa7b12816f411cbaf987175543040a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTctNC0xLTEtNjI3MTM_6f87e157-3468-46d4-8795-955da4d34b53"
      unitRef="usd">-79000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTgtMi0xLTEtNjI3MTM_ec0a9197-32a1-4e46-8239-a60336ecc625"
      unitRef="usd">116000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i80b79fe5495f4aa19c106fa7bab820ac_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmUwOWNhNjNmMTI3OTQwODRhZDlmZmU3YzUwMWYyMjdlL3RhYmxlcmFuZ2U6ZTA5Y2E2M2YxMjc5NDA4NGFkOWZmZTdjNTAxZjIyN2VfMTgtNC0xLTEtNjI3MTM_1dd779a7-478f-45c6-b091-9086e9397fe5"
      unitRef="usd">185000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RleHRyZWdpb246ZTcxNjUyYzIxN2ZkNDJkNzljZjEwZjcwZGRiZGJlNzBfMTY0OTI2NzQ0NzQ4OA_cd6634b2-fdbc-472e-aa98-e00f2c9a77a9"
      unitRef="usd">19000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3a5f78e9f3c74fa9b02f7b5e6ee65670_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmRlNzM4YzdiYzc5NDRhNzliYWNlNDYwZjI1YmEwMjM1L3RhYmxlcmFuZ2U6ZGU3MzhjN2JjNzk0NGE3OWJhY2U0NjBmMjViYTAyMzVfMi0zLTEtMS0xMDc4NTI_66e16fa4-b013-489c-8352-47324dee4ee4"
      unitRef="number">0.06</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2183c0c64c434e5a9aeea41c54cb625b_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmRlNzM4YzdiYzc5NDRhNzliYWNlNDYwZjI1YmEwMjM1L3RhYmxlcmFuZ2U6ZGU3MzhjN2JjNzk0NGE3OWJhY2U0NjBmMjViYTAyMzVfMy0zLTEtMS0xMDk0MTQ_33e2f315-e20f-4f4a-a2be-d09cca187891"
      unitRef="number">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i74eb275af8db41049d9007f8bc834661_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmRlNzM4YzdiYzc5NDRhNzliYWNlNDYwZjI1YmEwMjM1L3RhYmxlcmFuZ2U6ZGU3MzhjN2JjNzk0NGE3OWJhY2U0NjBmMjViYTAyMzVfNC0zLTEtMS0xMDk0MTQ_30cee946-5a03-4f9c-8015-33126f8b890f"
      unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3048afb6b1df4c98bbe9928ae66d4d4d_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmRlNzM4YzdiYzc5NDRhNzliYWNlNDYwZjI1YmEwMjM1L3RhYmxlcmFuZ2U6ZGU3MzhjN2JjNzk0NGE3OWJhY2U0NjBmMjViYTAyMzVfNS0zLTEtMS0xMDk0MTQ_5b5ce435-b223-407d-bb03-f2792f4859da"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3dbef4e516584b3c8b89e91c01bce178_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmRlNzM4YzdiYzc5NDRhNzliYWNlNDYwZjI1YmEwMjM1L3RhYmxlcmFuZ2U6ZGU3MzhjN2JjNzk0NGE3OWJhY2U0NjBmMjViYTAyMzVfNi0zLTEtMS0xMDk0MTQ_8b924e97-0141-49ab-b79b-3246192afe24"
      unitRef="number">0.70</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3007927605bd40d6aa8bd18ae2feac19_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmRlNzM4YzdiYzc5NDRhNzliYWNlNDYwZjI1YmEwMjM1L3RhYmxlcmFuZ2U6ZGU3MzhjN2JjNzk0NGE3OWJhY2U0NjBmMjViYTAyMzVfNy0zLTEtMS0xMDk0MTQ_6d9edad6-000a-4483-abbf-f9ec903cc97b"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i825a3f474bef4d57a41b659e4276eb92_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RleHRyZWdpb246ZTcxNjUyYzIxN2ZkNDJkNzljZjEwZjcwZGRiZGJlNzBfMTM2MA_93a6d8f3-395e-4e6e-9b2b-922bfa3837a3"
      unitRef="number">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4923cfb94e8049c1ba541c14e5fc41f1_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RleHRyZWdpb246ZTcxNjUyYzIxN2ZkNDJkNzljZjEwZjcwZGRiZGJlNzBfMjc0ODc3OTA3NTMxMA_58941595-4e7f-4adf-b659-92e8d3512d37"
      unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8b90eb0ef6054ab7a5b9de59365a28ac_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMy0yLTEtMS02MjcxMw_621c0576-deb9-4723-b1bb-8ccccd129410"
      unitRef="number">0.33</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i746c110841a342e1b5c9555eaa2e1ce1_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMy01LTEtMS02MjcxMw_01066a15-0c34-485d-a8b0-e3d97d7f11b8"
      unitRef="number">0.33</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iedec36bdebec43808dffc518431446b5_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfNC0yLTEtMS02MjcxMw_ac610203-386e-451d-8466-a867b0916565"
      unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ide10fb2fb37f424dbdc6a428a5cbd88a_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfNC01LTEtMS02MjcxMw_dcc60cb3-72a4-4a70-8a15-241e6bbcfb7a"
      unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i61a07a11680e4116a22f12f9e4f59402_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfNS0yLTEtMS02MjcxMw_2d35f0e4-cb18-4df2-bdd0-0e38ec29047c"
      unitRef="number">0.03</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3ab02c4c09bc448e9e4bbf6710b688a3_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfNS01LTEtMS02MjcxMw_e5c68af4-6aca-4880-bf7e-6f33dde6aa38"
      unitRef="number">0.03</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i417b78725106447a96236599f5fe7024_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfNi0yLTEtMS02MjcxMw_25b9f9fe-aa98-4726-9235-7d601de57f9d"
      unitRef="number">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3830eddd6eec4653b1b850774f83f799_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfNi01LTEtMS02MjcxMw_5055f5e0-6ea8-455d-8247-501f4688e817"
      unitRef="number">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i79dab9a38edd41d3a954624d9e05a0bb_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfNy0yLTEtMS02MjcxMw_f506bdff-4d2c-4a40-9245-fb0683ff9be6"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie8117aec118647b49d7490ddbaeaea3e_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfNy01LTEtMS02MjcxMw_df37ec84-d9a1-4b88-bbcd-32cd4c61e3a0"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i97d7a4a287334750b35878de0c632079_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfOC0yLTEtMS05MjcxOA_1fdbd248-cac4-40d0-ad79-a62dba9b51da"
      unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i26bbe833ac1640c89c7c526a81516775_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfOC01LTEtMS05MjcxOA_03510dd5-4729-46e9-9b7e-b69c03e8ddf1"
      unitRef="number">0.06</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i052b0fc813da42178769b516bf6454df_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfOC0yLTEtMS02MjcxMw_5d3355f1-4374-400f-827a-b20ad0bdf5f5"
      unitRef="number">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i159d29d0958b4e4bba0eedf9dd60d3b5_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfOC01LTEtMS02MjcxMw_5eaa3cf7-06a9-43d1-8381-d1043d6ca572"
      unitRef="number">0.07</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i684f9f739fd74d75980dc46564a4fc1d_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTAtMi0xLTEtNjI3MTM_265fd4d7-d078-45bd-ac5f-b5b015bd2efa"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2769b1c5b55f417f9f0a0b3a7b69c023_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTAtNS0xLTEtNjI3MTM_a118a1f4-5cf8-4ebf-8520-c40156b93c01"
      unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i264bcb59d1fb4a8b8f8f5ad7b7fe1dd8_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTEtMi0xLTEtNjI3MTM_be2858db-7ab0-4635-b966-592b58f0c9ac"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i7ed314c335fd49008ec3b335ea3c14f9_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTEtNS0xLTEtNjI3MTM_f0a17d8c-d32b-41f1-8584-37b6f852d7ff"
      unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i260a34245a4a4431a0f5f91d94de3567_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTItMi0xLTEtNjI3MTM_02249e4a-4330-4a70-8b0f-b999d7bd8b4e"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i42e6cf57392445509d1e157867ac3729_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTItNS0xLTEtNjI3MTM_d47cf153-6d52-499c-8b4f-76cf5402d500"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i68962e875b5c463d9cda87f98c695ea9_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTMtMi0xLTEtNjI3MTM_bd43d1cc-e844-4710-a326-6b759635d151"
      unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie488b698386942d488eb9191bf6c03e9_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTMtNS0xLTEtNjI3MTM_784c6551-004d-4884-a219-1c78ee43f4b1"
      unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8ca24239316c482eaa1b9a014e855a41_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTQtMi0xLTEtNjI3MTM_ee24ec34-562a-44bb-9d65-f4c67552f039"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id94210280c4f459a95a0145d49e7170a_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTQtNS0xLTEtNjI3MTM_90b66b3a-3ea8-42ad-a311-c67a3cdb6e4a"
      unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i59c4149e9cc24e3abe5f72106c11a911_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTUtMi0xLTEtNjI3MTM_23b4d277-4fab-4d53-b3a4-3009af5e5e18"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i55565f7982054624baa5bc769685ff9a_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTUtNS0xLTEtNjI3MTM_b0cfd8e7-96bc-4960-986b-7af4c5b0af29"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia206ce29644b481c940c521fcb640e60_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTYtMi0xLTEtNjI3MTM_faa6adb1-2b3f-4050-bbb5-17a66c7cb97b"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3315b5d84b164803b2a50689febd9ff5_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJkYjk0NDBhM2MzOTRhNmZiMmEwOGIwYjUxZWZhZGQ0L3NlYzpiZGI5NDQwYTNjMzk0YTZmYjJhMDhiMGI1MWVmYWRkNF81NS9mcmFnOmU3MTY1MmMyMTdmZDQyZDc5Y2YxMGY3MGRkYmRiZTcwL3RhYmxlOmU1YTY2ZDcyZWNlNDRhNjQ5OTg0YWQ0MTA0Y2ExZTQwL3RhYmxlcmFuZ2U6ZTVhNjZkNzJlY2U0NGE2NDk5ODRhZDQxMDRjYTFlNDBfMTYtNS0xLTEtNjI3MTM_f34ea846-c2cf-4ca7-9183-f2bed86a1855"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>61
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MI#& W]="Z..%>4!UI#G[#U!+ P04    " "BA6%5]%GSH=P&  !]'0  &
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M:8$^I5D&<Z#.)QH@&$>3N'G=N_IU9.!UMWQU@J@W1L0CQ#+\RCW\8UD,#9]
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M(&@/B)!\%IG>*?(>P<3'ZT=H4&,5?;+JBGH5WD#^EH3C,T+'E#KP;%Z^//#
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M*H5"&NT6JMKWN *_,]*4/6O40<!)"_WMB$>Q-\AU9R-#<'I5![D"-/ 4] =
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MX% 6_Y8X!9/C!7A?6!NZ&W:P.5>?_@=02P,$%     @ HH5A50BK+=6\ @
M"08  !@   !X;"]W;W)K<VAE971S+W-H965T."YX;6R55&UOVC 0_BNG;)I:
M"35O0 L#I-)2#:FE%73MAVD?3'(0JXZ=V::T_W[G)&2M5M"F2(Y]ON?Q<V??
M#;9*/YD,T<)++J09>IFU1=_W39)ASLR)*E#2SDKIG%E:ZK5O"HTL+4&Y\*,@
MZ/HYX](;#4K;G1X-U,8*+O%.@]GD.=.O8Q1J._1";V>8\W5FG<$?#0JVQ@7:
M[\6=II7?L*0\1VFXDJ!Q-?3.P_ZX[?Q+AP>.6_-F#BZ2I5)/;C%-AU[@!*'
MQ#H&1K]GO$ A'!')^%5S>LV1#OAVOF._*F.G6);,X(42CSRUV= [\R#%%=L(
M.U?;;UC'TW%\B1*F'&%;^<:1!\G&6)778%*0<UG]V4N=AS> LV /(*H!4:F[
M.JA4><DL&PVTVH)VWL3F)F6H)9K$<>DN96$U[7+"V=%T]C"9W=_.IY-%"V:3
M^X%OB=7M^4G-,*X8HCT,,=PH:3,#$YEB^A[ODYI&4K23-(X.$BZP.($X:$$4
M1-$!OK@),2[YXGTARF>45NE7N.0F$<IL-,*/\Z6QFM[$SX\BK@C;'Q.Z.NF;
M@B4X]*@0#.IG]$9?/H7=X.L!N>U&;OL0^S_=R/\QP"X#'$T+)-H6)(K*REA,
M0:W 9@@K):@^N5P#,V3K0\^/ ]_= '2;V167G)Y:"FNE4@.?H1OW:.ST8IBS
M+3U+BYHS88#)%"A!3VSM&*E!0-@+X9'J$[B$0JL$C8&P V$7KJ=7M\#<Z4R2
M&8YZ[6,X:@?'<*\L$P1X+YX./.T&]7A-/'V8*9ELM":WO[V/PF/HT%>1[74C
MNDZG'AWD$"4WU(X2I>FYNW!N*7^:TF:0VN-'#\!_4YXYZG79A S=P4;:JE(;
M:]/GSJOR_N->-<D;IBFE!@2N"!J<G'8\T%7CJ196%66Q+Y6EUE%.,^K5J)T#
M[:^4LKN%.Z#I_J/?4$L#!!0    ( **%856FOQNT6PT  ! L   8    >&PO
M=V]R:W-H965T<R]S:&5E=#DN>&ULQ5IM4QLY$OXK*H[:VJUR,+8)$))010C9
MXRIA<T#V/ES=!WE&MG69&<U*,QCOK[^G6YHW>^Q +E=7%,8>I.Y6OS[=\INE
ML5_=0JE"/*9)YM[N+8HB/QL.7;10J70')E<9_C,S-I4%/MKYT.56R9@WI<EP
M?'AX/$RESO;.W_"SS_;\C2F+1&?JLQ6N3%-I5^]48I9O]T9[U8-;/5\4]&!X
M_B:7<W6GBB_Y9XM/PYI*K%.5.6TR8=7L[=[%Z.S=$:WG!;]KM72M]X).,C7F
M*WVXCM_N'9) *E%1010D_CRH2Y4D1 AB_!%H[M4L:6/[?47] Y\=9YE*IRY-
M\@\=%XNW>Z=[(E8S62;%K5G^587SO"1ZD4D<OXJE7WL,CE'I"I.&S?B<ZLS_
ME8]!#ZT-IX=;-HS#AC'+[1FQE.]E(<_?6+,4EE:#&KWAH_)N"*<S,LI=8?%?
MC7W%^8?KFXN;R^N+C^+ZYN[^]LNGJYO[.W%Q\UY\N+B^%;]??/QR)3Y=7=Q]
MN;WB_[T9%F!+FX=18/'.LQAO83$1GTQ6+)RXRF(5=_</(6XM\[B2^=UX)\$[
ME1^(R>% C _'XQWT)K4.)DQO\J-T(/YY,76%A4?]JT\=GMM1/S>*LC.7RTB]
MW4,8.64?U-[Y3W\9'1^^WG&6H_HL1[NH_QA[_F 6XH/.9!9IF8A;[;Z*3S)#
MO".R"R&S6+Q75C]("DYQG4&M)?W'B?N%$I<FS66V$MH)]9@;IV)1&!$I6R#=
MB,BDJ8EUL1H(9"?$'QZ5UJHL6C%AG14*&BZ$E842%JP=\DB"#TQ&@XG)YD9G
M<S$M'4[I\"!76(U\X9A$Z91#D-<"ZI: ()'J0L^).-%B"4NKZ!_% I;U+ _H
M%%Y.\=GJ2&THH7W25*Z(:7,V,2L+$'4#B-;(Y98RQYJ,G9!%232$(;Y"@U)4
M"#,3.;-[,#BR3H@6I4&1&\L)$0M(;%)=)!TIQ<HE!(#2R%16_5%JRQ+B#/=\
MH$:J1B>.99XJG#]:R&R.\UN)0!?&"O.@[ O(]"(R)1FC)3*=0D)9<Y5!XTFR
M(D%(.A V,0F7X5"P#W85H"N*I1$K)6U'H7EIP122$;E*02TF8) J258!MT+,
MI+;B02:E$F3P.42W7U'Y_BA-$:QNIN1;6#ZS)F5]7BYT).=&O#/2LF#W=+Y-
M"S4*(&'Z5(6W,E%T@@M'A)#("I5.<<(JFPUX[]_*3+4>D1"9(?%@%IF2*FEW
MOS&6THG]R2'3V1^?#&!'ERNN?0D"98G#+.HH@(-  QK*AP=5_NO@Y<*9U51!
MZT8GY(\Q6X<$^6 ,[3-Q20JNXX;8_1N:G)5J;<.OH)^T8^P -'RT7E;1^JV(
MD(F#?.Q!".HF VSX5TO7G>A(F7;7^8N&R4]_.1V/3EYW@F$CI=3Q+9TSR&:T
M:*F+!1.J'9&B*GN K,:NJK#9(-7(UKC_0I*#E%7VV1D I)^*:.UUSW![G7DX
M1YH@W\>RZ6J38NVN]YL>R!("Y;D"IB>:&X?$@R5%3",7^P48]6G>E5.G8PUO
M5&RQA8KGJFV/2L.NHV*Q1(H7^Z.)=_C)"-;I#ZV^R&K'Q@&J3Z@7MY32O^63
M+7?<<,-NY>EXXDP_;KKA% I;4"Y:VXGXI"CB>@+Y"QWIG/U..U>BI+*[@2+G
M[H(,-BTJI]LFPRZ/2RB4O;,MK%)M=]M&[CM];6I@C8Y_5;I=J"0FU]_*\,GV
M;16*09USKMI)NFOQ]ZTTVI8H5@X[L<)QP6PE?N_A@[H"]%<ARH3;'+E=<ET/
MCMD,HEW4FK#8Q#];*=3+<KGRR 8JQO\68H:6S0=BL)&:S53D0W\+**IU%1,5
MVNM]H%D!-_@-[DQ8( 4 7E"#!R(_)\:Y7[ 2C[UQ;E!.X'\9"#@?YI)D3R"4
M.Q._(O\[OTMA'TYCYIG^D\_S! ;W[-_MQD2\&DX.A^Q)U;M1']+H+3'[XN?)
M+WCE=#9^77M;*Y7V[!KAY[ICI-YE%=&)N =,28C9F)@=B8\FDE4>F6\H)$&A
MTC-=89F+*"K3TA=^TZ.@#/KN*HF36\<,FUK_KYF0J;O6ZW#\P8:Z-"Y XX!@
MG$&Z(5WNBY=/-%L_C5%MIR>8M%X"4 '-(&>Q32O[GN)WXB/.%3KUX50#/RH&
MZE'C/P@M4BB9OM'J]]A@6TY%+2A"]X7 ]WT3H'['[IM>0JA(9QZWJD=T)4N5
M@&_JC0AR^Z,1)6<NEKFTQ28"7&L,+X/FQ&VK*^DDZ9):G#\I!Z/Z $10MT.U
ML>H\*07IH@PM%*7GFCLACEE?M]*?X[KEBF& \TJ0<_BJ%VU.Q$@;K(72 \,G
M,O =GBJ<3\V$N;B[X]S)2& .1MQW/HTBX(;3_N1<71FU*HE&H*4% *#+ *OQ
M)'7!TZBW:HX5FL(V@A,!Y[=)D9OD%"41TC55-QQA"??CA2V$$)QYBQH0A4K%
M324M";6\B-6,^[,.OT3+J6]QJZ,&E1V(WSR/I^I>9SW$@MY\F$P14T_$EYG)
M?-3[EM*54#DKM^H GT-+:8[EMNHS:IFS55<7U $&.\6U(?RJRA@#.@HPUM-T
MZ(NOMX:*^]UDN^^O _VG&J+'U6H:$8ZF.;]2ON'34#J:9QY<WE%/0JCI)YGF
MK\5G8VR]E33["3UL0RS ZTJGC)R*]00QH&7(.W1NI$0)J(RF04!&N#:U !9Y
ML2CJ7@T$4YWIM$Q)07A"T,P5'(US/S]HGP'-1W]#VCVIMP1U$0@%,"1\MDYX
ML!Z-H:':$6A8G,2L<"I)LQ*T&U_1?P:(D>T(&2HI/6'S'6Z^;@I.4V%4M7:H
MA82U%;)*;?L-)5=ZXXZ#9'B.9S2>OF5:L#[QVMT&U%.1IH'P SH:$X8)!8N.
MHIR4)'R[UE7CE$HW/1DVE%QJM]CI/(A'6SDGIXU8>SZ1;>G!I]9\5=:SHA.Q
M] 1Q"$AD'@Q49]X^P_J652F&0D)L"SB5"76TG1'M\Q0,:?8]]_U1_]R+FM46
M<D':^&Q5+G5<X;! VH,F[L$*\B[5U%[2"*WDE@S 3\<L;)!>\$T,001;PC@7
M?FNGO056='7/Q<&3EE3:<+@L]OQ9+61\5,FJ(2.G9S]DPD&FM6DVR@WE(W\X
MU$EE+<N9TME\%.<0,R 8#B,:*(08]F/&IU$@A1I69V_2JC27L<.G4*9*\\2L
M%"52&I[X:SG"M*@2U32OHP=\]C8# VV[(GC!T#"S!#[H?>M 7FYCMD0]FNN4
M*9:>!6N!5%B2,$6]B'7L*J<AB_F$SL-B.4U@9H4S:LI"7I=^!^S!5SHX.F%0
M7EEWUWBJ:ZA9'ZU]Q4$.I9%CE6?GA[,T6L\ >0!B[8K'PQQ-5E$'/^BZ [MW
MVRO]%("S2:LO#JOU\QRZ-0/J\=IO38'"Y"?,VSGOK<]]9&=ZX*%GK\HI'"@A
M^,E"E?%IKDQ<?Z^097/KU+Y6:IY62H..JM)%Q+<<@Z].+,E@>9@MG7Z>"EE'
M;5PV[>8BFH=I%R5\RT4U)ZOQL1]Z>$!%W3":?C4W/"FM5C2"+C2* 5K@U9GX
MR!AE=";^WJ-]'RY<S/US[YEP0)HS-OK!LY9Z#@+1\9GX;4J7EVP;3^ %78^3
M['GI]Y69:=:$QUQ$O*-::Z;&RC 1#,)!=;)B,CD37WI(P/?Y4C\ 3 0=35/Q
MB4.LA327# W*-/\!8*2Y(OB6 _$)&:@]SY5"F+9 5K=[#1Y<I27FT"UFH4,(
M9B<+!&/Y:Z5.KB 0669Q[Q&?4P6VB!)D@,X!)K? IRUPTK/V]X'^%B!@%\;)
M]]UX8+_(K7G0,;MT,VN64U/Z"]%.'-9RALF9##IH[..>)^]9:QYU7+][%WC>
M,<]68KJ4UJY(]*MZLM/S* "'GJG6)NQY.H09B?WZMQI6->]ZF-$U\_>Q&O//
M,7XV9FJ;(^WGD!V%'S^RH]\3_OW8BL">DU3(L6%ZX9V*D-6*O8AOI*/(EJH;
MSZ,6S^[O_]$73;N2KV>@!F&$BD*WEC0-:W*0;F8$_TL'KN:<+Z9*VK5Z/0@Y
MC^_A4>WJ$N AQ26!X%XT_//H%V^ X]/Z]?38O]SKE-I<[D"_16,,]_$_]^W,
M2-I[:@;L(BKXR.@T_+[BWWTQ?G78O!Z^"J]M;[TQ17#YQ!#)RA^W/:=!\9@&
MQ$>G]>MX<A)>+T/ P P57**+/>#L%P2$^8J0B7[L/MJQ3^S<2!<?B/7!T<E+
MO(Y?GO+[([Q.V"CCP>EXPG^/#_WGD]'(?\9SLL-V*WF<D/IO_E D=*S;9 G]
M_6[&;0*P%%I0U-EP^A7!$*\!&"Z6*P^#^,L+NZ6EFPP;^Y(?H3^O.\\<B>&1
M@\.UXO" K;G-TNO';U^W?SFX.^!)@K*,$'*9*]LTT5@UI.%@N*N/K5QF50N[
M9<;43/  %WS5;KKFYY\+;O&]OMC',%3^SNRXNZUMZ&B#\X#GHK&BY3Q[\'T)
MN@I#$Z'5&CAN;JHA1LXHM7-G[1$5-6T]L&=\T/=-OF'K6YJPVIR_BQJ&6OX+
MF_73^NNN%_Y;GLUR_UW93SPR<?#(&;8>'IR\W!/6?__4?RA,SM_Y!-8M3,IO
M%TH"P- "_']F<+SP@1C47P(^_P]02P,$%     @ HH5A55:\NP@L!   ^@@
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MUR LG:@M=-:L9>PK:FN0*4A>/*,;@&\0KDS;";V%X-"!T(#.2^H K&BC@U"
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M    >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;)U5;6_:,!#^*Z=,FEH)D9!
M7Q@@0<O6?BA"T&T?IGTPR858=>S,=DKW[W=V(*,2K;1]2/QVSW//77R7T4[I
M)U,@6G@IA33CH+"V&H:A20LLF>FJ"B6=Y$J7S-)2;T-3:629!Y4BC*/H(BP9
ME\%DY/>6>C)2M15<XE*#J<N2Z=\S%&HW#GK!86/%MX5U&^%D5+$MKM%^K9::
M5F'+DO$2I>%*@L9\'$Q[PUG?V7N#;QQWYF@.+I*-4D]N<9^-@\@)0H&I=0R,
MAF>\02$<$<GXM><,6I<.>#P_L'_VL5,L&V;P1HGO/+/%.+@*(,.<U<*NU.X.
M]_$,'%^JA/%OV#6V211 6ANKRCV8%)1<-B-[V>?A"'#U%B#> V*ONW'D5=XR
MRR8CK7:@G36QN8D/U:-)')?NHZRMIE-..#M9S!]A/ETM[A=?UK"<KV!]-UW-
MX6R^7)^/0DL>G%V8[MEF#5O\!EL"#TK:PL!<9IB]QH>DK)47'^3-XG<)UUAU
M(8DZ$$=Q_ Y?TH:;>+[D#;XYTY++K8$E:E@73"/\F&Z,U70[?IZ*MZ'KGZ9S
M%3,T%4MQ'%!)&-3/&$P^?NA=1)_>$=MOQ?;?8__G;_/_;/!8(.1*4(E2=H ;
ML+2A,54RY8(S7T J][L[?]$Q _:,FNH69%UN*)MT;%Q"#5#M&\MDYJC.N"24
MJ@VMS3G4AH!60<I$6@MFT9443T%2^R$A[HBL#9XPS+BHG=N]Z9 T:\17%PZN
MPR0*W55I9SV8>0>]..DDR36-<>?Z*H);QT;] ##/J4%X]5:E3Z J%ZP!T@N*
MXM4PN!Q KQ-=Q V(W#BRZUZ?QGXGZL<PE99G!\*W:)S?Q!-=[36Y2/!P(2LR
M\?GSD-NC8$^9T--FAAQ(6!P;,FLUW]26;02Z)-X(I=5+]]25#(]:1XEZZQND
M@535TC9=I-UM>_"T:3U_S9L&_L#TEE/( G."1MW+00"Z:8K-PJK*-Z*-LM36
M_+2@_PAJ9T#GN5+VL' .VC_3Y ]02P,$%     @ HH5A50HZ!/0H P  )@<
M !D   !X;"]W;W)K<VAE971S+W-H965T,3(N>&ULE55M3]LP$/XKIVS:J#21
M-"EO75L)NDY#&E#1C7V8]L%-KHV'8P?[VL)^_<Y)R$ JU5"DQ"]WSSV7\ST>
M;(R]=3DBP7VAM!L&.5'9#T.7YE@(MV]*U+RS,+80Q%.[#%UI46254Z'".(H.
MPT)('8P&U=K4C@9F14IJG%IPJZ(0]N$,E=D,@V[PN' MESGYA7 T*,429TC?
MRZGE6=BB9+) [:318'$Q#$Z[_;.>MZ\,;B1NW),Q^$SFQMSZR7DV#")/"!6F
MY!$$?]8X1J4\$-.X:S"#-J1W?#I^1/]<Y<ZYS(7#L5$_9$;Y,#@.(,.%6"FZ
M-ILOV.1SX/%2HUSUADUMFQP%D*X<F:)Q9@:%U/57W#?_X8G#<?2"0]PXQ!7O
M.E#%\I,@,1I8LP'KK1G-#ZI4*V\F)[4ORHPL[TKVH]'XZF)Z/?DRN9R=WTS@
M_)+G$]C[>C6;=08A<0!O%J8-V%D-%K\ EL"%T90[F.@,L^?^(1-KV<6/[,[B
MG8 S+/<AB3Y ',7Q#KRDS3:I\)*7\,BDM[E1&5KW'B9W*TD/<&D(X>?IW)'E
M,_)K6]HU:F\[JN^;OBM%BL. &\.A76,P>O>F>QA]W,&YUW+N[4)_;85V@FVG
MNB,"?,L1%D9Q[TJ]!!)SA5!:LY89.A"/O0QF 6-3,&3N^W6-('5J"H0]99SK
M,((%8J02K329X]U,IH(PZW, B_CLW,!)F$2AKW@[ZL(EZQ,*JYF%@[=P?,2O
M;B^!*X:UD#Z+W02M*7P S:[,C\1]'[B3N4\U=Y:UJ-,'X)IKIT2M$-EO;CA6
M''*P%Y]T^)5TJL@KS8*GY!\FMV2A<W4(Y"#LQH=)KH47%UX_[D 7IHUH"9U!
M:?A<(4F+'ACFJ'$AZ5FL+C_?# D%YC79P%YRZ#EV.]O__0'C\C_\BL[U&_QT
MFYT@LG*^JFM+!K3A=4V6J^YK+C4A'Q7F&;<\_PMGK(PU]URGWHDO%A=Q6S>$
M3[2K0+NL%-IQA)6F6L;:U?82.*VU[Y]Y?8-<"+OTQ5&X8-=H_^@@ %NK<CTA
M4U9*.#?$NEH-<[[(T'H#WE\8EH)FX@.T5^/H+U!+ P04    " "BA6%5.H"!
MK/D%  !<$@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6RU6&USVS8,
M_BL\K]?)=VEL4;(MY^TN;[MV6]LL3K?;[?:!EF"+JT2J)!4G^_4#2?FML5VG
M:S_8$D7B 0@\ "B=S*3ZJ', 0Q[*0NC35FY,==3IZ#2'DNE#68' F8E4)3,X
M5-..KA2PS F518=VN_U.R;AHG9VX9S?J[$36IN ";A31=5DR]7@!A9R=ML+6
M_,$MG^;&/NB<G51L"B,P'ZH;A:/. B7C)0C-I2 *)J>M\_#H(K;KW8+?.<ST
MRCVQ.QE+^=$.WF2GK:XU" I(C45@>+F'2R@*"X1F?&HP6PN55G#U?H[^D]L[
M[F7,-%S*X@^>F?RTE;1(!A-6%^96SEY#LY^>Q4MEH=T_F?FU%#6FM3:R;(1Q
M7'+AK^RA\<.*0-+=(D ; >KL]HJ<E5?,L+,3)6=$V=6(9F_<5ITT&L>%#<K(
M*)SE*&?.1G?O+W]Y_?[7J^O;T8_D^K</;^[^/.D81+;SG;1!N? H= M*1-Y*
M87)-KD4&V;I\!RU:F$7G9EW0G8 CJ Y)U#T@M$OI#KQHL<W(X45;\*X_U=P\
MDK_.Q]HH9,+?F_;H(>+-$#8[CG3%4CAM(?TUJ'MHG;W\(>QWCW<8&"\,C'>A
M[QV'_5'(RQ\2&@Z.&S!RF3,Q!4VX("8'DLJRD@*$T41.R,C(]&,NBPR4GLN!
M]]D,%!"FR406F,'VJAQ !8K+S.)E/&4&LB-RERN -2H0#*2!<@P*HTF"*\1@
MRME0\J+ M-0$'E)<8^&(SAGJRI#'Q_Z^L5;6FHE,M\FE+$M,96<M.<\R;C.;
M%>2&\>P5+KUD%3<XO@6#]0C57S,EN)AJ<H<52]?J<2Z;IG59%]9L\@X14[19
MH7&X%E4:W+)&Q]Q)"[;)-PV?SDM9"T-&WM;UT04KF$B=Z]#!/]<"YH0.R0L2
M1B'^N@>#V(T.PJ3OKMW(7H/P(!KVVR08' S[8=L^Z<5]>PT3N[XWI.0=5FR8
M;\_918^?7,.8;I_#V8B\QU@JQP8%N2VV]T""0FKT-A?X&+;*;[L&%"U>&USQ
M>YX!1I 822X+J>0#T2M>)<&+\##LKW( 4B0*9.WM6M#X[;/KJ];T"RDV1_NY
M^USH0 WVYWCRRK:(S/D3G<E<Y_E<8+@W]+ )#Y15(1\QMYS72(7,\OT,$P">
M6A[0(9J4M$E$":7)T_E>>YD0#62MTMR9_N7PHG00]NA3[[NI==ZOYO]V\O<;
M\M-!0_YDZ,B?)#U/_O[ D7\PM.2/!SN2BV[ Q\<>/TX:_-@G5\_JP2?Q8.CQ
M(_P?T.%^R97TMDY1D@R^1VI%_?;Z8(_4HH?1,U.+#O=)+;?J.Z>6I5KO&:D5
M=O?&QJ5?EUSA/+E"Y%O\9#[^4@9L8F@XM,Q+(MKP,^PY?D9S_H<]S\\N_L?#
M_FHS7VUE<@/C!%)YG77,&,7'M6'C E9H,WY<'@J^9=?'TS.>C;''UDJ!2!\)
MGL"$+GP 6?8/'G)+=PZQ25<+K$L%_Q=!IMC"M3<=T'A<C(3F]\P>XS6Y:5X,
M\&! *HFG.C!<@04B8Q PX68-^_E>VMV_@[@;V9#X0=B/ETWZRVD_!G0GX#L-
M9J+6?&(]Z<Y" <6J&J]0#6GF3Q5Z935N8:)D^15[6FU9%.';Y(V?,.QAX;8
M'FR"0=LM6-J"8[3.!LE'TC1DV*A[76] 42$RWA\']N@004S=<8?ZA.A'RS:P
MN_0'<9RX5&D"8]O4O,#_K\ ,_?:7'@R_4V@2ZZE@L#LT!X[W'GG9<Y9W7QFE
MIK*%OK?L4<?0L;XSAY%W=[BL5VA_4=MJ@$5JLF\-8,[]I3N;^&SV^6_3OY!B
M^@I;2ND[B]T*$X_X&*'(++<52X,QA9?C&ON1<>7<O@E@_6+"\)17+BC-6Y"U
M2P.X2CBI#>H\Q'IFD5P!%)*P)L887YER)SOC)K?2&AK=WR+^GQ=8]XZ)V\P.
M-[U==E;>^$M04_==0Z,2M-6__"^>+CZ=G/LO!LOE_KO+6Z:FMM 6,$'1[N&@
MUR+*?\OP R,K]_U@+(V1I;O-@6$MM@MP?B*EF0^L@L4'I;/_ %!+ P04
M" "BA6%5@'L4O(0%  "[#   &0   'AL+W=O<FMS:&5E=',O<VAE970Q-"YX
M;6RE5W]/'#<0_2JC"XU HO<3 B& =)"+2A42!&FKJNH?OMW9.RM>>V-[.8Y/
MWV=[=SE:0$TK='?KM6?\YLV;L3E>&?O5+9D]W95*NY/>TOOJ:#!PV9)+X?JF
M8HV9PMA2> SM8N JRR*/1J4:C(?#-X-22-T[/8[OKNSIL:F]DIJO++FZ+(5=
MG[$RJY/>J->^N):+I0\O!J?'E5CP#?M?JBN+T:#SDLN2M9-&D^7BI#<='9WM
MA?5QP:^25V[CF4(D<V.^AL%%?M(;!D"L.//!@\#/+9^S4L$18'QK?/:Z+8/A
MYG/K_4.,';',A>-SHWZ3N5^>] Y[E',A:N6OS>HG;N+9#_XRHUS\IE5:.\&.
M6>V\*1MCC$NITZ^X:WC8,#@</F,P;@S&$7?:**)\+[PX/;9F13:LAK?P$$.-
MU@ G=4C*C;>8E;#SI[/+JX^??Y_-Z&SV:?;AX@M=?9Q^NCD>>/@.*P99X^<L
M^1D_XV="ET;[I:.9SCE_;#\ I@[8N 5V-G[1X0U7?9H,=VD\'(]?\#?I IU$
M?Y-G_%VSEY8A)T]GK+F0WM$?T[GS%L+X\ZF D[^]I_V%8CERE<CXI(=J<&QO
MN7?Z^M7HS?#="VCW.K1[+WG_CK3\%S_T9<ET;LI*Z#4MA2-!N2G9>9G1MUHH
M64C.J6I*KU)"T[:'R16>=OK1.CR2=%18<\^:T!U(*$65L' BX1BMXF'A HQ;
MS*]I)3H;+@J.-4D_UYJ;7(]&G2\N*V76S&Z7^"[CRL>9C*U'KR$(7R5S>)T+
MN\!+@-XP6BV-:_8O+/,]Q\TW=A6Z1A^B4=SW;9^F@0CD$@5-IJ VXL9ZE[1Y
M<$_",K&2"SE73-X 3PEQ9?Q 0>PZ0-KY"7%EF:V9 N\BSV58(A3-6T'6*![;
M&?3ILZ9+ 80'J0QVXU23N->O#L>C@W>.SHRP>0#\'@+/O+$ 5U76W(*.&(]1
M=<0"E)XMFHCPO+%)R)( ]CP6QTJ">M /O88ECKU7J6P:2EI9F#FB3T&NI%\2
MXPO@!:FZK$*3!Q-K' ,Q;*IJFT%I 9+6M?3K/EWX(""^JP :[P,Z\95I=!@>
MQWM4IH:2N*T4-Z#;$,+&4%(97^8AI 9@%_R_"[UQ'D-J(K0F8^?"T$ M5NH%
M4.<A>5!A&'4AMJ=+TD/.(">/7(&4)33>JM7RHE8"N5DW\(1*)F;NHW#[=%Y;
M"U.UCEG&%,C1QA-K4R^6$%(Z@>-1=BND$HWP<DZ1I;B@75F&(,&V772<;)#V
MM_JM0U4607AY(S^'A*0.,&O43AO-\T*#,*8;SFJ+--(T\[0]N[ZXF>Y$-X$>
M6ZM0(9%!]''/Y1Q^VV:> !0F:"RL]C&2="N0]S#T35:,QH;1B<;MI$(B3(X.
MU50+EKC4$IXJ"ON 6";$H8VY(^R-:GYT6-';P60X",BZIQ'"!&7HB&F7+=K'
M9X]FK5CAOK::VNXH'.K$T?9HA[8G^.SMT+0TZ /WHA56K5&<9J$184X2E#@:
MX^^+\6@ P?<61L%!(&<5+Q.A6&[1-Y%&9?3BQY#$AWJQC>2?AE*'4HMMLJSJ
MJ-G 4B%=ANW6+&Q(Q>0%8J&-<?_@AY2L_\7_DH5"?\B"W&,28A_>&D;;N<%4
M5&C,2U/S'//R3^G$,@SYZ=/[VK91?9_IHR:*JU3.M)5FMR:),>VMG->IK%%@
MH3%WQ^,SNMH-S:9JSZ,^]K>W,N/$4:?EMAJ?I7.79!$.A]U /ZZG*J4:J-J#
MY]%R;!L.2A,;[T;%!*8?67^.*[83XIVH(>W"B<:^_]1M9;!QH2P9?21<FQVV
MJ+5/=\ON;7<SGZ8+Z</R=*V_1!N2(%)Q =-A_V"_1S9=E=/ FRI>3Z$$7';C
M(Q2#1A068+XPQK>#L$'W_\KI7U!+ P04    " "BA6%5D-+N?3 )  !*&
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M/G84G3E2GI!)\4[)H!M_WL0ZWV FCE<K:6H&W_+/5<D\"D\IK5P2MVA7-I5
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M'4#N& <$L"Z#K[R!-2 .OUFQHN-"2]P"P2LFTBG. '0[937H4+A3E_QMQOJ
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M%O1E@I8-:']EC-\M.$#WK3/^#E!+ P04    " "BA6%5]X-#?,P"   -!@
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M5&;@*W3B+HWM;@Q/;$-/TZ+F3!A@,@,ZFU>V=(S4)"#LAO!"-0I<0J%5BL9
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M('*$4&!J'0*CY05O4 @'1#1^MYA!E](%[N]WZ%^\=M*R9@9OE'CBF2W&P54
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MXXNC<,VNT='I<0"VT>%F0Z:LM6]EB)6T7N;\Z4+K#?A^;7CFVXT/T'T,IS\
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MO\HIJZ96ZIH'"GT81.*AVRKU24"W%]->N,D!5AT[LPUTWWZV$P*=:"95I6_
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MMY?^M"([K24;F6_RBH:DYB-'#2.Q7VO )W/]*-P*4BOZRF2>5<AGN]P'9SM
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M97%:%@,MLOS F0H-QU=^N8 /#")- #R?":$_!N8,*S]9HK]02P,$%     @
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MH*^0.[FB+G0,O",DB T8W=]_LQO6'T7T+P26$Z.6B5$K0^]JTI)40F0-R%N
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MQ;Z8TLT?."VHH?#FU.?))]BDL8X%YC$7-$B3)8. A-MO])HVHI#@UBL28)H
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M"*S4N.NL<=<_**3KG:'\**3=B HAM3,R[9\14ON@D'01)4:NDR_XCGXYHD%
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M.;05$M?;VV%-<E*1=(^0],@#SU4BR32/('H=;Z/@1K6[53UQ3P(&4%P0S_E
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MD,[% "F)JN54$\4+4[677&$/,,,$NS0([8#K,>=J.]$;-'W?_PU02P,$%
M  @ HH5A5;6DZ=W! P  XPL  !D   !X;"]W;W)K<VAE971S+W-H965T,S8N
M>&ULK5;;;MLX$/T50EMT$Z"-+K[&:QM('!<-T"1&O.T^+/I 2V.+&XIT2=I.
M^O4=2HKB"ZUF@;S8)#5S>.;"F>EOI'K0*8 ACQD7>N"EQBQ[OJ_C%#*JS^02
M!'Z92Y51@UNU\/52 4URI8S[41"T_8PRX0W[^=E$#?MR93@3,%%$K[*,JJ=+
MX'(S\$+O^>">+5)C#_QA?TD7, 7S=3E1N/,KE(1E(#23@BB8#[R+L#<*(ZN0
M2WQCL-%;:V)-F4GY8#?7R< ++"/@$!L+0?%O#2/@W"(ACQ\EJ%?=:16WU\_H
MGW+CT9@9U3"2_!^6F'3@=3V2P)RNN+F7F\]0&M2R>+'D.O\EFU(V\$B\TD9F
MI3(RR)@H_NECZ8@M!<1Q*T2E0K2OT#RBT"@5&KFA!;/<K"MJZ+"OY(8H*XUH
M=I'[)M=&:YBP89P:A5\9ZIGAZ.YF<C_^/+Z=7G\;D^M;W(_)R9>[Z?24G$PQ
M:9(5!R+G9"0SS)/4!G -Y%K$,@,4N0)#&=>GY"/Y.KTB)^].R3O"!+EAG&.8
M=-\WR-+>Y<<EH\N"472$48/<2&%23<8B@617WT?K*A.C9Q,OHUK *2S/2"/X
M0*(@BAQ\1J]7#VOH-"J/-W*\QC$\(^.'5/($E/Z3C'^LF'DBM]( ^?=BIHW"
MQ/[N\EJ!VG2CVM?>TTL:P\##,&E0:_"&[_\(V\%?+I/?"&S' <W* <TZ].$M
M%B>@2C"Q<*9'H=W.M6T56@^[G;Z_WJ9_*!(V&Y7,#JM6Q:I5&Y8[DX(B\4Z6
MGW"I,;59GNP?B$#B^!(,?>RY>+?>,D!O!+;CBG;EBG9M@+ ^8O436'Z4 A$_
M$4Q*H3DMZF[R'U8E+.3&&;P"N;45F8_1^5[T7#)'HM>I*'=^FU,K@7V,LY^0
MD 7V+UV$#S" 2!M?&UM3VS*<M#N'E+I[K ]%0C?G;L6Y6\MY4C9#*A*RE/CR
MP3 %UK-D!@+FS/S.V=T:2@7I.HD=TN<5Z?-:TG]+0SF1_^>QN)B?'_J[T=[C
M[I")CK /@Y=V%]3RWVUC!5EGCPH.;F_M.]<A$]H.XV2XU9##6H9?0.L>*?P<
M.]@2:HQBLY6A,^S,1A(A\5P8);'CB@5*&<":X,Z8\NYMRM&^58<BQ[P>O=@4
MO2)K7F7-B$LEG3E3WK%=]9O[I<4A$QXDC;\U+F6@%OD4J9'>2IABK*A.JTGU
M(I_/]LXO[02;CV$O,,7X>T/5PI8@#G.$#,XZZ$Y53)3%QLAE/I3-I,$1+U^F
M.(6#L@+X?2YQ(B@W]H)JKA_^ E!+ P04    " "BA6%5;5SW\-D'   5,
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MRF+0^6&.5Q%HMP'?SY2RZXDK4%]NR3]02P,$%     @ HH5A54WOEZ:C P
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M=YKI:B*YY#F.H&_)F8(#>P0K^/,/M^O\U>2<25AH"%9SM5.YVFFC!Q,YB>;
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M%> 8F&H@[R\H%2\%U4%U(!3\ %!+ P04    " "BA6%5!RU+%(,#  !N"P
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MX-=?W+;S>QW;$X'M<&^6W)LF],$]H\\L8NJ=8)$A- P%A%0!6:0J%8"I'T/
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MK(?9.&EOQ?.I?$)%B(4-62Y0U;F\POB)?-#-%XJOLEGQF2N</+/;)=  A!;
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M;V]K+GAM;,696X^;.!2 _XK%RTZEU29<9MJ.FDJ4. G:Q*28C':>*@\X$ZN
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M*^JM!'HKZJT$>BOJK01Z&^IM!'H;ZFT$>AOJ;01Z6V>SA$!O0[V-0&]#O8U
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M4$L! A0#%     @ HH5A55^^K2WN    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ HH5A59E<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " "BA6%5"[K;^<D%  "['@  &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ HH5A5?X[R4(D!0  WA0
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M965T-BYX;6Q02P$"% ,4    " "BA6%5M+$;9#4&  !C#P  &
M    @(%,+   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
MHH5A50BK+=6\ @  "08  !@              ("!MS(  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    ( **%856FOQNT6PT  ! L   8
M          " @:DU  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    " "BA6%55KR[""P$  #Z"   &0              @($Z0P  >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( **%856,!2^A]0(  *4&
M   9              " @9U'  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ HH5A50HZ!/0H P  )@<  !D              ("!R4H
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " "BA6%5.H"!
MK/D%  !<$@  &0              @($H3@  >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    ( **%856 >Q2\A 4  +L,   9
M  " @5A4  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
MHH5A59#2[GTP"0  2A@  !D              ("!$UH  'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    " "BA6%57><#&_L%   '#P  &0
M            @(%Z8P  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    ( **%856&'IJQ% H  ! :   9              " @:QI  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ HH5A5=Y=(3?' P
M]P@  !D              ("!]W,  'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    " "BA6%5]X-#?,P"   -!@  &0              @('U
M=P  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( **%854U
MS#V.3 8  ,D2   9              " @?AZ  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ HH5A57:./R3J @  908  !D
M     ("!>X$  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( **%857S,ABU2@,  (H.   9              "
M@3R6  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ HH5A
M5=Z=$GH. P  #@L  !D              ("!O9D  'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    " "BA6%59D"MGD4#  "@#   &0
M        @($"G0  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   ( **%855.$T\TZ (  +X(   9              " @7Z@  !X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ HH5A51Y9Q@56!   %1(
M !D              ("!G:,  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    " "BA6%5?D[O-1D$  #+$@  &0              @($JJ
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( **%854=P*Y4
MJ@0  *8=   9              " @7JL  !X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ HH5A51T0N#)U!@  &BT  !D
M ("!6[$  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " "B
MA6%5,[N-EFP"  "W!0  &0              @($'N   >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( **%854SG8>]\ (   ,(   9
M          " @:JZ  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#
M%     @ HH5A5;6DZ=W! P  XPL  !D              ("!T;T  'AL+W=O
M<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " "BA6%5;5SW\-D'   5
M,   &0              @(')P0  >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM
M;%!+ 0(4 Q0    ( **%8541%>;'%08  /PA   9              " @=G)
M  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ HH5A54,2
MMS:K @  Z 8  !D              ("!)=   'AL+W=O<FMS:&5E=',O<VAE
M970S.2YX;6Q02P$"% ,4    " "BA6%53>^7IJ,#   <$@  &0
M    @($'TP  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M **%854'+4L4@P,  &X+   9              " @>'6  !X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ HH5A54*D&SKR P  >A   !D
M             ("!F]H  'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    " "BA6%5V,-6P=,"  "K"   &0              @('$W@  >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( **%857"GCXV]@4
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M<F5L<R\N<F5L<U!+ 0(4 Q0    ( **%854-B+FQ#00  &H>   /
M      "  13R  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "BA6%5N#;$
MW*D!   N&P  &@              @ %.]@  >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    " "BA6%54]DK*;(!  !3&P  $P
M    @ $O^   6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     -0 U &H.   2
%^@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>180</ContextCount>
  <ElementCount>204</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>58</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - RESTRUCTURING AND RELATED COSTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS</Role>
      <ShortName>RESTRUCTURING AND RELATED COSTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - INVENTORIES, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/INVENTORIESNET</Role>
      <ShortName>INVENTORIES, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - NET EARNINGS PER SHARE (EPS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/NETEARNINGSPERSHAREEPS</Role>
      <ShortName>NET EARNINGS PER SHARE (EPS)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS</Role>
      <ShortName>COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - EMPLOYEE BENEFIT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/EMPLOYEEBENEFITPLANS</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES</Role>
      <ShortName>OTHER CONTINGENCIES AND GUARANTEES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - SEGMENT RESULTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SEGMENTRESULTS</Role>
      <ShortName>SEGMENT RESULTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - RESTRUCTURING AND RELATED COSTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables</Role>
      <ShortName>RESTRUCTURING AND RELATED COSTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - INVENTORIES, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/INVENTORIESNETTables</Role>
      <ShortName>INVENTORIES, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/INVENTORIESNET</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - NET EARNINGS PER SHARE (EPS) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/NETEARNINGSPERSHAREEPSTables</Role>
      <ShortName>NET EARNINGS PER SHARE (EPS) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/NETEARNINGSPERSHAREEPS</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables</Role>
      <ShortName>COMPREHENSIVE INCOME (LOSS) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/EMPLOYEEBENEFITPLANS</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - SEGMENT RESULTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SEGMENTRESULTSTables</Role>
      <ShortName>SEGMENT RESULTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.clorox.com/role/SEGMENTRESULTS</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - RESTRUCTURING AND RELATED COSTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails</Role>
      <ShortName>RESTRUCTURING AND RELATED COSTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails</Role>
      <ShortName>RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails</Role>
      <ShortName>RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - INVENTORIES, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/INVENTORIESNETDetails</Role>
      <ShortName>INVENTORIES, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/INVENTORIESNETTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - INCOME TAXES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/INCOMETAXESNarrativeDetails</Role>
      <ShortName>INCOME TAXES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/INCOMETAXES</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails</Role>
      <ShortName>NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/NETEARNINGSPERSHAREEPSTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails</Role>
      <ShortName>COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Equity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Schedule of Equity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails</Role>
      <ShortName>OTHER CONTINGENCIES AND GUARANTEES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - SEGMENT RESULTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails</Role>
      <ShortName>SEGMENT RESULTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/SEGMENTRESULTSTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - SEGMENT RESULTS (Reportable Segment Information ) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails</Role>
      <ShortName>SEGMENT RESULTS (Reportable Segment Information ) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/SEGMENTRESULTSTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="clx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - SEGMENT RESULTS (Net Sales Percentages) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails</Role>
      <ShortName>SEGMENT RESULTS (Net Sales Percentages) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.clorox.com/role/SEGMENTRESULTSTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="clx-20220930.htm">clx-20220930.htm</File>
    <File>clx-20220930.xsd</File>
    <File>clx-20220930_cal.xml</File>
    <File>clx-20220930_def.xml</File>
    <File>clx-20220930_lab.xml</File>
    <File>clx-20220930_pre.xml</File>
    <File>clxq1fy23ex311ceocertifica.htm</File>
    <File>clxq1fy23ex312cfocertifica.htm</File>
    <File>clxq1fy23ex32ceocfocertifi.htm</File>
    <File>clxq1fy23exhibit101.htm</File>
    <File>clxq1fy23exhibit102.htm</File>
    <File>clxq1fy23exhibit103.htm</File>
    <File>clxq1fy23exhibit104.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>clx-20220930_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="520">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>66
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "clx-20220930.htm": {
   "axisCustom": 1,
   "axisStandard": 24,
   "contextCount": 180,
   "dts": {
    "calculationLink": {
     "local": [
      "clx-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "clx-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "clx-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "clx-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "clx-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "clx-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 366,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 5
   },
   "keyCustom": 14,
   "keyStandard": 190,
   "memberCustom": 25,
   "memberStandard": 33,
   "nsprefix": "clx",
   "nsuri": "http://www.clorox.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "role": "http://www.clorox.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - INCOME TAXES",
     "role": "http://www.clorox.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - NET EARNINGS PER SHARE (EPS)",
     "role": "http://www.clorox.com/role/NETEARNINGSPERSHAREEPS",
     "shortName": "NET EARNINGS PER SHARE (EPS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - COMPREHENSIVE INCOME (LOSS)",
     "role": "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS",
     "shortName": "COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - STOCKHOLDERS' EQUITY",
     "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - EMPLOYEE BENEFIT PLANS",
     "role": "http://www.clorox.com/role/EMPLOYEEBENEFITPLANS",
     "shortName": "EMPLOYEE BENEFIT PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES",
     "role": "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES",
     "shortName": "OTHER CONTINGENCIES AND GUARANTEES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - SEGMENT RESULTS",
     "role": "http://www.clorox.com/role/SEGMENTRESULTS",
     "shortName": "SEGMENT RESULTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - RESTRUCTURING AND RELATED COSTS (Tables)",
     "role": "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables",
     "shortName": "RESTRUCTURING AND RELATED COSTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - INVENTORIES, NET (Tables)",
     "role": "http://www.clorox.com/role/INVENTORIESNETTables",
     "shortName": "INVENTORIES, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)",
     "role": "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
     "shortName": "Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - NET EARNINGS PER SHARE (EPS) (Tables)",
     "role": "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSTables",
     "shortName": "NET EARNINGS PER SHARE (EPS) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Tables)",
     "role": "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables",
     "shortName": "COMPREHENSIVE INCOME (LOSS) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)",
     "role": "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables",
     "shortName": "EMPLOYEE BENEFIT PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - SEGMENT RESULTS (Tables)",
     "role": "http://www.clorox.com/role/SEGMENTRESULTSTables",
     "shortName": "SEGMENT RESULTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostIncurredCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - RESTRUCTURING AND RELATED COSTS (Narrative) (Details)",
     "role": "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails",
     "shortName": "RESTRUCTURING AND RELATED COSTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i47cf58703a824db8a0117fad3f780179_I20230630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostExpectedCost1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostIncurredCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details)",
     "role": "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails",
     "shortName": "RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i09ad333c626b4d51be54887b41e252f1_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostIncurredCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "if09ffc76813043a5aa916a91f25540db_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details)",
     "role": "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails",
     "shortName": "RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "if09ffc76813043a5aa916a91f25540db_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "ief9b7921268144ca978e6451b72f275f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - INVENTORIES, NET (Details)",
     "role": "http://www.clorox.com/role/INVENTORIESNETDetails",
     "shortName": "INVENTORIES, NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "ief9b7921268144ca978e6451b72f275f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "ief9b7921268144ca978e6451b72f275f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "ief9b7921268144ca978e6451b72f275f_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)",
     "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i63b417fd4e2e4baca829a11debf18917_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details)",
     "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i63b417fd4e2e4baca829a11debf18917_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "ief9b7921268144ca978e6451b72f275f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)",
     "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i63b417fd4e2e4baca829a11debf18917_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - INCOME TAXES (Narrative) (Details)",
     "role": "http://www.clorox.com/role/INCOMETAXESNarrativeDetails",
     "shortName": "INCOME TAXES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)",
     "role": "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails",
     "shortName": "NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details)",
     "role": "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
     "shortName": "COMPREHENSIVE INCOME (LOSS) (Schedule of Comprehensive Income) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Equity) (Details)",
     "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails",
     "shortName": "STOCKHOLDERS' EQUITY (Schedule of Equity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "if09ffc76813043a5aa916a91f25540db_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)",
     "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails",
     "shortName": "STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i6052bc3b28d746c0bd0c11c456d9f13f_I20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "icab4c536fd8d4a618d358572c4a848e7_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)",
     "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
     "shortName": "STOCKHOLDERS' EQUITY (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "icab4c536fd8d4a618d358572c4a848e7_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "ief9b7921268144ca978e6451b72f275f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "ief9b7921268144ca978e6451b72f275f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)",
     "role": "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
     "shortName": "EMPLOYEE BENEFIT PLANS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i1947113776464ef48d89fbe12f701aff_D20220517-20220517",
      "decimals": null,
      "lang": "en-US",
      "name": "clx:DefinedBenefitPlanPlanTerminationPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income (Details)",
     "role": "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
     "shortName": "EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "ief9b7921268144ca978e6451b72f275f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccrualForEnvironmentalLossContingencies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)",
     "role": "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails",
     "shortName": "OTHER CONTINGENCIES AND GUARANTEES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "ief9b7921268144ca978e6451b72f275f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccrualForEnvironmentalLossContingencies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reportablesegment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - SEGMENT RESULTS (Narrative) (Details)",
     "role": "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
     "shortName": "SEGMENT RESULTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reportablesegment",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - SEGMENT RESULTS (Reportable Segment Information ) (Details)",
     "role": "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails",
     "shortName": "SEGMENT RESULTS (Reportable Segment Information ) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i3007927605bd40d6aa8bd18ae2feac19_D20220701-20220930",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "ia206ce29644b481c940c521fcb640e60_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - SEGMENT RESULTS (Net Sales Percentages) (Details)",
     "role": "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
     "shortName": "SEGMENT RESULTS (Net Sales Percentages) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "ia206ce29644b481c940c521fcb640e60_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - RESTRUCTURING AND RELATED COSTS",
     "role": "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS",
     "shortName": "RESTRUCTURING AND RELATED COSTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - INVENTORIES, NET",
     "role": "http://www.clorox.com/role/INVENTORIESNET",
     "shortName": "INVENTORIES, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clx:FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clx-20220930.htm",
      "contextRef": "i364166d8d9dd4461b0dd1fd64580b7a7_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clx:FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 58,
   "tag": {
    "clx_AlamedaCountyCaliforniaMatterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alameda County, California Matter [Member]",
        "label": "Alameda County, California Matter [Member]",
        "terseLabel": "Alameda County, California Matter"
       }
      }
     },
     "localname": "AlamedaCountyCaliforniaMatterMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_BagsWrapsAndContainersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bags, Wraps, And Containers [Member]",
        "label": "Bags, Wraps, And Containers [Member]",
        "terseLabel": "Bags and Wraps"
       }
      }
     },
     "localname": "BagsWrapsAndContainersMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_CatLitterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cat Litter [Member]",
        "label": "Cat Litter [Member]",
        "terseLabel": "Cat Litter"
       }
      }
     },
     "localname": "CatLitterMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_CleaningMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cleaning [Member]",
        "label": "Cleaning [Member]",
        "terseLabel": "Cleaning"
       }
      }
     },
     "localname": "CleaningMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_CommodityPurchaseDerivativeContractsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commodity Purchase Derivative Contracts [Axis]",
        "label": "Commodity Purchase Derivative Contracts [Axis]",
        "terseLabel": "Commodity Purchase Derivative Contracts [Axis]"
       }
      }
     },
     "localname": "CommodityPurchaseDerivativeContractsAxis",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "clx_CommodityPurchaseDerivativeContractsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commodity Purchase Derivative Contracts [Domain]",
        "label": "Commodity Purchase Derivative Contracts [Domain]",
        "terseLabel": "Commodity Purchase Derivative Contracts [Domain]"
       }
      }
     },
     "localname": "CommodityPurchaseDerivativeContractsDomain",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_CostOfGoodsAndServicesSoldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of Goods and Services Sold",
        "label": "Cost of Goods and Services Sold [Member]",
        "terseLabel": "Costs of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_DefinedBenefitPlanPlanTerminationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Termination Period",
        "label": "Defined Benefit Plan, Plan Termination Period",
        "terseLabel": "Plan termination period"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanTerminationPeriod",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instruments subject to contractually defined counterparty liability position limits.",
        "label": "Derivative Instruments Subject To Contractually Defined Counterparty Liability Position Limits",
        "terseLabel": "Derivative instruments subject to contractually defined counterparty liability position limits"
       }
      }
     },
     "localname": "DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_DickinsonCountyMichiganMatterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dickinson County, Michigan Matter [Member]",
        "label": "Dickinson County, Michigan Matter [Member]",
        "terseLabel": "Dickinson County, Michigan Matter"
       }
      }
     },
     "localname": "DickinsonCountyMichiganMatterMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments and fair value measurements.",
        "label": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "clx_FinancialInstrumentsAndFairValueMeasurementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial Instruments and Fair Value Measurements [Abstract]",
        "label": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]",
        "terseLabel": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]"
       }
      }
     },
     "localname": "FinancialInstrumentsAndFairValueMeasurementsAbstract",
     "nsuri": "http://www.clorox.com/20220930",
     "xbrltype": "stringItemType"
    },
    "clx_FoodProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Food Products [Member]",
        "label": "Food Products [Member]",
        "terseLabel": "Food"
       }
      }
     },
     "localname": "FoodProductsMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_GrillingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grilling [Member]",
        "label": "Grilling [Member]",
        "terseLabel": "Grilling"
       }
      }
     },
     "localname": "GrillingMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_HealthAndWellnessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health and Wellness",
        "label": "Health and Wellness [Member]",
        "terseLabel": "Health and Wellness"
       }
      }
     },
     "localname": "HealthAndWellnessMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_HouseholdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Household [Member]",
        "label": "Household [Member]",
        "terseLabel": "Household"
       }
      }
     },
     "localname": "HouseholdMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_InternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International [Member]",
        "label": "International [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_InventoryCurrentAndNoncurrentNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/INVENTORIESNETDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.clorox.com/role/INVENTORIESNETDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory, Current And Noncurrent, Net",
        "label": "Inventory, Current And Noncurrent, Net",
        "totalLabel": "Total inventories, net"
       }
      }
     },
     "localname": "InventoryCurrentAndNoncurrentNet",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock options. Also includes the net cash inflow (outflow) from other financing activities.",
        "label": "Issuance Of Common Stock For Employee Stock Plans And Other",
        "terseLabel": "Issuance of common stock for employee stock plans and other"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForEmployeeStockPlansAndOther",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_LetterOfCreditBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing capacity under the letter of credit without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding.",
        "label": "Letter of credit",
        "terseLabel": "Letter of credit"
       }
      }
     },
     "localname": "LetterOfCreditBorrowingCapacity",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_LifestyleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lifestyle [Member]",
        "label": "Lifestyle [Member]",
        "terseLabel": "Lifestyle"
       }
      }
     },
     "localname": "LifestyleMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_LongTermInterCompanyLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term inter-company loans included in foreign currency adjustments.",
        "label": "Long-Term Inter-Company Loans [Member]",
        "terseLabel": "Long-Term Inter-Company Loans"
       }
      }
     },
     "localname": "LongTermInterCompanyLoansMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_MaximumExposureUndiscountedCost": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum potential amount of future payments (undiscounted) that the Company could incur over an estimated remediation period.",
        "label": "Maximum Exposure, Undiscounted Cost",
        "terseLabel": "Maximum undiscounted costs"
       }
      }
     },
     "localname": "MaximumExposureUndiscountedCost",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_NaturalPersonalCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Natural Personal Care [Member]",
        "label": "Natural Personal Care [Member]",
        "terseLabel": "Natural Personal Care"
       }
      }
     },
     "localname": "NaturalPersonalCareMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_NotesAndLoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes and Loans Payable [Member]",
        "label": "Notes And Loans Payable [Member]",
        "terseLabel": "Notes and loans payable"
       }
      }
     },
     "localname": "NotesAndLoansPayableMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_OperatingLeaseRightofUseAssetAndLiabilityNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-of-Use Asset And Liability, Net",
        "label": "Operating Lease, Right-of-Use Asset And Liability, Net",
        "terseLabel": "Operating lease right-of-use assets and liabilities, net"
       }
      }
     },
     "localname": "OperatingLeaseRightofUseAssetAndLiabilityNet",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_OtherEmployeeStockPlanActivitiesAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount includes the value of stock granted during the period as a result of exercises of employee stock options or vesting of other share-based awards.",
        "label": "Other Employee Stock Plan Activities, Amount",
        "terseLabel": "Other employee stock plan activities"
       }
      }
     },
     "localname": "OtherEmployeeStockPlanActivitiesAmount",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_OtherEmployeeStockPlanActivitiesShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of exercises of employee stock options or the vesting of other share-based awards.",
        "label": "Other Employee Stock Plan Activities, Shares",
        "terseLabel": "Other employee stock plan activities (in shares)"
       }
      }
     },
     "localname": "OtherEmployeeStockPlanActivitiesShares",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clx_OtherExpenseIncomeNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines.",
        "label": "Other Expense (Income), Net",
        "terseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherExpenseIncomeNet",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_OtherIncomeExpenseNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Income (Expense), Net",
        "label": "Other Income (Expense), Net [Member]",
        "terseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherIncomeExpenseNetMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_ProfessionalProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Professional Products [Member]",
        "label": "Professional Products [Member]",
        "terseLabel": "Professional Products"
       }
      }
     },
     "localname": "ProfessionalProductsMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_PurchasesofInventoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases of Inventory [Member]",
        "label": "Purchases of Inventory [Member]",
        "terseLabel": "Purchases of Inventory"
       }
      }
     },
     "localname": "PurchasesofInventoryMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_RemediationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated time frame of disbursements over which remediation efforts are estimated to occur for an individual site.",
        "label": "Remediation period",
        "terseLabel": "Remediation period (in years)"
       }
      }
     },
     "localname": "RemediationPeriod",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "clx_RestructuringAndRelatedCostsBenchmarkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Related Costs Benchmark",
        "label": "Restructuring and Related Costs Benchmark [Member]",
        "terseLabel": "Restructuring and Related Costs"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostsBenchmarkMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_RetirementIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retirement Income [Member]",
        "label": "Retirement Income Plans [Member]",
        "terseLabel": "Retirement Income Plans"
       }
      }
     },
     "localname": "RetirementIncomeMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_SiteContingencyAgreedPercentageOfCostSharing": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of costs that the entity has agreed to under cost-sharing arrangements with other potentially responsible parties for an individual site.",
        "label": "Percentage of liability for aggregate remediation and associated costs, other than legal fees",
        "terseLabel": "Percentage of liability for aggregate remediation and associated costs, other than legal fees"
       }
      }
     },
     "localname": "SiteContingencyAgreedPercentageOfCostSharing",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "clx_TotalCommodityPurchaseDerivativeContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Commodity Purchase Derivative Contracts [Member]",
        "label": "Total Commodity Purchase Derivative Contracts [Member]",
        "terseLabel": "Total Commodity Purchase Derivative Contracts"
       }
      }
     },
     "localname": "TotalCommodityPurchaseDerivativeContractsMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_TrademarksNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite or finite period of benefit.",
        "label": "Trademarks, net",
        "terseLabel": "Trademarks, net"
       }
      }
     },
     "localname": "TrademarksNet",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trust Assets For Nonqualified Deferred Compensation Plans [Member]",
        "label": "Trust Assets for nonqualified deferred compensation plans [Member]",
        "terseLabel": "Trust assets for nonqualified deferred compensation plans"
       }
      }
     },
     "localname": "TrustAssetsForNonqualifiedDeferredCompensationPlansMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_VitaminsMineralsAndSupplementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vitamins, Minerals and Supplements",
        "label": "Vitamins, Minerals and Supplements [Member]",
        "terseLabel": "Vitamins, Minerals and Supplements"
       }
      }
     },
     "localname": "VitaminsMineralsAndSupplementsMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_WalmartStoresIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Walmart Stores, Inc. and its affiliates [Member]",
        "label": "Walmart Stores, Inc. [Member]",
        "terseLabel": "Walmart Stores, Inc."
       }
      }
     },
     "localname": "WalmartStoresIncMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clx_WaterFiltrationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Water Filtration [Member]",
        "label": "Water Filtration [Member]",
        "terseLabel": "Water Filtration"
       }
      }
     },
     "localname": "WaterFiltrationMember",
     "nsuri": "http://www.clorox.com/20220930",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.clorox.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r99",
      "r146",
      "r165",
      "r166",
      "r167",
      "r168",
      "r170",
      "r172",
      "r176",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r252",
      "r254",
      "r256",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r99",
      "r146",
      "r165",
      "r166",
      "r167",
      "r168",
      "r170",
      "r172",
      "r176",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r252",
      "r254",
      "r256",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r182",
      "r296",
      "r297",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r234",
      "r236",
      "r238",
      "r239",
      "r259",
      "r270",
      "r382",
      "r388",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r574",
      "r576",
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r234",
      "r236",
      "r238",
      "r239",
      "r259",
      "r270",
      "r382",
      "r388",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r574",
      "r576",
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r182",
      "r296",
      "r297",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r204",
      "r234",
      "r236",
      "r238",
      "r239",
      "r259",
      "r270",
      "r323",
      "r382",
      "r388",
      "r414",
      "r415",
      "r416",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r574",
      "r576",
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r204",
      "r234",
      "r236",
      "r238",
      "r239",
      "r259",
      "r270",
      "r323",
      "r382",
      "r388",
      "r414",
      "r415",
      "r416",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r574",
      "r576",
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r109",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r109",
      "r114",
      "r232",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r109",
      "r114",
      "r232",
      "r383",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForEnvironmentalLossContingencies": {
     "auth_ref": [
      "r205",
      "r206",
      "r207",
      "r208",
      "r231",
      "r237"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies.",
        "label": "Accrual for Environmental Loss Contingencies",
        "terseLabel": "Liability for aggregate future remediation costs"
       }
      }
     },
     "localname": "AccrualForEnvironmentalLossContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r50",
      "r56",
      "r64",
      "r65",
      "r66",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Pension and postretirement benefit adjustments"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r10",
      "r200"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment, accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r49",
      "r56",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Net unrealized gains (losses) on derivatives"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r21",
      "r53",
      "r55",
      "r56",
      "r558",
      "r581",
      "r582"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive net (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r64",
      "r65",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r52",
      "r56",
      "r64",
      "r65",
      "r66",
      "r101",
      "r102",
      "r103",
      "r458",
      "r519",
      "r577",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Net (Loss) Income",
        "verboseLabel": "Accumulated other comprehensive net (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r48",
      "r56",
      "r64",
      "r65",
      "r66",
      "r458",
      "r509",
      "r510",
      "r511",
      "r512",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r101",
      "r102",
      "r103",
      "r418",
      "r419",
      "r420",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r390",
      "r421",
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operations:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r423"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive stock options and other (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r13",
      "r95",
      "r154",
      "r167",
      "r174",
      "r185",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r250",
      "r251",
      "r253",
      "r255",
      "r257",
      "r258",
      "r452",
      "r459",
      "r506",
      "r520",
      "r522",
      "r538",
      "r556"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r31",
      "r95",
      "r185",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r250",
      "r251",
      "r253",
      "r255",
      "r257",
      "r258",
      "r452",
      "r459",
      "r506",
      "r520",
      "r522"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r495"
     ],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets, estimated fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BankTimeDepositsMember": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest.",
        "label": "Bank Time Deposits [Member]",
        "terseLabel": "Time deposits"
       }
      }
     },
     "localname": "BankTimeDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r501",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Amount"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r9",
      "r91"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents, estimated fair value"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r86",
      "r91",
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "End of period",
        "periodStartLabel": "Beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Cash, cash equivalents, and restricted cash:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r86",
      "r507"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "terseLabel": "Estimated amount of the existing net gain (loss) to be reclassified into earnings in the next 12 months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaper": {
     "auth_ref": [
      "r14",
      "r539",
      "r557"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.",
        "label": "Commercial Paper",
        "terseLabel": "Notes and loans payable"
       }
      }
     },
     "localname": "CommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r39",
      "r543",
      "r564"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r228",
      "r229",
      "r230",
      "r240",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "OTHER CONTINGENCIES AND GUARANTEES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommodityContractMember": {
     "auth_ref": [
      "r324",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices.",
        "label": "Commodity Contract [Member]",
        "terseLabel": "Commodity purchase derivative contracts",
        "verboseLabel": "Commodity purchase options contracts"
       }
      }
     },
     "localname": "CommodityContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r101",
      "r102",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r18",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance, common stock (in shares)",
        "periodStartLabel": "Beginning balance, common stock (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r18",
      "r522"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of September\u00a030, 2022 and June\u00a030, 2022; and 123,355,986 and 123,152,132 shares outstanding as of September\u00a030, 2022 and June\u00a030, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r60",
      "r62",
      "r63",
      "r74",
      "r549",
      "r569"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive income attributable to Clorox"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r60",
      "r62",
      "r73",
      "r450",
      "r451",
      "r463",
      "r548",
      "r568"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Total comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r60",
      "r62",
      "r72",
      "r449",
      "r463",
      "r547",
      "r567"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Comprehensive income",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r71",
      "r79",
      "r546",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r138",
      "r139",
      "r182",
      "r503",
      "r504",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r138",
      "r139",
      "r182",
      "r503",
      "r504",
      "r583",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r138",
      "r139",
      "r182",
      "r503",
      "r504",
      "r583",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r138",
      "r139",
      "r182",
      "r503",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r135",
      "r138",
      "r139",
      "r140",
      "r503",
      "r505",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r138",
      "r139",
      "r182",
      "r503",
      "r504",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r168",
      "r170",
      "r176",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r77",
      "r535"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": {
     "auth_ref": [
      "r218",
      "r219",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.",
        "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]",
        "terseLabel": "Restructuring Liabilities"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r136",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r261",
      "r263",
      "r264",
      "r500"
     ],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinancialLiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Current maturities of long-term debt and Long-term debt, estimated fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationPlanAssets": {
     "auth_ref": [
      "r12"
     ],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.",
        "label": "Deferred Compensation Plan Assets",
        "terseLabel": "Trust assets for nonqualified deferred compensation plans"
       }
      }
     },
     "localname": "DeferredCompensationPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r89",
      "r96",
      "r432",
      "r437",
      "r438",
      "r439"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "verboseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r425",
      "r426"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r301",
      "r339",
      "r366",
      "r372",
      "r373"
     ],
     "calculation": {
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Amortization of unrecognized items"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r347",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "terseLabel": "Weighted average long-term expected rate or return on plan assets (percentage)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r316",
      "r324",
      "r326",
      "r370",
      "r372",
      "r373"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Discretionary contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r301",
      "r338",
      "r365",
      "r372",
      "r373"
     ],
     "calculation": {
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r301",
      "r305",
      "r337",
      "r364",
      "r372",
      "r373"
     ],
     "calculation": {
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r335",
      "r362",
      "r372",
      "r373"
     ],
     "calculation": {
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Total",
        "verboseLabel": "Net periodic benefit cost (benefit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r89",
      "r149"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r43",
      "r44",
      "r45",
      "r500"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r45",
      "r470",
      "r473",
      "r477",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r468",
      "r470",
      "r477",
      "r481",
      "r482",
      "r485",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r43",
      "r44",
      "r45",
      "r500"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r465",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r464",
      "r466",
      "r467",
      "r468",
      "r469",
      "r474",
      "r477",
      "r483",
      "r484",
      "r487",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r291",
      "r555"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "negatedTerseLabel": "Dividends to Clorox stockholders"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r377",
      "r381",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net earnings per share attributable to Clorox"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r75",
      "r106",
      "r107",
      "r108",
      "r109",
      "r110",
      "r115",
      "r117",
      "r122",
      "r123",
      "r124",
      "r129",
      "r130",
      "r493",
      "r494",
      "r550",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net earnings per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r75",
      "r106",
      "r107",
      "r108",
      "r109",
      "r110",
      "r117",
      "r122",
      "r123",
      "r124",
      "r129",
      "r130",
      "r493",
      "r494",
      "r550",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net earnings per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r125",
      "r127",
      "r128",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET EARNINGS PER SHARE (EPS)"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/NETEARNINGSPERSHAREEPS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r507"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate on earnings from continuing operations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee-Related Costs"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r64",
      "r65",
      "r66",
      "r101",
      "r102",
      "r103",
      "r105",
      "r111",
      "r113",
      "r132",
      "r186",
      "r284",
      "r291",
      "r418",
      "r419",
      "r420",
      "r433",
      "r434",
      "r492",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r514",
      "r519",
      "r577",
      "r578",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r261",
      "r263",
      "r264",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r495",
      "r496",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r495",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of Assets and Liabilities for Fair Value Disclosure"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r261",
      "r263",
      "r264",
      "r324",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r372",
      "r496",
      "r524",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r261",
      "r263",
      "r264",
      "r495",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r261",
      "r263",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r261",
      "r324",
      "r326",
      "r331",
      "r372",
      "r496",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r261",
      "r263",
      "r264",
      "r324",
      "r326",
      "r331",
      "r372",
      "r496",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r261",
      "r263",
      "r264",
      "r324",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r372",
      "r524",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "totalLabel": "Total liabilities, estimated fair value"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r45",
      "r324",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign exchange derivative contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign exchange forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r11",
      "r189",
      "r190",
      "r197",
      "r199",
      "r522",
      "r537"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r76",
      "r95",
      "r154",
      "r166",
      "r170",
      "r173",
      "r176",
      "r185",
      "r244",
      "r245",
      "r246",
      "r249",
      "r250",
      "r251",
      "r253",
      "r255",
      "r257",
      "r258",
      "r506"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r69",
      "r154",
      "r166",
      "r170",
      "r173",
      "r176",
      "r536",
      "r544",
      "r553",
      "r571"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Earnings (losses) before income taxes",
        "totalLabel": "Earnings before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r202",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r97",
      "r429",
      "r430",
      "r431",
      "r435",
      "r440",
      "r444",
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r98",
      "r112",
      "r113",
      "r152",
      "r427",
      "r436",
      "r442",
      "r572"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes.",
        "label": "Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable",
        "verboseLabel": "Income taxes payable / prepaid"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r118",
      "r119",
      "r120",
      "r124",
      "r391"
     ],
     "calculation": {
      "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive effect of stock options and other (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of the entity to which the long-term intercompany foreign balances of the entity relate.",
        "label": "Intercompany Foreign Currency Balance by Description [Axis]",
        "terseLabel": "Intercompany Foreign Currency Balance by Description [Axis]"
       }
      }
     },
     "localname": "IntercompanyForeignCurrencyBalanceByDescriptionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntercompanyForeignCurrencyBalanceNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name or description of the foreign entity or investment that is of a long-term nature.",
        "label": "Intercompany Foreign Currency Balance, Name [Domain]",
        "terseLabel": "Intercompany Foreign Currency Balance, Name [Domain]"
       }
      }
     },
     "localname": "IntercompanyForeignCurrencyBalanceNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r68",
      "r148",
      "r515",
      "r516",
      "r551"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateContractMember": {
     "auth_ref": [
      "r45",
      "r324",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.",
        "label": "Interest Rate Contract [Member]",
        "verboseLabel": "Interest rate derivative contracts"
       }
      }
     },
     "localname": "InterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "INVENTORIES, NET"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r25",
      "r187"
     ],
     "calculation": {
      "http://www.clorox.com/role/INVENTORIESNETDetails_1": {
       "order": 3.0,
       "parentTag": "clx_InventoryCurrentAndNoncurrentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLIFOReserve": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.clorox.com/role/INVENTORIESNETDetails_1": {
       "order": 2.0,
       "parentTag": "clx_InventoryCurrentAndNoncurrentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.",
        "label": "Inventory, LIFO Reserve",
        "negatedLabel": "LIFO allowances"
       }
      }
     },
     "localname": "InventoryLIFOReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r5",
      "r30",
      "r522"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.clorox.com/role/INVENTORIESNETDetails": {
       "order": 1.0,
       "parentTag": "clx_InventoryCurrentAndNoncurrentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "verboseLabel": "Total current inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNoncurrent": {
     "auth_ref": [
      "r12"
     ],
     "calculation": {
      "http://www.clorox.com/role/INVENTORIESNETDetails": {
       "order": 2.0,
       "parentTag": "clx_InventoryCurrentAndNoncurrentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.",
        "label": "Inventory, Noncurrent",
        "terseLabel": "Less: Noncurrent inventories, net"
       }
      }
     },
     "localname": "InventoryNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r30",
      "r187"
     ],
     "calculation": {
      "http://www.clorox.com/role/INVENTORIESNETDetails_1": {
       "order": 4.0,
       "parentTag": "clx_InventoryCurrentAndNoncurrentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Raw materials and packaging"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r26",
      "r187"
     ],
     "calculation": {
      "http://www.clorox.com/role/INVENTORIESNETDetails_1": {
       "order": 1.0,
       "parentTag": "clx_InventoryCurrentAndNoncurrentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r495"
     ],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Trust assets for nonqualified deferred compensation plans, estimated fair value"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letter of credit, amount outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r35",
      "r95",
      "r168",
      "r185",
      "r244",
      "r245",
      "r246",
      "r249",
      "r250",
      "r251",
      "r253",
      "r255",
      "r257",
      "r258",
      "r453",
      "r459",
      "r460",
      "r506",
      "r520",
      "r521"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r24",
      "r95",
      "r185",
      "r506",
      "r522",
      "r542",
      "r561"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r36",
      "r95",
      "r185",
      "r244",
      "r245",
      "r246",
      "r249",
      "r250",
      "r251",
      "r253",
      "r255",
      "r257",
      "r258",
      "r453",
      "r459",
      "r460",
      "r506",
      "r520",
      "r521",
      "r522"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r15",
      "r260",
      "r262",
      "r263",
      "r264",
      "r540",
      "r557"
     ],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Current maturities of long-term debt and Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-Term Debt [Member]",
        "terseLabel": "Current maturities of long-term debt and Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r37",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r231",
      "r233",
      "r234",
      "r235",
      "r236",
      "r241",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r231",
      "r233",
      "r234",
      "r235",
      "r236",
      "r241",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r231",
      "r233",
      "r234",
      "r235",
      "r236",
      "r241",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarginDepositAssets": {
     "auth_ref": [
      "r12"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash or securities placed with a broker or counterparty as security for a trading or derivatives securities position which was partially obtained with funds provided by the broker dealer.",
        "label": "Margin Deposit Assets",
        "terseLabel": "Cash margin balances amount"
       }
      }
     },
     "localname": "MarginDepositAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.",
        "label": "Maximum Length of Time, Foreign Currency Cash Flow Hedge",
        "terseLabel": "Maximum duration, foreign exchange contracts (in years)"
       }
      }
     },
     "localname": "MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Length of Time Hedged in Cash Flow Hedge",
        "terseLabel": "Maximum duration, commodity contracts (in years)"
       }
      }
     },
     "localname": "MaximumLengthOfTimeHedgedInCashFlowHedge1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum period the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Length of Time Hedged in Interest Rate Cash Flow Hedge",
        "terseLabel": "Maximum duration, interest rate contracts (in years)"
       }
      }
     },
     "localname": "MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r42",
      "r95",
      "r185",
      "r244",
      "r249",
      "r250",
      "r251",
      "r257",
      "r258",
      "r506",
      "r541",
      "r560"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Dividends to noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Interest-bearing investments, including money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used for financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used for investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r86",
      "r87",
      "r90"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operations"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r3",
      "r58",
      "r61",
      "r66",
      "r70",
      "r90",
      "r95",
      "r104",
      "r106",
      "r107",
      "r108",
      "r109",
      "r112",
      "r113",
      "r121",
      "r154",
      "r166",
      "r170",
      "r173",
      "r176",
      "r185",
      "r244",
      "r245",
      "r246",
      "r249",
      "r250",
      "r251",
      "r253",
      "r255",
      "r257",
      "r258",
      "r494",
      "r506",
      "r545",
      "r565"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net earnings attributable to Clorox"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r58",
      "r61",
      "r66",
      "r112",
      "r113",
      "r455",
      "r462"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Net earnings attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r101",
      "r102",
      "r103",
      "r291",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r518"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r518"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r517"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r168",
      "r170",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r12"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r56",
      "r64",
      "r65",
      "r508",
      "r510",
      "r514"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Other comprehensive (loss) income before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r49",
      "r53"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Net unrealized gains (losses) on derivatives"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r49",
      "r53",
      "r471",
      "r475",
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Gains (losses) recognized in Other comprehensive (loss) income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r53",
      "r57",
      "r476"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r59",
      "r62",
      "r64",
      "r65",
      "r67",
      "r71",
      "r284",
      "r508",
      "r513",
      "r514",
      "r546",
      "r566"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive (loss) income",
        "totalLabel": "Total other comprehensive (loss) income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive (loss) income, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r51",
      "r53"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Pension and postretirement benefit adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r54",
      "r64",
      "r71",
      "r427",
      "r441",
      "r443",
      "r508",
      "r511",
      "r514",
      "r546",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "negatedLabel": "Income tax benefit (expense)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.",
        "label": "Other Intangible Assets, Net",
        "terseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "OtherIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r347",
      "r348",
      "r350",
      "r353",
      "r357",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other Postretirement Benefits Plan"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [
      "r211",
      "r212",
      "r222",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r80",
      "r82"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Treasury stock purchased"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r84",
      "r212"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "terseLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Cash dividends paid to Clorox stockholders"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r323",
      "r325",
      "r331",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r372",
      "r374",
      "r375",
      "r376",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "EMPLOYEE BENEFIT PLANS"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails",
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r17",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r17",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r17",
      "r522"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-Term Debt",
        "terseLabel": "Notes and loans payable, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r3",
      "r58",
      "r61",
      "r66",
      "r85",
      "r95",
      "r104",
      "r112",
      "r113",
      "r154",
      "r166",
      "r170",
      "r173",
      "r176",
      "r185",
      "r244",
      "r245",
      "r246",
      "r249",
      "r250",
      "r251",
      "r253",
      "r255",
      "r257",
      "r258",
      "r449",
      "r454",
      "r456",
      "r462",
      "r463",
      "r494",
      "r506",
      "r553"
     ],
     "calculation": {
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net earnings",
        "totalLabel": "Net earnings",
        "verboseLabel": "Net earnings"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r201",
      "r522",
      "r554",
      "r563"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net of accumulated depreciation and amortization of $2,575 and $2,530, respectively"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r522",
      "r562",
      "r584"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r56",
      "r64",
      "r65",
      "r508",
      "r512",
      "r514"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "negatedLabel": "Amounts reclassified from Accumulated other comprehensive net (loss) income",
        "terseLabel": "Amounts reclassified from accumulated other comprehensive net (loss) income"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r424",
      "r534",
      "r604"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r210",
      "r212",
      "r215",
      "r225",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "RESTRUCTURING AND RELATED COSTS"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r211",
      "r214",
      "r222",
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Restructuring and related implementation, expected cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostIncurredCost": {
     "auth_ref": [
      "r211",
      "r214",
      "r222",
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.",
        "label": "Restructuring and Related Cost, Incurred Cost",
        "terseLabel": "Total restructuring and related implementation costs"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostIncurredCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r89",
      "r209",
      "r218",
      "r222"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r211",
      "r212",
      "r222",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r212",
      "r220"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending Accrual Balance",
        "periodStartLabel": "Beginning Accrual Balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r20",
      "r291",
      "r522",
      "r559",
      "r580",
      "r582"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r101",
      "r102",
      "r103",
      "r105",
      "r111",
      "r113",
      "r186",
      "r418",
      "r419",
      "r420",
      "r433",
      "r434",
      "r492",
      "r577",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r353",
      "r358",
      "r359",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r377",
      "r381",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r353",
      "r358",
      "r359",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r377",
      "r381",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r347",
      "r348",
      "r350",
      "r353",
      "r357",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r384",
      "r385",
      "r386",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r347",
      "r348",
      "r350",
      "r353",
      "r357",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r384",
      "r385",
      "r386",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r145",
      "r146",
      "r165",
      "r171",
      "r172",
      "r179",
      "r180",
      "r182",
      "r295",
      "r296",
      "r535"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r138",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue from Contract with Customer"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r56",
      "r513",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Effects of Derivative Instruments Designated as Hedging Instruments on OCI"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/COMPREHENSIVEINCOMELOSSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r356",
      "r357",
      "r360",
      "r361",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails",
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Effects of Derivative Instruments Designated as Hedging Instruments on Net Earnings"
       }
      }
     },
     "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r8",
      "r27",
      "r28",
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories, Net"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/INVENTORIESNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Components of Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r211",
      "r212",
      "r213",
      "r214",
      "r222",
      "r223",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails",
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r216",
      "r217",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r212",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserve by Type of Cost"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r154",
      "r157",
      "r169",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r154",
      "r157",
      "r169",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Selected Financial Information Relating to the Company's Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r16",
      "r17",
      "r18",
      "r93",
      "r133",
      "r134",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r277",
      "r282",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "terseLabel": "Schedule of Stockholders Equity"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r141",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r165",
      "r166",
      "r167",
      "r168",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r176",
      "r182",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r214",
      "r224",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r141",
      "r143",
      "r144",
      "r154",
      "r158",
      "r170",
      "r174",
      "r175",
      "r176",
      "r177",
      "r179",
      "r181",
      "r182",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT RESULTS"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Results"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShorttermDebtFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinancialLiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.",
        "label": "Short-Term Debt, Fair Value",
        "terseLabel": "Notes and loans payable, estimated fair value"
       }
      }
     },
     "localname": "ShorttermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r141",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r165",
      "r166",
      "r167",
      "r168",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r176",
      "r182",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r203",
      "r214",
      "r224",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails",
      "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r41",
      "r64",
      "r65",
      "r66",
      "r101",
      "r102",
      "r103",
      "r105",
      "r111",
      "r113",
      "r132",
      "r186",
      "r284",
      "r291",
      "r418",
      "r419",
      "r420",
      "r433",
      "r434",
      "r492",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r514",
      "r519",
      "r577",
      "r578",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r18",
      "r22",
      "r23",
      "r95",
      "r184",
      "r185",
      "r506",
      "r522"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance, ending",
        "periodStartLabel": "Balance, beginning",
        "totalLabel": "Total Clorox stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r65",
      "r95",
      "r101",
      "r102",
      "r103",
      "r105",
      "r111",
      "r185",
      "r186",
      "r291",
      "r418",
      "r419",
      "r420",
      "r433",
      "r434",
      "r447",
      "r448",
      "r461",
      "r492",
      "r506",
      "r508",
      "r509",
      "r514",
      "r519",
      "r578",
      "r579"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r94",
      "r269",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r291",
      "r294",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionDomain": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction [Domain]",
        "terseLabel": "Transaction [Domain]"
       }
      }
     },
     "localname": "TransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionTypeAxis": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction Type [Axis]",
        "terseLabel": "Transaction Type [Axis]"
       }
      }
     },
     "localname": "TransactionTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "periodEndLabel": "Ending balance, treasury stock (in shares)",
        "periodStartLabel": "Beginning balance, treasury stock (in shares)",
        "terseLabel": "Treasury Stock, Common, Shares"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r18",
      "r284",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Treasury stock purchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r40",
      "r292",
      "r293"
     ],
     "calculation": {
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost: 7,385,475 and 7,589,329 shares as of September\u00a030, 2022 and June\u00a030, 2022, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r284",
      "r291",
      "r292"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Treasury stock purchased"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r211",
      "r212",
      "r222",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r116",
      "r124"
     ],
     "calculation": {
      "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
      "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares outstanding (in thousands)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r115",
      "r124"
     ],
     "calculation": {
      "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited",
      "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(1)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(3)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13207-110859"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6571209&loc=d3e13703-110860"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q1)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e526-108580"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Subparagraph": "b.",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123398031&loc=d3e60009-112784"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r605": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r606": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r607": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r608": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r609": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r610": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>67
<FILENAME>0000021076-22-000035-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000021076-22-000035-xbrl.zip
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M2H_#"*L2=-<X"!N->P"C#*NK&TV.W*\'3ON=\>L/#PVHU=6;]8(9GN9A=2*
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M3/<^ERPB<(J@C-(.<8,,,SAE= ($@X"@T0O]G$-+"RWH)[%6;C5AT0I*(@)
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M&)C!>$(<+K,1[(Y L=,U:9I,JI?5.QGT;\^5*0IJ]7=' W?\I(+&,\,G'GA
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MB#JQ,**94[IL5K4SG82H42!M*&<@&JN$0@I<'W(8H\EFLHL@IN=.E\VJQ$,
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MBO:L$[Z?RGQKRRJ[G_(!HVA)M%1&1IA/VV4:!GR/.^M5I<J*UI956U:)?);
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MJW#6_+EU>.NZ#J-(O3.!9XC1--3E0V8P?#3:,HNY4_ UL C0E;U!?CS!X*E
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M&BUQ0?T0C,LZJ>'9QS'KD;NKQJP58U[;;C2P(1^W#*MQM?47"8[RT#A+?TT
MX'4QI@^NY+3?&9O_\-#D 6*G:Y!  D5.N:!Y$/!<JU 4F'AB-3=,*/1I*ST
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M,4: D4AD,PQF+HFD3*6J;R"[$EGY+Y6:VNI_!C4?Y)W',))Z7=@S,Y*IU"X
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MSXL69/O=+?_?8;,7P8:#U1Z<_]VRG;R-M ._/<V75)9[+LO];<8KB"QH25A
MP*PBX@YCY()V2+F 3<*669PM]V..S%0;R*]<_Q??<+/2_Z?2_VGF'IB6CNN
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MO-U9.P =W0K=[(DNX5O?:;IW.Q,QI]+/R[ASM7MTXTO_WH6_:K]\V/K\^Z^
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M5YG].^S#"X6K^6Q>S6>^11M,X5&^>;Y7,<)A+^8/P(CT1X_<6,*)+^[XKCD
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M-O1S-J%_]+K#4WC^&^::N+'UU7NKE(@)14DYX@9'I(6**+J4@R+.4(&G0R)
M2+EGBGL%WR%1VVB5\2DZJ21.A$]ST_WKK*, W-->]WLS%):X/*^0-<BZ[G!0
M"-8UME.[?A:]5-QK/*4_GT"^FSW[^W#\OC'*]/,INCZE2D;FM+?4!LH=4=92
MSCA10I.0L,?/WD[#F TJS4.Z:5"^0=G#>E#<>5NZ 0K^)&TO%M_Z0V]P58VU
M&NLJC=7<ZZZO*(WYYI2:9^N5L,A+S7T6X#F[!)B%]UAXK7,@;YR#5]=DZ'Z3
M,2+HM8*A%[O![Z]1OZ=1UI68FJOH:3$O_S<.S!7_*ES+Q4[.*O0BN=_,O;>]
MWCF,MIBIK2(CKNKI\H!YW!FG%183F>6Q^*&4R4KV*ME;!ME[IK*,[68(K?C\
M&VFXC-Y>.\?Q@$)G"Q.P!U=2JP99#?)-#')N0$K%_Y84D.[=2FSF!/F#X.KG
M<_&BK>]NGHU[G[==Q)0\2)A7<EKOTTEP[NF:9XI6O,S2O5[QU910(LH$J3QE
M7!$>(S=862,$%TD)'@._;P+*58[NZTA6*.L?Y=I'VT>\<?(G//>('^Q_O*C_
M\0^,K=%J7!PV#_?KY_DLVN%^JS5=_VCOW]VSO>TC6F__<[*W?7S<V*Z?P;/.
M#^@7UFC_V:I?[+*]_49K[]]_<C\A,E7_2*5 I%0,!:P\XB1:9)TD*%CB:1 D
MK]/<C2+NBW!/6D.X0IJWB324$A5Y3#98F6N>:QLE!?3A/B62F*B0YGF0ADTA
MC>!<$(8M4A9CQ+$+@#2>HBBPUD)(QSBMD*9"FM5!&LUPT(HE[Y/G-E<TX=QR
M2Z+76'@>[YN#.8LTK[G3SO,AD)A"("])R&4=$4V>( X\!QG.@?5@JF-@P23[
MT$X[%0Y5./1RC =+Z0.8UESLR"ALJ"-&"H^!SAMI5(5#+XM#/P"#?F0L:ISL
MLOI^_2MABL$Z"42LU[G\%44Z48QR=CD)*@E'V#("T>O:S+EW[+1_9D\?&SG]
M^4PL88CO:2.G"]P&6*UIO<_QJJHGTL,[GIF F>-1&B)X<E0[EBO=BI T9Y[C
M*@#P#&:O\7XFU"B"](XF8-X)1\2%3<AB$A!F3%B'$\<)WU0;IVI7]FI44S)&
MK20V6D.YH]@)JY(FV%G):8BWE&VM5'/1JCD=FTM)$L!'CCRC"7'-&'):$)08
MC4XX[X/BE6J^:M6DE.< B!?V_V?OVY_:NIG^_Q4/[V7:F8CJLKJESS!# \E#
MO[5)$]J^Y)>,KL'$V#RV28"__BL=&P*V26PPX(O:*05;YQP=K?:CSZY6NU2!
M,T$91:B6G#K@VDV?4*RHYL-4<]1II97P2L2 7, 6 0L4Z4@=LM@('I75*HB-
M+5%4<W554U,9E.4LT=I$DK133,O I?$<:\5<+*KY-*HYYL<Q0C*C15)+G19+
MD%(@K;Q%@C.F),,$.[58NOD##\[B50@J+>?;<AW"'U]WNNG/]K>,NK'3_9HS
M.)?@QQ+\^)PNO&F'ZWN,9]K-NJ5F/%2K: 1P$ 1R4E E*6>4VD"$P*!M\1,\
M!>-I7KOP>/UX%_;__"B#\981A@SC,L?P**1L\"BH8 ,WAA@K5S*&IZCF=08@
MP ;;:!5W#@QEBB7#Q&!CL;8L$%U4\VE4D]U03=[X])%$ ,6L04RG'V -1MI9
MFU13>EW5QO*K&<A;5/-*-2$*)ZBG %JE_[SU1!,:,6<2B\"+G^")5)-_4\V]
MK_6O'QE65 =&$1& $4255%,$BJ1-D)FT3_LHBFJNM&I**JV4DBD"!BP%!4E1
MO7)4,R\ 'A"B551S%M6\=N'M'^Q=U ^V/UHM.=,N(J-86C:QQ\C2 $AIBT.,
MP21ZNUBZ65QX:]YR':+PILX%]B1A98MZCWN?CK]?K/>SSHCI8[UG>_D?HN^S
MOO5,L346B(P>0EJ_TJB81#H-(3[82)0FLACF3T$QQD_8A@!<8!,1.)H8ADF&
MN?(R&0/<.8.===*YC2V8TR;A=+-^>NYQ/?L+;A7<>IS, )1J&8,+GAG 6BL7
M3:!12BM(#*(X%)\(MT9C H4.FC')D0!,$WA9A30#GW#+@C-",."RX%;!K77%
M+5XE,J$>E'"  ]8T.UI-)%J!"-P5E\[3X-9HP*146D@5%,+851LA%&D,";R4
MU3@2&4CVZ,B"6P6WUA*WP#E/N0&F=  "S#K/&&:>&RJ,%U!PZVEP:RR:%&OE
MC=$$D:A# B[ND*& D6688RL51(R7!;A6*\QP<MK7/[X5U%J4X+E5N,>-B4GG
MFW>T='(E.CDSMEB1_UU0;)DZ"T$\ZY]UPT/S$/QX+!8PVG9[4)TNUPV_J*IN
MY2!FXUSW+-RJ:SB/$;G77%[*4;U? M=IA^M[(1\3AFOU0C[FG_'T!N$H9'L&
MLKW_?FQ31@5#/7"%!'$Y%X%.7)MXCYB*AF)P5FL\A["/R;CPJ"%913^?+4]H
MT<][Z^?HYD/ &BL2*9+ #8)( TIR8H@2C8F36"@H^KG:^CG_[)I%/^^MGV-9
M"5BP$01!U,2T?A)ID'%!(T:=LX8X080J^KG2^CG_K)-%/^^MGV/.9$IP!$(I
M JMT4E LD4IJBH@V44G*F( %4] 2U[SF+<L$6/.6#]TT>FY7]J+?8TI7_ "6
M)WCCYQPFL%RIP^<T."M#_^8?;E[HWSTSC!_L]1NC] _':+57B"8Y(0A>(QTQ
M0]:I(%Q.&C;/8BOST8T%+X]0T+&@XS,&M1=T?  Z7MQ&1YOF,9,!4#!:(! ,
M(\TA(F,5)4%Y:VE!QX*.!1V7)G2^H./]T7%_- Z51:F]Y8@Q1A$ %\A(I9&+
ME#B/6?"8%'0LZ%C0<5D"] LZWA\=ZX.-SX20A^F>NY<?'0TB\A"0UQPCT"X@
MI24@JRG30+E/J]BJP&/ED?VEGV,NMZH7RA.UV3XSU1O]ZQ??_#+I\_3QU8L-
ME0#HIN1)44X[O69N\[(;6M74_/5KT_>/KI3DQH7#-\;?+C$VO=U9_^Y+QL(M
MGU[7:>Z3OA;R8'QN_#SJ7G7FU'P*R':#^8Q,3'U]:5I?S45OXY=;KW32;*.1
M(1Q]^R<__%"]8V/_8+<&F[77>XWMQJN][3]J>XWW!^_^JN\V#M[7MAL[M=?;
M>^]J?V__\==NK;Z[_?ZO=[N#[WYZ-9@KP?\\:9Q&)M, I(1QP5+&P"@,FF##
ML(@D06+DQ!EN-NZX3HK K'*&&D_!$FD,!09$<D5\Q [?GC\GIOLIC?=PYJDT
M#L-/LG:I:L%_CNET<)0S6+=:G:])G6N5,M9.NYTO39^>T6P/:C3F5S:V<]:O
M]5-S:UJF[4*M=Q1"O^9:IM=KQJ3E@V9M7S6*IMFM?3&MLW2;3JP^>M4Y22]X
M454>E+_VAHFB!PFBJ^MN!%OGK-JUKT=-=U3SS9YK=7IGW9!O].V^M6:OU@W_
M.6MV@W]Y)>S!"UQK>05?:2A;YK077E[]\NO5_E"S70U(==&OMP64E6$$O2H$
M&'P]U!.M-K44656&&TO#!P^U:+/2HA$P'GQ'89-P=>?7>)/<^=UW;TLVTRIQ
MK]M^_SO.YM]9M<GQ??M3^EKZ^AQ]%5/=]0=[S3.>%7I6TV+J7&DS["T_4U,]
MC0">\BB-GNHDJ/Z%X5^R438/(2SI&(B)8S"EFLTP=Y9B,'X;\J_WF7_]RW9_
MV7IUBX,]CK(NQ="\SNSP[\P.JW'Y=S-T3=<=751__1&^A-9\!^=. WF"C;S8
M(_?*=+L7J;?52&V?Y!.1TYS@F^;]UVH<=WO]9K*8@J\&,L_'ZI?!G"QSK\R]
M19A[JY7D=_)@;#^X=OS<)MAC9N\MG2R=7/Y.KE9&G\F6]%Y>+D*OCVPPW>QL
M;;:_I#]/TC+2>Y'^<*VS_"ZUDTX[7-1.3/=SZ-=B>N?'*BCX75_#8NU\#&E"
M[ZCR$[OTRVWO_@+V-GNFOYA6EF[MJK-S[8?8Y%-T9,*F6-9+Q#8G>+BMZ85\
M@XVMG\CH_LDS'S=8Y:PG#XS_6(,HCM6,Q? >&#C+/ 4/CH-ADD4(DG$>-0">
M-HXW ^-VV^?_[7Y#G>W^E5U5&0 K$IOQZ;SQYL-1X^##Y_J;WX\.+_,U?_$/
M.Y](8^?#<7IN\_#X$]0O]R['8C-V=O&'DUW2.$G]/'E]W'CS)_MPT$K/^ LW
M3AKI'7]O[N]\NJP?-V)]/-.^)"%J+R,BT@0$23[(4@F(>4\Q1!.YA00 0BU0
M-9\"0 6 O@= 6G$9 #LBA 8?HM6$*L6I811T".%A )0=$!7T[%SOX!<0F@V$
MQC+7$ K""(54#J$%8R/20 UB7%$5A0E$N@)"!82>_=UF2<7C03@9!7!N0-%H
M"39$!<(P-\QJ,6U$:F%!CP! HZEYC$UT-8!",7"-P$>.K%8*:<REBQ@K8&QC
M2XF"/P5_E@1_I"/:ND1]E#.@'=8B$J5(SK!)'2?T8?A32-"#,6@L_1"/$JB-
M%E%O9&)!S"(=/4FD2"?[6>J@HETP$%JM';?).I=OEC2D<C@^:..M^*R+S_K)
M?=:/4%%U.7S6T\05WG^XOI?)<,)PK5XF0Q:D(IAQ[P0 &&I#H)$F9F%(#,!C
M<?(^%[5HO!IW\@I/C'<$>0PD,0L1D*5")!L'G)*Y8$Z<8SG5I[1NBKY.FS[
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M3B%@G"+@EB&CC$:*6,V(5E0P5["L8%G!LKF5:2LD[#[ ->J/ ^R,4\2@R*)
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MC5?[]=W:P?;_[;Z_HKM#^4Z8VXLR32>C[K]&-'DP97X\(K='D#(,&M,(/A(
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M/;MQE-JSQK$_2=S@XO"@E=[AM\^'EZW$X3[SCUXSYJ(42$+$"()TR+*@40C
M-7<QV<5VU&J#P)7SZ:=VB0*DV4XB(RI-_$"(("Z.VKV-W8/:[O:[QE[CS?O:
MV]UWM??_WGZW6_MI]^W[G[]O!T]<(7_X^%GG^N-.M_?N*"W1K; ?_ZDF>QK$
M+XE8?@J-BN3NQVH2]@ZR5;BV4_%X^_RCQL'R !0%00T"'S+%Q!1AFS-K4H>C
MXZ-3ZUE6@\HCVVFU.E\KE\2 !&3[.JW(K>9@I@[IS->AR)/A7\F\-K!LKNE)
M[];FP4\52>B<I<[YWL_9;5%1@T2 W%FK<L6:7IJAF<4DW<E?I=:)FXPW],V\
MKOJKIB^OU*K:E_RV(%=[H6G86N:T%UY>_?+K5;J>9KMZ^>JB7V\KTH1L'-5B
M/?AZN#AIM8FUSNO3\&C-\,'#I6NS6KI&=G8'WTFQR;2X\VN\2>[\[GNWU9M2
MZGO=]?O?<>"/T5=U][<C=UV%C$\_/'^DQYHN6I:5R25C#BICMSXP=G>SL3M%
MVI7G'>H;06$S!$PLN!ST+PS_DI?I:;+>3//:ZSE\Y-%G[T*DFWM@ 97GB+/[
M+=.#AQ3)N.]L7:+SY@/:-=\M!#3F6_XNU=__1ODJB4T7A,B6TR88!B$>GC<.
M=L\_'!Q>U"\_G>_OO#NN'QPU]]^DNYS4SU/?>+H//4S6PF@08N-XE]0/7K<:
MQWN7^SN[T'A3/T_O ZEM\_#R=3.;L3F0L4X;L=X<A';?J!A*:-1)M#Q9%2[F
M4X<8*< 111L%>$>=EWICBU#V@K'Q0GN/47&F*.2/%?*!>SU%(1='(2]'%%):
M'J5S&$7))0+"DT*R?"!8,VX<YY0*GA62OM!J?.-P%;G',E&,G>Q8R!LX@ZV<
MRI'1[[C/M<[I8+_G.KIV"DFM,(#-G5'LM5VWVN<QK5RRH=,>0-=VO]]MVK/*
M17/0J3[[+<>MO#47N?%VMYOWH:K]H0)<LP#7Q1B3D-Y'[H)"+A"&@!.5F(3T
MR'K*E"0JL$@WMOB$S) SJ,(49&&%M6;NR_X\M*9P@;FIU"@7,-X1S3E#7"1>
M#B0*I!UWR 0EP5$3O$TJ15Y@0=>"":R$%V)GL/=0_! +P!KN,'N&(AJS?@K8
MS0OL&J_&^ ,$80QC'ADMD[E#@D5:@460'13 A>1ZZ(G09#S!9?%$K @E*2KY
M?"HYYHL@##N/#=+>"@0Z C)@+/(:,Z^9-#R8K)+P L-J,9"1:#Y"*V"8YV[A
M^-GK>]@X3_C(A1752I/%[7:_Z:]\2O?W)-UG+)9]99H[6;PIB_?!#4^0[IX/
M(IA?=SLG.0PY6<VY<_MQ-(YRNSK47-:KN:U7XYM9.! /#C!R(?I\]B+[SL$@
MPYT/#$L71%6>1*OQ?!J/2B"_E[1\VNJ?RZZ/<V>*11\731]'^6,D7#JA XI8
M  )):.*/..]J&:,4QU0(-_!?+7YI\07E/]>I=$;CQ!?N4,/D8.'?KD-VKX^X
MYHP@@^-'F>+LW C5G=0D)QNYBNNMCB,W;C8T-SS9.03X57JKSOD/$S$\1=H%
M8,N6=D$^^MF3#-C=<!3:O>MSISG+S,+$_5\?+_T[/><O:)SLD?U_&JT/!^]:
M'_XYA 2QN'[\KKE_L'UQ2'?QX<G>U[&X_W_>)=C\1#/L'M*_6XTW?[<^'!\E
MB/WSHI'Z4M_Y_?CPX%WS\/BW6#_X$W_TE%JIM$'.*(QRK2UD@XP(JP2N,@;0
M($:/H*2AQ9%Z)HDB$+4W1' <63!8VL2-QHZ@O-JOOWVW^^_=QON]OW=KPT0,
M/_VQ__[]S[5['$'YX>.?[E#)A!GU1Z>W8,=)GGY:77ZD4E$;TA@ZZRD";Q)-
M!NL0!2!4L4"$%F/'218)J*8Y?#+ _>ILJJ^.Q/;.3DYR6I].K-V:&5?9,7YJ
MI<GQ\_4Y[+3.-#L^'U/UB2ZD!>;EA*7@R0^-<*;N>6@$\_L=X?C>;4FZ4-[O
M?,>/3HW,O[-Z4S)63HV44R/EU$@Y-;)(PU=.C2RJ"_Z6/7G/?+MS3.']K&-Q
MWQ3>\TC1O9BNSO$4W0_==QC+U?VVVXG-?K9:%B7C]GTMEJ$_<N^\<?E;\\/.
M'CT\^.UX?Z?*GGWTX:1^67]S>)GZF_K]%TW?XU%_9/UXE]7?_/ZY?OSAJ/ZF
M#NG]FH?_O#Y)5WW]<)PS/?V)JTS>Q^\F'79Q.$CE!$746(_ 6H44(1))AQFF
M3J4OV<:6DO--MCW/9-KWJZTZGSH%!<36!\0>NEE30&QN(#:ZJ>*8T$Y30,I0
MAX!:0(8X@?+.)W6&:QMSG!S,N63 4Z/8TI'=9>*T^\.4;#<]8$/7UU7VUF$N
MN+XY?_F$EMV\C<!U#FP:+,9ZP:?BZTXW_=D>YF9W%[5^-]UMF+W1^..S8<&)
M.R?A:L96_/2T%D=.?IE^&UVU*YRX8PME*+A70[D=9+$-^KK=]@??A+A]+<-D
M2>_' W->&, ,#&!"I+Q))"Q:1Y#E(C$ S3'2+B=CCYPQ:PS#.<L;'3^N__/B
MA%.46*K[Z_L<R'G1]P76]U'&STB(S#N.L.,1@:(<&6,XBH1X%911UN0R8>.$
M?X'T?>E8UE*2J>RK/FMW0^I*KF3PR33;O0&Q#XG:=W*QB&[S2Y6'>!I"M>(X
M^CR\*5<Z>]WJ?/UW\)_"FR2A_.%VSFW\+ER5#7+F"E<+>LZ&GN_'V))6BG&.
M.1)<!P0<.%(R.N0X(9)Q2P--F# >@'H7>#X>1LY ?990,Y_3^UCT\?GT<93-
M8"N2XE&,A'. @$F+# X2@='*1Q<-YV)C:\9:TH6XK*A[Z&U6U^P):OO:::?7
M[X9^<Y"RI&9#.\1< 7)MG40+SW6&TDO 6;5Z>TN OPWD][:51J 8C0^#V0F)
M'8TBW!&#=.(]", I9$( Y(72UHL8=9@=9HNC:)ET_GG\1$7GGTSGQQU%*B1+
MAR-J)4&@M$ZFCG<Y!9M2W!NE02^#SB\=YUJFO=^#3M^TKHMR3;4#/ VM>E",
MT.+![.+[D0IHW@<TQ_-6:I<L3Y,/0C'P"&0@R"IO$+.*NZ"U 9= DXV7:[S3
MN_X\ 3.S\*$U5M;G(45%6>^GK&/.(Q^2Y:(EPD1P!#R'P5G@R;1AP6&*0Y!Y
MZWN<XBR8LBX=PUF)HQR3CGP^Q&6T:CCZG*<<)AW]'X+F7E4D-HWEVTZW\L/?
M2D_<Z+1SS[J=5GJA3WOYA%?H]0O0S@"T^^,Q1L(X[W&5=8 [!(9A9*W%R%#%
M%;49A_'&%I^7+;DL1R4*.CS/!EY!AV=%AS$:QACHD'.2:ZH1"":1!<90"$0+
MH[ 'JJHB)<L-#TO'TI:)C/T1>KV7M8$WRDW*Q3&:NZE]2Y53JX$N3[7I=]?\
M67$<?DJ65G!WWK@['LN4(!<PHPXE]I7,7\\],M%C)+G3RDAIB<KF[XRH.Y5R
M+)ZS:L5U]RDY5-'=^>ON>&$W(YQ1'#DED^ZR0) &FOYT$2PHA16%V3?GGD%W
MEXX5K83O:@:B-$AR>4^./<Q%=CM7_-T$?(W._S]H9%9F67I*2EF6G%E2!1QL
MY^6FHHR-XSU6/ZA_E$X$#%8A1UW.'6H(4CSF2#"B><C4D24['<9/"C[(3'^(
MHBQ'*I0"D@4D%X6[%Y"<%20O;H,DUR$Q<"N0#2;O*=MD5.,(2-)<=2PM<#'*
M[,R<\U['XJ#D@A+ZZ]3VUTG:;V6AGCEI^]4#ATH-=%/FC+NGG5XSW^!E-[2J
MDY&_7N6UK93^QH5#B>%OEQB;!'36O_N2L>233X]=55ID0FX/Q\V?,Z2L%QM7
M%QUUO[ER/@5DN\%\1B:?FGII6E_-16_CE]OIHIOMJQY!'O71 ;M;<DN5(E\]
M>HK\][D(U%&GE5"BM_N?LV;_(F?(WVGV7*O3.^LN3%+S1G.X&IPD##[Y*UWS
M^?+#SF\G'W;>?:[_\Q<<'AQ"G;X[;ES^W:S_T_C<N-P['TUJGM#_XL/!;T?[
M!XW/]3<?/C?>_'G^X>#HJ''\Z?+#FSIK_+-W?DC_9/7CUW%_9^_\(W"I#:9N
MD,H<( "R*@ADB+):4>8YF-%<^1"E22V9T%B \$)AK$$E;DQ<T"&$T23H[P_V
M7_V_?^__L;/[[OU=N?$G9L7_\8-N=XR#-<$K 89+2"PAO8F,,;V!=(8X*YX)
M2O[WOQ0E\GK5>PY5J^W^^=?>P>&W;*QC:\%WBA/\<%A'Q* "P0 1"ZT\&)!6
M<R(BX2YX3Y4.&T]7S&!<]Q>JCL$SJ#S^F%BV$H9@%$P^1*J]0<9RBX@#KJGA
M&%M8PCH&KXYRB?5<>: J1)#]?HD?M?N]'))_<QX,U;$6JOE0^QIR49S>L 9"
M[SN5#&IC!&GKB4L9I-5_$P\8P*RU#&@B;^SNK^];'H!O@E2/4<K@4?I*E'B$
MOC(%<^^KW,1*+DE?Q2864Y>(>.:^/M9\?9R^+L]\)7@30"])9^4FG;ZFR3/W
M56]23:>ZZT.+;7"R:(5-U#WKFM3>A]-^R&70:PS?<C9-+E9-]:1BU=W$!KZ3
M1&86?_2UN?YH0S/N@,T3_*>=S$"Z%2E*=V]599##N4O#<Z,BH#=]\^O@]R%]
MZIREA_K>SR-^A=$9HV<,.5GXJ?2J<W*2K)Z*+3XDA^]4V70GS*\5&<;MU-=L
M/II6[:UI>I3FU"MSVNR;5AG4>P_JN] WZ4-?NRK+^[ACN7*Z?= -IG?6O2C:
M_5#M=N[L9% ]MG(^5Z<XJ]]N[;E5G^3TBC_]41V2W_O^X;$R[C\:]T9:F68+
MYRYC^D-0J&+$)GF'!M["*<@CH9/(XX^&:>E&:E#\O92LN\?0O1\PZRG&[G'J
M/JSEH)?YNEKS=:DCEJ<;]]],R[1=M1G1B;7?S]JAQO"+VJ1:EU-&S"Q\ ;(?
MNS%6L_[8=.\]0_R<!Q6ED-PHJ<%'J8 1PB.!&,!:RC_N56%SXD=A<^,;IDM]
M6OB>&ZR#"+N3W8L<8==X\[I5O]SF^SOOTC/JO'[YB7UXTV@V#ARN_[/'#R]_
M_SP:87=XL,=27_#A/W]=UG<^0^/-[M?4U\O]'?_YD.Z1QN6?YX?'K=2G=[$^
MGF&)!<L(5@0IR+D$2"Y5P@)%7A+C+)-4D7Q:F)5D BN03."!6##PV\X'#MB$
M*-J33KL"A0$KV#_K]_JFG0=O(V^5GY@<\7'>?]D^.T&^TT?#NUTC "L(, T"
MC)Y]"U'9/*&0CY$AB"0@PP5#3E/FG&!$<9P1 +^0L&XH4,A/(3^WT(X''C#E
M-"$:!NVBD9Q1[K7B@4@*[*G)SS2X6)C15+A(1O.H1&F-IA19&4)B1L0AZX)$
M JA5F$9&E4^X^(*H\?23!14+*JX1*CKJ-3=24.(#!$,L4*JY-1$4\T':@HI+
MBXIL!!6C)^"L$D@PI1 X#L@&85$BB<Q[A8&$"A7QA*2\!14+*BX[*LZ2SEC&
MX)R/@3C% !MOL %EP1E/<> 1WPV+=V0Q+OBX</C(1UFC,UIC+1$7*B)@@B1\
MC 1A9B&PR+&%G$GF!=,S)"U?=FA<8V?:W7@QT9MV3\@8\Z9=A2!5B#%TK0V?
M5UQI\W.FC^;T<)08@K5#(3"6"SL)I&"0#-TKKJ53WFULR1=:S) %?=FUOQ"C
M0HQNHYR0FDE;9:,%D)XH*I.UB(7B)%H)]-F(4>$^L\'?2+8.(H@S(@!*1"<@
M"%PBY7&R$"48Q87,544WMCBL$?4IX+<.X#?+#H+PW'&A=>06DKHHT(I%$B63
M#KA]<E]9@;R9(*\QPOBX$\$2SY'!!! DJHYT9!%IX84''!W/6=R(*CNG!??6
M&O=B$ IX%("M!BN\MLR D H(\,! %MQ;;-P;I7I.*6XH1<H)@0 'A90T%GD=
M@E'&6<Q)HGIZ::I,S!SU&ZM_%C/J=[*VYB-2X4='^K[GHIOPRLOAA:N.VM!?
M9YQZDR7\J*OJR"/OY4@M4BI2*E):<RG-P,P,2;8+)<8X8X 3JZ-+Y$P%BREE
M7L>9$^*^[79BLY_/XA::-0/-:KP:B[:PDA!NN412XBJ!FD2*IC^=3/^"3$*0
M.=H"'LRRBGH6$"U2*E(J4BI2>G9"PEV2I_<0G2#@*374.DFUU#8JPR$40O)D
MA&3,WRV,5-H9@<!ZB\ (BI3&!E&I)=$N5U90LU?**MJY/-HY]_H913OOKYVC
MY3*(IQRP0@)S0* L1\8E>R$ )A$X%T'9;"^P!=+/E4JW,%F[JKQ5(_7A?FI5
MN:J:W\]5-47 Y/*!S?T(VV2Q+TM8:Y%2D5*14I%2D5*14I%2D=*J2VF6</#H
ME0@BL'QP&**V&B0)"IQCGBG/]106Y1UQX17QGE"?,1N;"U>C<2F,SO?C4=]:
M6^NHCR@)32'@@2)C94 $?#3",^H,V=B:4*)QYJ#OHKT%8XN4[H6Q<_#:%8Q]
M.HP==>QYHPTS3")EC4' 3$0F1YUK3*P@F!O!W.)@[%/'4CY'T9.L@#O-+TT?
MVKY7ZW=JK](C.^>I!]_BDVNUG_[[>SKZ-G2K4[GSU=6]QNOO)->[[O/5PW>"
M:Z7_^6L=Q45'?ZRC3?SU5JS.A<8?_N\(NY._V^8??;9_DFM=NZ_[_[P^:M##
MKXV#=R>'EW_"(=U-O_]%ZP>MUH>=0UX__M#\O\LZ_VB$H]1)AZP C$!J@W)Z
M,80ET=YP&Q*5VM@BFV3\[-S-^CI#6?ZHG,Y*[F&5.( BI2*E(J7UD=(L!L#<
MHWROB40A][,1A]$@7TR8PMA+Y$A.P.LM1XIS0 &3:!AA!F.8O&D_/;DOFEGP
MLTBI2*E(J4BI2&E]I?3$+N/"&.?"&,?<P4HI\(I;%"/HG&?.HT0A.0K*)"6$
M@$&R!:*,:Q#B><L5W+Z5<V**\IDKN3U5-A&+E(J4BI2*E(J4BI2*E(J4BI2*
ME!;=ZI_[X>MZL]WI5FGZ!E;03G Y.7UXW>V<[#1[@UQ]J5.]NW+U_7L03%.<
M!K,X#2:D*O41HL::(*4(1Q"M1,88C)(&1\:M- [4QM9#7 9%KQ=7K^?NS2MZ
M_5QZ/>(,9,)AH2$@RHE'@#E#-D:+I*5)?H%'EK.N+XA>_\ 5Z)N]TY:YR/T,
MWX>"TK*T7+:6:Y!CMHHQ1C:M [Y*>!#:/9/1IN2;+9NA14I%2H^:FD@DTII,
M&>ZBS%6:A5+28^X5,R$2[OC,''?;'Y_U^B>AW4\L=CN-7.Z!:;TU3;_7?F5.
MFWW3J@Y15(#WZ@;>O0O_.6OVFOWP/G2_-%UXF]Z]X]\%U_G4KN[RMVF=A<)]
M9^"^^^_':G0K%B,6(AFREA($F@:D#%9I'C)AF>642[>QI1<HVU%1^0+,14I%
M2D5*14I%2D5*14HKE<NT& R+93",9TCEPA%0%BD.#D&@&EG#"0HT&!6LE53
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MO5:3AJ\DV:94@1(LXF@!O(LF,(Z]"@$"B5[*BFQ3+ K97D"R_=?820OJ+?'
M,2(2.$H&5$36 D$$<X6#SP95G.=)BP7R(,RR/[Q\N\"S;0+?4ZO+J8GG4^21
MN#@3C0T*>^2QH0ALTF95)>>,F#M%O.# YGUJ8H&4N;"-E60;-H)4GC-CTXRV
M.NHTPZ.RCI($3,S9IV8;)8)M?@@V>LY!$2"*>4!>*XE !H\LQ3+]X& )8P+S
M?.CS19)XP:^"7TN!7]$PBI60BN:Z>-H98E1DW@HN),,A%/Q:8OP:86 4IS4J
MGU=/4@8$#E-D=/K3IX7+,.8%TZ8ZF0 K6""DX-?RX-=,B;V4,N"BX@XK,%P9
MJSEHZA4U>;^5W U@Y2S!TB#9Z%D"C8WEA+,$70PG) L<&0,4!8<#55Y(KV5U
ME@#&3YR6PH++I_8374+WU/QR+N"9_$&CYP(\MI!8)\GF5#XH*2RRTDOD*?-!
M:!>Q"/E< )_'@: %4N+"1%:3B23SGUK';%J ) B'K<^GNQUPX74D+#X;$RED
M8T:@&HGDMUK:R*1#5IB(@!&"E#06@1#>X&0G R2V 1/"6PM,+9 NKS!,S6(O
MN<B8II%1SP!KJKBGA%GKA,:4D[(]ONC@-!)[#U8[3J5!FHGJF)%&UE! E$1"
M)1$81!5[SXI+IR#44B!4Q#I&)X4B# ,SW!A-1/HO4LX!^R??4BL(-2-"C>9P
M]]8'XVB.X,&YC E%!J3/?QI!:%J'G$UV'IW7Z:!2C7,JC6R$?BV8;CMUMU<J
M<);J'D5*14I%2JLII5G.*@*5V@?AM0AIK=;:A.R\$MI2K[EG5:$<>E4HA_[X
MT.+;;B<V^W]T>KU"I6:B4H=C&_A&<BFM-8A1E9B4,0Q9[AT*06"#L0 EQ<;6
MA#0Z13T76CT+B!8I%2D5*:V/E&8@)-Z0M,@Q[#0!P& U-YXQ#4Y:;V. 0DB>
MCI",>9\Q2$V9I2@Q1HD O$<V&(I8])QCAR.U9&/KP>'013T75CV9 "*$5UY[
M#R"(Q=Z3Z 7P7'+3R**>3ZF>(ZY7RATS4C*$I64(N"/(.!R0,2("Y][2P)+!
M\. \)7/4SY4ZHSY9N_;[1Z&;7N[DM!N.0KO7_!)J/[72A/^YUFRGC\.]W+%+
M&_9W/\:V>-N114I%2D5*14I%2D5*14I%2D5*]XNC)C2G^"#!FAB!&:<=>!:H
MH=8$Z7&<PJ*\(Z"Z(MZO;O+NO8IO9V.S$?K[\<"<%Z-S)J/3C8=+JUS.)3*'
M:'0.@;0<*0D.,6\ALB150L7&%BLGLY9'?0O(+H.49@'9.;CM"L@^)<B.>/;2
M##5,1(NBL+D /0-D@D]SV!@:K.;!8;XX(/O4X92^^>59-'"G^:7I0]OW:OU.
M[55Z9.<\]>!;&'*M]M-_?T])WX9N=?1TOLJZUWC]G31HUWV^>OA.<*WT/W^M
MI+@HZ11*^JE??W4K7.>+?_,W^'__WOI 6U_L<0=_V/E\WJ!IA'9^;S:._\0?
MCG?)_L[GU/8S^W#<:M8/_CQO'.Q>[+]6E_M_?N141^<]1]Q0C=(,<,A2(A%F
MV(#0C*M\[(QN3E#RVFGHUJI#TWD:5-+\IO>5<JS'/E8)!BA2*E(J4EH?*<UB
M \P]U/>:2A1^/R-U&(WT9518&0T@@!C3#RUS;@R&(C@O28R<Y 0W5(^?ZIR>
MWQ?5+ !:I%2D5*14I%2DM+Y2>F*W<:&,<_(VC;J$(R9 K<.(1.X39[0.V<@8
M$BHJ"TP*3NT"<<8U"/2\Y0YNWTHO46L.\TO<[^S]TNY1E9W$(J4BI2*E(J4B
MI2*E(J4BI2*E(J5%-_OG?@:[WFQWNE5&OH$5M!-<SL(>7G<[)SO-WB M7^I4
M[ZZT?/\>!-04K\%,7H//XR>XG=%2$<Y1%'FGB4F#E/(<>4EMD-I[Q<S&UGA*
MF1*LNPJ*/7=_7E'L9U/L$7>@UH1@20,"0C0"*2(R(DJD ^7:1"P=C@NCV#]P
M!OIF[[1E+G(_P_>QH+0L+9>MY1HDFZTBC9%-"X&O$A^$=L]DM"F)9\M^:)%2
MD=*CIB@*.A<7UP8@:."2:T)-9,KEV+JHC)Z9Y&[[X[->_R2T^XG&;J>1RSTP
MK;>FZ??:K\QILV]:U5&*"O!>W<"[=^$_9\U>LQ_>A^Z7I@MOT[MW_+O@.I_:
MU5W^-JVS4,CO+.3W>'>L4C/VA AB! I6<00V2=8*K%$^>FI4D%3X7.D4+U#>
MHZ+T!9J+E(J4BI2*E(J4BI2*E%8JJVDQ&1;,9!CSER?+D!G.+'),6@3$!:24
MH"A*JH2@U!#L%\QF6(,0VD&NU'!RVNI<A%"KDBG43ENI'WGTOR0%""6"MFS"
M%BD5*3WR5OD<O(@C&9-<ZWR0+6EW"&_5+LG;!&[;U]BV?9(&NA2AG&UUWQMS
M"'HJE5.Y9K>3'(')B[O0%#EA0U"28T)B6MQ7JX)WT=TY9CHHNOMDNCN2"T$R
M2$:8RJG.DMJ"!X^T2G]:;72,( R19F-+%=5=&M6=07.EQ<H8+;PS&*@WEFLN
M23#,1T9XG#[RM"CLHRGL_LAB:S"%2"A##J1&Z5>%%/$:,4%5=(19',/&%B,+
M5.^YJ.U#U+;*-->;L^:R633W_; '0\UE17.GTMQZTMI;3C!C%!?*8T2,8 B"
M)4@I:I#A3H/P% AW&UL40]'=Y=+=XH\H4BI26MY]I$)?'W$1',VM'2566AC$
MM'<(A$SKGZ$882Y"4-%ZGA?!15H"R_&)TG)M6Y;)7UJN;<N5.CLD)]*MWTQB
M.2[43*_6B;7WX;0?3FSHUAA^4<ND:=;("]OI^M!%_<[IR[S>]CJMIJ_EM_@Q
M%5VTZ(C_?J1W7Q7ZK814WD0;<1!@/#.$,.$H-E)BP3%\W)LN>NO]C1H>N_\Y
MJ\XWN]99'K"WG6[NQ79_<+39V%:XZVAS8>8S,?.K1 4W=H)L-!""0XS'1,RM
M94BI*!&/AEM",-<AAV@]W+,\D[8L4<SF Z!O>6!@HC?ZGDC OE,X9^!SWC_K
M]_JFG0=OHQ8[W1/33X\[[[]LGYT@W^FCX=V*;WI6Y1_9!@:=10<480,VYS.0
M2!/LD)962.H88T)FY<<O)*P5 !2^4_C.59R+)]9:+"Q6'C!0904&SQ@E@D8-
M[JGYSC1X6,C0='@X&M*F+?,0#4&<F42&2(A(D?2;]"*Q(VV4,C3AX0LR(>%S
M0<."AJN/AC%Z&R@$'W4$J1,P<JZEEYHIYXRCQ?I;;, ;C0,TVD<0 4E-&0(E
M S(R67\2&YL6MZB$2M:?8K3 78&[58&[6:*<J0 5&"0;*?TG'6A%*14NFEPP
MU+)P-][=4<JYT,#%0\718$M)=$P4+R +GJ,D>X=4I!;Q)'+O\KJG<*:!C#PD
MU=\R0>*Z.L3NAHJ)'K%[HL681^P@Y_<\ZUY48#%TCPV?5]QA<W2'C89J4E#8
M.BH1X2:7^Z'Y2),1B#D:&4E3(N8C3?(%4^NB^(4+%2YTA6Z8FX"IU9S+9#/@
MH#%AQ$7%>62!V^_8?H_,A0K=F1'VZK=A3[&HK=(&1>5-@CUND?(*$O:!9CQ8
M0:C;V.)KPW8*Z*TVZ,V >5SI$$D@7C(!)A)E G$0J;9$R02 Q=^UX% W4IH!
M,R#1$H<$PQ8!91@I1Q4BE!IEE(^<A63:R7FEI"EX5_#NV5]ZEHP<B0E(30D5
MB@!4A4R" $ZLI)%*'@O>+3C>C9R[L-@+I2-&G!N&P$6)E"4"N<!!!;#64K&Q
M!5HL!=X-(W.O>C&<Y*H"L\E8^$.'U@W8_-9U.KGK4]RD/*\\KSSO*9[WJ$=4
MROF7TK),JM*R3(#2LK0LD[^T+"W+Y"\M2\LR^4O+TK),_M*RM"R3O[0L+<OD
M+RU+RS+Y2\O2LDS^TG+-6Y;)7UJN;<LR^4O+M6U9)G]IN;8MR^0O+=>V99G\
MI>7:MBR3O[1<VY9E\I>6:]NR3/[2<FU;ELE?6JYMRS+Y2\NU;5DF?VFYMBW+
MY"\MU[9EF?REY=JV+)._M%S;EF7REY9KV[*:_+]4F2K3_WWSR]95ML3&V4GH
M-MW@[YS LMD^,U7ZQ'^E9E?W/#'=3\TV&N0RK')V#C\9YCK;&&0%W?J7[?ZR
M=9UQL7K.C;L,LQT"3]>?=GK-_)B7W=!*S_L2?OW:]/VCJWR?-ZX:/A1_N\38
M7J=UUK_[DALY&5W(F3@WYIRUE. ?I2VEN4^$WAZ+FS^/KI- GII/ =EN,)^1
MB:FS+TWKJ[GH;?QR6P1IM&\.X.B[/_8;CI5AK]ZPL7^P6U.;M?<'^Z_^W[_W
M_]C9???^?_]+42)_K>W^^=?>P6'MIU>#617\SY-&8V3:#;*DJD P0,1"*P\&
MI-6<B$BX"]Y3I</&]+-SD%OSUF2OW4H8RP00(;SRVGL 02SVGD0O@"MLI9$?
M=ZJ$L1(3]"US[$BN6'<4_%DK[,=MY\Y.SM*,#GZ_?Q2ZKSHGI]UP%-J]-,7W
MVJYS$O[H]'H'5<[8U(7?6AWW>3E3P[;"O]]=?/C'GUH*XL-)_>+#P6]'^P>-
MS_4W'SXWWOQY_N'@Z*AQ_.GRPYLZ:_RS=WY(_V3UX]=Q?V>7?\36<R*C1[G8
M# (1-#(6:T1!:G#*:A/B1BWTG#G-"MT]"\^DPZ^.3/M3NEVS7;LAW%HG2S=-
MI!OBK;5#O_93*XGWY]0ZB[IF;J0(KO4[M5>ISYWSFKVHKDP W>[7OH9N:MBK
MQ4ZKU?F:_]^MI9O73E-_.SX_V#==?N;+*_49W.X:'JNDDVDX6N:T%UY>_?+K
MU3K0;%<O55WTZVU5R3@RDJZV@L[!U]\@9A,/8&9(GX9/'GZ]67UUM2#=^@[8
M)M'JSJ_Q)KGSN^_=EM!-BN%>M_W^=YS=_=#2V07L+,?3W?8'Y/_'1</(6-L)
MJ>('7.-I\J;K'RW/U<@<''5#J-53NZ->;;?M$W"]#Z?]<&(3>#%\*S?V0\?H
M6],[4VA/R**]V./WNM--?[9K[JS;#6UW4>MWT\U: Z9B_/%9KW^2.MT;33)^
MWT%9J\%MI.7RK)UX;RM=XVN?3+/=&ZR?(:V@:8#3>S:_5,9!&>#[#/#;S$OR
M1&W[6C*>^MW0;W9#GK U&]HA-OME#C]PB&>FA+- [GB- H?SO]\;HJ<K5_)C
M"[$:H=],R[1=Q7 [L?;[63NDA>=%+9E29.K2#,/7GGK:/',AEQ];%C-6<IGY
M_9^IF,N4+SY+R3X392"*Z0"" 05ME2>4<ATB""Z-J,JY$"P>4+)O8S5JM*1G
M7.[1^LGOK<-_&JWZ3OK\X$^^GYZ7VGU-STG7_<4:]/7Q:(V6](SC^O'AQ>')
MWT>']*^OC3>OCQH[GWGC)+W]\79ZIV3 'SB6[AOKS4&EX?I[3.O'[KS^]2,5
M'EOJ&>)@- *'+=(.""*.TN"!$4^2\0Z8/:#XWJP:\-CUJ$: >.IZ5 7)5@K)
M9@ RYRBCE#!&&0'#<QUN(2D7W IGJ.!W UG!K_GBU^4(?FD7K*%>HLB$1$ L
M1U9A@QPG404KL5)\8RO3E8<5F"H85C!L 3%L%C;F@.'HG(B.$I  AD;BC22&
M.B&$5(6-/3F:D1$TX\0KX9E'!FN%(&J*%(L8A4B9-R)1: \;6T1 86,%R=87
MR8343%HMC,( TA-%);<&"Y46?2N!%B1[<B1CHTCF#'BN!-*><906&X]LU!8)
MG1@T\](9GW@9A_'*GXN'9#-[^D8*'M]\-M$+#D#[$QRAM_?%;8B=;JAU@VN9
M7J\9\P9W$MS=/F@ZVU!-!.KE!BSE6"!61QXQ@^B\20:EET1)IK1FC%1A*N0J
M3(5,*G!\!W)]+U#EMTI0[T;E-/CXP)P7C)L%XR[&?&>1<:D-%XBJZ!%P&9#1
M#A!GS@7B C72)MN3/@#BOH,DSU2M?<6U>@:EUMB#T-8(H@D01XT+,DJ0EGBA
M,,=3*'71Y>?2Y5$_$C:8)2.+(2JSY64=0X9'FPPQ;*RD&(N@-[;&[:[[U2DO
M^KR ^FRL$%Y$S@C3 %XKZP--B[3QD'Y8^L3ZG'XY,?W4K_/^R]@\#QY=AFZG
MZ/EL>C[J80'+7;(<!;(NZ[DV$6D&&H7$R#C7'.N8]+R*@J:_%FU?,FV?A9-'
MKT00@1EB 9)IJD&2H, YYIGR7!=.O@SZ/>IWT$EZB85Q1'SZ 3909(DUB'-G
M<*;EV)"-+:(6@Y//*89H.3P+VR?I3?J]&XZ#X&NQVSF9/3;_7JZ&"6.W)+#V
MM)Z&VV V"E6OD\"F."CSJ@JZ[;^MSD$45C-/U&N\&O-$L+2*!6<YXMHS!&GU
M0HI[@Y037A&6M_SFQVJ^@T'/M$>TXNH_"ZN9NU-BSOI?]'P6/1_U4M!HDB7*
M *G $[MA@)$5P)$#KB/F7)$H-K;F$*M7E'L!U_8Y."CNL%B*DC^CDH^Z*!SW
MVH".*%@P"#012*F D>9"!.]5E-)L;(WO*I1E?+$U_8F=$T7#%T;#1YT4@20U
MID0A;JE.=#TJI#V52<,=.,.="3(MX^,QJ\^RC*]5],-@UM?ZYOSZE-U/X?PT
MJ408&_SB2WT\K\/W\V\4 )H)@-Z/G_JQ05%)/?*,)#M"LX"4CPP1;0@HD@BE
M= \#H++UL;AVQ),&+A2OW]RT>-0;$') N)(66<$E BD(LHDV(ANBLLQJ =Z4
MO<QE5>B9#MH^9>A"67]GUMQ1$S\XII,MIU&B2) ,@!R%8!A/]D $)8C03-FR
M_JZLNL[=NB_J.E=U'3O,H")5E&(4$I@B8-$CFP-]";=<41TIIW&21VZ98PH6
MVDS/V8<&:9WZPU1[$^,&YA8S\+!#9LL-5L]S=B%)>#\6Z)H1NL;S>S"2L LS
M@DR(#H&($FF<#'\:O?$D4<- ?(*N-4KOL<YZOZA.@J+M]]/V48] %#8( QIQ
M+$,^/YZS^7B#C$W6!3#BI&&3[(K53H91-'[QG A%X^^G\:.>!&:P!2H5(@I'
M!(F4(>6T0%):ZK,C08(O&K].&K_X9R"*[M]/]T?=$BPPQ62@2?>%0>"#1!8[
MA9@D.%CIN0$\,??5XG'[.049+(C38IIDJC=3><^8477X[G<*9:73WLSV\JL#
MU0X\#P)R\M0(GFHC)#,^RF Y)(.>#'/>3(_0)>?-P_!X/!\$)-%XYS!*F*P0
M,);S01"*.-<B!J-LM'QC"^A#<M[,-/V?><?GWB^Q[ABV9# V XI9BG50S("2
M%ABV)CH"UE =&0D^P-TH5L!KON UE@!#FD",#(AJ2I,A23RR3EDD'+$2A+&"
MNHG);.X71[(PEF3!L()A,U(QPJ,4X'W(\=J4V+RN:_#:4*6$)[Q0L2='LU&W
MF%=4.NDQTIBX1,6"0#I9PRA@322WTC+0.9'J0_:]"I(5)%MR)#/&>4*#Y)3%
MM.1S&Z2)%H,G2@$84Y#LR9%LU,D7G:5<4XXP\(1D( 12CC)D; [^Y0QSEA.I
M"KD$2#;T\EUUY&K:0H53\W;]3W&/&R],'U02ZUDZ67KX6#U</V_TS=)>]"%1
MBRM*#E9T_1<A> 8"2ZTM& S6D!"8(M@'S[$<K/^T)%)_JO5_?_RH'@=G9("
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M#4<;*'L<4+9.I=/ $.,9[D6^QXPV2:@I#2,=P;8S#AA?CF0-@-TW@,W8E7X
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M&*I^X^KN S#8Q\/;K8 &I9&B<3[(4">":$L])D'),[WQ./A>4@([.DAW3$K
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M 5<"!-/'2CXT<$6DN4M)$!ON@TKTQ:SMO2,&L<G0WD!^M*YME%>8&PQ26)%
MN<]ZU@T,;(I.C]*] ?Q75_J7P",CY\>L@33>_M5N$C2LB^=S1MX:I*HF6KL^
M; XL&L:\7^CG]0\O:A]^VK,O;F]Z,3TZ[O5G\J*M6Z3\>NP&:'FE*Z *JU1/
MKKYNV:]F4KG+[R*_%7K1TJ^]%EGZW4W#$M(B\?*O;QKVYN\"_VZCWCI9?]5A
M=R<2M#S$=FL"=S)WZ8*#.Z53;JNJ9IQ=P);0.2X-CB/4A4LK>FX+J1?FRM]Z
MAF++UR'YW?=^7U2FY*ZO_3C)1QZ<>YOX_@Y=N7;=(V'PWRVM>[2L3Q,(HRY*
MFVWE4VC5BS[:@ZAKO_]V'T1=(W3N$ZT$4RK"0I0)-;'R$JXEU@KQ=2"3M2M1
MSKN*:I;$G>:3;3F3>L=-9GDF]?+SQ7'W#<SK/3Q77;9__/WC\]D'=OSZ77#\
MX^+RY*SS]?CRHGO<_:<S>R85QKG^]/'HQ^>W_URVZ;'??MWNM,_.KXXOO_XX
M>7L<G'S\^_KD[2?8R/YCZE(AQZ<>/;Z4WX^OOJA ),(7OAO'AKC,8.J$1Q5L
M4WWN<P(KASTPYP^DKEDK9%UY>.@#]C- O/(!^P;7'BNN24H39D).C!\P38P(
M_$ )JN(D5F$<>+<DAC6X]K"X]F,&UXBA-$ZT[T:2,I<1IMPX#(3K"1;[AD>!
MXL&3EVRW<6WG+.*[&KZ;B.A:@#BJPYVY'@SSGE-'^7E1Z$%1L\F]SBQL!2M,
M;4&F%W*?Z[<6>"@%+S0.\.2E\Y0\FTE'FEU@NG"U]K!^\B^P5&OV>6^YY\0&
M.0\MZS3XO@:^MU_-V:W<*([9?"Y6Y'096+&([\IE4GM:J3 21#UY.5_C;EDA
ME8<#Z37*G.^YP/T"$ZH1N/L2N%F#2G*%18N9*R//N(S'U.6 E*[0/$G\, ZI
MH(L,JE\O<#MG%6W?A'?EROTJ/+\880^[&4SF!Z\3:8:]7,OLO =#*"<=Z&ZQ
M-"CQZ%MXWH.)MZ0ZWKSJF5RG$_.6I[WB3WOFK=$\ZVB>=,[4\[7/5"QBUU"M
M7>;'RDU$%+B$&64B(1BCWG9U\[PC&C6M>!_0<FSD^%?+\:P%F21$JBA,W) J
M[*P <LQU(ET:A]H$C 5!L!-RO =FT YV#S[+!KQSQ\Y'5>[>?,'+I7[;O0[B
MW"]Q]D;)_ )_8%M71[E3.9$MW2B6=13+? S;HX'P?!:Y 0N(RX@R;HP]5)-8
M:.(K276B[R'6<Z]BL^$>BPUP-L"Y3=9Y YR_ CAG+7(>&&W"P'<EQ3,JRE.N
M8$'HXE%-S:1*?/3I_K1%OL7 N:6V?%TSZEX%/U[I@,]3\LR>8RLOP@/ 0%9^
MKB?*-HW. .?5X<"%P7%G6)0%FO \T-">[K.EFE*46>=:\QS/J_DW'!!*B^65
MFWI#//HV:\'=Y43;&(C\%9P#13'L]NW!Q _P>J]X1^+Q0WBYQ0A5QZ/^!.+A
MZ=8Z+C43DW+I;@+8W<^S7G[UOR0L4,0WRDU@P5P61=KE<4Q=%42*A9X/MAO"
M3VN^U>)O"^KC3%:GV(US=#]U-.Y"\\[@PI%XUM6>C[-%&_ZU5JDS$24&6X\'
MAG%.$DF\T/!(<!%3C\M&;=\[U_\XOX;=2I+$-/)<+\$3^40+%U8W<#T>,ZJB
MD :<K[=O_3G4:];Q;NMH6!@SGS(W\B/J,AC"30@+7,U4[(4R3FBLGKST5J@V
MAM(.^'11'BBW)^:J(_K:GAY?<M+;'IU'R9PO?[+EX/=ZF-?FP!U>=ZJLBM/E
M2J\%>PID3T91%+,D82H4B<\B%E")R">-"NY!7%[!\_)4V H)Q1_7U6G__-'*
M2_OUUZLO2B4A_!>[VA:O\I+ Y9K&KB2"&!V&/$S"19L-N^YK+7 0F(A2IBF)
M62A]+@U5OO \!?I.B^@>]%JSP',+['\)XM#7,F:NXERXC+$(*QYHE_K<4Y1R
MRHVW*"6OW"-,$!2+;V"1IU&IK245 0ZP$$F_KFW5<G8-!D]U_BV5NC3Y1E43
MZLHB2ZW# R<U6!CK #=(N3:=<C,&5*R+;DU=#F3"(F'C@I15;8:R1._$W;;^
MGO.TI/ SN\OK%5C-2P]6*4>YO.+AZC49 _ID&Y?OA@*)Q'OP"HF@Z;II65?Y
ML*=>6;J?ZYY,]?;5123'=>77R_<7GWX<DS:@RV=\QN7?P<G'_US G\ZGLT_T
MF'X*3LYPK#<7L\C3?OL&GO/!;U^^Z;3?'E%LL?BI>Q1@V\7VY:<?GR^_!CCO
MXX]O 'GD=?OO+Q'6&22><@G%6DA&QBXW)G&-\K6*8TDUC68K(P8F]'3().R!
M#).Q3 +.J(Z\")8%C(.YRH@G9_\^>N^\.FF?O8-9M5^].SIU#MNOG;<?#M\?
MML^.CNY2)?'V2<R4<PQ4HDD2>,83+*%<>'"=%QD#-P2^WK8B,HLE9XJ'=PVU
M)TM" @"GO6]9YUOEZ:J*4NG>MS3/>BBRO ,6ZF"@<X#AU%92MW6<0&^!HM,.
MKXM<#9QO'+!^6#@@Q)8_JK*0X^J3> A%HH]4.9V4B[23#E(LN8.!<1QT'1M)
MFP2,(0K2$A/&)$^B&+@P("*BAD:!6=XM=AJ;#K%,(^^\R?*CR7?&A)FI1=X6
MR^B7X]/QV5<?],3U\>NO/XY??PH )[XD(0V#6#'7$ &&DN?%KI 1<:6.N)(1
MY4Q+L(3GW5YKF\+&2XR1$2RR[S&?!YPG)(0_A@8! WNX6N:P6>:?768PA+\$
M*@S]@$9NZ)'095Q+6%=E7.T+%<:,1"K@L*[Q@G6]J:*;776L_#K]\;3U>V"]
M"&@U%Q>V_!V8B.?GN3Y'%WW9$L$V9%!IJ7RL9>C8LV-5,4];VKS"JMVSI4]Z
M]>2QGFTJ+["H(!9QQ^+L0)FU-I!)9$(I? H6&_--& <BEHQ1*0)/<ZH:<+PO
MJ?GQX?H+"[ :K(<"PPB@H> N#TS@$DFXIMKS2>"7-=]_%@TIC61(M=:28F^/
M0&@9*>X)CX5&R<!OT/"AE-[EIR^2"L%B'KF1;T#I*6'<6%/IQA%C!NP/Q9F!
M99[/TJGWPW/&S_6]P&8)@=;G,&VVE0@YVP$"-L_UA&:#,UA&%#;0&6S:^<BJ
MXTZ1#G1IU)5&XF$'F$EQN!W0"2;P"LN(9WDOY2WG7<]I9]_LRV"I[?  ARA?
M_K]#+,)C@ZU5Q=/"OF'=EP)GFA8#CI6UX:K9=^EAL6XL-C[M/2V& O:6-LSK
MO-&\2"O*G@Z&ZAJNA,?K;[PSM).O+=2L#(!:7 7@YN>U,]>^*DXJK7L&H?^F
M:^D[6L52XUCJMIPWHU*29IA;_X."+>VP*.P#1N\V\<Y 0:!,-/T:(][@"  X
M1 7]8UZQ)='MDM9SLFI/:)PL5HA5#E >:U_?M)W78>QY$64*]EI@4,F8 ?_Z
M26)\15F@^ W;>2Q[_'ZL@6\H<'P%[U+HWJ,#C4_>R=D[VO[QMW?R^@,Y_OL+
MC6G$=2)<[A.!AWR)*T =NTGBA9)2H6,,L?B>B]D$<V6.2^?9@2-L'7,\/#66
MW9J%JZKS<ZQO17$$+%78@4^7O<=,AW%I^L)*##+_4DX><_%R(3S-TH[S#^\#
MM[[K#?*AK=W^7L/O@\I*FQJF-'6P,P%6-"[G5L(,QT+%H(G&=\W"9\OY>)%V
M]-14A.ZD^AN(*UJ2%A@'TS(\;T.6?D1> !5$1Q],%TN>O!PQK'+CEG?AE*_U
MP#$I$- >9T/RS<@[2')'U?=.S16]Q%AAVOJ%)Q]4;ZIM?P2;MP*K47(#5K>W
M9>LG5JZZO"9F^< *P2; 8@I7RE?'TWA]G(<M/?W=7MBY_J6V)J+*,8='#[M'
MW_O6%?AA8J+;%*;= *)\H">'7[@(@;;<<VFB Y?YDKLBBK!8>N1)/Y1!B"6N
M%FW+2H70FV""1C=LAVXX_ )KFO@);+9CQF!5C5!N+#C6P5=@:?J,^":Z73<
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M\^;L/(\:Q8VG2"@#1BGL^4D<:^U[,H!-#I\KMK$#F( JLU1[Z!3.KIS*6;\
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M?OO,L:TP\7;0Z_B*#YP_T\% YYOV..X]VGL!%9Z1,?$59Y1$<12BL1 *$[*
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M>=>KS#LLD6"3,PKMZ&]9YQN^*1 4=C>]<S3]LMYYAI]M$J6'O:KPPJ#.E=+
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ML"?+&/X85Y8T5R^&HDA5RFU9=$"ST<1;MNXXO"'\BDA_#BA;)^X4V-+ =F$
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M%@;R"F&@P/\S]3E])E;(,.* <AR!F.=%826^W(F"('K@S"CQTJ=]'(^_$$M
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M'OB8.;P51P)L!3UWD(\_-;^"=*;#<CQPE+%\'O6"7X[%3<DBPLA-#7&LV8Z
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M\@7>\Q*?++_W%M][Q+)Z552H%7YY>6>Y61M[9[E9:W1GN5EK=&>Y66MTYW1
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MZX'/HS1V%EH&AX8&L\Z^9CVPH+S\#WZBL#5H 4F+XR=W^%Q""S#(<8_R_L-
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M2WOOQKYNH8A&7UC5!RRPG$_3'I.6#2W6I>,Z(+Z(F0<,DD:,P30WOO?50R*
M>KHC&%B>/B0T)=.V,6,";E I=O/..0C=PB</XL+5#3X-_A^@P(=^YU'.8< '
MYQ F7LU89GIMA,J3E \ OL7,8Y)?:.[E#5,WR/@;TR!CB-%)Q*[0R@8Y3EJ4
M & L(?9+AZ'JG/<A6(%LUJ'W +V-%U9>X@H$76$5T)"4T=W,]VAX,SXV[9@5
MSG$1JE%+U$0?,0?+.T3#:TTXU[0(SF<9I4T[^O*WR:^=RCR-!&C25H\2GT5
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M(UJQ%[A^7PM>.I*!DX9X_7&FE+>='A$6,8%[I,_8.XF)-.,N7'&A>VQYY:Q
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M,I/^XB[.@8H7MK)F]1Y=@NFS*LIV8W>VE?-+*VJ/Z)_>L!_\Q_\'4$L#!!0
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M7E!\-)V)M9^7^]&L0Q+^E23DNV!)I<FO1H9CF,Z-\A'*-Y AI,QB(I;AZ$A
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M68G>@POTSJGL++U]B=Q$X:.3EF2Q7G)KVV5?A71'8WZ;Z,>-,;\=2>A=>;Z
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MW_\:3Y;XIF>-=0*Y]Y'.RJSJX/>*QAF$P**E$U.9$M>*H]\Z[_?RDQ^ ]=!
MI(TGX=>VNS?E J9E9^L:H!K.Q5\)9/]3\G=E:-Q+O(V'L*\&%U#'%.M%;CY+
M4-J0@VU3HJ^4"KI8Y52+4?I[YOR&P?I[H7P3J38NLOE7&))+/'M'OX'3%Z.T
M.%GHL39E'FM&QM>:(@4Q,OK6)!_(F_52K=,8<OVG[W=(>R.QCYO*;!_MQ!?K
M!J[D85^,RGAR<G:Q4J.ZBG6>T;C48N-E7:J^L*JV_&O#4=";JV(T@L7$M.#T
M/Y\N5U^L\[@=QQ*>?>[9@P:C#]\]X#P=9Z342@AR+J3E]3XTTMQZ(Y9Q/AD3
MA,72NO9Z'5R=0YQ'7]+P=-Y54>?L3C&_#U^.<Q))%XZ0YDW\/&0(T7 (A9$0
M,K)RN6NQ=\#S.IC[]TF:Z]&&(="=R>H0$#V;_E"+[):H!Z-3@OB&C/ZY9*9/
MD*2$9[]'@'%Z](561L\?C,+DZUQHK\GJK^L=#X=SL9Z-HS\6T68>Z CA/F:R
M"IP#SQ@"<LT28TF;YN/=.R[G >KK72&_2VIH.IN<IMEI[3=]/,IO<1@6K<BT
MFM/)9-&6;(N4WC$/VN<Z., '<%I;0IWI?8RN7.GP;K!7K@7M >I;#U+VD13X
MOC K%\>E51&<D *4T)+6;ST8';-./&(HK17F;E7#==>29N+O, G^?#S>#6)X
M\G7QEV?!+\XR&E%J=SOA5CS5"['('8J%2QZ3JDW2K2W3S6'NJZ*NN_KTINC0
MA7?5@7]:+P$>#O)\+7.1G=T)S9@P123(NG;L)G+AG> .F&*H:2\-P:Q5Z7!+
M*.KZIQ]^8F4GOL=-Y=XX+GD5T?+>]S4P-0Q)K\*Q_XAT"XYNI'P' >^+_*@<
MF=@V \N>]-NY!'5>''C#2\KTMYF+>T?Z#2'I?7&^B5Q[#+T^\\M&'Y9](\OV
M1)=UG:X$7/@Z3H<.SJAI3S.9)93::=-\[OD**/N-8[?AZ?+@Z@9"[E*Y-J%C
MC=PE\K<7R):=BM4A"EF#+UY7+2=/F_L$1O+,9;(IY=8#;%>">0#\MQ%TA[?_
MW8Q S>>HGT[)4IY.EPIZ5FL3@F",6=),13ZST0J"LAIL"3%H::+2K;7@1D /
MW1QLSTJ'2,8"R[*@;@TPG0H:+P Y3 EC0Z(NJ\#.4NZQ6UP I0/33 O:NGCQ
MM5DMT%<&P672;5XB\ZIUN\0>*+^E-'%?C&\BW,:U"O_$,)Q]?#S*_\+AL"YQ
M>9-&3$%[80"UJ#?>LUIF3V9++&A2]!%YO#22^=IBA14??["@XS8"'[>55N/Q
M'O\<GT[QXWB8%U ,T]K5M(E-U@$MQT.P*M09;.AU(@,TK#/*X]+'WEO"=I!.
MXS?MY:#@=/9UN)R4GQQ:%HP"8PPC$S-Z<$61@YFRX-5Z\&Z=,3N7/O:^$K6+
M=!I/^YUG($=S,R\,%W!D\$FAHVT^!-(6(QP$1[N^S:G:>,D);M<@ZYJ/OJ^$
M[2JE#KF56UL9E3,L%-J<M:\#O;@JM$T'A)I/YIPY&6-[1_=N=I+OV\MIRLU>
M=.=29^,Z^'ZVF6_-Z*:-P]O0<8@V<RDD^0.R7EQO:$O,2A%.XZ$49:QU3J+O
M/[SB/K29=]6635AH?JG4RI*5Z3>8B_,S.RY#2!$<<D-GL;+@#-)^;CP/PC+!
M>%[#RMC@D7>@KVLGKL;]!;WG)G*CM4[*"? $!I2."D)Q!ER=1<A,*L[_ $WD
M=\ \V8J1#K<0W-0(N0ZTGQWF&U*X01_Q-O+?=X>YK>E%VN"8C194;:/Q407(
MSJ*PM*=ROU8F_RZKQ@X=YKTT8Q.Q=]"(WR?C3&?AJB9G6ILR#@VD'.F,#36S
M*<AESUZS)+W(F>O&2G$SHCM@AVQ+WN7K3-M)?O\-;:]Q]BX,<7I>,#MM-A]X
M]4>WGA2\YB(N=:T%@X$'B]$HI:)Q(1@5@Q/6:@Q)L,LS@U<_90_-:C8*&S6I
MI/.^;EM,DH:B@Y)$Y+$$'U/K:V;VT:QV8^5V2HD7>CU ETCVG>*!-FW'(+-L
M+<?"R6G\63B_B69L5#B_B?@[^$S;> 1".<LD!L!2ZBT.GB!;HR 78512QF-S
M7^J^%\[OHCZ]*3ITX?SZL2PMB[#5?IC'LHR5$'E@4 (J(<@7Y3_,Q-KN.K%Q
MGF$#;@X1,%X'W\\\P]:,;IQGV(*.0ZA-<MF$ZJ-@UN171)\@2L$ 32'/PO'J
MMSP(==DYS]!36S9AX6#C;(/40;FD@:&0M+W* #$6 =G*0$ =_:>UJMS7<;8;
M\;G5.-M-R-AS)B(&);7,'$HT"$JP#,&+2/8@U]99+U-H[6,^D$Q$8P-F*T;V
M/.MV'6@_,Q$;4KA!O'D;^>\[$\&=\:5(L$P44-;6U)Q)8)A1(=-)C++U@*7[
ME(GHI1F;B'W_F8CBE8R6T#$A.2B,%CPB(YN,<8T8LDFM2_+N529B$_(VRT1L
M(OD>\;P;>RNX-<X+D4"E.J5#Z0(^> =:"L]Y,=*KYB,O'DHSVB[61SM6>LQ.
MN5"XO Z8'[49;2.B;FQ-VD;*W9O19/926O+(?+&$S*D",:.%S WME=[DW'X@
MSAUO1FO'^";"W5,SFA1:IR0E%.Y$O<M004B!@TB!,<F#B>K2!9+WJ1EM(X&O
MT8RVB;0Z-Z,%%K7/40&9$W6&'RW-D=$"Q3N1?'!"Y;6Z".]6,]K6A.T@G<[-
M:"&F;(5.4$HB.]/1]N%"0! \(I.BE'QY!OE]:$;;EJA=I+.'9C3%M,-8&# 7
M(EGN!6N;E01C D$+4JK+ET+<EV:T;0G;54H]C-73.+UP0#.N"@8!6M7KX+5D
MX#-/X)F,Q3(;M0ZM;9:+$'X8'V8'R7>HW_X.SM*F7@-0+\_E,I@#>2^[4+2:
M[AWDV\-GN0(LUQ%0BK:D[ T'19L=:;7B$#7R@+8P7=:ZS>?N$7Z;[]*5[TW$
MVMB.>CK$,**=;-FUSK*.UF8PKGIA.DJ(,0GP+C"EG/<YE35.YHN?>H!#>3<1
MCYO(I[%K\OMD3$;==&XA+"*C2X?)%BZR\04$:@7*)P>AUKPY0TOF,24GUFF[
M6_V$^\Q@([DU?N_^<S +)X/1]-5@A),PG)(7_.[TTZ>S0K_I-[,]N\!Y';(F
M'*@ZSLT[5R#Q;)B6@BSW=4:AK/.L^\QP<UDV=H&>A _3?TW"IPJL5E*$BG.)
M*P:-P=/1(4-VM9^BU(LO KD-43.MZ&C1; V.;WK&?>:VF>P:>D@5UV^3P?RV
MAV4NJE:62ROK\R6H2(9_$,R XIA*%"G%RR5)U[)X\5/O,V\[R*>A"S,_P</L
MY6 V.R]8,ES*VI1=HB4 SM;%, L\,,%<SDGH=6XQN_2Q]YFK721TE2R]"UG/
MQ^-\Z9#.#&UVCH,T,H%2B!!#)G ILIAB=.7R (IK^;KZR?>9LAWE=)4ULPMK
MK\/LE [>WVEGKE;6TS!9!AZ-$=HSH\%QVIP5>4T0;(I@<I"$UQB[UHRPE0^X
MSQRVD=I5*NUN5S_2/O!\,%R46RPS,CSJ&+,$&^MXP*(21*X,"(Y1%U>;#<T:
M-%[[X?>9PMVE=94^=V.+[.+']8\8IO@?__;_ U!+ P04    " "BA6%5VX;%
M@^8W  ":.@  $P   &-L>"TR,#(R,#DS,%]G,2YJ<&>]NG=4$^'7/SCT)KT7
MB0I*$Q"ITB(B341 J2)$1:2)B%0E) ("2A$! 44%% %I1J0) J&# B*]EP2E
MEX02!M)^PW?WW?>/??><W3UG]X')F0,S\]Q[GWL_]_-Y)O0Q^AS =\G4PA1@
M8&  7D(_ !T'Z)J$>=\% "LK0!$  ': R98/8(#.& X_;/D!YL-SX/!<X+_/
M#P=]$C &&!D8#G__]\'$PG0X6)F9F5C86-G8#@]V#BX.=G9.=C8V3FY.3JXC
MT&#CX.'E/L)S>'[XD,/;#^^"?H^PL[$?^7\\Z$T /SM@P?B B>$$P,C/P,3/
M0&\#8)"M+ S_&?]E,@,C$S,+*V02)Q=T014?9#X3$R-D+ LSY!I#!/1_@)F?
M1>"XFA&KH.TMMA,!0F<C4SZPRUPH;Q:^VD^05;_],(J#4T143%SBY"DY>05%
M#4TM;9USNL8734S-S"TN7;.S=W!T<K[N?L?CKJ>7MT]@4'!(:-BCQ]%/8V+C
MGCV/3TU[E9Z1^?I-UL>\3_D%A9^+BK]55%95UWROK6MI;6OOZ.SZ^6M@<&AX
M9'1L? *'G__[;V%Q:7F%N+6]LTO: _</#OUB )@8_FO\CW[Q0WXQ0FO S';H
M%P-CZ.$%_,PLQ]58!8QLV6X%")XX&\DN="'E0WDSAXSZ58+P[8?]G"*R&KB3
MQ$/7_N/9_SW'HOY?>?9_./;??DT 1Y@8H,5CX@?@ )7R>4/%O>KYW_01G?FK
M&VO-]N?_IH8S7,DR$KA_E[/DI^P< X*--IY31>UKCW!;;74[6A>&5/)9./<O
M$5?ER99J32&RY=)4"A,9=J2T6[^_FQ=>D_<6+LT?4-KU_[BZ]-8P\/GW3.ZT
M6Q$-?G=V$A__I#T/CC"XE^P +M,!EJ,#^B=#M=[/33K5&X7S*^X-JKG(PM?F
M%])6SC0N?-67(5]=@8F7B6.K[I_>Y _4?/KPD0M;\7K'O[T5/7RC:5&IZN(
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MEI1/R+LR6$9I$'V'[0[]6Z6%,V1O6Q2P+W83TNTNV4I&NV:^_8/'>O2-82W
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M9WD-Z5K"CM3.O?&A=7QZNMQ8-[M/Z(2W(_7S"%8%0NV%V7WKQ34(>]Q01^G
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M<<*BMZK]BXKRRW<YBL&<A3I&J=8[MZ"0Z&,%(:C+1Q.NJ8)*J,@ PCP.V]2
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MV(5H]Y+]P>&VWB,Z\)(+_1V=CC8.0#^#C[W15[<WG@A4C<L:F<0H-5)30#K
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MM[+XEG-9WFIY,T6EXH&24.& 0)RF":2,8HAD+"(6J!!%Q(6O3HN:&C\93<U
M>BJ6XIFO2E!J)=U8J0-7.Q;R@]; K+,&JE(3T(4 :T7!;1=DSA1S'@U/E-(A
M:%0*.6_P/F58O-'70Z3(O]%5_DU^S!?RPTH^EK,P%BPC7,*(FMCR6 604A'
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MO7*M[!6@6[.!:-E=/4=;!COZ"_GJ9CON>HW.&YCN6B:!MDU78&-5U4=MNZ[
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MV[E\FDOSP_5"7#^:LZ#_JJ=$&@2"HR"#1"448IE%D- PA;&F#<0"@47B5.[
M1NCT:&2K<W7O2%O*NO*(!>:V?.(7R<%Y9:ON%=@H7.%Y;8-G#XZQ!\@;UUB(
M')ES[$$XY!Z'=R^[V&T2,:<ICJDD$LK$G!'++(4DBR-(,T:51 BQ+.ESM3O-
MG-:M2\U>R:SWP+,\)NH-R="'0_9H]+[D'21A]5[CKW+1VYVB^L13/9/2KU,<
MR6^RH%K+M8L=X6F*: BS@*40AY+"C"81#"@)4Q$G2919N=B=D3.U0;Q6$_;P
MI#L'J=V(]@#4P$-[FU5NK>( E7O/P. K._T)*>/FI^\V]2!#_9G'>X9EK;-?
M?E;K&KOE-=-[%,I7,TY8H@CA, A) '$:!Y PS0@B90)% 0IPX%1#L4O8U!AA
M6^%KJ;:5K$N]AVX4=ISF.X&VHPA?\ W,$Q<@YQ[E9 &)KU"F+E'CQBM9&'T0
ME&3S3E^_L6LA]!>HK&1\+JK<V-J0F42QS' J("7F]EB:3/L24Q@31,* JDP(
MJ]#-<X*F1AV-(U2C[%5=+-!D]UPK[.HY=@+?;M;PB=K0*XO>@/7P'>M&XP+?
ML1,-C^P[UFW>H>_8F>?=KY)U$THWF"\7=*Y_%L]\M;ZGBT.". TE#&6$(0YD
M#&F"8_TKU<N)D"%!K>-W3HN9&AVT-05K5>TO/SOP["8 ?R@-?69P#* >U\0=
M2-G?$/M!;*3+X9[(.=WYG@>DX[JWX^71;GK/&]"^Y+5X^L( [0^+I^=5^5%O
MX^9H_?54+(P238Q)&L<0$U,3%BMI"E.3E$M),<YZA60?RIH:.[9K@=;:7H%*
M7X!Z!E\?P==N?^4)M8'9L@.P <YC+##Q'41]1-+KA$V?-OEDH'3'*[U3 CXN
M156:<%%MUIIO=(!2%F$A89Q) G&29)"&(H21B&,B1$(BY'2C>T+.U-ABHR9X
MTDT^T%("L75UX(WNC@>WIS".1<02*1&4L4 0<Q5!1O5/B8R3+$L502J<?9,%
M6XZ(<EO>J#BOJU1X!MF.FCT -S M;Q%;JS@ &Y^!P5_6Q*-2QLZ8V&7JD6R)
MG8]?FK3LKS*_?UA)<6T.W^]E70?FLZK+@51IG+;)710*C#^TA 1E>@VG-&\0
MQDT0A6*14!A3NWC)B[28&G.W,V2MS0"-'6!;5J<V!7S6L^B*+L0Z1\#U8I6+
M?/Y<T;Q+^:++>M+R7'[H_AGZP-ZI:\9)6M8#2>\IRUQT>*6$93U@.IVNK$]C
MPU5)^5+5T=*?%U(O/][)^M_-E1E10BD2<BAD)C3)Q@0R(27D,HRB*(DUK$X>
MT9>K-#7&/5O7HUU;Y4_^BWR<Z4 [;AVW6P8F6J<"(8/<E_J#<\1*(F<4FER=
M$3L ^U0AL6SYT@"4BNOU]I>$6* 4TB@.(99I"#/.&%2<1C+,9(Q3)^^/O?:G
M1I>MD(EZB=,[N*2&SX[?+@!E8+)RP.."P)$=J[W'BM2MOU)XR(YIIR-"=A_K
M65Z(\^?'Y\ISL8M&ZB]F%@<\"A(.:6QR_B<\@ PS @67L7'.CI,8N8QK%^%3
M&_0MW<'9V;D?+SCUC1UI#(7XP(SB%VSWJD8]4/-5Z,A%]+BUCWJ <E .J4\;
M/:]#:/EPO1#FGYN_/VL&G9OHYBI^,Y"812DQI4P":4)D8TAQ@&%(8AJD2< 5
M=[I#/2UJ:B16^5B:4[+JAY:RO8)D.R"V/*OW MS0Q_5],7,_LS\+AZ]C^]."
MQCVY/VOPP>']^3?<_=#N"BJDR5UJ=D^S4"98! &%@IG4T<J$H_&4ZQT-X33E
M<1Q)JT*O!RU/C0RVRE7'._;>4[MX=0_UBU 8>&1[ L#>8ZPW$",YB;VE1?%2
M7:0\+I\7*_##LLCO\T554L]D7*[3A)C*F\L"Z(G[6[Y\+N<OH)!\>;_(_TON
MADI7K)D_/M&\,,K_"&A9G2$^2,#HO H+*A^D7 %AG'A-F^9/A3E:UK*X'M^%
M;G'U4"R?[Q^TD/O<G%Y4+>MF*%BMX32U:^YIO@"56LN5Y"L@O_/Y<[58?"YE
M_3S3OR]D60*#P14H7Q[9<F[>J6M+"VT/KYR)R]7+O%:(FO;^LZZ?DR^$5/DB
MKQV.FY^>JG,6TSZ3"_WGE:?\*4>_*AWN<[O/C^8Q=U3-MI/<\0?Z+>G>T#(O
M/ZLO^BN_'@MZ+KC-]5=/Y9PN5GIY:;ZW^AM<51W(9;F]H*-AB#F*$41("(BY
MI) EG$/%DBS,0H83Z11J?(DR4YL);G_]Y9?KK_\!/K\'MQ]^_O3A_8>WUY_N
MP/7;MY]__73WX=//X,OGCQ_>?KBY=5L@7M1A=DO(L;IAX*FH,L.P2-N0BC];
MIH"M+6!MC-[\#G&]Z@-63XO5BU09=3GK [3]!:^7-B^NP[?2K;UY>3NGZ],G
M%H5"(40@0XQ '"D,&<$,,A%G2HB8D< I)W^'K,F19;N FU'6U&FKU.UWZM<%
MLQT'>@)O8(J[ +=+2MJ=0L1_V;H#2:]5FNZ4R1WEYTZ^TH\Z]%K/;-&K&#$A
MQ9N77TLI/BP^Z]5R56SRFJ_R;_E*D]4L#06F>L<-&<L8Q"+63)(P"6.F9$*"
MD'*,7:J5VXMV(I81BI>;"WU>I1-N=#<#9%GKO;1-(-JC!^Q(9AA<!^8< VEU
M;/>E!>D/1G.]F_L1;)0'6^W]D9 [8IXXR4'PJ!3E#L@^8_5HH6^DNKF-*)Z6
M]>"K8E[?FG56\?)V*>0LXS'+:*2@WC92B ,D]=)'KX325!(9L@P)[ABPWBEO
M:FN@)@Q[1^=6,':C.3"JNT:P=^/>S54#H#DP0?D LD=DNQ4\%P2X=[<_<IR[
ME;&'X>YVK_7T:ET3UD?CE?4QIRR?;ZNSS% 29YSS$.H%4 0Q2BG,0B9@3 @3
M/ Q#A9PN*+O%38U<UF6!EIO9>6[4!O-&[ZY)N@_:=NL??Q@.3"G;14VEZ178
MZ'JUKKCDT4O4"A5?'J#=PL;U[K0R_,!ST^ZM2[TRZZ(O,TD3Q"(::@:)#8W@
M$%)%(J@0C^(P0"K(9#^WS%K U(CCND?9I0/0[-C@$B@&'O\M;\Q*MR%\,7>-
M]NZ,V33_2MZ8N\:==L?<>Z[?H/VXG=0V\0XQ)@$- @0EP7IS@5,)B2 ""I6J
M#)%8)FZ5TX[(F-K0_=AW;C^&G]T0OA"5@4=Q2[M!PCLZK/<TG(])&'5$=YBX
M/ZB['KWHKGKO=N:E_N_VDE.D/)4R4U"D$8>84PY9)%*H",TB%-) IDY3M)W8
MJ8W^H[>?O:Z:S^'M=*GL$<6QKH^W*E_55\0OX+?FWR'OB2V1\GLC?$[H:]S]
M6@)QXI;7]NV>B;R5DGSU6=U\YP_ZRR._FCQ^"W.>NN=.696*RXW/4^-NN?M!
MZ\E9B G&01;""&4IQ#'*(,L$@P%!F=YYB(@0IZ7* #I.C>QJ$\U@E8V1H##'
M??7/>A0OJEN@J_HN2&X-N:K\08J-G=4#CHG'!_@*V%'J*W?LT,>XFSY=VP>^
M5D>XB^KZZ>K =_P*;,UJ'C&=N_?A[ALF7TF^>#8G.Y_/WPJZYU,?KH=\Y6(?
M0,-Q\[@/!_%!#O@!1?4L_5*8 ]W5BRE.L=)R3,M/QB_8^%"K5$B4Q@*BC)@<
M#5D""9(<IHCIG6^"DHABIT(P'<*F-B&L=;T"3T;;B@CD6M]-Y@7:"HD3706J
MS,/_,[R*T[CZD_DQ"J[,O/$DS?6HG+\XEIWIZC@[]O?5'0/3^+8GOFQZXF;;
M$Y]\'J;90.*K8$V7J''+UU@8?5#,QN8=]Z"?ORR?2_FPG(LFNQS2BU?-01E,
M$AP8_W!3BBJE4)),_R&221Q9I>(ZTO;4"&>CGGW$RSY:W</^0@P&'N4;S7HD
MCM['P3[VYP(\1HK^<<#%*93EA.4=P2S[;XP6SG)"U79 RZE'>E12EZN5R9KU
MMI B7[U9%L7R=[VX?TMU_^2KEUD4))2'*8)(* YQEF'(%--K(BR02(SW-;7R
M,;*0-36&JM4U*QE>*>Q0 /P,J.>)RR-40]\1#(:20YET?VB-1',;'0%OE 3/
M"SUBJ^##^1ZDX/=\];!\7IE<MF4N9"O\</'2U$]?;<YDJJRW^L^FI2:$<O5
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M.0?W70</7'Y8,$NCE'+!&8Q(0"!&*H49E0E,5!J'C&"E8J?R3>W&I[90&/V
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M(8XS";.,9C B*9$\YD$@B$NF^E;;3@0Q0BKZ.R.C?\+5-FJ6NZA^6 R]=;(
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M3I<7HNGD=FD+3X?KY=DF1G._M#6F[8)I_4Y/-TQS0OY95>GZ/N8+6:W!9N9
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M1VVOP9Y.0/D+_;03.W8@J!,81\)"W=[W5;MI?09ALNS->(I01F()F4@3B*-
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M9RB*G=PM; 5/;>)J,];UMNQ=JXIAM?IL%2]]EY=\OC2%#7N6)3W7-7;SRQ"
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M_"SS1,P;G6/6&]M\AMEP?>\F164/V*(-4A%G,6,9U8CR#*1Y*FQIX 0P01C
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MLWV$^FCW5D:9 579]C_^.TE@_A^1*FST?%6'>724J1PA& .28@20UH9K8\I
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M%*K7P>GPX[8T:##NK'-!TW5]#Q.K_KG'[7.K/KG[5Q<EVO@#2@.A,F1<\Y0
M0F ,("4<LEPE7'OEQ;H(G1HU['4^Z9U=J=W?7W!Y *[G$&%A'9Q4+D:TQP&"
M.T3!C@<<1(Z\^>\.POG6OL>]?=-7;Q[5^H=YA_QEO?IS^_!^]?C$EB\S;OO-
M8D9!FC'CC$"1 F:;M&5"0P0U4S'2?BFLM7*F1CQ5DN9.UZA4-JJT]4UDK8>V
MG5\" C8PI?3$JD=*:RL2%Z2UUH\[<FIKJW'GZ:WME_NG+7R8BW_.EYO5\KVM
MF_CR:2X>YC_8\A.S!1:K73"""$(R8V8]H@1 MCP[RU(%()2)2G),E%NXH:.\
MJ9'"7N6HU/DJVFD=E6J[Q_B[H-W.#P-@.#!/=,+7(U?"!4?WY(G >(Z431$
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MTPRD.C.C<ZKBW#L[P%GZU*:UT3EZW"E=N([FPG\R6PZ@9U5<IV?@YH /ANS
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M9NEXL!<"SIVP$<!42QD"2;>]H,NP&?A%?*S<_XQ*]1J"_,/M!C4C$F@3J$;
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M:J9MSQH:)Q*@1") L4VUXR(U%(LSC/LEV)W+FAJSU@=E]]R#;L/8S9$+A-S
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MS7".\HPZE<!JD3$U8BG5+)8#.T7=H]&;<&RGC4#H#$P4-<#TB-=O0L@]3#\
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M[R.=H7@A%OP,Q4WZ&YVA>$'3?(;B-TR8[M]E&?+3=@$$(R)PEH&4L-R6^(.
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MS1C">::U67XERG;PUAJP!"4@UHF(J52(<>=(EN.!I\965K?(*A=9[=S76:_
MZEY<]85@Z#UD-^N]5E%UIO9:.KT::+3U4IWZQXNDVG^_I)[@_A4F->*8)CG
M0IAYEQLO@A.E 622F,5/+C/M-.7JAY_:Q+O^_OWF_GN?RH%[P-(TIBHF&DC!
M-$#4L!6C20HR34E",@I3DLQ^JC5?#0_9L9@!0>M=;K%7G<4).D&E8@/651RT
MH.);5E)T*Z$8J':B+0QHZP)^4'QKTQNKB(XL2R3$60PD%M!0'.* I@H##C.B
MA,R-S^%UBE0O9FI4=ZB2:/6\*M-\_0)E.G!UW;>Y%*W!]V@,4/>^0/78HFG#
M(=AV3*V0D;=>V@P]WV9IO;IWKT?;H:IL&F.3 '=-93[,-V*QLO7N/%]-'B-.
MZ*M]U/;HG5HJ/1_H)=8#G7"=$)TEC]TET1>2F@Z*WD/TFR\?V7S]=[9X5N]>
M]C_^=6Z6^VOQ\'*G?AJDBGYL7&("XPQ ;6/28Y4 LV+G &<Y2V*<,XR]U@IN
M8J?V8K6J1H6NT5[9(J/\\_7?>QV5.*+O1E3A,1V8HRZ!TYNH_- )Q%&.0D>E
M)S\@3IG)\V[_5FVWF\TS,X:\:@#]<;6^>7Q:K%Z4*GZW'>(VAAB+1+L9Q7%.
M<YX#K&@"4"H-.4F) :9QG.0QD50X=W'S%S\UDMI98*-@1=GKO"R?:ENAJ\J,
M7455:T@QY5;6%/<V9SV>4CN)#8_]P&2VA_W+ZQ;SD3$@VEE0?538$!DCHB^#
MP^[>>&Y8^$?J27?_H,JBF?.E7JS^M(GB*S$O:BC\.=\^1$;MB#VNGHU?O"ZZ
M,9E_L!P9/:P6AJ VD?IE6U<7/87-M>8%5<Z4U9/5>_-OT?5BL[(U.Q?/4FV*
MX99J^TKD;ZOGK?WA]W+@8F9%>KXTV+X^I?RW,-WR^C^WED9Z/08=K<=>?X./
MV^]=,$K?P.>%^=<??S'+L35;F$&OY>-\.;=NO/E&J%UC;AWG*>7&RU9)B@!"
M,0>49!"HE,:4)!3%*?:+?'81.[6W6*5U\6YBKQ0V,[30V#L<V@E]-U<[/*8#
MOYTJA:^B2N4"U]=*AV^A[H=2L'AH)Z$C!T3[ '$>$>UUM[_+_9YM[^9;,ZNK
M7K6"(<4@@4!H8A;[N2: QM#\2F-)E<ABI9QBC&K&GAK-&/6B4C]W)^P4KF['
M]@(0!N:%@_T]>AV? N'N:EX R$A^I \P7MY:@^DMKMCI':/Y60VJ'CM139<$
M"MTN$L]F,1*&A#("((H36RTT X1E,4A5QCDE.I=<712F78B9&C6=!! 7T76%
MHI>&8Y>@NA[A70K5X$=XWBA='F+]"H2APJE+(6\;.OW*T,XPZ==7!PV)_KA;
M/M>$XIHED4Q2S4%*8 Q0ED+ 8:X,6Z0Y0Y))S+T63/XJ3(TZ/M9L-H0)B6Y[
M#FZ,,BRZ [--1TCT ?>W"8EV ''8D.@V!:80$NT D&-(M,M((=K ?IO_>-A^
MT49H$2\U@YS"/,,QP!G+#-DQ"6AJ_H!QK 2B,17*JSA8J[2I\=J7DZ:O:ZLN
M6&GPO%&]6D.W8^U&:,$0')B[SIJ^?MNA9Y0MBX0.U?&U 91!NKV>RGK#3J\-
M9K=W>6VZJ6?(]Z$T<;&%75/@8[?I@V*AL$: 05M*%"(.B%8Q$$101&5&4^6U
MR'*6/#62.2Z[7=;2?5WYQOH 5=F;/F6%W)\(,7XKD20%U): 1%289:]*8D#2
M%!)(8XAT[AEN/L0S&2D2_>BIE"=JXM53L8=PORV*IS(?]*FXO10&07K@%\3U
ME_>WT?5VNY[SYVU1SVF[BKZR==$>.-@>6&^$0@7&.\L=-V;>%XZS<'KO 7H&
M#):.+UOLVI$;SW<?"70(3YP1VST\,72%8&(=U50#)I &F4:"0LUXDJ<^C4(=
MY7J]34;H\'EO942+@\Y7D=ILYX\%D6D; /?3&N 9-NCX#-RX:@!D!V:JO<;1
MD<K143CA0>N  81^,(6*('24.FX(H1\49S&$GK?WSP0X(<#/J^U1P<9,XUPS
MDH,TR35 G"6 Q@D&DF4L3^,TET+[>+Q= J?FZ+[_\NGKMYN_WGS^?OOWF^CV
ML_G]QGBV7[Y_]VRJWHFT&P^%Q&_H8].66IA6Y^B/0>K+N2(4,,.B5=SH:14N
MQM?E4CC=US.JRS9S?V<6[O(X:6-&1*PYEQ!D<4X-N> 4,&S()1892K#4+$^@
M5Q17K9BI44H1,P>X5;-8G^WT] S5JH?4C44N!VI@[B@4!(6&9G7U4J1H7:_7
MMG>Q_?G*$,BR""<-'X_5"DVH^*MZ(>/&6[4:>A9?U7[U!2V\COP;^U"?UW8M
M/4/*>!80&Y<#$EOO!%% M#34@/.,4)08XO#R.YI%38T>RNVTH\50C]Y=]9@Z
M;M4'06KH??H"I+OC%>-!S\ -O%JQ"-G"JU[0^$V\6@VN;>/5?H=_L.4_V.*1
MK;?F36F^-,8=J;85M<@5)P@!I(S3@"2T73P20P\RCXVW$',EG7.8ZD5,C0PJ
M+:-2S2OK13<G1+C"V,X#8< 9>/[7X=(C.+,!(/<8S<N!&BE4LQ8P&]]N<]Z9
MUF;VLJT-Q @:Q]D.3TLX9\.-HT5UMBM^'-S9<64_Q^AV:<A%;;;?S#.QT6,V
M8F)W!,DIS@CF(%4Y XBF!) \C0&FBBC&49;GT._ JUG8]$ZX=KI&:Z-L9 "=
M_RSS,D2EN*>WU *TF[<4!KR!V7*/FM4RVJDYP'E5-QJ!_*460:/Z2]T&G_I+
M#G?TXPQ;'>:DP7M5B BIA&5QH@$T)&%KV&6 I(P"!0F"*5*92+W*X39*FIKW
M5)0J6NGHE:H]BSPUP^M&%$% &Y@G>N+E31.=6 1BB68YHY)$I[FG'-%]0_^6
M'O=KMMS,K;-9=@^9$0UIC&,-TMAV14,T!EQK!0B1.4E2H1%S"I9L$S(U8M@W
MK3@H6K7!\6_J<09H.Q^$@FE@*NB!4*^V'DT07-37XVS0T1M[-)E5U]FC\5K_
M?1-[9F,S\>]69LBO[,4&*%7N;"PA9%QF(!/VK 4;=X"+A &2Y4)CC8PSX!2Z
MV"YF:A.]T+18YRZLKM%3J:S[#D$+HMW;*&%P&GBFEQ#9.BN%FE&E9X_=E!:L
MW'=4PF VTJ[*X>OEB9W7+DHW)"T[*2TWC[:;TFW \8Z*P]7^[L^=07CQ]6&U
M5)^?BV]DCB7F&9(@3C/C]G!#A30G&5 B00RG(N?$J2-TW>!38\%"OZA0,"HU
M='=SSH#K=F\N@6-@LO- PLN=:3*YEQMS-MAH[DN3&<=N2^,U_;8MJM/]S?WJ
M6OSK>;Y67]>K)[7>OMBJ0EM# [9'_).]9!9SH345"<BP( !!I0'%U';Y83R7
M!'*NZ6RI?MBP4;>=#'?A3M]A6GZ'CU48[JO\GCW-;=AL4>E'SFWK)<_-3P_H
MW?8X L,Y#B7LE+:!_)7:T4[OJZ(*W?:J>,7OE0^W$>(/6*"=$0_!HVZ5^ -R
MNG?28X0+SFAL_!9;OGQ<K=7\Q_)]<? M7MZQA2V:]ME\ZZH]PCC5N?F?34Y2
M&4 HHX#K1 "1<JB3/!<4>94&]A$^-6_D6/>H4C[::1]5ZE]%UH">>[5>C\;C
MG&< P,<X^0F%=;_C($_00AX0N8H>_\C($Y3:0R3?,?K2G%C;E-L/JOS[=GF[
M_&G8<[6>J\V,)HG6AM- GMFR(@Q1F\ D *%)IA+(F,ZXGTO6*F]Z7MB1<E<V
MO]*7J-K =66F2P$;BXI*_:+?=IK:+-3H2-F0Q.. 23"F:9,U,K4XF'W.)2XW
M]2U4].>U$+:0L&U2OUXMS8^BB.#>U+:LG\4()3+%$L@$<H!(E@">,0@8SJC&
M,(-2>X7]^BHP-5_IFQ)&U\5+9 OQ*AD=C(F^;\VBA*VEYZ+/^Y&XL="00 ^]
M :[^/,;UM?)F!5@H'OU1_3U(SE)?]((5*O(4/W*9HG[@G!<IZCF._SE<$11=
MIE%5"2J?U2ZN#*N8VKH40.66XB@UWE(B,J ISV7":<R9=#V(:Y$S-28K(_9_
M*^M._+ZK3^WA,W7AVGT<%PBM@>FH!&J7+EDI^OM545+%_TRN#3'W0[E R(UT
M*M>"8)@#.0<X6D[DVNX>[4C.P83C,SF7R_UI\L,^?O=V:6.="B[^_LS_2XGM
M_6H7'?G,%HN7#TK/ES;Y[-DN?9_8>ONR2SHQO%V&3]S-'^?;S0P*#!.6(D!M
M? ,B"0><Y Q@9"MSTSA%N5.IR\$TG!HU'XPT"[*]E=&F--/NBXMC0R-96AJ)
M(U/W"6LOT5-EK/G(6NO.5<-\';K?"V_^D =^HQP]WR,#H\K"Z'X5O;(QJHR,
MCJW<Y]J]1#L[H[M)/%_WM]B;/^>1WG_#SN= #7D&?1@M;]]AY([VWAX4MN,W
M_K""0NU%?UVK)S:71@.U7BM9^2:[7D1E]^R9XA0FBC @54(!2C("*-(8)%((
MIO(T0ZEGW$ _1::W>UUIO>\6=.AR%U5)O+TJQO9\3GWWNX-A_Z8;X;MG4:E?
M/(IR)7/=_@@"[([[(#C8MKF3$F^\G^X#5/=&N]=HO0M\[=JV%24\-E^>MQN[
M<SQ?_IC1))=0Y@H8&M0 L3@##"D"TE@(8J@(,;_=]C9A4UOTO#_J^GD5;0IU
MH]5!7[M557WL7^FK&7*2R(SSQ+Q\<HD DD(#2E0,:)I1@CD36<QF3^;=NY+?
MM^9-.B[PIX*'@_^=^C%?+BW.?!>$\*H/ZS#H8RBITJDR<&L!$)+$?N$Q4"1E
M.<H11;&LT+]9.OH"8;'?B1T.^9ORZSTF[&XO]E! #OSZ/NY;>Q65FEY%1[H&
M+677B4BX,G;-HL8N8==I=$WYNNY[^KU _[):R3_G"_/U37.*TS0!A @&4"H0
MX(PS$!,"4VW^#P7S*[RP&]KGRSU.F86=9GX<L(?*;;[W,7_@N=UIM_<4/C4R
MT'3=#SOJU#PUYG0:GOV[WY3;K+<S&[?V17]B_[5:OW\V[Z1'M:[B-'.MDU@R
M;>8?R8VSJA- <0P!1X+I#&9Q)IT2=EJE3,Y+K;3S#(1M1[)]>@;#9^CWL#,T
MSI/6R?2V&6P&.)J]YK?#S&T?>Y1I[&3>;DZ[77Q!W<>OJ\UVK;;S=1&"\4XM
ME9YOBU;BU7YB]5%U6)VK.,$L3D 6$P@0S@T1H%P DD'!N5809DYA$Q?H,#5R
M*'>'7ML051IOBLR5'J4C/1^+VZM^8+ '9IING <HI70!9"%K4GIJ,'ZQRGX0
MU5:Q[#E4$P<>?Q?NS$__Z[_M/C%_V/+/_^N__?]02P,$%     @ HH5A5<8#
MP2>P9P  D'T$ !0   !C;'@M,C R,C Y,S!?<')E+GAM;.R]V7:;27(N>N^G
MJ-/G]D17SH.7[;THB:KBLHJD29;;/C=8.9+8#0$R *I$/_V.!#@3H##DSS]5
MWLOND@11R,B(+R,C,J9_^E_?/H]^^IJFL^%D_,]_H7\E?_DIC<,D#L>7__R7
MWR\^@OG+__J7?_B'?_I_ /[CW=FGGSY,PO7G-)[_]'Z:W#S%G_X8SJ]^^EM,
ML[__E*>3SS_];3+]^_"K _B7Q3]Z/_ER,QU>7LU_8H2QYW\[_4=-I!0R,3#:
M1Q#,*G"<:O LNF"3$33S_^_R'QE1/.7,( 7#0(A$P)(DP=/D30Z<*I$77SH:
MCO_^C^4_WLW23[BY\6SQQW_^R]5\_N4??_[YCS_^^.LW/QW]=3*]_)D1PG^^
M^^F_W/[XMQ<__P=?_#2UUOZ\^-O['YT-5_T@?BW]^3]^^W0>KM)G!\/Q;.[&
MH2PP&_[C;/'AITEP\P7/OTO73VM_HOP)[GX,RD= &7#ZUV^S^)=_^8>??EJR
M8SH9I;.4?RJ__GYV]&3),)I,)]_^&B:??RY__?/["8+AU%T68A?_>'[S)?WS
M7V;#SU]&]Y]=35/^Y[^$T3<H0B66D[+B__OP;W]^6/S+-,T0+XO-?L(/;K^B
M++8+(>G;/(UC6F[O;HW1)#SYH5%A[F1Z]R]'SJ?1XM-!3,/!XIL/_&P^=6$^
ML#*IQ(@$$A%/@M& H%()B,7_8R1QG?W3?1>B9TCU0A:S%/YZ.?GZ,W[QSX49
MY3<+KBPX\F*Y)6=VH_ONZ%W@SPXH(MYI*X#)9 !_2\$FYH IYBV-TEB1]B+[
M\6I/J7XLT8-I^&DRC6F*NN-N.3<-+Z3[%+>W/_'S%S?%+X)P-1S%NW]=E$@-
M6<TG%3BW% N2^Y>?<-<Y3:<I?EI*9>WF%CN;HT9-BY^L(?%_NW93_,;1S5GZ
M,IG.!Y+&Z)DH1SUQY$-(8 -UX PA+$BGE,I5A/]LX8UPP-K'P3[\; 02IVDZ
MG,3#<?R M_# )*Y\]A*"DAJ$X8AI+3@P%DBD.G"?0A5 /%EV(SCP]N&P.R\;
M </%U(UGP\+X6T KR;.D%K%,C<?_! '6!/RC$SI1EP-^3YW;X=G*&T%"M ^)
MO3C:,RH.Q_/A_.;C<)2.KS_[-!UDO.F<EQ2D+S:VC&AM1QE 4>^]]3':+/="
MP_,5-T*!;!<%>W&P">F?I<MA8<)X?NP^IX$S"C57)J I;D)08M'F2:C8%!6,
MT^ )KX& IZMNA +5.@KVX&032#A";WZ**FS!^'/D?WH_N1[/IS?O)S$-"$V*
M:"X@VF+Y)"O!HCL.A$DF5!;>R5@!&*\2L1%.=.LXJ<?G)F!SX;X=163?, ^7
M#Q6WFE"[J'Q0!G*D!(0.!KPA%"CEDN3$A7(U +-F^8V@8EJ'2@W>-@&2@QA1
M!+/;7SX-QXD.I& F.^V 2Q- %/X8XCT8FP+GSN,Q8!4 LF+IC<!A6P?'OCQM
M"1CO\;<GTXO)'V-TL=%<EMJ"2A:]*D4"6$M1'XIDB'0Z2KF?1[)FX<V>KL@/
M@HH=&=H2)A97X\GT=#KY.AR'-. I&6N% B<"*CUK%1I4T@-ER66:K!>QQH6R
M>O7-T-'PRV8UUK8$D=/);.Y&___PR\)TLM%SS6@&Z1)ZWC$;-)VT1UVH2=9"
M)$=M/8 \67LS>#3\X%F)K3V#HVB]@VER"[J5T(H0I0')1E:DS,'S4"QIU(9!
M.<L%WPL.CU?;#  -/W'NS+J>15["HZ/3J\GX[@4FH,KR@CE(D: N<V@6.XI<
M8(1[W XR).YG/SQ?<3/1-_R4N1<+>Q;_>0K74X0N9?YB.!^E@?#2$"$M4)W+
M518$ND9<019"9*6I<70_K^+YBIN)O^$WS+U8V+/X+Z:N)*"<WWSVD]' 6>H4
MMP2X8Q$$B8A;H2AP':)V-@:QIP'P9+G-!-_PL^7NS&ODT!]^"U=N?)D6[ZTR
M6!X#L6B7<(=**V6PQ6HQGCOGB2Z^3I6#_WC5S3#0\)/DWJQLPAUX?STM[%I&
MX JD40;7LX%77%O#&!!AT/,-,N ]Q@1D[05:./BA$GM!XK75-X-&\T^0%5C;
M!$2.QOAMR([AU_3!S=WMM@942[1Q!!).RUV7J 5OJ0<IM5:<<Y.SJ@"1U:MO
M!I'F'R(KL+8)B)0P[O2]FZ?+R?1FP&(40;L$/$ODB=$);$93R&09HU/):4TJ
M(./)HINE337_!KD[(YO P?EG-QJ]NYX-QVDV&[@LM=<D0)9)E"P.#YZ45!\O
MT3D.7))4(TSQ9-'-<-#\:^/NC&P"!X>?T_02K[Q?II,_YE?O)Y^_N/'-(!%.
M3!(.ROT'(G)$<M ,3")&!^*9KI(CLW+QS7#1_#/C_HQM A_G5VDTNJ,^T*"T
M=030B<H@=(F\.8\^E&7&)<:5H#5LS<=K;H:&AM\<]V1C$R! PC^7-(Y)^/OY
M%?)M=G(]+T4<Q;,>"*Z]TJCMF$-364A/4-MI"=*4W'+FC4_[^:3?IV$SD#3\
M.EF9S6V !CDW=:.C<4S?_C7=#%QT>O'B@DXWHIZG")Z5.*U/GDL6'9$U;,UG
MRVX&C89?+O=G9L]H./B<QK%D$7\<N<M!YHYQEB,XAM>>".@P.8-L4"ZR%)0@
M(>Y7K/%DN<VDW_#SY>[,ZSM*N720/PYGP8W^,[GI74%!L(DE[SEXPSCN(2)H
MB4#?.6LG$--22[T7 -:MO!D6&G[&K,+21FHTEIM8EII\Q,]F RT]\R(8B,44
M$B8:<,)QT)(H)@/12>WG<JQ=>C-@-/R(68>I32&CP'NY!:>DTL$'"))Z!'=&
MLYD8#M1P+6)0)"M3$1?W"V^&BH;?+6LPM!HF_NGG%VS\A!_L6I6-9M!XEB+^
M9C89#6,IO5^D>Y7]SB;YT$W':#//T'0N/M<T7>&/#[^FDI7^.?T^=M=QB/_D
MZ2XW+.JNM'25FO NV+!G2?GU#"Z=^S)8KG%/S3V:6;:!94=!<X,:2:$;@Y:L
M@^@5B=R;D.1KL8CL9GX!M=MUEF<ZC>:SNT\>#O=W2-E56=U][5GZFL;7Z2,>
M713 XBO_-IQ?O;^>S7&YZ>&W,+HNGMO!;);P_^.%^S9 VYQ&&S)P7ZHIO73@
M4]3HT]D82S@)/ZJ\^QW([*? O29R[O3@6\FJQ[OS;HOO)[/Y2?YE,HFS@W$\
M3].OPY!FYY-1'!A<ST69@>:,&E\X#P8U/=! HHY2F4Q?>Z'9!77KJ>FG:KY+
M<%7B? ,8^F4ZF<U.IY,\G ^,]IPHBU1+BKXF<P(\LQE485.665OS6B;Z+J!Y
MM'P_Q?1=HF17WNX.B\G<C:K XCR-1B62D<9IZD:(\8/X>3A>U(&6>/CAMR_%
M#!GHR%4P/H.@5B!WJ &O>,FJI8)IJK2/K[5=V 4QFU'63QE^EV#J0"(-J)^#
MB'[/?#C#G=WM@,J4F2(4D">X@R@B^) R[L"'Z$*@(;SF_>V"J9=4]%/ WR5^
M]N1T U@Y0R$@ 5>(_0]HW(TF7PIS[C8C0U3>X&T;T'<#D6D$B_N"[*)1W*>D
M0^W+ZU6"^BG^[]:BKL7_!L"T2.Y*LWOR8Q3>,33]E><!!(^N5!,R2"0J20)'
M$^ZU(,5N3NH3$OKI M E8/;A<8\0":-O@Y/Y5?$1%W0O67.<YH,LHM0Q6#"Q
MI/IX8<$E(X%R%FG6+DCR3,>\>$U:^^7]5/9W(?XZ_&M"1Q3"/Z$1?_>*,!Q?
MX_UY\B4MNUS,WJ4\F=YN\,)]2[/#;\@W%-9P[*8W1\C,V?$$_W8\1]**^79W
M) :!26&3BF!*!Q7!T5>TR6C0A)F24$CH<RA5>A3K9#O]=![H5G>U(?L&?,'[
M+=Z>YW?H@A27EG@B4TE\I!$O>Q%I .>MAAPB4;A'O/5?"^ON#N$7I/34XZ![
M_.W'] 94Z/+UHQRC08HJ9>\D)%."4*4-D$E"E%[&F@8CA.&O)1SO I>'U7OJ
M<] E0G9D;0,*!4V!!_5Z,)]/A_YZ[OPH74S6:$SO-4]6HKG@(FY02P.&:0E:
M*9L("<9S6AD[6Q/94Z^$+B'6K: :4$]/-CC0(I(4- &:!+(JD0PV*@+>"8&K
MLTAB[0OM"0$]-5MX,P1MQ> &]-1=,/TT31?)N?<<"=8P)%Y#"J)<PBF!E4:
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M^ZC4$9@J"Z,!>)VEN1N.4[QK\'H0PO7GZU%I6(*.YS"4B1H\)B^10Z6A3$D
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MSV4@W7(7TB4>2S\B'35:1$IFL 1M(U0%W'OI6/2U0PZK*>EY)%=K$*P@K@9
M]Z)QT>TLQ'=IG-#J&;ALDM .65(&VXG@,QZ?S"!H(;-+FJ#]4UT=ODI2SV.]
M6H-A30$V8;(N2M5*^CTR<;FIVQT-##*C$ S4)UKJTPA8K?&D><*U<HZJ5-NW
M7DM,SR/$6D-A':$U4=R*Y)<WTO0A+7]]Q+3;3@+W')->^<"I */2HHT  \]"
M"?$P9CV+MG[&R>;4]3P#K36$=B36!J[PESM[-#U]$$0R7"<//D?4_\R4HBD9
M07B:;%"VC,CN'*./".K7D>D*!=\%VZXB:50EWHU?+[WEN K<E?ZIWID,(EH&
M5C#4\$2I)#TGEM5^#GJ5H'[]E-X0MJM(&D78Z7(T^YUYNW)$^R!HGG)&EYXK
M&DN&(0$796E$KKT3*CE6O1QB-TK[=5IZPV1U(38*UDVF= R<35E(GB!)C9:P
M,0IL=@RBDH1Q132IWKER-TK[]6UZ VMU(?8^:'G%X/#)_>!PW-]#B_TT'Q#I
MC8@L@Y&E-R,)#LK (HA>X/%4T3J^R1SF;=;LUT7I&&B="J!)M^/^"2K=G:%%
M:Z%''S]8P0.5@O?$!] E@"I\=&!9,,"3<XX9FF/U.,M^%/>;9-^C6=F14)MX
M;-P\"CM0@:%WAOH^$%ZJ6;Q#,X4J<%1$XHW)R=7NY[(Y=?W:EV\<R^Y(: WT
M:UFSL^+:S=8PTCDI*<?C[7U&1C)DJ9., =61<$V"%:IV=O_V5#93'?XF"6>U
MQ-7 )8\J__8-]R#\U_5PFM8W7& A&Y=,!LE9:8CC+5B*%P"53'/JB6;5!VUO
M3EV3"6O5</(\8:T;H37A>]_M[>-DBKL**<791^3WXCUA!3\'S"J/^T"U'TK(
M@&L/>*H)2$>-EBY8[VH_3FY)8I-I:%U#LPOQ-8'/S?DYH%1GHDM?&I=9Z><0
MP2L;(%#I> Q6*5Z[E&ISZIHT*+M"94=":]>@O*TM6LG(;(@UN,4R61'-<Z\)
M6(G;#%ZCY^@5(['V/;X]E<UT@GD3@[*6N%HP*!]I_;/TY?8Z.,GG5Y/I_&ZV
M[$"(1+25'M!-0QX:;L!D)]"!8R*0[+Q2]<?R;$!8DV9D-72\K'NH+*H6\/=@
M@.">KJ?ARLT2'N/'PT&2L);$#,ZB.2R$96"\SLB]9()VG.3ZE37?I:I)*[$S
MY-454A.&X>G]^?DP+$P<Q]GC_6C"+<LI@5:.@B"YC*-%:P;O"Y(--934;U[T
M*D5-&H!= ZZ"<'H%6XDYE:83I2'MD_.")^GP\Y?1Y":E91^=D1O/[N+P Q4T
M$R1JM&(Y 1&% (LV"Q"6K(\J."F>M8M=&?K;?N5^(\UO!+(W$$H#%^OFS!Q0
M*:QC9>:6)ZBQ74!VLLA!FJ1TB#S6GWV^.77]QJ3?6.]U)+0&'-_#G%- _^SP
M&QH/X\MTAKKU9%PV6_Y7'D"_NE%1^6?HXD^' 35O^0L\?4\_>/23@QQI-I)G
MH,I&$+KD*.6$[EUD61 K&#>U(X =;*.9?I=U7>>^!=Z "MYKLZ=I.IS$E_'_
MVR$9C]FZ9/5 VJ0$40&B+.65)2G*<1\A!^MX-L$$7KU/W9ONL)GVG75/2L,P
M:>#BV(L[]_*Q(AF7I 3N2@Y.3'@I4VN BH"",T%H7;WG7@W"F^DDVA#D=Q+J
MCWX=#+@5@686@*-A5X9V:?!$&S"669-%+"4&+2&XWZ?9'@!6$^);27MG:']9
MW!UXR*?S%@ N)%6*!F 4E8J@0:)QYPUN7AOFB9(TU+;FNP=X9R_ /SS MY#V
MG@ _'#]^Q*O:X?#\]]]^.SC[SY./YT>_'!]]/'I_<'QQ\/[]R>_'%T?'OYR>
M?#IZ?W1X_G0?&S4UW/"+*_0QW&4+E5H7WA9X+$;^C8;A266QBDPYY2$3@<:%
MIB4=U7&P(6K*=)"!U1X<NYZ:??7B.S<;SD[RZ6,5,8[GP\OQ, ]#20%[L?0%
MLOC=:/'6[5S2R@A@WJ'/*UT"G[5#ZST$SY@0QM7.2MF'WI[[(M5!U'-5]V8"
M;+./Z]GA^<79[^\O\.>.?SDX_G!V^.G@XO##^Y/SBUUTVZM?5T&C;4YN)3VV
MN.6NP_QZ6IYHRZVWF)>VXFTX4.*82A2XP5M64%&:7[$RKE0PHBWU0=:V<38F
M;E\M]]V%/@QG**K9]30]' [OC/;&) B6Z_(8D<$KK\#+&&WRRGE?^\UJ%SK[
MU6K=X.NYDNM<?FTJMZ/C?S\\OC@Y0R/G^/!B!W7V[ LJ*+#72*JDLNZ:$]P\
M"/4>1$E9JA+*E"53ZK^3 ,^E@<AHB,1*+U/]2L"UY.Q?%OGBJQ_@&TT,TG-T
M>$K-L$C:@O6+='N2A<PT)U)[+NMK]/3=BZ4.)E[6,%:20)L*Y./1\<'Q^Z.#
M3T?'Q>[X#8_N.5H='P^.SO[]X-/OA[\='IS_?G:X^'P'];+5UU=0/KMO9T_5
M5-(R[F<L'(W+9;3( <*KZ*,;3A?CI7Y;#$M8=MA_F/QMHB)1:Y NXZ7'+5X_
MAF60U"K&5=!2;Y(ML\O:^^0%;</H1^>%IXCN!(%LC2NS)@Q>[EF!E51SJA21
MCFVRV5T6[T<]O0DN'N<&=2^8-A79T?'[D]\.+P[^8Z<7J\?_NHH-M(:8:@;0
M;;W\BLN.<1,4SQXX(P*$\0*,17EFR;WG(F<>:O>U?(6<"GTAGG_U VKQAHV.
M<PNT=#T3B%4PGB&(G;61!9L4KV\ K:>G;P.H#B96-'&H(X$V]0;Z*(<'9\='
MQ[^<GQZ>G?]Z<'9X>+J+"EGS116TR28D5E(LAVXZ1@=Z=C<)\^$!DE#J@E3
MBULN."?@8W+@M#6:2&9,2)6/VCI:]D[F>_:]#VAFP1.'ICQP'CP(RB(88PA$
MHBG+*@A?O5AM+3']*I,J.'B15%>%\6VJ$;SO3\\.?ST\/C_Z]\/E]?_IY'P7
M/;+NFVI,_=J$R&J3O5"P5Y,1XG160J?SF^/)_ %'WFJO-5,0=2S34 6ZY 4
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MBH@6I'1H-R+1$ES@$8AR-BB?K=JL*Q!^ZR-XX9\>H/5DP9YOR*[$.=F7MRT
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M],KP9QNM$DK'X#>XE-:OT P,=A';I#H/&U 7#]KSP<<\&\[^OC@CC#F55/!
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M=;<DL5\L=@:5%XTRNI-; [ \G,V'G]T\G>0-^"@\4\H2M')%N5>B\GBTR\,
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MU7M:_>E=53X3UN')AF@LLM!8#F@_,5#)"QJ]9T'55JG[T-LO<FMA9M*3 !L
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M-)G-!EXE2XPNED?.I9R.E7'0IK3G"5ZFR$RLW2WK8?6>"^_K2?U%6\K=&-R
MD7<ROTK3%<>O[.4XS4_RA?N&RG<XB0L#&$W;#VGYZSWCI*"!)>XA.B)!L!C!
M:4TA.]3$T;C(JWLH^U/=KX?2(13?6*"-0_CC9(H&\OC]-=(U#C<7Z(W-<(M%
MS..X^--H*?3XOZ^7N=QW/!HPY()V3 (I+[O"RU)S[$M=B46+V3L97&UWIIN=
M]*MUWQJ/6QR'-P)'XT>D%%9]'$W^^#7%R_2+&X[+AP<9%S]+8>1FLV$>!G?'
M%=P[;C8;$QPXISCNV'BPFJ!T#'-46>UIJOTZ7)/^?C5_P\>A4R T?@A.RP>+
MC2U^ZG2"O$[SX6W?_#1.:-XM.@&NT 56^9!L1F>4>]0%SI5Q[ER H8$0;Z(U
MLK9)W=%6^GT?:_AHO!4\MC\E=GE*QNG2S5.\>%._8! YU8M1A9ED"H)K#BYP
M"IZB"J!:BT!K)PYL0E>_SV8-PW@GP37P"KQB.W=;P3^-KLO+]GUW]<?QF.,)
M_O!XCN3@5U\>C?$R2;/Y@&8\?"$J/)+*('^%!".0O]%8*;G,-,K:27>5M]"O
MIN[0?>U3U&TC?:/M6NN34'C%*%LZ%+OR,!ZE!.DHLXI+H:-^.V170W)GRKH?
M)%<790/6]2O;'0@K>32) W/&@4B9X$TC+1###<DAX4FLW</S%7+ZS9'O!W%;
MB:#-O.;SBY/W__KKR:</AV?GA__V^]'%?S[$CY:,W#T^MOEW5XB&[;B16DE_
MBQ4>DEB%HB1Y!YF9DI/"-'B9'"3A3.0A1U%]GL53"O8N_KSEW4E>G*QW-^_+
M4\6R;9_7DK$R1<=I)TN@VH$/TD JJ;.92RJJ=W5]A9R>D_=VE_N+"M!*+&_@
MUCI' 2R<^"5[B@:=C!<]S!:=;RW1UA@)+@94QC1[L,*6+I ^28V^>R:U(UNO
M$M1S_+26V)_#J9H,&@#4LSW<]L2US 0= H&<!)XVZO"T)1TA6;SA>78BB-KU
MHRL)Z3L 7TW0S\LI]N9Z ]"Y32LM9^NV]S&7GIM$(U!7:NJ#(&"-2Z #\L(3
M'I/LHL_%$R):N+7V$NR*7A>[<[D!F!S$."SL+\TZAO%H_-Y]&:+9?;L930GC
M)E*(%%U'D1P#PT3"/QJN6 C1V>K=FEXCJ.=,\.KPJ<?]!J!T5OR,<8IW69:W
MNT R&?(H Y'9XF6N/;A$R_,SM\8;HF6J;3:OIJ3G?.WJX*G [P90<S%=M*^Z
M6>C0I3J]W4@.Q@2B!<AH/&[$6>0-ZE14KB0KU+-)Q,K 64M,S[G3U;%3A^L-
MP.<@A.O/UZ,2KEP7J[K=F*%4,,50?0:K04A"P;ED@"N;O/"91%4[T61CXOI]
M1.S@7NM$*@W ;?7K^IWI%UAF61$@-(724:+,7Q,!$D^!YR@I-[53-UZCI]^6
M&_5!58WW#>!H\=AQ^_3QZ;XQ(V$DVL0R,*89"!\R6.\<*,DUU9XDH6K?>"L)
MZ3F=N:.7H?UYW@)P'AS.#\.OPYC&\;Z<Z4-)K$.2!GA]ZZQ8!*5+L(_:@/RR
M'#RZ#TQZD3J8)+ !7?TZ_Q7$O][YKR.+!O#U/(OH:/PRQ'B&&OCC9/J'F\9!
M9,%P+0,8W N('"2@CD>7P^&'0?(DNFASLPV)_2JS^JCK4D(- /#E9G;*U-&*
MHFEI(YC(RSAO[\ HF2$@LY-+F>GJPWKJ4-Y[AZ+NP/4B4O/FDMX9WU\6*9;G
M<S>=U[[&7U;59T]D<B8!M:+T:))HY&BTE!5ESD@=4OWQH:_1TZ\"?4M$5I-*
M,SA;\<ZSW-E &">4,Q:R]!;YY#DX00R@@^:L=(:(ZM'HM<3T^S+[E@BK(X]F
MX/6H4IDBW<+G""R:TNK213P>I4LS<Z6M'55"U$[]V;(4O+/GV;<$T(X<;\"P
MVZB4@%.)R.<20LX:+W-T\IV7'(06ULO2\LC5?@&I5@/2V?OL6^*KNI0:0-Z]
M<S[PG!&;HX2H1"F%*5.T@B&@HI;1RD@LK6U9W2_>[W/L6V)H-WZW4ZWVVW \
MF2[<D:6+<<>STD_HPW"V]$E*-]5U/LFO2ZX.3#*.:4I!<E_2(JT'GQ@!8WPT
MDJDLJE<&U:*]WUG;;XG67J2]+]@KY?[<E9?BWM:DHBRL4U]Z$#Z>;WF64 2S
MX3R=I^G784C+"L2S%":7X\6W+ <ON.!R,#2"EH2@RV046"/03*'6FZ1T0!Y5
M3Q_J=D\;G0OS9S@73:&C1RLBC+XMK:+#SU]&DYN4%BQ?3'@M/;>70P66C>0L
M"8E(IR$%7:86H6V.&B" PEM0YT2]C\^LUQ>U(YNOMA$2[8^,Q(XXWSB6;M\#
M?#:,>YN B%"*JA,R+.&5$K@@B<K $Y,5L+3% PPE?W8P[<#Z!MR;)V]*RRF1
M 5FV&$E=\B/F5Y,XX%SH&' 3- ATV? \@"&L#*3F@DEGN3:=)M.MH6LSX/TI
MPAW5Q=2.P_1D:[>=K&_W-J#&BRA9@BPIWO(Q*W"&*B"<,FE-=*QZ$_Q7R-D,
M;W^*8$8MH;0#LTH!P^2)<,(9H))D$,*&TK2:0_(\$D]L2*IV'<Q;AH;_%'&2
M'D2]9U#E<%S'*7\U!NF\C$3)!,'A'2&2)>"99>!)LLQ;'GUUZ.X=&:9_BKA+
M-;$T K/U@4B7C?9.,\C.H?5+9,G(C@28SYJDP#(1M1\M]PL,TS]%X*6.0*JB
MZ\T:;KR_*F--9L/QJW4#QVD1]]QGB%<'1'3<PJ,&:SKJ]1%S0-\X@$XDH=+C
M&0R- 3(U%.U('4VNW=&X;J^/#8I4"E-O$\\)359("]J60VAER=AD$9S-/*4H
M4Z0]5 _=T]="7?5.R-BA<F@WH33P4/-ZQP+)O55>* C!XF:4E^ ED\A$C=X8
M%]:FVK76#;<'Z0X'6_4+V48H#2!L==&5XRYE2Q,"@ 1D3Q;+!J A)Z-X)I;&
M;KHR_4#]0K82]$;]0K;A>@/0V;QDDVA%:*FR2S'YDOV3P1$?@"5"E$J<9)G>
M_BILM[_(5D#8N9!V&ZGL#+>O:>HG]0&W<CK"[;[0\XG<!@N21 Y"1 /E?1*(
M-E*((",CU7,(_D][5];<UK&<W_-?.IE]>4F51-..JV3*$>6X\L3JV63D4H *
M !TIOSX]6$01W'" @<Y0R</5%27Y3$_W-]/=T]M>E'6O'P\!QN/P:R6COJXZ
M<IRVLPE6^3[D:7V8KI@Z__<;O)Z4+Y/IASNC#+9M-E1T@HQ93?!1U2NGC:-T
M$J0N13"KC"K-6^,TH'O<8H[OCMKO(]^^,/U3+K4MS,.#!+:MA6SQ.?L$/->J
MU"(C6<P.(2E))K0SRH?6/72'43AN2<AWQVEKF?6%R*<\N#=?BV(Y"X*L(3IG
MGGY1' -X4BL0,QGAEEN!OG5%TE :N[\]V_C$)Q5=!]#<G4!45<,>>UZ/]EJN
MTQF_=E_?OGK5XBU%3" >F%)KNNLSO4#@) ADR=IHV_<Y:[^/[LW:(Y!WKX':
MR##HX"C<#VA=J52X]JR0^1Y(I7'29FAD)HV#9/KXQ'1L_;!_GXIQ83@^,I[-
MAQ@DIFX*1I\ZU*]SF<WS+NLW?US+SBP&6[@LH'/MFB&L V]KIJ]SDDZ_)M7V
M/0=$/4?ON,9"=Q#^;J+OX%9MP?S;S7,O2I8^0RJUR%*(NGE16PH'(UV2.K/6
M_;Z;;F!<7ZZ[@S >.+JH.GO:=?E\%;P+W&H-4>=<+3H$SZ0$EIWWWFDTOO73
MQ#,DC=M=H#O\MA1@]XB\G=$<+4M%,7#9:?*G309O! /&"K$0G24#[#O"LH_.
M!"\*FP>)LH,I?@_8_BY6>S]+X"X3BU H<"G7@I'LC0X\!M\Z&^E %^UD#0VZ
M@]Z18GI)F9L7.)_31__.+3,Q[WWT))F53Y-^FDS)XHID7'"0JO8F9LH!R3[5
MT31!!J:DD*U/ZXB9DB6*5**-P!-7=+LZ4O\)#5B,R:J8N6\^GO'%9DH.0<91
MF9)#A-*!_[PJX*$=?,+IEY_)T9E\F*XO[OCE-5[C-.;77W[*BSB??%I)KF9P
M.<1@Z4H%Z[,G7@8!OO $6FE2Z38IEEL;: >0^2*>UP_ S+TFM:<5X(O Z 5^
MS)L<L%",J4>=MF49_8(20DBY^NO>,">C2JVSF(;0-W;3V1.#93 X#Y3<R)TE
MWLRF'][G^<?5_L[6^WLSP^DVI<5ZS%JM!I=;!.5$ *R_XR+%E%76,3QGMNVQ
M3.]8.E2VL],PNH.;;'#057*M94P.M#>D&6IMFL<D@$X=:AZC5:'UH),?.%/C
M&#U[4M%U ,VV;^6&\^SJX)!8= V4LMK8!1DP5,R+)$AQM'9-OG\@96SC\4"L
MG31(,D3PS5#?]!'F_+??W[S]S_/SU^<7YS__^O[W-Z\N+AL\P^SUV08/,</)
M;_04<_9-7[I7T_0N+R?S51703Y,%$;FXF>>OWC@&9-;S",B-KLUL.;@D&!F6
M+BK-@R'+LO'U,("\=J/M'T@VO5UNHY0LNDPF=AW^)U?MR!-@E GHH%BAF1,Y
MM5;Q@P@<>9;0B5!U[TWY9#+K0+?7351C?.7/1:^M2E;7L<EU3!(O0#JB0)(F
M9N6-1=NZZ\2WZX]<FG@Z,>^VCS^4YQWAY:OSYI3V4D'AL:;#:PY!10W%IJQU
M,I[GUD\J=RD8%S.'2_(12!S UI'?.VZOW3LE&1B+H3W45W1C0&F; 56*$"*6
M>G:,,^49L^CQK_<A]$-D-6O*N [N@]M=5+9<?II-%[/YF]G:7U@="Q.B9TDH
MVE!FY%GG#%X;"<:4%#EREECK3.9GB>IEMN:I-4U;Z?0.M\V!3$E+%P('X6HF
M=D1?IQDKX([.EC))Q-S:@]B#K+%SZ9L"80C,#I!*!T CJO-B.8EU0YN;.=+]
MSA)R2)5X%>O8VQHL=H(K50K/DK?. +Y/1<<P.D30NT-+CN/ZF*90[8 ^_W+U
MQ^55<MH:&RPHTM6@T)&;&5C]'1-6*>?O-:"_@Y-%CO_\8?;WOVR^N(;)YH=;
MA-RN-RXBCI78["CVC2CPQ7QY]:ZVA5O=GBPX1I>DAL2(7B44W9Y.%I!>)=+0
M2C&SUZ,V??6;>X%^NI7XG07'S>8_O0%S.'=[@,2V+-TP+H5(1*P+M'&.@%Y)
M^I%I'H46VN_U?+</*,;4#D<(:U?<!W!N9('_-IE./MY\W'IO!&D4=.TE9$AW
MGZ_V5*Q#V:)WOI2LQ5[UQ\^(_,ZB(PO]$)'-6O!O;,'CYV\(SUPG9FG3404-
M*BC:/N<1#.&=''G&W'X/8<\)_MM%Q_%BFPG^8/[UX![<TWNW:N\V]IJ#L=DE
MTGQ&U*@#[:S6-4#05GMEI$K-9TCO1=BXM53?[_FCO91&?FR]OZ'ZOYH%-9FN
MY+>.N5^)XHH2AH%C1H!R/$,M^:)SQ8ST=)A"W.?U=<_E1O9 V@MY=EJ.=WE_
M7>1-PL8D;OZT3L2YBJ@M=XGN95_;")OZ+,34JOI;<B4PE]+Z,6U?VL9]Q#T=
M[$XJHRZZ3M[?V5F=&[*=\?GZRV8\V/R*;#X7BD/0J?)/:@4N"@.T,^NYEQQ#
MZ^#!WL2-ZX./@;\64GHYF5VWS8EG9?E7;>]?3]NL[ ;NVB9^#5WU1'EA1VU^
MA+0Q0[YA5C6M)SNZ ZT6X&L3:68RS\QC"+9UW[INT\92$:@$J\Z3<*!\)%Y4
MS1!3)&7@D>7<NC?T#YHV-@15QZ6-#9%9!_;CW4#0>_JOU@W<M0E&9EN'=B90
M9 :#1VY!1,."1I:T;SUG\&%*7E(JV2#1/QEY/4@.7:)I$TL43CJ5> *C5UW;
MI:EI,0A)\,*RR5YA^W:.#]/24^#U,#D_"YT#F-X!>%95"+^3<3+_NJ$[Q^W.
M"=R\-GI>LLI)@N8Z@(J20S64(2O'2M3"2VRM(0\@LS?('8*/AUK#G%!8'>#Q
M3DYHX>L&D9"=4NNQ$YX< ' N.J0?;1D_H[J3/+=CU.#!/.\(+]M!)>B5YT)!
M4":NW[L#.@_2Q,3166_V"QK_"!G5@R3Y=$;U$+;VF5&=Z[@#:0LP4>=:ZN0
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M(3FH'"SXG!G9$HSKG#&9V#JC]\4F @P1_+!$@"%2Z !33Y>]<6N<%V(U3E&
M4KJ 1^] 2^$Y+T9ZU;R!R]&UIEUEB!^C!=O)I@>@W:G,D,E+:<D(]<72#IPJ
M$%*VD+BA8^E-2NT[ [V46M-!@GVRUG0(E\<N-WRD8E(*K6.4$@IWHO9>4X 1
M.8B(1 %'$]1.\[N76FLZ2%A[U)H.X=S8PM^IH$06M$]! :G+&AXG5CA2RE"\
M$]&C$RKM56#<;ZWIP<(^@E.=U9IBB,D*':&42#:8HVO.(680/&0F12EIMQOW
M2ZLU/53(QW"JPUI3Q;3+H3!@#@-9Q"77RDD)QB!M!:54NTT07V*MZ:'"/I9C
M/9AV-V%QQX!A7)6, O1J"JJ6#'SB$3R3H5AF@];8VKB[2\++*YLYRD\X@O]]
MP6=SEE)M]Z4(_\D;\J'I9!$S%(>@,\=L"].E>=O472)&-@V/$>GC\#B OR,K
ME+/KC%,Z.=NV"RSI8&T"XZIOI(.$$*( [Y IY;Q/L>RA2^Y^M1M1'R*>61->
MC2SEW^<S,GD6*QVX>5_;NC&V<)&,+R"R5J!\=$#_K0-GB$4\Q.C$/O6\CZ\P
MLEO03/J->#@R$OYCLL2/D^GBM\DTS_%Z07[MY<VG3]?YVVZ0&))#SFL7/^%J
M:^1:3^,*1)X,TU*03;Q/+Z)]UAK9GVB&CN9\'1DGK_'#XL\Y?JH;J?%HK/O:
M[B.@SNA)/4I<->S/I5:;(!GD03.M2'UJM@<^GEIC9 NS&2Z:\7%D//PRGZQ*
M++91&%X2EU96>B6H0(8U"F9 \1Q+$#&&W021!Q%P]ZLC%QXVD_D1O!K;&L3E
MF\ER>9MN8KB4M:-%"98(=K9NGEG@R 1S*46A]QG8M?/9O>1L^I?S,=P:6= _
MSV9IQXA)+-OD' =IZG@7E3,$3+29&%B((;BRVS[H05G?__)>XK;]B_M(GHTL
M\0M<WI!A\CM]K%JP9\2\;3]%([1G1H/CI( 4><* -@8P"27MSQB[5U/"1Q?8
M2_ZN?_FWX>#HDQGI.S]/KC>)%=M8%@\ZA"3!AMHWM:@(@2L#@N>@BPO&[?;;
M?V0PXP,?WTO\OG_Q'\^Y'MX"]ZECHZW8H!6"\[[VA2&KQ5=WMD01>"CH0VR=
MF?EC]J4XZM&YM:0Z0-^318XQQFHH:] E!-*EG)B5'!U3EJRE>Y4KWCIEY>AZ
MTW$[30R2_I!ZTR&B.'V]Z>8OZB\!%_E?_^E_ 5!+ P04    " "BA6%5(X'8
MQ9D'  #+(0  '@   &-L>'$Q9GDR,V5X,S$Q8V5O8V5R=&EF:6-A+FAT;=U:
M:W/;-A;]WE^!.K.I/:,7]7 2V?%,:KNSGLDF78]V,OMI!R1 $35(L  H6?WU
M>RY(R9(MM]*VVUKQ!UD@+H#[.#CW@M#YMU>?+R?__O&:93[7[,=_??_QYI(=
MM;O=+X/+;O=J<L7^/OG'1S;L]"(VL;QPRBM3<-WM7G\Z8D>9]^6XVYW/YYWY
MH&/LM#NY[=)4PZXVQLF.\.+HXIR>X%-R<?'-^;?M-KLR297+PK/$2NZE8)53
MQ91]$=+=L7:[D;HTY<*J:>99O]?OLR_&WJD9K_N]\EI>+.<Y[];M\VY8Y#PV
M8G%Q+M2,*?'^2,FX/XC[?,C[O7AX.AS%\2A)!JGDP^%I=,K?_">"DEV(UV.<
M7VCY_BA713N3M/YXV.^\&97^;*Z$S\91K_>WHTU1;J>0CHWW)A^_A63SQ)LR
M-+V\]VVNU;08!XLP/#6POQF?&&WL^%4O_)U13SOEN=*+\7<3E4O'/LDYNS4Y
M+[YK.42A[:15:2WHU"\2*F&1T)S7&K_!/%H5<FE!U">=K^\S%2O/!E$G.N^2
M_-+NI];O85*"$$C[%]ET>7T[N?GAYO+#Y.;SITVCULPIN1" 6%O+U(\'IYOZ
M_U0YK]+%_]V X58#;EKLHRH$9[>R$%JV6"(MJ<-\QOWK5Z.W9_M:A=D0D7$[
M0IS^(J.BSE+I/W_ULPVW1+W.B-QPPS(^D\S*F9)S4([/E&,_5]P"NGJ!YZ6Q
MGIF"_6!LSJ)>^Y_,I&R2278)I<T]Z"@O>;% 1-X=8D3Z+RXBWW.'.,#C^8+=
M%6:NI9@"_B$P33B$@0J%0:+ "EP5# %@5>%M)6$!4D?((H@39SE:5G'-4I[@
MD64F!]-Y4\L]$2AD(IWC=D$B.;^36'=M3H=G LI@21U2$-8@@419I!R(%1@.
M382T;)ZI)&.NHH^'\7-I93,)&9 KIY&;*,W-E<]@H"ME$A2D>4NH9@3,G&&8
M8/%BW0V'"KG!X4!.LE05""KAXR&(+> -XNBV:_VJ2$$1G"HA?$]T)3 G@+(6
ML19 IHA62L29($K0U?H!@TWXW:.E 7,12JP6250: @"> 3K"<B[HDW"7L52;
MN5NBTLJI<A[UF6><'M9Z0\O6&KC<4IDGVAXJOH8O#E^3C6"\?O6V'[TY<PV"
MFKQ.%&#25*$9PG3#N)4!$ BPBK6DP#$)%,9:N8S$22P'_1$%4ELHEVCC*HPC
M8K1&U\@HK4FDP&/'C@$$(8&L.MK7]TG&BZED'\ YMY6&1#3@[6AT+$_"T&@D
MZE;=5%31%34B:7Y&Q+0&U!HXI,O."Z4;"Z58B.Q\#%](4)[>H^X9#5\0)(_Y
M";N2#E4EW!%2PF_'JD79*N&5VWT(I8U8PN_-2G4B,I7%!-CM,^4"AT!*%F$>
MJB4?V&>=P:S4/ 2RR40/P6@U[$:="DP$79S12H03FZMBIX3B5I$!JLZ7@5,+
MFJERE,,"[EU(>(%Q<"2$0CBKA4$E:B^55)H34<*LH,1#+L2(.K.N%P3X%DL2
M!)=AO!1[<-?+ DK\&"@[;[DG>-E]L^X,&T!MI@2A@3L<^(F5N .2J.XAB' K
MEN$"@!2/E59^0?EHV[($WA#9$+0:=QNB:W53(+_[QJ"RLB5 XT+^3!)C15 @
M5%!362 M:F '/;(D4)((JL,:'P"O*L$_!XN0Y(1=S[BNPGXC]\DT1<V@9C#<
M;<G]JW2S W_4S>WE0  $!F+ON[KHB$WEG]=@%X;C*VE)%57ZVT4OBY>U6L"X
MK#T!?4(\:8%#C*G KJ_=]=3M=+9IDF?HV1K;/?8Z4;Y)DLJ2<]?X=<NLN7$>
MS^E%#N9R"29JCL;L^)DA*5""7?A(NE$<):H,QS(ZL1752J^36JN,NU4RHOT;
M4"5%(+;@CX9T%CA\W4G=G-$>R;=^MXOV1-*+JGU'7TGM&U[*B.66:#WL>B*A
M=5@^$  !:X]D^:2N6:G&4=MX8]TJ/X4'F#+/E?=2_@K%Q@89D/J%@GYADF.
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M9C"7\CPW*+T/NRN+SPIU=5BP.IQQ00E<(<H2?!K%G$6H!_5J/F=P$44\9,I
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M ZRNB'(R-8%$.26)BE@A*LPP'PP.8VU[1'K=L>#.Q(BO&9)(>$$O<M=#(9"
M<R$YWBH@ECZ'0([/$\*C%@P6H&N"6#)9(9K%^U95OG?\,0ATV$H.?)I5>U@O
M63#$8D&;KEP_,D"%@,\9:CU!F/FI9ET(95)"\S19I.AYO0/:OE$>@</-H>VW
ML 2<L!*V@63^Q=9D>\E8ZB GW1H7&TO]SJ&4?(V]+6N+0XV99'*A?W #$*WG
M26HE,(YAIV=%19T3O++MUM5*J]&_S<7S%:NE<.'\F?:_M!P2IU (&X>Q,F0<
M#6\/[4X\NT=W8J33N3D.-)&!A)S(6:> E.EY* *X8R]W3&G>"2PR"=9\D1Z8
MO'RO?&LW0: UHT=OTBP4ZLI:,T%VZ\@R AAB/S+WTV(,6F"H4C1B@:"2R\Z-
MZ:HJ,%J36550=#U35WGY:HX1>%U-4[68>5OC;0E)8/\*&8OS2K2%%5!DGID*
MC#M)[+!C/4EJ O\U4"DW"P#M)SE""=U:@1%7Q?44KH!U7D63YDD -$%!8A^:
M(8<@0Z5E= ;\..=% U=\ 7_'L *.>,09*U&/5WNHX'%73;#6!)12>7H$TRJ7
M:=WI1BH4&D4#K=@6>H1V_# *\\O6\C1R$&B[D],@291$2(K$\RE%S]AIY^BX
M<IT#I?.N[A<.- .Y9FVIHHY!09$W[HQXKHE4-GF-EQS%1K9ZQB2)/SQ'_X9>
MH2[^%<I@;TKF;6E>'DTDF%UB=:L)8RC7L>X?HI/6E?#-NOFHFB I A<:N9JL
M4*BL7<(-8?Q;II"@PF#D&OO*;W!QF1(Y1$57A 77.70%.10QLC21;5D"68ZW
M;?2XA4[1A8%W!%3J#!;$^F92VPH+HA2 1F^@:XK<W<H7=Y&[A@"^\7. KZ4K
M=J#Q)6FZL%=0LY$^D!H+2 >B>&Q@< -J? %S"QE&_*G<;;)?5 %^<_R\BVBS
MC9*#[I.7>9/%X[._A%8W(WN5B%9KLWR];+-L(FQB;=(*@$DWJZZ1)CYP151W
M;Y]AW8CF^WNOZGA^<+A[\')MJ!YN#JK3?1\M1T@!Z%^_O0,2TP3[%[M[S]8'
M^TT$/DET,3R<7WI;K_>V,?$B<VZ$"1K_MBL]$<<ZQP&(%98$ZXXJ4/PDR:15
MD63AE5)V(63X/KCP:O?5_AIQ86.1 4UVF.5U9T@@ FF#$/H7KOIC>,7FAE<T
MW[9U<KWS3;UL$U0EMIYOF[S*N[URK@YHM=7&81P;R%W9/_AR)^GWH=[/45!>
M$SIM+#8ADOPE7DU<^3$L9(UF[B.;F8?')U&WY>U<XU8PPY^B?3WO/5I6))+)
M6E>JAL^;8EU#5"5'EU@[L"%F2[ PRZF9@EW#6/.<:)2)Q8.@ZT*JDUC@2"K>
M%EE=2OG5WI9ML5]10.L%S 3/'NQM6Z\G$_;R+&TFC)BTS"XD"#J)T.HVN0;
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M5?N/]KOC+JZBT^W"-N%9>:YW>GH&TYV=T.B>64!MWI[[J8N3#,Z.C[S.Q\$
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M5LBQ2L8D),:;=PE9SVS,O3BKG-BQ>M;"++G0YQB%&"<R< D&9<#00 0LRZ;
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M*)OEXGLZ3H)+^,\LGT>__7]02P,$%     @ HH5A516.>LJ+.@  9VT! !<
M  !C;'AQ,69Y,C-E>&AI8FET,3 R+FAT;>U]Z5,;2;;O]_=7U'7/],"$P"S&
M:]^.D(5L:RX&GA#MZ??E1DF5DJI=JM+4 FC^^G>VS,K:0&"W)30XPC9(M>1R
M\NSG=W[YK^.SSN#W\ZXS36>!<W[Y_J37<9[M/'_^Y;#S_/GQX-CY-/A\XKS8
MW=MW!K$;)G[J1Z$;/'_>/7WF/)NFZ?SM\^?7U]>[UX>[43QY/N@_QT>]>!Y$
M4:)VO=1[]NLO^ G\JUSOU__SRW_M[#C'T2B;J3!U1K%R4^4Y6>*'$^>+IY*O
MSLZ.7-6)YHO8GTQ3YV#OX,#Y$L5?_2N7OT_]-%"_ZN?\\IQ__^4YO>278>0M
M?OW%\Z\<W_OO9_[!FY>OC_8.7Q\=>B]?[.T?P2]O7H]>C?9?C ^'^Z/A_QX>
MPBB?P_5\4Y(N O7?SV9^N#-5.("WKP[FZ;MKWTNG;_?W]O[ZK'!=JF[2'3?P
M)^%;&BY\.XY@<O+U* JB^.U/>_3G'7ZS,W9G?K!X^[>!/U.)<ZJNG7XT<\._
MM1)8XIU$Q?Z8+TS\?ZNW^_OP<OKUFD?S IX3^*'2H]O?/X A=6^F_M!/G?V]
MW8-?GN/U>DZ5F5DC'L'RJ?B[#_G%4D,>?.HZG9.S_MD_G<[9Y_/VZ>_%@:_A
MD _V]HZ<B\%9YW^<WFFG>SKH_=9USD_:IVL_\O-N_\-9_W,;1NU<?&KWNT[[
M2[M_[+0_]KO=SS"3R@QXG'"<XE\;OOM^<]@KS>%5[1Q.SP8]&/[9!Z<ZFX_]
M]NG J?S1(_]SAUN_Y,X/7[:&<S953@=>%=T 4YW-W7#1<ESG6 7NM1LK9\2?
M.5LI7/?S3Z\/#O;>R77TV_Z[[98S ?:?)DX:.7C51_Q-*2=T9\"^ARJ(KEN.
M'SKN:!3%GAN.E'/MIU.Z%DA^ECC1V*D.P^'CE$:CKTXOQ./A7RGG/'##PF#P
M ST2QPT]>*R?.',5CZ-X1B]+IC@1G([GN)-8*1(O]C/:^M-\2OCM. I@["A]
MPFPV5#&.\]QZ\ 4^&$8?6E-)5 KWQ3 ]FOC//QV]?M>TU4VG)W6'@=)T,(0U
M4_$.D$/@SA/U5O_PSO.3>> NWOHA;2K=]&[FQA,03<,H3:/9VR.@@"L5I_[(
M#83-$,?AKT5HO7FU^^KH)<JM%$:3>OK%(M)V2:0]3[WJ=R^.=E\<O6K\>F]W
MO_&[6Q_[:O?-_LOO_MC#W<.#Y0;[G!:"%P.6.P%J_.]GA\_T#7/7\X HWA[,
M;QP4OV497UGR:/[=V?IR+)'87K=+1&CH3&9_OXD%:KR2>=7SK)]_>KGW+O_G
MW,5Q^3";U#D%I@,?'KS+_[G'S/=PWAM'!H-V_V-WP")]TVEA  P06+"P9A9%
MWA-!U/ %I[?QQ$#;3_-\VO\F=1]^[IUM'B7\(PL6SGZ+W0/I-(ZRR=3Y1Q8J
MYW"//CWZCZ>"X_: S"7B!AM' +6LX-A-E;/C'#PQA.)B770'@Q,R]!VDBHTC
MAB]@;X(%NG^PYWCN(K$L.[3< C=)\7.T[_!WV\:#G_W(<Z+82;+1%"X%,P^N
M!3+RV>Q35VA-PIVNXZFQBF,W0.NS:-V236JLS)8SCZ,KWU->P5Z>NHD3JYD+
MH_?,TV?S(%J0P8I#4/&5#X.2<6I#&;[QP?R^R(:)[_EN[,/":99'HZ;Q;JF;
MD9J3=0ICQ:'YH8LN6WQ<_7N\3*%1[RDWG;:<8S]QAW[@I_3&ODK]6*8# S<S
M(K-W^YM.U'.R95?N&?E![J'Z$_DPSUMI;7?P%+[=?ZV/IA]ZL%]O=_"3%9W$
M_=W5.=W>%9=E;_=(+XRG1E%,A^%M!FL4XYV@)I/,J'7ZK-)S^(-6L)XN5^LS
M'5A<;ZIB-5PT^![Q9S$%V^3XR_UR[C"Z4L""76%W8^=ZZ@.3! [MJ;FB(^)D
M<_'JN:.I#RQ>7SH"B08,NN!?G$1ND#BS*%;.. M [?14,HK](7/Q"S4B)GM8
ME0.[#DP(/Z 1P@])-OP#+M>3(?'10K'BAQ1<2\C!2:PVH5^UP$*GJ/%]VL]O
M!X%^3'Y;BZX=1:&GGSJ?!R"GT>LHKZYQ<^8K*++)O#6,4NM;W!?T]L8H(N%8
MS?%DH6!8@'0# :G@F3AS?A&</EQ:W% S0'H$3 WF@D\($S^AB\AK[%K76=-G
MCVW#TES[L P3V/8XE#49N7,_!:WDWRB#24JG4S>E06>)%K_V6IJ)1O#4^-I/
M%.\+7"L33J8N/'CJ7C'US90; J^!Q=7$P$L[LY=OU[F?;WC]^?O!(^+OIVZ:
M860 =O9"I6E@3CD=R/]<%K]2'C^HYSX4OH%#-,_B)$.Q3*>I<$)C-8<K\2<\
M7M$<&$^:A:BNPK6Q&BF,'^F835&#1A(X]E&!A1^Z_\K\*S=0*%: R9 &+;=M
MN4D]=W\A>N]N040Q2_"3)%-E 16%,A;2QQ6(&>=*)<@G*Y-WMN9!EA"+K!VC
M.QK%&=Q([!%&.1<10@-O>FBRW7+ 0@@]PYB<4.'GP&:G42!1LY83J(1?+2N
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M Q@I7#%W;I-A9@_*A# -5T!R5E[39186 .LZFT9@CZI6^1,"2(!EOG+%&-W
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MBZYW0'2A5>KT3G@.-A4?\ET#=E3[H#RB@K?*I,$'E7X"-?E/4E=A3A"1LHG
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MX))(&=,&A(9!OP<K>%Q(A@4J>>HB,:$-:X5),0;EPT:W,!=T)9%C3<QKV1!
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MGR;N^I!Z[-#^=")U.5:33Q*8V*Q@:Z/C.?.NX\"[:QW?@&-Q9E,$L"D;]OK
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MI1-,A?A:%E1N*.\>SI05<"=6[A#!,-0:Y!-89S8V.MQ]-"+'T0,2.8X-\A3
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M89BK!=O\,R?=^CL0WIX!(4EXX(1D>'\("3&@9[\?.R<W'H]<FA+5=JW-/OB
M.DJ1HE"?+;N &C<1%'=Y4/Q@PQ&KG271$(1?-5 )4.U6X47!2&3RF,'+40(+
M9*=#^<I0Q[!*LN*&8C*J>TU6OC='AS8N.P%U<T$N!J"L>CQ&J4QND/.I5&_U
M];OQ>"2NE_<,X:^3N)I%/DU2\V\^1$"FGLZ+-$;,9W)_+^)=*@8%)2"+@\]R
M:%2+ =U#30JK6&5H+54]F"@]\P DU9:\KZ3]Y(=ANX%33(0-,#\7U[1LE<(;
M)6$D,-%(9<3$6$M'U4.G.0;L1.Q+0^UF+LJ.5>J'&=SKHF)F(5@;-P)J6;OS
MN3<!!!I ^?J^[[G$SYY=J1[=4HE/$4_28XLJ>?6 [C)E2HYU:DGY/0E6.X\I
M",,/;&+&P4%;-0W>E\[$F9N[=44NU,02 [Y;^128UG#!MC0V!;*/Y))0&1T>
M@L/ Z4 >'!;B&T(&KRX2$UK[:)@40V#LUDR*42Q++J@UQM/Y"DOTX8J;5%E;
MS=YAPUY!]I\D)%K7SM0WB#RF>_CZ =W#%F#CA-"D!2.G2;3I"VBM^A3?0P&2
MY(<,E@ -MEQ0@_5:4@S138)N51%&WH)^SY8JT$69UN\LJL,?$]#/>J0IL]=!
M'"TXZR4,N=@9)P4&_#S?=B%'+@L.8S8Q)LJRR14KV5ZE+\)MXKSO%<%?SG?T
MQO<=_8 KMJ$+=9-J(UJ1=TY6*^+=Q B@54CE$S%[7G5AIX)-JQ(/?XXMWE(<
MK:8R%$EGXORK<"_>L!#8D:X%(TL(WPQC\RA22K;/6:;JU]$Z4OP[G*#745M!
M=YZD>=VO"/=$Y&DTL0@@Y.?,Y@@,L1V#,0H51="W>U0B,JK80+Q]B<B(*.E'
MYMW:7M1@P1NH4HI49T(7.B77+*$>B0,B\-:B4EEB9R];QFXVM[NA@>E8[+:^
M-;N?M]X@?66W?4PK-)F]8.@(-EE"\COZ*/P(.#(LQBK$Y!R*M&7843S(U5=-
M\ Q5&(P5JQ6AK(/RB_$0*E+47 +=9_,<3H:C13!6R\Q)4,%HEE$9"#8Q0-QK
MU!DNY)N?]D(.MPE+8"\C##5<#EOV3@8C?DI=R6%82G$!*]#+B,E7,-JAUG+.
M0!W9<1H=9XSM:'_A!(I)JC"5PF6*$]JI-,7K)#$!M[J22Q>P$KIHF77I66O4
M"8]=,&$B8'.F(I7"92#]UKBL^,HR<I5.-$BX25P W',D/9C]#F\A\<D7U:>]
M!ZS<H2:P[@D 03NOI?1":=8B,ZM.83"XIAS14'^M5 WN</\L;M 5MRNGQ RB
M;"(9/=W(;W0C1ZL#NIE%6=^"%V@#0ASB8!BH7&X;<CAR#2<VE+H\=PD'O_L5
M<?QD>7@.U5@!GG^?9T5.X,+M0'<0D9I90G%# -;1BP#V4DL4/3(*F "!MF_>
M'M#O@1Q/$1U/$1UWN\4A\U42=])<<MZL_%:CA3<Z"OP+O-7<]ETD*_R"M?$H
M2^0]@',WYT0=2)3@2'VE^P6#_JST5V]7N?UZT<A&/BHV*X-:D>%>7TXU'5<(
MOW&\I(GY[P8. B@QF@(!;(#""!(!2.JHXR21">5DTM(PN$U6,+;@504Q+T]C
MB#7;.*FK]&9GF<Z=>.7!##\4,[V4BE%[T'K(*E8ZD2<R-=,NP"YVID#Z6G)+
M_3@D5C1L.*!L&;T%L@H%@,/--F-.@P&903:2 P!"D?A!!,04UI\4Y= ML8(\
MK#,..=L-\<88\Z58OE(4H@@GX&2HJIM'K$G*1KV31I6@EJ9A@!C@ N*Q]68?
M" RP#.=MJ=.(KW%R&>EPXE15%UN[R_&4-2@P$6Y69#E=@Q%'>0*^@.YN0)2H
MK+Q,-!9D\]==)F*CYP=E2C23-3@%KIK;[#PXC8#N@<LRXD@4,IN'F!K$J5 8
MQLOR\\BDHV*&]PR-!*-(&?%22U -;!ZE6K)">R=Z6GJ=RU5FB=L4#I/8.JHD
M#?[-R[%;Y6(VU6L;)II#9C 7U04Z:YO"1R,X[*'0&B0;(A<:],1M'=G3+_,J
M0 *7Q#9"!S[5[=V@69'<EWE:MHP+C<HSE;#SVO1A0<*DZ!$YQ4R3+K&HHIP-
M<*&,?[=L-M'"$?GG2726?8DP\EIKWN/QRK]Y0!Z$LS3)M0NV'Z08D]W7&,W*
M%_?$"X.%9WH:"0%\VJBCX2DR<E.1D=?F_94%/7Y:['CQNKQ0%C\.CW8/7VT,
M1<S]01':4:'_]S.YKSD>@RI'4H$PRTUBJG5SH8.+2T<DZ43%-D1JQ':7B(RG
M]@-+I,"!6>Q!4;5\="F8^)9W@;'Z&]V&E[O[SS=W&YZNPQVN0RN)QQCA1>;I
M3HQ:H]HT<Z]>BE466Y!7IJB=<?R-5=+1R:Q3$#=C'8%P[]8B5E05&M3N+T U
M\3/6Y@4HZR-\>:)!\283 .IA3E'*42+RW!CPUP5+0%3"ZD)'R9Q<) U^%/2B
M4GAB\]+(WV4/LD:I\350AU#T#GZW,TTNZZ8#,1,O4S#T4[)A!!XAU7.J\7$S
M\8(DJGE09#HI=ZA,&+AQ,E9++C '@6N+F#2DW$KT53))PJ!>9P'!5?CKQYCG
M#="DU[NO#S9(DYZ(TAV)4H1Q9W#90#M!Q]C]H4?B8D.@R'.*)C7,9!U-X<6&
MGV(B 1=,D\CXZ/'V1M5U=*M;CLZE*PK98#<1WS:/!+%Y$*U"6$IK-HPX?(#<
MG[D4I.*B<[< WX^4\@C$BK(PETGZE=(+G)<JOTRH1E)6]2C=/E-G*2=J/3V2
M4DWUN!\QS%B88%_F+E&'"E14\T+A8&U2-#PP-1G9>_&$_I4,K4&5;!U(HCDT
MH^%O@AJ)_;5BQ%O'7QOBR\6 #0E<FU%ZN/4TN#1O'4]Q6C9#>D6<T.&77S?%
M[IJ4DDQ+Q0Z3^P9/9&\9T'7R FHT98>EM=FO:%19G\]$W*;;O:/'J5X/&^EA
M:'W%2>OY-*4"4&J4%^3W%R<U6KTNC";>-],S( YQ6,PHF%;ZH&0DZBI#):'(
M$.;#0,$PE:$5&LDX]@X6,],ZYTJ&N06V/L0E (WIO$5&V?44QCN*$.K-\*U-
M:I873VSKK[&MKD?J[QGO6LF. EM[3\<3->&H522Y0PS7H5 (2D'T?D4.HU*L
M"T%/>ERH81D,41DF:Z[Z%RFS$D>[S.8?CUWOOB4J7H?8/5NGIL<UWR33%VB\
MI"Y@? B,1YZ!.*@:E.^CA@FLL1.STJ(B<EX A+QNB:>TA<)9!<NT38SRF2$%
MR]EBNSGYC5&P@*>&(-M9T8/R?9W'AS(@;_9HW5[\:5"B9Q*Y IY2LS/+G=8U
MDKH7XI1$<6-+<W:[7:Q$NM4USJJOV0'*W!PV:]MGC]]L4$P_F\#F<R;/&)7;
MN&3"-5F2 PAM4O4Z9+NU*EVK)T27@%+/Y9S'JR2J:H'%M3",BY1$?ELR5,JG
M9DO5''UI!-/X1-B1M!W%(FX]1.&V*RP#"+41<*J6$C9^8 DA_JLF&J,K/(DG
MXP*KU^4U7":V,F;5)D/Q-KC4J7:6RHH5H!(EH5PU<=B%&>=78A45$U\DT84.
MMTG\98F.$H9SV6#6;4R>I&X+GF+-?JI8,Z\JP8_F$]YELMJZ;^W"VW(S:B]5
MQNJ,&U6U&)0BDU;HU)J:$JF-1"4%5H).L%(UJOQ4D[CD-+7JNU769:DIF0<*
MJFW+FA-F.##,CJSS$TQGU]/7TI@A? @4V)2+1HKR3,S0IE.'ULR0.79A-WMK
M+>GR\ZQ*FZ>4PF#39\/6_:Z$M7I9TQB)@LH@^E'6U;KU7UV=UDT;7$G;7,K3
M+#/"$AN;@MW*KBCS9H9!,FEI1:40$Y.YM!H;XR'YU8]&*A[='ZGX9F_W:<+5
MIZ4/! MMK2(#;H'<#]/C"S38P(>'*>R2#AARN7;,$@9!*.*P+B$.DKM09-?:
MNI"Y7VI,_V?"HBV)J@O %) EU6K-TLY*<%*>.IM1M#K$\CI9^<ZS@BI+\A8F
MG0 6Q,G,C (57L 8JHS3NUGJDGA.3,X V05#7U,GNY">O$ZS6 6R5X2;?#$^
M/2*S[3I29-AZ)KI:O0(G]C1)6=AL^-;<U=P(5T1EJ#S#ZFUY$;XW-;-,1V-K
M9\6_[?Z5;!;3X*SMT OWC>![(IS<5'DMYL$6(3@A]G+*F7_F6!J?&1Q]Z2KD
MWX+_T/>^Q(V?OQK*ZBD#ZDHKBNLCX.$8+ 1#DD?X(!HS';WP[.PF)].I6HWO
M4S.7J[3"@I*);T_P^(:K@T.Y$B)HSL4$9DNTR'7@P-O"#IQ\$7#WQ1+G"*!7
MW1_EFQNQY]O),B@FCZ98;=4SVGO^1U%[':2KJ8"[4K>]2F5EA;(LO70"L%+%
MW065AR>:K"]KX<P=:U#%VT'1B%F]I>PXDSEH5R&Y,_+C),)^:&,JC3,(,3"N
M.$U4:!W]J@@-D?<MKE>#7JA(<]0PIAEB: "Z(51H$GYSI#(\1@D/(.$UH>:S
MI6V3+EVL+[.YFLO-F:F)^C<2BFV[RPR&7Q2$?>.(9BM7)&D.,PRF]AP;**?-
M-0EKW(4APLKOD<ZS,H[_?EG&L0>ZM'H-SD^/V[W^H'EZW \&GYH#^*?3#\Z:
MO28\<?8I@ ^GW4'0@8?AR>-@T W@V>"XV^8?SGK=3YWW'7RO';2ZI\?GK4%P
MW.ZW>IWW[>-&\/Z<GOFC ]\%'[H]?JYYVFJ?G#2QN2$VN</OI#DIC-T,>NW!
M>>\4Y^)1J4^[?;#_J=F#L62HC[UN'R!O_J/Y_J2-,[7:[>-^[=G.A\!?<_]3
M]_SD.&A]ZG;[;9SECT[W!!MITMKE?IQV:=&]#^U>&Z -OG0&GX+6>7_0_0P;
MAM/WS\_.3CKPP=X@6F<?UW1\WNN<?J1)5W9TQ-=QP [\==HF&OMGN]D+FA]@
M1H:\/1B<4.._ 'M\/IZ2@>']T3EN[N65!'T6'FIU:_7&:^-O5L=H/"D9W 3@
M2<OX#EJ&".RVW(;GJ/$\JE(VH)Z/WY"B1.N.S-L!+T %'3D\J0YE@E5^HCOL
MSHJ4JMO,<(= G(J&X)J \1SKU0/?(W9/5 6!^4E1^+:*PI-L^O!DT]/NZ4Z_
M>])I=08.P/;GLY/NGVT8Z@')GT^^OX?J^[LWBL)&^Y7=U3G1B?]5Q"Q1(H/H
M$F-INN2''J9YCS>L,KQ?V Y"90DWJQEP2$?92W<EB\JYDE%-K!VY"%46;NN-
M C@F 8/:V$#D>3Z];]>("#@C^WSK=D5R^(AE-W$_U]RH]\>+"MLZ S&B\$)J
M[+M#J>6\O#\HW?*7MNX$%=[ \XJIS72#&CR!3,WU<S5-T,#.9!CU9WWH\013
M9]1,X1&Y"A98N!#K%B@1;!$D>$_GV(^8P.4>5O2\CC']GO^6\K8VJX>*87"V
M#]8#T+&5D=:5SO#KVYOJO9$:?V4O'RZ0,&8MR]8K=9M#P?:H^13E3HE.YO?C
MXLI=%/6"V?<(N[N9"MMR7$J-;JY?MM1A'A<,$!%-984#7FE('7 2#"MR_G+)
M8#'W2^!21I%+SK[XADKL8(L-3W:UM8!AEF%J*/K;JZ;"X4NVCN1895-CVY(M
MYE(3,ALE<XD97[7%;@/*#:Z$3=3[@$@>AI1[6*Y\+.^S,H\5Y& 5B'FK*[#P
M0GD9;HD-0+_0C!?5I=J=N+73B*1CVGT+-SZ,#4'T1$52I,[:G5<AG&"+BZ_W
M)Q;\<2AL,[!<>4JWQ.4DL/*I.;4NE#J #>G'4"L!6#=#7+=DAF(Y:80L Q<Z
MY:M"]J*1F<.[F:MYZ-6(9Z2.7)N\<0$:3Y:ON06R\LKKC\>*.;X_PLGA[L$-
MPLD9VB)R/+2>*Q2+I.#8F?PVWBUXF=C %9D4B@OBW9;6+#]J$38KBQ A>2@+
MYH*FD1E$WPN3>+;'L4:#:F1Y0ZHG1>1\W C>!.\5%?[%I)>)COD"5[XF*L$6
MJ9GZ:AQ++DVM-IPYI5HZ&,;M;M9:"+ALF>V-U; R%UHYL),W5?'DGMZVJ!*'
M?,9A96*<TZM)S&[IZFU>W0W*%;!O!%8RJU:G,>5F>Z*3+YQQ3=52$+-$JFK*
M<S8@!5IA&NO%SB@R?*CFP@ UUQ)B0#]26IQ-A0BJXEF9 5?)&+;U43DZT!;X
MP4U9IK]NB-84V>4)\I*@2R4D4VG(42)5XI\QBI)R_3Q>6 8QC[>K?%\:A1*&
MUZ0+9]M9TRUHQ-'+:(W"@JO&EJ$$?B%Y;@P!-CYE:<#'LG$)MK0G\/9*9'IO
M69<D3H72C067SE(4=9^?\ 3(3C1FL+C;A<L@1N-U1[!@EUWH=X.SB&IK9EJO
M/H5U,OT9\U)<BPT Y_I8WS>L[UZ50P*U_[YPIQ??.-F%/Y%D=YK$.WZP0ME1
M\B&ZYIX\<T^>N>_GF6.9QS;:ME:,]6XX91.$$JR_SURNX2IU-TC@R;G>)[ K
MQ27JG,[6L$+2NA3-0%*7U/HG.%?;!?]A_T@,(,S,V#A/#LH]-I,%$\ZEXSCN
MO'NQHL65&T^)1MY&2%K0>H :93?2)<L&LV^+'!G98P#IK$"!E4I3KL/H>JU3
MT_&J&<A%1CJT%*/,VCU:RA?WY0AF]-9>)>C%W0\8?^H9_*LS1.]%_H3=X.J:
M;D(ROTA\AE##8K-HX<EC:%TT\9/C\<GQ^+]P/-I!/_2ZGX,>OD"^N7Z[]T>G
M!2_@R^B=_'""OCGXI=O[V#SM_#<Y^!Z(DY*7%?3/6Y_*A=W1"?E-') _@W1^
M\("D<^!E')C2+5/L?JXN[4^>ZB=/]6,J&HL2&H@+EO5_,#&(&*!$;OA:=ZHM
M":6NEB_'D/ BR?'^"L9V!:[_%YJ4DI2"^;T^8#I-$R[T3W76IUYKTK)M*8?(
M3K"6-O4 :JS7"D%W*T*NV!5%F)\_ ST]B<G\>$GI1+Z'E71IRD/ J$;2 *R@
M%FOQA5*)<Y*E_"7::NH92F+BRJK(;.RF19?XA$ ,_?X)(F,Z 7YI^-*G6XJM
M:\?AREU>47INV.,T6QDX7#Z450+]S;(K_K\33+WPA+\FIGH#H#/9)$46>046
MKQ&+/4_X+7?J]CL3;.'O$K^YBN%ZP9R#):W3<\1KM )QPZE@U3@4%FO]H+9$
MD?4#W]@X;,AM%[#VB=,DU2PI8LGI8VTK*V9P.I?+;;*J942^#\%\2>+,S11S
MB<OGR?SMSA&]3=E0(Q4);\139+KYZR]O#MX=P+]'M^S)]!-X.1]2U:16I"Z'
M:O15/ ";Y69-M/!F7J<,;#CKB 7<A3/KB\<*>UBX!=UQ0@-:X@USJ28V_V@+
MS7)8\UV[\D-UOXBX/WI4T8=R=>VV #WKN'Y^+:]#'U-FF9O?MQ2'H/(=-7:P
M%4UV;7"Y,Q#S4,PQ9IPDR"8NJ@:9T/^R56,I5(:#)'@I]>@+%29H.;1]Y$I*
M<YR$X<X'V.*OP1<D<_T\U3J'K:#>/#A/BWH+P]!>R:SF**_$@=3]G\@>\#P6
MEH'0T;JC+./3_$4P<2RW2Y:RU*L8MR86F4>:DZ08\T+6. ]%5ABE;$MF/WD
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MN:]D^25Z*I>I41M-!KC&M+0>8Y_".!]J&.<#)RV3^T-:;E1#.I7+M&F&5EI
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MC^OWM',_=N>^QUOWW2RT-TS"!?S/-)]%O_]_4$L! A0#%     @ HH5A55D
M@XQA:0$ %-<1 !               ( !     &-L>"TR,#(R,#DS,"YH=&U0
M2P$"% ,4    " "BA6%5:L25CE\-  !;@@  $               @ &/:0$
M8VQX+3(P,C(P.3,P+GAS9%!+ 0(4 Q0    ( **%854L&=9;ZAD   3O   4
M              "  1QW 0!C;'@M,C R,C Y,S!?8V%L+GAM;%!+ 0(4 Q0
M   ( **%854W8A6H\CL  +&* @ 4              "  3B1 0!C;'@M,C R
M,C Y,S!?9&5F+GAM;%!+ 0(4 Q0    ( **%857;AL6#YC<  )HZ   3
M          "  5S- 0!C;'@M,C R,C Y,S!?9S$N:G!G4$L! A0#%     @
MHH5A50.$.Y.+J   D;4& !0              ( !<P4" &-L>"TR,#(R,#DS
M,%]L86(N>&UL4$L! A0#%     @ HH5A5<8#P2>P9P  D'T$ !0
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M)0, 8VQX<3%F>3(S97@S,F-E;V-F;V-E<G1I9FDN:'1M4$L! A0#%     @
MHH5A554P.L4=,   [24! !<              ( !]RH# &-L>'$Q9GDR,V5X
M:&EB:70Q,#$N:'1M4$L! A0#%     @ HH5A516.>LJ+.@  9VT! !<
M         ( !25L# &-L>'$Q9GDR,V5X:&EB:70Q,#(N:'1M4$L! A0#%
M  @ HH5A58G7 D90,   #Q<! !<              ( !"98# &-L>'$Q9GDR
M,V5X:&EB:70Q,#,N:'1M4$L! A0#%     @ HH5A5:H=,3TR+@  9 \! !<
M             ( !CL8# &-L>'$Q9GDR,V5X:&EB:70Q,#0N:'1M4$L%!@
0   .  X O0,  /7T P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
